Term,NES,FDR q-val,Perturbation
METABOLISM_OF_RNA,3.64358823,0,flutamide
RRNA_PROCESSING,3.436637185,0,flutamide
TELOMERE_MAINTENANCE,2.515692989,0.000866849,flutamide
TRANSLATION,2.402031133,0.001300274,flutamide
EXTENSION_OF_TELOMERES,2.335771521,0.002600547,flutamide
MITOTIC_G2_G2_M_PHASES,2.317576529,0.002600547,flutamide
MRNA_SPLICING,2.193619932,0.007058628,flutamide
DNA_REPLICATION,2.102859452,0.010402188,flutamide
RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES,2.090884919,0.010980087,flutamide
RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES,2.057733118,0.012222571,flutamide
GPCR_LIGAND_BINDING,-2.238474106,0.08042667,lonidamine
MUSCLE_CONTRACTION,1.931232429,0.56417021,lonidamine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,1.870612729,0.446351532,lonidamine
EUKARYOTIC_TRANSLATION_INITIATION,1.841015385,0.365917626,lonidamine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.876982372,0.583967559,lonidamine
P75_NTR_RECEPTOR_MEDIATED_SIGNALLING,1.794475296,0.391124026,lonidamine
NEDDYLATION,1.783754455,0.333744064,lonidamine
SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES,1.782850253,0.280385797,lonidamine
SELENOAMINO_ACID_METABOLISM,1.756994007,0.283379816,lonidamine
REGULATION_OF_PLK1_ACTIVITY_AT_G2_M_TRANSITION,1.756024838,0.250223083,lonidamine
CELLULAR_RESPONSE_TO_STARVATION,3.196896288,0,TG-101348
CELL_CYCLE_CHECKPOINTS,-2.52080127,0,TG-101348
S_PHASE,-2.632516553,0,TG-101348
DNA_REPLICATION,-2.735307725,0,TG-101348
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.740489956,0,TG-101348
CELL_CYCLE,-2.754601406,0,TG-101348
CELL_CYCLE_MITOTIC,-2.822460212,0,TG-101348
SYNTHESIS_OF_DNA,-2.685219873,0,TG-101348
DNA_STRAND_ELONGATION,-2.830580326,0,TG-101348
EUKARYOTIC_TRANSLATION_ELONGATION,2.969256869,0,TG-101348
GPCR_LIGAND_BINDING,-2.56236835,0.000742744,MLN-8054
SIGNALING_BY_GPCR,-2.359084384,0.004827837,MLN-8054
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.109600466,0.033423485,MLN-8054
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,-1.979636427,0.072046179,MLN-8054
MITF_M_DEPENDENT_GENE_EXPRESSION,-1.967683255,0.062687603,MLN-8054
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.940993101,0.061895343,MLN-8054
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,1.984196008,0.948944477,MLN-8054
RESPIRATORY_ELECTRON_TRANSPORT,1.983658925,0.477050892,MLN-8054
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-1.919669771,0.061223336,MLN-8054
DEVELOPMENTAL_CELL_LINEAGES,-1.848440453,0.089500666,MLN-8054
TRANSLATION,3.346966389,0,sparfosic-acid
RRNA_PROCESSING,2.999200045,0,sparfosic-acid
RESPIRATORY_ELECTRON_TRANSPORT,2.763079012,0.002637674,sparfosic-acid
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,2.623855648,0.001978255,sparfosic-acid
MITOCHONDRIAL_TRANSLATION,2.481237741,0.004220278,sparfosic-acid
METABOLISM_OF_RNA,2.475764548,0.003516898,sparfosic-acid
G1_S_DNA_DAMAGE_CHECKPOINTS,2.441939799,0.004144916,sparfosic-acid
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.438570639,0.003626801,sparfosic-acid
HOST_INTERACTIONS_OF_HIV_FACTORS,2.266698076,0.008499171,sparfosic-acid
S_PHASE,2.24540036,0.007649254,sparfosic-acid
TCR_SIGNALING,2.240278483,0.030798845,losartan
DOWNSTREAM_TCR_SIGNALING,1.970190631,0.193085067,losartan
NONSENSE_MEDIATED_DECAY_NMD,1.863492585,0.29890674,losartan
MYD88_INDEPENDENT_TLR4_CASCADE,1.836977041,0.275116606,losartan
REGULATION_OF_TP53_ACTIVITY,1.828344084,0.239520249,losartan
INTEGRIN_CELL_SURFACE_INTERACTIONS,-1.828351291,1,losartan
NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION,1.781289753,0.285086745,losartan
SENSORY_PERCEPTION,-1.749764341,0.828937767,losartan
SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES,1.703384974,0.41510751,losartan
METABOLISM_OF_VITAMINS_AND_COFACTORS,-1.701965278,0.712491747,losartan
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,-2.902228067,0,pazopanib
MRNA_SPLICING,-2.817764399,0,pazopanib
CHROMATIN_ORGANIZATION,-2.780414462,0,pazopanib
GPCR_LIGAND_BINDING,2.701736714,0,pazopanib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.655919075,0,pazopanib
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.620208912,0,pazopanib
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.321712807,0.000485696,pazopanib
METABOLISM_OF_RNA,-2.386514214,0.00167578,pazopanib
SIGNALING_BY_GPCR,2.222046901,0.001457087,pazopanib
POTASSIUM_CHANNELS,2.095076393,0.008451103,pazopanib
RESPIRATORY_ELECTRON_TRANSPORT,3.370613151,0,AR-C133057XX
TRANSLATION,3.292926302,0,AR-C133057XX
EUKARYOTIC_TRANSLATION_INITIATION,2.815863542,0,AR-C133057XX
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.770254838,0,AR-C133057XX
METABOLISM_OF_RNA,2.714866646,0.000920817,AR-C133057XX
EUKARYOTIC_TRANSLATION_ELONGATION,2.71268363,0.000767348,AR-C133057XX
RRNA_PROCESSING,2.686323985,0.001315453,AR-C133057XX
HOST_INTERACTIONS_OF_HIV_FACTORS,2.585351143,0.001151021,AR-C133057XX
INFLUENZA_INFECTION,2.477247418,0.002302043,AR-C133057XX
S_PHASE,2.412523242,0.002762451,AR-C133057XX
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,3.513478872,0,capsaicin
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,2.447103634,0.003977273,capsaicin
MRNA_SPLICING,2.441871705,0.002651515,capsaicin
MHC_CLASS_II_ANTIGEN_PRESENTATION,2.235814386,0.007954545,capsaicin
INFLUENZA_INFECTION,2.092931902,0.015909091,capsaicin
SEMAPHORIN_INTERACTIONS,1.731572867,0.114015152,capsaicin
HCMV_INFECTION,1.661734232,0.139772727,capsaicin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.833697736,0.158208955,capsaicin
GPCR_LIGAND_BINDING,-1.809193326,0.10261194,capsaicin
PI3K_AKT_SIGNALING_IN_CANCER,-1.802566713,0.072139303,capsaicin
MHC_CLASS_II_ANTIGEN_PRESENTATION,2.860571908,0,lenalidomide
INFLUENZA_INFECTION,2.843747421,0,lenalidomide
TRANSLATION,2.760811714,0,lenalidomide
EUKARYOTIC_TRANSLATION_INITIATION,2.580175713,0.003921278,lenalidomide
SELENOAMINO_ACID_METABOLISM,2.523803854,0.004705534,lenalidomide
EUKARYOTIC_TRANSLATION_ELONGATION,2.518033627,0.003921278,lenalidomide
RRNA_PROCESSING,2.510855742,0.003361096,lenalidomide
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.453374568,0.006862237,lenalidomide
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.381081059,0.006971162,lenalidomide
GPCR_LIGAND_BINDING,-2.225785042,0.003818482,lenalidomide
EUKARYOTIC_TRANSLATION_INITIATION,2.723899022,0,valdecoxib
RESPIRATORY_ELECTRON_TRANSPORT,2.711699522,0,valdecoxib
EUKARYOTIC_TRANSLATION_ELONGATION,2.678036077,0,valdecoxib
SELENOAMINO_ACID_METABOLISM,2.476540528,0.003813763,valdecoxib
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.40079379,0.005666162,valdecoxib
MUSCLE_CONTRACTION,2.259711639,0.013802189,valdecoxib
STRIATED_MUSCLE_CONTRACTION,2.253635621,0.012141775,valdecoxib
INFLUENZA_INFECTION,2.2028055,0.013892993,valdecoxib
TRANSCRIPTIONAL_REGULATION_BY_RUNX2,2.196278929,0.012349327,valdecoxib
TRANSLATION,2.190952041,0.011550253,valdecoxib
TRANSLATION,2.807140936,0,7-nitroindazole
RRNA_PROCESSING,2.584064383,0.000985662,7-nitroindazole
HOST_INTERACTIONS_OF_HIV_FACTORS,2.570665592,0.000657108,7-nitroindazole
METABOLISM_OF_RNA,2.568868575,0.000492831,7-nitroindazole
DNA_REPLICATION,2.438404701,0.006702499,7-nitroindazole
CELL_CYCLE_MITOTIC,2.396494327,0.006242523,7-nitroindazole
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.354009057,0.006758822,7-nitroindazole
PCP_CE_PATHWAY,2.345268783,0.0064068,7-nitroindazole
REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS,2.327019016,0.007228185,7-nitroindazole
APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1,2.305453032,0.006451603,7-nitroindazole
METABOLISM_OF_RNA,3.116195313,0,promethazine
HOST_INTERACTIONS_OF_HIV_FACTORS,3.000504788,0,promethazine
REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS,2.909201724,0,promethazine
TRANSLATION,2.790519276,0,promethazine
RRNA_PROCESSING,2.70552915,0,promethazine
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,2.566002625,0.001647599,promethazine
UCH_PROTEINASES,2.550463638,0.001412227,promethazine
RESPIRATORY_ELECTRON_TRANSPORT,2.528139909,0.001853548,promethazine
THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT,2.491421045,0.001647599,promethazine
MRNA_SPLICING,2.413267546,0.001977118,promethazine
GPCR_LIGAND_BINDING,2.880610303,0,olaparib
MITOTIC_METAPHASE_AND_ANAPHASE,-2.875803476,0,olaparib
CELL_CYCLE_CHECKPOINTS,-2.680664779,0,olaparib
CELL_CYCLE,-2.643745754,0,olaparib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.583336405,0,olaparib
M_PHASE,-2.546243853,0,olaparib
SEPARATION_OF_SISTER_CHROMATIDS,-2.504231868,0.000351396,olaparib
G2_M_CHECKPOINTS,-2.4246547,0.000585659,olaparib
RESOLUTION_OF_SISTER_CHROMATID_COHESION,-2.357101617,0.000658867,olaparib
MITOTIC_PROMETAPHASE,-2.358670318,0.000752991,olaparib
CELL_CELL_JUNCTION_ORGANIZATION,2.029162313,0.179334196,carbimazole
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-1.990423829,0.393227744,carbimazole
CELL_CELL_COMMUNICATION,1.829355136,0.379281518,carbimazole
ECM_PROTEOGLYCANS,-1.870522393,0.487621967,carbimazole
CELL_JUNCTION_ORGANIZATION,1.775930407,0.37137982,carbimazole
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.773217198,0.282915154,carbimazole
CELLULAR_RESPONSE_TO_STARVATION,1.77136059,0.230248617,carbimazole
INTERFERON_ALPHA_BETA_SIGNALING,-1.836883929,0.402031351,carbimazole
REGULATION_OF_T_CELL_ACTIVATION_BY_CD28_FAMILY,1.710270483,0.277933649,carbimazole
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.669963971,0.312583332,carbimazole
METABOLISM_OF_RNA,4.302061784,0,rosiglitazone
RRNA_PROCESSING,3.55186718,0,rosiglitazone
MRNA_SPLICING,3.418631861,0,rosiglitazone
EUKARYOTIC_TRANSLATION_INITIATION,3.235502644,0,rosiglitazone
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,3.047755963,0,rosiglitazone
INFLUENZA_INFECTION,2.821090061,0,rosiglitazone
UB_SPECIFIC_PROCESSING_PROTEASES,2.663598693,0,rosiglitazone
TRANSLATION,2.659481731,0,rosiglitazone
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,2.40068844,0.000715927,rosiglitazone
CELLULAR_RESPONSES_TO_STIMULI,2.389851047,0.000966502,rosiglitazone
GPCR_LIGAND_BINDING,2.703127377,0,AZD-7545
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.643288349,0,AZD-7545
SIGNALING_BY_GPCR,2.305567617,0.003742688,AZD-7545
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,-2.385498996,0.051695534,AZD-7545
GASTRULATION,2.188222318,0.011602334,AZD-7545
POTASSIUM_CHANNELS,2.150105323,0.013024555,AZD-7545
G_ALPHA_I_SIGNALLING_EVENTS,2.085511298,0.017715391,AZD-7545
CYTOPROTECTION_BY_HMOX1,2.036243522,0.024380941,AZD-7545
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.957233005,0.042385944,AZD-7545
NEURONAL_SYSTEM,1.864128441,0.075103278,AZD-7545
METABOLISM_OF_RNA,3.116813945,0,progesterone
HOST_INTERACTIONS_OF_HIV_FACTORS,2.725823086,0,progesterone
S_PHASE,2.682785469,0,progesterone
SEPARATION_OF_SISTER_CHROMATIDS,2.675589629,0,progesterone
MITOTIC_G2_G2_M_PHASES,2.591045174,0,progesterone
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,2.584327389,0,progesterone
SYNTHESIS_OF_DNA,2.471125218,0.000188617,progesterone
RRNA_PROCESSING,2.48524811,0.000209575,progesterone
DNA_REPLICATION,2.517043214,0.000269453,progesterone
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,2.50621828,0.000235771,progesterone
NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_NLR_SIGNALING_PATHWAYS,2.648210239,0,tosedostat
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.337601138,0.011638417,tosedostat
DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA,2.266754754,0.020505782,tosedostat
INTERFERON_ALPHA_BETA_SIGNALING,2.240979379,0.019535914,tosedostat
GAP_JUNCTION_TRAFFICKING_AND_REGULATION,-2.14023469,0.041186379,tosedostat
MYD88_INDEPENDENT_TLR4_CASCADE,2.221855625,0.018953993,tosedostat
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.212487115,0.016072099,tosedostat
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,2.168668321,0.018288941,tosedostat
NUCLEAR_EVENTS_MEDIATED_BY_NFE2L2,2.16647685,0.016210652,tosedostat
INTERLEUKIN_1_FAMILY_SIGNALING,2.091362129,0.02918841,tosedostat
MUSCLE_CONTRACTION,2.126663748,0.077690533,PX-12
ANTIGEN_PROCESSING_CROSS_PRESENTATION,2.104561853,0.046182706,PX-12
SENSORY_PERCEPTION,-1.854145911,0.869206106,PX-12
SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX,-1.843021125,0.476219588,PX-12
METABOLISM_OF_STEROIDS,-1.821008853,0.379641131,PX-12
SIGNALING_BY_TGFB_FAMILY_MEMBERS,-1.816253261,0.296056867,PX-12
VISUAL_PHOTOTRANSDUCTION,-1.796787993,0.275195921,PX-12
HOST_INTERACTIONS_OF_HIV_FACTORS,1.655557218,0.439383124,PX-12
METABOLISM_OF_VITAMINS_AND_COFACTORS,-1.718551945,0.408439071,PX-12
CHROMATIN_ORGANIZATION,-1.67258159,0.491421287,PX-12
MUSCLE_CONTRACTION,2.688069587,0,carbamazepine
GPCR_LIGAND_BINDING,2.271539955,0.008912274,carbamazepine
CARDIAC_CONDUCTION,2.226705717,0.009619597,carbamazepine
METABOLISM_OF_STEROIDS,-2.360250678,0.08852094,carbamazepine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.09594221,0.023341669,carbamazepine
NEURONAL_SYSTEM,2.044130991,0.029198306,carbamazepine
G_ALPHA_I_SIGNALLING_EVENTS,1.923871885,0.063659098,carbamazepine
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.905015442,0.062446543,carbamazepine
REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF,-2.067661918,0.368438507,carbamazepine
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,1.880834317,0.065038378,carbamazepine
CELL_CYCLE,-3.338732755,0,selumetinib
MITOTIC_PROMETAPHASE,-2.510443751,0,selumetinib
ORC1_REMOVAL_FROM_CHROMATIN,-2.537559244,0,selumetinib
MITOTIC_SPINDLE_CHECKPOINT,-2.604069207,0,selumetinib
MITOTIC_METAPHASE_AND_ANAPHASE,-2.626715244,0,selumetinib
G1_S_SPECIFIC_TRANSCRIPTION,-2.642852498,0,selumetinib
DISEASES_OF_METABOLISM,2.67043804,0,selumetinib
CHROMOSOME_MAINTENANCE,-2.691290205,0,selumetinib
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,-2.717359138,0,selumetinib
REGULATION_OF_TP53_ACTIVITY,-2.727300317,0,selumetinib
TRANSLATION,3.338423541,0,batimastat
RRNA_PROCESSING,3.275890514,0,batimastat
EUKARYOTIC_TRANSLATION_INITIATION,3.169592589,0,batimastat
METABOLISM_OF_RNA,2.981182144,0,batimastat
HOST_INTERACTIONS_OF_HIV_FACTORS,2.482460209,0.002773281,batimastat
RESPIRATORY_ELECTRON_TRANSPORT,2.407384837,0.003301524,batimastat
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.364787612,0.004527805,batimastat
NUCLEAR_EVENTS_MEDIATED_BY_NFE2L2,2.320992434,0.005199901,batimastat
DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR,2.263344259,0.007043252,batimastat
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,2.238445538,0.006933201,batimastat
EUKARYOTIC_TRANSLATION_INITIATION,4.489962331,0,ASN-05257430
SARS_COV_1_INFECTION,2.9638377,0,ASN-05257430
INFECTIOUS_DISEASE,3.235247897,0,ASN-05257430
SARS_COV_1_HOST_INTERACTIONS,3.272861387,0,ASN-05257430
NERVOUS_SYSTEM_DEVELOPMENT,3.308705576,0,ASN-05257430
VIRAL_INFECTION_PATHWAYS,3.498424835,0,ASN-05257430
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,3.530756443,0,ASN-05257430
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,3.54582895,0,ASN-05257430
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,3.587954056,0,ASN-05257430
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.603758246,0,ASN-05257430
METABOLISM_OF_RNA,4.705203951,0,phenacetin
CELL_CYCLE_MITOTIC,2.758579741,0,phenacetin
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,2.742902094,0,phenacetin
CELL_CYCLE,2.742386242,0,phenacetin
DOWNSTREAM_TCR_SIGNALING,2.73904266,0,phenacetin
APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1,2.728745419,0,phenacetin
THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT,2.714202782,0,phenacetin
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.702497136,0,phenacetin
DEGRADATION_OF_AXIN,2.699386187,0,phenacetin
AUF1_HNRNP_D0_BINDS_AND_DESTABILIZES_MRNA,2.6982335,0,phenacetin
RRNA_PROCESSING,3.38780644,0,BRD-K31342827
TRANSLATION,2.694279209,0,BRD-K31342827
CELLULAR_RESPONSE_TO_STARVATION,2.514060632,0.002894576,BRD-K31342827
METABOLISM_OF_STEROIDS,2.478562834,0.005427331,BRD-K31342827
REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF,2.32909947,0.006512797,BRD-K31342827
ACTIVATION_OF_GENE_EXPRESSION_BY_SREBF_SREBP,2.265288832,0.007598263,BRD-K31342827
METABOLISM_OF_RNA,2.183252419,0.010854662,BRD-K31342827
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.160693716,0.035995846,BRD-K31342827
GPCR_LIGAND_BINDING,-2.159790433,0.017997923,BRD-K31342827
BIOLOGICAL_OXIDATIONS,2.157722778,0.010854662,BRD-K31342827
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,3.010383629,0,curcumin
GPCR_LIGAND_BINDING,2.955014569,0,curcumin
M_PHASE,-2.924574147,0,curcumin
INFLUENZA_INFECTION,-2.881224076,0,curcumin
TRANSLATION,-2.730124225,0,curcumin
METABOLISM_OF_RNA,-2.715700871,0,curcumin
CELL_CYCLE,-2.686917283,0,curcumin
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.632510895,0,curcumin
CELL_CYCLE_MITOTIC,-2.607167483,0,curcumin
MITOTIC_METAPHASE_AND_ANAPHASE,-2.553188245,0,curcumin
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,2.000495024,0.061705087,zileuton
MRNA_SPLICING,1.936680027,0.049135533,zileuton
GLYCOSAMINOGLYCAN_METABOLISM,1.79691456,0.073893747,zileuton
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.731414605,0.08398748,zileuton
G_ALPHA_Q_SIGNALLING_EVENTS,-1.930579623,0.207060236,zileuton
EUKARYOTIC_TRANSLATION_ELONGATION,-1.908564128,0.132236196,zileuton
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.896562368,0.096941838,zileuton
SELENOAMINO_ACID_METABOLISM,-1.882358171,0.082824094,zileuton
GPCR_LIGAND_BINDING,-1.88084869,0.067576931,zileuton
RAB_GEFS_EXCHANGE_GTP_FOR_GDP_ON_RABS,1.571561121,0.162261526,zileuton
EUKARYOTIC_TRANSLATION_INITIATION,-2.349383674,0.002167362,dacarbazine
EUKARYOTIC_TRANSLATION_ELONGATION,-2.324949404,0.002709202,dacarbazine
NONSENSE_MEDIATED_DECAY_NMD,-2.308429439,0.002528589,dacarbazine
RRNA_PROCESSING,-2.287094742,0.002438282,dacarbazine
METABOLISM_OF_RNA,-2.207766615,0.008235975,dacarbazine
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.245089705,0.036034485,dacarbazine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.169518554,0.010114356,dacarbazine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.06810339,0.025389097,dacarbazine
INNATE_IMMUNE_SYSTEM,1.967778899,0.104426468,dacarbazine
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-1.990963809,0.04578552,dacarbazine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,4.833548984,0,gossypol
UNFOLDED_PROTEIN_RESPONSE_UPR,3.092889887,0,gossypol
KEAP1_NFE2L2_PATHWAY,3.086597645,0,gossypol
HH_MUTANTS_ABROGATE_LIGAND_SECRETION,3.075576174,0,gossypol
TRANSCRIPTIONAL_REGULATION_BY_RUNX3,3.072203536,0,gossypol
ASYMMETRIC_LOCALIZATION_OF_PCP_PROTEINS,3.039803151,0,gossypol
PROGRAMMED_CELL_DEATH,3.01911506,0,gossypol
VIF_MEDIATED_DEGRADATION_OF_APOBEC3G,2.984839782,0,gossypol
DEGRADATION_OF_GLI1_BY_THE_PROTEASOME,2.972320447,0,gossypol
NUCLEAR_EVENTS_MEDIATED_BY_NFE2L2,2.969422957,0,gossypol
METABOLISM_OF_RNA,-3.951078487,0,pyrazolanthrone
MRNA_SPLICING,-3.255364121,0,pyrazolanthrone
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-3.183040417,0,pyrazolanthrone
CHROMATIN_ORGANIZATION,-2.91941224,0,pyrazolanthrone
GPCR_LIGAND_BINDING,2.280907244,0.000649923,pyrazolanthrone
HATS_ACETYLATE_HISTONES,-2.542292718,0.001890799,pyrazolanthrone
M_PHASE,-2.533102102,0.002363499,pyrazolanthrone
MITOTIC_METAPHASE_AND_ANAPHASE,-2.383590596,0.002701142,pyrazolanthrone
CELL_CYCLE_CHECKPOINTS,-2.301226921,0.003545249,pyrazolanthrone
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,-2.237609611,0.003151332,pyrazolanthrone
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.75011659,0,ruxolitinib
EUKARYOTIC_TRANSLATION_ELONGATION,2.69879967,0,ruxolitinib
EUKARYOTIC_TRANSLATION_INITIATION,2.68729705,0,ruxolitinib
RRNA_PROCESSING,2.650304189,0,ruxolitinib
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.646664696,0,ruxolitinib
NONSENSE_MEDIATED_DECAY_NMD,2.59232286,0.000229523,ruxolitinib
INFLUENZA_INFECTION,2.45938837,0.000590203,ruxolitinib
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.439117678,0.000516427,ruxolitinib
SIGNALING_BY_ROBO_RECEPTORS,2.352168739,0.001224124,ruxolitinib
SELENOAMINO_ACID_METABOLISM,2.290107629,0.002616565,ruxolitinib
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.518571789,0.003396935,sildenafil
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.318222049,0.01075696,sildenafil
NEUTROPHIL_DEGRANULATION,-2.212972537,0.021891358,sildenafil
REGULATION_OF_TP53_ACTIVITY,2.051569465,0.232666481,sildenafil
RNA_POLYMERASE_II_TRANSCRIPTION,2.003092962,0.173081163,sildenafil
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,1.989185934,0.130047322,sildenafil
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,1.932862141,0.156766135,sildenafil
NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK,1.856944209,0.177810156,sildenafil
UB_SPECIFIC_PROCESSING_PROTEASES,1.858263444,0.21166975,sildenafil
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,1.83251814,0.17956664,sildenafil
EUKARYOTIC_TRANSLATION_ELONGATION,-3.244677961,0,tamoxifen
TRANSLATION,-2.644915292,0,tamoxifen
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.774032489,0,tamoxifen
GPCR_LIGAND_BINDING,2.787240599,0,tamoxifen
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.86567918,0,tamoxifen
SARS_COV_1_HOST_INTERACTIONS,-2.886814709,0,tamoxifen
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.976856334,0,tamoxifen
EUKARYOTIC_TRANSLATION_INITIATION,-3.022095764,0,tamoxifen
INFLUENZA_INFECTION,-2.758936023,0,tamoxifen
SELENOAMINO_ACID_METABOLISM,-3.074028544,0,tamoxifen
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,2.927539262,0,vorinostat
MITOTIC_SPINDLE_CHECKPOINT,-2.525143408,0.000801034,vorinostat
MITOTIC_PROMETAPHASE,-2.448101397,0.002002585,vorinostat
CELL_CYCLE_CHECKPOINTS,-2.433560028,0.001335056,vorinostat
RESOLUTION_OF_SISTER_CHROMATID_COHESION,-2.322760098,0.002803619,vorinostat
GPCR_LIGAND_BINDING,2.409609232,0.010553714,vorinostat
M_PHASE,-2.28491116,0.002563308,vorinostat
CELL_CYCLE_MITOTIC,-2.268935188,0.002403102,vorinostat
G_ALPHA_Q_SIGNALLING_EVENTS,2.299946858,0.012989187,vorinostat
CELL_CYCLE,-2.241962493,0.003318569,vorinostat
RRNA_PROCESSING,5.182178928,0,nabumetone
SARS_COV_2_INFECTION,3.407811616,0,nabumetone
CELL_CYCLE,3.36397734,0,nabumetone
SARS_COV_INFECTIONS,3.344915032,0,nabumetone
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,3.304073333,0,nabumetone
MITOTIC_METAPHASE_AND_ANAPHASE,3.260887248,0,nabumetone
SARS_COV_2_HOST_INTERACTIONS,3.257096948,0,nabumetone
NERVOUS_SYSTEM_DEVELOPMENT,3.185542677,0,nabumetone
RESPIRATORY_ELECTRON_TRANSPORT,3.179363498,0,nabumetone
M_PHASE,3.159044704,0,nabumetone
GPCR_LIGAND_BINDING,2.623143734,0,BRD-K97118047
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.44435923,0.009680746,BRD-K97118047
SIGNALING_BY_GPCR,2.214668077,0.020283469,BRD-K97118047
G_ALPHA_I_SIGNALLING_EVENTS,1.984833891,0.053935587,BRD-K97118047
PI3K_AKT_SIGNALING_IN_CANCER,1.708612195,0.220167831,BRD-K97118047
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,1.635970182,0.271521885,BRD-K97118047
INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,1.602456665,0.27777815,BRD-K97118047
CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM,1.575422464,0.279704421,BRD-K97118047
SIGNALING_BY_INSULIN_RECEPTOR,1.567395372,0.259689862,BRD-K97118047
SIGNALING_BY_INTERLEUKINS,1.533393948,0.277422531,BRD-K97118047
TRANSLATION,3.489854292,0,BRD-K76188144
RRNA_PROCESSING,3.241530396,0,BRD-K76188144
EUKARYOTIC_TRANSLATION_INITIATION,3.089631506,0,BRD-K76188144
METABOLISM_OF_RNA,2.940277022,0,BRD-K76188144
RESPIRATORY_ELECTRON_TRANSPORT,2.668315961,0.000772082,BRD-K76188144
MITOCHONDRIAL_TRANSLATION,2.488510207,0.001286804,BRD-K76188144
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.427595737,0.011352625,BRD-K76188144
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.290667858,0.005239129,BRD-K76188144
HOST_INTERACTIONS_OF_HIV_FACTORS,2.203669221,0.008927201,BRD-K76188144
S_PHASE,2.078082705,0.020159924,BRD-K76188144
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,4.369539387,0,palbociclib
CELL_CYCLE_MITOTIC,-2.462256757,0,palbociclib
PROTEIN_LOCALIZATION,2.600181609,0,palbociclib
RRNA_PROCESSING,2.635305259,0,palbociclib
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.652484935,0,palbociclib
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,3.252599282,0,palbociclib
INFLUENZA_INFECTION,3.2761591,0,palbociclib
SIGNALING_BY_ROBO_RECEPTORS,3.398629682,0,palbociclib
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.424085327,0,palbociclib
NEUTROPHIL_DEGRANULATION,2.557544402,0,palbociclib
EUKARYOTIC_TRANSLATION_ELONGATION,4.145222425,0,synephrine
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.880114338,0,synephrine
SARS_COV_1_INFECTION,3.047390258,0,synephrine
SARS_COV_1_HOST_INTERACTIONS,3.087098585,0,synephrine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.125670084,0,synephrine
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,3.144963255,0,synephrine
METABOLISM_OF_RNA,3.214442049,0,synephrine
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,3.285870951,0,synephrine
TRANSLATION,3.313260789,0,synephrine
SIGNALING_BY_ROBO_RECEPTORS,3.438311504,0,synephrine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.095632569,0.007976753,IPI-145
CELL_CYCLE_MITOTIC,1.943263293,0.166531011,IPI-145
GPCR_LIGAND_BINDING,-2.013738169,0.018346533,IPI-145
M_PHASE,1.851594961,0.118590265,IPI-145
SIGNALING_BY_GPCR,-1.997557568,0.014358156,IPI-145
DNA_REPAIR,1.800532734,0.111020674,IPI-145
SENSORY_PERCEPTION,-1.977576451,0.014358156,IPI-145
G_ALPHA_I_SIGNALLING_EVENTS,-1.971391868,0.012762806,IPI-145
AMINE_LIGAND_BINDING_RECEPTORS,-1.963181219,0.011699238,IPI-145
KERATINIZATION,-1.961967697,0.010141872,IPI-145
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,2.509160248,0.005297524,dienestrol
CELL_CELL_COMMUNICATION,1.932544206,0.110585808,dienestrol
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,1.847141135,0.117428442,dienestrol
CELLULAR_RESPONSE_TO_STARVATION,-1.934787213,0.35480126,dienestrol
EUKARYOTIC_TRANSLATION_ELONGATION,-1.930043612,0.186861997,dienestrol
INTEGRIN_CELL_SURFACE_INTERACTIONS,1.785118992,0.12780276,dienestrol
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-1.917353214,0.141920504,dienestrol
SELENOAMINO_ACID_METABOLISM,-1.9017016,0.122524702,dienestrol
INFLUENZA_INFECTION,-1.869633384,0.1294315,dienestrol
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-1.838976861,0.145231982,dienestrol
GPCR_LIGAND_BINDING,-2.304315355,0.005650818,swainsonine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.179151411,0.008005326,swainsonine
SIGNALING_BY_GPCR,-2.135451575,0.011301637,swainsonine
SARS_COV_2_HOST_INTERACTIONS,1.684194136,0.4790053,swainsonine
SENSORY_PERCEPTION,-1.69293176,0.391554625,swainsonine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.392387322,1,swainsonine
DEUBIQUITINATION,1.32010594,1,swainsonine
MUSCLE_CONTRACTION,1.288415139,0.903549225,swainsonine
DNA_REPAIR,1.265543841,0.801824297,swainsonine
SARS_COV_2_INFECTION,1.226828616,0.79133544,swainsonine
REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF,3.337745885,0,trifluoperazine
METABOLISM_OF_STEROIDS,3.226496489,0,trifluoperazine
ACTIVATION_OF_GENE_EXPRESSION_BY_SREBF_SREBP,3.178679225,0,trifluoperazine
MRNA_SPLICING,1.909722109,0.047672337,trifluoperazine
INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,-1.948023287,0.132198743,trifluoperazine
DISEASES_OF_METABOLISM,1.636885811,0.168128917,trifluoperazine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.609466614,0.157564906,trifluoperazine
DISEASES_OF_GLYCOSYLATION,1.575646799,0.160762246,trifluoperazine
TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,1.500720503,0.210832587,trifluoperazine
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,1.397313181,0.312145628,trifluoperazine
GPCR_LIGAND_BINDING,2.225473682,0.024521505,troglitazone
KERATINIZATION,2.04793566,0.068455867,troglitazone
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.040365147,0.050405315,troglitazone
FORMATION_OF_THE_CORNIFIED_ENVELOPE,1.989792321,0.058494006,troglitazone
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.986678552,0.047816934,troglitazone
GASTRULATION,1.946116109,0.057897997,troglitazone
SIGNALING_BY_INTERLEUKINS,1.907936086,0.069623558,troglitazone
VISUAL_PHOTOTRANSDUCTION,1.886752941,0.072542785,troglitazone
CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM,1.880249851,0.067434138,troglitazone
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,-1.812684263,0.739558118,troglitazone
MUSCLE_CONTRACTION,2.156500645,0.117033994,fluspirilene
DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA,2.080587204,0.112098826,fluspirilene
STRIATED_MUSCLE_CONTRACTION,2.039832623,0.102933513,fluspirilene
CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE,2.032963599,0.081782791,fluspirilene
SELENOAMINO_ACID_METABOLISM,2.006229743,0.079526714,fluspirilene
RESPIRATORY_ELECTRON_TRANSPORT,1.95802033,0.094238216,fluspirilene
P75_NTR_RECEPTOR_MEDIATED_SIGNALLING,1.893736581,0.127508638,fluspirilene
DEATH_RECEPTOR_SIGNALING,1.782141804,0.21943874,fluspirilene
PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES,1.75926553,0.223884308,fluspirilene
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,1.736491088,0.230401864,fluspirilene
CELL_CYCLE,-6.51952478,0,alisertib
RESOLUTION_OF_SISTER_CHROMATID_COHESION,-4.133229826,0,alisertib
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.527654464,0,alisertib
G2_M_DNA_DAMAGE_CHECKPOINT,-4.006164867,0,alisertib
PROCESSING_OF_DNA_DOUBLE_STRAND_BREAK_ENDS,-3.98799195,0,alisertib
HDR_THROUGH_HOMOLOGOUS_RECOMBINATION_HRR,-3.884056843,0,alisertib
HOMOLOGOUS_DNA_PAIRING_AND_STRAND_EXCHANGE,-3.879211215,0,alisertib
ORC1_REMOVAL_FROM_CHROMATIN,-3.741097296,0,alisertib
HDR_THROUGH_SINGLE_STRAND_ANNEALING_SSA,-3.684473321,0,alisertib
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-3.627550076,0,alisertib
CELL_CYCLE,-4.968906756,0,dasatinib
MITOTIC_G2_G2_M_PHASES,-3.153150321,0,dasatinib
REGULATION_OF_TP53_ACTIVITY,-3.116704759,0,dasatinib
HOMOLOGOUS_DNA_PAIRING_AND_STRAND_EXCHANGE,-3.084207456,0,dasatinib
DISEASES_OF_DNA_REPAIR,-3.073723814,0,dasatinib
HIV_INFECTION,-3.029962078,0,dasatinib
TRANSCRIPTIONAL_REGULATION_BY_TP53,-3.008135548,0,dasatinib
TRNA_PROCESSING,-2.980004244,0,dasatinib
PROCESSING_OF_DNA_DOUBLE_STRAND_BREAK_ENDS,-2.969191591,0,dasatinib
ACTIVATION_OF_THE_PRE_REPLICATIVE_COMPLEX,-2.955363162,0,dasatinib
GPCR_LIGAND_BINDING,2.520208387,0.004142086,afatinib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.408755769,0.003796912,afatinib
METABOLISM_OF_RNA,-2.184787246,0.080529343,afatinib
CHROMATIN_ORGANIZATION,-2.138701038,0.053686229,afatinib
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.138395072,0.035790819,afatinib
MRNA_SPLICING,-2.092399649,0.03611038,afatinib
DEVELOPMENTAL_CELL_LINEAGES,2.066276365,0.048094222,afatinib
GLOBAL_GENOME_NUCLEOTIDE_EXCISION_REPAIR_GG_NER,-1.9115362,0.119387947,afatinib
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,1.887692863,0.12892243,afatinib
SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,1.88544056,0.104656709,afatinib
CELL_CYCLE,-3.504712076,0,etoposide
KINESINS,-2.555307019,0,etoposide
DNA_DOUBLE_STRAND_BREAK_REPAIR,-2.556647241,0,etoposide
RESPIRATORY_ELECTRON_TRANSPORT,2.613094032,0,etoposide
G2_M_CHECKPOINTS,-2.702747105,0,etoposide
MITOTIC_G2_G2_M_PHASES,-2.761611832,0,etoposide
SEPARATION_OF_SISTER_CHROMATIDS,-2.802509685,0,etoposide
RHO_GTPASES_ACTIVATE_FORMINS,-2.780100712,0,etoposide
RESOLUTION_OF_SISTER_CHROMATID_COHESION,-2.867116168,0,etoposide
M_PHASE,-3.044359262,0,etoposide
GPCR_LIGAND_BINDING,3.575385039,0,mitoxantrone
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,3.270789846,0,mitoxantrone
CELL_CYCLE_MITOTIC,-2.93779042,0,mitoxantrone
CELL_CYCLE,-2.910209394,0,mitoxantrone
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.712820379,0,mitoxantrone
CELL_CYCLE_CHECKPOINTS,-2.677398354,0,mitoxantrone
M_PHASE,-2.515538103,0,mitoxantrone
METABOLISM_OF_RNA,-2.486354337,0,mitoxantrone
MITOTIC_METAPHASE_AND_ANAPHASE,-2.469897331,0,mitoxantrone
EXTRACELLULAR_MATRIX_ORGANIZATION,2.687062369,0.000204564,mitoxantrone
CELL_CYCLE,-3.895468245,0,PD-0325901
DNA_REPAIR,-2.810761437,0,PD-0325901
G2_M_DNA_DAMAGE_CHECKPOINT,-2.75426125,0,PD-0325901
DNA_STRAND_ELONGATION,-2.729599488,0,PD-0325901
SEPARATION_OF_SISTER_CHROMATIDS,-2.72412521,0,PD-0325901
TRANSCRIPTIONAL_REGULATION_BY_TP53,-2.701508394,0,PD-0325901
DISEASES_OF_DNA_REPAIR,-2.700369358,0,PD-0325901
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,-2.689933007,0,PD-0325901
RESOLUTION_OF_SISTER_CHROMATID_COHESION,-2.676106347,0,PD-0325901
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,2.639978667,0,PD-0325901
EUKARYOTIC_TRANSLATION_INITIATION,3.212889747,0,tanespimycin
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,2.660140466,0,tanespimycin
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,2.774920969,0,tanespimycin
CELLULAR_RESPONSE_TO_STARVATION,2.84105323,0,tanespimycin
TRANSLATION,2.904578536,0,tanespimycin
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.995447099,0,tanespimycin
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.0190186,0,tanespimycin
RRNA_PROCESSING,2.948874838,0,tanespimycin
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.04967432,0,tanespimycin
NONSENSE_MEDIATED_DECAY_NMD,3.057900246,0,tanespimycin
GPCR_LIGAND_BINDING,3.395793113,0,alvocidib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,3.274543064,0,alvocidib
EXTRACELLULAR_MATRIX_ORGANIZATION,3.194359423,0,alvocidib
PEPTIDE_LIGAND_BINDING_RECEPTORS,3.095459069,0,alvocidib
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,2.874742238,0,alvocidib
SIGNALING_BY_GPCR,2.808252418,0,alvocidib
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.628710918,0,alvocidib
CELL_CYCLE,-2.582783686,0,alvocidib
METABOLISM_OF_RNA,-2.574742607,0,alvocidib
CELL_CYCLE_MITOTIC,-2.558320335,0,alvocidib
G2_M_CHECKPOINTS,-3.536129182,0,BRD-K59333713
CELL_CYCLE_CHECKPOINTS,-3.407668971,0,BRD-K59333713
CELL_CYCLE,-3.356596928,0,BRD-K59333713
HOMOLOGY_DIRECTED_REPAIR,-3.003913969,0,BRD-K59333713
DNA_REPLICATION,-3.003478781,0,BRD-K59333713
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.636799837,0,BRD-K59333713
GPCR_LIGAND_BINDING,2.685855639,0,BRD-K59333713
METABOLISM_OF_STEROIDS,2.363582096,0.000471814,BRD-K59333713
CHOLESTEROL_BIOSYNTHESIS,2.494587995,0.00041939,BRD-K59333713
DNA_REPLICATION_PRE_INITIATION,-2.683770992,0.00026194,BRD-K59333713
TRANSLATION,3.620980697,0,metformin
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,3.592508177,0,metformin
MRNA_SPLICING,3.147711164,0,metformin
RESPIRATORY_ELECTRON_TRANSPORT,2.847738715,0,metformin
MITOTIC_METAPHASE_AND_ANAPHASE,2.787662227,0,metformin
METABOLISM_OF_RNA,2.781472038,0,metformin
COPI_MEDIATED_ANTEROGRADE_TRANSPORT,2.719410693,0,metformin
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.673755669,0,metformin
HIV_INFECTION,2.636402385,0.000569439,metformin
RRNA_PROCESSING,2.533780955,0.000512495,metformin
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.537618279,0,BRD-K57044355
GPCR_LIGAND_BINDING,2.537075674,0,BRD-K57044355
SIGNALING_BY_GPCR,2.498628296,0.000183628,BRD-K57044355
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.411078363,0.000275442,BRD-K57044355
G_ALPHA_Q_SIGNALLING_EVENTS,2.314938167,0.000550884,BRD-K57044355
SENSORY_PERCEPTION,2.163232624,0.004039815,BRD-K57044355
AMINE_LIGAND_BINDING_RECEPTORS,2.160275847,0.003541396,BRD-K57044355
VISUAL_PHOTOTRANSDUCTION,2.028780564,0.010742235,BRD-K57044355
G_ALPHA_I_SIGNALLING_EVENTS,2.007873275,0.012425491,BRD-K57044355
G_ALPHA_S_SIGNALLING_EVENTS,1.953926164,0.019170758,BRD-K57044355
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,1.768338932,0.481680791,budesonide
INTERLEUKIN_1_FAMILY_SIGNALING,1.644429031,0.466181162,budesonide
NEUTROPHIL_DEGRANULATION,-1.831669019,0.911110256,budesonide
EXTRACELLULAR_MATRIX_ORGANIZATION,1.589936599,0.409746614,budesonide
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,-1.799945923,0.604021608,budesonide
TRANSCRIPTIONAL_REGULATION_BY_RUNX2,1.433558248,0.672147391,budesonide
SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,1.313069356,0.960023201,budesonide
INNATE_IMMUNE_SYSTEM,-1.611243447,1,budesonide
MITOTIC_G2_G2_M_PHASES,1.234656723,1,budesonide
INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,1.206843202,1,budesonide
EUKARYOTIC_TRANSLATION_ELONGATION,-3.118829806,0,disopyramide
METABOLISM_OF_RNA,-2.507355633,0,disopyramide
SIGNALING_BY_ROBO_RECEPTORS,-2.554243577,0,disopyramide
CELLULAR_RESPONSE_TO_STARVATION,-2.61046997,0,disopyramide
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.650466528,0,disopyramide
TRANSLATION,-2.725812113,0,disopyramide
INFLUENZA_INFECTION,-2.797309061,0,disopyramide
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.456108628,0,disopyramide
SELENOAMINO_ACID_METABOLISM,-2.856737184,0,disopyramide
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.885957936,0,disopyramide
TRANSLATION,4.897684952,0,BRD-K98297262
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.804773452,0,BRD-K98297262
SEPARATION_OF_SISTER_CHROMATIDS,2.855330167,0,BRD-K98297262
REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS,2.856929706,0,BRD-K98297262
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,2.870351142,0,BRD-K98297262
HOST_INTERACTIONS_OF_HIV_FACTORS,2.955617812,0,BRD-K98297262
THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT,3.015609651,0,BRD-K98297262
SYNTHESIS_OF_DNA,3.036635294,0,BRD-K98297262
MITOCHONDRIAL_PROTEIN_DEGRADATION,3.086478308,0,BRD-K98297262
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,3.122301885,0,BRD-K98297262
EUKARYOTIC_TRANSLATION_INITIATION,4.866939259,0,diphemanil
SEPARATION_OF_SISTER_CHROMATIDS,2.790901815,0,diphemanil
ACTIVATION_OF_APC_C_AND_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS,2.805085601,0,diphemanil
APC_C_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS,2.805085601,0,diphemanil
THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT,2.919159652,0,diphemanil
MITOTIC_METAPHASE_AND_ANAPHASE,2.922226638,0,diphemanil
CELL_CYCLE,2.926340031,0,diphemanil
HOST_INTERACTIONS_OF_HIV_FACTORS,3.053583086,0,diphemanil
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,3.143518699,0,diphemanil
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,3.149477588,0,diphemanil
GPCR_LIGAND_BINDING,-2.416739107,0.006375184,anagrelide
SIGNALING_BY_GPCR,-2.397156014,0.003187592,anagrelide
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.371742176,0.002428642,anagrelide
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,-2.355969923,0.001821481,anagrelide
CELLULAR_RESPONSE_TO_STARVATION,2.446488785,0.00858866,anagrelide
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.431566589,0.00429433,anagrelide
RRNA_PROCESSING,2.357199598,0.003680854,anagrelide
NEURONAL_SYSTEM,-2.291226471,0.00291437,anagrelide
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,-2.157813242,0.009714567,anagrelide
TRANSLATION,2.104235945,0.023925553,anagrelide
EUKARYOTIC_TRANSLATION_ELONGATION,-3.276471403,0,estrone
SARS_COV_2_HOST_INTERACTIONS,-2.54420593,0,estrone
NERVOUS_SYSTEM_DEVELOPMENT,-2.57587274,0,estrone
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.643463831,0,estrone
TRANSLATION,-2.649465038,0,estrone
RRNA_PROCESSING,-2.715781894,0,estrone
SARS_COV_1_INFECTION,-2.78292346,0,estrone
SIGNALING_BY_ROBO_RECEPTORS,-2.905734694,0,estrone
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.944435185,0,estrone
EUKARYOTIC_TRANSLATION_INITIATION,-2.994273825,0,estrone
EUKARYOTIC_TRANSLATION_ELONGATION,3.420200591,0,nimodipine
STRIATED_MUSCLE_CONTRACTION,3.353314126,0,nimodipine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.274382634,0,nimodipine
MUSCLE_CONTRACTION,3.220397432,0,nimodipine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.172299488,0,nimodipine
EUKARYOTIC_TRANSLATION_INITIATION,3.139245781,0,nimodipine
SELENOAMINO_ACID_METABOLISM,2.982481893,0,nimodipine
TRANSLATION,2.979344312,0,nimodipine
INFLUENZA_INFECTION,2.939395555,0,nimodipine
RRNA_PROCESSING,2.707631337,0.000112763,nimodipine
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,1.899321586,0.287785778,midodrine
MUSCLE_CONTRACTION,1.882040482,0.155274248,midodrine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-1.903505992,0.396018284,midodrine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.694962935,0.299709106,midodrine
EUKARYOTIC_TRANSLATION_ELONGATION,-1.861477949,0.286956815,midodrine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-1.833542567,0.241663528,midodrine
PHOSPHOLIPID_METABOLISM,-1.752871566,0.365177131,midodrine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-1.747737733,0.302511484,midodrine
CELLULAR_RESPONSE_TO_STARVATION,-1.724342961,0.304090789,midodrine
REGULATION_OF_TP53_ACTIVITY,1.449171474,0.801572817,midodrine
EUKARYOTIC_TRANSLATION_ELONGATION,-2.615457271,0,diltiazem
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.551085892,0,diltiazem
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.530919733,0,diltiazem
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.51984907,0,diltiazem
EUKARYOTIC_TRANSLATION_INITIATION,-2.507893993,0,diltiazem
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.465533628,0,diltiazem
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.413506253,0.000130487,diltiazem
SELENOAMINO_ACID_METABOLISM,-2.398310632,0.000228353,diltiazem
SARS_COV_1_HOST_INTERACTIONS,-2.396432396,0.00020298,diltiazem
NONSENSE_MEDIATED_DECAY_NMD,-2.331222763,0.000639388,diltiazem
G_ALPHA_Q_SIGNALLING_EVENTS,2.885761287,0,sertraline
GPCR_LIGAND_BINDING,2.531554161,0.001514456,sertraline
SENSORY_PERCEPTION,2.511547352,0.001009637,sertraline
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.376415305,0.002271684,sertraline
SIGNALING_BY_GPCR,2.329202341,0.003634695,sertraline
MUSCLE_CONTRACTION,2.237490202,0.008581918,sertraline
HEMOSTASIS,2.156184967,0.016442667,sertraline
GASTRULATION,1.965186582,0.056792106,sertraline
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.96195685,0.051996329,sertraline
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,1.955889577,0.049219826,sertraline
EUKARYOTIC_TRANSLATION_ELONGATION,3.225619257,0,nitrendipine
NONSENSE_MEDIATED_DECAY_NMD,3.22202672,0,nitrendipine
INFLUENZA_INFECTION,3.197372462,0,nitrendipine
EUKARYOTIC_TRANSLATION_INITIATION,3.12416774,0,nitrendipine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.115137308,0,nitrendipine
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,3.071295098,0,nitrendipine
CELLULAR_RESPONSE_TO_STARVATION,2.977220858,0,nitrendipine
RRNA_PROCESSING,2.942505551,0,nitrendipine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.864280931,0,nitrendipine
TRANSLATION,2.741559303,0,nitrendipine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,3.774302079,0,pantoprazole
MRNA_SPLICING,3.219735729,0,pantoprazole
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.18142871,0.012429591,pantoprazole
SELENOAMINO_ACID_METABOLISM,-2.140019366,0.008434365,pantoprazole
EUKARYOTIC_TRANSLATION_ELONGATION,-2.13372316,0.006214795,pantoprazole
RRNA_PROCESSING,-2.119780099,0.006436752,pantoprazole
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.098342078,0.007280189,pantoprazole
NONSENSE_MEDIATED_DECAY_NMD,-2.071463606,0.00784248,pantoprazole
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.067727788,0.006975791,pantoprazole
EUKARYOTIC_TRANSLATION_INITIATION,-2.006853874,0.010542957,pantoprazole
MUSCLE_CONTRACTION,3.073102978,0,semaxanib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.256007259,0.002000489,semaxanib
GPCR_LIGAND_BINDING,-2.220916391,0.002500612,semaxanib
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.965827338,0.055680284,semaxanib
SIGNALING_BY_GPCR,-1.930067527,0.060264739,semaxanib
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,1.819137272,0.118316406,semaxanib
DEATH_RECEPTOR_SIGNALING,1.806935802,0.085866758,semaxanib
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-1.860444526,0.102225001,semaxanib
GASTRULATION,-1.854829788,0.091689091,semaxanib
APOPTOSIS,-1.827669411,0.102882304,semaxanib
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,2.137478213,0.084279421,thalidomide
MUSCLE_CONTRACTION,2.017271978,0.092083071,thalidomide
INTEGRIN_CELL_SURFACE_INTERACTIONS,2.009338971,0.062429201,thalidomide
NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK,1.892251265,0.097545626,thalidomide
MAPK1_MAPK3_SIGNALING,1.891305632,0.078660793,thalidomide
EXTRACELLULAR_MATRIX_ORGANIZATION,1.867078097,0.077256136,thalidomide
CONSTITUTIVE_SIGNALING_BY_ABERRANT_PI3K_IN_CANCER,1.851523919,0.072016542,thalidomide
CARDIAC_CONDUCTION,1.84566198,0.064770296,thalidomide
NEUTROPHIL_DEGRANULATION,-1.948618772,0.274350024,thalidomide
INTERLEUKIN_12_FAMILY_SIGNALING,1.792564507,0.080464303,thalidomide
INTEGRATION_OF_ENERGY_METABOLISM,2.374346609,0.013733539,montelukast
TRANSCRIPTION_OF_THE_HIV_GENOME,-2.099626388,0.070615073,montelukast
MUSCLE_CONTRACTION,2.093625494,0.074771489,montelukast
DEVELOPMENTAL_CELL_LINEAGES,2.017890579,0.078840686,montelukast
RNA_POLYMERASE_II_PRE_TRANSCRIPTION_EVENTS,-2.022069956,0.068608963,montelukast
VISUAL_PHOTOTRANSDUCTION,1.978514917,0.080875284,montelukast
METABOLISM_OF_FAT_SOLUBLE_VITAMINS,1.967930603,0.070193643,montelukast
SIGNALING_BY_NOTCH4,1.9146658,0.085198806,montelukast
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,1.842632158,0.111612252,montelukast
SENSORY_PERCEPTION,1.817556739,0.111585003,montelukast
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,-2.058239687,0.400548118,paroxetine
GLYCOSAMINOGLYCAN_METABOLISM,1.728115495,0.359423566,paroxetine
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,1.656715195,0.271263069,paroxetine
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-1.939340182,0.491901198,paroxetine
TRNA_PROCESSING_IN_THE_NUCLEUS,1.597981134,0.250918339,paroxetine
ORGANELLE_BIOGENESIS_AND_MAINTENANCE,-1.912869042,0.394859465,paroxetine
TRNA_PROCESSING,1.521618853,0.280224438,paroxetine
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,1.49597238,0.256924878,paroxetine
METABOLISM_OF_STEROIDS,-1.828227117,0.514488498,paroxetine
CILIUM_ASSEMBLY,-1.819950836,0.432873054,paroxetine
SELENOAMINO_ACID_METABOLISM,2.167909484,0.089970688,cilostazol
EUKARYOTIC_TRANSLATION_ELONGATION,2.062825964,0.124574799,cilostazol
NONSENSE_MEDIATED_DECAY_NMD,2.011276736,0.120422306,cilostazol
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.047941904,0.173948539,cilostazol
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,1.942426514,0.141184772,cilostazol
CELLULAR_RESPONSE_TO_STARVATION,1.90159705,0.151704422,cilostazol
TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,1.880793673,0.146029348,cilostazol
MYD88_INDEPENDENT_TLR4_CASCADE,1.876039059,0.128331817,cilostazol
EUKARYOTIC_TRANSLATION_INITIATION,1.86494593,0.122671573,cilostazol
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,1.852752954,0.117192589,cilostazol
NEURONAL_SYSTEM,-2.0854489,0.030410194,pimozide
EUKARYOTIC_TRANSLATION_ELONGATION,-2.072027846,0.01796966,pimozide
SELENOAMINO_ACID_METABOLISM,-2.068421062,0.012594121,pimozide
GPCR_LIGAND_BINDING,-2.064776167,0.00944559,pimozide
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.02616839,0.01400712,pimozide
SIGNALING_BY_GPCR,-1.982168803,0.019044768,pimozide
TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM,1.740114248,0.443671766,pimozide
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-1.943694347,0.026855756,pimozide
MRNA_SPLICING,1.709760826,0.257424528,pimozide
METABOLISM_OF_STEROIDS,1.699538882,0.185851809,pimozide
HCMV_INFECTION,2.754886781,0,amiloride
HCMV_EARLY_EVENTS,2.684977936,0,amiloride
INFLUENZA_INFECTION,2.550622993,0.002040069,amiloride
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.530921995,0.001530051,amiloride
MRNA_SPLICING,2.504524982,0.001224041,amiloride
CELLULAR_RESPONSE_TO_STARVATION,2.313317551,0.008160274,amiloride
M_PHASE,2.311661718,0.006994521,amiloride
RHO_GTPASES_ACTIVATE_FORMINS,2.279884071,0.006885231,amiloride
MITOTIC_METAPHASE_AND_ANAPHASE,2.279873402,0.006120206,amiloride
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,2.2339028,0.006426216,amiloride
EUKARYOTIC_TRANSLATION_INITIATION,-3.352539074,0,procyclidine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.752467191,0,procyclidine
SIGNALING_BY_GPCR,2.865119832,0,procyclidine
SARS_COV_1_INFECTION,-2.952320942,0,procyclidine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,2.954529829,0,procyclidine
SIGNALING_BY_ROBO_RECEPTORS,-2.964293755,0,procyclidine
TRANSLATION,-2.982490652,0,procyclidine
EXTRACELLULAR_MATRIX_ORGANIZATION,3.003857626,0,procyclidine
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-3.016627671,0,procyclidine
CELLULAR_RESPONSE_TO_STARVATION,-3.097084428,0,procyclidine
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.084311921,0.080347207,tofacitinib
UNFOLDED_PROTEIN_RESPONSE_UPR,1.791388354,0.207211217,tofacitinib
GPCR_LIGAND_BINDING,-1.942050367,0.132772028,tofacitinib
INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,1.67679772,0.23399362,tofacitinib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.924143304,0.078648399,tofacitinib
METABOLISM_OF_RNA,1.578796787,0.304473626,tofacitinib
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.540903881,0.298553305,tofacitinib
MRNA_SPLICING,1.50133284,0.296720825,tofacitinib
NUCLEAR_EVENTS_MEDIATED_BY_NFE2L2,1.471866953,0.297828368,tofacitinib
POTENTIAL_THERAPEUTICS_FOR_SARS,1.436569338,0.321388827,tofacitinib
NGF_STIMULATED_TRANSCRIPTION,2.828539074,0.000767047,cladribine
NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION,2.804073018,0.000767047,cladribine
FORMATION_OF_THE_CORNIFIED_ENVELOPE,2.687575606,0.000383523,cladribine
KERATINIZATION,2.687575606,0.000383523,cladribine
PI3K_AKT_SIGNALING_IN_CANCER,2.175382904,0.013806842,cladribine
SIGNALING_BY_PDGF,-2.062306692,0.207900314,cladribine
SIGNALING_BY_NTRKS,1.967183493,0.046278488,cladribine
RESOLUTION_OF_SISTER_CHROMATID_COHESION,-1.96793947,0.223718816,cladribine
SIGNALING_BY_ALK_IN_CANCER,1.951914265,0.044488712,cladribine
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-1.947652703,0.174380155,cladribine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,4.3313178,0,bromfenac
NERVOUS_SYSTEM_DEVELOPMENT,-2.522818986,0,bromfenac
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.671276096,0,bromfenac
EXTRACELLULAR_MATRIX_ORGANIZATION,2.688125122,0,bromfenac
SARS_COV_1_INFECTION,-2.828566943,0,bromfenac
RRNA_PROCESSING,-2.95775702,0,bromfenac
TRANSLATION,-3.014388854,0,bromfenac
INFLUENZA_INFECTION,-3.031460135,0,bromfenac
SIGNALING_BY_ROBO_RECEPTORS,-3.110125304,0,bromfenac
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-3.126698747,0,bromfenac
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.89078264,0,pentobarbital
MRNA_SPLICING,2.73359144,0,pentobarbital
MITOTIC_METAPHASE_AND_ANAPHASE,1.717790172,0.202077241,pentobarbital
GLOBAL_GENOME_NUCLEOTIDE_EXCISION_REPAIR_GG_NER,1.67423925,0.158273671,pentobarbital
NUCLEOTIDE_EXCISION_REPAIR,1.67423925,0.158273671,pentobarbital
HOST_INTERACTIONS_OF_HIV_FACTORS,1.6640091,0.1367349,pentobarbital
G_ALPHA_Q_SIGNALLING_EVENTS,-2.026420283,0.382752548,pentobarbital
SEPARATION_OF_SISTER_CHROMATIDS,1.524072889,0.240107175,pentobarbital
RESPIRATORY_ELECTRON_TRANSPORT,1.476277023,0.266360795,pentobarbital
RESOLUTION_OF_SISTER_CHROMATID_COHESION,1.36420928,0.404154482,pentobarbital
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.996158459,0,tacrine
EUKARYOTIC_TRANSLATION_ELONGATION,2.8238237,0,tacrine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.722910557,0,tacrine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.718947089,0,tacrine
CELLULAR_RESPONSE_TO_STARVATION,2.610037789,0,tacrine
SELENOAMINO_ACID_METABOLISM,2.596089902,0,tacrine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.743327932,0.000360844,tacrine
INFLUENZA_INFECTION,2.532157303,0.000186296,tacrine
EUKARYOTIC_TRANSLATION_INITIATION,2.479948987,0.000159682,tacrine
SIGNALING_BY_ROBO_RECEPTORS,2.45352273,0.000279444,tacrine
EUKARYOTIC_TRANSLATION_INITIATION,4.926276292,0,ethotoin
CELL_CYCLE_MITOTIC,2.87364518,0,ethotoin
CELL_CYCLE_CHECKPOINTS,2.920016097,0,ethotoin
CELL_CYCLE,2.934526033,0,ethotoin
THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT,3.001337212,0,ethotoin
S_PHASE,3.065189239,0,ethotoin
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,3.117839572,0,ethotoin
DNA_REPLICATION_PRE_INITIATION,3.253659266,0,ethotoin
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,3.287509707,0,ethotoin
SYNTHESIS_OF_DNA,3.300514817,0,ethotoin
METABOLISM_OF_RNA,4.418797198,0,clonidine
TRANSCRIPTIONAL_REGULATION_BY_RUNX3,2.504644568,0,clonidine
M_PHASE,2.635991091,0,clonidine
SYNTHESIS_OF_DNA,2.666108585,0,clonidine
MITOTIC_G2_G2_M_PHASES,2.698679094,0,clonidine
HOST_INTERACTIONS_OF_HIV_FACTORS,2.772174102,0,clonidine
SEPARATION_OF_SISTER_CHROMATIDS,2.80659622,0,clonidine
DNA_REPLICATION_PRE_INITIATION,2.873554417,0,clonidine
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,2.889724238,0,clonidine
RESPIRATORY_ELECTRON_TRANSPORT,2.952481426,0,clonidine
EUKARYOTIC_TRANSLATION_ELONGATION,-2.528964443,0.001972663,primidone
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.415553193,0.003945326,primidone
EUKARYOTIC_TRANSLATION_INITIATION,-2.396989383,0.003616549,primidone
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.380381551,0.002958995,primidone
CELLULAR_RESPONSE_TO_STARVATION,-2.362398406,0.002958995,primidone
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.358797193,0.002465829,primidone
TRANSLATION,-2.345220045,0.002536281,primidone
SELENOAMINO_ACID_METABOLISM,-2.312406989,0.003205578,primidone
RRNA_PROCESSING,-2.28895245,0.004274104,primidone
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.195954748,0.010948281,primidone
METABOLISM_OF_RNA,2.819681614,0,albendazole
RRNA_PROCESSING,2.460433442,0.003464819,albendazole
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.233110464,0.015399195,albendazole
SIGNALING_BY_ALK_IN_CANCER,2.176456589,0.016169154,albendazole
REGULATION_OF_TP53_ACTIVITY,2.148864088,0.016169154,albendazole
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,2.140049269,0.014244255,albendazole
TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,2.118617461,0.015509189,albendazole
RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_PATHWAY,2.112668713,0.014436745,albendazole
MRNA_SPLICING,2.044851577,0.016425807,albendazole
INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS,1.88999734,0.046890547,albendazole
PLATELET_HOMEOSTASIS,2.051909462,0.157895618,bosentan
METABOLISM_OF_RNA,-1.932136112,0.557015039,bosentan
MUSCLE_CONTRACTION,1.900321471,0.263319827,bosentan
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.690135616,0.776641048,bosentan
NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK,1.688576338,0.586813288,bosentan
GASTRULATION,-1.676217559,1,bosentan
G_ALPHA_I_SIGNALLING_EVENTS,1.667433589,0.531260988,bosentan
APOPTOSIS,-1.630142618,1,bosentan
CARDIAC_CONDUCTION,1.635319386,0.46557201,bosentan
PI3K_AKT_SIGNALING_IN_CANCER,1.637709222,0.537551139,bosentan
REGULATION_OF_T_CELL_ACTIVATION_BY_CD28_FAMILY,2.255265091,0.038046925,oxybutynin
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,1.976635598,0.175967026,oxybutynin
MYD88_INDEPENDENT_TLR4_CASCADE,1.807354947,0.360653139,oxybutynin
DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA,1.781476382,0.317751268,oxybutynin
ADAPTIVE_IMMUNE_SYSTEM,1.764264257,0.285351934,oxybutynin
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,1.749761801,0.260581801,oxybutynin
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.74619618,0.229300661,oxybutynin
PHOSPHOLIPID_METABOLISM,-1.796884309,1,oxybutynin
TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,1.680507501,0.294863665,oxybutynin
TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,1.678732966,0.264214754,oxybutynin
CELL_CYCLE,-3.695137797,0,idelalisib
CELL_CYCLE_MITOTIC,-3.314497724,0,idelalisib
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,-2.976316481,0,idelalisib
MITOTIC_METAPHASE_AND_ANAPHASE,-2.960362461,0,idelalisib
M_PHASE,-2.931008251,0,idelalisib
S_PHASE,-2.665975697,0,idelalisib
METABOLISM_OF_RNA,-2.57113882,0.000981499,idelalisib
CELL_CYCLE_CHECKPOINTS,-2.456250305,0.002576434,idelalisib
GPCR_LIGAND_BINDING,2.163357848,0.006425077,idelalisib
MITOTIC_G2_G2_M_PHASES,-2.356020367,0.005343715,idelalisib
METABOLISM_OF_STEROIDS,2.889988815,0,gefitinib
KERATINIZATION,-2.489712651,0.000562918,gefitinib
FORMATION_OF_THE_CORNIFIED_ENVELOPE,-2.489712651,0.000562918,gefitinib
SIGNALING_BY_GPCR,-2.359650384,0.00225167,gefitinib
GPCR_LIGAND_BINDING,-2.285235984,0.003940423,gefitinib
REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF,2.295737041,0.009993895,gefitinib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.208197437,0.007880846,gefitinib
G2_M_CHECKPOINTS,-2.154510312,0.011258351,gefitinib
MAPK1_MAPK3_SIGNALING,-2.140129577,0.010775851,gefitinib
MAPK_FAMILY_SIGNALING_CASCADES,-2.071766553,0.017872633,gefitinib
GPCR_LIGAND_BINDING,-2.56985458,0,papaverine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.544233266,0,papaverine
SIGNALING_BY_GPCR,-2.410460803,0.000452181,papaverine
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.341604175,0.000678271,papaverine
SENSORY_PERCEPTION,-2.183417837,0.003933975,papaverine
SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3,2.181506717,0.079904388,papaverine
G_ALPHA_Q_SIGNALLING_EVENTS,-2.098277049,0.008817529,papaverine
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,1.973971743,0.172101759,papaverine
SUMOYLATION,1.961244431,0.130100734,papaverine
AUTOPHAGY,1.949590886,0.108331911,papaverine
EUKARYOTIC_TRANSLATION_ELONGATION,-2.966055028,0,physostigmine
EUKARYOTIC_TRANSLATION_INITIATION,-2.959312501,0,physostigmine
TRANSLATION,-2.89705478,0,physostigmine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.891748519,0,physostigmine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.856683624,0,physostigmine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.823911111,0,physostigmine
SELENOAMINO_ACID_METABOLISM,-2.730855682,0,physostigmine
NONSENSE_MEDIATED_DECAY_NMD,-2.607486685,0.000218742,physostigmine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.594369215,0.000194437,physostigmine
RRNA_PROCESSING,-2.544995903,0.000174993,physostigmine
METABOLISM_OF_RNA,-3.319605127,0,atorvastatin
S_PHASE,-2.90979224,0,atorvastatin
DNA_REPLICATION,-2.77627607,0,atorvastatin
SYNTHESIS_OF_DNA,-2.721482838,0,atorvastatin
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.596674521,0.000743697,atorvastatin
CELL_CYCLE_MITOTIC,-2.555849947,0.001032913,atorvastatin
CELL_CYCLE,-2.513241313,0.001593637,atorvastatin
MRNA_SPLICING,-2.476940981,0.002478991,atorvastatin
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.300939968,0.010531445,atorvastatin
DNA_REPLICATION_PRE_INITIATION,-2.317743223,0.00729925,atorvastatin
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,2.829887684,0,etodolac
REGULATION_OF_TP53_ACTIVITY,2.573181143,0.004854369,etodolac
GPCR_LIGAND_BINDING,-2.171602594,0.007881088,etodolac
SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES,2.281579783,0.019417476,etodolac
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,-2.107098768,0.011540164,etodolac
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.12267654,0.042071197,etodolac
TRANSCRIPTIONAL_REGULATION_BY_TP53,2.090574352,0.041423948,etodolac
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,2.082470542,0.03613808,etodolac
SARS_COV_2_HOST_INTERACTIONS,2.020748549,0.040684235,etodolac
SARS_COV_2_INFECTION,1.956608015,0.051779935,etodolac
CELLULAR_RESPONSE_TO_STARVATION,2.84064322,0.010852713,phenprocoumon
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.774037222,0.005426357,phenprocoumon
MRNA_SPLICING,2.68665152,0.003617571,phenprocoumon
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.624236201,0.005426357,phenprocoumon
HOST_INTERACTIONS_OF_HIV_FACTORS,2.333988435,0.015193798,phenprocoumon
REGULATION_OF_RAS_BY_GAPS,2.18783586,0.028940568,phenprocoumon
INFLUENZA_INFECTION,2.173456128,0.024806202,phenprocoumon
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.387864066,0.034025407,phenprocoumon
CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6,2.082956067,0.040697674,phenprocoumon
VIF_MEDIATED_DEGRADATION_OF_APOBEC3G,2.018931657,0.040999139,phenprocoumon
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,3.140038085,0,ondansetron
TOLL_LIKE_RECEPTOR_CASCADES,2.699441358,0,ondansetron
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.650478416,0,ondansetron
GPCR_LIGAND_BINDING,-2.580952414,0,ondansetron
SIGNALING_BY_GPCR,-2.253680376,0,ondansetron
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.32759116,0,ondansetron
AMINE_LIGAND_BINDING_RECEPTORS,-2.233214096,0.000116321,ondansetron
HCMV_INFECTION,2.477969624,0.005161115,ondansetron
MITOTIC_PROPHASE,2.363141998,0.007741673,ondansetron
MITOTIC_PROMETAPHASE,2.34675455,0.006193338,ondansetron
INNATE_IMMUNE_SYSTEM,2.603374833,0.004649123,methocarbamol
NEUTROPHIL_DEGRANULATION,2.238977874,0.022083333,methocarbamol
SIGNALING_BY_NTRKS,2.147575113,0.023245614,methocarbamol
SENSORY_PERCEPTION,-2.14092111,0.05556719,methocarbamol
REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE,1.929398187,0.063344298,methocarbamol
ECM_PROTEOGLYCANS,1.810790044,0.099026316,methocarbamol
MITOTIC_SPINDLE_CHECKPOINT,1.683886798,0.178603801,methocarbamol
MITF_M_DEPENDENT_GENE_EXPRESSION,1.68205528,0.154417293,methocarbamol
MITOTIC_PROMETAPHASE,1.672507045,0.142379386,methocarbamol
VISUAL_PHOTOTRANSDUCTION,-1.906924642,0.306053665,methocarbamol
MUSCLE_CONTRACTION,2.81577539,0,resatorvid
STRIATED_MUSCLE_CONTRACTION,2.49351503,0.001009342,resatorvid
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.241193027,0.005383159,resatorvid
CARDIAC_CONDUCTION,2.048734574,0.026747571,resatorvid
RAB_GEFS_EXCHANGE_GTP_FOR_GDP_ON_RABS,1.863214646,0.069442749,resatorvid
C_TYPE_LECTIN_RECEPTORS_CLRS,-1.876374573,0.789193525,resatorvid
RAB_REGULATION_OF_TRAFFICKING,1.806141348,0.082766067,resatorvid
ESTROGEN_DEPENDENT_GENE_EXPRESSION,1.706238939,0.123332014,resatorvid
TRANSPORT_OF_SMALL_MOLECULES,1.659822653,0.140550913,resatorvid
CELLULAR_RESPONSE_TO_STARVATION,1.638291556,0.140560259,resatorvid
CELLULAR_RESPONSE_TO_STARVATION,2.864023186,0,linifanib
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.773007605,0,linifanib
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.613941996,0,linifanib
EUKARYOTIC_TRANSLATION_ELONGATION,2.603858019,0,linifanib
EUKARYOTIC_TRANSLATION_INITIATION,2.570140979,0,linifanib
INFLUENZA_INFECTION,2.555516518,0,linifanib
SELENOAMINO_ACID_METABOLISM,2.341388834,0.001679845,linifanib
NONSENSE_MEDIATED_DECAY_NMD,2.299310895,0.002939728,linifanib
SARS_COV_1_HOST_INTERACTIONS,2.212187194,0.006794038,linifanib
SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,-2.120696398,0.095687021,linifanib
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.604568554,0,erlotinib
SELENOAMINO_ACID_METABOLISM,2.593341661,0,erlotinib
EUKARYOTIC_TRANSLATION_ELONGATION,2.56936052,0.000264008,erlotinib
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.461808192,0.000792023,erlotinib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.217618619,0.009187464,erlotinib
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.168456892,0.012012345,erlotinib
CELLULAR_RESPONSE_TO_STARVATION,2.146453982,0.012559218,erlotinib
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.122365199,0.013266381,erlotinib
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.098149194,0.197871942,erlotinib
ANCHORING_OF_THE_BASAL_BODY_TO_THE_PLASMA_MEMBRANE,-2.048688253,0.14931441,erlotinib
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.494762974,0.000989959,celecoxib
CHEMOKINE_RECEPTORS_BIND_CHEMOKINES,-2.393181757,0.001979918,celecoxib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.317423878,0.003959836,celecoxib
GPCR_LIGAND_BINDING,-2.260254948,0.004454815,celecoxib
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,-2.159151871,0.007919672,celecoxib
NEURONAL_SYSTEM,-2.125708349,0.009074624,celecoxib
SIGNALING_BY_GPCR,-2.042313311,0.019940602,celecoxib
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,2.029700455,0.165744315,celecoxib
TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,1.870419386,0.245547133,celecoxib
INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,-1.844439332,0.103945694,celecoxib
GPCR_LIGAND_BINDING,-2.363705719,0.000799124,oxypurinol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.226873613,0.001198686,oxypurinol
NEUTROPHIL_DEGRANULATION,2.294650138,0.033131413,oxypurinol
SIGNALING_BY_NTRKS,2.236940774,0.023468084,oxypurinol
SIGNALING_BY_GPCR,-2.12149352,0.005061117,oxypurinol
SENSORY_PERCEPTION,-2.110503214,0.004794743,oxypurinol
RHO_GTPASE_CYCLE,1.84712816,0.160135163,oxypurinol
SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3,1.808328731,0.153232785,oxypurinol
SUMOYLATION,1.794167837,0.134734413,oxypurinol
G_ALPHA_Q_SIGNALLING_EVENTS,-1.932435387,0.053541294,oxypurinol
METABOLISM_OF_STEROIDS,2.615880729,0.012458776,nintedanib
PROTEIN_LOCALIZATION,2.461520576,0.01557347,nintedanib
FATTY_ACID_METABOLISM,2.401482051,0.010382313,nintedanib
NUCLEOTIDE_EXCISION_REPAIR,2.387819579,0.007786735,nintedanib
GLOBAL_GENOME_NUCLEOTIDE_EXCISION_REPAIR_GG_NER,2.12650574,0.013704654,nintedanib
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.070779835,0.01557347,nintedanib
NEUTROPHIL_DEGRANULATION,1.843421872,0.037376328,nintedanib
S_PHASE,1.834680198,0.038155002,nintedanib
MEMBRANE_TRAFFICKING,1.829994351,0.034607711,nintedanib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.93651601,0.034487262,nintedanib
REGULATION_OF_T_CELL_ACTIVATION_BY_CD28_FAMILY,2.33797023,0.017997858,ketoprofen
GASTRULATION,-1.976377448,0.35692666,ketoprofen
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.944774217,0.15440268,ketoprofen
NONSENSE_MEDIATED_DECAY_NMD,1.82313307,0.232077648,ketoprofen
NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK,1.755610718,0.256469482,ketoprofen
DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR,-1.786128526,0.860101207,ketoprofen
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.781925883,0.589423301,ketoprofen
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,1.670000875,0.333055106,ketoprofen
SIGNALING_BY_ALK_IN_CANCER,1.608933833,0.381744049,ketoprofen
ORGANELLE_BIOGENESIS_AND_MAINTENANCE,1.606983302,0.33113353,ketoprofen
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.341403734,0.026889637,aminosalicylic-acid
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-1.8849836,0.322675647,aminosalicylic-acid
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,1.866365255,0.866127762,aminosalicylic-acid
GLYCEROPHOSPHOLIPID_BIOSYNTHESIS,-1.795406468,0.360679668,aminosalicylic-acid
GPCR_LIGAND_BINDING,-1.760728703,0.332624813,aminosalicylic-acid
MEMBRANE_TRAFFICKING,1.8001866,0.677380893,aminosalicylic-acid
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.732492609,0.312565143,aminosalicylic-acid
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.762513777,0.578695982,aminosalicylic-acid
CILIUM_ASSEMBLY,1.738171297,0.515221464,aminosalicylic-acid
INFLUENZA_INFECTION,-1.679194119,0.343111771,aminosalicylic-acid
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.725652163,0.001769977,phenytoin
NEUTROPHIL_DEGRANULATION,2.175953126,0.031859582,phenytoin
PHOSPHOLIPID_METABOLISM,-1.94568086,0.524360956,phenytoin
EXTRACELLULAR_MATRIX_ORGANIZATION,1.68569997,0.556362698,phenytoin
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,1.568526885,0.779896014,phenytoin
C_TYPE_LECTIN_RECEPTORS_CLRS,-1.684444853,1,phenytoin
BACTERIAL_INFECTION_PATHWAYS,1.556797014,0.660732328,phenytoin
G_ALPHA_Q_SIGNALLING_EVENTS,-1.665595606,1,phenytoin
INNATE_IMMUNE_SYSTEM,1.517667525,0.671706184,phenytoin
GLYCEROPHOSPHOLIPID_BIOSYNTHESIS,-1.635578939,1,phenytoin
CELL_CYCLE_MITOTIC,3.135572706,0,trimipramine
HIV_LIFE_CYCLE,2.856293987,0,trimipramine
SUMOYLATION,2.813092437,0,trimipramine
SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3,2.801286493,0,trimipramine
VIRAL_INFECTION_PATHWAYS,2.753615475,0,trimipramine
M_PHASE,2.726303239,0,trimipramine
HIV_INFECTION,2.685464843,0,trimipramine
MITOTIC_PROMETAPHASE,2.599762441,0,trimipramine
CELL_CYCLE,2.475791927,0,trimipramine
RNA_POLYMERASE_II_PRE_TRANSCRIPTION_EVENTS,2.353572754,0.000763871,trimipramine
METABOLISM_OF_RNA,5.033508613,0,rilmenidine
ASYMMETRIC_LOCALIZATION_OF_PCP_PROTEINS,3.066536358,0,rilmenidine
SCF_BETA_TRCP_MEDIATED_DEGRADATION_OF_EMI1,3.043014464,0,rilmenidine
UBIQUITIN_DEPENDENT_DEGRADATION_OF_CYCLIN_D,3.021642538,0,rilmenidine
REGULATION_OF_RUNX3_EXPRESSION_AND_ACTIVITY,3.021642538,0,rilmenidine
SCF_SKP2_MEDIATED_DEGRADATION_OF_P27_P21,3.021642538,0,rilmenidine
S_PHASE,2.984506802,0,rilmenidine
REGULATION_OF_ORNITHINE_DECARBOXYLASE_ODC,2.979708082,0,rilmenidine
SIGNALING_BY_NOTCH4,2.927901273,0,rilmenidine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.906126996,0,rilmenidine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.041726217,0.03736447,amodiaquine
MITF_M_DEPENDENT_GENE_EXPRESSION,1.83688268,0.10675563,amodiaquine
CELLULAR_RESPONSE_TO_HEAT_STRESS,1.770854457,0.10675563,amodiaquine
HOST_INTERACTIONS_OF_HIV_FACTORS,1.727908875,0.101417848,amodiaquine
INFLUENZA_INFECTION,1.705368137,0.09501251,amodiaquine
CELLULAR_RESPONSE_TO_STARVATION,1.701687293,0.082735613,amodiaquine
MRNA_SPLICING,1.503161732,0.21579888,amodiaquine
TRANSCRIPTIONAL_REGULATION_BY_RUNX2,1.483486667,0.212176814,amodiaquine
G2_M_CHECKPOINTS,1.481832204,0.190380873,amodiaquine
REGULATION_OF_PLK1_ACTIVITY_AT_G2_M_TRANSITION,1.450243828,0.200700584,amodiaquine
CELL_CYCLE_MITOTIC,3.45815395,0,benzthiazide
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,2.346943529,0.00783162,benzthiazide
CELL_CYCLE_CHECKPOINTS,2.285967071,0.01827378,benzthiazide
METABOLISM_OF_RNA,2.26995996,0.01566324,benzthiazide
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.122514376,0.006955239,benzthiazide
TOLL_LIKE_RECEPTOR_CASCADES,2.232221799,0.01566324,benzthiazide
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,2.21744542,0.01435797,benzthiazide
GPCR_LIGAND_BINDING,-2.107242709,0.004109914,benzthiazide
CELL_CYCLE,2.18667329,0.014544437,benzthiazide
M_PHASE,2.122977459,0.01566324,benzthiazide
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.492637238,0.000944793,hydroxyurea
EUKARYOTIC_TRANSLATION_ELONGATION,2.417592154,0.00141719,hydroxyurea
CELLULAR_RESPONSE_TO_STARVATION,2.263401092,0.005196364,hydroxyurea
SELENOAMINO_ACID_METABOLISM,2.273317302,0.006928485,hydroxyurea
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.230937723,0.005290843,hydroxyurea
INFLUENZA_INFECTION,2.135857028,0.012912177,hydroxyurea
COLLAGEN_FORMATION,-2.328882185,0.108517052,hydroxyurea
REGULATION_OF_INSULIN_SECRETION,-2.29876358,0.072344701,hydroxyurea
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.272748172,0.057450204,hydroxyurea
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.272311302,0.043087653,hydroxyurea
METABOLISM_OF_RNA,-3.1525321,0,sonidegib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.808277074,0,sonidegib
GPCR_LIGAND_BINDING,2.79095312,0,sonidegib
SIGNALING_BY_GPCR,2.594558764,0,sonidegib
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.575644331,0,sonidegib
G_ALPHA_Q_SIGNALLING_EVENTS,2.460029173,0,sonidegib
G_ALPHA_I_SIGNALLING_EVENTS,2.385479577,0,sonidegib
INFLUENZA_INFECTION,-2.234714486,0.019104386,sonidegib
CELLULAR_RESPONSE_TO_STARVATION,-2.167982301,0.019104386,sonidegib
EUKARYOTIC_TRANSLATION_INITIATION,-2.12496764,0.021970044,sonidegib
CELLULAR_RESPONSE_TO_STARVATION,2.668136881,0,roscovitine
EUKARYOTIC_TRANSLATION_ELONGATION,2.650662592,0,roscovitine
NONSENSE_MEDIATED_DECAY_NMD,2.645664355,0,roscovitine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.589689021,0,roscovitine
EUKARYOTIC_TRANSLATION_INITIATION,2.533981278,0,roscovitine
SELENOAMINO_ACID_METABOLISM,2.496457117,0,roscovitine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.411356664,0.000749366,roscovitine
INFLUENZA_INFECTION,2.386996077,0.000786835,roscovitine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.30836845,0.001515385,roscovitine
SIGNALING_BY_ROBO_RECEPTORS,2.278090746,0.001678581,roscovitine
METABOLISM_OF_RNA,4.912987938,0,CCT-018159
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,3.225420976,0,CCT-018159
G2_M_CHECKPOINTS,3.245885795,0,CCT-018159
C_TYPE_LECTIN_RECEPTORS_CLRS,3.246115422,0,CCT-018159
ANTIGEN_PROCESSING_CROSS_PRESENTATION,3.263358754,0,CCT-018159
KEAP1_NFE2L2_PATHWAY,3.269600218,0,CCT-018159
SOMITOGENESIS,3.276620366,0,CCT-018159
ACTIVATION_OF_NF_KAPPAB_IN_B_CELLS,3.290324171,0,CCT-018159
TRANSLATION,3.298220345,0,CCT-018159
RRNA_PROCESSING,3.302048485,0,CCT-018159
TRANSLATION,3.640194607,0,moxisylyte
METABOLISM_OF_RNA,3.462882181,0,moxisylyte
MRNA_SPLICING,2.911827408,0,moxisylyte
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.806884233,0,moxisylyte
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.781711137,0,moxisylyte
DNA_REPLICATION,2.598995293,0,moxisylyte
RRNA_PROCESSING,2.536289514,0,moxisylyte
MITOTIC_METAPHASE_AND_ANAPHASE,2.510888451,0.000661165,moxisylyte
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.496001862,0.001175404,moxisylyte
S_PHASE,2.471645705,0.001057864,moxisylyte
REGULATION_OF_T_CELL_ACTIVATION_BY_CD28_FAMILY,2.470004393,0.002159752,fenoterol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.139434138,0.025557069,fenoterol
GPCR_LIGAND_BINDING,2.069287621,0.034796009,fenoterol
RRNA_PROCESSING,-1.979476121,0.437149585,fenoterol
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.961645039,0.064972548,fenoterol
PI3K_AKT_SIGNALING_IN_CANCER,1.938512663,0.061336965,fenoterol
TRNA_PROCESSING,-1.880939142,0.450559081,fenoterol
NEURONAL_SYSTEM,1.84890217,0.098388715,fenoterol
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.835243962,0.093177884,fenoterol
NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK,1.80590551,0.100878429,fenoterol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.464831994,0,chlortalidone
GPCR_LIGAND_BINDING,-2.46199268,0,chlortalidone
TOLL_LIKE_RECEPTOR_CASCADES,2.304514523,0.018574824,chlortalidone
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.211555907,0.001964266,chlortalidone
POTENTIAL_THERAPEUTICS_FOR_SARS,2.216631754,0.027862237,chlortalidone
SIGNALING_BY_GPCR,-2.168875614,0.002619021,chlortalidone
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,2.042383863,0.051080767,chlortalidone
SENSORY_PERCEPTION,-2.102891724,0.005499945,chlortalidone
SARS_COV_1_HOST_INTERACTIONS,1.982038186,0.066172812,chlortalidone
SARS_COV_2_HOST_INTERACTIONS,1.905264173,0.086372934,chlortalidone
CELLULAR_RESPONSE_TO_STARVATION,4.970383581,0,carvedilol
TRANSLATION,4.593424288,0,carvedilol
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,4.572387108,0,carvedilol
INFLUENZA_INFECTION,3.942611765,0,carvedilol
EUKARYOTIC_TRANSLATION_ELONGATION,3.712429732,0,carvedilol
EUKARYOTIC_TRANSLATION_INITIATION,2.954394561,0,carvedilol
RRNA_PROCESSING,2.738116209,0,carvedilol
NUCLEOTIDE_EXCISION_REPAIR,2.598763421,0.001329626,carvedilol
NONSENSE_MEDIATED_DECAY_NMD,2.373556211,0.003191104,carvedilol
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.374454156,0.003545671,carvedilol
SIGNALING_BY_GPCR,3.030482277,0,guanaben-acetate
GPCR_LIGAND_BINDING,2.962966892,0,guanaben-acetate
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.860791632,0,guanaben-acetate
PEROXISOMAL_PROTEIN_IMPORT,-2.612518308,0.00276299,guanaben-acetate
NEUTROPHIL_DEGRANULATION,-2.537616625,0.00276299,guanaben-acetate
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.425584505,0.001082298,guanaben-acetate
PROTEIN_LOCALIZATION,-2.381651067,0.006446977,guanaben-acetate
G_ALPHA_I_SIGNALLING_EVENTS,2.324171068,0.002164596,guanaben-acetate
G_ALPHA_Q_SIGNALLING_EVENTS,2.322657172,0.00180383,guanaben-acetate
FATTY_ACID_METABOLISM,-2.289863532,0.010361213,guanaben-acetate
MUSCLE_CONTRACTION,1.996621231,0.154307208,naloxone
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,1.92648365,0.120607932,naloxone
S_PHASE,1.920688595,0.084543796,naloxone
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.837176949,0.110409468,naloxone
NEUTROPHIL_DEGRANULATION,-1.990545688,0.215494902,naloxone
HOMOLOGY_DIRECTED_REPAIR,1.809646163,0.100033638,naloxone
G_ALPHA_Q_SIGNALLING_EVENTS,1.783377938,0.10434951,naloxone
SYNTHESIS_OF_DNA,1.719772931,0.131249809,naloxone
GPCR_LIGAND_BINDING,1.657557783,0.16361885,naloxone
PROTEIN_LOCALIZATION,-1.867499237,0.325828291,naloxone
SIGNALING_BY_ROBO_RECEPTORS,2.040930933,0.205530961,venlafaxine
NEUTROPHIL_DEGRANULATION,2.034801329,0.1048771,venlafaxine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,1.865192756,0.202715469,venlafaxine
BACTERIAL_INFECTION_PATHWAYS,1.820968418,0.19743642,venlafaxine
INFLUENZA_INFECTION,1.769547715,0.208628003,venlafaxine
EUKARYOTIC_TRANSLATION_INITIATION,1.743401817,0.202480844,venlafaxine
INNATE_IMMUNE_SYSTEM,1.73863349,0.178582675,venlafaxine
TOLL_LIKE_RECEPTOR_CASCADES,1.725425074,0.166114064,venlafaxine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.685252582,0.182224939,venlafaxine
METABOLISM_OF_RNA,1.683117945,0.165691741,venlafaxine
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-3.336997753,0.011162583,rivaroxaban
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-3.327055123,0.007255679,rivaroxaban
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-3.246081743,0.010418411,rivaroxaban
HEMOSTASIS,-3.114470775,0.014232293,rivaroxaban
SIGNALING_BY_GPCR,2.091336549,0.056843815,rivaroxaban
GPCR_LIGAND_BINDING,2.034355699,0.040196698,rivaroxaban
NEURONAL_SYSTEM,1.748109142,0.208427321,rivaroxaban
AUTOPHAGY,1.718311349,0.185351439,rivaroxaban
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,-2.907607182,0.222581905,rivaroxaban
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,1.691746388,0.17507895,rivaroxaban
TRANSLATION,3.414388121,0,NU-1025
RRNA_PROCESSING,3.335012196,0,NU-1025
METABOLISM_OF_RNA,3.252468555,0,NU-1025
HOST_INTERACTIONS_OF_HIV_FACTORS,2.898456954,0,NU-1025
REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS,2.37453259,0.004244376,NU-1025
RRNA_MODIFICATION_IN_THE_NUCLEUS_AND_CYTOSOL,2.371393455,0.00353698,NU-1025
SYNTHESIS_OF_DNA,2.295102283,0.005684433,NU-1025
SEPARATION_OF_SISTER_CHROMATIDS,2.278288525,0.005305471,NU-1025
DNA_REPLICATION,2.270212601,0.005010722,NU-1025
CELL_CYCLE_CHECKPOINTS,2.239921634,0.007162385,NU-1025
METABOLISM_OF_RNA,2.948550594,0,phentermine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.916832134,0,phentermine
NONSENSE_MEDIATED_DECAY_NMD,2.818390021,0,phentermine
INFLUENZA_INFECTION,2.768150747,0,phentermine
MRNA_SPLICING,2.644898664,0,phentermine
HOST_INTERACTIONS_OF_HIV_FACTORS,2.299904088,0.006816962,phentermine
REGULATION_OF_TP53_ACTIVITY,2.224731317,0.012416609,phentermine
GPCR_LIGAND_BINDING,-2.162383607,0.021515659,phentermine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.190802189,0.017255435,phentermine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.131867801,0.016674635,phentermine
REGULATION_OF_RUNX2_EXPRESSION_AND_ACTIVITY,3.370865821,0,ranitidine
TRANSCRIPTIONAL_REGULATION_BY_RUNX2,2.753259712,0,ranitidine
HEDGEHOG_LIGAND_BIOGENESIS,2.742831577,0,ranitidine
S_PHASE,2.737416413,0,ranitidine
DNA_REPLICATION,2.724859459,0,ranitidine
REGULATION_OF_PTEN_STABILITY_AND_ACTIVITY,2.724428831,0,ranitidine
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.720627064,0,ranitidine
DEGRADATION_OF_CRY_AND_PER_PROTEINS,2.697085489,0,ranitidine
DECTIN_1_MEDIATED_NONCANONICAL_NF_KB_SIGNALING,2.675174686,0,ranitidine
MITOTIC_METAPHASE_AND_ANAPHASE,2.666309797,0,ranitidine
RRNA_PROCESSING,3.629128262,0,phenothiazine
TRANSLATION,3.490588232,0,phenothiazine
METABOLISM_OF_RNA,3.382770814,0,phenothiazine
EUKARYOTIC_TRANSLATION_INITIATION,3.330475547,0,phenothiazine
EUKARYOTIC_TRANSLATION_ELONGATION,3.100537328,0,phenothiazine
RESPIRATORY_ELECTRON_TRANSPORT,2.929891016,0,phenothiazine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.86664168,0,phenothiazine
SIGNALING_BY_ROBO_RECEPTORS,2.787639589,0,phenothiazine
SELENOAMINO_ACID_METABOLISM,2.73259077,0,phenothiazine
DNA_REPLICATION,2.591193706,0,phenothiazine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,3.72274875,0,prilocaine
G_ALPHA_Q_SIGNALLING_EVENTS,2.734114755,0,prilocaine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.965188871,0,prilocaine
TRANSLATION,-3.031529048,0,prilocaine
SARS_COV_1_INFECTION,-3.045365716,0,prilocaine
RRNA_PROCESSING,-3.116994748,0,prilocaine
INFLUENZA_INFECTION,-3.174627754,0,prilocaine
CELLULAR_RESPONSE_TO_STARVATION,-3.204744673,0,prilocaine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-3.245537554,0,prilocaine
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-3.275474485,0,prilocaine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,3.131853599,0,orciprenaline
GPCR_LIGAND_BINDING,3.053120586,0,orciprenaline
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.74285709,0.000225665,orciprenaline
SIGNALING_BY_GPCR,2.390268875,0.004231223,orciprenaline
EXTRACELLULAR_MATRIX_ORGANIZATION,1.869335081,0.093425405,orciprenaline
COLLAGEN_FORMATION,1.841701051,0.090040426,orciprenaline
G_ALPHA_Q_SIGNALLING_EVENTS,1.791106504,0.099905221,orciprenaline
PLATELET_HOMEOSTASIS,1.763439207,0.098164375,orciprenaline
G_ALPHA_I_SIGNALLING_EVENTS,1.712372853,0.112606949,orciprenaline
EUKARYOTIC_TRANSLATION_ELONGATION,-2.85521397,1,orciprenaline
SENSORY_PERCEPTION,2.22226606,0.055936145,pipamperone
GPCR_LIGAND_BINDING,2.11201597,0.066424172,pipamperone
VISUAL_PHOTOTRANSDUCTION,2.062568022,0.066191105,pipamperone
G_ALPHA_Q_SIGNALLING_EVENTS,1.99563857,0.075513795,pipamperone
SIGNALING_BY_GPCR,1.925313271,0.101524103,pipamperone
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,1.889686679,0.104647204,pipamperone
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.792414645,0.166609803,pipamperone
MUSCLE_CONTRACTION,1.753629432,0.183190874,pipamperone
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,1.710085803,0.206808358,pipamperone
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.397856496,1,pipamperone
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.764375123,0.217717056,bicalutamide
MITOCHONDRIAL_TRANSLATION,1.754439235,0.118907007,bicalutamide
MRNA_SPLICING,1.680976125,0.116953136,bicalutamide
EUKARYOTIC_TRANSLATION_ELONGATION,-2.976501444,1,bicalutamide
RNA_POLYMERASE_II_TRANSCRIPTION_TERMINATION,1.55660336,0.169777435,bicalutamide
SELENOAMINO_ACID_METABOLISM,-2.962027054,0.637309799,bicalutamide
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.952440668,0.475196019,bicalutamide
EUKARYOTIC_TRANSLATION_INITIATION,-2.940152015,0.407564176,bicalutamide
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.90795178,0.412174287,bicalutamide
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.860388441,0.426393016,bicalutamide
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,3.266692728,0,buspirone
GPCR_LIGAND_BINDING,3.05694776,0,buspirone
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.661624945,0,buspirone
SIGNALING_BY_GPCR,2.606205623,0,buspirone
MUSCLE_CONTRACTION,2.578834201,0.000145755,buspirone
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.566681814,0.002457251,buspirone
RRNA_PROCESSING,-2.486941258,0.001842938,buspirone
EUKARYOTIC_TRANSLATION_INITIATION,-2.439255616,0.001228625,buspirone
INFLUENZA_INFECTION,-2.399095475,0.001842938,buspirone
EUKARYOTIC_TRANSLATION_ELONGATION,-2.392077905,0.001474351,buspirone
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,3.642039012,0,selegiline
GPCR_LIGAND_BINDING,3.458386122,0,selegiline
SIGNALING_BY_GPCR,3.076591814,0,selegiline
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.81723044,0,selegiline
G_ALPHA_Q_SIGNALLING_EVENTS,2.523093858,0.000618694,selegiline
HEMOSTASIS,2.21695605,0.007561819,selegiline
G_ALPHA_I_SIGNALLING_EVENTS,1.905531453,0.052147089,selegiline
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,1.859017008,0.059420429,selegiline
EXTRACELLULAR_MATRIX_ORGANIZATION,1.761793622,0.092804141,selegiline
SIGNALING_BY_INTERLEUKINS,1.755709999,0.085482925,selegiline
GPCR_LIGAND_BINDING,4.26387254,0,proxymetacaine
NEUTROPHIL_DEGRANULATION,-2.752865852,0,proxymetacaine
G_ALPHA_I_SIGNALLING_EVENTS,2.76320217,0,proxymetacaine
CELLULAR_RESPONSES_TO_STIMULI,-2.821028078,0,proxymetacaine
SARS_COV_1_INFECTION,-2.919519411,0,proxymetacaine
G_ALPHA_Q_SIGNALLING_EVENTS,2.930995173,0,proxymetacaine
RRNA_PROCESSING,-2.941488978,0,proxymetacaine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-3.005683867,0,proxymetacaine
INFLUENZA_INFECTION,-3.032753954,0,proxymetacaine
TRANSLATION,-3.046220991,0,proxymetacaine
RRNA_PROCESSING,3.123910776,0,BRD-K47869605
METABOLISM_OF_RNA,2.264507845,0.023485204,BRD-K47869605
SIGNALING_BY_INTERLEUKINS,2.036262337,0.064304726,BRD-K47869605
ESR_MEDIATED_SIGNALING,1.972635547,0.074649399,BRD-K47869605
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,1.930207751,0.080185198,BRD-K47869605
HOST_INTERACTIONS_OF_HIV_FACTORS,1.731607211,0.227023642,BRD-K47869605
METABOLISM_OF_STEROIDS,-2.14444445,1,BRD-K47869605
CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM,1.67736927,0.261212987,BRD-K47869605
SENSORY_PERCEPTION,-2.071062659,0.710863367,BRD-K47869605
DNA_REPLICATION,1.66931119,0.239884587,BRD-K47869605
GPCR_LIGAND_BINDING,3.227145329,0,alprenolol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,3.211351936,0,alprenolol
SIGNALING_BY_GPCR,2.933276635,0,alprenolol
NEUTROPHIL_DEGRANULATION,-2.874254599,0,alprenolol
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.615065837,0,alprenolol
MEMBRANE_TRAFFICKING,-2.667362166,0.002837454,alprenolol
G_ALPHA_Q_SIGNALLING_EVENTS,2.524824286,0.00043688,alprenolol
G_ALPHA_I_SIGNALLING_EVENTS,2.512267095,0.000485423,alprenolol
VESICLE_MEDIATED_TRANSPORT,-2.475268829,0.005674909,alprenolol
ASPARAGINE_N_LINKED_GLYCOSYLATION,-2.364163181,0.009221727,alprenolol
REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF,3.441591078,0,maprotiline
INFLUENZA_INFECTION,3.250101959,0,maprotiline
NONSENSE_MEDIATED_DECAY_NMD,3.249159622,0,maprotiline
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.241232875,0,maprotiline
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.130055476,0,maprotiline
TRANSLATION,3.073469317,0,maprotiline
EUKARYOTIC_TRANSLATION_ELONGATION,2.872488782,0,maprotiline
EUKARYOTIC_TRANSLATION_INITIATION,2.804079271,0,maprotiline
GPCR_LIGAND_BINDING,-2.316196304,0,maprotiline
SELENOAMINO_ACID_METABOLISM,2.506166935,0.00095422,maprotiline
NEUTROPHIL_DEGRANULATION,2.072495842,0.293253736,nicorandil
ANTIGEN_PROCESSING_CROSS_PRESENTATION,2.038547086,0.194080654,nicorandil
ANTIMICROBIAL_PEPTIDES,2.027741905,0.14182817,nicorandil
BIOLOGICAL_OXIDATIONS,-1.833730003,0.22415409,nicorandil
TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,1.872348845,0.379363697,nicorandil
EPIGENETIC_REGULATION_BY_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES,1.816027504,0.455769624,nicorandil
INTERFERON_SIGNALING,1.764590706,0.535499095,nicorandil
PTEN_REGULATION,1.748916189,0.510032991,nicorandil
INTEGRATION_OF_ENERGY_METABOLISM,-1.376213864,0.874640468,nicorandil
ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES,1.700331276,0.622631,nicorandil
EUKARYOTIC_TRANSLATION_INITIATION,4.842651934,0,profenamine
SEPARATION_OF_SISTER_CHROMATIDS,2.734417722,0,profenamine
VIRAL_INFECTION_PATHWAYS,2.787104309,0,profenamine
CELLULAR_RESPONSES_TO_STIMULI,2.79525446,0,profenamine
DNA_REPLICATION,2.827788078,0,profenamine
CELLULAR_RESPONSE_TO_HYPOXIA,2.845735139,0,profenamine
REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS,2.880827032,0,profenamine
MITOTIC_METAPHASE_AND_ANAPHASE,2.891697189,0,profenamine
THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT,3.014160841,0,profenamine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.033802248,0,profenamine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.295370152,0.039308478,pizotifen
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.222436487,0.038975356,pizotifen
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.053845745,0.237035225,pizotifen
SIGNALING_BY_GPCR,2.041941193,0.133332314,pizotifen
NEUTROPHIL_DEGRANULATION,-2.125014495,0.049968405,pizotifen
MAPK1_MAPK3_SIGNALING,2.022142148,0.101669521,pizotifen
GPCR_LIGAND_BINDING,2.008226871,0.084530944,pizotifen
DNA_REPLICATION,1.963296761,0.096208415,pizotifen
S_PHASE,1.953783272,0.085983366,pizotifen
MAPK_FAMILY_SIGNALING_CASCADES,1.923646142,0.090880102,pizotifen
RRNA_PROCESSING,2.446980445,0.012944032,eugenol
MITOTIC_METAPHASE_AND_ANAPHASE,2.294157836,0.011326028,eugenol
M_PHASE,2.227644391,0.011865362,eugenol
METABOLISM_OF_RNA,2.18239801,0.01213503,eugenol
SEPARATION_OF_SISTER_CHROMATIDS,1.982053194,0.033007281,eugenol
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.735235485,0.109484935,eugenol
HCMV_INFECTION,1.685943321,0.121581441,eugenol
RHO_GTPASES_ACTIVATE_FORMINS,1.566716345,0.203059498,eugenol
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,1.562759096,0.183014227,eugenol
MRNA_SPLICING,1.545806605,0.180569243,eugenol
SIGNALING_BY_GPCR,3.508290165,0,coumarin
GPCR_LIGAND_BINDING,3.466790586,0,coumarin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,3.263569012,0,coumarin
G_ALPHA_Q_SIGNALLING_EVENTS,3.206911962,0,coumarin
NEUTROPHIL_DEGRANULATION,-2.383912035,0.005104374,coumarin
G_ALPHA_I_SIGNALLING_EVENTS,2.445762019,0.001344569,coumarin
SENSORY_PERCEPTION,2.399495945,0.001760745,coumarin
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.285336348,0.003292822,coumarin
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.27285381,0.003121321,coumarin
PEROXISOMAL_PROTEIN_IMPORT,-2.242157576,0.014292248,coumarin
ADAPTIVE_IMMUNE_SYSTEM,2.01344068,0.256892637,erythromycin
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.953117811,0.304465747,erythromycin
REGULATION_OF_T_CELL_ACTIVATION_BY_CD28_FAMILY,1.913684954,0.257534869,erythromycin
TOLL_LIKE_RECEPTOR_CASCADES,1.885986966,0.200804411,erythromycin
MUSCLE_CONTRACTION,1.869852147,0.170512488,erythromycin
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,1.809210904,0.20551411,erythromycin
METABOLISM_OF_STEROIDS,-1.744035216,0.65185878,erythromycin
TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,1.68093108,0.373136555,erythromycin
NEURONAL_SYSTEM,1.668741411,0.340933228,erythromycin
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,1.642758194,0.343915018,erythromycin
GPCR_LIGAND_BINDING,3.452121908,0,testosterone
SIGNALING_BY_GPCR,3.183333844,0,testosterone
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,3.163566687,0,testosterone
G_ALPHA_I_SIGNALLING_EVENTS,2.463150982,0.000212451,testosterone
G_ALPHA_Q_SIGNALLING_EVENTS,2.336975193,0.001359689,testosterone
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.245167329,0.002974319,testosterone
NEURONAL_SYSTEM,1.989909202,0.032535407,testosterone
G_ALPHA_S_SIGNALLING_EVENTS,1.873914759,0.071596104,testosterone
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,1.87090727,0.065151747,testosterone
VISUAL_PHOTOTRANSDUCTION,1.799451863,0.098237504,testosterone
SELENOAMINO_ACID_METABOLISM,2.590807584,0.002077922,ciglitazone
MUSCLE_CONTRACTION,2.457366579,0.003116883,ciglitazone
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.27354484,0.007800963,ciglitazone
GPCR_LIGAND_BINDING,-2.263965295,0.004767255,ciglitazone
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.207187371,0.011082251,ciglitazone
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.149992335,0.010690209,ciglitazone
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.059199945,0.027532468,ciglitazone
EUKARYOTIC_TRANSLATION_ELONGATION,2.028550171,0.026181818,ciglitazone
NONSENSE_MEDIATED_DECAY_NMD,1.81701581,0.07965368,ciglitazone
SIGNALING_BY_GPCR,-1.904555232,0.112030498,ciglitazone
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-3.096900223,0,glibenclamide
SARS_COV_1_INFECTION,-2.390322897,0,glibenclamide
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.509490351,0,glibenclamide
SARS_COV_1_HOST_INTERACTIONS,-2.546913319,0,glibenclamide
SIGNALING_BY_ROBO_RECEPTORS,-2.662044828,0,glibenclamide
INFLUENZA_INFECTION,-2.663473718,0,glibenclamide
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.710718596,0,glibenclamide
RRNA_PROCESSING,-2.746582878,0,glibenclamide
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.858725106,0,glibenclamide
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.830654446,0,glibenclamide
SELENOAMINO_ACID_METABOLISM,-2.729605286,0,caffeine
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.416350009,0,caffeine
TRANSLATION,-2.43500806,0,caffeine
INFLUENZA_INFECTION,-2.468652207,0,caffeine
CELLULAR_RESPONSE_TO_STARVATION,-2.48039499,0,caffeine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.495940858,0,caffeine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.514609784,0,caffeine
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.550588118,0,caffeine
SIGNALING_BY_ROBO_RECEPTORS,-2.45967048,0,caffeine
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.564020746,0,caffeine
SELENOAMINO_ACID_METABOLISM,-2.623672329,0,clomipramine
EUKARYOTIC_TRANSLATION_ELONGATION,-2.609384327,0,clomipramine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.594781472,0,clomipramine
CELLULAR_RESPONSE_TO_STARVATION,-2.576206456,0,clomipramine
EUKARYOTIC_TRANSLATION_INITIATION,-2.545091444,0,clomipramine
NONSENSE_MEDIATED_DECAY_NMD,-2.515702719,0,clomipramine
RRNA_PROCESSING,-2.497296068,0,clomipramine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.492558956,0,clomipramine
TRANSLATION,-2.410276754,0.000108538,clomipramine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.398501461,9.77E-05,clomipramine
SELENOAMINO_ACID_METABOLISM,-2.928639055,0,mestinon
SARS_COV_2_HOST_INTERACTIONS,-2.334271365,0,mestinon
TRANSLATION,-2.374614523,0,mestinon
SIGNALING_BY_ROBO_RECEPTORS,-2.490228717,0,mestinon
INFLUENZA_INFECTION,-2.497634877,0,mestinon
SARS_COV_1_INFECTION,-2.54895831,0,mestinon
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.55313043,0,mestinon
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.559616913,0,mestinon
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.616605968,0,mestinon
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.626287394,0,mestinon
GPCR_LIGAND_BINDING,-2.653011742,0,filgotinib
MHC_CLASS_II_ANTIGEN_PRESENTATION,2.630174426,0,filgotinib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.625435962,0,filgotinib
GOLGI_TO_ER_RETROGRADE_TRANSPORT,2.610430415,0.00109101,filgotinib
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.459724655,0.000282868,filgotinib
SIGNALING_BY_GPCR,-2.323583389,0.001697206,filgotinib
G_ALPHA_Q_SIGNALLING_EVENTS,-2.304948601,0.001697206,filgotinib
SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3,2.096714816,0.042913063,filgotinib
SIGNALING_BY_NTRKS,1.827137503,0.144558835,filgotinib
RESOLUTION_OF_SISTER_CHROMATID_COHESION,1.826981451,0.115647068,filgotinib
TRANSLATION,3.614238886,0,diclofenac
EUKARYOTIC_TRANSLATION_ELONGATION,3.06073493,0,diclofenac
CELLULAR_RESPONSE_TO_STARVATION,3.059272494,0,diclofenac
NONSENSE_MEDIATED_DECAY_NMD,3.000073433,0,diclofenac
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.976051857,0,diclofenac
INFLUENZA_INFECTION,2.856649296,0,diclofenac
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.349679564,0,diclofenac
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.419082391,0.000745957,diclofenac
TOLL_LIKE_RECEPTOR_CASCADES,2.419514702,0.00080812,diclofenac
RRNA_PROCESSING,2.463859762,0.000881585,diclofenac
GPCR_LIGAND_BINDING,2.717137428,0,AT-7867
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.706710101,0,AT-7867
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.615722077,0,AT-7867
G_ALPHA_Q_SIGNALLING_EVENTS,2.267401105,0.001066525,AT-7867
SIGNALING_BY_GPCR,2.219349599,0.001584552,AT-7867
METABOLISM_OF_RNA,-2.197134974,0.08287651,AT-7867
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,-2.128502624,0.078514589,AT-7867
ADAPTIVE_IMMUNE_SYSTEM,-2.112599733,0.055251007,AT-7867
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,-2.079447564,0.052343059,AT-7867
CELL_CYCLE,-1.981211639,0.068918361,AT-7867
METABOLISM_OF_RNA,-3.396488736,0,nilotinib
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,-2.535519259,0,nilotinib
EXTENSION_OF_TELOMERES,-2.539859262,0,nilotinib
REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS,-2.571630894,0,nilotinib
ORC1_REMOVAL_FROM_CHROMATIN,-2.57260262,0,nilotinib
MRNA_SPLICING,-2.74332884,0,nilotinib
CHROMOSOME_MAINTENANCE,-2.755323083,0,nilotinib
CELL_CYCLE_CHECKPOINTS,-2.814322153,0,nilotinib
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.751450383,0,nilotinib
M_PHASE,-2.816377703,0,nilotinib
CELL_CYCLE,-3.793608764,0,geldanamycin
CELL_CYCLE_MITOTIC,-3.789700278,0,geldanamycin
M_PHASE,-3.07176217,0,geldanamycin
MITOTIC_METAPHASE_AND_ANAPHASE,-2.972124717,0,geldanamycin
RESOLUTION_OF_SISTER_CHROMATID_COHESION,-2.930556392,0,geldanamycin
MITOTIC_PROMETAPHASE,-2.896680589,0,geldanamycin
MHC_CLASS_II_ANTIGEN_PRESENTATION,-2.85495334,0,geldanamycin
RHO_GTPASES_ACTIVATE_FORMINS,-2.827090722,0,geldanamycin
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,-2.826411199,0,geldanamycin
DNA_REPLICATION,-2.772524927,0,geldanamycin
CELL_CYCLE_MITOTIC,3.138946243,0,prochlorperazine
CELL_CYCLE,2.85354018,0,prochlorperazine
M_PHASE,2.697694844,0,prochlorperazine
CELL_CYCLE_CHECKPOINTS,2.576278003,0,prochlorperazine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.321985181,0,prochlorperazine
GPCR_LIGAND_BINDING,-2.260460774,0.000273425,prochlorperazine
RHO_GTPASE_EFFECTORS,2.417846821,0.002821869,prochlorperazine
SUMOYLATION,2.402915244,0.002351558,prochlorperazine
MITOTIC_PROMETAPHASE,2.39638335,0.002015621,prochlorperazine
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,2.30137999,0.002645503,prochlorperazine
REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE,2.380548118,0.013077594,ropinirole
SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3,2.166770397,0.019616391,ropinirole
SENSORY_PERCEPTION,-2.19845104,0.045609509,ropinirole
RHO_GTPASE_CYCLE,2.01637453,0.047951177,ropinirole
RESOLUTION_OF_SISTER_CHROMATID_COHESION,1.823388332,0.130775937,ropinirole
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,1.821242551,0.106190061,ropinirole
MHC_CLASS_II_ANTIGEN_PRESENTATION,1.785144635,0.110723627,ropinirole
HCMV_EARLY_EVENTS,1.751744185,0.118071989,ropinirole
GPCR_LIGAND_BINDING,-1.982365822,0.189486778,ropinirole
MITOTIC_PROMETAPHASE,1.705000027,0.134372276,ropinirole
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,2.361441368,0.016001182,theophylline
SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS,2.093520705,0.044803309,theophylline
NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK,1.954552112,0.07253869,theophylline
DEUBIQUITINATION,1.763793422,0.176813057,theophylline
GPCR_LIGAND_BINDING,-1.871622752,0.337104418,theophylline
INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS,1.663142279,0.266259662,theophylline
PI3K_AKT_SIGNALING_IN_CANCER,1.55300211,0.391495577,theophylline
G2_M_CHECKPOINTS,1.525950609,0.383114006,theophylline
MITOCHONDRIAL_BIOGENESIS,1.499805028,0.385628477,theophylline
HCMV_EARLY_EVENTS,1.494871819,0.351670414,theophylline
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.30074186,0.009150838,dantrolene
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,2.157025403,0.022877094,dantrolene
METABOLISM_OF_STEROIDS,-2.19371172,0.092602783,dantrolene
REGULATION_OF_T_CELL_ACTIVATION_BY_CD28_FAMILY,2.128091862,0.020843574,dantrolene
SIGNALING_BY_GPCR,2.102853902,0.019826815,dantrolene
NEUTROPHIL_DEGRANULATION,-2.146656529,0.078413647,dantrolene
G_ALPHA_I_SIGNALLING_EVENTS,2.044296435,0.028825138,dantrolene
GPCR_LIGAND_BINDING,1.943147909,0.061005584,dantrolene
METABOLISM_OF_LIPIDS,-1.855696778,0.363441029,dantrolene
GLOBAL_GENOME_NUCLEOTIDE_EXCISION_REPAIR_GG_NER,-1.854540504,0.274447764,dantrolene
GPCR_LIGAND_BINDING,-2.273248154,0.01417562,tazarotene
CELLULAR_RESPONSE_TO_STARVATION,2.217878967,0.094416096,tazarotene
INNATE_IMMUNE_SYSTEM,2.150174647,0.075870077,tazarotene
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.172623154,0.020757158,tazarotene
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.156031248,0.016706981,tazarotene
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.073030997,0.027971536,tazarotene
TCR_SIGNALING,1.945845427,0.204568209,tazarotene
RESPIRATORY_ELECTRON_TRANSPORT,1.935720285,0.163120666,tazarotene
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.982249904,0.044248186,tazarotene
SIGNALING_BY_GPCR,-1.96124526,0.04320189,tazarotene
CELLULAR_RESPONSE_TO_STARVATION,2.197134332,0.045401584,canertinib
SELENOAMINO_ACID_METABOLISM,2.112228422,0.048962493,canertinib
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.11831186,0.159157482,canertinib
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.092391207,0.039466736,canertinib
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,2.047404747,0.047182038,canertinib
REGULATION_OF_TP53_ACTIVITY,2.004036404,0.059111082,canertinib
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.967099734,0.202393175,canertinib
EUKARYOTIC_TRANSLATION_ELONGATION,1.968157017,0.066915407,canertinib
SYNTHESIS_OF_DNA,-1.851511845,0.265262469,canertinib
EUKARYOTIC_TRANSLATION_INITIATION,1.915309054,0.086097682,canertinib
METABOLISM_OF_RNA,-3.054162522,0,hexachlorophene
CELL_CYCLE,-2.785228384,0,hexachlorophene
RRNA_PROCESSING,-2.709928774,0,hexachlorophene
CELL_CYCLE_MITOTIC,-2.683787126,0,hexachlorophene
CELL_CYCLE_CHECKPOINTS,-2.611797462,0,hexachlorophene
MITOTIC_METAPHASE_AND_ANAPHASE,-2.606329333,0,hexachlorophene
TRANSLATION,-2.553763076,0.000457184,hexachlorophene
AUTOPHAGY,-2.530876941,0.000600055,hexachlorophene
DNA_REPLICATION,-2.512929824,0.000711176,hexachlorophene
SEPARATION_OF_SISTER_CHROMATIDS,-2.404997099,0.002400218,hexachlorophene
EXTRACELLULAR_MATRIX_ORGANIZATION,3.356813489,0,clozapine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,2.733317359,0,clozapine
MITOCHONDRIAL_TRANSLATION,2.048735267,0.009742085,clozapine
EUKARYOTIC_TRANSLATION_ELONGATION,-3.20702416,0.254642551,clozapine
SELENOAMINO_ACID_METABOLISM,-3.179611935,0.228539026,clozapine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-3.114475782,0.425114552,clozapine
EUKARYOTIC_TRANSLATION_INITIATION,-3.113201518,0.324429527,clozapine
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-3.079240202,0.378447842,clozapine
NONSENSE_MEDIATED_DECAY_NMD,-3.040482646,0.423871527,clozapine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-3.032157414,0.380822273,clozapine
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.20027451,0.054700158,milrinone
SENSORY_PERCEPTION,-2.167933545,0.034498395,milrinone
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.053920136,0.054700158,milrinone
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,1.910583699,0.659866825,milrinone
SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,-1.92896289,0.094792887,milrinone
DEUBIQUITINATION,1.833740235,0.598306922,milrinone
ADAPTIVE_IMMUNE_SYSTEM,1.802880259,0.491556978,milrinone
METABOLISM_OF_VITAMINS_AND_COFACTORS,-1.837404206,0.140106995,milrinone
TCR_SIGNALING,1.747857057,0.525334228,milrinone
METABOLISM_OF_STEROIDS,-1.779053088,0.169798407,milrinone
EUKARYOTIC_TRANSLATION_ELONGATION,3.059467515,0,repaglinide
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.998888991,0,repaglinide
EUKARYOTIC_TRANSLATION_INITIATION,2.990302821,0,repaglinide
SELENOAMINO_ACID_METABOLISM,2.974587964,0,repaglinide
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.974383085,0,repaglinide
NONSENSE_MEDIATED_DECAY_NMD,2.921818704,0,repaglinide
CELLULAR_RESPONSE_TO_STARVATION,2.812283347,0,repaglinide
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.773445403,0,repaglinide
INFLUENZA_INFECTION,2.474431744,0.000291471,repaglinide
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.528663328,0.001538193,repaglinide
MUSCLE_CONTRACTION,1.939015944,0.302030495,triclosan
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.915976489,0.169532103,triclosan
METABOLISM_OF_VITAMINS_AND_COFACTORS,-1.711747383,1,triclosan
METABOLISM_OF_STEROIDS,-1.707260068,1,triclosan
ANTIGEN_PROCESSING_CROSS_PRESENTATION,1.584258933,0.712967535,triclosan
SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,-1.679331656,1,triclosan
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.53436986,0.687386841,triclosan
APOPTOSIS,-1.652554036,0.967939455,triclosan
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,1.511909641,0.614759618,triclosan
PROGRAMMED_CELL_DEATH,-1.64431512,0.819876273,triclosan
METABOLISM_OF_RNA,2.276578619,0.032649023,dapsone
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.25180549,0.010569652,dapsone
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.186895344,0.033609288,dapsone
NONSENSE_MEDIATED_DECAY_NMD,2.107708083,0.051214154,dapsone
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.101003647,0.041771544,dapsone
EUKARYOTIC_TRANSLATION_ELONGATION,2.062219164,0.044556314,dapsone
SENSORY_PERCEPTION,-2.094886945,0.030828152,dapsone
SELENOAMINO_ACID_METABOLISM,2.028720874,0.047053004,dapsone
SIGNALING_BY_ROBO_RECEPTORS,2.026243581,0.041428592,dapsone
VISUAL_PHOTOTRANSDUCTION,-2.050541846,0.034253502,dapsone
METABOLISM_OF_RNA,2.137146157,0.035608309,zolpidem
RRNA_PROCESSING,1.817078534,0.133531157,zolpidem
GPCR_LIGAND_BINDING,-1.916903331,0.091961274,zolpidem
INFLUENZA_INFECTION,1.664259501,0.196834817,zolpidem
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.835220324,0.125120387,zolpidem
SEMAPHORIN_INTERACTIONS,1.427209014,0.525222552,zolpidem
G_ALPHA_Q_SIGNALLING_EVENTS,-1.741685198,0.23167167,zolpidem
MITOCHONDRIAL_BIOGENESIS,1.392582782,0.49495549,zolpidem
NEURONAL_SYSTEM,-1.693107971,0.276547003,zolpidem
AUTOPHAGY,1.296865397,0.651829871,zolpidem
METABOLISM_OF_RNA,4.833368619,0,febuxostat
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,3.002802167,0,febuxostat
MRNA_SPLICING,2.877142521,0,febuxostat
GPCR_LIGAND_BINDING,-2.043833819,0.011348305,febuxostat
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.015658968,0.008916526,febuxostat
INTERLEUKIN_1_FAMILY_SIGNALING,1.837023006,0.081880901,febuxostat
INFLUENZA_INFECTION,1.820684352,0.069077705,febuxostat
SIGNALING_BY_ROBO_RECEPTORS,1.767773548,0.074437182,febuxostat
EPIGENETIC_REGULATION_BY_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES,1.748625414,0.069758274,febuxostat
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.886306934,0.034315113,febuxostat
METABOLISM_OF_RNA,-3.097844147,0,ARN-509
TRANSLATION,-3.006733561,0,ARN-509
RRNA_PROCESSING,-2.92692243,0,ARN-509
CELL_CYCLE_CHECKPOINTS,-2.493252037,0.00260722,ARN-509
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.482878999,0.002346498,ARN-509
EUKARYOTIC_TRANSLATION_INITIATION,-2.448519145,0.002824488,ARN-509
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,-2.354756399,0.00502821,ARN-509
MITOTIC_METAPHASE_AND_ANAPHASE,-2.313928201,0.00651805,ARN-509
CLEC7A_DECTIN_1_SIGNALING,-2.300265302,0.00651805,ARN-509
SIGNALING_BY_ROBO_RECEPTORS,-2.288101691,0.006778772,ARN-509
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,5.455351318,0,didanosine
SCF_BETA_TRCP_MEDIATED_DEGRADATION_OF_EMI1,2.869341923,0,didanosine
RNA_POLYMERASE_II_TRANSCRIPTION_TERMINATION,2.885987629,0,didanosine
SIGNALING_BY_NOTCH4,2.886647748,0,didanosine
APC_C_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS,2.900132838,0,didanosine
G1_S_DNA_DAMAGE_CHECKPOINTS,2.903829098,0,didanosine
CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6,2.905103863,0,didanosine
APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1,2.862032193,0,didanosine
CELL_CYCLE_CHECKPOINTS,2.91513414,0,didanosine
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,2.922399095,0,didanosine
GPCR_LIGAND_BINDING,-2.592574813,0,diazepam
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.530169799,0,diazepam
SENSORY_PERCEPTION,-2.440949564,0,diazepam
SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3,2.538295001,0.008469367,diazepam
SIGNALING_BY_GPCR,-2.304034755,0.001253777,diazepam
G_ALPHA_Q_SIGNALLING_EVENTS,-2.292074286,0.001289599,diazepam
RHO_GTPASE_CYCLE,2.315837052,0.022232088,diazepam
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.206343127,0.002746369,diazepam
G_ALPHA_S_SIGNALLING_EVENTS,-2.099129897,0.009006726,diazepam
EUKARYOTIC_TRANSLATION_INITIATION,-2.009207583,0.01997088,diazepam
METABOLISM_OF_RNA,-2.601841927,0.006662646,tandutinib
GPCR_LIGAND_BINDING,2.432755589,0.003235433,tandutinib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.336649185,0.004529606,tandutinib
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.274667503,0.005608084,tandutinib
MITOTIC_METAPHASE_AND_ANAPHASE,-2.325437903,0.025817754,tandutinib
CELL_CYCLE_MITOTIC,-2.246522481,0.03220279,tandutinib
TCR_SIGNALING,2.142260628,0.011162244,tandutinib
RRNA_PROCESSING,-2.153240049,0.043723615,tandutinib
CELL_CELL_JUNCTION_ORGANIZATION,2.081687159,0.016047747,tandutinib
SEPARATION_OF_SISTER_CHROMATIDS,-2.118000974,0.047304787,tandutinib
METABOLISM_OF_RNA,5.024912865,0,LY-364947
HOST_INTERACTIONS_OF_HIV_FACTORS,2.889974286,0,LY-364947
HIV_INFECTION,2.890906471,0,LY-364947
SARS_COV_1_HOST_INTERACTIONS,2.913390218,0,LY-364947
SARS_COV_2_INFECTION,2.979675384,0,LY-364947
REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS,3.044039043,0,LY-364947
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,3.049912885,0,LY-364947
SARS_COV_2_HOST_INTERACTIONS,3.058935807,0,LY-364947
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.168790989,0,LY-364947
SARS_COV_INFECTIONS,3.265792278,0,LY-364947
CELLULAR_RESPONSE_TO_STARVATION,2.08410851,0.208735825,zafirlukast
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.089597544,0.092197945,zafirlukast
TRANSLATION,2.045937133,0.136982885,zafirlukast
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,1.975260976,0.165249195,zafirlukast
NONSENSE_MEDIATED_DECAY_NMD,1.952038731,0.14863109,zafirlukast
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,1.934728679,0.14052394,zafirlukast
REGULATION_OF_TP53_ACTIVITY,1.9317529,0.119277614,zafirlukast
PARASITE_INFECTION,1.867880888,0.15948056,zafirlukast
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,1.866339502,0.141642167,zafirlukast
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.908585094,0.211127838,zafirlukast
GPCR_LIGAND_BINDING,-2.706391594,0,fostamatinib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.627273511,0,fostamatinib
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.374600214,0.000196573,fostamatinib
SIGNALING_BY_GPCR,-2.312211166,0.000442289,fostamatinib
AMINE_LIGAND_BINDING_RECEPTORS,-2.218224642,0.000471775,fostamatinib
KERATINIZATION,-2.213178022,0.000393145,fostamatinib
SENSORY_PERCEPTION,-2.17715591,0.000421227,fostamatinib
HATS_ACETYLATE_HISTONES,2.302692362,0.033555036,fostamatinib
AUTOPHAGY,2.275326167,0.019174306,fostamatinib
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,2.23994302,0.015978589,fostamatinib
EUKARYOTIC_TRANSLATION_ELONGATION,1.935978733,0.53492823,BRD-K24255045
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,1.859277048,0.502392344,BRD-K24255045
SIGNALING_BY_GPCR,1.799575516,0.526953748,BRD-K24255045
GPCR_LIGAND_BINDING,1.76673105,0.494736842,BRD-K24255045
G_ALPHA_I_SIGNALLING_EVENTS,1.763654736,0.404019139,BRD-K24255045
INFLUENZA_INFECTION,1.762594195,0.339393939,BRD-K24255045
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,1.747906783,0.323308271,BRD-K24255045
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,1.720865802,0.34354067,BRD-K24255045
NEUTROPHIL_DEGRANULATION,-2.260577188,1,BRD-K24255045
SELENOAMINO_ACID_METABOLISM,1.697217186,0.357469431,BRD-K24255045
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,2.221793058,0.049300803,olopatadine
HEMOSTASIS,2.116357471,0.074978305,olopatadine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.080898471,0.069500438,olopatadine
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,2.014638352,0.092695781,olopatadine
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,1.892401141,0.207474213,olopatadine
ADAPTIVE_IMMUNE_SYSTEM,1.827076785,0.288786301,olopatadine
CDC42_GTPASE_CYCLE,-1.494277452,1,olopatadine
RHOA_GTPASE_CYCLE,-1.442226534,0.93896454,olopatadine
RHO_GTPASE_EFFECTORS,1.696687078,0.598652608,olopatadine
G_ALPHA_Q_SIGNALLING_EVENTS,1.673731362,0.606502587,olopatadine
NEURONAL_SYSTEM,2.216204501,0.045495049,BRD-A20239487
MUSCLE_CONTRACTION,2.144543078,0.038774189,BRD-A20239487
CARDIAC_CONDUCTION,2.055344087,0.056179492,BRD-A20239487
RRNA_PROCESSING,-1.982060137,0.356663471,BRD-A20239487
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,1.922843746,0.132607727,BRD-A20239487
METABOLISM_OF_RNA,-1.924731153,0.26126558,BRD-A20239487
PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES,1.77100182,0.314743019,BRD-A20239487
REGULATION_OF_T_CELL_ACTIVATION_BY_CD28_FAMILY,1.72100824,0.362754081,BRD-A20239487
TRANSCRIPTIONAL_REGULATION_BY_RUNX2,-1.675316383,0.791307127,BRD-A20239487
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,1.693694846,0.366176057,BRD-A20239487
RRNA_PROCESSING,3.597473947,0,methylene-blue
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.53826462,0,methylene-blue
EUKARYOTIC_TRANSLATION_INITIATION,3.458365043,0,methylene-blue
EUKARYOTIC_TRANSLATION_ELONGATION,3.279364651,0,methylene-blue
CELLULAR_RESPONSE_TO_STARVATION,3.003649003,0,methylene-blue
SELENOAMINO_ACID_METABOLISM,2.885885107,0,methylene-blue
TRANSLATION,2.427317087,0.000943361,methylene-blue
RRNA_MODIFICATION_IN_THE_NUCLEUS_AND_CYTOSOL,2.190018305,0.007428969,methylene-blue
REGULATION_OF_TP53_ACTIVITY,-1.975740938,0.183561492,methylene-blue
CELL_CYCLE,-1.950636292,0.123261098,methylene-blue
CELL_CYCLE,-4.264854235,0,BMS-754807
S_PHASE,-2.796378125,0,BMS-754807
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.790192535,0,BMS-754807
RHO_GTPASE_EFFECTORS,-2.771395118,0,BMS-754807
MITOTIC_G2_G2_M_PHASES,-2.767085369,0,BMS-754807
HOMOLOGY_DIRECTED_REPAIR,-2.734108522,0,BMS-754807
DNA_REPLICATION_PRE_INITIATION,-2.727700851,0,BMS-754807
G2_M_DNA_DAMAGE_CHECKPOINT,-2.682773405,0,BMS-754807
MITOTIC_PROPHASE,-2.677761746,0,BMS-754807
SELENOAMINO_ACID_METABOLISM,2.657048979,0,BMS-754807
GOLGI_TO_ER_RETROGRADE_TRANSPORT,3.520427762,0,sorafenib
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,2.790589909,0,sorafenib
TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM,2.760409005,0,sorafenib
MHC_CLASS_II_ANTIGEN_PRESENTATION,2.488265103,0.002129978,sorafenib
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.476246667,0.001703983,sorafenib
METABOLISM_OF_RNA,2.293882661,0.002839971,sorafenib
MRNA_SPLICING,2.063132157,0.018256956,sorafenib
S_PHASE,2.008233463,0.021299782,sorafenib
RHO_GTPASE_EFFECTORS,1.780884162,0.05963939,sorafenib
GPCR_LIGAND_BINDING,-1.910095423,0.211084811,sorafenib
TRANSLATION,4.032220626,0,triamterene
METABOLISM_OF_RNA,2.373767999,0.013553531,triamterene
MRNA_SPLICING,2.274137221,0.014198937,triamterene
S_PHASE,2.20674404,0.015489749,triamterene
RRNA_PROCESSING,2.126518314,0.020911162,triamterene
TELOMERE_MAINTENANCE,2.095284557,0.020652999,triamterene
HIV_TRANSCRIPTION_INITIATION,2.001722446,0.027107062,triamterene
RNA_POLYMERASE_II_PRE_TRANSCRIPTION_EVENTS,1.993046791,0.023718679,triamterene
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,1.944230049,0.030979499,triamterene
PLATELET_HOMEOSTASIS,-2.05254848,0.059879032,triamterene
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.478208688,0,letrozole
MRNA_SPLICING,2.10643649,0.022426912,letrozole
MITOTIC_METAPHASE_AND_ANAPHASE,1.905471658,0.059805099,letrozole
HOST_INTERACTIONS_OF_HIV_FACTORS,1.701485282,0.118542251,letrozole
SEPARATION_OF_SISTER_CHROMATIDS,1.560120039,0.20248298,letrozole
MHC_CLASS_II_ANTIGEN_PRESENTATION,1.55577975,0.171939661,letrozole
G_ALPHA_Q_SIGNALLING_EVENTS,-1.756811138,0.305261627,letrozole
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,1.417477029,0.31123062,letrozole
M_PHASE,1.400429932,0.301962355,letrozole
GOLGI_TO_ER_RETROGRADE_TRANSPORT,1.363908901,0.321808392,letrozole
INFLUENZA_INFECTION,2.655109194,0,benzbromarone
CELLULAR_RESPONSE_TO_STARVATION,2.610890597,0,benzbromarone
EUKARYOTIC_TRANSLATION_INITIATION,2.45596226,0.003065228,benzbromarone
EUKARYOTIC_TRANSLATION_ELONGATION,2.398350378,0.004597842,benzbromarone
TRANSLATION,2.395339884,0.003678274,benzbromarone
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.389488698,0.003065228,benzbromarone
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.381019116,0.002627338,benzbromarone
RRNA_PROCESSING,2.339563503,0.003448382,benzbromarone
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.255021716,0.001753252,benzbromarone
SELENOAMINO_ACID_METABOLISM,2.283796306,0.006130456,benzbromarone
DNA_REPLICATION,3.879900394,0,calcipotriol
NUCLEAR_EVENTS_MEDIATED_BY_NFE2L2,3.111768781,0,calcipotriol
M_PHASE,3.174168076,0,calcipotriol
G1_S_DNA_DAMAGE_CHECKPOINTS,3.304776623,0,calcipotriol
SEPARATION_OF_SISTER_CHROMATIDS,3.326522009,0,calcipotriol
CELL_CYCLE_MITOTIC,3.511154375,0,calcipotriol
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,3.535062914,0,calcipotriol
S_PHASE,3.544840113,0,calcipotriol
ORC1_REMOVAL_FROM_CHROMATIN,3.45260912,0,calcipotriol
DNA_REPLICATION_PRE_INITIATION,3.550611784,0,calcipotriol
CELL_CYCLE_CHECKPOINTS,2.65777319,0,sulfinpyrazone
RRNA_PROCESSING,2.502867395,0.000719424,sulfinpyrazone
RHO_GTPASES_ACTIVATE_FORMINS,2.433986784,0.002398082,sulfinpyrazone
CELL_CYCLE_MITOTIC,2.376628059,0.002877698,sulfinpyrazone
SEPARATION_OF_SISTER_CHROMATIDS,2.37233039,0.002302158,sulfinpyrazone
NEUTROPHIL_DEGRANULATION,-2.169958599,0.023157471,sulfinpyrazone
MITOTIC_METAPHASE_AND_ANAPHASE,2.228589687,0.005995204,sulfinpyrazone
DNA_REPLICATION,2.211876645,0.006166495,sulfinpyrazone
BETA_CATENIN_INDEPENDENT_WNT_SIGNALING,2.193782287,0.005755396,sulfinpyrazone
S_PHASE,2.147035269,0.005915268,sulfinpyrazone
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-4.128161129,0,cyclophosphamide
SIGNALING_BY_GPCR,2.692975205,0,cyclophosphamide
G_ALPHA_Q_SIGNALLING_EVENTS,2.49455768,0,cyclophosphamide
HIV_INFECTION,-2.870932641,0,cyclophosphamide
DNA_REPAIR,-2.880479632,0,cyclophosphamide
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.835705096,0,cyclophosphamide
GPCR_LIGAND_BINDING,2.945384963,0,cyclophosphamide
NUCLEOTIDE_EXCISION_REPAIR,-3.087351996,0,cyclophosphamide
MRNA_SPLICING,-4.015525161,0,cyclophosphamide
METABOLISM_OF_RNA,-4.102967823,0,cyclophosphamide
CELL_CYCLE_MITOTIC,3.132144262,0,W-7
SEPARATION_OF_SISTER_CHROMATIDS,3.005601762,0,W-7
S_PHASE,2.859006152,0,W-7
MITOTIC_METAPHASE_AND_ANAPHASE,2.822783899,0.000985999,W-7
CELL_CYCLE_CHECKPOINTS,2.427655704,0.000985999,W-7
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.743945445,0.001577598,W-7
M_PHASE,2.586639599,0.001314665,W-7
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,2.51799594,0.001126856,W-7
CELL_CYCLE,2.162336745,0.00262933,W-7
SIGNALING_BY_INTERLEUKINS,2.001103329,0.012620785,W-7
EXTRACELLULAR_MATRIX_ORGANIZATION,2.848058675,0,cortisone-acetate
GPCR_LIGAND_BINDING,2.819182349,0,cortisone-acetate
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,2.564502111,0.000191979,cortisone-acetate
SIGNALING_BY_GPCR,2.600744574,0.000239974,cortisone-acetate
COLLAGEN_FORMATION,2.654853024,0.000319965,cortisone-acetate
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.382307791,0.002079773,cortisone-acetate
G_ALPHA_S_SIGNALLING_EVENTS,2.334798929,0.003428197,cortisone-acetate
G_ALPHA_Q_SIGNALLING_EVENTS,1.87373347,0.061073327,cortisone-acetate
MUSCLE_CONTRACTION,-2.975127865,0.82985381,cortisone-acetate
BIOLOGICAL_OXIDATIONS,-2.939519502,0.679934965,cortisone-acetate
METABOLISM_OF_RNA,2.266557174,0.039305446,telmisartan
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,2.263222236,0.019652723,telmisartan
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.212266394,0.02110848,telmisartan
REGULATION_OF_TP53_ACTIVITY,2.196769232,0.018560905,telmisartan
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.220652233,0.025742861,telmisartan
G2_M_DNA_DAMAGE_CHECKPOINT,2.096833875,0.045419626,telmisartan
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.156857087,0.023133788,telmisartan
PROCESSING_OF_DNA_DOUBLE_STRAND_BREAK_ENDS,2.040041116,0.061505744,telmisartan
CELL_CYCLE,2.025891078,0.058958169,telmisartan
CELL_CYCLE_CHECKPOINTS,2.003727646,0.060049987,telmisartan
RESPIRATORY_ELECTRON_TRANSPORT,2.952173029,0,tocainide
EUKARYOTIC_TRANSLATION_INITIATION,2.830767742,0.002173126,tocainide
DNA_REPLICATION,2.658366983,0.002897501,tocainide
SYNTHESIS_OF_DNA,2.596941855,0.002173126,tocainide
TRANSLATION,2.59437578,0.001738501,tocainide
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.461194398,0.003984064,tocainide
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,2.436718226,0.003725358,tocainide
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.436151561,0.003259689,tocainide
S_PHASE,2.322157821,0.002765796,tocainide
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.422315745,0.003138959,tocainide
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.36020279,0.000836365,quizartinib
GPCR_LIGAND_BINDING,2.339018865,0.000418183,quizartinib
AMINE_LIGAND_BINDING_RECEPTORS,2.270462116,0.000836365,quizartinib
SENSORY_PERCEPTION,1.975614796,0.023418224,quizartinib
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.934389394,0.028436415,quizartinib
SIGNALING_BY_GPCR,1.884633499,0.040981893,quizartinib
MRNA_SPLICING,-2.038960011,1,quizartinib
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.012312764,1,quizartinib
VISUAL_PHOTOTRANSDUCTION,1.796096129,0.081724824,quizartinib
FOXO_MEDIATED_TRANSCRIPTION,-1.693886419,1,quizartinib
EUKARYOTIC_TRANSLATION_ELONGATION,2.83619558,0,quetiapine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.696567911,0,quetiapine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.627682357,0.000462623,quetiapine
INFLUENZA_INFECTION,2.538648805,0.000346967,quetiapine
SELENOAMINO_ACID_METABOLISM,2.490554156,0.000277574,quetiapine
EUKARYOTIC_TRANSLATION_INITIATION,2.439394926,0.000462623,quetiapine
NONSENSE_MEDIATED_DECAY_NMD,2.407477063,0.001189602,quetiapine
CELLULAR_RESPONSE_TO_STARVATION,2.357747637,0.001387869,quetiapine
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.24771645,0.004472023,quetiapine
TRANSLATION,2.147563518,0.010825379,quetiapine
EUKARYOTIC_TRANSLATION_ELONGATION,-3.301978388,0,diphenidol
SARS_COV_1_INFECTION,-2.516264956,0,diphenidol
SARS_COV_2_HOST_INTERACTIONS,-2.617154117,0,diphenidol
SARS_COV_1_HOST_INTERACTIONS,-2.630799695,0,diphenidol
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.645132985,0,diphenidol
TRANSLATION,-2.849693558,0,diphenidol
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.857092784,0,diphenidol
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.927682361,0,diphenidol
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.942622386,0,diphenidol
SIGNALING_BY_ROBO_RECEPTORS,-3.007422341,0,diphenidol
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.921290444,0.62811145,escitalopram
METABOLISM_OF_STEROIDS,-1.879233647,0.408202184,escitalopram
REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE,-1.853501455,0.321315775,escitalopram
RRNA_PROCESSING,-1.810341243,0.312650554,escitalopram
METABOLISM_OF_RNA,-1.779762272,0.301830737,escitalopram
RHOA_GTPASE_CYCLE,-1.69236597,0.414525454,escitalopram
SIGNALING_BY_VEGF,-1.674490633,0.388027943,escitalopram
PHOSPHOLIPID_METABOLISM,-1.667795281,0.353049221,escitalopram
NUCLEOTIDE_EXCISION_REPAIR,-1.590077158,0.460427707,escitalopram
EXTRA_NUCLEAR_ESTROGEN_SIGNALING,-1.569181774,0.458647824,escitalopram
SELENOAMINO_ACID_METABOLISM,-2.71599644,0,toremifene
SIGNALING_BY_ROBO_RECEPTORS,-2.375337427,0,toremifene
TRANSLATION,-2.379615327,0,toremifene
INFLUENZA_INFECTION,-2.408019543,0,toremifene
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.413970671,0,toremifene
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.438423744,0,toremifene
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.465659292,0,toremifene
CELLULAR_RESPONSE_TO_STARVATION,-2.469790257,0,toremifene
RRNA_PROCESSING,-2.581840426,0,toremifene
EUKARYOTIC_TRANSLATION_INITIATION,-2.586714925,0,toremifene
CELLULAR_RESPONSE_TO_STARVATION,2.779857369,0,neratinib
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.745065237,0,neratinib
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,2.618649085,0,neratinib
DNA_REPAIR,-2.593108956,0,neratinib
EUKARYOTIC_TRANSLATION_ELONGATION,2.530494274,0,neratinib
CYTOPROTECTION_BY_HMOX1,2.472264061,0,neratinib
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.470383883,0,neratinib
CELL_CYCLE_MITOTIC,-2.537888105,0.001274963,neratinib
SELENOAMINO_ACID_METABOLISM,2.342030621,0.000333705,neratinib
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.303825654,0.000681313,neratinib
GPCR_LIGAND_BINDING,3.457695847,0,propoxycaine
G_ALPHA_Q_SIGNALLING_EVENTS,2.581456001,0,propoxycaine
NONSENSE_MEDIATED_DECAY_NMD,-2.803840221,0,propoxycaine
MEMBRANE_TRAFFICKING,-2.812282695,0,propoxycaine
G_ALPHA_I_SIGNALLING_EVENTS,2.911560886,0,propoxycaine
VESICLE_MEDIATED_TRANSPORT,-2.768646419,0,propoxycaine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-3.089332934,0,propoxycaine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,3.182523762,0,propoxycaine
SIGNALING_BY_GPCR,3.323473774,0,propoxycaine
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,-2.918451913,0,propoxycaine
KERATINIZATION,-2.190845242,0.01008031,amiodarone
GPCR_LIGAND_BINDING,-2.187309083,0.005040155,amiodarone
SENSORY_PERCEPTION,-2.158711799,0.005280162,amiodarone
VISUAL_PHOTOTRANSDUCTION,-2.150519893,0.004500138,amiodarone
CELL_CYCLE_MITOTIC,2.128368216,0.107958478,amiodarone
POTENTIAL_THERAPEUTICS_FOR_SARS,2.093356579,0.062975779,amiodarone
MITOTIC_PROMETAPHASE,2.060274998,0.047981546,amiodarone
REGULATION_OF_PLK1_ACTIVITY_AT_G2_M_TRANSITION,1.980451885,0.052854671,amiodarone
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.056115919,0.012240377,amiodarone
TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,1.890461148,0.071072664,amiodarone
PLATELET_HOMEOSTASIS,2.010891243,0.25425319,diazoxide
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,-1.884662823,0.824624843,diazoxide
EXTRA_NUCLEAR_ESTROGEN_SIGNALING,-1.835572712,0.595444768,diazoxide
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.76366979,0.750562922,diazoxide
NUCLEOTIDE_EXCISION_REPAIR,-1.762128646,0.640786785,diazoxide
EPIGENETIC_REGULATION_BY_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES,-1.713300288,0.632230023,diazoxide
REGULATION_OF_T_CELL_ACTIVATION_BY_CD28_FAMILY,1.681780066,0.834063047,diazoxide
SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES,1.635437925,0.800991369,diazoxide
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,1.622988277,0.689954966,diazoxide
MUSCLE_CONTRACTION,1.619089294,0.587315487,diazoxide
SIGNALING_BY_GPCR,2.769580805,0,doxylamine
GPCR_LIGAND_BINDING,2.705449562,0,doxylamine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.49375953,0.000318691,doxylamine
G_ALPHA_I_SIGNALLING_EVENTS,2.177052634,0.013624051,doxylamine
G_ALPHA_Q_SIGNALLING_EVENTS,2.088262198,0.023519414,doxylamine
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.929750238,0.064694322,doxylamine
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,1.925200637,0.05709126,doxylamine
S_PHASE,1.822030839,0.110546024,doxylamine
DNA_REPLICATION,1.818824726,0.099856589,doxylamine
DNA_REPLICATION_PRE_INITIATION,1.813644635,0.094268869,doxylamine
EUKARYOTIC_TRANSLATION_INITIATION,-3.010922753,0,cyproheptadine
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.548725451,0,cyproheptadine
INFLUENZA_INFECTION,-2.564027025,0,cyproheptadine
CELLULAR_RESPONSE_TO_STARVATION,-2.714821876,0,cyproheptadine
RRNA_PROCESSING,-2.774728883,0,cyproheptadine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.783148944,0,cyproheptadine
NONSENSE_MEDIATED_DECAY_NMD,-2.794606659,0,cyproheptadine
SENSORY_PERCEPTION,-2.556585916,0,cyproheptadine
SELENOAMINO_ACID_METABOLISM,-2.823557464,0,cyproheptadine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.830750262,0,cyproheptadine
GPCR_LIGAND_BINDING,3.524687149,0,isocarboxazid
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,3.466352109,0,isocarboxazid
SIGNALING_BY_GPCR,3.34463857,0,isocarboxazid
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.612269314,0,isocarboxazid
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.759958104,0.005461627,isocarboxazid
G_ALPHA_Q_SIGNALLING_EVENTS,2.520531594,0.00022542,isocarboxazid
G_ALPHA_I_SIGNALLING_EVENTS,2.442358139,0.0003757,isocarboxazid
NONSENSE_MEDIATED_DECAY_NMD,-2.592283678,0.011833525,isocarboxazid
MEMBRANE_TRAFFICKING,-2.552069415,0.011530101,isocarboxazid
VESICLE_MEDIATED_TRANSPORT,-2.370576063,0.035500575,isocarboxazid
GPCR_LIGAND_BINDING,-2.260310853,0.001442588,vanoxerine
INNATE_IMMUNE_SYSTEM,2.407818222,0.047527208,vanoxerine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.20616296,0.003967117,vanoxerine
TOLL_LIKE_RECEPTOR_CASCADES,2.272902351,0.035645406,vanoxerine
KERATINIZATION,-2.16343739,0.00528949,vanoxerine
SENSORY_PERCEPTION,-2.111570846,0.006311323,vanoxerine
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.077070736,0.007789976,vanoxerine
HIV_LIFE_CYCLE,2.016769164,0.088717454,vanoxerine
G_ALPHA_Q_SIGNALLING_EVENTS,-2.071482796,0.00721294,vanoxerine
SIGNALING_BY_GPCR,-2.068969665,0.006285562,vanoxerine
GPCR_LIGAND_BINDING,-2.619810722,0,ibudilast
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.547336627,0,ibudilast
REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF,2.606337102,0.007085059,ibudilast
SIGNALING_BY_NTRKS,2.452970097,0.007085059,ibudilast
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.256126936,0.002472886,ibudilast
SIGNALING_BY_GPCR,-2.246059511,0.002266812,ibudilast
G_ALPHA_Q_SIGNALLING_EVENTS,-2.194471073,0.004451194,ibudilast
SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3,2.116498474,0.02676578,ibudilast
SENSORY_PERCEPTION,-2.152270697,0.006731744,ibudilast
MHC_CLASS_II_ANTIGEN_PRESENTATION,2.084599272,0.02538813,ibudilast
SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3,2.323792916,0.036780095,tesaglitazar
GPCR_LIGAND_BINDING,-2.424827224,0.010985502,tesaglitazar
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.343249866,0.01216252,tesaglitazar
INNATE_IMMUNE_SYSTEM,2.102971555,0.056584761,tesaglitazar
NEUTROPHIL_DEGRANULATION,2.040415018,0.05847092,tesaglitazar
SENSORY_PERCEPTION,-2.260418536,0.022232563,tesaglitazar
MHC_CLASS_II_ANTIGEN_PRESENTATION,1.946074375,0.079218665,tesaglitazar
RHO_GTPASE_CYCLE,1.905616535,0.079784513,tesaglitazar
ADAPTIVE_IMMUNE_SYSTEM,1.862697519,0.087706379,tesaglitazar
GOLGI_TO_ER_RETROGRADE_TRANSPORT,1.824296403,0.092556502,tesaglitazar
EUKARYOTIC_TRANSLATION_ELONGATION,-2.870050016,0,estriol
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.816099781,0,estriol
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.802299463,0,estriol
CELLULAR_RESPONSE_TO_STARVATION,-2.798386555,0,estriol
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.786795886,0,estriol
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.725775155,0,estriol
SELENOAMINO_ACID_METABOLISM,-2.709041275,0,estriol
EUKARYOTIC_TRANSLATION_INITIATION,-2.659492167,0,estriol
SARS_COV_1_HOST_INTERACTIONS,-2.647483457,0,estriol
NONSENSE_MEDIATED_DECAY_NMD,-2.606242222,0,estriol
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.238843696,0.062777357,betrixaban
NEDDYLATION,1.766396642,1,betrixaban
ADAPTIVE_IMMUNE_SYSTEM,1.714678805,1,betrixaban
PEROXISOMAL_PROTEIN_IMPORT,1.698541488,0.846830521,betrixaban
DEUBIQUITINATION,1.596552093,1,betrixaban
REGULATION_OF_PLK1_ACTIVITY_AT_G2_M_TRANSITION,1.575787616,1,betrixaban
RRNA_PROCESSING,-1.565170476,1,betrixaban
CILIUM_ASSEMBLY,1.566944648,0.925572331,betrixaban
TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,1.527791151,0.972282589,betrixaban
SENSORY_PERCEPTION,-1.502937153,1,betrixaban
SENSORY_PERCEPTION,-2.029954641,0.265867728,GDC-0199
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.002486944,0.162025774,GDC-0199
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.995680977,0.112057725,GDC-0199
NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION,1.916835713,0.567313622,GDC-0199
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.889593902,0.176773755,GDC-0199
MITF_M_DEPENDENT_GENE_EXPRESSION,1.837298511,0.491466257,GDC-0199
SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,-1.884261945,0.146429278,GDC-0199
METABOLISM_OF_STEROIDS,-1.762592945,0.266675837,GDC-0199
RETROGRADE_TRANSPORT_AT_THE_TRANS_GOLGI_NETWORK,1.704707545,0.758884743,GDC-0199
GPCR_LIGAND_BINDING,-1.703374687,0.325321432,GDC-0199
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.683533537,0,dabigatran-etexilate
NEUTROPHIL_DEGRANULATION,2.280914713,0.009881541,dabigatran-etexilate
ESTROGEN_DEPENDENT_GENE_EXPRESSION,1.826384715,0.228059693,dabigatran-etexilate
SIGNALING_BY_GPCR,-1.807053633,1,dabigatran-etexilate
MUSCLE_CONTRACTION,1.697344579,0.366558117,dabigatran-etexilate
CLEC7A_DECTIN_1_SIGNALING,-1.754233654,1,dabigatran-etexilate
SIGNALING_BY_WNT,-1.749755707,0.711078274,dabigatran-etexilate
INNATE_IMMUNE_SYSTEM,1.59123173,0.424278864,dabigatran-etexilate
SIGNALING_BY_ALK_IN_CANCER,1.591382667,0.509134637,dabigatran-etexilate
G_ALPHA_Q_SIGNALLING_EVENTS,-1.68911233,0.781191827,dabigatran-etexilate
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.535596234,0.004561309,BRD-K72166146
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.533040345,0.002280655,BRD-K72166146
EUKARYOTIC_TRANSLATION_ELONGATION,2.187641989,0.070899564,BRD-K72166146
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.243921496,0.0208517,BRD-K72166146
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.014575191,0.143065191,BRD-K72166146
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,1.993890261,0.11816594,BRD-K72166146
REGULATION_OF_T_CELL_ACTIVATION_BY_CD28_FAMILY,1.953689457,0.126606364,BRD-K72166146
SELENOAMINO_ACID_METABOLISM,1.909158998,0.148129446,BRD-K72166146
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,1.8939325,0.140744075,BRD-K72166146
CELLULAR_RESPONSE_TO_STARVATION,1.879699157,0.13257495,BRD-K72166146
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.228438792,0.060808369,mazindol
GLOBAL_GENOME_NUCLEOTIDE_EXCISION_REPAIR_GG_NER,-1.951407267,0.227754981,mazindol
TOLL_LIKE_RECEPTOR_CASCADES,1.87400311,0.702365009,mazindol
MUSCLE_CONTRACTION,1.836557547,0.465478122,mazindol
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.835286633,0.312162226,mazindol
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-1.795879769,0.430818078,mazindol
REGULATION_OF_TP53_ACTIVITY,1.805214685,0.285508611,mazindol
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,1.796394646,0.243892101,mazindol
METABOLISM_OF_RNA,-1.71462995,0.52295197,mazindol
NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION,1.740273371,0.29034774,mazindol
EUKARYOTIC_TRANSLATION_INITIATION,-2.912231815,0,imiquimod
EUKARYOTIC_TRANSLATION_ELONGATION,-2.829704379,0,imiquimod
NONSENSE_MEDIATED_DECAY_NMD,-2.803508375,0,imiquimod
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.755516903,0,imiquimod
RRNA_PROCESSING,-2.751000065,0,imiquimod
TRANSLATION,-2.729384256,0,imiquimod
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.662795206,0,imiquimod
SELENOAMINO_ACID_METABOLISM,-2.513560693,0,imiquimod
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.507609355,0,imiquimod
METABOLISM_OF_RNA,-2.487056788,0.000104111,imiquimod
INTERFERON_ALPHA_BETA_SIGNALING,1.838350647,0.650814634,molindone
TRANSPORT_OF_SMALL_MOLECULES,-1.867657331,0.869931376,molindone
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,1.646897053,1,molindone
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,1.646710455,0.7030405,molindone
SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES,1.623012765,0.5962453,molindone
MYD88_INDEPENDENT_TLR4_CASCADE,1.603094016,0.534578605,molindone
TOLL_LIKE_RECEPTOR_CASCADES,1.591532125,0.471148729,molindone
PHOSPHOLIPID_METABOLISM,-1.741058579,1,molindone
SARS_COV_2_HOST_INTERACTIONS,1.553774783,0.494902251,molindone
SIGNALING_BY_ALK_IN_CANCER,1.544276807,0.453293732,molindone
CELL_CYCLE,-2.955824372,0,dorsomorphin
M_PHASE,-2.469911869,0,dorsomorphin
DNA_REPAIR,-2.519824612,0,dorsomorphin
MITOTIC_PROMETAPHASE,-2.614768973,0,dorsomorphin
CELL_CYCLE_MITOTIC,-2.656578667,0,dorsomorphin
HOMOLOGY_DIRECTED_REPAIR,-2.517730271,0,dorsomorphin
GPCR_LIGAND_BINDING,2.669063342,0,dorsomorphin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.862934126,0,dorsomorphin
CELL_CYCLE_CHECKPOINTS,-2.920371952,0,dorsomorphin
DNA_DOUBLE_STRAND_BREAK_REPAIR,-2.656915511,0,dorsomorphin
G_ALPHA_Q_SIGNALLING_EVENTS,-2.319242487,0,foretinib
GPCR_LIGAND_BINDING,-2.265367097,0,foretinib
CELL_CYCLE,-2.211631864,0.000669748,foretinib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.136244662,0.002762708,foretinib
CELL_CYCLE_MITOTIC,-2.121244823,0.00281294,foretinib
METABOLISM_OF_LIPIDS,2.198231126,0.021065591,foretinib
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,-2.102529465,0.003516174,foretinib
CELL_CYCLE_CHECKPOINTS,-2.0910754,0.003300898,foretinib
METABOLISM_OF_STEROIDS,2.095923396,0.017235483,foretinib
MITOTIC_METAPHASE_AND_ANAPHASE,-2.041583068,0.005114435,foretinib
MRNA_SPLICING,3.042754526,0,paracetamol
METABOLISM_OF_RNA,2.688861117,0,paracetamol
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.393533711,0.001350402,paracetamol
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,2.161628947,0.003038405,paracetamol
RRNA_PROCESSING,1.953404611,0.01701507,paracetamol
GOLGI_TO_ER_RETROGRADE_TRANSPORT,1.883486438,0.02228164,paracetamol
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.046710609,0.032381041,paracetamol
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-1.997579431,0.034131367,paracetamol
TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,-1.980605103,0.027130061,paracetamol
TOLL_LIKE_RECEPTOR_CASCADES,-1.954133694,0.027348852,paracetamol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.630825643,0,eprosartan
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.629765767,0,eprosartan
GPCR_LIGAND_BINDING,2.581113999,0,eprosartan
SIGNALING_BY_GPCR,2.18401364,0.006274541,eprosartan
SIGNALING_BY_INTERLEUKINS,1.896413892,0.073577251,eprosartan
G_ALPHA_Q_SIGNALLING_EVENTS,1.802313603,0.128573053,eprosartan
G_ALPHA_I_SIGNALLING_EVENTS,1.759007194,0.155023625,eprosartan
INTERFERON_ALPHA_BETA_SIGNALING,-2.077234809,1,eprosartan
DISEASES_OF_METABOLISM,-2.0613789,1,eprosartan
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,1.736939904,0.15950544,eprosartan
GPCR_LIGAND_BINDING,-2.723969174,0,BRD-K26619122
SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,-2.438559581,0.002770186,BRD-K26619122
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.434060375,0.001846791,BRD-K26619122
SENSORY_PERCEPTION,-2.378968938,0.003957409,BRD-K26619122
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.372184059,0.00348252,BRD-K26619122
TRANSLATION,-2.34957111,0.004485063,BRD-K26619122
GASTRULATION,-2.230908194,0.012437571,BRD-K26619122
RRNA_PROCESSING,-2.078808704,0.035913485,BRD-K26619122
METABOLISM_OF_VITAMINS_AND_COFACTORS,-2.044624354,0.041948533,BRD-K26619122
BETA_CATENIN_INDEPENDENT_WNT_SIGNALING,-2.03161052,0.041631941,BRD-K26619122
VIRAL_INFECTION_PATHWAYS,3.361749928,0,amlodipine
GPCR_LIGAND_BINDING,-2.453590939,0,amlodipine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.505411541,0,amlodipine
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.386825238,0,amlodipine
EUKARYOTIC_TRANSLATION_INITIATION,2.682262163,0,amlodipine
NONSENSE_MEDIATED_DECAY_NMD,2.738037038,0,amlodipine
INFLUENZA_INFECTION,3.22638202,0,amlodipine
EUKARYOTIC_TRANSLATION_ELONGATION,2.56453533,0.001577707,amlodipine
HIV_INFECTION,2.42793159,0.00071714,amlodipine
RRNA_PROCESSING,2.433186693,0.000788854,amlodipine
EUKARYOTIC_TRANSLATION_ELONGATION,2.841896202,0,haloperidol
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.76061236,0,haloperidol
SELENOAMINO_ACID_METABOLISM,2.728263076,0,haloperidol
CELLULAR_RESPONSE_TO_STARVATION,2.600240314,0.000864585,haloperidol
EUKARYOTIC_TRANSLATION_INITIATION,2.561083691,0.001383336,haloperidol
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.55973995,0.00115278,haloperidol
NONSENSE_MEDIATED_DECAY_NMD,2.537309126,0.001235122,haloperidol
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.45774885,0.00172917,haloperidol
SIGNALING_BY_ROBO_RECEPTORS,2.357151332,0.00345834,haloperidol
TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,2.285041569,0.005706261,haloperidol
GPCR_LIGAND_BINDING,2.619350514,0.002040094,rucaparib
DISEASES_OF_METABOLISM,2.208101006,0.024481129,rucaparib
COPII_MEDIATED_VESICLE_TRANSPORT,-2.139264475,0.12117667,rucaparib
SIGNALING_BY_GPCR,2.117154708,0.036381678,rucaparib
GLYCOSAMINOGLYCAN_METABOLISM,2.107728888,0.028561317,rucaparib
SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,1.966975773,0.066915086,rucaparib
TRANSLATION,1.954873034,0.06222287,rucaparib
G_ALPHA_Q_SIGNALLING_EVENTS,1.895024607,0.081312322,rucaparib
MEMBRANE_TRAFFICKING,-1.882245445,0.430029401,rucaparib
NEUTROPHIL_DEGRANULATION,-1.879851299,0.290955364,rucaparib
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-3.620827333,0,cediranib
SARS_COV_1_HOST_INTERACTIONS,-2.958404326,0,cediranib
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.915443296,0,cediranib
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.905319277,0,cediranib
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.839798472,0,cediranib
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.822103696,0,cediranib
CELLULAR_RESPONSES_TO_STIMULI,-2.7979864,0,cediranib
M_PHASE,-2.792008995,0,cediranib
HIV_INFECTION,-2.782775768,0,cediranib
TRANSCRIPTIONAL_REGULATION_BY_TP53,-2.731287239,0,cediranib
SIGNALING_BY_MET,2.049293204,0.284510923,bosutinib
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,2.021502531,0.171647086,bosutinib
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,1.973631502,0.162764284,bosutinib
SYNTHESIS_OF_DNA,-1.925408591,0.816697315,bosutinib
DNA_DOUBLE_STRAND_BREAK_REPAIR,-1.908954635,0.456115547,bosutinib
DNA_REPLICATION,-1.876310393,0.384853561,bosutinib
PARASITE_INFECTION,1.876285789,0.234349218,bosutinib
SIGNALING_BY_RECEPTOR_TYROSINE_KINASES,1.827035393,0.251122038,bosutinib
HOMOLOGY_DIRECTED_REPAIR,-1.784936246,0.539998866,bosutinib
RRNA_MODIFICATION_IN_THE_NUCLEUS_AND_CYTOSOL,-1.753248117,0.523571716,bosutinib
MRNA_SPLICING,3.277309914,0,dyphylline
METABOLISM_OF_RNA,3.256542375,0,dyphylline
MITOTIC_METAPHASE_AND_ANAPHASE,3.195980235,0,dyphylline
TRANSLATION,2.913482804,0,dyphylline
ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES,2.891536996,0,dyphylline
S_PHASE,2.832978795,0,dyphylline
NUCLEOTIDE_EXCISION_REPAIR,2.824498924,0,dyphylline
DNA_REPLICATION,2.693838611,0,dyphylline
SYNTHESIS_OF_DNA,2.693838611,0,dyphylline
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.674766129,0,dyphylline
METABOLISM_OF_RNA,4.456734185,0,mefenamic-acid
NUCLEOTIDE_EXCISION_REPAIR,2.672655933,0,mefenamic-acid
HIV_INFECTION,2.691570236,0,mefenamic-acid
DNA_REPLICATION_PRE_INITIATION,2.707070151,0,mefenamic-acid
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.82671616,0,mefenamic-acid
RRNA_PROCESSING,2.855034482,0,mefenamic-acid
SYNTHESIS_OF_DNA,2.868280448,0,mefenamic-acid
S_PHASE,2.796705783,0,mefenamic-acid
CELL_CYCLE_CHECKPOINTS,2.884618678,0,mefenamic-acid
APC_C_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS,2.923850861,0,mefenamic-acid
TRANSLATION,4.077033643,0,triflupromazine
METABOLISM_OF_RNA,3.436245379,0,triflupromazine
RRNA_PROCESSING,2.98503517,0,triflupromazine
MRNA_SPLICING,2.820040229,0,triflupromazine
MITOTIC_METAPHASE_AND_ANAPHASE,2.693137459,0.000896582,triflupromazine
SEPARATION_OF_SISTER_CHROMATIDS,2.69258556,0.000747152,triflupromazine
HIV_INFECTION,2.537222435,0.00320208,triflupromazine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.42775087,0.005043276,triflupromazine
TRANSCRIPTION_OF_THE_HIV_GENOME,2.426924122,0.004482912,triflupromazine
RESPIRATORY_ELECTRON_TRANSPORT,2.370161414,0.004931203,triflupromazine
TRANSLATION,5.524018061,0,triprolidine
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,3.089779958,0,triprolidine
MITOCHONDRIAL_TRANSLATION,3.052943459,0,triprolidine
SEPARATION_OF_SISTER_CHROMATIDS,3.014812658,0,triprolidine
MITOTIC_METAPHASE_AND_ANAPHASE,2.993441014,0,triprolidine
SARS_COV_1_INFECTION,2.991213447,0,triprolidine
THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT,2.986265845,0,triprolidine
APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1,2.978927812,0,triprolidine
VIRAL_INFECTION_PATHWAYS,2.966712224,0,triprolidine
S_PHASE,3.322604821,0,triprolidine
RRNA_PROCESSING,5.325247295,0,mephenytoin
CELL_CYCLE_MITOTIC,3.211844109,0,mephenytoin
HOST_INTERACTIONS_OF_HIV_FACTORS,3.165301931,0,mephenytoin
HIV_INFECTION,3.06407085,0,mephenytoin
SEPARATION_OF_SISTER_CHROMATIDS,3.063325658,0,mephenytoin
DNA_REPLICATION_PRE_INITIATION,3.045103952,0,mephenytoin
CELL_CYCLE_CHECKPOINTS,3.039218179,0,mephenytoin
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.998775108,0,mephenytoin
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,2.982281518,0,mephenytoin
APC_C_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS,2.86150761,0,mephenytoin
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.546435572,0,irbesartan
M_PHASE,1.905219444,0.083248731,irbesartan
MRNA_SPLICING,1.903334511,0.055499154,irbesartan
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-1.934103609,0.028594751,irbesartan
RHOA_GTPASE_CYCLE,1.865110793,0.054342922,irbesartan
CDC42_GTPASE_CYCLE,1.864354776,0.044399323,irbesartan
REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE,1.796105896,0.043606478,irbesartan
CELLULAR_RESPONSE_TO_HEAT_STRESS,1.796105896,0.043606478,irbesartan
METABOLISM_OF_RNA,1.789158276,0.041046249,irbesartan
RESOLUTION_OF_SISTER_CHROMATID_COHESION,1.770691894,0.040596603,irbesartan
EUKARYOTIC_TRANSLATION_ELONGATION,2.801216906,0,pentoxifylline
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.689288638,0.000780772,pentoxifylline
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.669402001,0.000520515,pentoxifylline
NONSENSE_MEDIATED_DECAY_NMD,2.663503193,0.000390386,pentoxifylline
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.600635294,0.000312309,pentoxifylline
EUKARYOTIC_TRANSLATION_INITIATION,2.590810124,0.000260257,pentoxifylline
SELENOAMINO_ACID_METABOLISM,2.558430151,0.000223078,pentoxifylline
SIGNALING_BY_ROBO_RECEPTORS,2.474642786,0.00104103,pentoxifylline
INFLUENZA_INFECTION,2.480794172,0.001171158,pentoxifylline
CELLULAR_RESPONSE_TO_STARVATION,2.113523205,0.017020834,pentoxifylline
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.41773946,0,AT-7519
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.94119318,0,AT-7519
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,2.845808391,0,AT-7519
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,2.545959638,0.001208313,AT-7519
NEUTROPHIL_DEGRANULATION,2.482714685,0.001933301,AT-7519
SIGNALING_BY_RECEPTOR_TYROSINE_KINASES,2.402362733,0.00362494,AT-7519
INFLUENZA_INFECTION,2.282016349,0.007595112,AT-7519
INTERFERON_ALPHA_BETA_SIGNALING,2.27842608,0.006645723,AT-7519
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.174091918,0.01396273,AT-7519
CELLULAR_RESPONSE_TO_STARVATION,2.148311822,0.015708072,AT-7519
EUKARYOTIC_TRANSLATION_INITIATION,-2.730504337,0,proguanil
TRANSLATION,-2.720033473,0,proguanil
EUKARYOTIC_TRANSLATION_ELONGATION,-2.706187191,0,proguanil
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.674441221,0,proguanil
SELENOAMINO_ACID_METABOLISM,-2.617547247,0,proguanil
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.593895019,0,proguanil
RRNA_PROCESSING,-2.587003982,0,proguanil
NONSENSE_MEDIATED_DECAY_NMD,-2.527228264,0.000234519,proguanil
CELLULAR_RESPONSE_TO_STARVATION,-2.429942287,0.000426399,proguanil
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.483655989,0.000521154,proguanil
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.617272586,0,tropicamide
S_PHASE,2.188622686,0.017236426,tropicamide
SYNTHESIS_OF_DNA,2.133664841,0.018194006,tropicamide
CELL_CYCLE_MITOTIC,2.131729892,0.013645504,tropicamide
DNA_REPLICATION,2.081399768,0.016087331,tropicamide
RRNA_PROCESSING,2.001955308,0.023460691,tropicamide
CELL_CYCLE,1.9392952,0.028522182,tropicamide
CELL_CYCLE_CHECKPOINTS,1.939133401,0.024956909,tropicamide
METABOLISM_OF_RNA,1.893636241,0.030163746,tropicamide
MITOTIC_G2_G2_M_PHASES,1.86864285,0.033754668,tropicamide
GLYCOSAMINOGLYCAN_METABOLISM,1.90696258,0.095955021,aliskiren
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,1.531672012,0.368577229,aliskiren
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-3.063627121,1,aliskiren
HEMOSTASIS,-2.530733776,1,aliskiren
EUKARYOTIC_TRANSLATION_ELONGATION,-2.352533506,1,aliskiren
SELENOAMINO_ACID_METABOLISM,-2.322204124,1,aliskiren
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.18763729,1,aliskiren
EUKARYOTIC_TRANSLATION_INITIATION,-2.146496448,1,aliskiren
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.087092582,1,aliskiren
NONSENSE_MEDIATED_DECAY_NMD,-2.065760602,1,aliskiren
ORC1_REMOVAL_FROM_CHROMATIN,3.110625964,0,finasteride
SYNTHESIS_OF_DNA,2.402714661,0.010267746,finasteride
S_PHASE,2.240061488,0.013690329,finasteride
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,2.211249917,0.013201388,finasteride
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.204722848,0.010561111,finasteride
THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT,2.092404368,0.01613503,finasteride
DNA_REPLICATION,2.025657665,0.023888226,finasteride
KEAP1_NFE2L2_PATHWAY,1.904627016,0.042171102,finasteride
PEROXISOMAL_PROTEIN_IMPORT,-1.980737394,0.123663267,finasteride
DNA_REPLICATION_PRE_INITIATION,1.823695094,0.064866081,finasteride
TOLL_LIKE_RECEPTOR_CASCADES,2.452341711,0.019825197,gemfibrozil
GLOBAL_GENOME_NUCLEOTIDE_EXCISION_REPAIR_GG_NER,2.351677093,0.024781496,gemfibrozil
NONSENSE_MEDIATED_DECAY_NMD,2.34810722,0.016520998,gemfibrozil
EUKARYOTIC_TRANSLATION_INITIATION,2.285535707,0.022303347,gemfibrozil
TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,2.254814593,0.021807717,gemfibrozil
NUCLEOTIDE_EXCISION_REPAIR,2.240745849,0.019825197,gemfibrozil
HIV_INFECTION,2.226331135,0.016993026,gemfibrozil
RRNA_PROCESSING,2.194697297,0.017347048,gemfibrozil
RNA_POLYMERASE_II_PRE_TRANSCRIPTION_EVENTS,2.186126084,0.016520998,gemfibrozil
TP53_REGULATES_TRANSCRIPTION_OF_DNA_REPAIR_GENES,2.181945434,0.014868898,gemfibrozil
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.901946535,0,labetalol
GPCR_LIGAND_BINDING,2.865800703,0,labetalol
MUSCLE_CONTRACTION,2.847488466,0,labetalol
CARDIAC_CONDUCTION,2.838844564,0,labetalol
TOLL_LIKE_RECEPTOR_CASCADES,-2.600435424,0,labetalol
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,-2.507097962,0,labetalol
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.505339723,0.000103347,labetalol
PI_METABOLISM,-2.503184237,0.000471981,labetalol
METABOLISM_OF_RNA,-2.426274854,0.000353986,labetalol
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,-2.36435708,0.001982319,labetalol
REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE,-2.176239226,0.068724143,rosuvastatin
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.073638658,0.073793957,rosuvastatin
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,1.964876245,0.302738422,rosuvastatin
NEUTROPHIL_DEGRANULATION,-1.663754265,0.525007388,rosuvastatin
MRNA_SPLICING,-1.636780319,0.450368462,rosuvastatin
NEURONAL_SYSTEM,1.755673389,0.84871479,rosuvastatin
METABOLISM_OF_STEROIDS,-1.608021817,0.417076684,rosuvastatin
TRNA_PROCESSING,-1.600406525,0.359956782,rosuvastatin
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-1.561677927,0.37532717,rosuvastatin
METABOLISM_OF_RNA,-1.553858582,0.341649121,rosuvastatin
RRNA_PROCESSING,2.88602017,0,zardaverine
UNFOLDED_PROTEIN_RESPONSE_UPR,2.764826429,0,zardaverine
DISEASES_OF_METABOLISM,-2.491934664,0.039590676,zardaverine
TOLL_LIKE_RECEPTOR_CASCADES,-2.085583019,0.785215082,zardaverine
TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,-2.042990875,0.699068703,zardaverine
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-2.029575016,0.570215714,zardaverine
METABOLISM_OF_RNA,1.649705776,0.446571769,zardaverine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.573762906,0.490738864,zardaverine
CELL_CELL_COMMUNICATION,-1.928888923,0.815128037,zardaverine
HEMOSTASIS,-1.919994215,0.70750005,zardaverine
GPCR_LIGAND_BINDING,3.107475483,0,piperine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,3.028200255,0,piperine
SIGNALING_BY_GPCR,2.958974987,0,piperine
G_ALPHA_I_SIGNALLING_EVENTS,2.534430469,0.000688949,piperine
NEUTROPHIL_DEGRANULATION,-2.535839292,0.002222271,piperine
G_ALPHA_Q_SIGNALLING_EVENTS,2.410941075,0.001102319,piperine
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.366242385,0.001224799,piperine
MEMBRANE_TRAFFICKING,-2.337129178,0.011111356,piperine
MUSCLE_CONTRACTION,2.209813845,0.005511595,piperine
FATTY_ACID_METABOLISM,-2.253791913,0.02000044,piperine
MUSCLE_CONTRACTION,3.225770513,0,risperidone
STRIATED_MUSCLE_CONTRACTION,3.211036037,0,risperidone
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.383174744,0.004200525,risperidone
SIGNALING_BY_ROBO_RECEPTORS,2.103461428,0.021325744,risperidone
C_TYPE_LECTIN_RECEPTORS_CLRS,-1.985972663,0.316802191,risperidone
CARDIAC_CONDUCTION,1.608094325,0.302631687,risperidone
G_ALPHA_Q_SIGNALLING_EVENTS,-1.756867349,1,risperidone
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.556646173,0.329741231,risperidone
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.741940465,0.808148264,risperidone
GPCR_LIGAND_BINDING,-1.733591531,0.644450316,risperidone
GPCR_LIGAND_BINDING,2.816503103,0,mitotane
G_ALPHA_Q_SIGNALLING_EVENTS,2.706664223,0,mitotane
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.617316003,0.000238735,mitotane
SIGNALING_BY_GPCR,2.492760015,0.000358103,mitotane
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.153926023,0.01117281,mitotane
ASPARAGINE_N_LINKED_GLYCOSYLATION,-2.107479526,0.191755411,mitotane
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,-2.066735584,0.132083273,mitotane
METABOLISM_OF_STEROIDS,-2.025066847,0.117556348,mitotane
NEUTROPHIL_DEGRANULATION,-2.021651191,0.089508208,mitotane
METABOLISM_OF_LIPIDS,-1.975470619,0.09627999,mitotane
TRNA_PROCESSING,2.543474936,0.001488226,felodipine
EXTRACELLULAR_MATRIX_ORGANIZATION,1.944949443,0.034229187,felodipine
EUKARYOTIC_TRANSLATION_ELONGATION,-2.969935717,0.205869823,felodipine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,1.778176522,0.058784908,felodipine
SELENOAMINO_ACID_METABOLISM,-2.94452302,0.205869823,felodipine
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-2.93355672,0.185146953,felodipine
TELOMERE_MAINTENANCE,1.635298495,0.099897137,felodipine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.888349882,0.367915872,felodipine
EUKARYOTIC_TRANSLATION_INITIATION,-2.860703881,0.460047714,felodipine
NONSENSE_MEDIATED_DECAY_NMD,-2.84307888,0.482740955,felodipine
MUSCLE_CONTRACTION,2.622435772,0.001337661,chloroquine
RHO_GTPASES_ACTIVATE_FORMINS,1.82806461,0.29696066,chloroquine
RESOLUTION_OF_SISTER_CHROMATID_COHESION,1.794405661,0.24835899,chloroquine
INFLUENZA_INFECTION,1.668057178,0.363509276,chloroquine
SEPARATION_OF_SISTER_CHROMATIDS,1.628382735,0.360098241,chloroquine
EXTRACELLULAR_MATRIX_ORGANIZATION,1.615948822,0.320146777,chloroquine
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-1.804389776,1,chloroquine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-1.774468815,0.814071426,chloroquine
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,-1.735318706,0.715946745,chloroquine
HCMV_INFECTION,1.46456312,0.580735807,chloroquine
GENE_SILENCING_BY_RNA,1.679188814,0.761063655,dopamine
EUKARYOTIC_TRANSLATION_ELONGATION,-3.143448313,0.982453767,dopamine
TRNA_PROCESSING_IN_THE_NUCLEUS,1.603451533,0.550166498,dopamine
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-3.130285904,0.577366195,dopamine
EUKARYOTIC_TRANSLATION_INITIATION,-3.104402628,0.493554973,dopamine
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-3.103280468,0.373425555,dopamine
SELENOAMINO_ACID_METABOLISM,-3.08646529,0.334499899,dopamine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-3.039772909,0.354180015,dopamine
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-3.005483618,0.342960841,dopamine
NONSENSE_MEDIATED_DECAY_NMD,-2.979137284,0.322440395,dopamine
SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3,3.462424981,0,perhexiline
TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,2.483326452,0.00466805,perhexiline
MYD88_INDEPENDENT_TLR4_CASCADE,2.433628199,0.006224066,perhexiline
TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,2.412461409,0.00466805,perhexiline
TOLL_LIKE_RECEPTOR_CASCADES,2.409709651,0.00373444,perhexiline
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.141938012,0.001708108,perhexiline
GPCR_LIGAND_BINDING,-2.097582025,0.003416216,perhexiline
KERATINIZATION,-2.078432506,0.002657057,perhexiline
METABOLISM_OF_STEROIDS,2.042273367,0.028008299,perhexiline
AMINE_LIGAND_BINDING_RECEPTORS,-2.036413196,0.003273873,perhexiline
RRNA_PROCESSING,2.694413139,0,alfuzosin
METABOLISM_OF_RNA,2.323337672,0.021244019,alfuzosin
DNA_REPLICATION,2.203986111,0.034317262,alfuzosin
TRANSLATION,2.202827303,0.026146485,alfuzosin
SYNTHESIS_OF_DNA,2.016072961,0.06438572,alfuzosin
RHO_GTPASES_ACTIVATE_FORMINS,1.906928414,0.11520795,alfuzosin
TELOMERE_MAINTENANCE,1.889526938,0.109021505,alfuzosin
CHROMOSOME_MAINTENANCE,1.857583624,0.115616489,alfuzosin
S_PHASE,1.844036174,0.113846154,alfuzosin
RRNA_MODIFICATION_IN_THE_NUCLEUS_AND_CYTOSOL,1.842633802,0.103932278,alfuzosin
EUKARYOTIC_TRANSLATION_INITIATION,4.908092638,0,amisulpride
ORC1_REMOVAL_FROM_CHROMATIN,2.842446741,0,amisulpride
REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS,2.837855445,0,amisulpride
MITOTIC_G2_G2_M_PHASES,2.814897126,0,amisulpride
AUF1_HNRNP_D0_BINDS_AND_DESTABILIZES_MRNA,2.804879897,0,amisulpride
CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6,2.793845999,0,amisulpride
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.792251051,0,amisulpride
ASYMMETRIC_LOCALIZATION_OF_PCP_PROTEINS,2.783841603,0,amisulpride
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,2.776765114,0,amisulpride
SCF_SKP2_MEDIATED_DEGRADATION_OF_P27_P21,2.759071048,0,amisulpride
EUKARYOTIC_TRANSLATION_INITIATION,3.007639145,0,mepacrine
DEVELOPMENTAL_CELL_LINEAGES,2.958324199,0,mepacrine
TRANSLATION,2.872249227,0,mepacrine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.859918166,0,mepacrine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.780081308,0.0006477,mepacrine
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,2.66642899,0.00053975,mepacrine
SELENOAMINO_ACID_METABOLISM,2.666326685,0.000462643,mepacrine
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,2.59232442,0.000404812,mepacrine
EXTRACELLULAR_MATRIX_ORGANIZATION,2.576546076,0.000359833,mepacrine
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,2.57023833,0.00032385,mepacrine
RHO_GTPASES_ACTIVATE_FORMINS,2.967295105,0,thioproperazine
SEPARATION_OF_SISTER_CHROMATIDS,2.788776772,0,thioproperazine
RRNA_PROCESSING,2.741882936,0,thioproperazine
MRNA_SPLICING,2.738434001,0,thioproperazine
METABOLISM_OF_RNA,2.722244682,0,thioproperazine
RESOLUTION_OF_SISTER_CHROMATID_COHESION,2.697092442,0,thioproperazine
CELL_CYCLE_CHECKPOINTS,2.624342513,0.000635084,thioproperazine
CELL_CYCLE_MITOTIC,2.581612516,0.001667096,thioproperazine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.554490359,0.001481863,thioproperazine
MITOTIC_PROMETAPHASE,2.528593239,0.002222795,thioproperazine
NUCLEAR_EVENTS_MEDIATED_BY_NFE2L2,2.707563435,0,doconexent
KEAP1_NFE2L2_PATHWAY,2.56509397,0.005350137,doconexent
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,2.41304962,0.007133516,doconexent
SEPARATION_OF_SISTER_CHROMATIDS,2.304823974,0.010700273,doconexent
CELL_CYCLE,2.269922771,0.011770301,doconexent
RHO_GTPASES_ACTIVATE_FORMINS,2.266268456,0.010700273,doconexent
RESOLUTION_OF_SISTER_CHROMATID_COHESION,2.161511381,0.01605041,doconexent
HOST_INTERACTIONS_OF_HIV_FACTORS,2.157182631,0.014044109,doconexent
SIGNALING_BY_INTERLEUKINS,2.081879677,0.017120438,doconexent
ANTIGEN_PROCESSING_CROSS_PRESENTATION,2.102497633,0.019022708,doconexent
GPCR_LIGAND_BINDING,-2.133630858,0.052776026,metoprolol
SIGNALING_BY_GPCR,-2.100352594,0.040089481,metoprolol
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.087715689,0.108506041,metoprolol
ESTROGEN_DEPENDENT_GENE_EXPRESSION,1.801616208,0.365847803,metoprolol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.800928042,0.429650982,metoprolol
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,-1.784641375,0.369178452,metoprolol
PROTEIN_FOLDING,-1.777778057,0.3107696,metoprolol
G_ALPHA_Q_SIGNALLING_EVENTS,-1.741918637,0.336278013,metoprolol
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,-1.701807823,0.391760502,metoprolol
RESOLUTION_OF_SISTER_CHROMATID_COHESION,-1.683925928,0.390111251,metoprolol
GPCR_LIGAND_BINDING,4.222020456,0,fluocinonide
SELENOAMINO_ACID_METABOLISM,-3.462989509,0,fluocinonide
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-3.472444119,0,fluocinonide
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,3.486131163,0,fluocinonide
EUKARYOTIC_TRANSLATION_INITIATION,-3.4864463,0,fluocinonide
PEPTIDE_LIGAND_BINDING_RECEPTORS,3.006133456,0,fluocinonide
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-3.51060823,0,fluocinonide
EUKARYOTIC_TRANSLATION_ELONGATION,-3.612823576,0,fluocinonide
SIGNALING_BY_GPCR,3.684282785,0,fluocinonide
NONSENSE_MEDIATED_DECAY_NMD,-3.499741705,0,fluocinonide
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,2.027133181,0.280867978,amantadine
MUSCLE_CONTRACTION,1.894291587,0.330741731,amantadine
REGULATION_OF_T_CELL_ACTIVATION_BY_CD28_FAMILY,1.883952594,0.236244094,amantadine
TRANSPORT_OF_SMALL_MOLECULES,-1.886936293,0.630144814,amantadine
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,1.787258606,0.31958576,amantadine
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,1.785176654,0.258556036,amantadine
GPCR_LIGAND_BINDING,-1.830255591,0.479104949,amantadine
ADIPOGENESIS,1.748086043,0.26599335,amantadine
VISUAL_PHOTOTRANSDUCTION,-1.753499884,0.531887698,amantadine
SENSORY_PERCEPTION,-1.743862523,0.423074031,amantadine
ECM_PROTEOGLYCANS,2.218903636,0.059303298,BRD-K25836724
GPCR_LIGAND_BINDING,1.894383642,0.201839294,BRD-K25836724
MUSCLE_CONTRACTION,-3.17040522,0.938916256,BRD-K25836724
BIOLOGICAL_OXIDATIONS,-3.138368885,0.61182266,BRD-K25836724
CARDIAC_CONDUCTION,-3.132111545,0.425287356,BRD-K25836724
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,1.726576802,0.346802911,BRD-K25836724
PEPTIDE_HORMONE_METABOLISM,-3.059350558,0.456896552,BRD-K25836724
SENSORY_PERCEPTION,1.63943489,0.413562471,BRD-K25836724
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,-2.122469599,0.693793103,BRD-K25836724
RRNA_PROCESSING,1.623845931,0.360397585,BRD-K25836724
GPCR_LIGAND_BINDING,3.753353801,0,carbinoxamine
SARS_COV_1_INFECTION,-2.538698208,0,carbinoxamine
SARS_COV_1_HOST_INTERACTIONS,-2.556098731,0,carbinoxamine
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.774336522,0,carbinoxamine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.782360218,0,carbinoxamine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.857605188,0,carbinoxamine
CELLULAR_RESPONSE_TO_STARVATION,-2.885637834,0,carbinoxamine
INFLUENZA_INFECTION,-2.928531869,0,carbinoxamine
SIGNALING_BY_ROBO_RECEPTORS,-2.617983163,0,carbinoxamine
EUKARYOTIC_TRANSLATION_INITIATION,-3.00000959,0,carbinoxamine
HCMV_INFECTION,2.268735444,0.016952933,ofloxacin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.287616946,0.006300617,ofloxacin
GPCR_LIGAND_BINDING,-2.285184009,0.003150309,ofloxacin
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.212575743,0.003733699,ofloxacin
MITOCHONDRIAL_PROTEIN_DEGRADATION,2.077603915,0.056509778,ofloxacin
G_ALPHA_Q_SIGNALLING_EVENTS,-2.116940976,0.008050789,ofloxacin
TRANSCRIPTIONAL_REGULATION_BY_TP53,1.940216491,0.090415644,ofloxacin
RESPIRATORY_ELECTRON_TRANSPORT,1.915925639,0.077700944,ofloxacin
SENSORY_PERCEPTION,-2.103141213,0.007560741,ofloxacin
MHC_CLASS_II_ANTIGEN_PRESENTATION,1.877296789,0.083634471,ofloxacin
EUKARYOTIC_TRANSLATION_ELONGATION,-3.393098784,0,BRD-K45330754
TRANSLATION,-2.721464085,0,BRD-K45330754
SARS_COV_1_INFECTION,-2.772514072,0,BRD-K45330754
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.850307718,0,BRD-K45330754
RRNA_PROCESSING,-2.950152958,0,BRD-K45330754
SARS_COV_1_HOST_INTERACTIONS,-3.016274724,0,BRD-K45330754
SIGNALING_BY_ROBO_RECEPTORS,-3.028472546,0,BRD-K45330754
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-3.05921939,0,BRD-K45330754
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.582343069,0,BRD-K45330754
INFLUENZA_INFECTION,-3.10713947,0,BRD-K45330754
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.921191239,0,equol
NEUTROPHIL_DEGRANULATION,2.467506092,0.0022881,equol
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.391165,0.00343215,equol
SIGNALING_BY_GPCR,-2.260032361,0.012417513,equol
GPCR_LIGAND_BINDING,-2.180710512,0.02005906,equol
G_ALPHA_Q_SIGNALLING_EVENTS,-2.151831263,0.019422264,equol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.130549239,0.019820261,equol
EUKARYOTIC_TRANSLATION_INITIATION,1.873951397,0.110972844,equol
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,1.858329487,0.099761154,equol
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.902532628,0.138120954,equol
METABOLISM_OF_STEROIDS,-2.106733187,0.233351398,navitoclax
ACTIVATION_OF_GENE_EXPRESSION_BY_SREBF_SREBP,-2.024477138,0.24291498,navitoclax
REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF,-2.011694752,0.178945243,navitoclax
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.922279017,0.398236485,navitoclax
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,-1.869872385,0.351302241,navitoclax
GPCR_LIGAND_BINDING,1.78845822,0.536643539,navitoclax
CHROMATIN_ORGANIZATION,-1.798344583,0.44349517,navitoclax
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.645270554,0.859352414,navitoclax
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,1.634187517,0.677218849,navitoclax
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,1.626968187,0.566782307,navitoclax
EXTRACELLULAR_MATRIX_ORGANIZATION,-3.133726682,0,candesartan
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.868253856,0,candesartan
ECM_PROTEOGLYCANS,-2.861785777,0,candesartan
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.581572347,0.002043965,candesartan
GENE_SILENCING_BY_RNA,-1.74815856,0.431218186,candesartan
CELLULAR_RESPONSE_TO_STARVATION,1.765848351,1,candesartan
APOPTOSIS,-1.700385077,0.449672268,candesartan
TOLL_LIKE_RECEPTOR_CASCADES,1.726504665,1,candesartan
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,1.704511513,0.86175968,candesartan
PROGRAMMED_CELL_DEATH,-1.608879549,0.575647245,candesartan
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.292342994,0,ilomastat
EUKARYOTIC_TRANSLATION_ELONGATION,3.26400365,0,ilomastat
SELENOAMINO_ACID_METABOLISM,3.152535575,0,ilomastat
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.09746192,0,ilomastat
NONSENSE_MEDIATED_DECAY_NMD,2.968202286,0,ilomastat
INFLUENZA_INFECTION,2.897181572,0,ilomastat
EUKARYOTIC_TRANSLATION_INITIATION,2.872445864,0,ilomastat
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.841630571,0,ilomastat
CELLULAR_RESPONSE_TO_STARVATION,2.793122062,0,ilomastat
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.73126903,0,ilomastat
NEUTROPHIL_DEGRANULATION,2.488318105,0.004314995,BRD-K33211335
INNATE_IMMUNE_SYSTEM,2.353943077,0.006472492,BRD-K33211335
TOLL_LIKE_RECEPTOR_CASCADES,2.240201318,0.010068321,BRD-K33211335
GPCR_LIGAND_BINDING,-2.123726897,0.019526657,BRD-K33211335
INTEGRIN_CELL_SURFACE_INTERACTIONS,2.077994754,0.025350593,BRD-K33211335
EUKARYOTIC_TRANSLATION_ELONGATION,-2.053052828,0.029714478,BRD-K33211335
BETA_CATENIN_INDEPENDENT_WNT_SIGNALING,-2.03295815,0.024337572,BRD-K33211335
ECM_PROTEOGLYCANS,1.977615671,0.036245955,BRD-K33211335
EUKARYOTIC_TRANSLATION_INITIATION,-2.005907307,0.025469552,BRD-K33211335
RRNA_PROCESSING,-2.000420691,0.023092394,BRD-K33211335
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,2.60737706,0,alectinib
GPCR_LIGAND_BINDING,-2.061129536,0.174264987,alectinib
SIGNALING_BY_GPCR,-2.059316429,0.088466154,alectinib
RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_PATHWAY,1.884501478,0.140101237,alectinib
TOLL_LIKE_RECEPTOR_CASCADES,1.860871688,0.109848769,alectinib
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-1.992843161,0.114102075,alectinib
SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES,1.741065127,0.171381702,alectinib
TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,1.735603155,0.140982377,alectinib
METABOLISM_OF_STEROIDS,1.726818472,0.123065867,alectinib
KERATINIZATION,-1.974648585,0.105136912,alectinib
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.305357138,0.037538022,zaleplon
ECM_PROTEOGLYCANS,-2.174993513,0.061897803,zaleplon
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.028846363,0.128853921,zaleplon
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.957069844,0.165926046,zaleplon
REGULATION_OF_T_CELL_ACTIVATION_BY_CD28_FAMILY,1.828081303,1,zaleplon
TCR_SIGNALING,1.716003119,1,zaleplon
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.695415083,0.79579242,zaleplon
CELL_CELL_JUNCTION_ORGANIZATION,1.693362349,0.606541471,zaleplon
NONSENSE_MEDIATED_DECAY_NMD,1.671352163,0.554802452,zaleplon
MEMBRANE_TRAFFICKING,1.660141522,0.494242148,zaleplon
METABOLISM_OF_RNA,4.83592126,0,imexon
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,3.81831356,0,imexon
MRNA_SPLICING,3.501686785,0,imexon
RESPIRATORY_ELECTRON_TRANSPORT,3.198169942,0,imexon
INFLUENZA_INFECTION,2.948698497,0,imexon
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,2.754812383,0,imexon
RRNA_PROCESSING,2.645324625,0,imexon
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,2.607798807,0.000677384,imexon
TRANSLATION,2.586702448,0.000602119,imexon
HIV_INFECTION,2.557024105,0.001083815,imexon
MRNA_SPLICING,1.570423098,0.691166489,nicotinamide
SEPARATION_OF_SISTER_CHROMATIDS,1.492289462,0.526374479,nicotinamide
CLATHRIN_MEDIATED_ENDOCYTOSIS,1.462503712,0.414557678,nicotinamide
G_ALPHA_Q_SIGNALLING_EVENTS,-2.050021154,1,nicotinamide
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.034639778,1,nicotinamide
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-1.974550222,1,nicotinamide
EUKARYOTIC_TRANSLATION_ELONGATION,-1.940278345,0.923833273,nicotinamide
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-1.935917118,0.740656864,nicotinamide
MITOTIC_METAPHASE_AND_ANAPHASE,1.403113889,0.430112479,nicotinamide
GPCR_LIGAND_BINDING,-1.865684064,0.671713093,nicotinamide
EUKARYOTIC_TRANSLATION_ELONGATION,-3.244256747,0,sirolimus
NERVOUS_SYSTEM_DEVELOPMENT,-2.435183389,0,sirolimus
RRNA_PROCESSING,-2.551093953,0,sirolimus
SARS_COV_1_INFECTION,-2.637548304,0,sirolimus
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.720275514,0,sirolimus
TRANSLATION,-2.815256499,0,sirolimus
INFLUENZA_INFECTION,-2.849512684,0,sirolimus
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.929907249,0,sirolimus
SIGNALING_BY_ROBO_RECEPTORS,-2.930160984,0,sirolimus
SARS_COV_1_HOST_INTERACTIONS,-2.959070095,0,sirolimus
RESPIRATORY_ELECTRON_TRANSPORT,3.691305648,0,PJ-34
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,3.227377621,0,PJ-34
TRANSLATION,2.957094891,0,PJ-34
THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT,2.577512164,0.001189267,PJ-34
RRNA_PROCESSING,2.533991317,0.001427121,PJ-34
METABOLISM_OF_RNA,2.340838331,0.005153491,PJ-34
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.157589676,0.020421656,PJ-34
HOST_INTERACTIONS_OF_HIV_FACTORS,2.220816933,0.011892672,PJ-34
MITOCHONDRIAL_PROTEIN_IMPORT,2.20794926,0.011595355,PJ-34
MITOCHONDRIAL_PROTEIN_DEGRADATION,2.110183265,0.015856896,PJ-34
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,4.095494685,0,isotretinoin
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.473331643,0,isotretinoin
TRANSLATION,-2.673861402,0,isotretinoin
CELLULAR_RESPONSE_TO_STARVATION,-2.883709921,0,isotretinoin
SIGNALING_BY_ROBO_RECEPTORS,-2.937683066,0,isotretinoin
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-3.005878111,0,isotretinoin
INFLUENZA_INFECTION,-3.082506439,0,isotretinoin
NONSENSE_MEDIATED_DECAY_NMD,-3.094710246,0,isotretinoin
SELENOAMINO_ACID_METABOLISM,-3.100001852,0,isotretinoin
RRNA_PROCESSING,-2.737342464,0,isotretinoin
NGF_STIMULATED_TRANSCRIPTION,3.356386788,0,menadione
METABOLISM_OF_RNA,3.192530095,0,menadione
NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION,3.174804226,0,menadione
NUCLEAR_EVENTS_MEDIATED_BY_NFE2L2,2.797105394,0,menadione
INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,2.742487902,0.00042251,menadione
RRNA_PROCESSING,2.710132697,0.000352092,menadione
KEAP1_NFE2L2_PATHWAY,2.583171838,0.000905379,menadione
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,2.560989154,0.000792207,menadione
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.501632432,0.001408368,menadione
SIGNALING_BY_NTRKS,2.496404583,0.001267531,menadione
MHC_CLASS_II_ANTIGEN_PRESENTATION,2.927825668,0,carprofen
GOLGI_TO_ER_RETROGRADE_TRANSPORT,2.791412702,0,carprofen
GPCR_LIGAND_BINDING,-2.65175656,0,carprofen
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.592952886,0,carprofen
SIGNALING_BY_GPCR,-2.376120531,0,carprofen
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.35272221,0,carprofen
G_ALPHA_Q_SIGNALLING_EVENTS,-2.320442007,0,carprofen
HCMV_INFECTION,2.254071817,0.005727328,carprofen
RESOLUTION_OF_SISTER_CHROMATID_COHESION,2.171102613,0.009204634,carprofen
NUCLEAR_ENVELOPE_NE_REASSEMBLY,2.158440234,0.008836448,carprofen
METABOLISM_OF_RNA,2.818977399,0,perospirone
RRNA_PROCESSING,2.689648284,0,perospirone
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.558591363,0,perospirone
EUKARYOTIC_TRANSLATION_INITIATION,2.478943467,0.003813837,perospirone
SIGNALING_BY_ROBO_RECEPTORS,2.437271061,0.004358671,perospirone
NERVOUS_SYSTEM_DEVELOPMENT,2.375148459,0.004721893,perospirone
CELL_CYCLE,2.366310742,0.004358671,perospirone
CELL_CYCLE_CHECKPOINTS,2.353622008,0.004631088,perospirone
SEPARATION_OF_SISTER_CHROMATIDS,2.318104808,0.004023388,perospirone
DEFECTIVE_CFTR_CAUSES_CYSTIC_FIBROSIS,2.339620692,0.005085116,perospirone
CELL_CYCLE,-3.229194668,0,tivozanib
CELL_CYCLE_CHECKPOINTS,-3.019666067,0,tivozanib
CELL_CYCLE_MITOTIC,-2.788084945,0,tivozanib
MITOTIC_METAPHASE_AND_ANAPHASE,-2.754359995,0,tivozanib
MITOTIC_SPINDLE_CHECKPOINT,-2.545926014,0.000918545,tivozanib
RESOLUTION_OF_SISTER_CHROMATID_COHESION,-2.544579932,0.000765454,tivozanib
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.428528244,0.000984155,tivozanib
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,-2.418312857,0.001148181,tivozanib
GPCR_LIGAND_BINDING,2.359901703,0.00257953,tivozanib
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.336286619,0.003572118,tivozanib
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,2.652322209,0.004135411,pindolol
INFLUENZA_INFECTION,2.342724411,0.014473937,pindolol
MYD88_INDEPENDENT_TLR4_CASCADE,2.301928414,0.011027762,pindolol
TOLL_LIKE_RECEPTOR_CASCADES,2.150097131,0.022744759,pindolol
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,2.147162092,0.018195807,pindolol
ORGANELLE_BIOGENESIS_AND_MAINTENANCE,2.066886548,0.025501699,pindolol
TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER,2.047173434,0.026584783,pindolol
REGULATION_OF_TP53_ACTIVITY,2.028450045,0.025846317,pindolol
TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,1.992755607,0.026650424,pindolol
TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,1.984713433,0.022556785,pindolol
GPCR_LIGAND_BINDING,-2.638069543,0,torasemide
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.473853019,0.000814815,torasemide
SIGNALING_BY_GPCR,-2.443127878,0.00054321,torasemide
EUKARYOTIC_TRANSLATION_INITIATION,-2.428278913,0.000407408,torasemide
G_ALPHA_Q_SIGNALLING_EVENTS,-2.399984326,0.000488889,torasemide
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.358944698,0.000950618,torasemide
EUKARYOTIC_TRANSLATION_ELONGATION,-2.357832846,0.000814815,torasemide
TRANSLATION,-2.345635001,0.000712963,torasemide
NONSENSE_MEDIATED_DECAY_NMD,-2.238998435,0.0018107,torasemide
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.201720251,0.002770372,torasemide
NEUTROPHIL_DEGRANULATION,-3.543277468,0,cetirizine
SIGNALING_BY_GPCR,3.179716889,0,cetirizine
GPCR_LIGAND_BINDING,3.13706878,0,cetirizine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,3.064238042,0,cetirizine
G_ALPHA_Q_SIGNALLING_EVENTS,2.477006687,0.000194654,cetirizine
G_ALPHA_I_SIGNALLING_EVENTS,2.453149911,0.000155723,cetirizine
G_ALPHA_S_SIGNALLING_EVENTS,2.414385819,0.000259539,cetirizine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.651247978,0.003744136,cetirizine
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,-2.505056642,0.009485144,cetirizine
PROTEIN_LOCALIZATION,-2.48191192,0.008985926,cetirizine
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,3.12197253,0,bisoprolol
G2_M_CHECKPOINTS,3.108555891,0,bisoprolol
HOST_INTERACTIONS_OF_HIV_FACTORS,2.820617383,0,bisoprolol
INFLUENZA_INFECTION,2.694877945,0,bisoprolol
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.650412761,0,bisoprolol
CELL_CYCLE_CHECKPOINTS,2.63240189,0,bisoprolol
CELL_CYCLE,2.608229187,0,bisoprolol
DEUBIQUITINATION,2.491208454,0.000522727,bisoprolol
CELL_CYCLE_MITOTIC,2.432283393,0.000929292,bisoprolol
REGULATION_OF_TP53_ACTIVITY,2.382469178,0.000836362,bisoprolol
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,3.68397857,0,tolazoline
THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT,3.564574584,0,tolazoline
ORC1_REMOVAL_FROM_CHROMATIN,3.281070625,0,tolazoline
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,3.102281568,0,tolazoline
HOST_INTERACTIONS_OF_HIV_FACTORS,3.077058691,0,tolazoline
UCH_PROTEINASES,3.059737698,0,tolazoline
SEPARATION_OF_SISTER_CHROMATIDS,3.055071476,0,tolazoline
MITOTIC_G2_G2_M_PHASES,3.037576968,0,tolazoline
SIGNALING_BY_NOTCH4,2.755026878,0.000145646,tolazoline
BETA_CATENIN_INDEPENDENT_WNT_SIGNALING,2.735959387,0.000139026,tolazoline
PEROXISOMAL_PROTEIN_IMPORT,-2.566469157,0,modafinil
ORC1_REMOVAL_FROM_CHROMATIN,2.247113303,0.046370688,modafinil
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.197967791,0.034778016,modafinil
TRANSCRIPTIONAL_REGULATION_BY_RUNX3,2.183183743,0.025563328,modafinil
NEUTROPHIL_DEGRANULATION,-2.116233043,0.035332711,modafinil
GASTRULATION,2.06279063,0.051721153,modafinil
S_PHASE,2.051248427,0.048154176,modafinil
SYNTHESIS_OF_DNA,1.888795539,0.129600129,modafinil
DNA_REPLICATION,1.86933648,0.124079809,modafinil
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,1.723016067,0.246790154,modafinil
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.720491713,0,bumetanide
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.555627761,0.001548233,bumetanide
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,1.867054785,0.145533942,bumetanide
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.844562711,0.126181024,bumetanide
GPCR_LIGAND_BINDING,1.686710576,0.263406114,bumetanide
CELL_JUNCTION_ORGANIZATION,1.602356118,0.352137091,bumetanide
REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF,-1.733433403,1,bumetanide
ESTROGEN_DEPENDENT_GENE_EXPRESSION,1.514706666,0.480542165,bumetanide
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,-1.660139705,1,bumetanide
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,1.453586823,0.571685193,bumetanide
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,1.891420116,0.114518634,amlexanox
GPCR_LIGAND_BINDING,-1.868899832,0.287037037,amlexanox
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.827583035,0.212901643,amlexanox
TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,1.510922775,0.41246118,amlexanox
G_ALPHA_Q_SIGNALLING_EVENTS,-1.822543294,0.151755784,amlexanox
GLYCOSAMINOGLYCAN_METABOLISM,1.455249725,0.362318841,amlexanox
SIGNALING_BY_GPCR,-1.789432008,0.158012938,amlexanox
TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,-1.770002106,0.15397351,amlexanox
NEURONAL_SYSTEM,-1.765828007,0.134013981,amlexanox
POTASSIUM_CHANNELS,-1.729386391,0.167551421,amlexanox
REGULATION_OF_TP53_ACTIVITY,2.022102133,0.236210184,lomerizine
SENSORY_PERCEPTION,-1.993377761,0.205985173,lomerizine
GPCR_LIGAND_BINDING,-1.984040976,0.112984405,lomerizine
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,1.959837743,0.205997253,lomerizine
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.753215273,0.435028389,lomerizine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.748737459,0.33645526,lomerizine
SIGNALING_BY_GPCR,-1.726147826,0.313589369,lomerizine
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,1.580413536,1,lomerizine
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-1.645832303,0.43592509,lomerizine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.63655491,0.395829718,lomerizine
RESPIRATORY_ELECTRON_TRANSPORT,4.517437236,0,tianeptine
CELL_CYCLE_CHECKPOINTS,2.60327187,0,tianeptine
DNA_REPLICATION,2.707494618,0,tianeptine
CELLULAR_RESPONSE_TO_STARVATION,2.845869293,0,tianeptine
NONSENSE_MEDIATED_DECAY_NMD,2.881600131,0,tianeptine
MITOTIC_METAPHASE_AND_ANAPHASE,2.901073182,0,tianeptine
INFLUENZA_INFECTION,2.908502784,0,tianeptine
METABOLISM_OF_RNA,2.918887961,0,tianeptine
SEPARATION_OF_SISTER_CHROMATIDS,2.956926592,0,tianeptine
SIGNALING_BY_ROBO_RECEPTORS,3.071230342,0,tianeptine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.595503925,0,azithromycin
GPCR_LIGAND_BINDING,2.464971878,0,azithromycin
TRANSLATION,-2.310032906,0.012290813,azithromycin
SIGNALING_BY_GPCR,2.312738979,0.000680521,azithromycin
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.308994027,0.00051039,azithromycin
THE_PHOTOTRANSDUCTION_CASCADE,2.213172324,0.00231377,azithromycin
METABOLISM_OF_RNA,-1.996415389,0.088084161,azithromycin
INNATE_IMMUNE_SYSTEM,-1.947518522,0.077841817,azithromycin
RRNA_PROCESSING,-1.935859,0.0624783,azithromycin
G_ALPHA_I_SIGNALLING_EVENTS,2.024812847,0.012249371,azithromycin
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-3.308865871,0,raloxifene
RRNA_PROCESSING,-2.667586553,0,raloxifene
SARS_COV_1_INFECTION,-2.751418222,0,raloxifene
SIGNALING_BY_ROBO_RECEPTORS,-2.757554416,0,raloxifene
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.820146727,0,raloxifene
EUKARYOTIC_TRANSLATION_INITIATION,-2.870509974,0,raloxifene
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.871596469,0,raloxifene
INFLUENZA_INFECTION,-2.901610919,0,raloxifene
NONSENSE_MEDIATED_DECAY_NMD,-2.918711184,0,raloxifene
CELLULAR_RESPONSE_TO_STARVATION,-2.928114426,0,raloxifene
G2_M_CHECKPOINTS,2.166419964,0.052225179,omeprazole
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.136032511,0.032031443,omeprazole
MUSCLE_CONTRACTION,1.927975578,0.077293266,omeprazole
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.89482075,0.640058308,omeprazole
SIGNALING_BY_INTERLEUKINS,-1.693515672,1,omeprazole
HOMOLOGY_DIRECTED_REPAIR,1.59297726,0.415538345,omeprazole
GLUCOSE_METABOLISM,-1.671879084,1,omeprazole
RAC2_GTPASE_CYCLE,-1.633391698,1,omeprazole
NEDDYLATION,1.442656078,0.707616365,omeprazole
VISUAL_PHOTOTRANSDUCTION,-1.578159067,1,omeprazole
RHO_GTPASES_ACTIVATE_FORMINS,3.168602255,0,hexylcaine
RESOLUTION_OF_SISTER_CHROMATID_COHESION,2.979426133,0.001931567,hexylcaine
SEPARATION_OF_SISTER_CHROMATIDS,2.873518344,0.001287712,hexylcaine
RHO_GTPASE_EFFECTORS,2.768582618,0.000965784,hexylcaine
CELL_CYCLE_CHECKPOINTS,2.514582731,0.003090508,hexylcaine
MITOTIC_METAPHASE_AND_ANAPHASE,2.413745575,0.003863135,hexylcaine
MITOTIC_SPINDLE_CHECKPOINT,2.404045031,0.003311258,hexylcaine
MITOTIC_PROMETAPHASE,2.404014552,0.002897351,hexylcaine
BILE_ACID_AND_BILE_SALT_METABOLISM,-2.187887703,0.013270153,hexylcaine
PEROXISOMAL_PROTEIN_IMPORT,-2.175164839,0.007372307,hexylcaine
RHO_GTPASES_ACTIVATE_FORMINS,2.126972563,0.058776553,hesperidin
RRNA_PROCESSING,2.083101033,0.039610286,hesperidin
SEPARATION_OF_SISTER_CHROMATIDS,2.020899357,0.036628867,hesperidin
METABOLISM_OF_RNA,1.96079949,0.038332535,hesperidin
RESOLUTION_OF_SISTER_CHROMATID_COHESION,1.906535685,0.045999042,hesperidin
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.879840198,0.048554544,hesperidin
MUSCLE_CONTRACTION,-2.956565456,0.205716986,hesperidin
MITOTIC_SPINDLE_CHECKPOINT,1.678283164,0.132521049,hesperidin
MRNA_SPLICING,1.595787438,0.185912793,hesperidin
BIOLOGICAL_OXIDATIONS,-2.843170247,0.543379498,hesperidin
METABOLISM_OF_RNA,-4.70634098,0,BRD-K89997465
G_ALPHA_I_SIGNALLING_EVENTS,2.484831024,0,BRD-K89997465
G_ALPHA_Q_SIGNALLING_EVENTS,2.622899654,0,BRD-K89997465
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.751296734,0,BRD-K89997465
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,-2.779097301,0,BRD-K89997465
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.817017059,0,BRD-K89997465
INFECTIOUS_DISEASE,-2.845850726,0,BRD-K89997465
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.930469952,0,BRD-K89997465
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-3.021871303,0,BRD-K89997465
MRNA_SPLICING,-3.03830507,0,BRD-K89997465
POTENTIAL_THERAPEUTICS_FOR_SARS,2.421034916,0.005636387,simvastatin
TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,2.303580548,0.016909162,simvastatin
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,2.26834816,0.011272775,simvastatin
TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,2.252557063,0.008454581,simvastatin
GPCR_LIGAND_BINDING,-2.133232168,0.008667937,simvastatin
TOLL_LIKE_RECEPTOR_CASCADES,2.17527703,0.01803644,simvastatin
SENSORY_PERCEPTION,-2.099763729,0.006810522,simvastatin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.065140962,0.008461558,simvastatin
SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3,1.944476702,0.061060864,simvastatin
RHO_GTPASE_EFFECTORS,1.940888913,0.052337884,simvastatin
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.805263897,0,niacin
NEUTROPHIL_DEGRANULATION,2.219260399,0.014289785,niacin
SIGNALING_BY_GPCR,-2.062331754,0.750624381,niacin
G_ALPHA_Q_SIGNALLING_EVENTS,-2.03338658,0.450684377,niacin
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.742211865,0.29593684,niacin
C_TYPE_LECTIN_RECEPTORS_CLRS,-1.820754365,0.915135364,niacin
GPCR_LIGAND_BINDING,-1.790178558,0.787277979,niacin
RAB_GEFS_EXCHANGE_GTP_FOR_GDP_ON_RABS,1.575618741,0.563755071,niacin
ESTROGEN_DEPENDENT_GENE_EXPRESSION,1.555230494,0.50060344,niacin
RAB_REGULATION_OF_TRAFFICKING,1.546975489,0.435300658,niacin
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.719793728,0,aminolevulinic-acid
NEUTROPHIL_DEGRANULATION,2.166326863,0.021649957,aminolevulinic-acid
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,2.117798668,0.020619007,aminolevulinic-acid
INNATE_IMMUNE_SYSTEM,2.010399166,0.043128089,aminolevulinic-acid
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,1.882444998,0.087012208,aminolevulinic-acid
HEMOSTASIS,1.737861288,0.18751841,aminolevulinic-acid
ADIPOGENESIS,-1.764577111,1,aminolevulinic-acid
MUSCLE_CONTRACTION,1.631327366,0.296030023,aminolevulinic-acid
SIGNALING_BY_VEGF,-1.683875647,1,aminolevulinic-acid
RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES,-1.674169395,1,aminolevulinic-acid
GPCR_LIGAND_BINDING,-2.538076234,0,levobunolol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.355369081,0.000406946,levobunolol
SIGNALING_BY_GPCR,-2.214163845,0.001627783,levobunolol
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.13189247,0.004069458,levobunolol
SIGNALING_BY_NTRKS,2.106298352,0.110971434,levobunolol
NEUTROPHIL_DEGRANULATION,2.031936971,0.086002861,levobunolol
G_ALPHA_S_SIGNALLING_EVENTS,-2.022008544,0.016115054,levobunolol
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,1.924214676,0.107272386,levobunolol
SUMOYLATION,1.834242478,0.131085006,levobunolol
G_ALPHA_Q_SIGNALLING_EVENTS,-1.93933295,0.032962611,levobunolol
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.254830842,0.029810067,cyclizine
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,2.119835205,0.099704061,cyclizine
GPCR_LIGAND_BINDING,-2.038202314,0.095392215,cyclizine
REGULATION_OF_TP53_ACTIVITY,1.923871641,0.235347957,cyclizine
G_ALPHA_Q_SIGNALLING_EVENTS,-1.924769255,0.147062999,cyclizine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.779851717,0.304275615,cyclizine
SIGNALING_BY_GPCR,-1.725273881,0.340345797,cyclizine
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.71810495,0.29795872,cyclizine
TRANSCRIPTIONAL_REGULATION_BY_TP53,1.664288607,0.901973945,cyclizine
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.647846349,0.382907272,cyclizine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.429060042,0.002981862,oxymetazoline
GPCR_LIGAND_BINDING,-2.33371923,0.003727327,oxymetazoline
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.289701089,0.004224304,oxymetazoline
SENSORY_PERCEPTION,-2.252717715,0.004845526,oxymetazoline
G_ALPHA_Q_SIGNALLING_EVENTS,-2.177781062,0.006709189,oxymetazoline
VIRAL_INFECTION_PATHWAYS,2.100501187,0.129053248,oxymetazoline
RHO_GTPASE_EFFECTORS,1.923740577,0.142338141,oxymetazoline
METABOLISM_OF_VITAMINS_AND_COFACTORS,-2.081393061,0.016275997,oxymetazoline
KERATINIZATION,-2.064882432,0.01554828,oxymetazoline
TOLL_LIKE_RECEPTOR_CASCADES,1.882715644,0.135379388,oxymetazoline
GPCR_LIGAND_BINDING,-2.522828121,0,talmapimod
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.494756006,0,talmapimod
SENSORY_PERCEPTION,-2.478996589,0.000248164,talmapimod
REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF,2.461686768,0.01295197,talmapimod
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.29200015,0.005769803,talmapimod
NEUTROPHIL_DEGRANULATION,2.080307681,0.076092822,talmapimod
SIGNALING_BY_GPCR,-2.213252639,0.010125074,talmapimod
MHC_CLASS_II_ANTIGEN_PRESENTATION,1.969909913,0.099298435,talmapimod
RHO_GTPASE_CYCLE,1.842543773,0.152995143,talmapimod
G_ALPHA_Q_SIGNALLING_EVENTS,-2.111243573,0.029531467,talmapimod
GPCR_LIGAND_BINDING,-2.05867351,0.183330927,aminocaproic-acid
SIGNALING_BY_GPCR,-1.78650458,0.710767284,aminocaproic-acid
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.752336289,0.578788213,aminocaproic-acid
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.751176154,0.436730741,aminocaproic-acid
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,1.710678923,1,aminocaproic-acid
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.709229087,0.955343787,aminocaproic-acid
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-1.66464148,0.571109431,aminocaproic-acid
SENSORY_PERCEPTION,-1.656896775,0.496721228,aminocaproic-acid
TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,1.616469549,1,aminocaproic-acid
REGULATION_OF_TP53_ACTIVITY,1.562715717,1,aminocaproic-acid
PKR_MEDIATED_SIGNALING,-2.053252001,0.222296099,dazoxiben
METABOLISM_OF_STEROIDS,-1.798074647,0.520574764,dazoxiben
RRNA_PROCESSING,-1.717054205,0.55678684,dazoxiben
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.762380782,1,dazoxiben
L1CAM_INTERACTIONS,-1.658337671,0.578974586,dazoxiben
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,1.733964104,0.826005178,dazoxiben
ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES,-1.543192935,0.840203901,dazoxiben
RAB_REGULATION_OF_TRAFFICKING,1.636162951,1,dazoxiben
INFLUENZA_INFECTION,-1.529640906,0.746847912,dazoxiben
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,1.608594222,0.929310082,dazoxiben
STRIATED_MUSCLE_CONTRACTION,2.44627685,0.005790046,dipyridamole
MUSCLE_CONTRACTION,2.137472653,0.032258827,dipyridamole
RHO_GTPASE_CYCLE,-2.096596842,0.152279093,dipyridamole
CDC42_GTPASE_CYCLE,-2.036093288,0.134071811,dipyridamole
RRNA_PROCESSING,1.894363587,0.138133951,dipyridamole
ION_HOMEOSTASIS,1.889158562,0.10773621,dipyridamole
C_TYPE_LECTIN_RECEPTORS_CLRS,-1.915755953,0.231361231,dipyridamole
TRANSLATION,1.729084681,0.241031337,dipyridamole
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,1.677527867,0.268823557,dipyridamole
RHOA_GTPASE_CYCLE,-1.745103106,0.590633223,dipyridamole
EUKARYOTIC_TRANSLATION_ELONGATION,5.122262229,0,emodin
DNA_REPLICATION_PRE_INITIATION,2.669853519,0,emodin
SARS_COV_2_HOST_INTERACTIONS,3.370293958,0,emodin
NERVOUS_SYSTEM_DEVELOPMENT,3.304972673,0,emodin
SARS_COV_2_INFECTION,3.173107316,0,emodin
HOST_INTERACTIONS_OF_HIV_FACTORS,3.115697145,0,emodin
SARS_COV_INFECTIONS,2.985522832,0,emodin
HIV_INFECTION,2.871444217,0,emodin
INFECTIOUS_DISEASE,3.539612343,0,emodin
CELLULAR_RESPONSE_TO_HEAT_STRESS,2.797508845,0,emodin
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,2.699554036,0.003080337,BRD-K40331046
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,2.351330758,0.018482023,BRD-K40331046
CELL_CYCLE_CHECKPOINTS,-2.130019699,0.047877217,BRD-K40331046
HEMOSTASIS,2.137378548,0.04363811,BRD-K40331046
LEISHMANIA_INFECTION,2.130607509,0.03580892,BRD-K40331046
M_PHASE,-2.075876112,0.043167982,BRD-K40331046
DNA_REPAIR,-2.042749579,0.038197124,BRD-K40331046
CELL_CYCLE,-2.041266982,0.029236497,BRD-K40331046
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.03936065,0.051133597,BRD-K40331046
SIGNALING_BY_INTERLEUKINS,1.974691785,0.06520047,BRD-K40331046
MUSCLE_CONTRACTION,3.102455776,0,relcovaptan
PLATELET_HOMEOSTASIS,2.362035819,0.005967181,relcovaptan
CARDIAC_CONDUCTION,2.16169754,0.026852312,relcovaptan
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,-1.913608644,0.80393758,relcovaptan
HEMOSTASIS,1.795985853,0.23371457,relcovaptan
NEURONAL_SYSTEM,1.708613698,0.305917454,relcovaptan
NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK,1.704196927,0.260898392,relcovaptan
VISUAL_PHOTOTRANSDUCTION,-1.774717321,1,relcovaptan
SIGNALING_BY_GPCR,1.592253737,0.411877531,relcovaptan
ECM_PROTEOGLYCANS,-1.727529447,1,relcovaptan
EUKARYOTIC_TRANSLATION_ELONGATION,3.213768149,0,ripasudil
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.811212856,0,ripasudil
SIGNALING_BY_ROBO_RECEPTORS,2.868562525,0,ripasudil
NONSENSE_MEDIATED_DECAY_NMD,2.901851563,0,ripasudil
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.9262683,0,ripasudil
EUKARYOTIC_TRANSLATION_INITIATION,2.938685561,0,ripasudil
ECM_PROTEOGLYCANS,-2.483928195,0,ripasudil
SELENOAMINO_ACID_METABOLISM,3.061400486,0,ripasudil
CELLULAR_RESPONSE_TO_STARVATION,3.104140549,0,ripasudil
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.172491106,0,ripasudil
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,4.528119177,0,deserpidine
SARS_COV_1_INFECTION,3.479152627,0,deserpidine
CELLULAR_RESPONSES_TO_STIMULI,3.471456265,0,deserpidine
SARS_COV_INFECTIONS,3.236292676,0,deserpidine
SARS_COV_2_INFECTION,3.185149387,0,deserpidine
NERVOUS_SYSTEM_DEVELOPMENT,3.006795829,0,deserpidine
THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT,2.49972455,0,deserpidine
KEAP1_NFE2L2_PATHWAY,2.502376419,0,deserpidine
CELL_CYCLE_MITOTIC,2.525859317,0,deserpidine
MRNA_SPLICING_MINOR_PATHWAY,2.526828431,0,deserpidine
EUKARYOTIC_TRANSLATION_ELONGATION,3.972035366,0,citalopram
VIRAL_INFECTION_PATHWAYS,2.585237805,0,citalopram
SARS_COV_2_INFECTION,2.586744434,0,citalopram
METABOLISM_OF_RNA,2.790139445,0,citalopram
NERVOUS_SYSTEM_DEVELOPMENT,2.830334506,0,citalopram
SARS_COV_2_HOST_INTERACTIONS,2.833958067,0,citalopram
SARS_COV_1_INFECTION,3.028850762,0,citalopram
SARS_COV_1_HOST_INTERACTIONS,3.072539266,0,citalopram
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,3.14458422,0,citalopram
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,3.222120315,0,citalopram
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.978281525,0,salmeterol
GPCR_LIGAND_BINDING,2.954447036,0,salmeterol
SIGNALING_BY_GPCR,2.692779259,0,salmeterol
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.457454625,0.000484868,salmeterol
G_ALPHA_Q_SIGNALLING_EVENTS,2.05369271,0.017843145,salmeterol
G_ALPHA_I_SIGNALLING_EVENTS,1.96153031,0.034156262,salmeterol
TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,-2.981193536,1,salmeterol
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,-2.968054688,1,salmeterol
COPII_MEDIATED_VESICLE_TRANSPORT,-2.717263396,1,salmeterol
ASPARAGINE_N_LINKED_GLYCOSYLATION,-2.599883894,1,salmeterol
RRNA_PROCESSING,-2.308253029,0.011295914,procainamide
ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT,-2.210796873,0.028753236,procainamide
METABOLISM_OF_RNA,-2.119888487,0.040391451,procainamide
GASTRULATION,-2.102468104,0.033887743,procainamide
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.959409753,0.082562865,procainamide
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,1.956595389,0.411227252,procainamide
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-1.897099643,0.11004959,procainamide
REGULATION_OF_T_CELL_ACTIVATION_BY_CD28_FAMILY,1.86203708,0.409765544,procainamide
REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS,-1.829852834,0.152714894,procainamide
CILIUM_ASSEMBLY,1.78767995,0.445983426,procainamide
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,4.173843588,0,hydroxyfasudil
NERVOUS_SYSTEM_DEVELOPMENT,2.794858986,0,hydroxyfasudil
VIRAL_INFECTION_PATHWAYS,2.913223393,0,hydroxyfasudil
SARS_COV_1_INFECTION,2.992164293,0,hydroxyfasudil
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,3.01210971,0,hydroxyfasudil
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,3.041057088,0,hydroxyfasudil
METABOLISM_OF_RNA,3.063147448,0,hydroxyfasudil
CELLULAR_RESPONSES_TO_STIMULI,3.197234431,0,hydroxyfasudil
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,3.285621342,0,hydroxyfasudil
SARS_COV_1_HOST_INTERACTIONS,3.327666576,0,hydroxyfasudil
METABOLISM_OF_RNA,3.65894647,0,flucytosine
CELL_CYCLE_MITOTIC,3.332334567,0,flucytosine
CELL_CYCLE,3.296871466,0,flucytosine
CELL_CYCLE_CHECKPOINTS,3.223540436,0,flucytosine
M_PHASE,3.042548338,0,flucytosine
G2_M_CHECKPOINTS,2.881966301,0,flucytosine
MITOTIC_METAPHASE_AND_ANAPHASE,2.829169848,0,flucytosine
RRNA_PROCESSING,2.776863069,0,flucytosine
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.557756665,0.000424486,flucytosine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.55319704,0.000382038,flucytosine
CELL_CYCLE,-4.176465648,0,daunorubicin
HOMOLOGOUS_DNA_PAIRING_AND_STRAND_EXCHANGE,-2.556847919,0,daunorubicin
REGULATION_OF_PLK1_ACTIVITY_AT_G2_M_TRANSITION,-2.58784548,0,daunorubicin
AURKA_ACTIVATION_BY_TPX2,-2.603097492,0,daunorubicin
MRNA_SPLICING,-2.630280748,0,daunorubicin
PROCESSING_OF_DNA_DOUBLE_STRAND_BREAK_ENDS,-2.643015119,0,daunorubicin
DNA_REPLICATION,-2.670330825,0,daunorubicin
SEPARATION_OF_SISTER_CHROMATIDS,-2.682362522,0,daunorubicin
G2_M_DNA_DAMAGE_CHECKPOINT,-2.682895545,0,daunorubicin
DISEASES_OF_DNA_REPAIR,-2.682977536,0,daunorubicin
TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,1.966159616,0.357600096,mirtazapine
TOLL_LIKE_RECEPTOR_CASCADES,1.935311454,0.233992346,mirtazapine
TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,1.854763643,0.282860526,mirtazapine
MYD88_INDEPENDENT_TLR4_CASCADE,1.749318442,0.452174398,mirtazapine
REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE,-1.658378605,1,mirtazapine
ISG15_ANTIVIRAL_MECHANISM,-1.6575546,0.818246544,mirtazapine
METABOLISM_OF_VITAMINS_AND_COFACTORS,-1.650809703,0.567757564,mirtazapine
SIGNALING_BY_ROBO_RECEPTORS,1.676752978,0.588257907,mirtazapine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,1.675342005,0.494814281,mirtazapine
METABOLISM_OF_STEROIDS,-1.604786968,0.548771206,mirtazapine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.644122272,0,TTNPB
METABOLISM_OF_RNA,2.463729131,0,TTNPB
GPCR_LIGAND_BINDING,-2.161247794,0.000830983,TTNPB
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.117874024,0.002077458,TTNPB
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.010478303,0.00637087,TTNPB
MRNA_SPLICING,1.969999607,0.06061828,TTNPB
SIGNALING_BY_GPCR,-1.928630028,0.013087983,TTNPB
EPIGENETIC_REGULATION_BY_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES,1.807023818,0.093682796,TTNPB
G_ALPHA_Q_SIGNALLING_EVENTS,-1.870192192,0.023267526,TTNPB
G_ALPHA_I_SIGNALLING_EVENTS,-1.817087081,0.03337782,TTNPB
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,2.100696832,0.122542311,quinapril
NEURONAL_SYSTEM,1.897292916,0.331318101,quinapril
METABOLISM_OF_STEROIDS,-1.756078832,1,quinapril
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.747159226,0.684140382,quinapril
DEATH_RECEPTOR_SIGNALING,1.742297872,0.655071861,quinapril
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,-1.691745693,0.622383611,quinapril
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,1.682117918,0.739225146,quinapril
BIOLOGICAL_OXIDATIONS,1.672116841,0.630412112,quinapril
TRANSPORT_OF_SMALL_MOLECULES,-1.59822225,0.802696386,quinapril
METABOLISM_OF_VITAMINS_AND_COFACTORS,-1.57376452,0.734112375,quinapril
NUCLEAR_EVENTS_MEDIATED_BY_NFE2L2,2.772327433,0,mestranol
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.471690927,0.003568946,mestranol
KEAP1_NFE2L2_PATHWAY,2.358399091,0.013086134,mestranol
PCP_CE_PATHWAY,2.327365428,0.010706837,mestranol
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,2.28220736,0.009993048,mestranol
SYNTHESIS_OF_DNA,2.216919436,0.011301661,mestranol
G2_M_CHECKPOINTS,2.212162802,0.009687138,mestranol
APC_C_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS,2.209037613,0.008476246,mestranol
CELL_CYCLE_CHECKPOINTS,2.201101835,0.007534441,mestranol
TRANSCRIPTIONAL_REGULATION_BY_RUNX2,2.188156499,0.008208575,mestranol
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.830983716,0,mebendazole
NONSENSE_MEDIATED_DECAY_NMD,2.124009088,0.033274071,mebendazole
NEUTROPHIL_DEGRANULATION,1.88398151,0.119509371,mebendazole
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,1.876525708,0.092751472,mebendazole
EUKARYOTIC_TRANSLATION_INITIATION,1.839189998,0.093001028,mebendazole
ESTROGEN_DEPENDENT_GENE_EXPRESSION,1.726698977,0.145435417,mebendazole
RRNA_PROCESSING,1.629368771,0.2150931,mebendazole
PEPTIDE_HORMONE_METABOLISM,1.549277189,0.285013212,mebendazole
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,1.457646897,0.396516009,mebendazole
CONSTITUTIVE_SIGNALING_BY_ABERRANT_PI3K_IN_CANCER,1.454342263,0.362105074,mebendazole
EUKARYOTIC_TRANSLATION_INITIATION,4.923264632,0,tiaprofenic-acid
BETA_CATENIN_INDEPENDENT_WNT_SIGNALING,2.746290647,0,tiaprofenic-acid
MITOCHONDRIAL_PROTEIN_DEGRADATION,2.788878202,0,tiaprofenic-acid
APC_C_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS,2.846968668,0,tiaprofenic-acid
ACTIVATION_OF_APC_C_AND_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS,2.846968668,0,tiaprofenic-acid
MITOTIC_METAPHASE_AND_ANAPHASE,2.989253456,0,tiaprofenic-acid
SEPARATION_OF_SISTER_CHROMATIDS,3.077322708,0,tiaprofenic-acid
CELL_CYCLE_CHECKPOINTS,3.125239968,0,tiaprofenic-acid
S_PHASE,3.190286805,0,tiaprofenic-acid
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.195434562,0,tiaprofenic-acid
TRANSLATION,4.230750704,0,propentofylline
RESPIRATORY_ELECTRON_TRANSPORT,2.951970207,0,propentofylline
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.997215259,0,propentofylline
NONSENSE_MEDIATED_DECAY_NMD,3.385484585,0,propentofylline
INFLUENZA_INFECTION,3.603006649,0,propentofylline
SIGNALING_BY_ROBO_RECEPTORS,3.638589987,0,propentofylline
RRNA_PROCESSING,3.719390029,0,propentofylline
CELLULAR_RESPONSE_TO_STARVATION,3.582490493,0,propentofylline
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.967130611,0,propentofylline
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.970940252,0,propentofylline
MUSCLE_CONTRACTION,1.86642839,0.657726147,droperidol
INTERLEUKIN_1_SIGNALING,-1.783104004,1,droperidol
CONSTITUTIVE_SIGNALING_BY_ABERRANT_PI3K_IN_CANCER,1.607835415,1,droperidol
PI3K_AKT_SIGNALING_IN_CANCER,1.576424632,1,droperidol
INTERLEUKIN_1_FAMILY_SIGNALING,-1.701350209,1,droperidol
CHROMATIN_ORGANIZATION,-1.680230592,1,droperidol
POTASSIUM_CHANNELS,1.502713682,1,droperidol
LEISHMANIA_INFECTION,1.500516811,0.935978474,droperidol
GASTRULATION,-1.620837706,1,droperidol
GPCR_LIGAND_BINDING,-1.593988464,1,droperidol
RRNA_PROCESSING,-2.56483479,0.005972416,gliquidone
TRANSLATION,-2.237778285,0.028866678,gliquidone
GASTRULATION,-2.049747979,0.073659798,gliquidone
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.009710372,0.070175889,gliquidone
METABOLISM_OF_RNA,-1.985657795,0.066094738,gliquidone
PLATELET_HOMEOSTASIS,1.991437243,0.175843002,gliquidone
NEURONAL_SYSTEM,1.985549409,0.09506959,gliquidone
G_ALPHA_I_SIGNALLING_EVENTS,1.890001514,0.14343833,gliquidone
METABOLISM_OF_VITAMINS_AND_COFACTORS,-1.786846575,0.201071341,gliquidone
METABOLISM_OF_STEROIDS,-1.744467323,0.217566585,gliquidone
NEURONAL_SYSTEM,2.416279897,0.006878458,aniracetam
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,2.338775088,0.007642731,aniracetam
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.301261811,0.007642731,aniracetam
LEISHMANIA_INFECTION,2.264792876,0.007642731,aniracetam
SIGNALING_BY_GPCR,2.230051893,0.007795585,aniracetam
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.195583441,0.008152246,aniracetam
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.146691535,0.010481459,aniracetam
TRANSLATION,-2.169937029,0.176232466,aniracetam
GPCR_LIGAND_BINDING,2.107295243,0.013088177,aniracetam
CELL_CELL_COMMUNICATION,2.04455826,0.017238604,aniracetam
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,2.486091714,0.005103736,thioridazine
METABOLISM_OF_STEROIDS,2.45961844,0.003062242,thioridazine
EXTRACELLULAR_MATRIX_ORGANIZATION,2.306257771,0.005443986,thioridazine
ACTIVATION_OF_GENE_EXPRESSION_BY_SREBF_SREBP,2.274176358,0.004593363,thioridazine
REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF,2.230388332,0.005103736,thioridazine
HOMOLOGOUS_DNA_PAIRING_AND_STRAND_EXCHANGE,-2.09350696,0.665344697,thioridazine
DISEASES_OF_METABOLISM,1.772784368,0.104456472,thioridazine
TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,-2.018736596,0.57620046,thioridazine
TRANSPORT_OF_SMALL_MOLECULES,1.684782749,0.145383577,thioridazine
ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS,-1.991923045,0.463483632,thioridazine
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,2.158654651,0.120601054,rofecoxib
S_PHASE,2.09065382,0.095140831,rofecoxib
FORMATION_OF_THE_CORNIFIED_ENVELOPE,-2.007838144,0.098886644,rofecoxib
KERATINIZATION,-2.007838144,0.098886644,rofecoxib
PROGRAMMED_CELL_DEATH,1.961348884,0.166161452,rofecoxib
SYNTHESIS_OF_DNA,1.954161734,0.103984909,rofecoxib
DNA_REPLICATION,1.954161734,0.103984909,rofecoxib
MITOCHONDRIAL_TRANSLATION,1.942023454,0.093577484,rofecoxib
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,1.937797219,0.081740714,rofecoxib
DNA_REPLICATION_PRE_INITIATION,1.800212789,0.168841475,rofecoxib
SIGNALING_BY_GPCR,2.856132919,0,dioxybenzone
GPCR_LIGAND_BINDING,2.765773435,0,dioxybenzone
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.711429698,0,dioxybenzone
G_ALPHA_Q_SIGNALLING_EVENTS,2.379951362,0.000337604,dioxybenzone
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,-2.431158359,0.005888278,dioxybenzone
NEUTROPHIL_DEGRANULATION,-2.304888703,0.01251259,dioxybenzone
UNFOLDED_PROTEIN_RESPONSE_UPR,-2.138172217,0.052994499,dioxybenzone
ASPARAGINE_N_LINKED_GLYCOSYLATION,-2.103899117,0.049682343,dioxybenzone
G_ALPHA_I_SIGNALLING_EVENTS,2.059291923,0.020661348,dioxybenzone
TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,-2.073678356,0.052111257,dioxybenzone
EXTRACELLULAR_MATRIX_ORGANIZATION,3.356905707,0,staurosporine
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,2.690868379,0,staurosporine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.639738383,0,staurosporine
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,2.635829737,0,staurosporine
EUKARYOTIC_TRANSLATION_ELONGATION,-2.320447302,0.00789271,staurosporine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.242351098,0.010359182,staurosporine
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.225223564,0.008550436,staurosporine
SELENOAMINO_ACID_METABOLISM,-2.213818097,0.008139357,staurosporine
NONSENSE_MEDIATED_DECAY_NMD,-2.209659036,0.006708804,staurosporine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.197821164,0.005355768,staurosporine
PROTEIN_LOCALIZATION,-2.749670104,0,BRD-K55591206
GPCR_LIGAND_BINDING,2.738091611,0,BRD-K55591206
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.669991488,0,BRD-K55591206
SIGNALING_BY_GPCR,2.584554117,0,BRD-K55591206
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.368499889,0,BRD-K55591206
G_ALPHA_Q_SIGNALLING_EVENTS,2.284332877,0.00055927,BRD-K55591206
G_ALPHA_I_SIGNALLING_EVENTS,2.031547603,0.011884491,BRD-K55591206
SIGNALING_BY_NUCLEAR_RECEPTORS,-2.015216273,0.114087934,BRD-K55591206
NEUTROPHIL_DEGRANULATION,-2.000531173,0.083589179,BRD-K55591206
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,1.913751927,0.038150216,BRD-K55591206
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,2.088023039,0.110075914,H-8
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,1.979473831,0.106740281,H-8
G_ALPHA_S_SIGNALLING_EVENTS,-1.972786331,0.119345925,H-8
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,1.955016447,0.087838356,H-8
MUSCLE_CONTRACTION,-1.89800532,0.146351207,H-8
EXTRACELLULAR_MATRIX_ORGANIZATION,1.832837995,0.149686565,H-8
DEVELOPMENTAL_CELL_LINEAGES,1.815788197,0.131757534,H-8
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,1.724178139,0.184571735,H-8
RAB_REGULATION_OF_TRAFFICKING,-1.811686165,0.227367054,H-8
GPCR_LIGAND_BINDING,-1.806609864,0.180325595,H-8
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,3.738894367,0,thenoyltrifluoroacetone
GPCR_LIGAND_BINDING,3.678282447,0,thenoyltrifluoroacetone
SIGNALING_BY_GPCR,3.547040355,0,thenoyltrifluoroacetone
MEMBRANE_TRAFFICKING,-3.04742555,0,thenoyltrifluoroacetone
VESICLE_MEDIATED_TRANSPORT,-2.993088774,0,thenoyltrifluoroacetone
G_ALPHA_Q_SIGNALLING_EVENTS,2.912110695,0,thenoyltrifluoroacetone
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.910481255,0,thenoyltrifluoroacetone
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,-2.901510053,0,thenoyltrifluoroacetone
NEUTROPHIL_DEGRANULATION,-2.901442524,0,thenoyltrifluoroacetone
ASPARAGINE_N_LINKED_GLYCOSYLATION,-2.8645133,0,thenoyltrifluoroacetone
ACTIVATION_OF_THE_PRE_REPLICATIVE_COMPLEX,-2.437915179,0,dabrafenib
CHROMOSOME_MAINTENANCE,-2.462731926,0,dabrafenib
CELL_CYCLE_MITOTIC,-2.726338948,0,dabrafenib
CELL_CYCLE,-2.714882908,0,dabrafenib
CELL_CYCLE_CHECKPOINTS,-2.676942982,0,dabrafenib
G2_M_CHECKPOINTS,-2.561027183,0,dabrafenib
DNA_REPLICATION,-2.468701464,0,dabrafenib
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,-2.464796026,0,dabrafenib
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.908865507,0.000869263,dabrafenib
RESPIRATORY_ELECTRON_TRANSPORT,2.894007661,0.000434631,dabrafenib
INFLUENZA_INFECTION,3.878476724,0,fasudil
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.787705925,0,fasudil
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.894065932,0,fasudil
CELL_CYCLE_CHECKPOINTS,3.000236347,0,fasudil
SARS_COV_2_HOST_INTERACTIONS,3.009311919,0,fasudil
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,3.035127515,0,fasudil
MRNA_SPLICING,3.038941775,0,fasudil
METABOLISM_OF_RNA,3.023427598,0,fasudil
TRANSLATION,3.064631124,0,fasudil
EUKARYOTIC_TRANSLATION_ELONGATION,3.139887222,0,fasudil
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,3.366289111,0,rufinamide
MRNA_SPLICING,3.279659019,0,rufinamide
RAB_GEFS_EXCHANGE_GTP_FOR_GDP_ON_RABS,1.683029613,0.507787247,rufinamide
DNA_REPLICATION,1.637527714,0.467234793,rufinamide
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.410099181,0.211623179,rufinamide
RAB_REGULATION_OF_TRAFFICKING,1.529268275,0.667176021,rufinamide
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.314115303,0.352313404,rufinamide
S_PHASE,1.465180388,0.748751102,rufinamide
HOST_INTERACTIONS_OF_HIV_FACTORS,1.451326753,0.690147349,rufinamide
NUCLEOTIDE_EXCISION_REPAIR,1.41118028,0.731707317,rufinamide
GPCR_LIGAND_BINDING,-2.338485408,0.005951079,tranilast
G_ALPHA_Q_SIGNALLING_EVENTS,-2.235663378,0.007651387,tranilast
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.180408552,0.010201849,tranilast
SIGNALING_BY_GPCR,-2.147448105,0.011902158,tranilast
KERATINIZATION,-2.069662671,0.025674654,tranilast
SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,-2.065161351,0.022529084,tranilast
INFLUENZA_INFECTION,1.898640641,0.397310434,tranilast
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,-1.921870655,0.072506002,tranilast
HCMV_EARLY_EVENTS,1.59513971,1,tranilast
REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE,1.574728884,0.744545258,tranilast
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.216496897,0.285247462,sobetirome
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.955768887,0.597125912,sobetirome
PKR_MEDIATED_SIGNALING,-1.923395356,0.465154576,sobetirome
TOLL_LIKE_RECEPTOR_CASCADES,1.700359511,1,sobetirome
G_ALPHA_Q_SIGNALLING_EVENTS,-1.678334447,0.948950842,sobetirome
PROTEIN_FOLDING,-1.637685652,0.862607264,sobetirome
CELL_CELL_COMMUNICATION,-1.629731778,0.742511375,sobetirome
NEUTROPHIL_DEGRANULATION,-1.549384447,0.842046451,sobetirome
GPCR_LIGAND_BINDING,-1.535306189,0.774369926,sobetirome
PEROXISOMAL_PROTEIN_IMPORT,1.605898866,1,sobetirome
CELLULAR_RESPONSE_TO_STARVATION,3.348330632,0,arbutin
INFLUENZA_INFECTION,3.299474251,0,arbutin
EUKARYOTIC_TRANSLATION_ELONGATION,3.080104086,0,arbutin
SELENOAMINO_ACID_METABOLISM,3.038054631,0,arbutin
SARS_COV_2_HOST_INTERACTIONS,2.930152556,0,arbutin
SIGNALING_BY_ROBO_RECEPTORS,2.862001234,0,arbutin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.313761257,0.000566743,arbutin
TRANSLATION,2.588880092,0.000997539,arbutin
EUKARYOTIC_TRANSLATION_INITIATION,2.611100087,0.001097293,arbutin
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.683071346,0.001219215,arbutin
NEUTROPHIL_DEGRANULATION,2.280535711,0.037409564,lorcaserin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.249480504,0.022996315,lorcaserin
MUSCLE_CONTRACTION,2.256340846,0.022044922,lorcaserin
SIGNALING_BY_GPCR,-2.200144545,0.019316904,lorcaserin
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.149940571,0.024494357,lorcaserin
GPCR_LIGAND_BINDING,-2.150598847,0.020236757,lorcaserin
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.064095409,0.029727243,lorcaserin
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.052320045,0.04093344,lorcaserin
SIGNALING_BY_ROBO_RECEPTORS,1.899353244,0.06840606,lorcaserin
G_ALPHA_I_SIGNALLING_EVENTS,-2.003380729,0.051143804,lorcaserin
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.296000167,0.027272231,probucol
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.062441616,0.162349693,probucol
NEURONAL_SYSTEM,2.031433263,0.121209915,probucol
REGULATION_OF_T_CELL_ACTIVATION_BY_CD28_FAMILY,1.90838899,0.190905616,probucol
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,1.906390509,0.144441816,probucol
EXTRA_NUCLEAR_ESTROGEN_SIGNALING,-1.816991283,0.561789334,probucol
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,1.716271901,0.422214538,probucol
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.722844953,0.68503651,probucol
MUSCLE_CONTRACTION,1.683505887,0.435513959,probucol
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,1.666892083,0.413412389,probucol
GPCR_LIGAND_BINDING,-2.182484122,0.104657824,suvorexant
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,-2.070169281,0.127409525,suvorexant
PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS,1.834223361,0.925456336,suvorexant
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.939850035,0.223219466,suvorexant
INTERLEUKIN_17_SIGNALING,1.751458545,0.760609426,suvorexant
AUTOPHAGY,-1.903085564,0.216330756,suvorexant
BIOLOGICAL_OXIDATIONS,1.669101654,0.776997716,suvorexant
INTERFERON_GAMMA_SIGNALING,1.639301992,0.666617767,suvorexant
SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES,1.619697259,0.586122346,suvorexant
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,-1.822482006,0.297895604,suvorexant
CELL_CYCLE_MITOTIC,-3.88957978,0,valrubicin
MRNA_SPLICING,-2.608271287,0,valrubicin
DNA_STRAND_ELONGATION,-2.625524406,0,valrubicin
DNA_REPAIR,-2.669842635,0,valrubicin
ACTIVATION_OF_THE_PRE_REPLICATIVE_COMPLEX,-2.682900895,0,valrubicin
HOMOLOGY_DIRECTED_REPAIR,-2.710158554,0,valrubicin
DNA_DOUBLE_STRAND_BREAK_REPAIR,-2.765810407,0,valrubicin
RESOLUTION_OF_SISTER_CHROMATID_COHESION,-2.780843386,0,valrubicin
G2_M_CHECKPOINTS,-2.786304801,0,valrubicin
RHO_GTPASES_ACTIVATE_FORMINS,-2.811456171,0,valrubicin
CELL_CYCLE_MITOTIC,-2.217421786,0.027854733,midostaurin
SIGNALING_BY_MET,2.363023004,0.028841987,midostaurin
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,-2.188880051,0.021664793,midostaurin
DNA_REPLICATION,-2.140466027,0.021664793,midostaurin
MITOTIC_PROMETAPHASE,-2.105338213,0.025533506,midostaurin
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.174558779,0.066987841,midostaurin
CELL_CYCLE,-2.076068039,0.028061065,midostaurin
RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES,-2.013446588,0.038859073,midostaurin
SELENOAMINO_ACID_METABOLISM,2.089421336,0.079703126,midostaurin
CELLULAR_RESPONSE_TO_STARVATION,2.059711481,0.069779001,midostaurin
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.368118448,0.260590623,lorazepam
ECM_PROTEOGLYCANS,-2.143479485,0.460517436,lorazepam
RAB_GEFS_EXCHANGE_GTP_FOR_GDP_ON_RABS,1.871146382,0.689352262,lorazepam
DISEASES_OF_METABOLISM,-2.008147628,0.65798253,lorazepam
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.001595921,0.512213552,lorazepam
RAB_REGULATION_OF_TRAFFICKING,1.710545329,0.983773001,lorazepam
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,1.70012834,0.699782626,lorazepam
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-1.789974487,1,lorazepam
LEISHMANIA_INFECTION,1.559010791,1,lorazepam
INNATE_IMMUNE_SYSTEM,-1.708249547,1,lorazepam
METABOLISM_OF_RNA,4.107505274,0,avanafil
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,2.803140823,0,avanafil
RESPIRATORY_ELECTRON_TRANSPORT,2.91270829,0,avanafil
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.948398643,0,avanafil
S_PHASE,2.977779948,0,avanafil
SARS_COV_1_HOST_INTERACTIONS,3.051387096,0,avanafil
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,3.077446967,0,avanafil
SARS_COV_1_INFECTION,3.084026346,0,avanafil
MRNA_SPLICING,3.097801397,0,avanafil
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,3.12254846,0,avanafil
IRE1ALPHA_ACTIVATES_CHAPERONES,-2.306939982,0.012993576,axitinib
G_ALPHA_Q_SIGNALLING_EVENTS,2.386091314,0.01397563,axitinib
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.361503921,0.007570133,axitinib
GPCR_LIGAND_BINDING,2.32393537,0.006017285,axitinib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.9823419,0.039597618,axitinib
SIGNALING_BY_GPCR,1.950620732,0.039947009,axitinib
KERATINIZATION,-1.945328566,0.272865093,axitinib
G_ALPHA_I_SIGNALLING_EVENTS,1.856491958,0.056970103,axitinib
UNFOLDED_PROTEIN_RESPONSE_UPR,-1.899838182,0.268140156,axitinib
MRNA_SPLICING,-1.893822354,0.213212767,axitinib
EUKARYOTIC_TRANSLATION_ELONGATION,2.871064834,0,tipifarnib-P2
CELLULAR_RESPONSE_TO_STARVATION,2.844083409,0,tipifarnib-P2
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.82750687,0,tipifarnib-P2
SELENOAMINO_ACID_METABOLISM,2.760780523,0,tipifarnib-P2
NONSENSE_MEDIATED_DECAY_NMD,2.758503211,0,tipifarnib-P2
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.701083299,0,tipifarnib-P2
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.549379738,0,tipifarnib-P2
EUKARYOTIC_TRANSLATION_INITIATION,2.525879707,0.000179409,tipifarnib-P2
DOWNSTREAM_TCR_SIGNALING,2.386753124,0.000574109,tipifarnib-P2
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.414141906,0.000637899,tipifarnib-P2
MHC_CLASS_II_ANTIGEN_PRESENTATION,-2.980483403,0,vandetanib
GOLGI_TO_ER_RETROGRADE_TRANSPORT,-2.893860342,0,vandetanib
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.884793031,0,vandetanib
MRNA_SPLICING,-2.804879251,0,vandetanib
MITOTIC_METAPHASE_AND_ANAPHASE,-2.80479762,0,vandetanib
M_PHASE,-2.681004642,0,vandetanib
METABOLISM_OF_RNA,-2.661883227,0,vandetanib
RRNA_PROCESSING,-2.17581589,0.00603155,vandetanib
CELL_CYCLE_CHECKPOINTS,-2.160436488,0.006186205,vandetanib
CELL_CYCLE_MITOTIC,-2.128441724,0.007052273,vandetanib
SIGNALING_BY_GPCR,4.861407997,0,BRD-K92073408
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,2.565049159,0,BRD-K92073408
NEURONAL_SYSTEM,2.703432449,0,BRD-K92073408
G_ALPHA_I_SIGNALLING_EVENTS,2.720241133,0,BRD-K92073408
CELLULAR_RESPONSES_TO_STIMULI,-2.736840456,0,BRD-K92073408
SARS_COV_1_INFECTION,-2.886568427,0,BRD-K92073408
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-3.034810957,0,BRD-K92073408
SARS_COV_1_HOST_INTERACTIONS,-3.037967639,0,BRD-K92073408
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-3.081920133,0,BRD-K92073408
G_ALPHA_S_SIGNALLING_EVENTS,3.16829931,0,BRD-K92073408
TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM,2.915093901,0,amitriptyline
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.775934155,0,amitriptyline
GOLGI_TO_ER_RETROGRADE_TRANSPORT,2.445057378,0.003572969,amitriptyline
HCMV_INFECTION,2.299426385,0.006699316,amitriptyline
MRNA_SPLICING,2.202978807,0.008575125,amitriptyline
HCMV_EARLY_EVENTS,2.120747913,0.011612148,amitriptyline
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,2.028237812,0.014547087,amitriptyline
METABOLISM_OF_RNA,2.013872083,0.015408427,amitriptyline
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.990866669,0.05789839,amitriptyline
HOST_INTERACTIONS_OF_HIV_FACTORS,1.814508662,0.051808045,amitriptyline
TRANSLATION,3.55097693,0,imipramine
METABOLISM_OF_RNA,3.06510086,0,imipramine
RRNA_PROCESSING,2.68838105,0,imipramine
MITOTIC_METAPHASE_AND_ANAPHASE,2.59789951,0,imipramine
GLOBAL_GENOME_NUCLEOTIDE_EXCISION_REPAIR_GG_NER,2.440194883,0.002950697,imipramine
CELL_CYCLE_CHECKPOINTS,2.384615709,0.002458914,imipramine
DNA_REPLICATION,2.329134117,0.002810188,imipramine
SEPARATION_OF_SISTER_CHROMATIDS,2.327317346,0.002458914,imipramine
GOLGI_TO_ER_RETROGRADE_TRANSPORT,2.280065062,0.004917829,imipramine
MRNA_SPLICING,2.274030256,0.005901394,imipramine
TRANSLATION,3.779298976,0,benzonatate
METABOLISM_OF_RNA,3.246372467,0,benzonatate
MRNA_SPLICING,3.07393101,0,benzonatate
MITOCHONDRIAL_TRANSLATION,2.913679489,0,benzonatate
MITOTIC_METAPHASE_AND_ANAPHASE,2.747943622,0,benzonatate
RRNA_PROCESSING,2.654419317,0.001520865,benzonatate
SEPARATION_OF_SISTER_CHROMATIDS,2.641170706,0.001303599,benzonatate
SIGNALING_BY_NOTCH4,2.568894008,0.001140649,benzonatate
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.568095636,0.00101391,benzonatate
S_PHASE,2.51240728,0.000912519,benzonatate
EUKARYOTIC_TRANSLATION_ELONGATION,3.96791131,0,indometacin
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.948564679,0,indometacin
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.946908422,0,indometacin
NONSENSE_MEDIATED_DECAY_NMD,3.844321967,0,indometacin
SELENOAMINO_ACID_METABOLISM,3.798225543,0,indometacin
EUKARYOTIC_TRANSLATION_INITIATION,3.676332527,0,indometacin
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.566563179,0,indometacin
CELLULAR_RESPONSE_TO_STARVATION,3.551121533,0,indometacin
INFLUENZA_INFECTION,3.408268402,0,indometacin
RRNA_PROCESSING,3.303523181,0,indometacin
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,3.819391164,0,warfarin
MRNA_SPLICING,3.133837054,0,warfarin
EUKARYOTIC_TRANSLATION_ELONGATION,-2.289265844,0.00178668,warfarin
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.288963267,0.00089334,warfarin
SELENOAMINO_ACID_METABOLISM,-2.27916978,0.00059556,warfarin
NONSENSE_MEDIATED_DECAY_NMD,-2.255131962,0.000670005,warfarin
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.244623632,0.000714672,warfarin
RRNA_PROCESSING,-2.219965909,0.00059556,warfarin
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.202672784,0.00051048,warfarin
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.187770265,0.000670005,warfarin
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.288614152,0.02245109,rizatriptan
RRNA_PROCESSING,-1.546264135,1,rizatriptan
SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX,1.594379991,1,rizatriptan
NEUTROPHIL_DEGRANULATION,-1.499160506,1,rizatriptan
REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE,-1.485675368,1,rizatriptan
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-1.460523217,1,rizatriptan
TRANSPORT_OF_SMALL_MOLECULES,-1.385672115,1,rizatriptan
GASTRULATION,-1.350330614,1,rizatriptan
MITOTIC_G2_G2_M_PHASES,1.457226018,1,rizatriptan
METABOLISM_OF_STEROIDS,-1.323790167,1,rizatriptan
CELL_CYCLE_CHECKPOINTS,2.993415397,0,buphenine
CELL_CYCLE_MITOTIC,2.962108166,0,buphenine
SEPARATION_OF_SISTER_CHROMATIDS,2.887771673,0,buphenine
MITOTIC_G2_G2_M_PHASES,2.652593854,0.000975763,buphenine
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.536762971,0.000780611,buphenine
G2_M_CHECKPOINTS,2.535965746,0.000650509,buphenine
MITOTIC_METAPHASE_AND_ANAPHASE,2.525065614,0.000557579,buphenine
RESOLUTION_OF_SISTER_CHROMATID_COHESION,2.437347285,0.000487882,buphenine
HOST_INTERACTIONS_OF_HIV_FACTORS,2.262965327,0.002168363,buphenine
MITOTIC_SPINDLE_CHECKPOINT,2.204262925,0.003512748,buphenine
EUKARYOTIC_TRANSLATION_ELONGATION,-3.063333835,0,riluzole
NERVOUS_SYSTEM_DEVELOPMENT,-2.376141062,0,riluzole
SARS_COV_2_HOST_INTERACTIONS,-2.514310025,0,riluzole
SARS_COV_1_INFECTION,-2.572319303,0,riluzole
TRANSLATION,-2.592306431,0,riluzole
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.644188473,0,riluzole
SARS_COV_1_HOST_INTERACTIONS,-2.678547255,0,riluzole
SIGNALING_BY_ROBO_RECEPTORS,-2.693958018,0,riluzole
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.718977378,0,riluzole
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.763252431,0,riluzole
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.025244257,0.276717596,pramipexole
SELENOAMINO_ACID_METABOLISM,1.960960123,0.249490363,pramipexole
CELLULAR_SENESCENCE,1.921927798,0.224115322,pramipexole
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,1.881289831,0.225319248,pramipexole
NONSENSE_MEDIATED_DECAY_NMD,1.864795355,0.201592658,pramipexole
EUKARYOTIC_TRANSLATION_INITIATION,1.839966043,0.204111641,pramipexole
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,1.81089,0.215436476,pramipexole
TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT,1.801001764,0.205871224,pramipexole
METABOLISM_OF_STEROIDS,-1.67707938,1,pramipexole
EUKARYOTIC_TRANSLATION_ELONGATION,1.776048572,0.21954658,pramipexole
G_ALPHA_Q_SIGNALLING_EVENTS,-2.289529919,0.001443455,sotalol
SARS_COV_2_HOST_INTERACTIONS,2.277261536,0.042216498,sotalol
SIGNALING_BY_GPCR,-2.162882941,0.009021595,sotalol
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,2.122211557,0.049892224,sotalol
GPCR_LIGAND_BINDING,-2.140681568,0.009141883,sotalol
INNATE_IMMUNE_SYSTEM,2.090904884,0.04093721,sotalol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.116749216,0.009923755,sotalol
KERATINIZATION,-2.087665425,0.010825914,sotalol
MITOTIC_PROMETAPHASE,1.823541794,0.172703854,sotalol
SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES,1.80430532,0.149676673,sotalol
TRANSLATION,5.06742376,0,alimemazine
APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1,2.789960241,0,alimemazine
INFLUENZA_INFECTION,2.926186212,0,alimemazine
SIGNALING_BY_ROBO_RECEPTORS,2.947350792,0,alimemazine
NONSENSE_MEDIATED_DECAY_NMD,3.250989787,0,alimemazine
CELLULAR_RESPONSE_TO_STARVATION,3.432734996,0,alimemazine
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,3.531626077,0,alimemazine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.545483426,0,alimemazine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.933908692,0,alimemazine
RRNA_PROCESSING,3.84866347,0,alimemazine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.321680455,0,purvalanol-a
EUKARYOTIC_TRANSLATION_INITIATION,3.170955429,0,purvalanol-a
EUKARYOTIC_TRANSLATION_ELONGATION,3.028465432,0,purvalanol-a
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.878307741,0,purvalanol-a
SELENOAMINO_ACID_METABOLISM,2.784646572,0,purvalanol-a
NONSENSE_MEDIATED_DECAY_NMD,2.725127557,0,purvalanol-a
TRANSLATION,2.683057979,0,purvalanol-a
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.584872111,0,purvalanol-a
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.583749225,0,purvalanol-a
CELLULAR_RESPONSE_TO_STARVATION,2.503374937,0,purvalanol-a
TRANSLATION,3.634573102,0,forskolin
CELLULAR_RESPONSE_TO_STARVATION,3.057118069,0,forskolin
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.966454877,0,forskolin
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.929070933,0,forskolin
EUKARYOTIC_TRANSLATION_ELONGATION,2.927566048,0,forskolin
EUKARYOTIC_TRANSLATION_INITIATION,2.92225006,0,forskolin
SELENOAMINO_ACID_METABOLISM,2.898361508,0,forskolin
INFLUENZA_INFECTION,2.87758085,0,forskolin
NONSENSE_MEDIATED_DECAY_NMD,2.461576101,0,forskolin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.315978029,0,forskolin
GPCR_LIGAND_BINDING,3.632876803,0,ramipril
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,2.680876126,0,ramipril
VIRAL_INFECTION_PATHWAYS,-2.72100589,0,ramipril
MUSCLE_CONTRACTION,2.744772132,0,ramipril
SARS_COV_1_INFECTION,-2.813120343,0,ramipril
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.855317841,0,ramipril
EXTRACELLULAR_MATRIX_ORGANIZATION,2.858807006,0,ramipril
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.882084396,0,ramipril
SARS_COV_1_HOST_INTERACTIONS,-2.900195223,0,ramipril
METABOLISM_OF_RNA,-2.979688146,0,ramipril
NEUTROPHIL_DEGRANULATION,-3.563906077,0,bromhexine
GPCR_LIGAND_BINDING,3.262026588,0,bromhexine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,3.096201408,0,bromhexine
SIGNALING_BY_GPCR,2.96406371,0,bromhexine
INNATE_IMMUNE_SYSTEM,-2.842049299,0,bromhexine
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,-2.778505373,0,bromhexine
TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,-2.614024283,0.000624051,bromhexine
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.522597816,0.000998481,bromhexine
G_ALPHA_Q_SIGNALLING_EVENTS,2.463040075,0.001210221,bromhexine
ASPARAGINE_N_LINKED_GLYCOSYLATION,-2.498022187,0.001248101,bromhexine
EUKARYOTIC_TRANSLATION_ELONGATION,3.50387551,0,Y-27632
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.728145706,0,Y-27632
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,2.746762263,0,Y-27632
SARS_COV_1_HOST_INTERACTIONS,2.7854297,0,Y-27632
TRANSLATION,2.867987852,0,Y-27632
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,2.987923189,0,Y-27632
RRNA_PROCESSING,3.102587124,0,Y-27632
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.140297798,0,Y-27632
SIGNALING_BY_ROBO_RECEPTORS,3.118470639,0,Y-27632
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.290761114,0,Y-27632
METABOLISM_OF_RNA,4.770706698,0,rolipram
TRNA_PROCESSING,2.60988023,0,rolipram
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,2.627424768,0,rolipram
G2_M_CHECKPOINTS,2.636606873,0,rolipram
CELL_CYCLE_CHECKPOINTS,2.742682458,0,rolipram
CELL_CYCLE,2.786539532,0,rolipram
MITOTIC_METAPHASE_AND_ANAPHASE,2.817644803,0,rolipram
DNA_REPLICATION,2.732692276,0,rolipram
CELL_CYCLE_MITOTIC,2.920729965,0,rolipram
TRANSLATION,2.968194352,0,rolipram
PEROXISOMAL_PROTEIN_IMPORT,-2.125885288,0.074124683,tolazamide
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,1.8734586,0.414845272,tolazamide
G2_M_CHECKPOINTS,1.84559135,0.239558537,tolazamide
RESPIRATORY_ELECTRON_TRANSPORT,1.615798815,0.320969487,tolazamide
S_PHASE,1.617153855,0.399751136,tolazamide
DNA_REPLICATION_PRE_INITIATION,1.618125978,0.531053884,tolazamide
AUTOPHAGY,1.555849404,0.362583856,tolazamide
MITOTIC_G2_G2_M_PHASES,1.50105221,0.410671778,tolazamide
PHOSPHOLIPID_METABOLISM,-1.801037445,0.73004194,tolazamide
TRANSCRIPTIONAL_REGULATION_BY_RUNX2,1.477169265,0.409732742,tolazamide
EUKARYOTIC_TRANSLATION_INITIATION,-3.475507159,0,aminoglutethimide
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.803418522,0,aminoglutethimide
METABOLISM_OF_RNA,-2.804027292,0,aminoglutethimide
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.89831171,0,aminoglutethimide
INFLUENZA_INFECTION,-2.971380071,0,aminoglutethimide
SIGNALING_BY_ROBO_RECEPTORS,-2.979462007,0,aminoglutethimide
CELLULAR_RESPONSE_TO_STARVATION,-3.118285583,0,aminoglutethimide
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-3.199812356,0,aminoglutethimide
SELENOAMINO_ACID_METABOLISM,-3.230521362,0,aminoglutethimide
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-3.236307827,0,aminoglutethimide
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,-2.777879235,0,procarbazine
GPCR_LIGAND_BINDING,2.393031403,0.000547511,procarbazine
SIGNALING_BY_GPCR,2.157001038,0.008486414,procarbazine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.143848323,0.006387623,procarbazine
GOLGI_TO_ER_RETROGRADE_TRANSPORT,-2.099884773,0.089317957,procarbazine
MITOTIC_G2_G2_M_PHASES,-2.039565636,0.095272488,procarbazine
NEURONAL_SYSTEM,2.024846381,0.017520339,procarbazine
NUCLEOTIDE_EXCISION_REPAIR,-2.007497032,0.089317957,procarbazine
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,1.984220008,0.021571917,procarbazine
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,1.96192678,0.022812941,procarbazine
NEUTROPHIL_DEGRANULATION,2.300205585,0.015050832,glimepiride
GPCR_LIGAND_BINDING,-2.205771378,0.009645607,glimepiride
ADAPTIVE_IMMUNE_SYSTEM,2.103025634,0.045152496,glimepiride
SIGNALING_BY_GPCR,-2.059009456,0.025319719,glimepiride
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.047958745,0.019827081,glimepiride
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,1.851780782,0.1344541,glimepiride
SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3,1.826219119,0.124169364,glimepiride
KERATINIZATION,-1.953904642,0.036773877,glimepiride
TOLL_LIKE_RECEPTOR_CASCADES,1.770436016,0.133651389,glimepiride
RHO_GTPASE_CYCLE,1.756126945,0.12191174,glimepiride
REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF,-2.947878185,0,nifedipine
GPCR_LIGAND_BINDING,2.931637576,0,nifedipine
SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3,-2.839858196,0,nifedipine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.764245837,0,nifedipine
COLLAGEN_FORMATION,-2.739999328,0,nifedipine
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.402972338,0.000209151,nifedipine
RHO_GTPASE_CYCLE,-2.63275516,0.000958131,nifedipine
RHO_GTPASE_EFFECTORS,-2.512391771,0.000766504,nifedipine
MEMBRANE_TRAFFICKING,-2.508340619,0.000638754,nifedipine
SIGNALING_BY_GPCR,2.346170747,0.000470589,nifedipine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-3.016557487,0,veliparib
METABOLISM_OF_RNA,-2.770472317,0,veliparib
AMINE_LIGAND_BINDING_RECEPTORS,2.322731864,0.00075786,veliparib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.252738139,0.00037893,veliparib
CELL_CYCLE_MITOTIC,-2.380484656,0.006625651,veliparib
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,-2.157134831,0.013665405,veliparib
GPCR_LIGAND_BINDING,2.129086873,0.00303144,veliparib
MITOTIC_G2_G2_M_PHASES,-2.037734586,0.014907714,veliparib
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.084097965,0.0037893,veliparib
CHROMATIN_ORGANIZATION,-1.971676921,0.023189778,veliparib
GPCR_LIGAND_BINDING,3.322990901,0,loxapine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,3.234256951,0,loxapine
SIGNALING_BY_GPCR,3.139420323,0,loxapine
NEUTROPHIL_DEGRANULATION,-2.931885806,0,loxapine
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.720781519,0,loxapine
G_ALPHA_Q_SIGNALLING_EVENTS,2.626377755,0,loxapine
G_ALPHA_I_SIGNALLING_EVENTS,2.381682731,0.000662466,loxapine
SENSORY_PERCEPTION,2.375815721,0.000567828,loxapine
INNATE_IMMUNE_SYSTEM,-2.414014019,0.009437996,loxapine
PROTEIN_LOCALIZATION,-2.37089692,0.008808797,loxapine
EUKARYOTIC_TRANSLATION_ELONGATION,-3.888684303,0,BRD-K66766661
NERVOUS_SYSTEM_DEVELOPMENT,-2.699004364,0,BRD-K66766661
GPCR_LIGAND_BINDING,2.89901603,0,BRD-K66766661
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,3.13406261,0,BRD-K66766661
SARS_COV_1_INFECTION,-3.173922886,0,BRD-K66766661
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-3.179043493,0,BRD-K66766661
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-3.261571856,0,BRD-K66766661
SARS_COV_1_HOST_INTERACTIONS,-3.296520727,0,BRD-K66766661
SIGNALING_BY_ROBO_RECEPTORS,-3.31521362,0,BRD-K66766661
EXTRACELLULAR_MATRIX_ORGANIZATION,3.357368995,0,BRD-K66766661
GPCR_LIGAND_BINDING,4.112118445,0,nadolol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,3.974058173,0,nadolol
SIGNALING_BY_GPCR,3.722149507,0,nadolol
PEPTIDE_LIGAND_BINDING_RECEPTORS,3.100148595,0,nadolol
G_ALPHA_I_SIGNALLING_EVENTS,3.093114548,0,nadolol
G_ALPHA_Q_SIGNALLING_EVENTS,3.000683103,0,nadolol
SELENOAMINO_ACID_METABOLISM,-2.465707901,0,nadolol
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.295764084,0.005991536,nadolol
SENSORY_PERCEPTION,2.291432664,0.003890595,nadolol
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.21738733,0.010139523,nadolol
GPCR_LIGAND_BINDING,4.106596955,0,sulfacetamide
SARS_COV_1_INFECTION,-2.673560525,0,sulfacetamide
G_ALPHA_S_SIGNALLING_EVENTS,2.899570939,0,sulfacetamide
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.941845041,0,sulfacetamide
MUSCLE_CONTRACTION,2.961920312,0,sulfacetamide
TRANSLATION,-2.989583613,0,sulfacetamide
INFLUENZA_INFECTION,-3.013940314,0,sulfacetamide
RRNA_PROCESSING,-3.016684195,0,sulfacetamide
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-3.017165009,0,sulfacetamide
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-3.041157358,0,sulfacetamide
METABOLISM_OF_RNA,1.523188549,1,SNS-314
TRANSCRIPTIONAL_REGULATION_BY_TP53,1.4985558,0.760296959,SNS-314
MRNA_SPLICING,1.433083814,0.735618157,SNS-314
SIGNALING_BY_INTERLEUKINS,1.423053949,0.573782162,SNS-314
METABOLISM_OF_LIPIDS,-1.677847795,0.920935657,SNS-314
CELL_CYCLE_CHECKPOINTS,1.296526584,0.769409133,SNS-314
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.287788011,0.66585308,SNS-314
SEPARATION_OF_SISTER_CHROMATIDS,1.196205138,0.859147768,SNS-314
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-1.567838901,0.922321564,SNS-314
MITOTIC_PROMETAPHASE,1.162695105,0.868859961,SNS-314
GPCR_LIGAND_BINDING,3.713044405,0,remoxipride
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.721714349,0,remoxipride
ASPARAGINE_N_LINKED_GLYCOSYLATION,-2.779482026,0,remoxipride
MEMBRANE_TRAFFICKING,-2.939051609,0,remoxipride
NEUTROPHIL_DEGRANULATION,-2.958619212,0,remoxipride
COPII_MEDIATED_VESICLE_TRANSPORT,-2.978366684,0,remoxipride
VESICLE_MEDIATED_TRANSPORT,-2.834719717,0,remoxipride
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-3.043195564,0,remoxipride
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,-3.196579545,0,remoxipride
SIGNALING_BY_GPCR,3.473587675,0,remoxipride
CELL_CYCLE,-3.367534185,0,AZD-8330
RHO_GTPASES_ACTIVATE_FORMINS,-2.414736014,0,AZD-8330
HDR_THROUGH_HOMOLOGOUS_RECOMBINATION_HRR,-2.460603239,0,AZD-8330
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,-2.467886004,0,AZD-8330
ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS,-2.482188189,0,AZD-8330
DNA_REPAIR,-2.490586689,0,AZD-8330
RESOLUTION_OF_SISTER_CHROMATID_COHESION,-2.527856292,0,AZD-8330
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,-2.533384774,0,AZD-8330
APC_C_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS,-2.56631284,0,AZD-8330
MITOTIC_SPINDLE_CHECKPOINT,-2.576083678,0,AZD-8330
KERATINIZATION,-2.390924142,0,iniparib
FORMATION_OF_THE_CORNIFIED_ENVELOPE,-2.232496404,0.003571075,iniparib
INNATE_IMMUNE_SYSTEM,2.045583852,0.245613124,iniparib
TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,2.009425985,0.146506074,iniparib
NEUTROPHIL_DEGRANULATION,2.003164569,0.09910705,iniparib
LEISHMANIA_INFECTION,1.839384064,0.169128336,iniparib
SENSORY_PERCEPTION,-2.013769163,0.033546461,iniparib
TOLL_LIKE_RECEPTOR_CASCADES,1.825891315,0.145644274,iniparib
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,1.770603678,0.170923753,iniparib
FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS,1.759537444,0.152661792,iniparib
MRNA_SPLICING,3.278671355,0,sitagliptin
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,3.196172043,0,sitagliptin
NONSENSE_MEDIATED_DECAY_NMD,-2.211066097,0.000147129,sitagliptin
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.233853169,0.000183911,sitagliptin
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.201129857,0.000122607,sitagliptin
EUKARYOTIC_TRANSLATION_ELONGATION,-2.241301683,0.000367822,sitagliptin
SELENOAMINO_ACID_METABOLISM,-2.254350373,0.000735645,sitagliptin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.236638212,0.000245215,sitagliptin
GPCR_LIGAND_BINDING,-2.166503505,0.000210184,sitagliptin
MRNA_SPLICING_MINOR_PATHWAY,2.225980291,0.009092831,sitagliptin
INFLUENZA_INFECTION,3.246652922,0,mecamylamine
EUKARYOTIC_TRANSLATION_ELONGATION,3.122457299,0,mecamylamine
NONSENSE_MEDIATED_DECAY_NMD,3.069798135,0,mecamylamine
RRNA_PROCESSING,3.051471725,0,mecamylamine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.997439372,0,mecamylamine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.321133086,0.00048575,mecamylamine
GPCR_LIGAND_BINDING,-2.348809942,0.000971501,mecamylamine
METABOLISM_OF_RNA,2.772584073,0.000959675,mecamylamine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.671208143,0.000872432,mecamylamine
CELLULAR_RESPONSE_TO_STARVATION,2.870004908,0.001199594,mecamylamine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.989676878,0.285410579,levamisole
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,1.972789006,0.155517839,levamisole
EXTRA_NUCLEAR_ESTROGEN_SIGNALING,-1.951975243,0.630578562,levamisole
REGULATION_OF_T_CELL_ACTIVATION_BY_CD28_FAMILY,1.800029033,0.370533032,levamisole
PLATELET_HOMEOSTASIS,1.783892843,0.308826617,levamisole
S_PHASE,-1.711159271,1,levamisole
PKR_MEDIATED_SIGNALING,-1.689747989,1,levamisole
DNA_REPLICATION,-1.681690998,0.791619496,levamisole
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.6151926,0.89752726,levamisole
CELL_CELL_COMMUNICATION,1.621681924,0.673321552,levamisole
STRIATED_MUSCLE_CONTRACTION,3.094031113,0,benzylpenicillin
MUSCLE_CONTRACTION,2.955828962,0,benzylpenicillin
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.330402924,0.007537934,benzylpenicillin
ANTIGEN_PROCESSING_CROSS_PRESENTATION,2.105450426,0.024498287,benzylpenicillin
SIGNALING_BY_GPCR,-2.105542832,0.116314503,benzylpenicillin
SMOOTH_MUSCLE_CONTRACTION,2.013257168,0.034889868,benzylpenicillin
INFLUENZA_INFECTION,1.953250016,0.041638114,benzylpenicillin
TRNA_PROCESSING,1.948533701,0.03707433,benzylpenicillin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.99771066,0.162742561,benzylpenicillin
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.835365783,0.065014684,benzylpenicillin
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.625977645,0.004335616,nortriptyline
REGULATION_OF_T_CELL_ACTIVATION_BY_CD28_FAMILY,2.491200577,0.004335616,nortriptyline
HEMOSTASIS,2.412724655,0.005780821,nortriptyline
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.342415426,0.007045376,nortriptyline
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,2.33961694,0.005636301,nortriptyline
CONSTITUTIVE_SIGNALING_BY_ABERRANT_PI3K_IN_CANCER,1.978193131,0.067924652,nortriptyline
INNATE_IMMUNE_SYSTEM,1.970740839,0.061008312,nortriptyline
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,1.96920786,0.054195201,nortriptyline
PI3K_AKT_SIGNALING_IN_CANCER,1.899728255,0.072139835,nortriptyline
EXTRACELLULAR_MATRIX_ORGANIZATION,1.832453751,0.096142287,nortriptyline
GPCR_LIGAND_BINDING,-2.095301443,0.123994426,enoxacin
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.017749389,0.109884715,enoxacin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.966011995,0.112307595,enoxacin
RRNA_PROCESSING,-1.909694106,0.122497941,enoxacin
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.884658451,0.118521568,enoxacin
VISUAL_PHOTOTRANSDUCTION,-1.8440613,0.130550453,enoxacin
SENSORY_PERCEPTION,-1.734173914,0.22160186,enoxacin
SIGNALING_BY_GPCR,-1.715604429,0.218272946,enoxacin
G_ALPHA_Q_SIGNALLING_EVENTS,-1.65689403,0.272027618,enoxacin
METABOLISM_OF_RNA,-1.583290467,0.36599734,enoxacin
METABOLISM_OF_RNA,5.293557739,0,tariquidar
MRNA_SPLICING_MINOR_PATHWAY,2.80626027,0,tariquidar
HOST_INTERACTIONS_OF_HIV_FACTORS,2.881593478,0,tariquidar
SARS_COV_INFECTIONS,2.913761273,0,tariquidar
SARS_COV_2_INFECTION,3.144595162,0,tariquidar
NERVOUS_SYSTEM_DEVELOPMENT,3.249092917,0,tariquidar
INFECTIOUS_DISEASE,3.556698017,0,tariquidar
SARS_COV_2_HOST_INTERACTIONS,3.58491845,0,tariquidar
VIRAL_INFECTION_PATHWAYS,3.610224788,0,tariquidar
SARS_COV_1_HOST_INTERACTIONS,3.622278982,0,tariquidar
CELL_CYCLE,-5.307169322,0,sunitinib
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.507194986,0,sunitinib
GPCR_LIGAND_BINDING,2.531589144,0,sunitinib
VIRAL_INFECTION_PATHWAYS,-2.893965131,0,sunitinib
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.963066974,0,sunitinib
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,-2.992114475,0,sunitinib
METABOLISM_OF_RNA,-3.174849791,0,sunitinib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.519623229,0,sunitinib
G2_M_CHECKPOINTS,-3.336368351,0,sunitinib
MITOTIC_METAPHASE_AND_ANAPHASE,-3.370105229,0,sunitinib
PEROXISOMAL_PROTEIN_IMPORT,-2.171481773,0.015267412,molsidomine
EXTRACELLULAR_MATRIX_ORGANIZATION,2.031639855,0.086388119,molsidomine
RHO_GTPASES_ACTIVATE_FORMINS,1.886063362,0.094441249,molsidomine
RHO_GTPASE_EFFECTORS,1.877041985,0.065889243,molsidomine
MITOTIC_PROMETAPHASE,1.870144888,0.051979292,molsidomine
RESOLUTION_OF_SISTER_CHROMATID_COHESION,1.847645596,0.047440255,molsidomine
PROTEIN_LOCALIZATION,-1.823489028,0.413174332,molsidomine
TRNA_PROCESSING_IN_THE_NUCLEUS,1.483505631,0.252819467,molsidomine
HOST_INTERACTIONS_OF_HIV_FACTORS,1.476376968,0.223395911,molsidomine
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,-1.761102223,0.458340425,molsidomine
ORC1_REMOVAL_FROM_CHROMATIN,3.007802804,0,rutin
TRANSCRIPTIONAL_REGULATION_BY_RUNX3,2.963986282,0,rutin
SEPARATION_OF_SISTER_CHROMATIDS,2.793509696,0.000982311,rutin
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.789177524,0.000736733,rutin
MAPK6_MAPK4_SIGNALING,2.715969457,0.001178773,rutin
REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS,2.711720109,0.000982311,rutin
THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT,2.703614551,0.000841981,rutin
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,2.703183354,0.000736733,rutin
SYNTHESIS_OF_DNA,2.656561289,0.001309748,rutin
S_PHASE,2.550024692,0.001262971,rutin
MRNA_SPLICING,2.739764956,0,zonisamide
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.481814265,0.003344801,zonisamide
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.043375806,0.011149337,zonisamide
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.921640405,0.050866271,zonisamide
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.917898196,0.025843347,zonisamide
GPCR_LIGAND_BINDING,-1.901336653,0.019416695,zonisamide
CELL_CYCLE_CHECKPOINTS,1.640747085,0.19232607,zonisamide
P75_NTR_RECEPTOR_MEDIATED_SIGNALLING,1.595691682,0.198012232,zonisamide
MHC_CLASS_II_ANTIGEN_PRESENTATION,1.570119025,0.187308869,zonisamide
G_ALPHA_I_SIGNALLING_EVENTS,-1.768882881,0.07158197,zonisamide
NEUTROPHIL_DEGRANULATION,2.798073101,0,oxybenzone
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.368047282,0.002415079,oxybenzone
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.152735423,0.012880422,oxybenzone
BACTERIAL_INFECTION_PATHWAYS,1.963467547,0.042263884,oxybenzone
INNATE_IMMUNE_SYSTEM,1.861889206,0.063371675,oxybenzone
SIGNALING_BY_GPCR,-1.912330668,0.462954732,oxybenzone
INFLUENZA_INFECTION,1.763538537,0.094188084,oxybenzone
SIGNALING_BY_ROBO_RECEPTORS,1.719319434,0.105159443,oxybenzone
ESTROGEN_DEPENDENT_GENE_EXPRESSION,1.675700511,0.117735105,oxybenzone
CELLULAR_RESPONSE_TO_STARVATION,1.634051246,0.136639807,oxybenzone
MUSCLE_CONTRACTION,3.216339017,0,betaxolol
STRIATED_MUSCLE_CONTRACTION,2.756771453,0.000693505,betaxolol
CARDIAC_CONDUCTION,2.712913105,0.000924673,betaxolol
DNA_REPLICATION,2.500052179,0.002427267,betaxolol
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.463049141,0.003051421,betaxolol
S_PHASE,2.45729021,0.003005187,betaxolol
SYNTHESIS_OF_DNA,2.445738358,0.002774019,betaxolol
DNA_REPLICATION_PRE_INITIATION,2.309915316,0.004507781,betaxolol
SEPARATION_OF_SISTER_CHROMATIDS,2.294519774,0.004315141,betaxolol
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,2.260226348,0.005548038,betaxolol
GPCR_LIGAND_BINDING,3.367378363,0,bepridil
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,3.339748577,0,bepridil
SIGNALING_BY_GPCR,3.304200157,0,bepridil
G_ALPHA_Q_SIGNALLING_EVENTS,2.827852147,0,bepridil
G_ALPHA_I_SIGNALLING_EVENTS,2.716816603,0,bepridil
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.693509718,0,bepridil
MUSCLE_CONTRACTION,2.664864282,0,bepridil
NEUTROPHIL_DEGRANULATION,-2.525619734,0.002839368,bepridil
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,-2.237009907,0.039751151,bepridil
CARDIAC_CONDUCTION,2.163587768,0.005648437,bepridil
SEPARATION_OF_SISTER_CHROMATIDS,3.494169298,0,dobutamine
RESOLUTION_OF_SISTER_CHROMATID_COHESION,3.253880489,0,dobutamine
MITOTIC_METAPHASE_AND_ANAPHASE,3.145615482,0.001432501,dobutamine
METABOLISM_OF_RNA,2.766541795,0.002148751,dobutamine
RHO_GTPASES_ACTIVATE_FORMINS,2.651696913,0.001719001,dobutamine
M_PHASE,2.575824356,0.002148751,dobutamine
PROTEIN_FOLDING,2.526290454,0.003069644,dobutamine
CELL_CYCLE_CHECKPOINTS,2.504852929,0.003223126,dobutamine
MITOTIC_SPINDLE_CHECKPOINT,2.438776211,0.003008251,dobutamine
MITOTIC_PROMETAPHASE,2.449624099,0.003342501,dobutamine
EUKARYOTIC_TRANSLATION_ELONGATION,-3.555649216,0,glipizide
NERVOUS_SYSTEM_DEVELOPMENT,-2.484230536,0,glipizide
EXTRACELLULAR_MATRIX_ORGANIZATION,2.626046863,0,glipizide
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.835405046,0,glipizide
SARS_COV_1_INFECTION,-2.880570613,0,glipizide
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.99842943,0,glipizide
SARS_COV_1_HOST_INTERACTIONS,-3.022599021,0,glipizide
SIGNALING_BY_ROBO_RECEPTORS,-3.052405708,0,glipizide
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-3.067620334,0,glipizide
TRANSLATION,-3.068537208,0,glipizide
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,2.270873382,0.095858742,methotrexate
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,2.220728617,0.063534282,methotrexate
DOWNSTREAM_TCR_SIGNALING,2.165051108,0.064648919,methotrexate
TRANSCRIPTIONAL_REGULATION_BY_RUNX2,2.153314089,0.052387917,methotrexate
AUF1_HNRNP_D0_BINDS_AND_DESTABILIZES_MRNA,2.11025139,0.059744518,methotrexate
SIGNALING_BY_NOTCH4,2.083219804,0.060561918,methotrexate
FORMATION_OF_PARAXIAL_MESODERM,2.068108451,0.055094892,methotrexate
REGULATION_OF_RUNX2_EXPRESSION_AND_ACTIVITY,2.063246276,0.049879985,methotrexate
ASYMMETRIC_LOCALIZATION_OF_PCP_PROTEINS,2.039235666,0.053502554,methotrexate
TCR_SIGNALING,2.035023062,0.049935717,methotrexate
MRNA_SPLICING,2.482493499,0.002598457,nefazodone
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.327468278,0.003248071,nefazodone
TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM,2.261277716,0.00346461,nefazodone
RNA_POLYMERASE_II_TRANSCRIPTION_TERMINATION,1.962776627,0.016240357,nefazodone
EUKARYOTIC_TRANSLATION_ELONGATION,-2.577419598,0.756784791,nefazodone
SELENOAMINO_ACID_METABOLISM,-2.562522874,0.468180422,nefazodone
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.552550589,0.355205378,nefazodone
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.527757337,0.348051936,nefazodone
TRNA_PROCESSING,1.380061944,0.298302883,nefazodone
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.488603709,0.359546777,nefazodone
METABOLISM_OF_RNA,4.073837018,0,mesoridazine
ACTIVATION_OF_APC_C_AND_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS,2.632271464,0,mesoridazine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.661933209,0,mesoridazine
ORC1_REMOVAL_FROM_CHROMATIN,2.72213327,0,mesoridazine
SEPARATION_OF_SISTER_CHROMATIDS,2.722284289,0,mesoridazine
APC_C_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS,2.742348075,0,mesoridazine
DNA_REPLICATION,2.758965053,0,mesoridazine
RRNA_MODIFICATION_IN_THE_NUCLEUS_AND_CYTOSOL,2.761090277,0,mesoridazine
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,2.790458504,0,mesoridazine
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,2.77302218,0,mesoridazine
GPCR_LIGAND_BINDING,2.974352635,0,riboflavin
SIGNALING_BY_GPCR,2.851076606,0,riboflavin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.729380344,0,riboflavin
NEUTROPHIL_DEGRANULATION,-2.513232846,0.003965044,riboflavin
G_ALPHA_I_SIGNALLING_EVENTS,2.43949626,0.000956476,riboflavin
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.210429306,0.00841699,riboflavin
G_ALPHA_Q_SIGNALLING_EVENTS,2.132114633,0.013645727,riboflavin
MEMBRANE_TRAFFICKING,-2.119492981,0.112342908,riboflavin
PEROXISOMAL_PROTEIN_IMPORT,-2.1175212,0.075776393,riboflavin
FATTY_ACID_METABOLISM,-2.106301202,0.061788599,riboflavin
EUKARYOTIC_TRANSLATION_ELONGATION,-4.20776185,0,bezafibrate
GPCR_LIGAND_BINDING,3.093310002,0,bezafibrate
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-3.377061266,0,bezafibrate
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,3.406371997,0,bezafibrate
SARS_COV_1_INFECTION,-3.408555947,0,bezafibrate
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-3.538644764,0,bezafibrate
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-3.566364577,0,bezafibrate
SIGNALING_BY_ROBO_RECEPTORS,-3.682149706,0,bezafibrate
INFLUENZA_INFECTION,-3.755279448,0,bezafibrate
TRANSLATION,-3.704101844,0,bezafibrate
MUSCLE_CONTRACTION,3.232330809,0,mexiletine
SIGNALING_BY_GPCR,2.598387885,0.000935151,mexiletine
PEROXISOMAL_PROTEIN_IMPORT,-2.430856207,0.003079356,mexiletine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.499964362,0.000935151,mexiletine
CARDIAC_CONDUCTION,2.413922849,0.001168939,mexiletine
G_ALPHA_Q_SIGNALLING_EVENTS,2.398363033,0.001122182,mexiletine
GPCR_LIGAND_BINDING,2.387935223,0.001246869,mexiletine
NEUTROPHIL_DEGRANULATION,-2.210209466,0.029767106,mexiletine
MEMBRANE_TRAFFICKING,-2.077641402,0.060218514,mexiletine
METABOLISM_OF_STEROIDS,-2.065977893,0.048499854,mexiletine
SIGNALING_BY_GPCR,3.272913931,0,dexamethasone
GPCR_LIGAND_BINDING,3.210762961,0,dexamethasone
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.994604466,0,dexamethasone
NEUTROPHIL_DEGRANULATION,-2.932441617,0,dexamethasone
CARDIAC_CONDUCTION,2.637132835,0,dexamethasone
ASPARAGINE_N_LINKED_GLYCOSYLATION,-2.50156979,0.001050397,dexamethasone
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,-2.441143542,0.001400529,dexamethasone
TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,-2.438049537,0.001050397,dexamethasone
G_ALPHA_Q_SIGNALLING_EVENTS,2.527573925,0.000897134,dexamethasone
MUSCLE_CONTRACTION,2.502346198,0.001196178,dexamethasone
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.456603585,0,ibuprofen
GPCR_LIGAND_BINDING,-2.442158799,0,ibuprofen
SENSORY_PERCEPTION,-2.308605296,0.001137054,ibuprofen
SIGNALING_BY_GPCR,-2.227402976,0.002131977,ibuprofen
POTENTIAL_THERAPEUTICS_FOR_SARS,2.297474657,0.032558605,ibuprofen
RESOLUTION_OF_SISTER_CHROMATID_COHESION,2.197952796,0.030054097,ibuprofen
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.131063766,0.005628419,ibuprofen
G_ALPHA_Q_SIGNALLING_EVENTS,-2.118600745,0.005827403,ibuprofen
G_ALPHA_I_SIGNALLING_EVENTS,-1.938190148,0.039472026,ibuprofen
SIGNALING_BY_VEGF,1.71275385,0.267982368,ibuprofen
GPCR_LIGAND_BINDING,3.242308646,0,pravastatin
SIGNALING_BY_GPCR,3.033274526,0,pravastatin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,3.027935875,0,pravastatin
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.566032203,0.000263728,pravastatin
G_ALPHA_Q_SIGNALLING_EVENTS,2.552341403,0.000210982,pravastatin
G_ALPHA_I_SIGNALLING_EVENTS,2.141885664,0.010724922,pravastatin
G_ALPHA_S_SIGNALLING_EVENTS,1.952888285,0.055608847,pravastatin
MUSCLE_CONTRACTION,1.945271084,0.052349928,pravastatin
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,1.79823017,0.137489986,pravastatin
ORC1_REMOVAL_FROM_CHROMATIN,1.797632566,0.124057461,pravastatin
TRNA_PROCESSING,1.87646844,0.113408995,cholic-acid
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.488598937,0.490374107,cholic-acid
TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM,1.464182725,0.373770492,cholic-acid
GLYCOSAMINOGLYCAN_METABOLISM,1.459510689,0.28791509,cholic-acid
EUKARYOTIC_TRANSLATION_ELONGATION,-2.24557131,1,cholic-acid
EUKARYOTIC_TRANSLATION_INITIATION,-2.173852882,1,cholic-acid
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.126938838,1,cholic-acid
SELENOAMINO_ACID_METABOLISM,-2.14497697,1,cholic-acid
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.118831575,0.924019043,cholic-acid
SARS_COV_1_INFECTION,-2.119825857,1,cholic-acid
RRNA_PROCESSING,3.560084052,0,phenylbutazone
TRANSLATION,3.149167707,0,phenylbutazone
EUKARYOTIC_TRANSLATION_INITIATION,3.096337864,0,phenylbutazone
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.019392966,0,phenylbutazone
SELENOAMINO_ACID_METABOLISM,2.952135976,0,phenylbutazone
EUKARYOTIC_TRANSLATION_ELONGATION,2.788379061,0,phenylbutazone
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.772459435,0,phenylbutazone
NONSENSE_MEDIATED_DECAY_NMD,2.721267727,0,phenylbutazone
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.712073376,0,phenylbutazone
INFLUENZA_INFECTION,2.699929095,0,phenylbutazone
PLATELET_HOMEOSTASIS,2.182657783,0.048267002,nimesulide
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.909348825,0.691518733,nimesulide
NEURONAL_SYSTEM,1.812698908,0.537694399,nimesulide
CELL_CELL_JUNCTION_ORGANIZATION,1.795610043,0.411878414,nimesulide
METABOLISM_OF_RNA,-1.752328751,0.858054208,nimesulide
REGULATION_OF_T_CELL_ACTIVATION_BY_CD28_FAMILY,1.753615615,0.409786844,nimesulide
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.721995666,0.410076446,nimesulide
CELL_JUNCTION_ORGANIZATION,1.699255228,0.398685434,nimesulide
CO_STIMULATION_BY_CD28,1.666599578,0.421301972,nimesulide
DEUBIQUITINATION,1.665956205,0.370207903,nimesulide
NEUTROPHIL_DEGRANULATION,-3.563282168,0,thiethylperazine
SIGNALING_BY_GPCR,3.183215854,0,thiethylperazine
GPCR_LIGAND_BINDING,3.066332829,0,thiethylperazine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.835516126,0,thiethylperazine
G_ALPHA_Q_SIGNALLING_EVENTS,2.753910225,0,thiethylperazine
INNATE_IMMUNE_SYSTEM,-2.662859188,0,thiethylperazine
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.399154613,0.000978898,thiethylperazine
G_ALPHA_S_SIGNALLING_EVENTS,2.350100229,0.001767455,thiethylperazine
G_ALPHA_I_SIGNALLING_EVENTS,2.297096033,0.002214174,thiethylperazine
SENSORY_PERCEPTION,2.195378855,0.005200396,thiethylperazine
GPCR_LIGAND_BINDING,3.763332273,0,GW-9662
G_ALPHA_Q_SIGNALLING_EVENTS,2.66469835,0,GW-9662
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.68469352,0,GW-9662
INFLUENZA_INFECTION,-2.959215184,0,GW-9662
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.965106134,0,GW-9662
CELLULAR_RESPONSE_TO_STARVATION,-2.971668205,0,GW-9662
SELENOAMINO_ACID_METABOLISM,-2.915620657,0,GW-9662
EUKARYOTIC_TRANSLATION_INITIATION,-3.008607419,0,GW-9662
NONSENSE_MEDIATED_DECAY_NMD,-3.031203977,0,GW-9662
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-3.043125111,0,GW-9662
GPCR_LIGAND_BINDING,3.321447405,0,rescinnamine
SIGNALING_BY_GPCR,3.209765464,0,rescinnamine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.945136989,0,rescinnamine
G_ALPHA_Q_SIGNALLING_EVENTS,2.544028964,0.000157116,rescinnamine
G_ALPHA_S_SIGNALLING_EVENTS,2.442205395,0.000377078,rescinnamine
NEURONAL_SYSTEM,2.335756273,0.000628464,rescinnamine
G_ALPHA_I_SIGNALLING_EVENTS,2.298003927,0.000628464,rescinnamine
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.272529846,0.000864138,rescinnamine
NEUTROPHIL_DEGRANULATION,-3.415889168,0.021588731,rescinnamine
SENSORY_PERCEPTION,2.185538205,0.00195522,rescinnamine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,3.606199188,0,puromycin
SIGNALING_BY_GPCR,3.573003289,0,puromycin
GPCR_LIGAND_BINDING,3.563963957,0,puromycin
G_ALPHA_Q_SIGNALLING_EVENTS,3.057948947,0,puromycin
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.69900122,0,puromycin
G_ALPHA_I_SIGNALLING_EVENTS,2.460121208,0.000391585,puromycin
G_ALPHA_S_SIGNALLING_EVENTS,2.414741069,0.000419555,puromycin
MUSCLE_CONTRACTION,2.159726243,0.005139555,puromycin
STRIATED_MUSCLE_CONTRACTION,2.065650738,0.011682289,puromycin
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,-3.220644204,0.276676464,puromycin
REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF,3.294217323,0,lapatinib
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.706126993,0,lapatinib
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.593488677,0,lapatinib
EUKARYOTIC_TRANSLATION_ELONGATION,2.574057882,0,lapatinib
INFLUENZA_INFECTION,2.553143718,0.001270017,lapatinib
EUKARYOTIC_TRANSLATION_INITIATION,2.460621824,0.003175041,lapatinib
GPCR_LIGAND_BINDING,-2.262083689,0.004106404,lapatinib
SARS_COV_1_HOST_INTERACTIONS,2.279079924,0.007257238,lapatinib
METABOLISM_OF_STEROIDS,2.269172791,0.007143843,lapatinib
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,2.265553038,0.006350083,lapatinib
CELLULAR_RESPONSE_TO_STARVATION,3.278840521,0,R-547
APC_C_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS,-2.317844363,0,R-547
M_PHASE,-2.355447081,0,R-547
MITOTIC_METAPHASE_AND_ANAPHASE,-2.412787324,0,R-547
MITOTIC_PROMETAPHASE,-2.420356387,0,R-547
SEPARATION_OF_SISTER_CHROMATIDS,-2.583665554,0,R-547
CELL_CYCLE_CHECKPOINTS,-2.588615741,0,R-547
RHO_GTPASES_ACTIVATE_FORMINS,-2.571721059,0,R-547
CELL_CYCLE_MITOTIC,-2.653626625,0,R-547
RESOLUTION_OF_SISTER_CHROMATID_COHESION,-2.704770287,0,R-547
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.331897757,0.069955577,riociguat
PEROXISOMAL_PROTEIN_IMPORT,1.922223983,0.403508901,riociguat
GPCR_LIGAND_BINDING,-1.944175017,0.400594672,riociguat
INTEGRATION_OF_ENERGY_METABOLISM,-1.855188082,0.424133184,riociguat
SIGNALING_BY_GPCR,-1.802651651,0.418413545,riociguat
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.738655082,0.472530124,riociguat
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.682765479,0.520927064,riociguat
MAPK1_MAPK3_SIGNALING,-1.643773019,0.546256891,riociguat
PCP_CE_PATHWAY,-1.639812502,0.485234321,riociguat
PROTEIN_FOLDING,-1.635890262,0.441145442,riociguat
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,3.062751301,0,olanzapine
MRNA_SPLICING,2.99666753,0,olanzapine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.349206881,0,olanzapine
SELENOAMINO_ACID_METABOLISM,-2.157105172,0.005831208,olanzapine
GPCR_LIGAND_BINDING,-2.151626494,0.004211428,olanzapine
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.137915813,0.003401538,olanzapine
EUKARYOTIC_TRANSLATION_ELONGATION,-2.125645978,0.002915604,olanzapine
NONSENSE_MEDIATED_DECAY_NMD,-2.095245895,0.00323956,olanzapine
EUKARYOTIC_TRANSLATION_INITIATION,-2.073015622,0.004442825,olanzapine
G_ALPHA_Q_SIGNALLING_EVENTS,-2.067914026,0.004008956,olanzapine
EUKARYOTIC_TRANSLATION_ELONGATION,-3.005540618,0,acebutolol
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.697751945,0,acebutolol
INFLUENZA_INFECTION,-2.699752578,0,acebutolol
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.707346821,0,acebutolol
SIGNALING_BY_ROBO_RECEPTORS,-2.731064233,0,acebutolol
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.763785589,0,acebutolol
CELLULAR_RESPONSE_TO_STARVATION,-2.766079874,0,acebutolol
NONSENSE_MEDIATED_DECAY_NMD,-2.796318701,0,acebutolol
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.879955762,0,acebutolol
SELENOAMINO_ACID_METABOLISM,-2.892000302,0,acebutolol
METABOLISM_OF_RNA,-2.725946815,0,rotigotine
RRNA_PROCESSING,-2.654192297,0,rotigotine
TRANSLATION,-2.622153983,0,rotigotine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.314746778,0.003792953,rotigotine
EUKARYOTIC_TRANSLATION_INITIATION,-2.274010046,0.005835313,rotigotine
SIGNALING_BY_ROBO_RECEPTORS,-2.150242464,0.015560834,rotigotine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,-2.14200089,0.014671643,rotigotine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.103097305,0.018527118,rotigotine
MUSCLE_CONTRACTION,2.085601241,0.137598262,rotigotine
CELL_CELL_JUNCTION_ORGANIZATION,2.06011107,0.084360839,rotigotine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.811379155,0,loratadine
TOLL_LIKE_RECEPTOR_CASCADES,2.049855655,0.207093148,loratadine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.007437843,0.146014984,loratadine
PKR_MEDIATED_SIGNALING,-1.961348847,0.186854051,loratadine
MYD88_INDEPENDENT_TLR4_CASCADE,1.976622373,0.127246174,loratadine
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.914820545,0.159685361,loratadine
TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,1.947881989,0.120486221,loratadine
TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,1.892816502,0.157848879,loratadine
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,1.887185876,0.137743983,loratadine
GPCR_LIGAND_BINDING,-1.78875912,0.248122218,loratadine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.587525258,0,meclofenamic-acid
GPCR_LIGAND_BINDING,-2.500833967,0,meclofenamic-acid
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.599781667,0.007402609,meclofenamic-acid
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.138483122,0.003462358,meclofenamic-acid
SIGNALING_BY_GPCR,-2.091310278,0.003462358,meclofenamic-acid
MRNA_SPLICING,2.03300552,0.051818266,meclofenamic-acid
G_ALPHA_Q_SIGNALLING_EVENTS,-1.971749909,0.016099966,meclofenamic-acid
SENSORY_PERCEPTION,-1.924776259,0.027266072,meclofenamic-acid
RRNA_PROCESSING,1.61304092,0.37753308,meclofenamic-acid
MITOCHONDRIAL_PROTEIN_DEGRADATION,1.606421794,0.289627094,meclofenamic-acid
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.514351683,0.005025329,duloxetine
G_ALPHA_I_SIGNALLING_EVENTS,2.094719467,0.112678257,duloxetine
BIOLOGICAL_OXIDATIONS,1.952100379,0.182691932,duloxetine
NEUTROPHIL_DEGRANULATION,-1.89340838,0.235352921,duloxetine
PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS,1.894276371,0.208217751,duloxetine
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,1.841848402,0.234381715,duloxetine
SIGNALING_BY_WNT,1.830426799,0.206759133,duloxetine
NEURONAL_SYSTEM,1.77270081,0.26455688,duloxetine
MUSCLE_CONTRACTION,1.735259853,0.294432506,duloxetine
SIGNALING_BY_GPCR,1.695638473,0.332154718,duloxetine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.260672165,0.013736492,cinnarizine
MITOTIC_METAPHASE_AND_ANAPHASE,-2.035249923,0.182482233,cinnarizine
CELL_CYCLE_MITOTIC,-2.001462307,0.13477446,cinnarizine
METABOLISM_OF_RNA,-1.979736399,0.111318138,cinnarizine
CELL_CYCLE,-1.978000465,0.084979471,cinnarizine
GPCR_LIGAND_BINDING,-1.956735115,0.081580293,cinnarizine
REGULATION_OF_INSULIN_SECRETION,-1.860240927,0.155845393,cinnarizine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-1.853290842,0.142101011,cinnarizine
GASTRULATION,-1.821861874,0.160268301,cinnarizine
MRNA_SPLICING,-1.820481642,0.142990799,cinnarizine
CELL_CYCLE,-3.820294141,0,vemurafenib
MITOTIC_METAPHASE_AND_ANAPHASE,-2.642675261,0,vemurafenib
G2_M_DNA_DAMAGE_CHECKPOINT,-2.635228428,0,vemurafenib
ORC1_REMOVAL_FROM_CHROMATIN,-2.575161199,0,vemurafenib
MITOTIC_PROMETAPHASE,-2.57125325,0,vemurafenib
REGULATION_OF_TP53_ACTIVITY,-2.565625714,0,vemurafenib
DISEASES_OF_DNA_REPAIR,-2.53510925,0,vemurafenib
DNA_DOUBLE_STRAND_BREAK_REPAIR,-2.668298002,0,vemurafenib
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,-2.521851107,0,vemurafenib
PROCESSING_OF_DNA_DOUBLE_STRAND_BREAK_ENDS,-2.492844418,0,vemurafenib
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,4.026204721,0,PLX-4720
RESPIRATORY_ELECTRON_TRANSPORT,3.963317465,0,PLX-4720
BIOLOGICAL_OXIDATIONS,2.991780579,0,PLX-4720
G2_M_CHECKPOINTS,-2.514546397,0,PLX-4720
CELL_CYCLE_CHECKPOINTS,-2.45055754,0.001028666,PLX-4720
CELLULAR_RESPONSE_TO_STARVATION,2.571256603,0.001098545,PLX-4720
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.547219057,0.000878836,PLX-4720
S_PHASE,-2.266570642,0.001714443,PLX-4720
DISEASES_OF_DNA_REPAIR,-2.251355508,0.001285832,PLX-4720
DISEASES_OF_METABOLISM,2.471466581,0.001171782,PLX-4720
METABOLISM_OF_RNA,3.442895746,0,tolterodine
CELL_CYCLE,2.868817332,0,tolterodine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.834871086,0,tolterodine
CELL_CYCLE_MITOTIC,2.810345459,0,tolterodine
RRNA_PROCESSING,2.752513668,0.000761132,tolterodine
M_PHASE,2.587583796,0.000634276,tolterodine
MITOTIC_METAPHASE_AND_ANAPHASE,2.525462732,0.000951414,tolterodine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.546883849,0.001087331,tolterodine
SIGNALING_BY_ROBO_RECEPTORS,2.4142652,0.001902829,tolterodine
CELL_CYCLE_CHECKPOINTS,2.43783228,0.002114254,tolterodine
SYNTHESIS_OF_DNA,2.443082713,0.002888446,GW-3965
DNA_REPLICATION,2.451014137,0.005776892,GW-3965
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-3.363837326,0.040635366,GW-3965
S_PHASE,2.201415154,0.027440239,GW-3965
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.172844294,0.025273904,GW-3965
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,2.127959242,0.026284861,GW-3965
DNA_REPLICATION_PRE_INITIATION,2.123668438,0.023588977,GW-3965
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-3.258669656,0.159224292,GW-3965
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-3.199887723,0.232202092,GW-3965
ASPARAGINE_N_LINKED_GLYCOSYLATION,-3.175072786,0.226604363,GW-3965
EUKARYOTIC_TRANSLATION_ELONGATION,3.436997632,0,loperamide
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.152950001,0,loperamide
SELENOAMINO_ACID_METABOLISM,2.558431794,0.000789231,loperamide
EUKARYOTIC_TRANSLATION_INITIATION,2.507596798,0.001183846,loperamide
MUSCLE_CONTRACTION,2.11609013,0.012785536,loperamide
ANTIGEN_PROCESSING_CROSS_PRESENTATION,2.012225538,0.020322688,loperamide
INTERLEUKIN_3_INTERLEUKIN_5_AND_GM_CSF_SIGNALING,-2.035419588,0.126049112,loperamide
RRNA_PROCESSING,1.968569537,0.026044609,loperamide
TRANSLATION,1.881023228,0.038327011,loperamide
RNA_POLYMERASE_II_PRE_TRANSCRIPTION_EVENTS,-1.964636412,0.14059324,loperamide
G_ALPHA_Q_SIGNALLING_EVENTS,-2.463743632,0,methimazole
SIGNALING_BY_ROBO_RECEPTORS,2.467173379,0.002703728,methimazole
SIGNALING_BY_GPCR,-2.316148701,0.001365807,methimazole
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.247982544,0.001821076,methimazole
GPCR_LIGAND_BINDING,-2.234574439,0.001365807,methimazole
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.145886473,0.00382426,methimazole
TRANSLATION,2.22241907,0.01960203,methimazole
NEUTROPHIL_DEGRANULATION,2.172039699,0.021629826,methimazole
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.029002563,0.043935585,methimazole
INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,-1.989210691,0.031413565,methimazole
GPCR_LIGAND_BINDING,3.686257138,0,DNQX
G_ALPHA_I_SIGNALLING_EVENTS,2.578586764,0,DNQX
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,-2.661818955,0,DNQX
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,-2.667245826,0,DNQX
G_ALPHA_Q_SIGNALLING_EVENTS,2.681602507,0,DNQX
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.693139631,0,DNQX
COPII_MEDIATED_VESICLE_TRANSPORT,-2.66159844,0,DNQX
MEMBRANE_TRAFFICKING,-2.905228835,0,DNQX
NEUTROPHIL_DEGRANULATION,-3.096214965,0,DNQX
SIGNALING_BY_GPCR,3.391511514,0,DNQX
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,3.151699758,0,phentolamine
MITOTIC_PROPHASE,2.677651758,0.00212766,phentolamine
SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS,2.465706366,0.002836879,phentolamine
REGULATION_OF_TP53_ACTIVITY,2.339157891,0.003191489,phentolamine
INTERLEUKIN_17_SIGNALING,2.306818083,0.003404255,phentolamine
MYD88_INDEPENDENT_TLR4_CASCADE,2.2638939,0.004964539,phentolamine
NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION,2.171360326,0.006914894,phentolamine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.175346294,0.007902736,phentolamine
SENSORY_PERCEPTION,-2.172053461,0.008297872,phentolamine
TOLL_LIKE_RECEPTOR_CASCADES,2.152985108,0.006619385,phentolamine
NEDDYLATION,2.427386817,0.005724527,etacrynic-acid
SELENOAMINO_ACID_METABOLISM,2.088110772,0.093023567,etacrynic-acid
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.019041677,0.101133314,etacrynic-acid
G2_M_CHECKPOINTS,2.002810869,0.087656823,etacrynic-acid
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,1.988831225,0.077567343,etacrynic-acid
MYD88_INDEPENDENT_TLR4_CASCADE,1.964352707,0.076804073,etacrynic-acid
REGULATION_OF_T_CELL_ACTIVATION_BY_CD28_FAMILY,1.950912448,0.072169932,etacrynic-acid
CELLULAR_RESPONSE_TO_STARVATION,1.948800913,0.063685365,etacrynic-acid
INFLUENZA_INFECTION,1.942745488,0.058040345,etacrynic-acid
TOLL_LIKE_RECEPTOR_CASCADES,1.901368703,0.070411684,etacrynic-acid
METABOLISM_OF_RNA,3.016787828,0,sibutramine
CELL_CYCLE,2.803002749,0.00214178,sibutramine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.596387481,0.003569633,sibutramine
CELL_CYCLE_CHECKPOINTS,2.526202546,0.002677225,sibutramine
CELL_CYCLE_MITOTIC,2.494351351,0.00214178,sibutramine
SEPARATION_OF_SISTER_CHROMATIDS,2.430598236,0.002498743,sibutramine
RRNA_PROCESSING,2.38627955,0.003059685,sibutramine
MRNA_SPLICING,2.328294423,0.004819005,sibutramine
RHO_GTPASES_ACTIVATE_FORMINS,2.266482594,0.007377241,sibutramine
TRANSCRIPTIONAL_REGULATION_BY_RUNX3,2.223645481,0.008995475,sibutramine
INFLUENZA_INFECTION,3.713305452,0,isradipine
VIRAL_INFECTION_PATHWAYS,2.382405955,0,isradipine
TRANSCRIPTIONAL_REGULATION_BY_TP53,2.405359885,0,isradipine
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,2.468299063,0,isradipine
RESPIRATORY_ELECTRON_TRANSPORT,2.546771911,0,isradipine
CELL_CYCLE_MITOTIC,2.606272973,0,isradipine
M_PHASE,2.700531508,0,isradipine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.481718328,0,isradipine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.725523569,0,isradipine
CELL_CYCLE_CHECKPOINTS,2.761989465,0,isradipine
MUSCLE_CONTRACTION,3.280212322,0,propofol
STRIATED_MUSCLE_CONTRACTION,3.069785041,0,propofol
G_ALPHA_I_SIGNALLING_EVENTS,2.417584984,0.002897021,propofol
SIGNALING_BY_GPCR,2.046032051,0.026073191,propofol
CARDIAC_CONDUCTION,1.86602965,0.06058913,propofol
GPCR_LIGAND_BINDING,1.849338857,0.055457264,propofol
POTENTIAL_THERAPEUTICS_FOR_SARS,1.629041048,0.16654916,propofol
STIMULI_SENSING_CHANNELS,1.582234298,0.185461092,propofol
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.68971029,1,propofol
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.515725302,1,propofol
RRNA_PROCESSING,2.709723414,0,raltitrexed
EUKARYOTIC_TRANSLATION_ELONGATION,2.683254671,0,raltitrexed
CELLULAR_RESPONSE_TO_STARVATION,2.674882962,0,raltitrexed
NONSENSE_MEDIATED_DECAY_NMD,2.666525191,0,raltitrexed
TRANSLATION,2.631445635,0.000257465,raltitrexed
EUKARYOTIC_TRANSLATION_INITIATION,2.627584744,0.000214554,raltitrexed
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.569321398,0.000367807,raltitrexed
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.545731767,0.000321831,raltitrexed
SELENOAMINO_ACID_METABOLISM,2.451102048,0.001001252,raltitrexed
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.381531071,0.001029859,raltitrexed
PI3K_AKT_SIGNALING_IN_CANCER,1.803167682,0.306412436,AR-A014418
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,1.748685758,0.214840904,AR-A014418
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.624981758,0.258278682,AR-A014418
CELL_CYCLE_CHECKPOINTS,1.617404267,0.198111489,AR-A014418
HCMV_INFECTION,1.503921796,0.293733301,AR-A014418
HOST_INTERACTIONS_OF_HIV_FACTORS,1.453696673,0.315217391,AR-A014418
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-2.744783417,0.850911889,AR-A014418
INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,1.414572149,0.328047469,AR-A014418
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,1.346849369,0.396663226,AR-A014418
COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC,1.344086376,0.356502847,AR-A014418
CELL_CYCLE,-3.500656481,0,trametinib
DISEASES_OF_DNA_REPAIR,-2.472800649,0,trametinib
RHO_GTPASES_ACTIVATE_FORMINS,-2.507886647,0,trametinib
HOMOLOGY_DIRECTED_REPAIR,-2.514668315,0,trametinib
MITOTIC_SPINDLE_CHECKPOINT,-2.540652734,0,trametinib
HDR_THROUGH_HOMOLOGOUS_RECOMBINATION_HRR,-2.556739737,0,trametinib
DNA_DOUBLE_STRAND_BREAK_REPAIR,-2.563984297,0,trametinib
MITOTIC_G2_G2_M_PHASES,-2.594998822,0,trametinib
SEPARATION_OF_SISTER_CHROMATIDS,-2.639553143,0,trametinib
ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS,-2.650770827,0,trametinib
GPCR_LIGAND_BINDING,-2.588518508,0,bambuterol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.391881043,0.000804809,bambuterol
REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF,2.586913859,0.007620568,bambuterol
SIGNALING_BY_NTRKS,2.46617405,0.003810284,bambuterol
SIGNALING_BY_GPCR,-2.336253917,0.001073078,bambuterol
G_ALPHA_Q_SIGNALLING_EVENTS,-2.297415318,0.001207213,bambuterol
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.148493348,0.004506928,bambuterol
G_ALPHA_S_SIGNALLING_EVENTS,-2.09322135,0.006304334,bambuterol
MHC_CLASS_II_ANTIGEN_PRESENTATION,2.051080735,0.036409382,bambuterol
GOLGI_TO_ER_RETROGRADE_TRANSPORT,2.039178652,0.03111732,bambuterol
DNA_REPLICATION,-2.647508657,0,pitavastatin
S_PHASE,-2.645682424,0,pitavastatin
CELL_CYCLE_MITOTIC,-2.596744518,0,pitavastatin
CELL_CYCLE,-2.592479355,0,pitavastatin
SYNTHESIS_OF_DNA,-2.544497776,0,pitavastatin
METABOLISM_OF_RNA,-2.47642025,0.000165294,pitavastatin
DNA_REPAIR,-2.424058443,0.000991765,pitavastatin
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,-2.267604408,0.004586912,pitavastatin
SIGNALING_BY_ALK_IN_CANCER,2.144466521,0.097641076,pitavastatin
DNA_STRAND_ELONGATION,-2.167068142,0.012892943,pitavastatin
MRNA_SPLICING,2.99350067,0,ifenprodil
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.985908771,0,ifenprodil
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.19893171,0.003625072,ifenprodil
TRNA_PROCESSING,2.10242165,0.011647607,ifenprodil
GPCR_LIGAND_BINDING,-2.112543159,0.005890742,ifenprodil
SELENOAMINO_ACID_METABOLISM,-2.070275865,0.007854322,ifenprodil
NONSENSE_MEDIATED_DECAY_NMD,-2.035380259,0.010422081,ifenprodil
EUKARYOTIC_TRANSLATION_ELONGATION,-2.028626944,0.00960644,ifenprodil
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.002625314,0.011479394,ifenprodil
G_ALPHA_Q_SIGNALLING_EVENTS,-1.993387678,0.010357348,ifenprodil
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,2.25313404,0.020236112,erteberel
REGULATION_OF_T_CELL_ACTIVATION_BY_CD28_FAMILY,1.990188374,0.126475701,erteberel
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.109346351,0.461801596,erteberel
NEUTROPHIL_DEGRANULATION,-1.959225147,0.516533637,erteberel
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,-1.956435672,0.349296845,erteberel
VISUAL_PHOTOTRANSDUCTION,-1.930663387,0.299600912,erteberel
SIGNALING_BY_TGFB_FAMILY_MEMBERS,1.848116157,0.272880906,erteberel
NEURONAL_SYSTEM,1.837610753,0.219377852,erteberel
AUTOPHAGY,-1.862829871,0.335461802,erteberel
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,1.800074556,0.237682335,erteberel
NEUTROPHIL_DEGRANULATION,2.601740436,0.001980239,ivacaftor
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.480710377,0.001980239,ivacaftor
SIGNALING_BY_GPCR,-2.31157587,0.016046024,ivacaftor
GPCR_LIGAND_BINDING,-2.17315248,0.032092048,ivacaftor
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.137374545,0.034432094,ivacaftor
G_ALPHA_Q_SIGNALLING_EVENTS,-2.02482268,0.076469334,ivacaftor
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,1.865850734,0.114193775,ivacaftor
MUSCLE_CONTRACTION,1.684980072,0.250500217,ivacaftor
G_ALPHA_I_SIGNALLING_EVENTS,-1.865632082,0.232667351,ivacaftor
INNATE_IMMUNE_SYSTEM,1.668309506,0.221192681,ivacaftor
GPCR_LIGAND_BINDING,1.992109746,0.318690137,rivastigmine
MITF_M_DEPENDENT_GENE_EXPRESSION,1.96539068,0.197879497,rivastigmine
DEVELOPMENTAL_CELL_LINEAGES,-2.350115095,0.844154408,rivastigmine
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,1.841415086,0.393676051,rivastigmine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.810604913,0.369982585,rivastigmine
SIGNALING_BY_GPCR,1.7524291,0.45054037,rivastigmine
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.966218713,1,rivastigmine
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.687020552,0.598672267,rivastigmine
RAB_REGULATION_OF_TRAFFICKING,1.673445154,0.560906543,rivastigmine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.860412733,1,rivastigmine
GPCR_LIGAND_BINDING,3.634122093,0,BRD-K73589401
SIGNALING_BY_GPCR,3.525220314,0,BRD-K73589401
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,3.418092376,0,BRD-K73589401
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.99977594,0,BRD-K73589401
G_ALPHA_I_SIGNALLING_EVENTS,2.937964046,0,BRD-K73589401
G_ALPHA_Q_SIGNALLING_EVENTS,2.80018136,0,BRD-K73589401
G_ALPHA_S_SIGNALLING_EVENTS,2.22013128,0.006958801,BRD-K73589401
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,2.085322796,0.014807221,BRD-K73589401
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,-2.09955578,0.116924313,BRD-K73589401
PEROXISOMAL_PROTEIN_IMPORT,-2.095499549,0.059843152,BRD-K73589401
DNA_REPAIR,2.80885707,0,procaine
TOLL_LIKE_RECEPTOR_CASCADES,2.599508914,0,procaine
TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,2.593592888,0,procaine
NUCLEOTIDE_EXCISION_REPAIR,2.499648233,0,procaine
METABOLISM_OF_RNA,2.373756137,0.002587931,procaine
MYD88_INDEPENDENT_TLR4_CASCADE,2.347700497,0.002156609,procaine
TRANSLATION,2.285798043,0.005545566,procaine
CELL_CYCLE_CHECKPOINTS,2.25941803,0.007278555,procaine
MRNA_SPLICING,2.234088103,0.007907566,procaine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.144094155,0.013564108,procaine
EUKARYOTIC_TRANSLATION_INITIATION,4.723097304,0,megestrol-acetate
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,3.033105939,0,megestrol-acetate
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.958196974,0,megestrol-acetate
CELL_CYCLE_CHECKPOINTS,2.919570074,0,megestrol-acetate
PCP_CE_PATHWAY,2.892571801,0,megestrol-acetate
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,2.798655949,0,megestrol-acetate
THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT,2.796032796,0,megestrol-acetate
SEPARATION_OF_SISTER_CHROMATIDS,2.710609054,0,megestrol-acetate
ACTIVATION_OF_APC_C_AND_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS,2.704473851,0,megestrol-acetate
APC_C_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS,2.704473851,0,megestrol-acetate
MUSCLE_CONTRACTION,2.262743878,0.015097188,nicotine
CELLULAR_SENESCENCE,-2.081150124,0.090929924,nicotine
SIGNALING_BY_VEGF,-1.83701868,0.564203748,nicotine
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-1.835220457,0.382343899,nicotine
CARDIAC_CONDUCTION,1.647086854,0.293586391,nicotine
NEUTROPHIL_DEGRANULATION,-1.810219928,0.353312056,nicotine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.598271802,0.250002247,nicotine
SIGNALING_BY_NUCLEAR_RECEPTORS,-1.785908241,0.336769383,nicotine
NUCLEAR_ENVELOPE_NE_REASSEMBLY,1.479534795,0.339012752,nicotine
ESR_MEDIATED_SIGNALING,-1.721867754,0.456658115,nicotine
SIGNALING_BY_GPCR,3.832038186,0,brimonidine
CELLULAR_RESPONSES_TO_STIMULI,-2.690534856,0,brimonidine
SARS_COV_1_INFECTION,-2.702621216,0,brimonidine
NEUTROPHIL_DEGRANULATION,-2.753610932,0,brimonidine
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.919653437,0,brimonidine
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.952222379,0,brimonidine
SARS_COV_1_HOST_INTERACTIONS,-3.049853409,0,brimonidine
TRANSLATION,-3.219058399,0,brimonidine
SIGNALING_BY_ROBO_RECEPTORS,-3.297847403,0,brimonidine
RRNA_PROCESSING,-3.328401231,0,brimonidine
GPCR_LIGAND_BINDING,-2.451236036,0,levocabastine
NEUTROPHIL_DEGRANULATION,2.376950583,0.02311678,levocabastine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.289134658,0.002551044,levocabastine
SIGNALING_BY_GPCR,-2.184910205,0.005952435,levocabastine
SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES,2.075499353,0.050856915,levocabastine
SENSORY_PERCEPTION,-2.040673732,0.031037697,levocabastine
ADAPTIVE_IMMUNE_SYSTEM,1.905352351,0.106337186,levocabastine
INNATE_IMMUNE_SYSTEM,1.902483102,0.080908729,levocabastine
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,1.826006477,0.100326823,levocabastine
SIGNALING_BY_NTRKS,1.813038863,0.088614322,levocabastine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-3.192724124,0,flupirtine
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-3.15310023,0,flupirtine
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-3.1409447,0.000445909,flupirtine
HEMOSTASIS,-2.858083218,0.04113507,flupirtine
SIGNALING_BY_GPCR,1.873649432,0.224501722,flupirtine
POST_TRANSLATIONAL_PROTEIN_MODIFICATION,-2.788637465,0.128956773,flupirtine
METABOLISM_OF_VITAMINS_AND_COFACTORS,-2.773268891,0.13600213,flupirtine
CLATHRIN_MEDIATED_ENDOCYTOSIS,-2.735848661,0.192441421,flupirtine
TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,-2.732469788,0.176914246,flupirtine
MEMBRANE_TRAFFICKING,-2.73135456,0.158594833,flupirtine
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.50864253,0.004778513,zolmitriptan
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.508470225,0.002389256,zolmitriptan
VESICLE_MEDIATED_TRANSPORT,-2.370012495,0.00637135,zolmitriptan
MEMBRANE_TRAFFICKING,-2.357795417,0.00549529,zolmitriptan
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.342339773,0.005160794,zolmitriptan
BACTERIAL_INFECTION_PATHWAYS,-2.102935184,0.048103696,zolmitriptan
PI3K_AKT_SIGNALING_IN_CANCER,1.77896703,0.75490543,zolmitriptan
HEMOSTASIS,-1.976277454,0.111680671,zolmitriptan
NEUTROPHIL_DEGRANULATION,-1.954658455,0.11348968,zolmitriptan
COPII_MEDIATED_VESICLE_TRANSPORT,-1.934165323,0.115321443,zolmitriptan
GPCR_LIGAND_BINDING,3.970935309,0,fluocinolone
NERVOUS_SYSTEM_DEVELOPMENT,-2.857586335,0,fluocinolone
SARS_COV_1_INFECTION,-3.256168339,0,fluocinolone
PEPTIDE_LIGAND_BINDING_RECEPTORS,3.272905312,0,fluocinolone
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-3.301695206,0,fluocinolone
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-3.355260815,0,fluocinolone
SARS_COV_1_HOST_INTERACTIONS,-3.408214212,0,fluocinolone
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-3.423821739,0,fluocinolone
TRANSLATION,-3.453621278,0,fluocinolone
INFLUENZA_INFECTION,-3.478375055,0,fluocinolone
G_ALPHA_I_SIGNALLING_EVENTS,2.070262498,0.08091215,nicergoline
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.916709459,0.513486349,nicergoline
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,1.889194251,0.248214876,nicergoline
METABOLISM_OF_RNA,-1.815416296,0.475424692,nicergoline
TRANSCRIPTIONAL_REGULATION_BY_RUNX2,-1.783569123,0.378771152,nicergoline
GPCR_LIGAND_BINDING,1.847846273,0.234027155,nicergoline
RRNA_PROCESSING,-1.727442066,0.390304988,nicergoline
SIGNALING_BY_GPCR,1.787751834,0.282349689,nicergoline
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.781849927,0.235319502,nicergoline
NEURONAL_SYSTEM,1.771142294,0.214782425,nicergoline
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,2.02800096,0.222687426,brompheniramine
S_PHASE,1.996393757,0.134943739,brompheniramine
DNA_REPLICATION,1.930947559,0.105292424,brompheniramine
SYNTHESIS_OF_DNA,1.930947559,0.105292424,brompheniramine
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,1.90132726,0.099725239,brompheniramine
SENSORY_PERCEPTION,1.867384971,0.087830134,brompheniramine
TRANSLATION,1.868097356,0.10226678,brompheniramine
MITOTIC_G2_G2_M_PHASES,1.851750053,0.084869325,brompheniramine
DNA_REPLICATION_PRE_INITIATION,1.670087258,0.207895387,brompheniramine
NEUTROPHIL_DEGRANULATION,-2.188144139,1,brompheniramine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,3.337037657,0,felbamate
MRNA_SPLICING,2.785255845,0,felbamate
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.066506199,0.010768191,felbamate
G_ALPHA_Q_SIGNALLING_EVENTS,-1.943068274,0.032304572,felbamate
POTASSIUM_CHANNELS,-1.932879065,0.02705853,felbamate
GPCR_LIGAND_BINDING,-1.925556482,0.021743462,felbamate
GLUCOSE_METABOLISM,1.659129809,0.308388838,felbamate
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.844271767,0.046386052,felbamate
RAB_GEFS_EXCHANGE_GTP_FOR_GDP_ON_RABS,1.532363479,0.482107875,felbamate
MITOTIC_METAPHASE_AND_ANAPHASE,1.515366869,0.421731749,felbamate
NUCLEOTIDE_EXCISION_REPAIR,1.538082221,1,valproic-acid
TRNA_PROCESSING_IN_THE_NUCLEUS,1.423576716,1,valproic-acid
RHO_GTPASES_ACTIVATE_FORMINS,1.348264815,1,valproic-acid
TRNA_PROCESSING,1.302568461,1,valproic-acid
RESOLUTION_OF_SISTER_CHROMATID_COHESION,1.277625235,0.94090863,valproic-acid
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-1.889774908,1,valproic-acid
AUTOPHAGY,1.267209711,0.823124768,valproic-acid
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,1.263941198,0.717661205,valproic-acid
SEPARATION_OF_SISTER_CHROMATIDS,1.230678967,0.731695568,valproic-acid
INTERFERON_GAMMA_SIGNALING,1.227426856,0.659477853,valproic-acid
SIGNALING_BY_ROBO_RECEPTORS,2.203315423,0.060829053,terazosin
ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT,2.193935277,0.034381639,terazosin
REGULATION_OF_RUNX2_EXPRESSION_AND_ACTIVITY,2.193231694,0.022921092,terazosin
DEFECTIVE_CFTR_CAUSES_CYSTIC_FIBROSIS,2.126412018,0.028827682,terazosin
ABC_TRANSPORTER_DISORDERS,2.126412018,0.028827682,terazosin
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.11205277,0.02754939,terazosin
NEGATIVE_REGULATION_OF_NOTCH4_SIGNALING,2.091747271,0.028336515,terazosin
ORC1_REMOVAL_FROM_CHROMATIN,2.090356197,0.025125044,terazosin
METABOLISM_OF_RNA,2.086947604,0.022774162,terazosin
REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS,2.063985329,0.025389518,terazosin
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,3.85784121,0,diphenylpyraline
MRNA_SPLICING,3.608347902,0,diphenylpyraline
RAB_REGULATION_OF_TRAFFICKING,2.494784479,0.002985075,diphenylpyraline
RAB_GEFS_EXCHANGE_GTP_FOR_GDP_ON_RABS,2.213211334,0.024626866,diphenylpyraline
SYNTHESIS_OF_DNA,2.012859105,0.043283582,diphenylpyraline
HOST_INTERACTIONS_OF_HIV_FACTORS,2.014372456,0.051940299,diphenylpyraline
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.503220295,0.02717067,diphenylpyraline
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,1.922417267,0.058848614,diphenylpyraline
GPCR_LIGAND_BINDING,-2.447421888,0.033789167,diphenylpyraline
ORC1_REMOVAL_FROM_CHROMATIN,1.802855268,0.091791045,diphenylpyraline
VIF_MEDIATED_DEGRADATION_OF_APOBEC3G,1.571317164,1,brexpiprazole
DNA_REPLICATION_PRE_INITIATION,1.512784033,0.544583859,brexpiprazole
DEFECTIVE_CFTR_CAUSES_CYSTIC_FIBROSIS,1.514290521,0.724998144,brexpiprazole
ABC_TRANSPORTER_DISORDERS,1.514290521,0.724998144,brexpiprazole
DEGRADATION_OF_DVL,1.503028282,0.381988269,brexpiprazole
REGULATION_OF_RAS_BY_GAPS,1.504615124,0.45638132,brexpiprazole
CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6,1.500762197,0.331714095,brexpiprazole
RAB_REGULATION_OF_TRAFFICKING,1.4704846,0.339529661,brexpiprazole
DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS,1.465592468,0.309971045,brexpiprazole
REGULATION_OF_RUNX3_EXPRESSION_AND_ACTIVITY,1.443149112,0.277607165,brexpiprazole
SELENOAMINO_ACID_METABOLISM,-2.929735836,0,propylthiouracil
SARS_COV_2_HOST_INTERACTIONS,-2.323940914,0,propylthiouracil
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.436207697,0,propylthiouracil
SARS_COV_1_INFECTION,-2.436340463,0,propylthiouracil
SIGNALING_BY_ROBO_RECEPTORS,-2.438714075,0,propylthiouracil
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.443940304,0,propylthiouracil
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.488260845,0,propylthiouracil
SARS_COV_1_HOST_INTERACTIONS,-2.49802433,0,propylthiouracil
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.50246249,0,propylthiouracil
TRANSLATION,-2.49950369,0,propylthiouracil
GPCR_LIGAND_BINDING,-2.664016565,0,EX-527
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.491702443,0.000195936,EX-527
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.453206901,0.000261249,EX-527
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.436816149,0.000195936,EX-527
EUKARYOTIC_TRANSLATION_INITIATION,2.46720304,0.008729226,EX-527
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.377229136,0.000470248,EX-527
SIGNALING_BY_GPCR,-2.370405903,0.000457185,EX-527
SIGNALING_BY_ALK_IN_CANCER,2.33107024,0.013093839,EX-527
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,2.17802854,0.045101002,EX-527
MEMBRANE_TRAFFICKING,2.118121825,0.05673997,EX-527
METABOLISM_OF_RNA,4.699355356,0,metoclopramide
SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX,2.593306065,0,metoclopramide
M_PHASE,2.619318947,0,metoclopramide
HIV_INFECTION,2.622526327,0,metoclopramide
CELL_CYCLE,2.64017845,0,metoclopramide
RESPIRATORY_ELECTRON_TRANSPORT,2.643680593,0,metoclopramide
RRNA_PROCESSING,2.704539832,0,metoclopramide
HIV_LIFE_CYCLE,2.483743199,0,metoclopramide
HOST_INTERACTIONS_OF_HIV_FACTORS,2.793294692,0,metoclopramide
TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM,3.088441533,0,metoclopramide
GPCR_LIGAND_BINDING,-2.255699572,0.019236148,almitrine
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,2.022624517,0.237728881,almitrine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.000351248,0.141367903,almitrine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.97958136,0.15984323,almitrine
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,1.950169432,0.134636098,almitrine
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,-1.956312426,0.132515686,almitrine
PHOSPHOLIPID_METABOLISM,-1.870088696,0.203353565,almitrine
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,1.763053,0.33264733,almitrine
REGULATION_OF_TP53_ACTIVITY,1.710191076,0.362594245,almitrine
ADIPOGENESIS,1.684203736,0.345822434,almitrine
GPCR_LIGAND_BINDING,-2.632900422,0,ellagic-acid
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.600943464,0,ellagic-acid
SIGNALING_BY_GPCR,-2.312441035,0.000824174,ellagic-acid
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.28634424,0.000927196,ellagic-acid
SENSORY_PERCEPTION,-2.271109441,0.000741757,ellagic-acid
REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF,2.37623163,0.023203352,ellagic-acid
G_ALPHA_Q_SIGNALLING_EVENTS,-2.242475343,0.00175137,ellagic-acid
SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS,2.272353502,0.02755398,ellagic-acid
CELLULAR_RESPONSE_TO_HEAT_STRESS,2.1259272,0.063809217,ellagic-acid
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,2.030844189,0.086287464,ellagic-acid
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,2.624998721,0.003803937,bortezomib
REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE,2.310901496,0.010460826,bortezomib
HOST_INTERACTIONS_OF_HIV_FACTORS,2.256415576,0.0120458,bortezomib
KEAP1_NFE2L2_PATHWAY,2.158242171,0.019495176,bortezomib
SIGNALING_BY_INTERLEUKINS,1.994169156,0.059341415,bortezomib
FATTY_ACID_METABOLISM,-1.98801945,0.139393081,bortezomib
CELLULAR_RESPONSE_TO_HEAT_STRESS,1.919522921,0.079248684,bortezomib
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,1.858432442,0.094011582,bortezomib
INNATE_IMMUNE_SYSTEM,1.83927609,0.091294484,bortezomib
CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM,1.83888438,0.081573312,bortezomib
INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,-1.826371169,0.59464704,ritonavir
GPCR_LIGAND_BINDING,-1.816903488,0.328214275,ritonavir
G_ALPHA_Q_SIGNALLING_EVENTS,-1.767053566,0.344624989,ritonavir
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.752745413,0.297806188,ritonavir
RESOLUTION_OF_SISTER_CHROMATID_COHESION,1.434564761,1,ritonavir
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-1.729340397,0.30562541,ritonavir
GASTRULATION,-1.71661195,0.290083499,ritonavir
TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,1.363808455,1,ritonavir
SIGNALING_BY_GPCR,-1.701602966,0.281878142,ritonavir
GOLGI_TO_ER_RETROGRADE_TRANSPORT,1.330942815,0.91347763,ritonavir
GPCR_LIGAND_BINDING,-1.956630561,0.02294965,CTS-1027
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.919980847,0.021674669,CTS-1027
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.864165708,0.200581395,CTS-1027
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,1.668407864,0.167151163,CTS-1027
METABOLISM_OF_RNA,1.669524562,0.250726744,CTS-1027
G_ALPHA_Q_SIGNALLING_EVENTS,-1.839195917,0.035982784,CTS-1027
PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS,1.660092306,0.132994186,CTS-1027
BIOLOGICAL_OXIDATIONS,1.552370862,0.200581395,CTS-1027
MITF_M_DEPENDENT_GENE_EXPRESSION,1.523464976,0.19622093,CTS-1027
ASPARAGINE_N_LINKED_GLYCOSYLATION,1.508681178,0.185008306,CTS-1027
G_ALPHA_Q_SIGNALLING_EVENTS,-2.181299282,0.057187386,enalapril
MUSCLE_CONTRACTION,2.138280305,0.063317849,enalapril
SIGNALING_BY_GPCR,-2.075464606,0.08292171,enalapril
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.01167255,0.106749787,enalapril
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.940666595,0.109337523,enalapril
GPCR_LIGAND_BINDING,-1.817804284,0.389446099,enalapril
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.722735424,0.284821528,enalapril
ESTROGEN_DEPENDENT_GENE_EXPRESSION,1.668010909,0.292273887,enalapril
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.773386318,0.433937886,enalapril
RAB_REGULATION_OF_TRAFFICKING,1.57092342,0.388131888,enalapril
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.420692729,0.014077376,paricalcitol
GPCR_LIGAND_BINDING,-1.971661084,0.336467078,paricalcitol
BACTERIAL_INFECTION_PATHWAYS,1.890507646,0.336577271,paricalcitol
RAB_REGULATION_OF_TRAFFICKING,1.870664994,0.260218169,paricalcitol
NEUTROPHIL_DEGRANULATION,1.835349132,0.2409151,paricalcitol
SIGNALING_BY_GPCR,-1.88346889,0.358927576,paricalcitol
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,-1.823119111,0.381975278,paricalcitol
MITF_M_DEPENDENT_GENE_EXPRESSION,1.675938153,0.485029603,paricalcitol
RAB_GEFS_EXCHANGE_GTP_FOR_GDP_ON_RABS,1.661740318,0.434052437,paricalcitol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.730305205,0.54874081,paricalcitol
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.320086666,0.044715862,allopurinol
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.02789222,0.202941219,allopurinol
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-1.910643972,0.294666064,allopurinol
PKR_MEDIATED_SIGNALING,-1.881483882,0.259266007,allopurinol
HEMOSTASIS,-1.877212847,0.210508519,allopurinol
GLOBAL_GENOME_NUCLEOTIDE_EXCISION_REPAIR_GG_NER,-1.85972044,0.193482095,allopurinol
CONSTITUTIVE_SIGNALING_BY_ABERRANT_PI3K_IN_CANCER,-1.750312627,0.300726456,allopurinol
SENSORY_PERCEPTION,-1.738118839,0.282698838,allopurinol
TRANSCRIPTIONAL_REGULATION_BY_RUNX2,-1.707625437,0.293519504,allopurinol
GLYCEROPHOSPHOLIPID_BIOSYNTHESIS,-1.662928384,0.336916821,allopurinol
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,2.902929974,0,bendroflumethiazide
REGULATION_OF_TP53_ACTIVITY,2.667853608,0,bendroflumethiazide
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.988982481,0.093091165,bendroflumethiazide
MRNA_SPLICING,1.943464003,0.089302571,bendroflumethiazide
TRANSCRIPTIONAL_REGULATION_BY_TP53,1.933362387,0.075338897,bendroflumethiazide
PROCESSING_OF_DNA_DOUBLE_STRAND_BREAK_ENDS,1.775996465,0.159120946,bendroflumethiazide
TOLL_LIKE_RECEPTOR_CASCADES,1.775323989,0.13824502,bendroflumethiazide
MYD88_INDEPENDENT_TLR4_CASCADE,1.7452241,0.144913718,bendroflumethiazide
SARS_COV_2_HOST_INTERACTIONS,1.730563362,0.137471837,bendroflumethiazide
SARS_COV_2_INFECTION,1.69725686,0.145806744,bendroflumethiazide
NONSENSE_MEDIATED_DECAY_NMD,3.318734741,0,alvimopan
SELENOAMINO_ACID_METABOLISM,2.880276082,0,alvimopan
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.745232558,0.000680501,alvimopan
INFLUENZA_INFECTION,2.553370103,0.002041504,alvimopan
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.409479191,0.004899609,alvimopan
EUKARYOTIC_TRANSLATION_INITIATION,2.343962303,0.00578426,alvimopan
TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM,2.086127943,0.024498043,alvimopan
CELLULAR_RESPONSE_TO_STARVATION,2.023326846,0.0359815,alvimopan
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,1.997439659,0.038788568,alvimopan
TRANSLATION,1.957571663,0.047975334,alvimopan
INTERFERON_ALPHA_BETA_SIGNALING,-4.280324996,0,amuvatinib
INTERFERON_SIGNALING,-3.461908774,0,amuvatinib
INTERFERON_GAMMA_SIGNALING,-2.655575697,0,amuvatinib
CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM,-2.262924669,0.020979326,amuvatinib
APOPTOSIS,-2.015811589,0.076659591,amuvatinib
SIGNALING_BY_WNT,-1.955109679,0.09072141,amuvatinib
TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT,-1.815892636,0.167510603,amuvatinib
ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES,-1.809148546,0.151958361,amuvatinib
NUCLEAR_EVENTS_MEDIATED_BY_NFE2L2,-1.79976623,0.141626201,amuvatinib
PROGRAMMED_CELL_DEATH,-1.760879923,0.156267628,amuvatinib
SIGNALING_BY_ROBO_RECEPTORS,2.497950368,0,demecarium
EUKARYOTIC_TRANSLATION_ELONGATION,2.776055216,0,demecarium
EUKARYOTIC_TRANSLATION_INITIATION,2.677889093,0,demecarium
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.666323432,0,demecarium
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.617251899,0,demecarium
SELENOAMINO_ACID_METABOLISM,2.530296639,0,demecarium
NONSENSE_MEDIATED_DECAY_NMD,2.52583785,0,demecarium
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,2.517732569,0,demecarium
CELLULAR_RESPONSE_TO_STARVATION,2.45551138,0.000276305,demecarium
INFLUENZA_INFECTION,2.399390797,0.000497349,demecarium
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-3.202378609,0.101535126,razoxane
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-3.183640577,0.078823322,razoxane
SIGNALING_BY_GPCR,1.908433753,0.162221441,razoxane
GPCR_LIGAND_BINDING,1.859098829,0.113699849,razoxane
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,1.842697608,0.085455937,razoxane
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-3.112705582,0.168779881,razoxane
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,1.783502571,0.09885369,razoxane
NEURONAL_SYSTEM,1.740754659,0.105733617,razoxane
CLATHRIN_MEDIATED_ENDOCYTOSIS,-2.969212526,0.409814474,razoxane
G_ALPHA_I_SIGNALLING_EVENTS,1.697901724,0.118286467,razoxane
EUKARYOTIC_TRANSLATION_ELONGATION,4.891696668,0,fluphenazine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.928028752,0,fluphenazine
MUSCLE_CONTRACTION,2.959650807,0,fluphenazine
RESPIRATORY_ELECTRON_TRANSPORT,3.132070244,0,fluphenazine
SIGNALING_BY_ROBO_RECEPTORS,3.348529501,0,fluphenazine
NONSENSE_MEDIATED_DECAY_NMD,3.757387551,0,fluphenazine
CELLULAR_RESPONSE_TO_STARVATION,3.825791078,0,fluphenazine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.95764157,0,fluphenazine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.740884369,0,fluphenazine
TRANSLATION,4.253376461,0,fluphenazine
EUKARYOTIC_TRANSLATION_ELONGATION,-3.701471878,0,entacapone
EUKARYOTIC_TRANSLATION_INITIATION,-3.670926666,0,entacapone
SELENOAMINO_ACID_METABOLISM,-3.622032396,0,entacapone
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-3.620981424,0,entacapone
NONSENSE_MEDIATED_DECAY_NMD,-3.515307668,0,entacapone
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-3.485526445,0,entacapone
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-3.480611365,0,entacapone
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.708937063,0,entacapone
GPCR_LIGAND_BINDING,2.843302945,0,entacapone
EXTRACELLULAR_MATRIX_ORGANIZATION,2.994949961,0,entacapone
EUKARYOTIC_TRANSLATION_ELONGATION,-4.033279123,0,amoxapine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,2.664036078,0,amoxapine
SARS_COV_INFECTIONS,-2.685591268,0,amoxapine
INFECTIOUS_DISEASE,-2.687958577,0,amoxapine
SARS_COV_2_INFECTION,-2.75789438,0,amoxapine
CELLULAR_RESPONSES_TO_STIMULI,-2.786736607,0,amoxapine
VIRAL_INFECTION_PATHWAYS,-2.84977444,0,amoxapine
NERVOUS_SYSTEM_DEVELOPMENT,-2.988005555,0,amoxapine
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-3.132528368,0,amoxapine
EXTRACELLULAR_MATRIX_ORGANIZATION,3.165441503,0,amoxapine
HIV_INFECTION,2.262705945,0.014416476,perindopril
CELL_CYCLE_MITOTIC,2.252245453,0.007208238,perindopril
TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,2.222584497,0.004805492,perindopril
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.888800594,0.027631579,perindopril
CELL_CYCLE,1.853828951,0.028832952,perindopril
BIOLOGICAL_OXIDATIONS,1.722519173,0.043249428,perindopril
ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES,1.667897432,0.055606407,perindopril
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-1.861560282,0.107369776,perindopril
AMINE_LIGAND_BINDING_RECEPTORS,-1.801545439,0.107813453,perindopril
M_PHASE,1.414578365,0.183209382,perindopril
EUKARYOTIC_TRANSLATION_ELONGATION,5.398076031,0,hexylresorcinol
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.350834339,0,hexylresorcinol
ORC1_REMOVAL_FROM_CHROMATIN,3.323777468,0,hexylresorcinol
HOST_INTERACTIONS_OF_HIV_FACTORS,3.293696865,0,hexylresorcinol
CELL_CYCLE_MITOTIC,3.237838653,0,hexylresorcinol
G2_M_CHECKPOINTS,3.225997434,0,hexylresorcinol
M_PHASE,3.13639225,0,hexylresorcinol
S_PHASE,3.10791389,0,hexylresorcinol
CELLULAR_RESPONSES_TO_STIMULI,3.088462884,0,hexylresorcinol
CELLULAR_RESPONSE_TO_HYPOXIA,3.065499112,0,hexylresorcinol
CELL_CYCLE,3.159832003,0,midazolam
CELL_CYCLE_MITOTIC,2.984632134,0,midazolam
S_PHASE,2.75764694,0,midazolam
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.733741422,0,midazolam
METABOLISM_OF_RNA,2.675705958,0,midazolam
DNA_REPLICATION,2.598046904,0,midazolam
CELL_CYCLE_CHECKPOINTS,2.27240499,0.003062285,midazolam
RRNA_PROCESSING,2.211883053,0.004976213,midazolam
M_PHASE,2.164033972,0.006124569,midazolam
SEPARATION_OF_SISTER_CHROMATIDS,2.128256361,0.00796194,midazolam
CELL_CYCLE,-3.817270586,0,topotecan
GOLGI_TO_ER_RETROGRADE_TRANSPORT,-2.561014887,0,topotecan
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.668760084,0,topotecan
CHROMOSOME_MAINTENANCE,-2.722359741,0,topotecan
COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC,-2.729511422,0,topotecan
SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3,-2.849955346,0,topotecan
G2_M_CHECKPOINTS,-2.861838116,0,topotecan
MITOTIC_G2_G2_M_PHASES,-2.897063939,0,topotecan
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,3.00332082,0,topotecan
GPCR_LIGAND_BINDING,3.003699529,0,topotecan
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,2.26557008,0.046109319,nocodazole
RRNA_PROCESSING,2.183581741,0.043397007,nocodazole
S_PHASE,2.098881319,0.053794206,nocodazole
DNA_REPLICATION_PRE_INITIATION,2.09108614,0.040684694,nocodazole
DNA_REPLICATION,1.945285812,0.091404945,nocodazole
G2_M_CHECKPOINTS,1.879675112,0.10826649,nocodazole
SYNTHESIS_OF_DNA,1.787031779,0.159638988,nocodazole
MAPK_FAMILY_SIGNALING_CASCADES,1.784553475,0.142226908,nocodazole
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,1.721496008,0.176903075,nocodazole
DISEASES_OF_METABOLISM,-2.026551595,1,nocodazole
RESOLUTION_OF_SISTER_CHROMATID_COHESION,2.886662301,0,pargyline
SEPARATION_OF_SISTER_CHROMATIDS,2.820331111,0,pargyline
MITOTIC_PROMETAPHASE,2.645288659,0,pargyline
RHO_GTPASES_ACTIVATE_FORMINS,2.606337004,0,pargyline
MITOTIC_METAPHASE_AND_ANAPHASE,2.559727484,0,pargyline
METABOLISM_OF_RNA,2.38729539,0.001448426,pargyline
RRNA_PROCESSING,2.364983389,0.001241508,pargyline
MITOTIC_SPINDLE_CHECKPOINT,2.138801544,0.012492676,pargyline
RHO_GTPASE_EFFECTORS,2.088773317,0.016512059,pargyline
M_PHASE,2.089519702,0.018346733,pargyline
NONSENSE_MEDIATED_DECAY_NMD,-5.166765564,0,moexipril
SIGNALING_BY_GPCR,3.668252715,0,moexipril
INFECTIOUS_DISEASE,-3.609902279,0,moexipril
NEUTROPHIL_DEGRANULATION,-3.556338947,0,moexipril
GPCR_LIGAND_BINDING,3.453235127,0,moexipril
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,3.354996234,0,moexipril
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-3.322871501,0,moexipril
MRNA_SPLICING,-3.144697068,0,moexipril
NERVOUS_SYSTEM_DEVELOPMENT,-3.065537467,0,moexipril
SARS_COV_2_INFECTION,-2.974891424,0,moexipril
SENSORY_PERCEPTION,-2.328253259,0.003212511,resveratrol
INTEGRIN_CELL_SURFACE_INTERACTIONS,2.459287344,0.016207455,resveratrol
GPCR_LIGAND_BINDING,-2.249118499,0.006023459,resveratrol
GLOBAL_GENOME_NUCLEOTIDE_EXCISION_REPAIR_GG_NER,2.268027629,0.025661804,resveratrol
POTASSIUM_CHANNELS,-2.200394202,0.009369825,resveratrol
COMPLEMENT_CASCADE,2.131681396,0.03871781,resveratrol
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,2.099312256,0.036466775,resveratrol
G_ALPHA_S_SIGNALLING_EVENTS,-2.098391364,0.019676633,resveratrol
TOLL_LIKE_RECEPTOR_CASCADES,1.972722685,0.063209076,resveratrol
NEUTROPHIL_DEGRANULATION,1.903096675,0.079236449,resveratrol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.556505543,0.001734647,caffeic-acid
GPCR_LIGAND_BINDING,2.504403691,0.001156431,caffeic-acid
EXTRACELLULAR_MATRIX_ORGANIZATION,2.094480823,0.02023755,caffeic-acid
SIGNALING_BY_GPCR,2.024004514,0.024574168,caffeic-acid
PLATELET_HOMEOSTASIS,1.879315671,0.043713109,caffeic-acid
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-3.140910267,0.729219046,caffeic-acid
MUSCLE_CONTRACTION,-3.10771109,0.544461754,caffeic-acid
SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,1.737348993,0.08104657,caffeic-acid
EUKARYOTIC_TRANSLATION_ELONGATION,-3.099922978,0.394221557,caffeic-acid
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-3.091876134,0.317738942,caffeic-acid
INTERFERON_ALPHA_BETA_SIGNALING,-3.12399281,0,ALW-II-49-7
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.470403725,0,ALW-II-49-7
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.410231309,0,ALW-II-49-7
GPCR_LIGAND_BINDING,2.402245599,0,ALW-II-49-7
G_ALPHA_Q_SIGNALLING_EVENTS,2.003248882,0.019811264,ALW-II-49-7
SIGNALING_BY_GPCR,1.968919508,0.023976709,ALW-II-49-7
MITOTIC_PROPHASE,-1.699502782,1,ALW-II-49-7
INTERFERON_SIGNALING,-1.686947767,1,ALW-II-49-7
INFLUENZA_INFECTION,-1.668109203,1,ALW-II-49-7
TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT,-1.640530777,1,ALW-II-49-7
NEUTROPHIL_DEGRANULATION,2.691217694,0,atracurium
GPCR_LIGAND_BINDING,-2.66714245,0,atracurium
MHC_CLASS_II_ANTIGEN_PRESENTATION,2.653977246,0,atracurium
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.600061264,0,atracurium
REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF,2.526722925,0.000985454,atracurium
SIGNALING_BY_NTRKS,2.478790134,0.000739091,atracurium
SIGNALING_BY_GPCR,-2.416517806,0.000256556,atracurium
G_ALPHA_Q_SIGNALLING_EVENTS,-2.267650691,0.001154502,atracurium
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.233363052,0.001077535,atracurium
GOLGI_TO_ER_RETROGRADE_TRANSPORT,2.205400777,0.011234177,atracurium
ECM_PROTEOGLYCANS,-2.195994899,0.082184245,naftifine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.988215809,0.195558897,naftifine
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,1.896466453,0.575702921,naftifine
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.911061504,0.201004841,naftifine
PLATELET_HOMEOSTASIS,1.824558092,0.498707688,naftifine
TCR_SIGNALING,1.804797775,0.383130965,naftifine
MUSCLE_CONTRACTION,1.721634243,0.515062884,naftifine
NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK,1.71370112,0.433991433,naftifine
CELL_JUNCTION_ORGANIZATION,1.694045405,0.409467025,naftifine
MYD88_INDEPENDENT_TLR4_CASCADE,1.624282672,0.545796276,naftifine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.362129681,0.083779016,tretinoin
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.17433308,0.195484371,tretinoin
SENSORY_PERCEPTION,1.907113328,0.393997908,tretinoin
NEUTROPHIL_DEGRANULATION,1.899368223,0.20701585,tretinoin
VISUAL_PHOTOTRANSDUCTION,1.892207788,0.14543049,tretinoin
METABOLISM_OF_VITAMINS_AND_COFACTORS,1.891245432,0.11074235,tretinoin
DISEASES_OF_METABOLISM,1.854678694,0.117531579,tretinoin
TRANSLATION,1.803226195,0.134671601,tretinoin
INNATE_IMMUNE_SYSTEM,1.684709977,0.255775344,tretinoin
O_LINKED_GLYCOSYLATION,1.620045799,0.329630077,tretinoin
MRNA_SPLICING,3.986218782,0,dalfampridine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,3.798904996,0,dalfampridine
RAB_REGULATION_OF_TRAFFICKING,2.218911567,0.024367731,dalfampridine
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,1.857085131,0.154328964,dalfampridine
DNA_REPLICATION,1.723255323,0.232305704,dalfampridine
SYNTHESIS_OF_DNA,1.615777909,0.342502,dalfampridine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.316717035,0.610668851,dalfampridine
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,1.489850426,0.605712176,dalfampridine
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,1.466213166,0.624423112,dalfampridine
GPCR_LIGAND_BINDING,-2.270766779,0.41333641,dalfampridine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.583175332,0,SN-38
SLC_TRANSPORTER_DISORDERS,1.881931132,0.070765314,SN-38
TRNA_PROCESSING,1.811952181,0.084918377,SN-38
RAB_REGULATION_OF_TRAFFICKING,1.677660265,0.132095252,SN-38
TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS,1.628510241,0.130837202,SN-38
ASPARAGINE_N_LINKED_GLYCOSYLATION,1.393490061,0.318968099,SN-38
SIGNALING_BY_GPCR,-2.144821003,1,SN-38
G_ALPHA_Q_SIGNALLING_EVENTS,-2.107795862,1,SN-38
GPCR_LIGAND_BINDING,-2.087058455,0.766595142,SN-38
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.089406194,1,SN-38
TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,1.584433962,0.734662836,zofenopril-calcium
NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION,1.581331056,0.375105628,zofenopril-calcium
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,1.518939673,0.331699623,zofenopril-calcium
MYD88_INDEPENDENT_TLR4_CASCADE,1.494787266,0.27889978,zofenopril-calcium
GPCR_LIGAND_BINDING,-1.793433904,0.303696599,zofenopril-calcium
MEMBRANE_TRAFFICKING,1.404274661,0.349839446,zofenopril-calcium
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.757107023,0.227551096,zofenopril-calcium
G_ALPHA_Q_SIGNALLING_EVENTS,-1.721570329,0.218106692,zofenopril-calcium
GLYCOSAMINOGLYCAN_METABOLISM,1.253466222,0.603149118,zofenopril-calcium
SIGNALING_BY_GPCR,-1.673727527,0.259868664,zofenopril-calcium
GPCR_LIGAND_BINDING,-2.76003465,0,ganaxolone
EUKARYOTIC_TRANSLATION_INITIATION,-2.636920596,0.000452895,ganaxolone
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.51454579,0.001509651,ganaxolone
TRANSLATION,-2.349378718,0.007019877,ganaxolone
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.312034344,0.009782539,ganaxolone
RRNA_PROCESSING,-2.190444581,0.020531255,ganaxolone
GASTRULATION,-2.187675933,0.017986414,ganaxolone
SIGNALING_BY_GPCR,-2.16883258,0.018115813,ganaxolone
SIGNALING_BY_WNT,-2.090237669,0.028884657,ganaxolone
SIGNALING_BY_ALK_IN_CANCER,2.001135016,0.30327398,ganaxolone
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,2.008729024,0.158935161,L-2167
DEVELOPMENTAL_CELL_LINEAGES,1.889175937,0.175935688,L-2167
CARDIAC_CONDUCTION,-2.898354303,0.749114306,L-2167
NEURONAL_SYSTEM,1.717188737,0.347127043,L-2167
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.819458306,1,L-2167
BIOLOGICAL_OXIDATIONS,-2.816354293,0.695248871,L-2167
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,-2.814415565,0.529805033,L-2167
GASTRULATION,1.647585177,0.387058513,L-2167
PEPTIDE_HORMONE_METABOLISM,-2.788144,0.53926996,L-2167
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.787627891,0.451315399,L-2167
NONSENSE_MEDIATED_DECAY_NMD,2.7594842,0,imatinib
SELENOAMINO_ACID_METABOLISM,2.639632507,0,imatinib
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.567745194,0,imatinib
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,2.420546645,0.002323704,imatinib
VESICLE_MEDIATED_TRANSPORT,2.345799027,0.00345236,imatinib
INFLUENZA_INFECTION,2.335624569,0.003319577,imatinib
CELLULAR_RESPONSE_TO_STARVATION,2.272309268,0.004742252,imatinib
MEMBRANE_TRAFFICKING,2.241011176,0.00564328,imatinib
EUKARYOTIC_TRANSLATION_INITIATION,2.145285595,0.010770182,imatinib
METABOLISM_OF_STEROIDS,2.064413385,0.016199533,imatinib
DISEASES_OF_METABOLISM,-3.289987623,0.041011794,GW-501516
SIGNALING_BY_GPCR,2.082984751,0.046221773,GW-501516
GPCR_LIGAND_BINDING,1.981417108,0.051050913,GW-501516
ADAPTIVE_IMMUNE_SYSTEM,1.664286824,0.262383296,GW-501516
METABOLISM_OF_VITAMINS_AND_COFACTORS,-1.847494888,1,GW-501516
TOLL_LIKE_RECEPTOR_CASCADES,-1.754621814,1,GW-501516
SENSORY_PERCEPTION,-1.739828273,1,GW-501516
CELL_JUNCTION_ORGANIZATION,1.471638116,0.54483052,GW-501516
SIGNALING_BY_VEGF,1.452724955,0.474911466,GW-501516
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,1.446981356,0.408177344,GW-501516
METABOLISM_OF_RNA,-4.677270997,0,mocetinostat
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.786512041,0,mocetinostat
HIV_INFECTION,-2.793367466,0,mocetinostat
CELL_CYCLE_MITOTIC,-2.805266373,0,mocetinostat
SIGNALING_BY_GPCR,2.870186876,0,mocetinostat
MITOTIC_SPINDLE_CHECKPOINT,-2.92174691,0,mocetinostat
MITOTIC_METAPHASE_AND_ANAPHASE,-2.989578078,0,mocetinostat
RRNA_PROCESSING,-2.987502837,0,mocetinostat
GPCR_LIGAND_BINDING,3.033565398,0,mocetinostat
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,3.041035855,0,mocetinostat
METABOLISM_OF_RNA,-2.821592402,0,leflunomide
RRNA_PROCESSING,-2.731417072,0.000598787,leflunomide
NEURONAL_SYSTEM,2.413000648,0.000887718,leflunomide
MUSCLE_CONTRACTION,2.260886445,0.006214029,leflunomide
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,2.23621128,0.006214029,leflunomide
CARDIAC_CONDUCTION,2.029973157,0.036618385,leflunomide
PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES,1.984936239,0.043498202,leflunomide
DNA_REPLICATION,-2.013810882,0.12933795,leflunomide
SYNTHESIS_OF_DNA,-1.871855263,0.2314311,leflunomide
S_PHASE,-1.806253682,0.266100857,leflunomide
METABOLISM_OF_RNA,2.983933494,0,hydroflumethiazide
HIV_INFECTION,2.729563867,0,hydroflumethiazide
HIV_LIFE_CYCLE,2.69477911,0,hydroflumethiazide
HCMV_INFECTION,2.586200098,0.001677114,hydroflumethiazide
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.305685269,0.008050148,hydroflumethiazide
MITOTIC_METAPHASE_AND_ANAPHASE,2.239796776,0.01453499,hydroflumethiazide
HOST_INTERACTIONS_OF_HIV_FACTORS,2.214663591,0.013416914,hydroflumethiazide
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.110371554,0.013055507,hydroflumethiazide
CELL_CYCLE_CHECKPOINTS,2.150376752,0.016771143,hydroflumethiazide
S_PHASE,2.101228125,0.015653066,hydroflumethiazide
CELL_CYCLE,2.711208709,0,oxcarbazepine
METABOLISM_OF_RNA,2.531293919,0.004905758,oxcarbazepine
CELL_CYCLE_MITOTIC,2.435792452,0.007631179,oxcarbazepine
PROGRAMMED_CELL_DEATH,2.391926937,0.005723384,oxcarbazepine
SIGNALING_BY_NOTCH,2.361552974,0.005886909,oxcarbazepine
HIV_INFECTION,2.326750487,0.005995926,oxcarbazepine
NEDDYLATION,2.290888621,0.00654101,oxcarbazepine
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,2.27453473,0.00654101,oxcarbazepine
S_PHASE,2.265261891,0.00654101,oxcarbazepine
DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS,2.244356154,0.008176263,oxcarbazepine
THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT,2.929395238,0,mifepristone
SEPARATION_OF_SISTER_CHROMATIDS,2.470858444,0.006907416,mifepristone
MITOTIC_METAPHASE_AND_ANAPHASE,2.450485765,0.006139926,mifepristone
ORC1_REMOVAL_FROM_CHROMATIN,2.229512203,0.012663597,mifepristone
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.216941471,0.011051866,mifepristone
HOST_INTERACTIONS_OF_HIV_FACTORS,2.182428915,0.012279851,mifepristone
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,2.132529006,0.01578838,mifepristone
HCMV_INFECTION,2.115054421,0.014966069,mifepristone
SYNTHESIS_OF_DNA,2.08194038,0.015861475,mifepristone
TRANSCRIPTIONAL_REGULATION_BY_RUNX2,2.038299014,0.017498788,mifepristone
GPCR_LIGAND_BINDING,2.973012868,0,phenazone
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.962234387,0,phenazone
SIGNALING_BY_GPCR,2.616224411,0.000225094,phenazone
CARDIAC_CONDUCTION,2.540092947,0.000506462,phenazone
CELLULAR_RESPONSE_TO_STARVATION,-2.532888849,0.00594793,phenazone
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.469914684,0.008921895,phenazone
MUSCLE_CONTRACTION,2.403371443,0.001890791,phenazone
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.394739693,0.001688206,phenazone
EUKARYOTIC_TRANSLATION_ELONGATION,-2.444978158,0.007534045,phenazone
SELENOAMINO_ACID_METABOLISM,-2.379697787,0.009219292,phenazone
GPCR_LIGAND_BINDING,-2.317813929,0.004791965,nicardipine
KERATINIZATION,-2.302652574,0.002395982,nicardipine
SIGNALING_BY_VEGF,2.401492077,0.025434465,nicardipine
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,2.271498474,0.032499594,nicardipine
FORMATION_OF_THE_CORNIFIED_ENVELOPE,-2.193252028,0.005932909,nicardipine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.172271398,0.006674522,nicardipine
RHO_GTPASE_CYCLE,2.002016814,0.105505928,nicardipine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.009275283,0.032037707,nicardipine
ORGANELLE_BIOGENESIS_AND_MAINTENANCE,1.899796692,0.141302582,nicardipine
EUKARYOTIC_TRANSLATION_INITIATION,-1.994442909,0.028751789,nicardipine
NEUTROPHIL_DEGRANULATION,2.580624461,0.002132293,yohimbine
GPCR_LIGAND_BINDING,-2.105530226,0.055365657,yohimbine
ADAPTIVE_IMMUNE_SYSTEM,1.881362165,0.154591235,yohimbine
INFLUENZA_INFECTION,1.821056383,0.138599038,yohimbine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.975448485,0.112928364,yohimbine
G_ALPHA_Q_SIGNALLING_EVENTS,-1.967288552,0.082902016,yohimbine
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,1.724225267,0.161521187,yohimbine
KERATINIZATION,-1.919992651,0.09908695,yohimbine
SIGNALING_BY_GPCR,-1.915702934,0.081730256,yohimbine
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.910849189,0.070891476,yohimbine
CELL_CYCLE,-4.015317659,0,doxorubicin
HOMOLOGY_DIRECTED_REPAIR,-2.821287392,0,doxorubicin
GOLGI_TO_ER_RETROGRADE_TRANSPORT,-2.820334503,0,doxorubicin
SEPARATION_OF_SISTER_CHROMATIDS,-2.815959767,0,doxorubicin
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.815895299,0,doxorubicin
DNA_STRAND_ELONGATION,-2.743648558,0,doxorubicin
CYCLIN_A_B1_B2_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION,-2.717251005,0,doxorubicin
TELOMERE_MAINTENANCE,-2.685205725,0,doxorubicin
ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS,-2.670948492,0,doxorubicin
KINESINS,-2.822143922,0,doxorubicin
METABOLISM_OF_RNA,3.846864716,0,nitrazepam
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.758059811,0,nitrazepam
MRNA_SPLICING,2.632480215,0,nitrazepam
MITOTIC_METAPHASE_AND_ANAPHASE,2.658667785,0,nitrazepam
RRNA_PROCESSING,2.657407063,0,nitrazepam
VIRAL_INFECTION_PATHWAYS,2.459100959,0.002183942,nitrazepam
SEPARATION_OF_SISTER_CHROMATIDS,2.479515169,0.002495934,nitrazepam
CELL_CYCLE_CHECKPOINTS,2.564589292,0.002329538,nitrazepam
M_PHASE,2.417353785,0.001941282,nitrazepam
REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS,2.402379507,0.002096584,nitrazepam
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-3.126107168,0.062964238,homosalate
GPCR_LIGAND_BINDING,2.070635232,0.097005705,homosalate
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-3.030969791,0.153967239,homosalate
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.989374154,0.236115894,homosalate
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,1.669778998,0.493112332,homosalate
GLYCOSAMINOGLYCAN_METABOLISM,1.65296261,0.36107679,homosalate
SIGNALING_BY_GPCR,1.646913794,0.277274639,homosalate
MUSCLE_CONTRACTION,-2.914214554,0.518963058,homosalate
TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,-2.899225967,0.476757342,homosalate
NEURONAL_SYSTEM,1.538472319,0.370992928,homosalate
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,3.121187595,0,pyrimethamine
CELL_CYCLE,-2.31114273,0.050883803,pyrimethamine
M_PHASE,-2.261339185,0.047855005,pyrimethamine
NEUTROPHIL_DEGRANULATION,-2.250214297,0.034730215,pyrimethamine
MITOTIC_METAPHASE_AND_ANAPHASE,-2.203702974,0.039677251,pyrimethamine
CELL_CYCLE_MITOTIC,-2.180209711,0.0380417,pyrimethamine
CONSTITUTIVE_SIGNALING_BY_ABERRANT_PI3K_IN_CANCER,2.042150067,0.066829176,pyrimethamine
MUSCLE_CONTRACTION,1.986901642,0.062216884,pyrimethamine
MITOTIC_SPINDLE_CHECKPOINT,-2.097707621,0.065422033,pyrimethamine
PI3K_AKT_SIGNALING_IN_CANCER,1.964262421,0.054317106,pyrimethamine
INTERFERON_ALPHA_BETA_SIGNALING,2.632672696,0,fluticasone-propionate
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.343956827,0,fluticasone-propionate
GPCR_LIGAND_BINDING,-2.33346758,0,fluticasone-propionate
ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES,2.103917231,0.042835109,fluticasone-propionate
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-2.071145368,0.014862778,fluticasone-propionate
INTERFERON_SIGNALING,2.004175519,0.061974201,fluticasone-propionate
SIGNALING_BY_GPCR,-1.905834662,0.063992515,fluticasone-propionate
CONSTITUTIVE_SIGNALING_BY_ABERRANT_PI3K_IN_CANCER,-1.904366371,0.05185458,fluticasone-propionate
MAPK_FAMILY_SIGNALING_CASCADES,-1.82928236,0.093167597,fluticasone-propionate
DNA_REPAIR,1.636282117,0.42424986,fluticasone-propionate
GPCR_LIGAND_BINDING,2.808509603,0,phenelzine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.784326601,0,phenelzine
SIGNALING_BY_GPCR,2.677892227,0,phenelzine
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.461065144,0,phenelzine
G_ALPHA_I_SIGNALLING_EVENTS,2.286232273,0.000432067,phenelzine
G_ALPHA_S_SIGNALLING_EVENTS,2.127243168,0.004860754,phenelzine
INNATE_IMMUNE_SYSTEM,-2.222110532,0.321585903,phenelzine
G_ALPHA_Q_SIGNALLING_EVENTS,2.063844134,0.008178412,phenelzine
NEUTROPHIL_DEGRANULATION,-2.178012013,0.216799485,phenelzine
SARS_COV_1_INFECTION,-2.155755059,0.169826263,phenelzine
MITOTIC_METAPHASE_AND_ANAPHASE,2.78312592,0,triamcinolone
SEPARATION_OF_SISTER_CHROMATIDS,2.765382416,0,triamcinolone
SYNTHESIS_OF_DNA,2.379717886,0.003349307,triamcinolone
CELL_CYCLE_MITOTIC,2.374035259,0.003349307,triamcinolone
M_PHASE,2.370918317,0.002679446,triamcinolone
RHO_GTPASES_ACTIVATE_FORMINS,2.281795539,0.005582178,triamcinolone
RRNA_PROCESSING,2.260020802,0.005263197,triamcinolone
DNA_REPLICATION,2.231439934,0.004605297,triamcinolone
DNA_REPLICATION_PRE_INITIATION,2.216566503,0.004837888,triamcinolone
RESOLUTION_OF_SISTER_CHROMATID_COHESION,2.173323553,0.006028753,triamcinolone
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,3.145534436,0,IC-261
GPCR_LIGAND_BINDING,3.139690697,0,IC-261
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.398922304,0,IC-261
G_ALPHA_I_SIGNALLING_EVENTS,2.156737118,0.004539433,IC-261
STIMULI_SENSING_CHANNELS,2.124101633,0.006329266,IC-261
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,-3.16316878,0.154309747,IC-261
COPII_MEDIATED_VESICLE_TRANSPORT,-3.099234992,0.199316757,IC-261
VISUAL_PHOTOTRANSDUCTION,1.93663698,0.028101251,IC-261
SENSORY_PERCEPTION,1.904519477,0.030979313,IC-261
TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,-2.998087809,0.492933916,IC-261
NEUTROPHIL_DEGRANULATION,-2.486577965,0.003061978,MDL-29951
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.136381047,0.042484944,MDL-29951
TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,-2.133894658,0.029088791,MDL-29951
S_PHASE,2.07683733,0.206851822,MDL-29951
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.119000693,0.024878571,MDL-29951
INNATE_IMMUNE_SYSTEM,-2.073455247,0.029854285,MDL-29951
SIGNALING_BY_GPCR,2.010284854,0.167130277,MDL-29951
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,-2.040988056,0.035850659,MDL-29951
MUSCLE_CONTRACTION,1.946416698,0.176373655,MDL-29951
DNA_REPLICATION,1.945745584,0.132280242,MDL-29951
GLYCEROPHOSPHOLIPID_BIOSYNTHESIS,-2.225617313,0.053086219,meclizine
PHOSPHOLIPID_METABOLISM,-2.068872594,0.133157932,meclizine
REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF,-1.954181872,0.214999185,meclizine
MYD88_INDEPENDENT_TLR4_CASCADE,1.719823432,1,meclizine
METABOLISM_OF_STEROIDS,-1.845065973,0.336212717,meclizine
REGULATION_OF_TP53_ACTIVITY,1.690738405,0.885345664,meclizine
MUSCLE_CONTRACTION,1.616437175,0.884338444,meclizine
VISUAL_PHOTOTRANSDUCTION,-1.755689814,0.450171133,meclizine
SENSORY_PERCEPTION,-1.75225089,0.383105544,meclizine
TOLL_LIKE_RECEPTOR_CASCADES,1.595221831,0.74604725,meclizine
MUSCLE_CONTRACTION,3.267805721,0,melperone
CARDIAC_CONDUCTION,2.435590101,0.004673694,melperone
ION_HOMEOSTASIS,2.357477071,0.006231592,melperone
NEURONAL_SYSTEM,2.0535101,0.049741455,melperone
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,1.857730892,0.158371452,melperone
RRNA_PROCESSING,-1.829086324,1,melperone
PLATELET_HOMEOSTASIS,1.639418961,0.439994886,melperone
PARASITE_INFECTION,1.611662427,0.437991874,melperone
INTRA_GOLGI_TRAFFIC,1.586187714,0.438492627,melperone
AUTOPHAGY,1.582077826,0.399415354,melperone
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.122228541,0.059465464,edrophonium
GPCR_LIGAND_BINDING,2.051235222,0.073188264,edrophonium
G_ALPHA_I_SIGNALLING_EVENTS,1.992553835,0.085081357,edrophonium
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.925750508,0.114356662,edrophonium
SIGNALING_BY_GPCR,1.909498061,0.103744364,edrophonium
TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,-2.144607259,1,edrophonium
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.127003839,1,edrophonium
TOLL_LIKE_RECEPTOR_CASCADES,-2.104071619,1,edrophonium
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.060397688,1,edrophonium
DISEASES_OF_METABOLISM,-1.966568746,1,edrophonium
M_PHASE,-2.632144908,0.001201187,cytarabine
MITOTIC_METAPHASE_AND_ANAPHASE,-2.576545281,0.001201187,cytarabine
RHO_GTPASES_ACTIVATE_FORMINS,-2.531237725,0.000800791,cytarabine
SEPARATION_OF_SISTER_CHROMATIDS,-2.488404465,0.001501484,cytarabine
MITOTIC_PROMETAPHASE,-2.444657031,0.001441424,cytarabine
CHROMATIN_ORGANIZATION,-2.433333848,0.001201187,cytarabine
RESOLUTION_OF_SISTER_CHROMATID_COHESION,-2.425993138,0.001029589,cytarabine
CELL_CYCLE_MITOTIC,-2.408785972,0.001051039,cytarabine
KINESINS,-2.374192202,0.001334652,cytarabine
MITOTIC_SPINDLE_CHECKPOINT,-2.364377337,0.001321306,cytarabine
CELL_CYCLE,-2.974798941,0,dacomitinib
MITOTIC_METAPHASE_AND_ANAPHASE,-2.847970734,0,dacomitinib
CELL_CYCLE_MITOTIC,-2.846473362,0,dacomitinib
MRNA_SPLICING,-2.745352033,0.001030369,dacomitinib
METABOLISM_OF_RNA,-2.709899978,0.00164859,dacomitinib
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.646079823,0.002060738,dacomitinib
MHC_CLASS_II_ANTIGEN_PRESENTATION,-2.600200748,0.001766346,dacomitinib
M_PHASE,-2.580727447,0.001545553,dacomitinib
TCR_SIGNALING,-2.457361718,0.002289708,dacomitinib
RESPIRATORY_ELECTRON_TRANSPORT,-2.434778698,0.002248077,dacomitinib
METABOLISM_OF_RNA,-3.756219188,0,regorafenib
RRNA_PROCESSING,-3.259203915,0,regorafenib
EUKARYOTIC_TRANSLATION_ELONGATION,-2.87199665,0,regorafenib
NONSENSE_MEDIATED_DECAY_NMD,-2.854888021,0,regorafenib
EUKARYOTIC_TRANSLATION_INITIATION,-2.848773063,0,regorafenib
MRNA_SPLICING,-2.826113869,0,regorafenib
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.806799234,0,regorafenib
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.782775349,0,regorafenib
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.755878132,0,regorafenib
DNA_REPLICATION,-2.6905183,0,regorafenib
CELL_CYCLE_MITOTIC,-2.134594055,0.019318686,irinotecan
CELLULAR_RESPONSE_TO_STARVATION,2.165343627,0.063149222,irinotecan
MITOTIC_SPINDLE_CHECKPOINT,-2.082988761,0.023098429,irinotecan
DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE,-2.062148748,0.018198762,irinotecan
CELL_CYCLE,-2.044259198,0.016798858,irinotecan
TOLL_LIKE_RECEPTOR_CASCADES,1.968837284,0.124120884,irinotecan
TRANSCRIPTION_OF_THE_HIV_GENOME,1.904466351,0.130653562,irinotecan
CYCLIN_A_B1_B2_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION,-1.990138874,0.029398001,irinotecan
RNA_POLYMERASE_II_PRE_TRANSCRIPTION_EVENTS,1.870551152,0.117043816,irinotecan
GPCR_LIGAND_BINDING,-1.893246675,0.067475412,irinotecan
INFLUENZA_INFECTION,3.102460536,0,solifenacin-succinate
GPCR_LIGAND_BINDING,-2.551064726,0,solifenacin-succinate
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.7857855,0,solifenacin-succinate
SELENOAMINO_ACID_METABOLISM,2.791638292,0,solifenacin-succinate
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.526314437,0,solifenacin-succinate
NONSENSE_MEDIATED_DECAY_NMD,2.849433154,0,solifenacin-succinate
EUKARYOTIC_TRANSLATION_INITIATION,3.071525943,0,solifenacin-succinate
EUKARYOTIC_TRANSLATION_ELONGATION,2.806979112,0,solifenacin-succinate
SARS_COV_INFECTIONS,2.735199394,0.002861568,solifenacin-succinate
SIGNALING_BY_GPCR,-2.27183232,0.000249548,solifenacin-succinate
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,3.165263164,0,E-2012
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.182380929,0,E-2012
MRNA_SPLICING,2.551007837,0.003096888,E-2012
GPCR_LIGAND_BINDING,-2.121312341,0.00080882,E-2012
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.968821148,0.009166626,E-2012
SIGNALING_BY_GPCR,-1.919331742,0.012132299,E-2012
SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS,1.752315314,0.142456865,E-2012
G_ALPHA_Q_SIGNALLING_EVENTS,-1.835692109,0.028955754,E-2012
SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR,1.611983551,0.270977732,E-2012
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,1.48373427,0.423654328,E-2012
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.702334619,0,etoricoxib
SIGNALING_BY_GPCR,-2.253895179,0.016534399,etoricoxib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.225504643,0.009726117,etoricoxib
G_ALPHA_Q_SIGNALLING_EVENTS,-2.224064692,0.006484078,etoricoxib
NEUTROPHIL_DEGRANULATION,2.265648728,0.012488298,etoricoxib
MUSCLE_CONTRACTION,2.222319391,0.009773451,etoricoxib
GPCR_LIGAND_BINDING,-2.11188513,0.020911152,etoricoxib
ION_HOMEOSTASIS,1.810588353,0.156375211,etoricoxib
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.903149683,0.119047676,etoricoxib
SIGNALING_BY_ROBO_RECEPTORS,1.787403689,0.143561131,etoricoxib
CELL_CYCLE,-3.175238573,0,cabozantinib
MITOTIC_METAPHASE_AND_ANAPHASE,-3.063416301,0,cabozantinib
CELL_CYCLE_MITOTIC,-2.878060677,0,cabozantinib
CELL_CYCLE_CHECKPOINTS,-2.730622427,0.000682408,cabozantinib
M_PHASE,-2.723045421,0.000545926,cabozantinib
SEPARATION_OF_SISTER_CHROMATIDS,-2.561304409,0.000909877,cabozantinib
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,-2.35852708,0.005069313,cabozantinib
METABOLISM_OF_RNA,-2.241871132,0.010918521,cabozantinib
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.209791827,0.010918521,cabozantinib
S_PHASE,-2.191511724,0.012010373,cabozantinib
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.302468946,0.042507396,trapidil
PLATELET_HOMEOSTASIS,1.988965391,0.192388731,trapidil
REGULATION_OF_T_CELL_ACTIVATION_BY_CD28_FAMILY,1.93569058,0.133041698,trapidil
MITOTIC_METAPHASE_AND_ANAPHASE,-1.982934429,0.343279427,trapidil
NEURONAL_SYSTEM,1.904983186,0.10978114,trapidil
MUSCLE_CONTRACTION,1.884342892,0.097661737,trapidil
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,1.873837642,0.083216278,trapidil
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.82195564,0.098585638,trapidil
NEGATIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION,-1.871244101,0.4564178,trapidil
MITOTIC_SPINDLE_CHECKPOINT,-1.833849032,0.436666888,trapidil
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.241056329,0.028573463,etizolam
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.211923179,0.019602724,etizolam
GPCR_LIGAND_BINDING,-1.872369727,0.140652317,etizolam
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,1.844418681,1,etizolam
INTERLEUKIN_17_SIGNALING,1.836431099,0.596118483,etizolam
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,1.816360477,0.45747671,etizolam
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,1.801346771,0.378899326,etizolam
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.745523381,0.230415075,etizolam
HATS_ACETYLATE_HISTONES,1.714108159,0.544775773,etizolam
TOLL_LIKE_RECEPTOR_CASCADES,1.699708943,0.496971103,etizolam
SENSORY_PERCEPTION,-2.511084159,0,disulfiram
GPCR_LIGAND_BINDING,-2.410002673,0.000289005,disulfiram
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.287564269,0.001348689,disulfiram
SIGNALING_BY_GPCR,-2.264369553,0.001445024,disulfiram
VISUAL_PHOTOTRANSDUCTION,-2.231257406,0.002196436,disulfiram
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,2.311563613,0.080989316,disulfiram
KERATINIZATION,-2.171790628,0.004335072,disulfiram
SUMOYLATION,1.958728426,0.26633025,disulfiram
G_ALPHA_Q_SIGNALLING_EVENTS,-1.98603094,0.023120381,disulfiram
NEUTROPHIL_DEGRANULATION,1.900075966,0.258542815,disulfiram
EUKARYOTIC_TRANSLATION_ELONGATION,2.855419116,0,BRD-K75516118
NONSENSE_MEDIATED_DECAY_NMD,2.774534392,0,BRD-K75516118
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.685098092,0,BRD-K75516118
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.676760681,0,BRD-K75516118
CELLULAR_RESPONSE_TO_STARVATION,2.661159733,0,BRD-K75516118
SELENOAMINO_ACID_METABOLISM,2.64427407,0,BRD-K75516118
EUKARYOTIC_TRANSLATION_INITIATION,2.552271608,0,BRD-K75516118
SIGNALING_BY_ROBO_RECEPTORS,2.532228204,0.000150794,BRD-K75516118
INFLUENZA_INFECTION,2.499112457,0.00013404,BRD-K75516118
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.464731856,0.000120636,BRD-K75516118
GPCR_LIGAND_BINDING,2.580009154,0.001267082,dactinomycin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.488647433,0.001900622,dactinomycin
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,-3.106094863,0.013435472,dactinomycin
SIGNALING_BY_GPCR,2.238510179,0.012670815,dactinomycin
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.161324234,0.020273305,dactinomycin
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-2.964581059,0.132563325,dactinomycin
MUSCLE_CONTRACTION,1.957135725,0.076278309,dactinomycin
TRANSPORT_OF_SMALL_MOLECULES,1.95129579,0.065254699,dactinomycin
SENSORY_PERCEPTION,1.935789793,0.061181937,dactinomycin
ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT,1.730847673,0.168838616,dactinomycin
DEVELOPMENTAL_CELL_LINEAGES,2.044620075,0.162663043,granisetron
SIGNALING_BY_GPCR,1.949345119,0.178817935,granisetron
G_ALPHA_Q_SIGNALLING_EVENTS,1.797274956,0.327182971,granisetron
GPCR_LIGAND_BINDING,1.785909338,0.259313859,granisetron
NEUTROPHIL_DEGRANULATION,-3.159478745,1,granisetron
INFECTIOUS_DISEASE,-2.487170962,1,granisetron
INNATE_IMMUNE_SYSTEM,-2.43669131,0.89732334,granisetron
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.677435464,0.393065217,granisetron
PROTEIN_LOCALIZATION,-1.890265778,0.790390792,granisetron
FATTY_ACID_METABOLISM,-1.829676649,0.659432548,granisetron
EUKARYOTIC_TRANSLATION_INITIATION,4.705713447,0,BRD-K34685430
MITOTIC_METAPHASE_AND_ANAPHASE,2.961113772,0,BRD-K34685430
ORC1_REMOVAL_FROM_CHROMATIN,3.00671745,0,BRD-K34685430
SCF_SKP2_MEDIATED_DEGRADATION_OF_P27_P21,3.025384366,0,BRD-K34685430
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,3.037074004,0,BRD-K34685430
CELLULAR_RESPONSE_TO_HYPOXIA,3.038361272,0,BRD-K34685430
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.118161365,0,BRD-K34685430
APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1,3.130855649,0,BRD-K34685430
CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6,3.182776083,0,BRD-K34685430
UCH_PROTEINASES,3.185475815,0,BRD-K34685430
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.995638728,0.202011735,trazodone
REGULATION_OF_T_CELL_ACTIVATION_BY_CD28_FAMILY,1.878952784,0.766411261,trazodone
REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF,-1.799540718,0.430008382,trazodone
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,1.789124398,0.705722587,trazodone
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.783561328,0.490133295,trazodone
ADIPOGENESIS,1.732134223,0.509784866,trazodone
METABOLISM_OF_STEROIDS,-1.698318202,0.537300922,trazodone
TRANSPORT_OF_SMALL_MOLECULES,-1.658645651,0.515926236,trazodone
RRNA_PROCESSING,-1.65702592,0.415590947,trazodone
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,-1.637843661,0.388097234,trazodone
SELENOAMINO_ACID_METABOLISM,-3.373650052,0,BRD-K82216340
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,-2.473710859,0,BRD-K82216340
CELLULAR_RESPONSES_TO_STIMULI,-2.492757583,0,BRD-K82216340
NERVOUS_SYSTEM_DEVELOPMENT,-2.547743354,0,BRD-K82216340
SIGNALING_BY_GPCR,2.676496741,0,BRD-K82216340
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.812522186,0,BRD-K82216340
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.913483192,0,BRD-K82216340
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.918072295,0,BRD-K82216340
RRNA_PROCESSING,-2.937280962,0,BRD-K82216340
INFLUENZA_INFECTION,-2.987501393,0,BRD-K82216340
PLATELET_HOMEOSTASIS,-2.112406647,0.020842667,LY-294002
CELL_CYCLE_CHECKPOINTS,1.754374698,0.421265006,LY-294002
TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,-1.927479477,0.069041334,LY-294002
TRANSLATION,1.691384996,0.288156966,LY-294002
PROGRAMMED_CELL_DEATH,1.655483967,0.230135512,LY-294002
KEAP1_NFE2L2_PATHWAY,1.578964182,0.250126097,LY-294002
HIV_INFECTION,1.522979061,0.262705538,LY-294002
PEPTIDE_HORMONE_METABOLISM,-1.802418199,0.182373335,LY-294002
RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_PATHWAY,1.450562973,0.320824507,LY-294002
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,1.449516951,0.276664121,LY-294002
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-3.265771184,0,equilin
TRANSLATION,-2.582049061,0,equilin
SARS_COV_1_INFECTION,-2.76088297,0,equilin
RRNA_PROCESSING,-2.763108551,0,equilin
SIGNALING_BY_ROBO_RECEPTORS,-2.869813259,0,equilin
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.874074683,0,equilin
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.913040357,0,equilin
CELLULAR_RESPONSE_TO_STARVATION,-2.995685181,0,equilin
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.499172165,0,equilin
NONSENSE_MEDIATED_DECAY_NMD,-3.005572239,0,equilin
PI3K_AKT_SIGNALING_IN_CANCER,2.177797625,0.057878943,capecitabine
HCMV_INFECTION,2.012891519,0.083689823,capecitabine
DNA_DOUBLE_STRAND_BREAK_REPAIR,1.993568721,0.061007534,capecitabine
HOMOLOGY_DIRECTED_REPAIR,1.932064427,0.070784383,capecitabine
HOST_INTERACTIONS_OF_HIV_FACTORS,1.843941419,0.093544886,capecitabine
BIOLOGICAL_OXIDATIONS,-3.056427687,0.350217122,capecitabine
MUSCLE_CONTRACTION,-3.047910179,0.20142021,capecitabine
PROCESSING_OF_DNA_DOUBLE_STRAND_BREAK_ENDS,1.740798915,0.140004469,capecitabine
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,1.732663978,0.126037543,capecitabine
DNA_REPLICATION,1.704381617,0.130618695,capecitabine
CHOLESTEROL_BIOSYNTHESIS,3.475369101,0,BRD-K68202742
METABOLISM_OF_STEROIDS,2.500686732,0.009864534,BRD-K68202742
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,2.482653447,0.006576356,BRD-K68202742
REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF,2.246192387,0.017038741,BRD-K68202742
GPCR_LIGAND_BINDING,-2.063865045,0.066255905,BRD-K68202742
ACTIVATION_OF_GENE_EXPRESSION_BY_SREBF_SREBP,2.058389855,0.045914922,BRD-K68202742
INTERFERON_ALPHA_BETA_SIGNALING,2.035327057,0.044838791,BRD-K68202742
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,1.952996726,0.061236978,BRD-K68202742
MITOTIC_PROMETAPHASE,-1.948675535,0.113698405,BRD-K68202742
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.932081942,0.088886523,BRD-K68202742
METABOLISM_OF_RNA,2.995952701,0,cilastatin
CELL_CYCLE_MITOTIC,2.714455334,0.001452919,cilastatin
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.573499384,0.001937226,cilastatin
CELL_CYCLE,2.463865944,0.002905838,cilastatin
DNA_REPLICATION_PRE_INITIATION,2.328611868,0.003487006,cilastatin
VIRAL_INFECTION_PATHWAYS,2.338188367,0.003874451,cilastatin
S_PHASE,2.353952078,0.003995528,cilastatin
DNA_REPLICATION,2.390392127,0.006392845,cilastatin
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,2.390222685,0.005327371,cilastatin
CELL_CYCLE_CHECKPOINTS,2.361049486,0.004566318,cilastatin
GPCR_LIGAND_BINDING,2.592340777,0.002569976,ritanserin
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,2.347691219,0.014134868,ritanserin
SIGNALING_BY_GPCR,2.252078078,0.017561503,ritanserin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.981226071,0.077420526,ritanserin
INTEGRIN_CELL_SURFACE_INTERACTIONS,1.852046562,0.124386837,ritanserin
DEVELOPMENTAL_CELL_LINEAGES,1.793713265,0.146488631,ritanserin
G_ALPHA_Q_SIGNALLING_EVENTS,1.725797166,0.182468294,ritanserin
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,1.689317936,0.196442539,ritanserin
G_ALPHA_I_SIGNALLING_EVENTS,1.675437054,0.186608811,ritanserin
TRANSLATION,1.663527465,0.179898318,ritanserin
CELL_CYCLE,-2.78571524,0,linsitinib
CELL_CYCLE_MITOTIC,-2.748635824,0,linsitinib
CELL_CYCLE_CHECKPOINTS,-2.64726319,0,linsitinib
M_PHASE,-2.599265973,0,linsitinib
SEPARATION_OF_SISTER_CHROMATIDS,-2.578390423,0,linsitinib
RHO_GTPASES_ACTIVATE_FORMINS,-2.495775788,0.000228759,linsitinib
MITOTIC_METAPHASE_AND_ANAPHASE,-2.494383381,0.000196079,linsitinib
RHO_GTPASE_EFFECTORS,-2.455714716,0.000343139,linsitinib
MITOTIC_G2_G2_M_PHASES,-2.405083669,0.000457518,linsitinib
MITOTIC_PROMETAPHASE,-2.396582536,0.000411767,linsitinib
EUKARYOTIC_TRANSLATION_ELONGATION,2.716871038,0,vismodegib
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.636206094,0,vismodegib
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,2.580766402,0,vismodegib
NONSENSE_MEDIATED_DECAY_NMD,2.499329044,0,vismodegib
EUKARYOTIC_TRANSLATION_INITIATION,2.495932368,0,vismodegib
SELENOAMINO_ACID_METABOLISM,2.471960111,0,vismodegib
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.434078968,0,vismodegib
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.421752074,0,vismodegib
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,2.390057491,9.23E-05,vismodegib
CELLULAR_RESPONSE_TO_STARVATION,2.369795932,8.30E-05,vismodegib
GPCR_LIGAND_BINDING,-2.353340526,0,topiroxostat
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,2.495604638,0.0147015,topiroxostat
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.179885104,0.002403035,topiroxostat
PEROXISOMAL_PROTEIN_IMPORT,2.323274859,0.025727625,topiroxostat
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,-2.090223481,0.006865814,topiroxostat
HIV_LIFE_CYCLE,2.186874121,0.037978875,topiroxostat
ORGANELLE_BIOGENESIS_AND_MAINTENANCE,2.05536993,0.056968312,topiroxostat
SIGNALING_BY_GPCR,-1.997227097,0.016134663,topiroxostat
DEUBIQUITINATION,1.927051391,0.087473925,topiroxostat
MYD88_INDEPENDENT_TLR4_CASCADE,1.916841546,0.076570312,topiroxostat
GLOBAL_GENOME_NUCLEOTIDE_EXCISION_REPAIR_GG_NER,2.275959322,0.036362095,SU-11652
NUCLEOTIDE_EXCISION_REPAIR,2.105652019,0.044626208,SU-11652
NEURONAL_SYSTEM,-2.07416573,0.037899716,SU-11652
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.033020199,0.048482794,SU-11652
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.018059761,0.037038358,SU-11652
VISUAL_PHOTOTRANSDUCTION,-1.973633076,0.03962243,SU-11652
POTASSIUM_CHANNELS,-1.929143,0.043067859,SU-11652
MRNA_SPLICING,1.766329249,0.137184269,SU-11652
TRANSCRIPTION_COUPLED_NUCLEOTIDE_EXCISION_REPAIR_TC_NER,1.747970696,0.124292253,SU-11652
GPCR_LIGAND_BINDING,-1.889435639,0.050992345,SU-11652
GPCR_LIGAND_BINDING,-2.208678511,0.017245808,glasdegib
INNATE_IMMUNE_SYSTEM,2.14785946,0.059975627,glasdegib
NEUTROPHIL_DEGRANULATION,2.147041909,0.029987813,glasdegib
ADAPTIVE_IMMUNE_SYSTEM,2.101869968,0.028449977,glasdegib
SIGNALING_BY_NTRKS,2.036819053,0.033447946,glasdegib
G_ALPHA_Q_SIGNALLING_EVENTS,-2.098293191,0.037509632,glasdegib
SENSORY_PERCEPTION,-2.094145473,0.025868712,glasdegib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.080009852,0.023281841,glasdegib
SIGNALING_BY_GPCR,-2.076373523,0.019142847,glasdegib
TOLL_LIKE_RECEPTOR_CASCADES,1.68826835,0.176236072,glasdegib
GPCR_LIGAND_BINDING,-2.40341858,0,TG-100801
SIGNALING_BY_GPCR,-2.178204296,0.006111159,TG-100801
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.100238138,0.01472946,TG-100801
G_ALPHA_Q_SIGNALLING_EVENTS,-2.066856876,0.017393298,TG-100801
G_ALPHA_I_SIGNALLING_EVENTS,-2.039918559,0.016171067,TG-100801
COMPLEMENT_CASCADE,-2.013001618,0.018960262,TG-100801
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,1.878719151,0.270330824,TG-100801
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,-1.904853031,0.044457002,TG-100801
CELLULAR_RESPONSE_TO_STARVATION,1.757843306,0.258725713,TG-100801
SENSORY_PERCEPTION,-1.883560555,0.047479004,TG-100801
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.377647805,0.03770978,BRD-K82225283
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.224804498,0.061413071,BRD-K82225283
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,1.934066999,0.45477774,BRD-K82225283
MYD88_INDEPENDENT_TLR4_CASCADE,1.890919015,0.317963053,BRD-K82225283
REGULATION_OF_T_CELL_ACTIVATION_BY_CD28_FAMILY,1.872101653,0.243755784,BRD-K82225283
ORGANELLE_BIOGENESIS_AND_MAINTENANCE,1.856885295,0.20593709,BRD-K82225283
TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,1.755830583,0.334457089,BRD-K82225283
GASTRULATION,-1.683953654,1,BRD-K82225283
PKR_MEDIATED_SIGNALING,-1.674969198,0.867594306,BRD-K82225283
REGULATION_OF_TP53_ACTIVITY,1.66490254,0.506262013,BRD-K82225283
METABOLISM_OF_RNA,4.358248702,0,dofequidar
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.751982329,0,dofequidar
HIV_INFECTION,2.770679128,0,dofequidar
ESTROGEN_DEPENDENT_GENE_EXPRESSION,2.876587808,0,dofequidar
RRNA_PROCESSING,2.883306566,0,dofequidar
SIGNALING_BY_ROBO_RECEPTORS,2.903538245,0,dofequidar
EUKARYOTIC_TRANSLATION_INITIATION,3.53843672,0,dofequidar
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.562489093,0,dofequidar
INFLUENZA_INFECTION,3.665158532,0,dofequidar
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,3.731404121,0,dofequidar
DNA_REPLICATION,-2.859042726,0,lestaurtinib
CELL_CYCLE_MITOTIC,-2.803319841,0,lestaurtinib
CELL_CYCLE,-2.745297915,0,lestaurtinib
MITOTIC_METAPHASE_AND_ANAPHASE,-2.731592651,0,lestaurtinib
SYNTHESIS_OF_DNA,-2.705067643,0,lestaurtinib
M_PHASE,-2.66715364,0,lestaurtinib
SEPARATION_OF_SISTER_CHROMATIDS,-2.660014874,0.000182042,lestaurtinib
DNA_REPLICATION_PRE_INITIATION,-2.485272847,0.000955718,lestaurtinib
CELL_CYCLE_CHECKPOINTS,-2.470477669,0.000849527,lestaurtinib
G2_M_CHECKPOINTS,-2.353376498,0.002201048,lestaurtinib
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-3.162058354,0.013804324,ketoconazole
GPCR_LIGAND_BINDING,2.220533408,0.016197944,ketoconazole
EUKARYOTIC_TRANSLATION_ELONGATION,-3.146430066,0.010353243,ketoconazole
SELENOAMINO_ACID_METABOLISM,-3.142501839,0.006902162,ketoconazole
EXTRACELLULAR_MATRIX_ORGANIZATION,2.058067252,0.024836847,ketoconazole
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-3.10047966,0.01577637,ketoconazole
SIGNALING_BY_ROBO_RECEPTORS,-3.078279111,0.018405765,ketoconazole
EUKARYOTIC_TRANSLATION_INITIATION,-3.078801816,0.021889713,ketoconazole
NONSENSE_MEDIATED_DECAY_NMD,-3.075789251,0.016621533,ketoconazole
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-3.074733387,0.014790347,ketoconazole
REGULATION_OF_PTEN_STABILITY_AND_ACTIVITY,2.969982634,0,phenethyl-isothiocyanate
VIF_MEDIATED_DEGRADATION_OF_APOBEC3G,2.884630941,0,phenethyl-isothiocyanate
TRANSCRIPTIONAL_REGULATION_BY_RUNX3,2.873401207,0,phenethyl-isothiocyanate
THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT,2.77960373,0,phenethyl-isothiocyanate
METABOLISM_OF_RNA,2.778122,0,phenethyl-isothiocyanate
DECTIN_1_MEDIATED_NONCANONICAL_NF_KB_SIGNALING,2.725126752,0,phenethyl-isothiocyanate
DEGRADATION_OF_BETA_CATENIN_BY_THE_DESTRUCTION_COMPLEX,2.680657951,0,phenethyl-isothiocyanate
DEGRADATION_OF_DVL,2.604711881,0.000306751,phenethyl-isothiocyanate
RRNA_PROCESSING,2.598713541,0.000272668,phenethyl-isothiocyanate
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,2.58409026,0.000245401,phenethyl-isothiocyanate
DNA_REPLICATION,2.290804966,0.06706384,dichloroacetic-acid
SYNTHESIS_OF_DNA,2.117177883,0.103314564,dichloroacetic-acid
ORC1_REMOVAL_FROM_CHROMATIN,2.09586757,0.077334878,dichloroacetic-acid
TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT,2.07638379,0.063438767,dichloroacetic-acid
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.055491119,0.060176202,dichloroacetic-acid
S_PHASE,2.036027764,0.057094891,dichloroacetic-acid
DEVELOPMENTAL_CELL_LINEAGES,-3.022134046,0.149349995,dichloroacetic-acid
G2_M_CHECKPOINTS,2.023895595,0.055152888,dichloroacetic-acid
RRNA_PROCESSING,2.015809448,0.050071313,dichloroacetic-acid
METABOLISM_OF_RNA,1.950949587,0.069077769,dichloroacetic-acid
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,2.033358781,0.295589714,BRD-K71860425
FATTY_ACID_METABOLISM,2.015328515,0.172813422,BRD-K71860425
NONSENSE_MEDIATED_DECAY_NMD,-1.800385601,0.61569403,BRD-K71860425
EUKARYOTIC_TRANSLATION_ELONGATION,-1.758595387,0.381372976,BRD-K71860425
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,1.946008248,0.197677552,BRD-K71860425
NEUTROPHIL_DEGRANULATION,1.922459009,0.174434996,BRD-K71860425
APOPTOSIS,1.918057019,0.143439773,BRD-K71860425
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-1.643311627,0.44298819,BRD-K71860425
CELLULAR_RESPONSE_TO_STARVATION,-1.5801507,0.438750712,BRD-K71860425
BETA_CATENIN_INDEPENDENT_WNT_SIGNALING,1.822996724,0.243699357,BRD-K71860425
STRIATED_MUSCLE_CONTRACTION,3.220433758,0,econazole
MUSCLE_CONTRACTION,2.425560746,0.003766321,econazole
SIGNALING_BY_GPCR,-2.178175803,0.028738858,econazole
GPCR_LIGAND_BINDING,-2.142914206,0.01930892,econazole
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.133745647,0.021091396,econazole
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.114857163,0.017063697,econazole
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,-2.037528779,0.03569905,econazole
G_ALPHA_Q_SIGNALLING_EVENTS,-2.021285094,0.034845865,econazole
DEVELOPMENTAL_CELL_LINEAGES,-1.976818036,0.047598734,econazole
G_ALPHA_I_SIGNALLING_EVENTS,-1.969713343,0.043364884,econazole
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-3.282545402,0,estradiol
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.569287078,0,estradiol
TRANSLATION,-2.595439236,0,estradiol
RRNA_PROCESSING,-2.741769581,0,estradiol
SARS_COV_1_INFECTION,-2.872628358,0,estradiol
SIGNALING_BY_ROBO_RECEPTORS,-2.873038147,0,estradiol
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.900632242,0,estradiol
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.930996107,0,estradiol
NONSENSE_MEDIATED_DECAY_NMD,-2.985664889,0,estradiol
SARS_COV_2_HOST_INTERACTIONS,-2.590542926,0,estradiol
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.188902514,0.044474394,ketanserin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.996600428,0.030654934,ketanserin
GPCR_LIGAND_BINDING,-1.946695418,0.031530789,ketanserin
MRNA_SPLICING,1.847930442,0.109332884,ketanserin
G_ALPHA_Q_SIGNALLING_EVENTS,-1.874995908,0.052551315,ketanserin
TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM,1.594127733,0.296495957,ketanserin
SIGNALING_BY_GPCR,-1.830663881,0.059120229,ketanserin
UNFOLDED_PROTEIN_RESPONSE_UPR,1.555608059,0.27425876,ketanserin
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.810481066,0.060784354,ketanserin
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,1.517834229,0.283153639,ketanserin
EUKARYOTIC_TRANSLATION_ELONGATION,-3.712307571,0,captopril
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-3.400835067,0,captopril
SIGNALING_BY_GPCR,2.943051878,0,captopril
CELLULAR_RESPONSE_TO_STARVATION,-3.446024735,0,captopril
GPCR_LIGAND_BINDING,3.478141274,0,captopril
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-3.418331298,0,captopril
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-3.630931764,0,captopril
NONSENSE_MEDIATED_DECAY_NMD,-3.631498206,0,captopril
SELENOAMINO_ACID_METABOLISM,-3.658466336,0,captopril
EUKARYOTIC_TRANSLATION_INITIATION,-3.686208552,0,captopril
GPCR_LIGAND_BINDING,3.203268066,0,mevastatin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,3.020673117,0,mevastatin
SIGNALING_BY_GPCR,2.940251584,0,mevastatin
MUSCLE_CONTRACTION,2.495891797,0.001553145,mevastatin
G_ALPHA_Q_SIGNALLING_EVENTS,2.417906898,0.002692118,mevastatin
NEUTROPHIL_DEGRANULATION,-2.380533352,0.027950496,mevastatin
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.261155197,0.007420582,mevastatin
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.335434059,0.02264954,mevastatin
G_ALPHA_I_SIGNALLING_EVENTS,2.25051038,0.007543848,mevastatin
FATTY_ACID_METABOLISM,-2.213396918,0.034375897,mevastatin
EUKARYOTIC_TRANSLATION_ELONGATION,-3.562343207,0,genistein
SARS_COV_2_INFECTION,-2.441814998,0,genistein
SARS_COV_2_HOST_INTERACTIONS,-2.630229152,0,genistein
NERVOUS_SYSTEM_DEVELOPMENT,-2.687193579,0,genistein
TRANSLATION,-2.919490807,0,genistein
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.972748768,0,genistein
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-3.007137428,0,genistein
RRNA_PROCESSING,-3.042630054,0,genistein
SARS_COV_1_INFECTION,-3.131750947,0,genistein
SIGNALING_BY_ROBO_RECEPTORS,-3.217468959,0,genistein
GPCR_LIGAND_BINDING,4.1981525,0,nomifensine
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,2.668355386,0,nomifensine
NERVOUS_SYSTEM_DEVELOPMENT,-2.724660341,0,nomifensine
SARS_COV_1_INFECTION,-2.783303239,0,nomifensine
G_ALPHA_I_SIGNALLING_EVENTS,2.817834965,0,nomifensine
NEURONAL_SYSTEM,2.831062805,0,nomifensine
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,2.940446031,0,nomifensine
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-3.067665172,0,nomifensine
SARS_COV_1_HOST_INTERACTIONS,-3.107790639,0,nomifensine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-3.108264402,0,nomifensine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.130648456,0.084390946,levonorgestrel
REGULATION_OF_T_CELL_ACTIVATION_BY_CD28_FAMILY,2.017767973,0.10970823,levonorgestrel
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.90035484,0.196581262,levonorgestrel
PLATELET_HOMEOSTASIS,1.881866337,0.169278309,levonorgestrel
G_ALPHA_Q_SIGNALLING_EVENTS,1.853349368,0.16500912,levonorgestrel
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,1.748724696,0.292720752,levonorgestrel
METABOLISM_OF_STEROIDS,-1.699897214,1,levonorgestrel
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,-1.684535909,0.998978977,levonorgestrel
NEURONAL_SYSTEM,1.737135843,0.270618361,levonorgestrel
TRANSCRIPTIONAL_REGULATION_BY_RUNX2,-1.682579773,0.673757511,levonorgestrel
SIGNALING_BY_GPCR,3.100379853,0,vicriviroc
GPCR_LIGAND_BINDING,2.867472786,0,vicriviroc
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.661381291,0,vicriviroc
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,-2.64960605,0,vicriviroc
G_ALPHA_Q_SIGNALLING_EVENTS,2.509831137,0,vicriviroc
POTASSIUM_CHANNELS,2.452978786,0.000190527,vicriviroc
METABOLISM_OF_RNA,-2.495427109,0.003672116,vicriviroc
DNA_REPLICATION,-2.412034335,0.003427308,vicriviroc
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.393797855,0.002570481,vicriviroc
APOPTOSIS,-2.369541324,0.002643923,vicriviroc
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.220062602,0.044157609,naproxen
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,2.10044699,0.057705966,naproxen
CELLULAR_RESPONSE_TO_STARVATION,2.03634361,0.062222085,naproxen
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,1.956686139,0.080788352,naproxen
METABOLISM_OF_STEROIDS,-1.880844533,0.649938129,naproxen
MITF_M_DEPENDENT_GENE_EXPRESSION,1.750737714,0.227612401,naproxen
RAB_REGULATION_OF_TRAFFICKING,1.667438223,0.298231122,naproxen
PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS,-1.723475182,1,naproxen
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.678444991,0.975073589,naproxen
HEMOSTASIS,1.519738296,0.530751518,naproxen
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.885356525,0,oxiconazole
RAB_REGULATION_OF_TRAFFICKING,2.001771344,0.127816151,oxiconazole
RAB_GEFS_EXCHANGE_GTP_FOR_GDP_ON_RABS,1.969290362,0.109069782,oxiconazole
C_TYPE_LECTIN_RECEPTORS_CLRS,-1.921117853,0.527818632,oxiconazole
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.838058051,0.525226202,oxiconazole
SIGNALING_BY_GPCR,-1.817772426,0.411332136,oxiconazole
GPCR_LIGAND_BINDING,-1.815646188,0.313424718,oxiconazole
G_ALPHA_Q_SIGNALLING_EVENTS,-1.790324696,0.299477448,oxiconazole
DISEASES_OF_METABOLISM,-1.728559367,0.386617642,oxiconazole
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.523235591,1,oxiconazole
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.313159192,0.013710647,pasireotide
G_ALPHA_Q_SIGNALLING_EVENTS,-1.982302511,0.384831861,pasireotide
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.937851467,0.279928715,pasireotide
PKMTS_METHYLATE_HISTONE_LYSINES,-1.934491245,0.19297691,pasireotide
NEUTROPHIL_DEGRANULATION,1.819191957,0.260141493,pasireotide
SIGNALING_BY_GPCR,-1.865393563,0.260294437,pasireotide
C_TYPE_LECTIN_RECEPTORS_CLRS,-1.81273411,0.305621571,pasireotide
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.799892189,0.283107599,pasireotide
GPCR_LIGAND_BINDING,-1.783367012,0.238836975,pasireotide
DISEASES_OF_METABOLISM,-1.784106132,0.271994864,pasireotide
CELL_CYCLE_MITOTIC,-3.783433453,0,SB-939
COLLAGEN_FORMATION,-2.721582646,0,SB-939
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.735987949,0,SB-939
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,-2.76034351,0,SB-939
METABOLISM_OF_RNA,-2.827147971,0,SB-939
RHO_GTPASES_ACTIVATE_FORMINS,-2.918378923,0,SB-939
COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES,-3.028293406,0,SB-939
RESOLUTION_OF_SISTER_CHROMATID_COHESION,-3.067672739,0,SB-939
SEPARATION_OF_SISTER_CHROMATIDS,-3.16488258,0,SB-939
MITOTIC_METAPHASE_AND_ANAPHASE,-3.190168735,0,SB-939
METABOLISM_OF_RNA,3.198049667,0,calcitriol
RRNA_PROCESSING,3.006215558,0,calcitriol
NUCLEAR_EVENTS_MEDIATED_BY_NFE2L2,2.557760055,0.000428869,calcitriol
SEPARATION_OF_SISTER_CHROMATIDS,2.584593464,0.000490136,calcitriol
HOST_INTERACTIONS_OF_HIV_FACTORS,2.702928457,0.000571825,calcitriol
DNA_REPLICATION,2.52922048,0.000381217,calcitriol
CELL_CYCLE_CHECKPOINTS,2.887514741,0.000857738,calcitriol
CELL_CYCLE_MITOTIC,2.910589227,0.001143651,calcitriol
CELL_CYCLE,2.798902887,0.00068619,calcitriol
RESPIRATORY_ELECTRON_TRANSPORT,2.411183597,0.002058571,calcitriol
CELLULAR_RESPONSE_TO_STARVATION,3.044607838,0,palonosetron
INFLUENZA_INFECTION,3.04292753,0,palonosetron
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.02684292,0,palonosetron
EUKARYOTIC_TRANSLATION_INITIATION,2.820988865,0,palonosetron
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.758327744,0,palonosetron
EUKARYOTIC_TRANSLATION_ELONGATION,2.719349151,0,palonosetron
TRANSLATION,2.652040162,0,palonosetron
SELENOAMINO_ACID_METABOLISM,2.628015147,0,palonosetron
SARS_COV_2_HOST_INTERACTIONS,2.553647961,0,palonosetron
SARS_COV_INFECTIONS,2.407744526,0,palonosetron
RESPIRATORY_ELECTRON_TRANSPORT,3.446165594,0,moxifloxacin
ESTROGEN_DEPENDENT_GENE_EXPRESSION,2.306122744,0.00552017,moxifloxacin
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.244587815,0.01104034,moxifloxacin
PROTEIN_LOCALIZATION,2.231912468,0.008280255,moxifloxacin
GPCR_LIGAND_BINDING,-2.133859712,0.00681337,moxifloxacin
METABOLISM_OF_RNA,2.178717415,0.007360226,moxifloxacin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.095418297,0.004542247,moxifloxacin
FATTY_ACID_METABOLISM,1.917437383,0.04170795,moxifloxacin
SIGNALING_BY_GPCR,-1.955137221,0.022711234,moxifloxacin
SENSORY_PERCEPTION,-1.930683342,0.022332713,moxifloxacin
GPCR_LIGAND_BINDING,3.220213552,0,lovastatin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,3.065357634,0,lovastatin
SIGNALING_BY_GPCR,2.910033421,0,lovastatin
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.793254664,0,lovastatin
NEUTROPHIL_DEGRANULATION,-2.877071988,0.001804199,lovastatin
G_ALPHA_I_SIGNALLING_EVENTS,2.563903432,0.000150699,lovastatin
G_ALPHA_Q_SIGNALLING_EVENTS,2.158356583,0.006279135,lovastatin
SENSORY_PERCEPTION,2.090270566,0.009472523,lovastatin
INNATE_IMMUNE_SYSTEM,-2.242176736,0.150650639,lovastatin
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.185031175,0.145538741,lovastatin
GPCR_LIGAND_BINDING,2.842518489,0,dicycloverine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.792041685,0,dicycloverine
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.419157596,0.001410598,dicycloverine
SIGNALING_BY_GPCR,2.207832468,0.015604737,dicycloverine
VISUAL_PHOTOTRANSDUCTION,2.192330425,0.015022865,dicycloverine
SENSORY_PERCEPTION,2.003020812,0.052544764,dicycloverine
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,1.923746973,0.08100861,dicycloverine
G_ALPHA_I_SIGNALLING_EVENTS,1.890456972,0.092570473,dicycloverine
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,1.856418922,0.102620982,dicycloverine
TRANSLATION,1.85215171,0.094051601,dicycloverine
NEUTROPHIL_DEGRANULATION,2.143741119,0.127477693,lansoprazole
PHOSPHOLIPID_METABOLISM,-1.816378565,0.526852215,lansoprazole
RHO_GTPASE_EFFECTORS,1.965530387,0.375621295,lansoprazole
CLATHRIN_MEDIATED_ENDOCYTOSIS,1.9235628,0.338967403,lansoprazole
SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES,-1.567209291,0.850842807,lansoprazole
GLYCEROPHOSPHOLIPID_BIOSYNTHESIS,-1.511998599,0.713837711,lansoprazole
LEISHMANIA_INFECTION,1.796425904,0.610627882,lansoprazole
CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS,1.794219148,0.494535601,lansoprazole
METABOLISM_OF_STEROIDS,1.772215239,0.469688804,lansoprazole
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.764350141,0.421635598,lansoprazole
METABOLISM_OF_STEROIDS,-2.201614148,0.764973406,bupropion
RHO_GTPASE_EFFECTORS,-1.619750191,1,bupropion
DISEASES_OF_METABOLISM,1.476776063,1,bupropion
SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3,-1.576916552,1,bupropion
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,1.462976509,1,bupropion
AUTOPHAGY,1.41458395,1,bupropion
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.405030367,1,bupropion
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,1.36680784,1,bupropion
RHO_GTPASE_CYCLE,-1.406585398,1,bupropion
SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX,-1.40753121,1,bupropion
GPCR_LIGAND_BINDING,3.433968078,0,tubocurarine
SIGNALING_BY_GPCR,3.097646326,0,tubocurarine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,3.096430235,0,tubocurarine
G_ALPHA_Q_SIGNALLING_EVENTS,2.740550443,0,tubocurarine
SENSORY_PERCEPTION,2.388703636,0.001655939,tubocurarine
POTASSIUM_CHANNELS,2.354850786,0.001756299,tubocurarine
G_ALPHA_I_SIGNALLING_EVENTS,2.349247659,0.001505399,tubocurarine
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.335725624,0.001505399,tubocurarine
MUSCLE_CONTRACTION,2.266903188,0.002843532,tubocurarine
NEURONAL_SYSTEM,2.152802132,0.006699026,tubocurarine
SARS_COV_2_HOST_INTERACTIONS,1.978820616,0.437108581,pioglitazone
REGULATION_OF_T_CELL_ACTIVATION_BY_CD28_FAMILY,1.96991572,0.243159741,pioglitazone
SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES,1.961907238,0.175132908,pioglitazone
INTERLEUKIN_1_SIGNALING,1.937594749,0.155593286,pioglitazone
DEUBIQUITINATION,1.840970835,0.248949258,pioglitazone
MYD88_INDEPENDENT_TLR4_CASCADE,1.833426601,0.2202429,pioglitazone
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,1.79819165,0.239437908,pioglitazone
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,1.779779763,0.237008378,pioglitazone
UB_SPECIFIC_PROCESSING_PROTEASES,1.763361658,0.233349725,pioglitazone
ADAPTIVE_IMMUNE_SYSTEM,1.752154201,0.228106995,pioglitazone
EUKARYOTIC_TRANSLATION_INITIATION,-2.795156802,0,oxaprozin
RRNA_PROCESSING,-2.529327998,0,oxaprozin
CELLULAR_RESPONSE_TO_STARVATION,-2.590387945,0,oxaprozin
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.653409774,0,oxaprozin
NONSENSE_MEDIATED_DECAY_NMD,-2.656708968,0,oxaprozin
SELENOAMINO_ACID_METABOLISM,-2.664340759,0,oxaprozin
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.563000637,0,oxaprozin
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.68922426,0,oxaprozin
TRANSLATION,-2.713287956,0,oxaprozin
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.742320479,0,oxaprozin
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,2.437039577,0.006735341,fluoxetine
INNATE_IMMUNE_SYSTEM,2.310549558,0.010103011,fluoxetine
GPCR_LIGAND_BINDING,-2.253147926,0.018923889,fluoxetine
G_ALPHA_Q_SIGNALLING_EVENTS,-2.186838443,0.027525657,fluoxetine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.181140671,0.018637164,fluoxetine
KERATINIZATION,-2.129511353,0.022579641,fluoxetine
TOLL_LIKE_RECEPTOR_CASCADES,1.873390224,0.124977989,fluoxetine
NEUTROPHIL_DEGRANULATION,1.820033652,0.124603803,fluoxetine
ADAPTIVE_IMMUNE_SYSTEM,1.818534582,0.099683043,fluoxetine
SIGNALING_BY_GPCR,-2.048855484,0.041804592,fluoxetine
TRANSLATION,2.645506797,0.002522586,promazine
RRNA_PROCESSING,2.634884946,0.001261293,promazine
RESPIRATORY_ELECTRON_TRANSPORT,2.631508157,0.000840862,promazine
METABOLISM_OF_RNA,2.550867851,0.002522586,promazine
REGULATION_OF_RUNX2_EXPRESSION_AND_ACTIVITY,2.544384937,0.002018069,promazine
APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1,2.410243702,0.002522586,promazine
DEGRADATION_OF_BETA_CATENIN_BY_THE_DESTRUCTION_COMPLEX,2.353188915,0.002882955,promazine
ASYMMETRIC_LOCALIZATION_OF_PCP_PROTEINS,2.305937506,0.003083161,promazine
SCF_SKP2_MEDIATED_DEGRADATION_OF_P27_P21,2.328574427,0.003468556,promazine
BETA_CATENIN_INDEPENDENT_WNT_SIGNALING,2.279556939,0.004036138,promazine
MUSCLE_CONTRACTION,4.157008351,0,probenecid
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.57067248,0,probenecid
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.633000142,0,probenecid
SIGNALING_BY_GPCR,2.643150516,0,probenecid
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,2.698590705,0,probenecid
TRANSLATION,-2.75528975,0,probenecid
INFLUENZA_INFECTION,-2.803191515,0,probenecid
SIGNALING_BY_ROBO_RECEPTORS,-2.814688915,0,probenecid
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.842088504,0,probenecid
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.855667796,0,probenecid
MYD88_INDEPENDENT_TLR4_CASCADE,-2.030422506,0.251756517,aloisine
NEDDYLATION,-1.814348492,0.405115241,aloisine
SARS_COV_INFECTIONS,-1.638491738,0.596887517,aloisine
O_LINKED_GLYCOSYLATION,1.867888804,0.995892281,aloisine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-1.605268387,0.533209666,aloisine
ANTIGEN_PROCESSING_CROSS_PRESENTATION,-1.54312202,0.562729004,aloisine
NEUTROPHIL_DEGRANULATION,1.804606127,0.796027594,aloisine
SIGNALING_BY_ROBO_RECEPTORS,-1.533686539,0.488443102,aloisine
ION_CHANNEL_TRANSPORT,-1.526078993,0.43360881,aloisine
SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR,-1.479891243,0.467611137,aloisine
TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,1.874721075,0.54755999,prazosin
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,1.820163403,0.417218261,prazosin
ADAPTIVE_IMMUNE_SYSTEM,1.775867765,0.379175939,prazosin
SARS_COV_2_HOST_INTERACTIONS,1.705208842,0.440916758,prazosin
MYD88_INDEPENDENT_TLR4_CASCADE,1.689688946,0.382418891,prazosin
INTERFERON_ALPHA_BETA_SIGNALING,1.673696584,0.347577944,prazosin
TOLL_LIKE_RECEPTOR_CASCADES,1.667049009,0.31146595,prazosin
INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS,1.628461841,0.331778946,prazosin
NEDDYLATION,1.605786088,0.334412113,prazosin
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,1.597585746,0.314566354,prazosin
EUKARYOTIC_TRANSLATION_ELONGATION,2.128956287,0.124710076,wortmannin
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.067845039,0.107749505,wortmannin
GPCR_LIGAND_BINDING,2.005479159,0.122714715,wortmannin
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.001245874,0.095029078,wortmannin
NONSENSE_MEDIATED_DECAY_NMD,1.977805226,0.089591718,wortmannin
EUKARYOTIC_TRANSLATION_INITIATION,1.879421524,0.152645133,wortmannin
INFLUENZA_INFECTION,1.854945366,0.152360081,wortmannin
DEVELOPMENTAL_CELL_LINEAGES,1.825644585,0.161624258,wortmannin
SARS_COV_2_HOST_INTERACTIONS,1.799011074,0.16949485,wortmannin
SELENOAMINO_ACID_METABOLISM,1.788301135,0.162921243,wortmannin
METABOLISM_OF_RNA,3.620234564,0,olmesartan
MITOTIC_G2_G2_M_PHASES,2.536981108,0,olmesartan
TRANSCRIPTIONAL_REGULATION_BY_RUNX2,2.543717374,0,olmesartan
MITOTIC_PROMETAPHASE,2.598462748,0,olmesartan
KEAP1_NFE2L2_PATHWAY,2.696443456,0,olmesartan
SEPARATION_OF_SISTER_CHROMATIDS,2.769732926,0,olmesartan
NUCLEAR_EVENTS_MEDIATED_BY_NFE2L2,2.792905611,0,olmesartan
S_PHASE,2.718247042,0,olmesartan
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.875818609,0,olmesartan
MITOTIC_METAPHASE_AND_ANAPHASE,2.925694183,0,olmesartan
GPCR_LIGAND_BINDING,3.140026286,0,perphenazine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,3.137551396,0,perphenazine
SIGNALING_BY_GPCR,2.877924174,0,perphenazine
MUSCLE_CONTRACTION,2.3199001,0.004187834,perphenazine
G_ALPHA_I_SIGNALLING_EVENTS,2.214544789,0.006477183,perphenazine
SENSORY_PERCEPTION,2.067155892,0.01656521,perphenazine
NEURONAL_SYSTEM,2.060086817,0.015475043,perphenazine
G_ALPHA_Q_SIGNALLING_EVENTS,2.020551968,0.017868091,perphenazine
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,1.913885961,0.034619427,perphenazine
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,1.868314519,0.041543313,perphenazine
EUKARYOTIC_TRANSLATION_INITIATION,-2.804085412,0,ramelteon
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.568441366,0,ramelteon
NONSENSE_MEDIATED_DECAY_NMD,-2.608317052,0,ramelteon
RRNA_PROCESSING,-2.621415663,0,ramelteon
TRANSLATION,-2.648962972,0,ramelteon
GPCR_LIGAND_BINDING,-2.599536238,0,ramelteon
SELENOAMINO_ACID_METABOLISM,-2.670446261,0,ramelteon
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.764535318,0,ramelteon
EUKARYOTIC_TRANSLATION_ELONGATION,-2.798743423,0,ramelteon
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.663588704,0,ramelteon
EUKARYOTIC_TRANSLATION_ELONGATION,5.361424611,0,SKF-91488
G1_S_DNA_DAMAGE_CHECKPOINTS,2.708565646,0,SKF-91488
SCF_SKP2_MEDIATED_DEGRADATION_OF_P27_P21,2.717896537,0,SKF-91488
APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1,2.718798162,0,SKF-91488
THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT,2.720220291,0,SKF-91488
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,2.730267319,0,SKF-91488
REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS,2.753505041,0,SKF-91488
HEDGEHOG_OFF_STATE,2.697782997,0,SKF-91488
AUF1_HNRNP_D0_BINDS_AND_DESTABILIZES_MRNA,2.753930224,0,SKF-91488
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,2.806812921,0,SKF-91488
SIGNALING_BY_GPCR,2.115825974,0.037597184,ropivacaine
GPCR_LIGAND_BINDING,1.811220759,0.158743666,ropivacaine
RRNA_PROCESSING,1.721117748,0.171972305,ropivacaine
METABOLISM_OF_LIPIDS,-1.743708053,0.67271004,ropivacaine
NEUTROPHIL_DEGRANULATION,-1.70547162,0.425304396,ropivacaine
S_PHASE,1.584737235,0.277540324,ropivacaine
APOPTOSIS,1.581827698,0.225583104,ropivacaine
G_ALPHA_I_SIGNALLING_EVENTS,1.542015679,0.228890264,ropivacaine
HIV_INFECTION,1.402463501,0.379254135,ropivacaine
TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,-1.484430397,1,ropivacaine
CELL_CYCLE_MITOTIC,2.402385031,0.018961684,acepromazine
RHO_GTPASES_ACTIVATE_FORMINS,2.300062389,0.017065516,acepromazine
SEPARATION_OF_SISTER_CHROMATIDS,2.262721177,0.015169347,acepromazine
BILE_ACID_AND_BILE_SALT_METABOLISM,-2.207565256,0.009148276,acepromazine
RRNA_PROCESSING,2.205903149,0.015169347,acepromazine
HOST_INTERACTIONS_OF_HIV_FACTORS,2.204245168,0.012135478,acepromazine
RESOLUTION_OF_SISTER_CHROMATID_COHESION,2.167732478,0.010112898,acepromazine
MITOTIC_METAPHASE_AND_ANAPHASE,2.165397409,0.008668199,acepromazine
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,2.024887424,0.021805937,acepromazine
CELL_CYCLE,1.943518695,0.031181436,acepromazine
MRNA_SPLICING,-3.338097998,0,exemestane
METABOLISM_OF_RNA,-3.195562595,0,exemestane
GPCR_LIGAND_BINDING,2.531872384,0,exemestane
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.529869419,0,exemestane
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.819160579,0.000978308,exemestane
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,-2.558255674,0.001467462,exemestane
G_ALPHA_Q_SIGNALLING_EVENTS,2.405633672,0.000151783,exemestane
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,-2.484464554,0.002934923,exemestane
COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC,-2.323599282,0.007826462,exemestane
SIGNALING_BY_GPCR,2.245436602,0.002049074,exemestane
GPCR_LIGAND_BINDING,3.18426143,0,BRD-K19136521
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.742694459,0,BRD-K19136521
NEUTROPHIL_DEGRANULATION,-2.74181983,0,BRD-K19136521
MUSCLE_CONTRACTION,2.604177614,0.000372361,BRD-K19136521
INNATE_IMMUNE_SYSTEM,-2.481447635,0.001411025,BRD-K19136521
SIGNALING_BY_GPCR,2.486852923,0.001954894,BRD-K19136521
G_ALPHA_Q_SIGNALLING_EVENTS,2.484148874,0.001563915,BRD-K19136521
G_ALPHA_I_SIGNALLING_EVENTS,2.386751485,0.003351247,BRD-K19136521
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.163977798,0.012447489,BRD-K19136521
SENSORY_PERCEPTION,2.0310081,0.027508152,BRD-K19136521
EUKARYOTIC_TRANSLATION_ELONGATION,-3.810747111,0,danazol
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-3.674689052,0,danazol
GPCR_LIGAND_BINDING,3.730116987,0,danazol
EUKARYOTIC_TRANSLATION_INITIATION,-3.73895827,0,danazol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,3.555147071,0,danazol
SELENOAMINO_ACID_METABOLISM,-3.756954839,0,danazol
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-3.77585837,0,danazol
NONSENSE_MEDIATED_DECAY_NMD,-3.810349077,0,danazol
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-3.746496729,0,danazol
SIGNALING_BY_GPCR,3.249145499,0,danazol
STRIATED_MUSCLE_CONTRACTION,3.088157901,0,mycophenolate-mofetil
MUSCLE_CONTRACTION,3.001121392,0,mycophenolate-mofetil
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,2.135609808,0.027362971,mycophenolate-mofetil
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,1.86584408,0.108230322,mycophenolate-mofetil
CARDIAC_CONDUCTION,1.825000922,0.108279185,mycophenolate-mofetil
NEURONAL_SYSTEM,1.822775074,0.091698527,mycophenolate-mofetil
TP53_REGULATES_METABOLIC_GENES,1.744992077,0.124110618,mycophenolate-mofetil
SIGNALING_BY_ALK_IN_CANCER,1.739025837,0.112261474,mycophenolate-mofetil
RAC1_GTPASE_CYCLE,-1.769064455,1,mycophenolate-mofetil
MITOTIC_SPINDLE_CHECKPOINT,-1.738820759,1,mycophenolate-mofetil
INFLUENZA_INFECTION,3.111623561,0,atomoxetine
EUKARYOTIC_TRANSLATION_ELONGATION,2.911577579,0,atomoxetine
CELLULAR_RESPONSE_TO_STARVATION,2.902043253,0,atomoxetine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.867139913,0,atomoxetine
RRNA_PROCESSING,2.819827171,0,atomoxetine
EUKARYOTIC_TRANSLATION_INITIATION,2.772074256,0,atomoxetine
NONSENSE_MEDIATED_DECAY_NMD,2.754188428,0,atomoxetine
SARS_COV_1_INFECTION,2.595123824,0.001049341,atomoxetine
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,2.637091329,0.001180508,atomoxetine
TRANSLATION,2.338990386,0.001180508,atomoxetine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.395847598,0.01023609,TG-100115
PEROXISOMAL_PROTEIN_IMPORT,2.326281861,0.01023609,TG-100115
PROTEIN_LOCALIZATION,2.201457874,0.021609524,TG-100115
HIV_LIFE_CYCLE,1.842771993,0.163777448,TG-100115
NONSENSE_MEDIATED_DECAY_NMD,1.790784886,0.17196632,TG-100115
INFLUENZA_INFECTION,1.692257855,0.242822813,TG-100115
AURKA_ACTIVATION_BY_TPX2,1.678701755,0.222269393,TG-100115
CIRCADIAN_CLOCK,1.617994167,0.264432337,TG-100115
CARDIAC_CONDUCTION,-1.763985633,0.65313458,TG-100115
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.754986696,0.356971831,TG-100115
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,2.706900531,0,pilocarpine
CARDIAC_CONDUCTION,2.521531413,0.000903953,pilocarpine
DEVELOPMENTAL_CELL_LINEAGES,2.364713526,0.002008784,pilocarpine
GPCR_LIGAND_BINDING,2.131851941,0.012655341,pilocarpine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.06313852,0.015789045,pilocarpine
POTASSIUM_CHANNELS,2.05793584,0.013760173,pilocarpine
SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,2.026680612,0.015151973,pilocarpine
SIGNALING_BY_GPCR,2.006901674,0.014990553,pilocarpine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.907273933,0.374054402,pilocarpine
EUKARYOTIC_TRANSLATION_ELONGATION,-2.864253876,0.380251086,pilocarpine
MUSCLE_CONTRACTION,3.161596623,0,nilutamide
STRIATED_MUSCLE_CONTRACTION,3.065792116,0,nilutamide
NEUTROPHIL_DEGRANULATION,-2.420002774,0.004366438,nilutamide
SENSORY_PERCEPTION,2.101731639,0.029268198,nilutamide
COPII_MEDIATED_VESICLE_TRANSPORT,-2.209915287,0.036678078,nilutamide
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.188294706,0.029982874,nilutamide
EUKARYOTIC_TRANSLATION_ELONGATION,-2.172569938,0.027071915,nilutamide
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.103164868,0.039472599,nilutamide
SELENOAMINO_ACID_METABOLISM,-2.099037307,0.033912668,nilutamide
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.059729037,0.039422696,nilutamide
PI_METABOLISM,-2.132007867,0.03980026,minoxidil
ANTIGEN_PROCESSING_CROSS_PRESENTATION,1.984138507,0.318551853,minoxidil
AUTOPHAGY,1.878001037,0.295191384,minoxidil
TRNA_PROCESSING_IN_THE_NUCLEUS,1.874701609,0.201041614,minoxidil
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,1.818271136,0.202811347,minoxidil
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.799005354,0.177539566,minoxidil
HOST_INTERACTIONS_OF_HIV_FACTORS,1.765896747,0.182990342,minoxidil
TRANSCRIPTIONAL_REGULATION_BY_RUNX3,1.71521054,0.210850989,minoxidil
GLYCOSAMINOGLYCAN_METABOLISM,1.681186932,0.224579056,minoxidil
GPCR_LIGAND_BINDING,1.656771614,0.226053834,minoxidil
TRANSLATION,3.73127556,0,verapamil
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.659964451,0,verapamil
EUKARYOTIC_TRANSLATION_INITIATION,3.647400986,0,verapamil
EUKARYOTIC_TRANSLATION_ELONGATION,3.527229693,0,verapamil
RRNA_PROCESSING,3.465406425,0,verapamil
SELENOAMINO_ACID_METABOLISM,3.343183424,0,verapamil
INFLUENZA_INFECTION,3.222382326,0,verapamil
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.214730804,0,verapamil
NONSENSE_MEDIATED_DECAY_NMD,3.138786541,0,verapamil
CELLULAR_RESPONSE_TO_STARVATION,2.818660108,0,verapamil
TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,1.795834985,1,diethylcarbamazine
DISEASES_OF_DNA_REPAIR,1.776626782,0.67949306,diethylcarbamazine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.764133587,0.492847267,diethylcarbamazine
NEURONAL_SYSTEM,-1.759216053,1,diethylcarbamazine
TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,1.686763172,0.592294193,diethylcarbamazine
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,-1.707296993,0.975239124,diethylcarbamazine
TRANSPORT_OF_SMALL_MOLECULES,-1.681016894,0.754390363,diethylcarbamazine
REGULATION_OF_TP53_ACTIVITY,1.651360897,0.584835673,diethylcarbamazine
MYD88_INDEPENDENT_TLR4_CASCADE,1.605512395,0.635802223,diethylcarbamazine
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,1.582935251,0.617051463,diethylcarbamazine
EUKARYOTIC_TRANSLATION_INITIATION,-4.132782087,0,beclomethasone-dipropionate
G_ALPHA_I_SIGNALLING_EVENTS,2.729119113,0,beclomethasone-dipropionate
METABOLISM_OF_RNA,-2.7992283,0,beclomethasone-dipropionate
G_ALPHA_Q_SIGNALLING_EVENTS,2.816739494,0,beclomethasone-dipropionate
CELLULAR_RESPONSES_TO_STIMULI,-2.870569806,0,beclomethasone-dipropionate
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.912849808,0,beclomethasone-dipropionate
SARS_COV_1_INFECTION,-3.054662397,0,beclomethasone-dipropionate
MUSCLE_CONTRACTION,3.066886629,0,beclomethasone-dipropionate
NEUTROPHIL_DEGRANULATION,-3.128125565,0,beclomethasone-dipropionate
SARS_COV_1_HOST_INTERACTIONS,-3.162818721,0,beclomethasone-dipropionate
INFLUENZA_INFECTION,3.202589809,0,tiludronate
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,2.435644089,0,tiludronate
NONSENSE_MEDIATED_DECAY_NMD,2.561646017,0,tiludronate
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.66101656,0,tiludronate
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.430124824,0,tiludronate
RRNA_PROCESSING,2.846361935,0,tiludronate
CELLULAR_RESPONSE_TO_STARVATION,2.883369377,0,tiludronate
TRANSLATION,2.956855199,0,tiludronate
SELENOAMINO_ACID_METABOLISM,2.732275723,0,tiludronate
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,2.354472175,0.000976394,tiludronate
GPCR_LIGAND_BINDING,-2.465100949,0,travoprost
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.44619898,0,travoprost
INFLUENZA_INFECTION,2.504002087,0.011474555,travoprost
SENSORY_PERCEPTION,-2.211572841,0.003084922,travoprost
TRANSLATION,2.186254524,0.045898219,travoprost
SIGNALING_BY_GPCR,-2.159243377,0.005123175,travoprost
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.150551114,0.004495173,travoprost
NEUTROPHIL_DEGRANULATION,2.009338877,0.087971587,travoprost
G_ALPHA_Q_SIGNALLING_EVENTS,-2.105784067,0.005839317,travoprost
SARS_COV_1_INFECTION,1.981492327,0.076018926,travoprost
EUKARYOTIC_TRANSLATION_ELONGATION,2.890813798,0,sulfasalazine
AMINE_LIGAND_BINDING_RECEPTORS,-2.227819065,0,sulfasalazine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.334625466,0,sulfasalazine
GPCR_LIGAND_BINDING,-2.25234545,0,sulfasalazine
INFLUENZA_INFECTION,2.791727566,0,sulfasalazine
CELLULAR_RESPONSE_TO_STARVATION,2.578990376,0.002144082,sulfasalazine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.207115576,0.000564232,sulfasalazine
SARS_COV_2_INFECTION,2.219734702,0.000595578,sulfasalazine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.633339198,0.002680103,sulfasalazine
NONSENSE_MEDIATED_DECAY_NMD,2.244408073,0.000670026,sulfasalazine
METABOLISM_OF_RNA,-3.036628814,0,nelarabine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,3.015170015,0,nelarabine
GPCR_LIGAND_BINDING,2.9547365,0,nelarabine
CELL_CYCLE_MITOTIC,-2.549780027,0.003042483,nelarabine
EPH_EPHRIN_SIGNALING,-2.501282254,0.002535402,nelarabine
CELL_CYCLE,-2.466164046,0.003042483,nelarabine
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.434988608,0.000727941,nelarabine
MITOTIC_G2_G2_M_PHASES,-2.433790356,0.003346731,nelarabine
PKR_MEDIATED_SIGNALING,-2.405709577,0.003549563,nelarabine
REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS,-2.376641036,0.003694444,nelarabine
GPCR_LIGAND_BINDING,-2.416366342,0.001581282,clotrimazole
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.368189025,0.000790641,clotrimazole
G_ALPHA_Q_SIGNALLING_EVENTS,-2.304363983,0.001054188,clotrimazole
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.160786349,0.007313429,clotrimazole
SIGNALING_BY_GPCR,-2.121347865,0.008697051,clotrimazole
RHO_GTPASE_CYCLE,2.001160433,0.276525223,clotrimazole
SIGNALING_BY_NTRKS,1.978420337,0.15421599,clotrimazole
SENSORY_PERCEPTION,-2.001147494,0.024378098,clotrimazole
SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3,1.84001135,0.220688399,clotrimazole
KERATINIZATION,-1.921741727,0.049697435,clotrimazole
SELENOAMINO_ACID_METABOLISM,3.086767069,0,azelaic-acid
INFLUENZA_INFECTION,3.029229264,0,azelaic-acid
NONSENSE_MEDIATED_DECAY_NMD,3.02591645,0,azelaic-acid
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.979727037,0,azelaic-acid
CELLULAR_RESPONSE_TO_STARVATION,2.935768141,0,azelaic-acid
EUKARYOTIC_TRANSLATION_ELONGATION,2.928123371,0,azelaic-acid
EUKARYOTIC_TRANSLATION_INITIATION,2.911898002,0,azelaic-acid
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.835345996,0,azelaic-acid
RRNA_PROCESSING,2.493050734,0,azelaic-acid
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.462845909,0,azelaic-acid
BIOLOGICAL_OXIDATIONS,2.130016974,0.117374743,ranolazine
FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS,2.121192912,0.065394499,ranolazine
PARASITE_INFECTION,2.110689854,0.048067752,ranolazine
GASTRULATION,-1.947438322,0.372713428,ranolazine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.869727625,0.185703611,ranolazine
VESICLE_MEDIATED_TRANSPORT,1.746982588,0.302491479,ranolazine
INNATE_IMMUNE_SYSTEM,1.70473092,0.318588587,ranolazine
PEPTIDE_HORMONE_METABOLISM,1.669320501,0.324337554,ranolazine
MEMBRANE_TRAFFICKING,1.643821717,0.323618933,ranolazine
PHASE_II_CONJUGATION_OF_COMPOUNDS,1.639743256,0.295858875,ranolazine
G_ALPHA_Q_SIGNALLING_EVENTS,-1.995934094,0.009829555,clomethiazole
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.977351864,0.006255171,clomethiazole
GPCR_LIGAND_BINDING,-1.969874512,0.004765845,clomethiazole
SIGNALING_BY_GPCR,-1.894323986,0.013180539,clomethiazole
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.810701096,0.224124514,clomethiazole
PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS,1.738907044,0.15233463,clomethiazole
BIOLOGICAL_OXIDATIONS,1.670362454,0.151750973,clomethiazole
TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,1.632168456,0.145330739,clomethiazole
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,1.560925646,0.169494163,clomethiazole
CIRCADIAN_CLOCK,1.56022867,0.142996109,clomethiazole
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,5.417010548,0,nitisinone
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,2.931589382,0,nitisinone
RESPIRATORY_ELECTRON_TRANSPORT,2.910527137,0,nitisinone
DOWNSTREAM_TCR_SIGNALING,2.884494831,0,nitisinone
HIV_INFECTION,2.870154451,0,nitisinone
KEAP1_NFE2L2_PATHWAY,2.856738038,0,nitisinone
REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS,2.85039512,0,nitisinone
CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6,2.837705763,0,nitisinone
ORC1_REMOVAL_FROM_CHROMATIN,2.827915489,0,nitisinone
NUCLEAR_EVENTS_MEDIATED_BY_NFE2L2,2.809623398,0,nitisinone
GOLGI_TO_ER_RETROGRADE_TRANSPORT,-2.640565475,0.006562999,ibrutinib
GPCR_LIGAND_BINDING,2.295248146,0.004380364,ibrutinib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.281213736,0.003066255,ibrutinib
MHC_CLASS_II_ANTIGEN_PRESENTATION,-2.260408159,0.022970496,ibrutinib
METABOLISM_OF_RNA,-2.044420398,0.037190327,ibrutinib
MITOTIC_METAPHASE_AND_ANAPHASE,-1.946760096,0.047581742,ibrutinib
RRNA_PROCESSING,-1.883136812,0.051191391,ibrutinib
SIGNALING_BY_GPCR,2.031979139,0.033582788,ibrutinib
AMINE_LIGAND_BINDING_RECEPTORS,1.974112725,0.043803636,ibrutinib
COPI_MEDIATED_ANTEROGRADE_TRANSPORT,-1.786904394,0.073651432,ibrutinib
RRNA_PROCESSING,-2.676969952,0,VX-745
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.505168626,0,VX-745
GPCR_LIGAND_BINDING,2.48949658,0,VX-745
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.391949158,0.000217327,VX-745
SIGNALING_BY_GPCR,2.132553476,0.00146696,VX-745
SENSORY_PERCEPTION,2.108942075,0.001564757,VX-745
NUCLEOTIDE_EXCISION_REPAIR,-2.055884617,0.083734561,VX-745
METABOLISM_OF_RNA,-2.008881352,0.075919336,VX-745
TRANSLATION,-1.991940661,0.063638267,VX-745
GLOBAL_GENOME_NUCLEOTIDE_EXCISION_REPAIR_GG_NER,-1.952449063,0.057609378,VX-745
EUKARYOTIC_TRANSLATION_ELONGATION,4.719169555,0,ubenimex
DNA_REPLICATION,2.531229744,0,ubenimex
HIV_INFECTION,2.551310532,0,ubenimex
MRNA_SPLICING,2.590844911,0,ubenimex
SYNTHESIS_OF_DNA,2.648592948,0,ubenimex
HOST_INTERACTIONS_OF_HIV_FACTORS,2.686829224,0,ubenimex
G2_M_CHECKPOINTS,2.715020611,0,ubenimex
SARS_COV_2_HOST_INTERACTIONS,2.779029213,0,ubenimex
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.886505885,0,ubenimex
S_PHASE,2.93119135,0,ubenimex
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.276347903,0.001890803,orlistat
ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES,2.291062096,0.009414423,orlistat
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.148572619,0.005672409,orlistat
GPCR_LIGAND_BINDING,-2.14406405,0.004411874,orlistat
INTERFERON_ALPHA_BETA_SIGNALING,2.082026189,0.017259775,orlistat
SIGNALING_BY_GPCR,-1.946379745,0.031907302,orlistat
TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,1.705697173,0.130755874,orlistat
G_ALPHA_Q_SIGNALLING_EVENTS,-1.862714456,0.062396503,orlistat
G_ALPHA_I_SIGNALLING_EVENTS,-1.85558819,0.054990857,orlistat
MITOTIC_PROPHASE,1.5068542,0.283217222,orlistat
EUKARYOTIC_TRANSLATION_INITIATION,4.930374876,0,tetryzoline
APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1,3.269238553,0,tetryzoline
THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT,3.257538791,0,tetryzoline
REGULATION_OF_RUNX2_EXPRESSION_AND_ACTIVITY,3.245092663,0,tetryzoline
UBIQUITIN_DEPENDENT_DEGRADATION_OF_CYCLIN_D,3.232728829,0,tetryzoline
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.223776855,0,tetryzoline
G2_M_CHECKPOINTS,3.203332245,0,tetryzoline
ACTIVATION_OF_APC_C_AND_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS,3.193466429,0,tetryzoline
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,3.147193437,0,tetryzoline
CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6,3.106969857,0,tetryzoline
MITOTIC_METAPHASE_AND_ANAPHASE,3.83374589,0,doxepin
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,2.654888575,0,doxepin
APC_C_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS,2.663071096,0,doxepin
S_PHASE,2.775176298,0,doxepin
RRNA_MODIFICATION_IN_THE_NUCLEUS_AND_CYTOSOL,2.82345538,0,doxepin
APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1,2.875989933,0,doxepin
RHO_GTPASES_ACTIVATE_FORMINS,2.889091323,0,doxepin
CELL_CYCLE_CHECKPOINTS,2.889595915,0,doxepin
RESOLUTION_OF_SISTER_CHROMATID_COHESION,3.105102333,0,doxepin
REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS,3.037165699,0,doxepin
INFLUENZA_INFECTION,2.199694688,0.099749438,tacrolimus
PROGRAMMED_CELL_DEATH,2.17570763,0.055416354,tacrolimus
APOPTOSIS,1.962682415,0.1668648,tacrolimus
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.947458462,0.349824283,tacrolimus
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-1.928594926,0.205503771,tacrolimus
G_ALPHA_I_SIGNALLING_EVENTS,-1.924812085,0.142041136,tacrolimus
NUCLEAR_EVENTS_MEDIATED_BY_NFE2L2,1.832254899,0.271078333,tacrolimus
REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE,1.772887147,0.307006602,tacrolimus
GPCR_LIGAND_BINDING,-1.837820865,0.211082245,tacrolimus
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.821142479,0.191467612,tacrolimus
EUKARYOTIC_TRANSLATION_ELONGATION,2.352331346,0.01936598,tadalafil
CELLULAR_RESPONSE_TO_STARVATION,2.301369753,0.013407217,tadalafil
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.291365147,0.010427835,tadalafil
NONSENSE_MEDIATED_DECAY_NMD,2.28423183,0.008938145,tadalafil
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.223177802,0.011023712,tadalafil
EUKARYOTIC_TRANSLATION_INITIATION,2.192566719,0.012662372,tadalafil
SIGNALING_BY_ROBO_RECEPTORS,2.173175389,0.012768778,tadalafil
INFLUENZA_INFECTION,2.149554401,0.014524485,tadalafil
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.110997365,0.017214204,tadalafil
NEUTROPHIL_DEGRANULATION,-2.292516483,0.090963361,tadalafil
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-3.167435494,0,reversine
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-3.063585352,0.002001735,reversine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.990145393,0.007117279,reversine
NEUTROPHIL_DEGRANULATION,-2.737304447,0.163808634,reversine
INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,-2.731035389,0.143057316,reversine
GPCR_LIGAND_BINDING,1.892188698,0.313696958,reversine
SIGNALING_BY_GPCR,1.848237144,0.211305817,reversine
HEMOSTASIS,-2.669874765,0.298036076,reversine
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,-2.668706732,0.261178736,reversine
KERATINIZATION,1.724845854,0.300082623,reversine
GPCR_LIGAND_BINDING,2.240547438,0.013450845,naltrexone
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.207614065,0.010346804,naltrexone
SIGNALING_BY_GPCR,2.165172006,0.012761058,naltrexone
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.926224808,0.125196324,naltrexone
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-3.471346913,0.790141778,naltrexone
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,1.858819233,0.185000849,naltrexone
SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR,1.827440311,0.198486183,naltrexone
SCF_SKP2_MEDIATED_DEGRADATION_OF_P27_P21,1.81615998,0.1866859,naltrexone
THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT,1.814868062,0.164772848,naltrexone
FORMATION_OF_PARAXIAL_MESODERM,1.805934601,0.157156451,naltrexone
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,3.444109874,0,dinoprostone
SIGNALING_BY_GPCR,3.146801966,0,dinoprostone
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.757772821,0,dinoprostone
GPCR_LIGAND_BINDING,3.341048786,0,dinoprostone
G_ALPHA_Q_SIGNALLING_EVENTS,2.537705968,0.00017743,dinoprostone
AMINE_LIGAND_BINDING_RECEPTORS,2.296335078,0.00096108,dinoprostone
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,2.264075809,0.001140622,dinoprostone
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,2.208446394,0.001885195,dinoprostone
G_ALPHA_I_SIGNALLING_EVENTS,2.178185839,0.002415022,dinoprostone
NEUTROPHIL_DEGRANULATION,-3.193430446,0.182745132,dinoprostone
METABOLISM_OF_RNA,3.372118304,0,donepezil
MRNA_SPLICING,2.777587077,0,donepezil
GPCR_LIGAND_BINDING,-2.265876838,0,donepezil
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.250023124,0,donepezil
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.237485347,0,donepezil
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.548608451,0.001565533,donepezil
INTERFERON_ALPHA_BETA_SIGNALING,2.144322783,0.010567349,donepezil
SIGNALING_BY_GPCR,-2.070913253,0.00223306,donepezil
ISG15_ANTIVIRAL_MECHANISM,1.720758205,0.124929551,donepezil
TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM,1.627046834,0.18003632,donepezil
GPCR_LIGAND_BINDING,-2.501098681,0,fluorouracil
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.443684646,0,fluorouracil
TRANSCRIPTIONAL_REGULATION_BY_TP53,2.412105694,0.003564619,fluorouracil
SENSORY_PERCEPTION,-2.338781366,0.000436061,fluorouracil
SIGNALING_BY_GPCR,-2.275709261,0.000327046,fluorouracil
G_ALPHA_S_SIGNALLING_EVENTS,-2.213767913,0.000915728,fluorouracil
KERATINIZATION,-2.158186305,0.002398336,fluorouracil
INFLUENZA_INFECTION,2.021135787,0.108720882,fluorouracil
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,1.974737083,0.09149189,fluorouracil
REGULATION_OF_TP53_ACTIVITY,1.935047297,0.086442013,fluorouracil
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.194418258,0.005433689,neostigmine
FATTY_ACID_METABOLISM,1.981650053,0.018112296,neostigmine
MRNA_SPLICING,1.968754233,0.013886094,neostigmine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.999822079,0.026041346,neostigmine
RAB_REGULATION_OF_TRAFFICKING,1.957641746,0.011772993,neostigmine
GPCR_LIGAND_BINDING,-1.90279035,0.04388449,neostigmine
CLATHRIN_MEDIATED_ENDOCYTOSIS,1.699254426,0.03731133,neostigmine
G_ALPHA_Q_SIGNALLING_EVENTS,-1.805409859,0.099342911,neostigmine
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.799476356,0.081017519,neostigmine
MEMBRANE_TRAFFICKING,1.307159725,0.345944858,neostigmine
EUKARYOTIC_TRANSLATION_INITIATION,-2.828051639,0,topiramate
EUKARYOTIC_TRANSLATION_ELONGATION,-2.78994453,0,topiramate
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.669427657,0,topiramate
NONSENSE_MEDIATED_DECAY_NMD,-2.619822423,0,topiramate
SELENOAMINO_ACID_METABOLISM,-2.564138311,0.000194274,topiramate
RRNA_PROCESSING,-2.533169017,0.000485686,topiramate
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.528108261,0.000416302,topiramate
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.526400096,0.000364264,topiramate
TRANSLATION,-2.48364693,0.000539651,topiramate
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.423810851,0.000485686,topiramate
NEUTROPHIL_DEGRANULATION,2.061693183,0.093379791,linagliptin
KERATINIZATION,-2.131925031,0.036540228,linagliptin
GPCR_LIGAND_BINDING,-2.130965693,0.018270114,linagliptin
SUMOYLATION,1.975887637,0.093379791,linagliptin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.059257907,0.025121407,linagliptin
TOLL_LIKE_RECEPTOR_CASCADES,1.836149546,0.171196283,linagliptin
SIGNALING_BY_GPCR,-2.005765964,0.035208033,linagliptin
COMPLEMENT_CASCADE,1.812291368,0.147851336,linagliptin
SENSORY_PERCEPTION,-1.959363085,0.047350046,linagliptin
TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,1.754606034,0.171196283,linagliptin
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.106567909,0.166769972,metamizole
PEROXISOMAL_PROTEIN_IMPORT,1.958000777,0.313274401,metamizole
GPCR_LIGAND_BINDING,-1.803764129,0.64411157,metamizole
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.770305461,0.728638223,metamizole
RRNA_PROCESSING,-1.679819151,0.84084022,metamizole
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.678442351,0.63612259,metamizole
TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,1.646867839,1,metamizole
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.567643742,0.879786501,metamizole
METABOLISM_OF_RNA,-1.543008964,0.821200643,metamizole
MUSCLE_CONTRACTION,1.601549153,1,metamizole
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.445112209,0.018332452,baricitinib
MRNA_SPLICING,2.07389172,0.04583113,baricitinib
GPCR_LIGAND_BINDING,-2.482057159,0.135040288,baricitinib
RAB_GEFS_EXCHANGE_GTP_FOR_GDP_ON_RABS,1.696606863,0.279569892,baricitinib
RAB_REGULATION_OF_TRAFFICKING,1.677340245,0.231447206,baricitinib
DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS,1.655882359,0.201656972,baricitinib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.427936056,0.153963131,baricitinib
CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6,1.547091308,0.327692579,baricitinib
TRNA_PROCESSING,1.499561694,0.359447005,baricitinib
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.33209829,0.281262257,baricitinib
CELL_CYCLE_MITOTIC,-2.589972693,0,PCI-24781
CELL_CYCLE,-2.524915361,0,PCI-24781
CELL_CYCLE_CHECKPOINTS,-2.2939275,0.00219692,PCI-24781
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,-2.215361111,0.00329538,PCI-24781
MITOTIC_PROMETAPHASE,-2.212611966,0.002636304,PCI-24781
DNA_DOUBLE_STRAND_BREAK_REPAIR,-2.192494576,0.003112304,PCI-24781
RNA_POLYMERASE_II_TRANSCRIPTION,-2.160153832,0.005021532,PCI-24781
S_PHASE,-2.159797459,0.004393841,PCI-24781
M_PHASE,-2.139901969,0.005004096,PCI-24781
METABOLISM_OF_RNA,-2.12551195,0.005162763,PCI-24781
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.054059193,0.14095757,rupatadine
GASTRULATION,-2.012720183,0.319546637,rupatadine
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.96001996,0.251293957,rupatadine
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,1.86138733,0.24914475,rupatadine
SIGNALING_BY_ALK_IN_CANCER,1.814994365,0.213680903,rupatadine
CILIUM_ASSEMBLY,1.775309609,0.207171716,rupatadine
VESICLE_MEDIATED_TRANSPORT,1.763187934,0.179922911,rupatadine
MEMBRANE_TRAFFICKING,1.739450506,0.17163305,rupatadine
DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR,-1.830549904,0.516376334,rupatadine
TNFR2_NON_CANONICAL_NF_KB_PATHWAY,-1.791435871,0.525080274,rupatadine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.198374312,0.040647171,voapaxar
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.185221178,0.022485669,voapaxar
EUKARYOTIC_TRANSLATION_ELONGATION,2.148880225,0.02363878,voapaxar
NONSENSE_MEDIATED_DECAY_NMD,2.12704539,0.021620836,voapaxar
CELLULAR_RESPONSE_TO_STARVATION,2.099027263,0.022139736,voapaxar
INFLUENZA_INFECTION,1.989958844,0.04338581,voapaxar
GLYCOSAMINOGLYCAN_METABOLISM,-2.189402691,0.439012238,voapaxar
SELENOAMINO_ACID_METABOLISM,1.967609281,0.044724243,voapaxar
EUKARYOTIC_TRANSLATION_INITIATION,1.964649522,0.039674233,voapaxar
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.148247479,0.289322081,voapaxar
SEPARATION_OF_SISTER_CHROMATIDS,2.401525673,0.01002907,phenazopyridine
ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT,2.364289417,0.008357558,phenazopyridine
MITOTIC_METAPHASE_AND_ANAPHASE,2.271970071,0.01002907,phenazopyridine
METABOLISM_OF_RNA,2.174061809,0.013372093,phenazopyridine
LEISHMANIA_INFECTION,-3.033653873,0.031391743,phenazopyridine
MRNA_SPLICING,2.040827424,0.031424419,phenazopyridine
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,-3.012404206,0.027180655,phenazopyridine
RESOLUTION_OF_SISTER_CHROMATID_COHESION,1.996840849,0.033430233,phenazopyridine
RHO_GTPASES_ACTIVATE_FORMINS,1.926939966,0.042981728,phenazopyridine
MITOCHONDRIAL_PROTEIN_DEGRADATION,1.884715139,0.046802326,phenazopyridine
TRANSLATION,4.794748067,0,purvalanol-b
VIRAL_INFECTION_PATHWAYS,2.887713015,0,purvalanol-b
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.891111492,0,purvalanol-b
DNA_REPLICATION,2.97040203,0,purvalanol-b
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,3.184185045,0,purvalanol-b
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.3184606,0,purvalanol-b
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,3.505687563,0,purvalanol-b
NONSENSE_MEDIATED_DECAY_NMD,3.575105422,0,purvalanol-b
INFLUENZA_INFECTION,3.624980305,0,purvalanol-b
SIGNALING_BY_ROBO_RECEPTORS,3.682022033,0,purvalanol-b
EUKARYOTIC_TRANSLATION_INITIATION,5.046046369,0,homatropine
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,3.536286605,0,homatropine
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,3.608909278,0,homatropine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,3.667706933,0,homatropine
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,3.734058297,0,homatropine
RESPIRATORY_ELECTRON_TRANSPORT,3.742309712,0,homatropine
INFLUENZA_INFECTION,3.929697972,0,homatropine
SIGNALING_BY_ROBO_RECEPTORS,4.441660278,0,homatropine
METABOLISM_OF_RNA,4.443042156,0,homatropine
CELLULAR_RESPONSE_TO_STARVATION,4.313754765,0,homatropine
RRNA_PROCESSING,4.351369223,0,pirlindole
SYNTHESIS_OF_DNA,2.576106971,0,pirlindole
APC_C_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS,2.60788827,0,pirlindole
MITOCHONDRIAL_TRANSLATION,2.644790774,0,pirlindole
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,2.649341053,0,pirlindole
ACTIVATION_OF_APC_C_AND_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS,2.661954292,0,pirlindole
CELL_CYCLE_CHECKPOINTS,2.774567425,0,pirlindole
THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT,2.81134571,0,pirlindole
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.82161881,0,pirlindole
APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1,2.837894894,0,pirlindole
TRANSLATION,-3.446805316,0,xaliproden
G_ALPHA_Q_SIGNALLING_EVENTS,2.521580626,0,xaliproden
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.551169712,0,xaliproden
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.632290503,0,xaliproden
MITOTIC_METAPHASE_AND_ANAPHASE,-2.64591315,0,xaliproden
CELL_CYCLE_MITOTIC,-2.67240496,0,xaliproden
EUKARYOTIC_TRANSLATION_ELONGATION,-2.683999844,0,xaliproden
CELL_CYCLE_CHECKPOINTS,-2.690188036,0,xaliproden
SELENOAMINO_ACID_METABOLISM,-2.714121969,0,xaliproden
CELLULAR_RESPONSE_TO_STARVATION,-2.71504182,0,xaliproden
S_PHASE,2.547071163,0.004400671,practolol
DNA_REPLICATION,2.522151108,0.003667225,practolol
SYNTHESIS_OF_DNA,2.451049232,0.003911707,practolol
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.415820754,0.003300503,practolol
MUSCLE_CONTRACTION,2.40852914,0.002640402,practolol
NEUTROPHIL_DEGRANULATION,-2.265314238,0.026018946,practolol
PEROXISOMAL_PROTEIN_IMPORT,-2.209438999,0.02154694,practolol
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,2.186130493,0.016624756,practolol
G2_M_CHECKPOINTS,2.004732396,0.038977368,practolol
DNA_REPLICATION_PRE_INITIATION,1.98757558,0.036305532,practolol
MUSCLE_CONTRACTION,2.651506884,0,orphenadrine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.64752766,0,orphenadrine
GPCR_LIGAND_BINDING,-1.996136211,0.222723228,orphenadrine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.975448189,0.140839688,orphenadrine
NEUTROPHIL_DEGRANULATION,1.802157203,0.229969829,orphenadrine
SIGNALING_BY_ROBO_RECEPTORS,1.74984679,0.231310761,orphenadrine
UNFOLDED_PROTEIN_RESPONSE_UPR,1.739039526,0.200737513,orphenadrine
SIGNALING_BY_GPCR,-1.891774067,0.18451091,orphenadrine
KEAP1_NFE2L2_PATHWAY,1.704765891,0.20315119,orphenadrine
HOST_INTERACTIONS_OF_HIV_FACTORS,1.680514066,0.20085245,orphenadrine
METABOLISM_OF_RNA,4.607512642,0,cisapride
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.996305291,0,cisapride
MITOTIC_METAPHASE_AND_ANAPHASE,2.992889562,0,cisapride
CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6,2.97384139,0,cisapride
HOST_INTERACTIONS_OF_HIV_FACTORS,2.973005151,0,cisapride
SCF_SKP2_MEDIATED_DEGRADATION_OF_P27_P21,2.969994461,0,cisapride
REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS,2.943263161,0,cisapride
AUF1_HNRNP_D0_BINDS_AND_DESTABILIZES_MRNA,3.03184093,0,cisapride
ASYMMETRIC_LOCALIZATION_OF_PCP_PROTEINS,2.900953991,0,cisapride
REGULATION_OF_RUNX2_EXPRESSION_AND_ACTIVITY,2.884740553,0,cisapride
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-3.108431729,0.063548221,retinol
G_ALPHA_Q_SIGNALLING_EVENTS,1.892678405,0.148050297,retinol
BIOLOGICAL_OXIDATIONS,-2.976915451,0.254931817,retinol
SIGNALING_BY_GPCR,1.821036713,0.120974951,retinol
SENSORY_PERCEPTION,1.715364871,0.170709097,retinol
AUTOPHAGY,1.682866349,0.1569794,retinol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.68194658,0.126505234,retinol
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.838351355,0.760608164,retinol
GPCR_LIGAND_BINDING,1.645026931,0.134416612,retinol
SIGNALING_BY_INTERLEUKINS,-2.742861403,0.837949797,retinol
PROTEIN_FOLDING,2.074126268,0.247378622,mesalazine
NEUTROPHIL_DEGRANULATION,2.002476263,0.250371106,mesalazine
RESOLUTION_OF_SISTER_CHROMATID_COHESION,1.97059369,0.220446272,mesalazine
ESR_MEDIATED_SIGNALING,1.96617931,0.172566539,mesalazine
RHO_GTPASES_ACTIVATE_FORMINS,1.94955749,0.155409635,mesalazine
THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT,1.924048555,0.15444539,mesalazine
SARS_COV_1_INFECTION,-1.640688234,0.934985231,mesalazine
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,1.89302107,0.167864065,mesalazine
HEMOSTASIS,1.888843603,0.151120408,mesalazine
SARS_COV_1_HOST_INTERACTIONS,-1.623496631,0.510731867,mesalazine
METABOLISM_OF_RNA,3.533148003,0,diphenoxylate
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.975925167,0,diphenoxylate
DNA_REPLICATION,2.879750512,0,diphenoxylate
SEPARATION_OF_SISTER_CHROMATIDS,2.820705847,0,diphenoxylate
RRNA_PROCESSING,2.811562745,0,diphenoxylate
DNA_REPLICATION_PRE_INITIATION,2.806424414,0,diphenoxylate
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,2.80406135,0,diphenoxylate
ORC1_REMOVAL_FROM_CHROMATIN,2.775636132,0,diphenoxylate
SYNTHESIS_OF_DNA,2.707474918,0.000302419,diphenoxylate
KEAP1_NFE2L2_PATHWAY,2.579458364,0.000340221,diphenoxylate
REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE,-2.0657584,0.248837209,tolbutamide
TRANSLATION,-1.965448873,0.252540144,tolbutamide
NEUTROPHIL_DEGRANULATION,-1.869921204,0.302653193,tolbutamide
RRNA_PROCESSING,-1.838439177,0.2777201,tolbutamide
CELLULAR_RESPONSE_TO_HEAT_STRESS,-1.773103525,0.313712625,tolbutamide
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.707637309,0.380908546,tolbutamide
NEURONAL_SYSTEM,1.736279382,1,tolbutamide
METABOLISM_OF_RNA,-1.652528041,0.436311501,tolbutamide
MUSCLE_CONTRACTION,1.722730716,0.698195167,tolbutamide
TRNA_PROCESSING,-1.621197254,0.446203627,tolbutamide
EXTRACELLULAR_MATRIX_ORGANIZATION,3.049458648,0,acetylcholine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,3.017787295,0,acetylcholine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.854495229,0,acetylcholine
EUKARYOTIC_TRANSLATION_INITIATION,-2.634413046,0,acetylcholine
SELENOAMINO_ACID_METABOLISM,-2.628307623,0,acetylcholine
EUKARYOTIC_TRANSLATION_ELONGATION,-2.625163632,0,acetylcholine
SIGNALING_BY_ROBO_RECEPTORS,-2.582826525,0,acetylcholine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.556141311,0,acetylcholine
TRANSLATION,-2.485889914,0.000472246,acetylcholine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.434145289,0.000688692,acetylcholine
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.386898951,0.017546996,candesartan-cilextil
S_PHASE,2.212438762,0.034296401,candesartan-cilextil
G_ALPHA_Q_SIGNALLING_EVENTS,2.08716364,0.073378347,candesartan-cilextil
ORC1_REMOVAL_FROM_CHROMATIN,2.079072169,0.059420509,candesartan-cilextil
NEUTROPHIL_DEGRANULATION,-2.086503368,0.115503827,candesartan-cilextil
PEROXISOMAL_PROTEIN_IMPORT,-2.079330946,0.060535138,candesartan-cilextil
PTEN_REGULATION,2.036018701,0.06540244,candesartan-cilextil
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.042235621,0.056360301,candesartan-cilextil
DNA_REPLICATION,1.937168258,0.09297629,candesartan-cilextil
SYNTHESIS_OF_DNA,1.937168258,0.09297629,candesartan-cilextil
GPCR_LIGAND_BINDING,3.414658744,0,olomoucine
SIGNALING_BY_GPCR,3.241254981,0,olomoucine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,3.152246475,0,olomoucine
G_ALPHA_Q_SIGNALLING_EVENTS,2.452753027,0,olomoucine
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.824143458,0,olomoucine
G_ALPHA_I_SIGNALLING_EVENTS,2.695166862,0,olomoucine
G_ALPHA_S_SIGNALLING_EVENTS,2.092562607,0.00765784,olomoucine
CARDIAC_CONDUCTION,-3.399963354,0.241077533,olomoucine
NEURONAL_SYSTEM,1.990727272,0.017050659,olomoucine
SENSORY_PERCEPTION,1.936596622,0.023452134,olomoucine
TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,2.380669399,0.014889411,carmustine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.40493024,0.007951122,carmustine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.338856643,0.011167059,carmustine
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,2.22486414,0.020472941,carmustine
TOLL_LIKE_RECEPTOR_CASCADES,2.213996695,0.017681176,carmustine
INNATE_IMMUNE_SYSTEM,2.094428591,0.040201411,carmustine
SENSORY_PERCEPTION,1.984807047,0.069173724,carmustine
HIV_LIFE_CYCLE,1.967636891,0.065938822,carmustine
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,1.947130064,0.066304411,carmustine
DISEASES_OF_METABOLISM,1.926853848,0.06948392,carmustine
REGULATION_OF_T_CELL_ACTIVATION_BY_CD28_FAMILY,1.929333626,0.486768217,terbinafine
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,1.764234309,0.698017194,terbinafine
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,1.763190301,0.468154425,terbinafine
DISEASES_OF_DNA_REPAIR,1.698920309,0.516269321,terbinafine
C_TYPE_LECTIN_RECEPTORS_CLRS,1.694705385,0.423762287,terbinafine
G_ALPHA_I_SIGNALLING_EVENTS,1.645636066,0.45990114,terbinafine
REGULATION_OF_TP53_ACTIVITY,1.637019363,0.413768036,terbinafine
TOLL_LIKE_RECEPTOR_CASCADES,1.622624297,0.390099421,terbinafine
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,1.619899132,0.35225723,terbinafine
SENSORY_PERCEPTION,-1.66471115,1,terbinafine
RRNA_PROCESSING,-2.126462247,0.117983628,mCPP
PEROXISOMAL_PROTEIN_IMPORT,1.895659214,0.723263357,mCPP
TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,1.845788124,0.5113518,mCPP
GPCR_LIGAND_BINDING,-1.839936808,0.454901665,mCPP
REGULATION_OF_T_CELL_ACTIVATION_BY_CD28_FAMILY,1.816840332,0.426510398,mCPP
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.811111217,0.360874806,mCPP
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,1.787346178,0.387544776,mCPP
G_ALPHA_Q_SIGNALLING_EVENTS,-1.772118154,0.345019025,mCPP
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.757523755,0.296122289,mCPP
SIGNALING_BY_GPCR,-1.73013713,0.288450584,mCPP
STRIATED_MUSCLE_CONTRACTION,3.076281005,0,quinidine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.592420054,0.000534584,quinidine
MUSCLE_CONTRACTION,2.511601942,0.000890973,quinidine
C_TYPE_LECTIN_RECEPTORS_CLRS,-2.099322718,0.20570038,quinidine
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,1.905980791,0.092483001,quinidine
HEMOSTASIS,1.818084354,0.12787245,quinidine
CLEC7A_DECTIN_1_SIGNALING,-1.826204784,0.886594677,quinidine
M_PHASE,-1.824640333,0.597138657,quinidine
MITOTIC_SPINDLE_CHECKPOINT,-1.815906642,0.477146768,quinidine
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,1.772079038,0.142466589,quinidine
METABOLISM_OF_RNA,-2.187550992,0.104609029,retigabine
RRNA_PROCESSING,-2.144771771,0.074561755,retigabine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.138523185,0.113069003,retigabine
TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,2.055688339,0.104677163,retigabine
GASTRULATION,-2.036275263,0.109802385,retigabine
REGULATION_OF_T_CELL_ACTIVATION_BY_CD28_FAMILY,1.995169903,0.103941036,retigabine
TRANSLATION,-1.986239574,0.127144485,retigabine
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,1.945888615,0.109535596,retigabine
ADAPTIVE_IMMUNE_SYSTEM,1.918131443,0.108298904,retigabine
CHROMATIN_ORGANIZATION,-1.900203057,0.187628536,retigabine
NEUTROPHIL_DEGRANULATION,-2.1844016,0.436961987,PS-178990
TRANSLATION,-2.062036445,0.436961987,PS-178990
AUTOPHAGY,-1.926938931,0.580787689,PS-178990
PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS,1.839609457,0.723175469,PS-178990
PROGRAMMED_CELL_DEATH,-1.860053351,0.589167365,PS-178990
APOPTOSIS,-1.859441416,0.472430868,PS-178990
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,-1.822483359,0.453721338,PS-178990
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,-1.772211595,0.473789028,PS-178990
SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR,-1.753238864,0.442446865,PS-178990
CELL_CYCLE_CHECKPOINTS,-1.73593958,0.417866484,PS-178990
PEROXISOMAL_PROTEIN_IMPORT,1.97058781,0.312064558,gabapentin
REGULATION_OF_TP53_ACTIVITY,1.835448534,0.3743672,gabapentin
GPCR_LIGAND_BINDING,-1.887790848,0.834902992,gabapentin
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,1.793057335,0.331913187,gabapentin
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.835533924,0.582382109,gabapentin
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.752892435,0.661275472,gabapentin
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.657949077,0.563480527,gabapentin
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-1.734842973,0.548138041,gabapentin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.723397333,0.466651136,gabapentin
REGULATION_OF_T_CELL_ACTIVATION_BY_CD28_FAMILY,1.594662389,0.643977745,gabapentin
TRANSLATION,-3.290837326,0,flumazenil
METABOLISM_OF_RNA,-3.287755677,0,flumazenil
RRNA_PROCESSING,-3.225851923,0,flumazenil
GPCR_LIGAND_BINDING,2.753221938,0,flumazenil
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.623089986,0,flumazenil
EUKARYOTIC_TRANSLATION_INITIATION,-2.605963428,0,flumazenil
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.554325252,0.000303381,flumazenil
CELL_CYCLE_CHECKPOINTS,-2.515324523,0.000247981,flumazenil
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.450875272,0.000212555,flumazenil
NEURONAL_SYSTEM,2.339642992,0.000758452,flumazenil
MITOTIC_METAPHASE_AND_ANAPHASE,1.849176973,0.22935036,minaprine
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,1.6737696,0.320462147,minaprine
MRNA_SPLICING,1.595996114,0.316273099,minaprine
SEPARATION_OF_SISTER_CHROMATIDS,1.594803597,0.238775717,minaprine
GLYCOSAMINOGLYCAN_METABOLISM,1.580343166,0.209871288,minaprine
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,1.52511681,0.22411405,minaprine
MITOTIC_SPINDLE_CHECKPOINT,1.469868731,0.247303421,minaprine
RHO_GTPASES_ACTIVATE_FORMINS,1.468206929,0.218746833,minaprine
INFLUENZA_INFECTION,1.460563153,0.201772463,minaprine
RESOLUTION_OF_SISTER_CHROMATID_COHESION,1.385920775,0.258883146,minaprine
GLYCOSAMINOGLYCAN_METABOLISM,1.617166288,1,ketorolac
METABOLISM_OF_STEROIDS,-1.914453105,1,ketorolac
NEUTROPHIL_DEGRANULATION,-1.851888208,1,ketorolac
NUCLEOTIDE_EXCISION_REPAIR,1.449490993,1,ketorolac
RNA_POLYMERASE_I_TRANSCRIPTION,1.4475948,0.963752128,ketorolac
RHOV_GTPASE_CYCLE,-1.820016575,1,ketorolac
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,1.420605359,0.81813024,ketorolac
CHROMOSOME_MAINTENANCE,1.390627262,0.755645212,ketorolac
RRNA_PROCESSING,1.383455934,0.652650823,ketorolac
L1CAM_INTERACTIONS,-1.773997864,0.917410822,ketorolac
RRNA_PROCESSING,4.531894618,0,quinethazone
MITOTIC_G2_G2_M_PHASES,2.910728981,0,quinethazone
S_PHASE,2.912609328,0,quinethazone
CELLULAR_RESPONSE_TO_STARVATION,3.08476798,0,quinethazone
CELL_CYCLE_MITOTIC,3.168101446,0,quinethazone
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,3.169595053,0,quinethazone
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,3.242570707,0,quinethazone
INFLUENZA_INFECTION,3.301636595,0,quinethazone
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,3.324437699,0,quinethazone
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,3.343966062,0,quinethazone
EUKARYOTIC_TRANSLATION_INITIATION,5.098551982,0,icosapent
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,3.396209703,0,icosapent
APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1,3.307456774,0,icosapent
CELL_CYCLE,3.235038689,0,icosapent
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,3.224070115,0,icosapent
CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6,3.19141751,0,icosapent
UCH_PROTEINASES,3.178940755,0,icosapent
M_PHASE,3.15619095,0,icosapent
THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT,3.151507044,0,icosapent
SCF_SKP2_MEDIATED_DEGRADATION_OF_P27_P21,3.127376477,0,icosapent
RESPIRATORY_ELECTRON_TRANSPORT,-2.363651829,0.012130402,BRD-K28761384
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,2.234580213,0.060432958,BRD-K28761384
HEMOSTASIS,2.138959504,0.067090827,BRD-K28761384
SIGNALING_BY_INSULIN_RECEPTOR,-1.977542255,0.072349182,BRD-K28761384
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,2.037024172,0.115061621,BRD-K28761384
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.957351879,0.160813127,BRD-K28761384
INSULIN_RECEPTOR_SIGNALLING_CASCADE,-1.658248582,0.234521102,BRD-K28761384
MRNA_SPLICING,-1.551951129,0.298061302,BRD-K28761384
ORGANELLE_BIOGENESIS_AND_MAINTENANCE,-1.483945459,0.322148814,BRD-K28761384
PEPTIDE_HORMONE_METABOLISM,1.75381718,0.503539701,BRD-K28761384
SEPARATION_OF_SISTER_CHROMATIDS,2.480159345,0.003775304,flufenamic-acid
MITOTIC_METAPHASE_AND_ANAPHASE,2.472619098,0.001887652,flufenamic-acid
SYNTHESIS_OF_DNA,2.04332039,0.037753043,flufenamic-acid
RHO_GTPASES_ACTIVATE_FORMINS,2.009827858,0.036809217,flufenamic-acid
RESOLUTION_OF_SISTER_CHROMATID_COHESION,1.974440343,0.041528347,flufenamic-acid
CELL_CYCLE_CHECKPOINTS,1.885255376,0.057887999,flufenamic-acid
MITOCHONDRIAL_PROTEIN_DEGRADATION,1.884370497,0.050696943,flufenamic-acid
PEROXISOMAL_PROTEIN_IMPORT,-2.030243952,0.105533918,flufenamic-acid
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.021031596,0.056233402,flufenamic-acid
RRNA_PROCESSING,1.805044775,0.070786956,flufenamic-acid
GPCR_LIGAND_BINDING,3.139455502,0,flunarizine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,3.092966786,0,flunarizine
SIGNALING_BY_GPCR,2.885810817,0,flunarizine
NEUTROPHIL_DEGRANULATION,-2.84362354,0,flunarizine
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.523226281,0.000162463,flunarizine
G_ALPHA_I_SIGNALLING_EVENTS,2.41545612,0.000259941,flunarizine
G_ALPHA_Q_SIGNALLING_EVENTS,2.374804987,0.000541543,flunarizine
INNATE_IMMUNE_SYSTEM,-2.333291118,0.015132822,flunarizine
MEMBRANE_TRAFFICKING,-2.289000612,0.014412211,flunarizine
POST_TRANSLATIONAL_PROTEIN_MODIFICATION,-2.223569831,0.016934348,flunarizine
GPCR_LIGAND_BINDING,3.753820691,0,niflumic-acid
EXTRACELLULAR_MATRIX_ORGANIZATION,2.684940472,0,niflumic-acid
SARS_COV_1_INFECTION,-2.84315751,0,niflumic-acid
SARS_COV_1_HOST_INTERACTIONS,-3.032733659,0,niflumic-acid
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-3.093324206,0,niflumic-acid
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-3.225252112,0,niflumic-acid
INFLUENZA_INFECTION,-3.229322714,0,niflumic-acid
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-3.23963715,0,niflumic-acid
SIGNALING_BY_GPCR,3.294314306,0,niflumic-acid
RRNA_PROCESSING,-3.353431921,0,niflumic-acid
MHC_CLASS_II_ANTIGEN_PRESENTATION,2.508394913,0.005582291,mianserin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.303766735,0.001936301,mianserin
GPCR_LIGAND_BINDING,-2.294279121,0.001290867,mianserin
GOLGI_TO_ER_RETROGRADE_TRANSPORT,2.285197569,0.025120308,mianserin
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.167784961,0.003657457,mianserin
MITOTIC_PROMETAPHASE,2.137466981,0.037215271,mianserin
SENSORY_PERCEPTION,-2.134912218,0.004195318,mianserin
COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC,2.092272207,0.034889317,mianserin
HIV_LIFE_CYCLE,2.061040184,0.027911453,mianserin
SIGNALING_BY_GPCR,-2.106030314,0.004776208,mianserin
GPCR_LIGAND_BINDING,3.206329942,0,desipramine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,3.122850156,0,desipramine
SIGNALING_BY_GPCR,3.051079376,0,desipramine
MUSCLE_CONTRACTION,2.794622319,0,desipramine
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.735201011,0,desipramine
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,-2.495010592,0,desipramine
ASPARAGINE_N_LINKED_GLYCOSYLATION,-2.469346783,0.000567195,desipramine
G_ALPHA_Q_SIGNALLING_EVENTS,2.630031591,0.000237526,desipramine
NEUTROPHIL_DEGRANULATION,-2.439516602,0.001512519,desipramine
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,-2.429149774,0.001134389,desipramine
SIGNALING_BY_GPCR,2.601455595,0.001525251,pergolide
GPCR_LIGAND_BINDING,2.496889249,0.003050503,pergolide
ORC1_REMOVAL_FROM_CHROMATIN,2.464402331,0.002033669,pergolide
SYNTHESIS_OF_DNA,2.448582856,0.001525251,pergolide
DNA_REPLICATION,2.441754139,0.001220201,pergolide
G_ALPHA_Q_SIGNALLING_EVENTS,2.4311837,0.00177946,pergolide
S_PHASE,2.274727259,0.006754685,pergolide
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.239954201,0.00800757,pergolide
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,2.213390701,0.008643091,pergolide
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.123245605,0.014947464,pergolide
GPCR_LIGAND_BINDING,3.372264676,0,flumetasone
NEUTROPHIL_DEGRANULATION,-3.241302085,0,flumetasone
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,3.203068462,0,flumetasone
SIGNALING_BY_GPCR,3.178601878,0,flumetasone
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.877738552,0,flumetasone
G_ALPHA_Q_SIGNALLING_EVENTS,2.795866508,0,flumetasone
NONSENSE_MEDIATED_DECAY_NMD,-2.790910548,0,flumetasone
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.674220992,0,flumetasone
G_ALPHA_I_SIGNALLING_EVENTS,2.454838137,0.000371252,flumetasone
COPII_MEDIATED_VESICLE_TRANSPORT,-2.618785486,0.003153538,flumetasone
METABOLISM_OF_RNA,-3.575625264,0,lomustine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-3.031779188,0,lomustine
CELL_CYCLE_MITOTIC,-3.029789633,0,lomustine
MRNA_SPLICING,-2.95629582,0,lomustine
M_PHASE,-2.885706929,0,lomustine
GPCR_LIGAND_BINDING,2.545024346,0,lomustine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.469684014,0.000182322,lomustine
MITOTIC_METAPHASE_AND_ANAPHASE,-2.570968841,0.001784215,lomustine
CELL_CYCLE,-2.570589534,0.001529327,lomustine
MITOTIC_G2_G2_M_PHASES,-2.471589408,0.004349024,lomustine
RAB_GEFS_EXCHANGE_GTP_FOR_GDP_ON_RABS,2.447145609,0.014269859,sulpiride
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.074393219,0.085619153,sulpiride
MRNA_SPLICING,2.068217058,0.057079436,sulpiride
RAB_REGULATION_OF_TRAFFICKING,2.044904879,0.047268908,sulpiride
DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS,1.548866681,0.347471064,sulpiride
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.348137024,1,sulpiride
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.281533779,1,sulpiride
GPCR_LIGAND_BINDING,-2.241486904,0.929942124,sulpiride
ABC_TRANSPORTER_DISORDERS,1.279476621,1,sulpiride
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.232677251,0.727258629,sulpiride
SIGNALING_BY_ROBO_RECEPTORS,1.954158235,0.509509658,sumatriptan
SIGNALING_BY_GPCR,-1.974937552,0.291085742,sumatriptan
GPCR_LIGAND_BINDING,-1.969136045,0.152003886,sumatriptan
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,1.915439167,0.320802377,sumatriptan
ADAPTIVE_IMMUNE_SYSTEM,1.863872946,0.314512135,sumatriptan
MYD88_INDEPENDENT_TLR4_CASCADE,1.838182961,0.277254543,sumatriptan
SARS_COV_2_HOST_INTERACTIONS,1.784463415,0.306286433,sumatriptan
TOLL_LIKE_RECEPTOR_CASCADES,1.722432689,0.36822113,sumatriptan
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.769275474,0.403530079,sumatriptan
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.754214382,0.335972796,sumatriptan
GPCR_LIGAND_BINDING,-2.433019352,0,KPT-330
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.374366852,0,KPT-330
SIGNALING_BY_GPCR,-2.26026795,0.0007682,KPT-330
SARS_COV_2_HOST_INTERACTIONS,2.172287178,0.070588235,KPT-330
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.102604092,0.004417148,KPT-330
SYNTHESIS_OF_DNA,-2.042925106,0.007835636,KPT-330
G_ALPHA_Q_SIGNALLING_EVENTS,-2.026906888,0.008066096,KPT-330
INFLUENZA_INFECTION,1.880809017,0.231932773,KPT-330
CHROMOSOME_MAINTENANCE,-1.961905099,0.017558849,KPT-330
SENSORY_PERCEPTION,-1.959043247,0.015556042,KPT-330
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,3.174191896,0,VP-20629
MRNA_SPLICING,3.169667998,0,VP-20629
RAB_GEFS_EXCHANGE_GTP_FOR_GDP_ON_RABS,2.145769586,0.027121001,VP-20629
RAB_REGULATION_OF_TRAFFICKING,1.890005946,0.110179068,VP-20629
DNA_REPLICATION_PRE_INITIATION,1.761790424,0.212899861,VP-20629
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,1.724073391,0.216968011,VP-20629
GPCR_LIGAND_BINDING,-2.429087712,0.248272549,VP-20629
G1_S_DNA_DAMAGE_CHECKPOINTS,1.666994469,0.264429764,VP-20629
DNA_REPLICATION,1.660067517,0.233918637,VP-20629
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.385883301,0.199932878,VP-20629
M_PHASE,-2.588212407,0.00386001,decitabine
MITOTIC_METAPHASE_AND_ANAPHASE,-2.54834974,0.001930005,decitabine
CELL_CYCLE_MITOTIC,-2.504164226,0.001930005,decitabine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.330532621,0.005248251,decitabine
CELL_CYCLE,-2.318564809,0.01109753,decitabine
GPCR_LIGAND_BINDING,2.245699542,0.009038654,decitabine
MITOTIC_SPINDLE_CHECKPOINT,-2.25903755,0.012738034,decitabine
MRNA_SPLICING,-2.226570716,0.013831704,decitabine
METABOLISM_OF_RNA,-2.212523272,0.012682891,decitabine
MITOTIC_PROMETAPHASE,-2.207137437,0.01133878,decitabine
REGULATION_OF_T_CELL_ACTIVATION_BY_CD28_FAMILY,2.153752968,0.046823395,KD-025
TRANSCRIPTIONAL_REGULATION_BY_RUNX2,-2.129112899,0.377235241,KD-025
INTERLEUKIN_2_FAMILY_SIGNALING,1.969273571,0.133446676,KD-025
G_ALPHA_I_SIGNALLING_EVENTS,-1.889676041,0.734465583,KD-025
AUTOPHAGY,-1.77119298,0.89069432,KD-025
INTERLEUKIN_3_INTERLEUKIN_5_AND_GM_CSF_SIGNALING,1.75504547,0.479419539,KD-025
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,-1.70536835,0.901292153,KD-025
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,-1.69860134,0.742181759,KD-025
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,-1.676345375,0.682548107,KD-025
SENSORY_PERCEPTION,-1.642535061,0.677104597,KD-025
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.357983615,0.006015663,lurasidone
SIGNALING_BY_ROBO_RECEPTORS,2.313293723,0.006015663,lurasidone
MUSCLE_CONTRACTION,2.261920527,0.008421928,lurasidone
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.019827399,0.041808855,lurasidone
SIGNALING_BY_GPCR,-1.995054462,0.165512651,lurasidone
GPCR_LIGAND_BINDING,-1.972563075,0.10923835,lurasidone
EUKARYOTIC_TRANSLATION_INITIATION,1.843308419,0.09432559,lurasidone
G_ALPHA_Q_SIGNALLING_EVENTS,-1.90974285,0.139030627,lurasidone
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.907967273,0.10640099,lurasidone
PEPTIDE_HORMONE_METABOLISM,1.814276324,0.095247991,lurasidone
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.56120335,0.000933479,clenbuterol
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.009989891,0.133954171,clenbuterol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.893838213,0.200075567,clenbuterol
NEDDYLATION,1.857688849,0.844287143,clenbuterol
ORGANELLE_BIOGENESIS_AND_MAINTENANCE,1.846195515,0.450949894,clenbuterol
REGULATION_OF_T_CELL_ACTIVATION_BY_CD28_FAMILY,1.754290974,0.593235672,clenbuterol
APOPTOSIS,-1.685305868,0.484008624,clenbuterol
GLOBAL_GENOME_NUCLEOTIDE_EXCISION_REPAIR_GG_NER,-1.610115172,0.594812526,clenbuterol
CILIUM_ASSEMBLY,1.635735137,0.940657387,clenbuterol
DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA,1.623089765,0.80783405,clenbuterol
EUKARYOTIC_TRANSLATION_ELONGATION,4.520116502,0,levallorphan
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.578815623,0,levallorphan
REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS,2.596834578,0,levallorphan
DNA_REPLICATION,2.607224474,0,levallorphan
DNA_REPLICATION_PRE_INITIATION,2.617779749,0,levallorphan
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.683604991,0,levallorphan
HIV_INFECTION,2.692268243,0,levallorphan
VIRAL_INFECTION_PATHWAYS,2.800899333,0,levallorphan
SARS_COV_2_HOST_INTERACTIONS,2.841008457,0,levallorphan
CELLULAR_RESPONSES_TO_STIMULI,2.909079572,0,levallorphan
EUKARYOTIC_TRANSLATION_INITIATION,5.399754804,0,droxidopa
REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS,2.943703865,0,droxidopa
HIV_INFECTION,2.968247633,0,droxidopa
HOST_INTERACTIONS_OF_HIV_FACTORS,3.006361503,0,droxidopa
SARS_COV_INFECTIONS,3.288533037,0,droxidopa
INFECTIOUS_DISEASE,3.538061316,0,droxidopa
SARS_COV_1_INFECTION,3.61233125,0,droxidopa
SARS_COV_2_HOST_INTERACTIONS,3.709566445,0,droxidopa
SARS_COV_1_HOST_INTERACTIONS,3.791970678,0,droxidopa
VIRAL_INFECTION_PATHWAYS,3.903407717,0,droxidopa
EUKARYOTIC_TRANSLATION_ELONGATION,2.529570632,0.001053177,guvacine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.48584115,0.001053177,guvacine
CELLULAR_RESPONSE_TO_STARVATION,2.399839297,0.001755295,guvacine
NONSENSE_MEDIATED_DECAY_NMD,2.397326518,0.001316472,guvacine
EUKARYOTIC_TRANSLATION_INITIATION,2.361409012,0.001474448,guvacine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.337082443,0.001930825,guvacine
SELENOAMINO_ACID_METABOLISM,2.322896731,0.001805447,guvacine
SIGNALING_BY_ROBO_RECEPTORS,2.201086684,0.005529181,guvacine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.14826171,0.008308398,guvacine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.077954497,0.015797659,guvacine
RESPIRATORY_ELECTRON_TRANSPORT,2.156308674,0.055668016,BRD-K63750851
SIGNALING_BY_ALK_IN_CANCER,2.091606089,0.047874494,BRD-K63750851
GPCR_LIGAND_BINDING,-2.028231832,0.209032258,BRD-K63750851
TP53_REGULATES_TRANSCRIPTION_OF_CELL_CYCLE_GENES,1.934785881,0.089439946,BRD-K63750851
NEDDYLATION,1.90209879,0.080161943,BRD-K63750851
CELL_CYCLE_MITOTIC,-1.993295376,0.14516129,BRD-K63750851
M_PHASE,-1.948997089,0.142580645,BRD-K63750851
MITOTIC_PROMETAPHASE,-1.92841684,0.129435484,BRD-K63750851
SEPARATION_OF_SISTER_CHROMATIDS,-1.90602836,0.125806452,BRD-K63750851
TP53_REGULATES_METABOLIC_GENES,1.736722985,0.175688259,BRD-K63750851
MUSCLE_CONTRACTION,3.879054376,0,epirubicin
GPCR_LIGAND_BINDING,3.087444003,0,epirubicin
STRIATED_MUSCLE_CONTRACTION,2.995916381,0,epirubicin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.946811355,0,epirubicin
CARDIAC_CONDUCTION,2.655961941,0.000971699,epirubicin
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.634473677,0.000809749,epirubicin
SIGNALING_BY_GPCR,2.56308083,0.000694071,epirubicin
RESPIRATORY_ELECTRON_TRANSPORT,2.462879322,0.001366452,epirubicin
DNA_DOUBLE_STRAND_BREAK_REPAIR,-2.368319514,0.006554543,epirubicin
G_ALPHA_I_SIGNALLING_EVENTS,2.369845974,0.002550711,epirubicin
ADAPTIVE_IMMUNE_SYSTEM,2.450073713,0.006447359,azathioprine
SARS_COV_2_HOST_INTERACTIONS,2.429267423,0.004835519,azathioprine
SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES,2.093264215,0.023640316,azathioprine
GPCR_LIGAND_BINDING,-2.129002399,0.02122757,azathioprine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.077226363,0.020002903,azathioprine
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.069056152,0.015240307,azathioprine
MITOCHONDRIAL_PROTEIN_DEGRADATION,1.903338136,0.05238479,azathioprine
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,1.895602593,0.043197304,azathioprine
KERATINIZATION,-2.043708429,0.016124789,azathioprine
SIGNALING_BY_GPCR,-2.02187283,0.016982056,azathioprine
NEURONAL_SYSTEM,-1.919324626,0.308572115,clofazimine
G2_M_CHECKPOINTS,1.797900566,0.875341338,clofazimine
MITF_M_DEPENDENT_GENE_EXPRESSION,1.792685052,0.448290061,clofazimine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.756769013,0.373195787,clofazimine
RAB_GEFS_EXCHANGE_GTP_FOR_GDP_ON_RABS,1.723307451,0.33944129,clofazimine
RAB_REGULATION_OF_TRAFFICKING,1.703839109,0.301894153,clofazimine
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,1.667955662,0.304928265,clofazimine
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,-1.779138383,0.520452695,clofazimine
ECM_PROTEOGLYCANS,-1.696710346,0.667311722,clofazimine
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,1.521208542,0.550691344,clofazimine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,5.636723659,0,myricetin
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,3.252502939,0,myricetin
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,3.207785934,0,myricetin
DNA_REPLICATION_PRE_INITIATION,3.193380998,0,myricetin
CELL_CYCLE,3.073337967,0,myricetin
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,3.068802114,0,myricetin
VIRAL_INFECTION_PATHWAYS,3.058019016,0,myricetin
CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6,3.056912841,0,myricetin
MITOTIC_METAPHASE_AND_ANAPHASE,3.048451626,0,myricetin
APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1,3.02879978,0,myricetin
ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES,2.219358843,0.012793177,fenoldopam
AMINE_LIGAND_BINDING_RECEPTORS,-2.117967172,0.004942798,fenoldopam
MITOTIC_METAPHASE_AND_ANAPHASE,2.044986689,0.019189765,fenoldopam
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.027944626,0.006178498,fenoldopam
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.984429976,0.029850746,fenoldopam
TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,1.965694559,0.025586354,fenoldopam
SEPARATION_OF_SISTER_CHROMATIDS,1.933530518,0.023027719,fenoldopam
GPCR_LIGAND_BINDING,-1.907945864,0.021967992,fenoldopam
TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,1.657295411,0.099147122,fenoldopam
G_ALPHA_Q_SIGNALLING_EVENTS,-1.889235097,0.021624742,fenoldopam
SYNTHESIS_OF_DNA,2.016665174,0.162095665,alizapride
G1_S_DNA_DAMAGE_CHECKPOINTS,1.94723101,0.1696939,alizapride
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,1.899874067,0.1452107,alizapride
UB_SPECIFIC_PROCESSING_PROTEASES,1.893002615,0.110174398,alizapride
CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6,1.885950779,0.094218106,alizapride
VIF_MEDIATED_DEGRADATION_OF_APOBEC3G,1.846853084,0.087560605,alizapride
REGULATION_OF_RAS_BY_GAPS,1.848573985,0.102154039,alizapride
DEGRADATION_OF_DVL,1.830105886,0.081681019,alizapride
UCH_PROTEINASES,1.820354335,0.075419511,alizapride
DEFECTIVE_CFTR_CAUSES_CYSTIC_FIBROSIS,1.802858283,0.069535356,alizapride
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.767725122,0,rabeprazole
SELENOAMINO_ACID_METABOLISM,2.607891229,0,rabeprazole
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.573614602,0.000605273,rabeprazole
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.45190224,0.003177683,rabeprazole
NONSENSE_MEDIATED_DECAY_NMD,2.326390544,0.004721128,rabeprazole
CELLULAR_RESPONSE_TO_STARVATION,2.234855069,0.009684366,rabeprazole
EUKARYOTIC_TRANSLATION_INITIATION,2.184426441,0.012451328,rabeprazole
INFLUENZA_INFECTION,2.098388348,0.023151688,rabeprazole
SIGNALING_BY_ROBO_RECEPTORS,2.054502146,0.028851341,rabeprazole
NEURONAL_SYSTEM,-1.986103013,0.138352084,rabeprazole
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-3.180291835,0,varenicline
NONSENSE_MEDIATED_DECAY_NMD,-3.119893929,0.000539578,varenicline
SELENOAMINO_ACID_METABOLISM,-3.071467667,0.000359719,varenicline
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-3.069230268,0.000269789,varenicline
EUKARYOTIC_TRANSLATION_ELONGATION,-3.023332814,0.001294987,varenicline
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,2.394535891,0.005335942,varenicline
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.940221926,0.002697889,varenicline
EUKARYOTIC_TRANSLATION_INITIATION,-2.934898242,0.002466642,varenicline
CELLULAR_RESPONSE_TO_STARVATION,-2.880001076,0.003237467,varenicline
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.846265654,0.003357373,varenicline
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.983986669,0,H-7
NONSENSE_MEDIATED_DECAY_NMD,2.781447179,0,H-7
EUKARYOTIC_TRANSLATION_INITIATION,2.678551939,0,H-7
EUKARYOTIC_TRANSLATION_ELONGATION,2.612177406,0.000849769,H-7
SELENOAMINO_ACID_METABOLISM,2.449327693,0.001359631,H-7
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.362638143,0.001699538,H-7
MUSCLE_CONTRACTION,-2.22660954,0.002176106,H-7
TRANSLATION,2.183903117,0.010682813,H-7
CARDIAC_CONDUCTION,-2.05609725,0.013782005,H-7
G_ALPHA_S_SIGNALLING_EVENTS,-2.028042135,0.013056636,H-7
GPCR_LIGAND_BINDING,2.890176661,0,BRD-K81538844
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.602529796,0,BRD-K81538844
SIGNALING_BY_GPCR,2.493568798,0.000385036,BRD-K81538844
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.146515144,0.019348047,BRD-K81538844
FATTY_ACID_METABOLISM,-2.289106313,0.130788486,BRD-K81538844
METABOLISM_OF_LIPIDS,-2.186297046,0.133800063,BRD-K81538844
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,-2.169630143,0.099525448,BRD-K81538844
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,1.884978809,0.120362182,BRD-K81538844
NEUTROPHIL_DEGRANULATION,-1.99598672,0.218124218,BRD-K81538844
G_ALPHA_Q_SIGNALLING_EVENTS,1.780161763,0.195020618,BRD-K81538844
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-3.432710084,0,dexketoprofen
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.658328611,0,dexketoprofen
GPCR_LIGAND_BINDING,2.495530792,0,dexketoprofen
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-3.388363578,0,dexketoprofen
EXTRACELLULAR_MATRIX_ORGANIZATION,2.201408127,0.01373085,dexketoprofen
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.93395493,0.055250809,dexketoprofen
SIGNALING_BY_GPCR,2.044952659,0.034136419,dexketoprofen
DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS,-2.8069052,0.107167517,dexketoprofen
G_ALPHA_Q_SIGNALLING_EVENTS,1.922710443,0.065450385,dexketoprofen
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,1.916934602,0.056703325,dexketoprofen
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.111783798,0.114282756,guanfacine
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.065055207,0.081725459,guanfacine
GPCR_LIGAND_BINDING,2.010008185,0.081503981,guanfacine
MUSCLE_CONTRACTION,1.966086657,0.083386546,guanfacine
S_PHASE,1.917874854,0.094083943,guanfacine
G_ALPHA_I_SIGNALLING_EVENTS,1.906857971,0.085047632,guanfacine
DNA_REPLICATION,1.89392958,0.079732155,guanfacine
SIGNALING_BY_GPCR,1.821520381,0.103984019,guanfacine
G2_M_CHECKPOINTS,1.781618209,0.115168669,guanfacine
SYNTHESIS_OF_DNA,1.776998914,0.10630954,guanfacine
SIGNALING_BY_GPCR,2.697594557,0,xanthinol
GPCR_LIGAND_BINDING,2.602776173,0,xanthinol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.570325796,0,xanthinol
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.315168928,0.002987571,xanthinol
NEUTROPHIL_DEGRANULATION,-2.373437628,0.032403881,xanthinol
G_ALPHA_Q_SIGNALLING_EVENTS,2.234712048,0.005649225,xanthinol
POTASSIUM_CHANNELS,2.166397822,0.00887218,xanthinol
G_ALPHA_I_SIGNALLING_EVENTS,2.117869178,0.013036672,xanthinol
PROTEIN_LOCALIZATION,-2.112769576,0.126015094,xanthinol
ASPARAGINE_N_LINKED_GLYCOSYLATION,-2.050653826,0.12481495,xanthinol
SIGNALING_BY_GPCR,3.049440811,0,halcinonide
GPCR_LIGAND_BINDING,2.977252461,0,halcinonide
MEMBRANE_TRAFFICKING,-2.865927111,0,halcinonide
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.835351954,0,halcinonide
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,-2.761421026,0.000686899,halcinonide
NEUTROPHIL_DEGRANULATION,-2.742620922,0.000457933,halcinonide
TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,-2.698088599,0.000343449,halcinonide
VESICLE_MEDIATED_TRANSPORT,-2.689215451,0.000549519,halcinonide
ASPARAGINE_N_LINKED_GLYCOSYLATION,-2.672352017,0.000457933,halcinonide
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.633090462,0.000588771,halcinonide
GPCR_LIGAND_BINDING,3.717391223,0,noretynodrel
SIGNALING_BY_GPCR,3.540970985,0,noretynodrel
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,3.524426938,0,noretynodrel
G_ALPHA_Q_SIGNALLING_EVENTS,3.011730722,0,noretynodrel
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.854929088,0,noretynodrel
G_ALPHA_I_SIGNALLING_EVENTS,2.568808376,0,noretynodrel
NEURONAL_SYSTEM,2.015687797,0.015940575,noretynodrel
SENSORY_PERCEPTION,2.012813056,0.014161493,noretynodrel
POTASSIUM_CHANNELS,1.990159924,0.015118244,noretynodrel
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,1.928199599,0.023398487,noretynodrel
STRIATED_MUSCLE_CONTRACTION,3.072978267,0,primaquine
MUSCLE_CONTRACTION,3.042342713,0,primaquine
UNFOLDED_PROTEIN_RESPONSE_UPR,2.081715469,0.032094446,primaquine
CARDIAC_CONDUCTION,1.918936328,0.069324003,primaquine
ION_HOMEOSTASIS,1.912359741,0.058411891,primaquine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.759325009,0.129340616,primaquine
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,1.655168921,0.201461421,primaquine
G_ALPHA_Q_SIGNALLING_EVENTS,-1.723617383,1,primaquine
MITOTIC_PROMETAPHASE,-1.701068279,1,primaquine
NEURONAL_SYSTEM,1.575429293,0.271679483,primaquine
CELL_CYCLE_MITOTIC,-3.117773109,0,amonafide
CELL_CYCLE,-2.903127152,0,amonafide
M_PHASE,-2.785629064,0,amonafide
MITOTIC_PROMETAPHASE,-2.683407304,0,amonafide
MITOTIC_METAPHASE_AND_ANAPHASE,-2.440978917,0.000436361,amonafide
MITOTIC_G2_G2_M_PHASES,-2.42462509,0.000545451,amonafide
RESOLUTION_OF_SISTER_CHROMATID_COHESION,-2.371877009,0.00046753,amonafide
SEPARATION_OF_SISTER_CHROMATIDS,-2.337434195,0.000681814,amonafide
MITOTIC_SPINDLE_CHECKPOINT,-2.305261896,0.000969691,amonafide
RHO_GTPASES_ACTIVATE_FORMINS,-2.281136732,0.001090903,amonafide
PROTEIN_LOCALIZATION,-2.371137868,0.004681104,tolmetin
MUSCLE_CONTRACTION,2.439641156,0.006890495,tolmetin
NEUTROPHIL_DEGRANULATION,-2.260443484,0.007021656,tolmetin
SENSORY_PERCEPTION,2.205510112,0.028136189,tolmetin
METABOLISM_OF_LIPIDS,-2.097113595,0.034328098,tolmetin
ECM_PROTEOGLYCANS,2.015558984,0.069287757,tolmetin
INNATE_IMMUNE_SYSTEM,-2.001183216,0.062492742,tolmetin
FATTY_ACID_METABOLISM,-1.986240112,0.057483961,tolmetin
GPCR_LIGAND_BINDING,1.884711989,0.128335473,tolmetin
PI_METABOLISM,-1.931825192,0.074897669,tolmetin
GPCR_LIGAND_BINDING,3.48896278,0,pseudoephedrine
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.702652901,0,pseudoephedrine
VESICLE_MEDIATED_TRANSPORT,-2.704035768,0,pseudoephedrine
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,-2.815265206,0,pseudoephedrine
INFLUENZA_INFECTION,-2.820590513,0,pseudoephedrine
NONSENSE_MEDIATED_DECAY_NMD,-2.87744319,0,pseudoephedrine
G_ALPHA_Q_SIGNALLING_EVENTS,2.639104972,0,pseudoephedrine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.974094921,0,pseudoephedrine
NEUTROPHIL_DEGRANULATION,-2.983864287,0,pseudoephedrine
SIGNALING_BY_GPCR,3.362458586,0,pseudoephedrine
REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF,-2.937041843,0,raclopride
NEURONAL_SYSTEM,2.388733845,0.000753423,raclopride
METABOLISM_OF_STEROIDS,-2.426740666,0.006972514,raclopride
POTASSIUM_CHANNELS,2.209502365,0.006404093,raclopride
NEUTROPHIL_DEGRANULATION,-2.198764056,0.01925742,raclopride
G_ALPHA_I_SIGNALLING_EVENTS,2.147522313,0.010799059,raclopride
GPCR_LIGAND_BINDING,2.097047692,0.012996541,raclopride
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.076512011,0.013410924,raclopride
STRIATED_MUSCLE_CONTRACTION,2.05587312,0.01406389,raclopride
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,2.023918889,0.016252404,raclopride
CELL_CYCLE,-3.329400031,0,tizanidine
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,-2.536256858,0,tizanidine
DNA_REPLICATION,-2.578253533,0,tizanidine
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,-2.581004324,0,tizanidine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.636558313,0,tizanidine
SEPARATION_OF_SISTER_CHROMATIDS,-2.725055907,0,tizanidine
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,-2.679651693,0,tizanidine
M_PHASE,-2.896913554,0,tizanidine
MITOTIC_METAPHASE_AND_ANAPHASE,-2.968756392,0,tizanidine
CELL_CYCLE_CHECKPOINTS,-3.000385546,0,tizanidine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.585592197,0,ciclopirox
EUKARYOTIC_TRANSLATION_ELONGATION,2.452434539,0.000386091,ciclopirox
EUKARYOTIC_TRANSLATION_INITIATION,2.416542958,0.000257394,ciclopirox
NONSENSE_MEDIATED_DECAY_NMD,2.397279942,0.000386091,ciclopirox
CELLULAR_RESPONSE_TO_STARVATION,2.386320195,0.000463309,ciclopirox
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.284525542,0.001158273,ciclopirox
SELENOAMINO_ACID_METABOLISM,2.170896143,0.005405273,ciclopirox
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.64857055,0.1546707,ciclopirox
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.613808138,0.097474764,ciclopirox
LEISHMANIA_INFECTION,1.980926646,0.027605501,ciclopirox
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.204780137,0.058775864,azelastine
GLOBAL_GENOME_NUCLEOTIDE_EXCISION_REPAIR_GG_NER,-1.865741722,0.42436174,azelastine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.785815354,1,azelastine
NUCLEOTIDE_EXCISION_REPAIR,-1.603290488,1,azelastine
SIGNALING_BY_INSULIN_RECEPTOR,-1.593534866,1,azelastine
TRANSPORT_OF_SMALL_MOLECULES,-1.558086215,0.973093208,azelastine
TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES,-1.55506012,0.823645777,azelastine
REGULATION_OF_T_CELL_ACTIVATION_BY_CD28_FAMILY,1.596792579,1,azelastine
METABOLISM_OF_VITAMINS_AND_COFACTORS,-1.528286582,0.804221754,azelastine
SENSORY_PERCEPTION,-1.512635821,0.761000502,azelastine
GPCR_LIGAND_BINDING,-2.610622062,0,marimastat
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.581560015,0,marimastat
SIGNALING_BY_GPCR,-2.52014007,0,marimastat
G_ALPHA_Q_SIGNALLING_EVENTS,-2.310792322,0.000148822,marimastat
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.310274659,0.000119058,marimastat
KERATINIZATION,-2.228754141,0.001190576,marimastat
RESOLUTION_OF_SISTER_CHROMATID_COHESION,2.189949495,0.083934193,marimastat
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,2.159891882,0.04859348,marimastat
AMINE_LIGAND_BINDING_RECEPTORS,-2.121249682,0.003571729,marimastat
SENSORY_PERCEPTION,-2.120110738,0.003125263,marimastat
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.021326438,0.927382846,agomelatine
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,1.865683939,0.814462204,agomelatine
SIGNALING_BY_HEDGEHOG,-1.759192657,1,agomelatine
GPCR_LIGAND_BINDING,-1.710148207,1,agomelatine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.679312114,1,agomelatine
REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS,-1.631931486,1,agomelatine
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,1.664677695,1,agomelatine
GLOBAL_GENOME_NUCLEOTIDE_EXCISION_REPAIR_GG_NER,-1.629404729,0.890742689,agomelatine
TRANSCRIPTIONAL_REGULATION_BY_RUNX2,-1.588146323,0.863281537,agomelatine
ADAPTIVE_IMMUNE_SYSTEM,1.633467678,0.948977455,agomelatine
GPCR_LIGAND_BINDING,-2.378744792,0.00132312,tolcapone
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.329899016,0.00132312,tolcapone
RESPIRATORY_ELECTRON_TRANSPORT,2.503308597,0.015759613,tolcapone
GLOBAL_GENOME_NUCLEOTIDE_EXCISION_REPAIR_GG_NER,2.444616015,0.007879807,tolcapone
TOLL_LIKE_RECEPTOR_CASCADES,2.389760732,0.007879807,tolcapone
MITOCHONDRIAL_PROTEIN_DEGRADATION,2.234781439,0.015759613,tolcapone
TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,2.119193174,0.018911536,tolcapone
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,-2.202661984,0.004851442,tolcapone
SIGNALING_BY_GPCR,-2.181237927,0.004134752,tolcapone
MRNA_SPLICING,1.838116919,0.114257197,tolcapone
METABOLISM_OF_RNA,-3.502627416,0,RAF-265
CELL_CYCLE_CHECKPOINTS,-3.368732147,0,RAF-265
CELL_CYCLE,-3.211718373,0,RAF-265
MRNA_SPLICING,-3.014832691,0,RAF-265
G2_M_CHECKPOINTS,-2.976512334,0,RAF-265
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.965697112,0,RAF-265
MITOTIC_METAPHASE_AND_ANAPHASE,-2.89191529,0,RAF-265
CELL_CYCLE_MITOTIC,-2.86926294,0,RAF-265
RRNA_PROCESSING,-2.779505076,0.000659502,RAF-265
S_PHASE,-2.715434786,0.001187104,RAF-265
MUSCLE_CONTRACTION,3.496388915,0,reserpine
STRIATED_MUSCLE_CONTRACTION,3.136300505,0,reserpine
CARDIAC_CONDUCTION,2.317218097,0.009223162,reserpine
PLATELET_HOMEOSTASIS,2.236564325,0.015218217,reserpine
PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS,1.983865117,0.055117616,reserpine
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,1.865930157,0.092416083,reserpine
NEURONAL_SYSTEM,1.852272004,0.084589571,reserpine
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,1.848185329,0.075952739,reserpine
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,1.779924395,0.101454782,reserpine
HEMOSTASIS,1.75821233,0.104369301,reserpine
INFLUENZA_INFECTION,2.501838651,0.003342762,lidocaine
NEUTROPHIL_DEGRANULATION,2.197145303,0.017967344,lidocaine
MUSCLE_CONTRACTION,2.080697962,0.025906403,lidocaine
TRANSLATION,1.944327654,0.046380818,lidocaine
SIGNALING_BY_GPCR,-1.99669099,0.341644424,lidocaine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.993243979,0.177071805,lidocaine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.85191232,0.06535099,lidocaine
MRNA_SPLICING,1.83162522,0.060587555,lidocaine
GPCR_LIGAND_BINDING,-1.903365515,0.255538919,lidocaine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.737924198,0.091090255,lidocaine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.437894329,0,conivaptan
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-1.96331474,0.048719405,conivaptan
TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,1.717098292,0.196788648,conivaptan
GPCR_LIGAND_BINDING,-1.837451029,0.120516422,conivaptan
SENSORY_PERCEPTION,-1.79422777,0.125074963,conivaptan
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-1.784782502,0.101285078,conivaptan
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,1.400520003,0.821110281,conivaptan
FATTY_ACID_METABOLISM,1.396546972,0.628566094,conivaptan
VISUAL_PHOTOTRANSDUCTION,-1.7551219,0.113849556,conivaptan
INTERLEUKIN_1_FAMILY_SIGNALING,1.337964482,0.675100822,conivaptan
EUKARYOTIC_TRANSLATION_ELONGATION,2.936024395,0,galantamine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.848291557,0,galantamine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.69514572,0,galantamine
SELENOAMINO_ACID_METABOLISM,2.669376857,0,galantamine
CELLULAR_RESPONSE_TO_STARVATION,2.666134102,0,galantamine
NONSENSE_MEDIATED_DECAY_NMD,2.637801116,0,galantamine
EUKARYOTIC_TRANSLATION_INITIATION,2.606082456,0,galantamine
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,2.480341194,0.000387693,galantamine
INFLUENZA_INFECTION,2.464611891,0.000344616,galantamine
SARS_COV_1_INFECTION,2.420123995,0.00041354,galantamine
EUKARYOTIC_TRANSLATION_ELONGATION,-2.577196938,0,mepivacaine
TRANSLATION,-2.261379175,0,mepivacaine
SIGNALING_BY_ROBO_RECEPTORS,-2.292637751,0,mepivacaine
INFLUENZA_INFECTION,-2.335788569,0,mepivacaine
RRNA_PROCESSING,-2.352462316,0,mepivacaine
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.357595899,0,mepivacaine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.398778036,0,mepivacaine
CELLULAR_RESPONSE_TO_STARVATION,-2.31880864,0,mepivacaine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.444898648,0,mepivacaine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.445469459,0,mepivacaine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.729255113,0,VX-702
GPCR_LIGAND_BINDING,-2.28086705,0.002366637,VX-702
G_ALPHA_S_SIGNALLING_EVENTS,-2.149811095,0.003944395,VX-702
NONSENSE_MEDIATED_DECAY_NMD,2.207459297,0.029941099,VX-702
SELENOAMINO_ACID_METABOLISM,2.100193465,0.037069933,VX-702
SIGNALING_BY_GPCR,-2.024308242,0.01472574,VX-702
EUKARYOTIC_TRANSLATION_INITIATION,2.021362166,0.046337416,VX-702
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,-1.975152224,0.019919193,VX-702
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.956717399,0.020826404,VX-702
NEURONAL_SYSTEM,-1.899724941,0.031029238,VX-702
SIGNALING_BY_GPCR,2.306308868,0.006342221,1-benzylimidazole
GPCR_LIGAND_BINDING,2.244984124,0.007248253,1-benzylimidazole
INTERLEUKIN_1_FAMILY_SIGNALING,2.082801176,0.015100526,1-benzylimidazole
RHO_GTPASE_CYCLE,-1.78145255,0.587701442,1-benzylimidazole
DNA_REPLICATION,1.732474322,0.153119337,1-benzylimidazole
SIGNALING_BY_RECEPTOR_TYROSINE_KINASES,-1.691113667,0.498388465,1-benzylimidazole
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,1.646096692,0.205306756,1-benzylimidazole
S_PHASE,1.628727664,0.188001553,1-benzylimidazole
ASPARAGINE_N_LINKED_GLYCOSYLATION,-1.547745437,0.713033644,1-benzylimidazole
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,-1.545340544,0.538910093,1-benzylimidazole
RHO_GTPASES_ACTIVATE_FORMINS,-2.044942925,0.205941765,moclobemide
GPCR_LIGAND_BINDING,-2.003807262,0.139922156,moclobemide
MITOTIC_PROMETAPHASE,-1.924004823,0.160943325,moclobemide
RESOLUTION_OF_SISTER_CHROMATID_COHESION,-1.879742839,0.168744149,moclobemide
INTERFERON_ALPHA_BETA_SIGNALING,1.787324524,1,moclobemide
MITOTIC_SPINDLE_CHECKPOINT,-1.813009404,0.216583732,moclobemide
SIGNALING_BY_GPCR,-1.75804826,0.253567851,moclobemide
PROTEIN_LOCALIZATION,1.695554926,0.887573964,moclobemide
REGULATION_OF_INSULIN_SECRETION,-1.720934389,0.273791341,moclobemide
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.6666487,0.332438291,moclobemide
INTERFERON_ALPHA_BETA_SIGNALING,2.535058657,0,levetiracetam
TRANSCRIPTIONAL_REGULATION_BY_TP53,-2.428385451,0.001273594,levetiracetam
KERATINIZATION,2.297599147,0.005981269,levetiracetam
VISUAL_PHOTOTRANSDUCTION,2.233222277,0.006147416,levetiracetam
RNA_POLYMERASE_II_TRANSCRIPTION,-2.181267941,0.030566248,levetiracetam
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-2.171789058,0.022075624,levetiracetam
FORMATION_OF_THE_CORNIFIED_ENVELOPE,2.105155203,0.015202393,levetiracetam
TRANSLATION,-2.069227975,0.054764528,levetiracetam
REGULATION_OF_TP53_ACTIVITY,-2.050259889,0.05247206,levetiracetam
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,-2.00667897,0.062830622,levetiracetam
METABOLISM_OF_RNA,4.181993098,0,dofetilide
ORC1_REMOVAL_FROM_CHROMATIN,2.51951426,0,dofetilide
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,2.51951426,0,dofetilide
DECTIN_1_MEDIATED_NONCANONICAL_NF_KB_SIGNALING,2.534246108,0,dofetilide
AUF1_HNRNP_D0_BINDS_AND_DESTABILIZES_MRNA,2.540264751,0,dofetilide
DNA_REPLICATION,2.560721299,0,dofetilide
SCF_SKP2_MEDIATED_DEGRADATION_OF_P27_P21,2.564929118,0,dofetilide
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,2.571668397,0,dofetilide
DNA_REPLICATION_PRE_INITIATION,2.58142951,0,dofetilide
SYNTHESIS_OF_DNA,2.593703391,0,dofetilide
EUKARYOTIC_TRANSLATION_ELONGATION,5.201444961,0,amyleine
MITOCHONDRIAL_PROTEIN_DEGRADATION,3.107638061,0,amyleine
THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT,3.121487281,0,amyleine
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,3.236207496,0,amyleine
DNA_REPLICATION,3.388157302,0,amyleine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.436667175,0,amyleine
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,3.466676066,0,amyleine
SIGNALING_BY_ROBO_RECEPTORS,3.950496326,0,amyleine
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,3.97103054,0,amyleine
CELLULAR_RESPONSE_TO_STARVATION,3.985089063,0,amyleine
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,2.178113439,0.072371744,glycopyrrolate
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.028029541,0.120796955,glycopyrrolate
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,1.895327369,0.233434351,glycopyrrolate
DEUBIQUITINATION,1.743775981,0.492766433,glycopyrrolate
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,1.742695241,0.39719316,glycopyrrolate
HEMOSTASIS,1.687145468,0.450904346,glycopyrrolate
MYD88_INDEPENDENT_TLR4_CASCADE,1.683152511,0.394699679,glycopyrrolate
REGULATION_OF_TP53_ACTIVITY,1.641292674,0.43795548,glycopyrrolate
COPI_MEDIATED_ANTEROGRADE_TRANSPORT,-1.613875789,1,glycopyrrolate
TRANSPORT_OF_SMALL_MOLECULES,-1.593591422,1,glycopyrrolate
CELLULAR_RESPONSE_TO_STARVATION,2.99215042,0,phenformin
MITOCHONDRIAL_PROTEIN_DEGRADATION,2.469113035,0,phenformin
EUKARYOTIC_TRANSLATION_INITIATION,2.474981933,0,phenformin
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.500622133,0,phenformin
SARS_COV_2_INFECTION,2.440070375,0,phenformin
EUKARYOTIC_TRANSLATION_ELONGATION,2.648296611,0,phenformin
TRANSLATION,2.920639927,0,phenformin
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.980763066,0,phenformin
SELENOAMINO_ACID_METABOLISM,2.642521425,0,phenformin
NONSENSE_MEDIATED_DECAY_NMD,2.405467793,0.001033238,phenformin
REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF,2.347089579,0.016721682,obatoclax
PI3K_AKT_SIGNALING_IN_CANCER,2.203356731,0.022096508,obatoclax
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,2.146158471,0.021499305,obatoclax
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.933676742,0.077636379,obatoclax
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.889718959,0.078114142,obatoclax
DEVELOPMENTAL_CELL_LINEAGES,1.823405513,0.091969249,obatoclax
GPCR_LIGAND_BINDING,1.727366488,0.130190236,obatoclax
MAPK1_MAPK3_SIGNALING,1.634278488,0.193941648,obatoclax
GLYCOSAMINOGLYCAN_METABOLISM,1.612033062,0.194024593,obatoclax
DISEASES_OF_METABOLISM,-1.812978155,1,obatoclax
SIGNALING_BY_GPCR,2.343582294,0.005736138,alvespimycin
MITOTIC_PROMETAPHASE,-2.271106917,0.017469754,alvespimycin
G_ALPHA_Q_SIGNALLING_EVENTS,2.223370817,0.010038241,alvespimycin
M_PHASE,-2.178349708,0.026204631,alvespimycin
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.152988435,0.020575488,alvespimycin
SENSORY_PERCEPTION,2.046205739,0.029636711,alvespimycin
NEURONAL_SYSTEM,1.960420878,0.040152964,alvespimycin
MITOTIC_SPINDLE_CHECKPOINT,-2.010169511,0.066385065,alvespimycin
CELL_CYCLE,-2.008115667,0.053573912,alvespimycin
MITOTIC_METAPHASE_AND_ANAPHASE,-2.003178129,0.046197794,alvespimycin
EUKARYOTIC_TRANSLATION_ELONGATION,5.720882676,0,oxprenolol
SEPARATION_OF_SISTER_CHROMATIDS,2.980699886,0,oxprenolol
VIRAL_INFECTION_PATHWAYS,2.996328317,0,oxprenolol
CELL_CYCLE_CHECKPOINTS,3.020003581,0,oxprenolol
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,3.183254858,0,oxprenolol
DNA_REPLICATION_PRE_INITIATION,3.348800785,0,oxprenolol
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.362162389,0,oxprenolol
DNA_REPLICATION,3.568473524,0,oxprenolol
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,3.75987411,0,oxprenolol
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,3.7669303,0,oxprenolol
GPCR_LIGAND_BINDING,2.663498319,0,HO-013
SIGNALING_BY_GPCR,2.545285737,0.000314738,HO-013
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.464903718,0.001049127,HO-013
CELL_CYCLE_CHECKPOINTS,-2.429584937,0.005104002,HO-013
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.407958565,0.001258952,HO-013
MITOTIC_METAPHASE_AND_ANAPHASE,-2.314525317,0.008294003,HO-013
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.310009685,0.005954669,HO-013
METABOLISM_OF_RNA,-2.247895096,0.006061002,HO-013
KERATINIZATION,2.255040276,0.004909913,HO-013
FORMATION_OF_THE_CORNIFIED_ENVELOPE,2.252647416,0.004301419,HO-013
GPCR_LIGAND_BINDING,3.505127509,0,fludarabine
TRANSLATION,-2.622505938,0,fludarabine
INFLUENZA_INFECTION,-2.631548393,0,fludarabine
CELLULAR_RESPONSE_TO_STARVATION,-2.671532414,0,fludarabine
RRNA_PROCESSING,-2.712654039,0,fludarabine
G_ALPHA_Q_SIGNALLING_EVENTS,2.717956379,0,fludarabine
CARDIAC_CONDUCTION,2.721837691,0,fludarabine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,2.811575044,0,fludarabine
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.82307912,0,fludarabine
MUSCLE_CONTRACTION,2.834912234,0,fludarabine
SEPARATION_OF_SISTER_CHROMATIDS,2.957983427,0,hyoscyamine
ORC1_REMOVAL_FROM_CHROMATIN,2.918881156,0,hyoscyamine
RESOLUTION_OF_SISTER_CHROMATID_COHESION,2.775128563,0,hyoscyamine
MITOTIC_METAPHASE_AND_ANAPHASE,2.731934517,0,hyoscyamine
RHO_GTPASES_ACTIVATE_FORMINS,2.647857293,0,hyoscyamine
DNA_REPLICATION,2.450939758,0.001203827,hyoscyamine
HOST_INTERACTIONS_OF_HIV_FACTORS,2.448723677,0.001070068,hyoscyamine
SYNTHESIS_OF_DNA,2.566354026,0.001605103,hyoscyamine
CELL_CYCLE_CHECKPOINTS,2.47249397,0.001375802,hyoscyamine
CELL_CYCLE_MITOTIC,2.343765223,0.002407654,hyoscyamine
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.634586628,0,BRD-K76022557
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.329339951,0.008269953,BRD-K76022557
ADAPTIVE_IMMUNE_SYSTEM,2.178894661,0.06866924,BRD-K76022557
GPCR_LIGAND_BINDING,-2.244104593,0.010493059,BRD-K76022557
PEROXISOMAL_PROTEIN_IMPORT,2.065782419,0.103003861,BRD-K76022557
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,2.024207054,0.103461655,BRD-K76022557
GASTRULATION,-2.044923599,0.038015107,BRD-K76022557
SIGNALING_BY_GPCR,-2.032381311,0.032652976,BRD-K76022557
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.023897155,0.029700692,BRD-K76022557
COLLAGEN_DEGRADATION,-1.94904269,0.042302525,BRD-K76022557
GPCR_LIGAND_BINDING,-2.175631449,0.029910407,zosuquidar
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,2.067981594,0.262093911,zosuquidar
REGULATION_OF_TP53_ACTIVITY,2.032075182,0.17592605,zosuquidar
PEROXISOMAL_PROTEIN_IMPORT,2.009196416,0.146605042,zosuquidar
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.004559726,0.089426012,zosuquidar
MITF_M_DEPENDENT_GENE_EXPRESSION,1.942496858,0.161115949,zosuquidar
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,-1.96029134,0.091765941,zosuquidar
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,1.866619475,0.211470293,zosuquidar
TCR_SIGNALING,1.850733629,0.195373658,zosuquidar
RESPIRATORY_ELECTRON_TRANSPORT,1.817058502,0.209521258,zosuquidar
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.468376487,0,doramapimod
GPCR_LIGAND_BINDING,2.459465909,0,doramapimod
S_PHASE,-1.990623135,0.178021845,doramapimod
INTEGRIN_CELL_SURFACE_INTERACTIONS,-1.948274106,0.117494418,doramapimod
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.070232805,0.020904383,doramapimod
METABOLISM_OF_RNA,-1.920628503,0.093758172,doramapimod
DNA_REPLICATION,-1.877061258,0.09168125,doramapimod
RESPIRATORY_ELECTRON_TRANSPORT,-1.847376178,0.088298835,doramapimod
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-1.773620041,0.113933981,doramapimod
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,-1.712843887,0.13631387,doramapimod
EUKARYOTIC_TRANSLATION_INITIATION,-3.011049121,0,ziprasidone
CELLULAR_RESPONSE_TO_STARVATION,-2.47246889,0,ziprasidone
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.535725971,0,ziprasidone
METABOLISM_OF_RNA,-2.554769486,0,ziprasidone
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.600628191,0,ziprasidone
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.722381261,0,ziprasidone
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.733939652,0,ziprasidone
INFLUENZA_INFECTION,-2.595578133,0,ziprasidone
TRANSLATION,-2.759576414,0,ziprasidone
SELENOAMINO_ACID_METABOLISM,-2.760275901,0,ziprasidone
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,2.089034299,0.150860703,aripiprazole
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,-2.095581143,0.136151523,aripiprazole
PEROXISOMAL_PROTEIN_IMPORT,2.024991923,0.127471447,aripiprazole
REGULATION_OF_TP53_ACTIVITY,2.012307009,0.093946846,aripiprazole
GPCR_LIGAND_BINDING,-2.008994989,0.137469119,aripiprazole
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,1.952371383,0.111683699,aripiprazole
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.932687332,0.099638232,aripiprazole
SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX,1.808671148,0.189063155,aripiprazole
ADIPOGENESIS,1.759163624,0.216016488,aripiprazole
TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER,1.755645825,0.192815181,aripiprazole
METABOLISM_OF_RNA,-3.007633068,0,indacaterol
RRNA_PROCESSING,-2.840484292,0,indacaterol
TRANSLATION,-2.785624235,0,indacaterol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.669664216,0,indacaterol
GPCR_LIGAND_BINDING,2.570072809,0.000277118,indacaterol
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.520268132,0.000364711,indacaterol
EUKARYOTIC_TRANSLATION_INITIATION,-2.496126906,0.000583537,indacaterol
CELL_CYCLE_CHECKPOINTS,-2.48742321,0.000486281,indacaterol
CELL_CYCLE,-2.427119458,0.001042031,indacaterol
MITOTIC_METAPHASE_AND_ANAPHASE,-2.369251095,0.002552975,indacaterol
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.465281186,0.008696319,radezolid
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.063147577,0.092941914,radezolid
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,2.059892091,0.151981503,radezolid
SENSORY_PERCEPTION,-1.865924035,0.24929449,radezolid
PKR_MEDIATED_SIGNALING,-1.844329292,0.210070466,radezolid
GPCR_LIGAND_BINDING,-1.83827263,0.174578612,radezolid
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.791060698,0.194580147,radezolid
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.825935157,0.514362399,radezolid
REGULATION_OF_T_CELL_ACTIVATION_BY_CD28_FAMILY,1.720270893,0.71494632,radezolid
TOLL_LIKE_RECEPTOR_CASCADES,1.708316659,0.580379365,radezolid
TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION,2.050770208,0.179218267,gestrinone
ADIPOGENESIS,1.955569389,0.177226953,gestrinone
VISUAL_PHOTOTRANSDUCTION,-1.849626504,1,gestrinone
NEUTROPHIL_DEGRANULATION,-1.825862372,0.865661305,gestrinone
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,-1.76521942,0.865211143,gestrinone
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,1.539500365,1,gestrinone
ORGANELLE_BIOGENESIS_AND_MAINTENANCE,1.491333766,1,gestrinone
TRANSPORT_OF_SMALL_MOLECULES,-1.717675846,0.873764219,gestrinone
GPCR_LIGAND_BINDING,-1.712949521,0.720439081,gestrinone
OPIOID_SIGNALLING,1.410289193,1,gestrinone
EUKARYOTIC_TRANSLATION_INITIATION,-2.379311682,0.00097555,SR-27897
EUKARYOTIC_TRANSLATION_ELONGATION,-2.327884565,0.00097555,SR-27897
RRNA_PROCESSING,-2.268682116,0.0019511,SR-27897
GPCR_LIGAND_BINDING,-2.260449575,0.0019511,SR-27897
SIGNALING_BY_GPCR,-2.172605032,0.007414179,SR-27897
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.134153255,0.010731049,SR-27897
NONSENSE_MEDIATED_DECAY_NMD,-2.128532461,0.010034228,SR-27897
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.1257428,0.008901893,SR-27897
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.105836504,0.009755499,SR-27897
SELENOAMINO_ACID_METABOLISM,-2.057097985,0.014243029,SR-27897
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.060560819,0.107817045,sphingosine
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-3.28609759,0.385952847,sphingosine
SIGNALING_BY_GPCR,1.947102045,0.129933362,sphingosine
SENSORY_PERCEPTION,1.942819916,0.089156403,sphingosine
NEUTROPHIL_DEGRANULATION,-3.215581143,0.445431881,sphingosine
GPCR_LIGAND_BINDING,1.882763254,0.098659508,sphingosine
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-3.147009059,0.537073653,sphingosine
HEMOSTASIS,-2.715117399,0.825436824,sphingosine
INNATE_IMMUNE_SYSTEM,-2.359399579,0.807857465,sphingosine
BIOLOGICAL_OXIDATIONS,-2.100181548,0.754061983,sphingosine
EUKARYOTIC_TRANSLATION_INITIATION,4.694427452,0,dipivefrine
RESPIRATORY_ELECTRON_TRANSPORT,2.68299061,0,dipivefrine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.883473649,0,dipivefrine
RRNA_PROCESSING,3.375397591,0,dipivefrine
INFLUENZA_INFECTION,3.412277526,0,dipivefrine
NONSENSE_MEDIATED_DECAY_NMD,3.61167443,0,dipivefrine
SIGNALING_BY_ROBO_RECEPTORS,3.851303675,0,dipivefrine
CELLULAR_RESPONSE_TO_STARVATION,3.607637287,0,dipivefrine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,4.090992942,0,dipivefrine
TRANSLATION,4.121786942,0,dipivefrine
SENSORY_PERCEPTION,2.251683058,0.032855109,oxibendazole
G_ALPHA_Q_SIGNALLING_EVENTS,2.230419125,0.021903406,oxibendazole
NEUTROPHIL_DEGRANULATION,-2.220152848,0.029881199,oxibendazole
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,2.095511869,0.043350491,oxibendazole
COPII_MEDIATED_VESICLE_TRANSPORT,-2.021047492,0.115682926,oxibendazole
TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,-2.012935657,0.082813608,oxibendazole
NEURONAL_SYSTEM,1.863816685,0.149559194,oxibendazole
MITF_M_DEPENDENT_GENE_EXPRESSION,-1.965570846,0.087936099,oxibendazole
PEROXISOMAL_PROTEIN_IMPORT,-1.928290448,0.099376329,oxibendazole
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,-1.880495071,0.117390424,oxibendazole
GPCR_LIGAND_BINDING,4.20051569,0,bethanechol
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.51481289,0,bethanechol
TRANSLATION,-2.709579631,0,bethanechol
SIGNALING_BY_ROBO_RECEPTORS,-2.710087089,0,bethanechol
INTEGRIN_CELL_SURFACE_INTERACTIONS,2.773021284,0,bethanechol
SARS_COV_1_INFECTION,-2.806491986,0,bethanechol
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.81613156,0,bethanechol
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.871931083,0,bethanechol
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,2.899779546,0,bethanechol
CELLULAR_RESPONSE_TO_STARVATION,-2.901333478,0,bethanechol
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,2.163538732,0.115790934,mometasone
SIGNALING_BY_FGFR,-1.792592336,0.632502277,mometasone
TRANSPORT_OF_SMALL_MOLECULES,1.975050106,0.247081442,mometasone
GASTRULATION,1.941419325,0.210307943,mometasone
SIGNALING_BY_FGFR2,-1.68104161,0.561418306,mometasone
SIGNALING_BY_FGFR_IN_DISEASE,-1.674811853,0.386367981,mometasone
CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS,-1.636313226,0.348166391,mometasone
APOPTOSIS,1.842141465,0.318880939,mometasone
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,1.832091834,0.273886588,mometasone
CLATHRIN_MEDIATED_ENDOCYTOSIS,-1.525825616,0.472926015,mometasone
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,3.328637213,0,moracizine
MRNA_SPLICING,2.834257892,0,moracizine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.133873615,0.010864911,moracizine
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,2.150271128,0.039566345,moracizine
HOST_INTERACTIONS_OF_HIV_FACTORS,2.031362774,0.053697183,moracizine
MITOTIC_METAPHASE_AND_ANAPHASE,1.773384305,0.149221646,moracizine
GPCR_LIGAND_BINDING,-1.938618742,0.053160458,moracizine
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.902540477,0.053807179,moracizine
G_ALPHA_Q_SIGNALLING_EVENTS,-1.888721773,0.047728003,moracizine
DOWNSTREAM_TCR_SIGNALING,1.648231095,0.238340128,moracizine
ANCHORING_OF_THE_BASAL_BODY_TO_THE_PLASMA_MEMBRANE,-2.125681004,0.13738617,bexarotene
MITOTIC_G2_G2_M_PHASES,-1.994021795,0.197492619,bexarotene
REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS,-1.922974059,0.237563585,bexarotene
G2_M_CHECKPOINTS,-1.917361665,0.184919331,bexarotene
AURKA_ACTIVATION_BY_TPX2,-1.876319992,0.206815252,bexarotene
METABOLISM_OF_RNA,-1.841391765,0.217732546,bexarotene
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,1.804970049,0.774084125,bexarotene
RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES,-1.829811319,0.208182104,bexarotene
M_PHASE,-1.828598095,0.183692669,bexarotene
MITOTIC_PROMETAPHASE,-1.811758379,0.188633392,bexarotene
GPCR_LIGAND_BINDING,-2.577788343,0,levalbuterol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.507708271,0,levalbuterol
SIGNALING_BY_GPCR,-2.277520236,0.001772088,levalbuterol
SIGNALING_BY_NTRKS,2.31645938,0.027468934,levalbuterol
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.254147791,0.002879643,levalbuterol
NEUTROPHIL_DEGRANULATION,2.1272782,0.043165468,levalbuterol
G_ALPHA_Q_SIGNALLING_EVENTS,-2.098400246,0.013113452,levalbuterol
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,1.890530285,0.101373447,levalbuterol
G_ALPHA_S_SIGNALLING_EVENTS,-1.949507471,0.055820777,levalbuterol
G_ALPHA_I_SIGNALLING_EVENTS,-1.93294244,0.055947355,levalbuterol
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.995168633,0.067091163,adenosine
MRNA_SPLICING,1.890122725,0.060801367,adenosine
RAB_REGULATION_OF_TRAFFICKING,1.86465773,0.044028576,adenosine
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.54350279,0.074900229,adenosine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.491438007,0.09338826,adenosine
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,1.708949866,0.101160895,adenosine
TP53_REGULATES_METABOLIC_GENES,1.666758541,0.10902314,adenosine
VESICLE_MEDIATED_TRANSPORT,1.416519473,0.330563752,adenosine
GPCR_LIGAND_BINDING,-2.358130786,0.458882413,adenosine
DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS,1.35191598,0.401049409,adenosine
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.44772681,0.006762806,resorcinol
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.204486989,0.022166976,resorcinol
SENSORY_PERCEPTION,-1.806256196,0.187855727,resorcinol
APOPTOSIS,-1.575772269,0.516603249,resorcinol
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-1.483457785,0.647726546,resorcinol
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,1.612610452,1,resorcinol
TCR_SIGNALING,1.606833606,1,resorcinol
DEUBIQUITINATION,1.550945428,1,resorcinol
ORGANELLE_BIOGENESIS_AND_MAINTENANCE,1.53089131,1,resorcinol
METABOLISM_OF_STEROIDS,-1.364096139,0.935020571,resorcinol
NONSENSE_MEDIATED_DECAY_NMD,3.496693935,0,naringenin
INFLUENZA_INFECTION,3.085341709,0,naringenin
SELENOAMINO_ACID_METABOLISM,2.94743165,0,naringenin
CELLULAR_RESPONSE_TO_STARVATION,2.913686658,0,naringenin
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.801989211,0,naringenin
TRANSLATION,2.747958168,0,naringenin
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.529512011,0.003574495,naringenin
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.498417615,0.004691525,naringenin
AUTOPHAGY,2.201563987,0.002780163,naringenin
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,2.212539176,0.002943702,naringenin
GPCR_LIGAND_BINDING,-2.5116424,0.001624032,dimethyl-fumarate
NEUTROPHIL_DEGRANULATION,2.406937822,0.024649348,dimethyl-fumarate
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.347714818,0.004466088,dimethyl-fumarate
SIGNALING_BY_GPCR,-2.268284639,0.008661504,dimethyl-fumarate
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,2.134869323,0.058884555,dimethyl-fumarate
SUMOYLATION,2.018224139,0.064818657,dimethyl-fumarate
SENSORY_PERCEPTION,-2.170792818,0.023548465,dimethyl-fumarate
TOLL_LIKE_RECEPTOR_CASCADES,1.894688816,0.110922068,dimethyl-fumarate
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.117734107,0.03442948,dimethyl-fumarate
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,-2.092028988,0.037894082,dimethyl-fumarate
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-3.85051789,0,AZD-9291
DOWNSTREAM_TCR_SIGNALING,-2.69318187,0,AZD-9291
MITOTIC_METAPHASE_AND_ANAPHASE,-2.676927507,0,AZD-9291
SARS_COV_1_INFECTION,-2.658001623,0,AZD-9291
TRANSCRIPTIONAL_REGULATION_BY_TP53,-2.651602989,0,AZD-9291
SARS_COV_1_HOST_INTERACTIONS,-2.647893476,0,AZD-9291
SARS_COV_2_HOST_INTERACTIONS,-2.642623584,0,AZD-9291
S_PHASE,-2.598511654,0,AZD-9291
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,-2.5904817,0,AZD-9291
CELL_CYCLE_CHECKPOINTS,-2.584928465,0,AZD-9291
EUKARYOTIC_TRANSLATION_INITIATION,-2.876445372,0,aminoguanidine
EUKARYOTIC_TRANSLATION_ELONGATION,-2.825491685,0,aminoguanidine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.780265582,0,aminoguanidine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.767504763,0,aminoguanidine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.735839854,0,aminoguanidine
NONSENSE_MEDIATED_DECAY_NMD,-2.729207091,0,aminoguanidine
TRANSLATION,-2.717901885,0,aminoguanidine
GPCR_LIGAND_BINDING,-2.692306264,0,aminoguanidine
SELENOAMINO_ACID_METABOLISM,-2.688118529,0,aminoguanidine
RRNA_PROCESSING,-2.598253793,0,aminoguanidine
REGULATION_OF_T_CELL_ACTIVATION_BY_CD28_FAMILY,2.187394132,0.040048903,pranlukast
RRNA_PROCESSING,-1.876706846,0.92548474,pranlukast
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,1.716437863,0.426478216,pranlukast
ADAPTIVE_IMMUNE_SYSTEM,1.571275169,0.602153725,pranlukast
DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR,-1.685371926,1,pranlukast
TRANSCRIPTIONAL_REGULATION_BY_RUNX2,-1.67217247,1,pranlukast
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,1.446650109,0.829523563,pranlukast
PARASITE_INFECTION,1.419419253,0.758884114,pranlukast
DNA_REPLICATION_PRE_INITIATION,-1.644319969,1,pranlukast
APOPTOSIS,-1.626955049,1,pranlukast
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,2.231276315,0.013049013,umeclidinium
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,2.210832022,0.00978676,umeclidinium
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.125257518,0.017398684,umeclidinium
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.061962452,0.006471637,umeclidinium
GPCR_LIGAND_BINDING,-1.971662095,0.012538797,umeclidinium
DRUG_ADME,1.910589419,0.052196053,umeclidinium
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.932530869,0.015909441,umeclidinium
MEMBRANE_TRAFFICKING,1.653750904,0.160502864,umeclidinium
ASPARAGINE_N_LINKED_GLYCOSYLATION,1.632326757,0.157675578,umeclidinium
SEMAPHORIN_INTERACTIONS,1.62935284,0.137946713,umeclidinium
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.178085763,0,BMS-387032
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.069056955,0,BMS-387032
EUKARYOTIC_TRANSLATION_INITIATION,2.86874349,0,BMS-387032
SELENOAMINO_ACID_METABOLISM,2.830201739,0,BMS-387032
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.792428178,0,BMS-387032
EUKARYOTIC_TRANSLATION_ELONGATION,2.767007534,0,BMS-387032
PLASMA_LIPOPROTEIN_ASSEMBLY_REMODELING_AND_CLEARANCE,2.587388587,0.000959958,BMS-387032
CELLULAR_RESPONSE_TO_STARVATION,2.491471633,0.001049954,BMS-387032
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.430392784,0.001866585,BMS-387032
NEUTROPHIL_DEGRANULATION,2.404612616,0.002183904,BMS-387032
EUKARYOTIC_TRANSLATION_ELONGATION,-3.079727492,0,propafenone
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.514379821,0,propafenone
SARS_COV_1_INFECTION,-2.594039553,0,propafenone
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.672038354,0,propafenone
SARS_COV_1_HOST_INTERACTIONS,-2.688844711,0,propafenone
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.725042221,0,propafenone
INFLUENZA_INFECTION,-2.768318071,0,propafenone
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.790094948,0,propafenone
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.873290718,0,propafenone
SIGNALING_BY_ROBO_RECEPTORS,-2.775926517,0,propafenone
RRNA_PROCESSING,4.14930626,0,CS-1657
APC_C_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS,2.797587554,0,CS-1657
MITOTIC_METAPHASE_AND_ANAPHASE,2.806681403,0,CS-1657
DEGRADATION_OF_BETA_CATENIN_BY_THE_DESTRUCTION_COMPLEX,2.81047644,0,CS-1657
CELL_CYCLE_CHECKPOINTS,2.8326393,0,CS-1657
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,2.845769956,0,CS-1657
NONSENSE_MEDIATED_DECAY_NMD,2.882788488,0,CS-1657
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.983952965,0,CS-1657
SEPARATION_OF_SISTER_CHROMATIDS,2.99202489,0,CS-1657
SIGNALING_BY_ROBO_RECEPTORS,3.041406401,0,CS-1657
SIGNALING_BY_GPCR,2.92383991,0,flupentixol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,3.318595067,0,flupentixol
GPCR_LIGAND_BINDING,3.333705436,0,flupentixol
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,-3.738260973,0.001755813,flupentixol
MUSCLE_CONTRACTION,2.467727696,0.000488899,flupentixol
AMINE_LIGAND_BINDING_RECEPTORS,2.354823723,0.000977799,flupentixol
TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,-3.686952614,0.011412784,flupentixol
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.234463699,0.00228153,flupentixol
NEUTROPHIL_DEGRANULATION,-3.54290243,0.063209264,flupentixol
G_ALPHA_Q_SIGNALLING_EVENTS,2.063881803,0.010685943,flupentixol
MRNA_SPLICING,2.726878294,0,dosulepin
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.646768684,0,dosulepin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.351501284,0,dosulepin
GPCR_LIGAND_BINDING,-2.24062016,0.000863222,dosulepin
SELENOAMINO_ACID_METABOLISM,-2.135165707,0.003165146,dosulepin
EUKARYOTIC_TRANSLATION_ELONGATION,-2.122302469,0.003237081,dosulepin
NONSENSE_MEDIATED_DECAY_NMD,-2.095501777,0.003625531,dosulepin
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.086639452,0.003740627,dosulepin
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.04695049,0.006289187,dosulepin
RRNA_PROCESSING,-2.03874015,0.005934649,dosulepin
GPCR_LIGAND_BINDING,2.524354055,0.005710839,bisacodyl
SIGNALING_BY_GPCR,2.317364977,0.009280113,bisacodyl
NEUTROPHIL_DEGRANULATION,-2.262945688,0.023152676,bisacodyl
INNATE_IMMUNE_SYSTEM,-2.223112321,0.015435118,bisacodyl
MUSCLE_CONTRACTION,2.19588896,0.020939741,bisacodyl
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-2.183872969,0.014863447,bisacodyl
G_ALPHA_Q_SIGNALLING_EVENTS,2.117333219,0.026055701,bisacodyl
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.102898131,0.023128896,bisacodyl
MEMBRANE_TRAFFICKING,-2.061432208,0.036444028,bisacodyl
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.058514189,0.030012729,bisacodyl
EUKARYOTIC_TRANSLATION_INITIATION,-2.917993827,0,hypericin
EUKARYOTIC_TRANSLATION_ELONGATION,-2.872825196,0,hypericin
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.833135995,0,hypericin
NONSENSE_MEDIATED_DECAY_NMD,-2.792540988,0,hypericin
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.726822291,0,hypericin
RRNA_PROCESSING,-2.699776213,0,hypericin
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.656118439,0,hypericin
TRANSLATION,-2.653463465,0,hypericin
SELENOAMINO_ACID_METABOLISM,-2.599366334,0,hypericin
METABOLISM_OF_RNA,-2.595165431,0,hypericin
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,2.714552952,0,cromoglicic-acid
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.417500227,0,cromoglicic-acid
GPCR_LIGAND_BINDING,-2.383011042,0.000332175,cromoglicic-acid
CHROMATIN_ORGANIZATION,2.335095816,0.013983538,cromoglicic-acid
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.2659997,0.0008858,cromoglicic-acid
G_ALPHA_Q_SIGNALLING_EVENTS,-2.252208364,0.00066435,cromoglicic-acid
SIGNALING_BY_GPCR,-2.200341177,0.001461569,cromoglicic-acid
RESPIRATORY_ELECTRON_TRANSPORT,2.021924452,0.058264743,cromoglicic-acid
MHC_CLASS_II_ANTIGEN_PRESENTATION,1.993431069,0.031462961,cromoglicic-acid
TOLL_LIKE_RECEPTOR_CASCADES,2.013947762,0.0454465,cromoglicic-acid
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.015955881,0.274636858,D-serine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.742212966,1,D-serine
SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX,1.702040846,1,D-serine
TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER,1.688061991,0.73161807,D-serine
TRANSPORT_OF_SMALL_MOLECULES,-1.63681862,1,D-serine
SENSORY_PERCEPTION,-1.630025532,1,D-serine
MUSCLE_CONTRACTION,1.621421542,0.815661955,D-serine
PEROXISOMAL_PROTEIN_IMPORT,1.600757953,0.728391311,D-serine
GLOBAL_GENOME_NUCLEOTIDE_EXCISION_REPAIR_GG_NER,-1.563582641,1,D-serine
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,1.538704083,0.864474906,D-serine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.841244653,0.339008252,quercetin
VISUAL_PHOTOTRANSDUCTION,-1.947646194,0.432029795,quercetin
INFLUENZA_INFECTION,1.669562681,0.433425024,quercetin
SIGNALING_BY_ALK_IN_CANCER,1.61761015,0.370728323,quercetin
MITOTIC_PROPHASE,1.547053485,0.406661215,quercetin
REGULATION_OF_TP53_ACTIVITY,1.514693463,0.375882834,quercetin
GOLGI_TO_ER_RETROGRADE_TRANSPORT,1.507552781,0.323148217,quercetin
TP53_REGULATES_METABOLIC_GENES,1.426561777,0.418662447,quercetin
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,1.41478126,0.390863133,quercetin
MHC_CLASS_II_ANTIGEN_PRESENTATION,1.412212151,0.351564113,quercetin
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.134554177,0.061831766,everolimus
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.061948882,0.048950148,everolimus
TRNA_PROCESSING,1.974348745,0.05496157,everolimus
DNA_REPLICATION,1.965112671,0.047661986,everolimus
S_PHASE,1.938235215,0.045343295,everolimus
CELL_CYCLE_CHECKPOINTS,1.924898808,0.039503628,everolimus
CELL_CYCLE,1.842707482,0.047109917,everolimus
NONSENSE_MEDIATED_DECAY_NMD,1.797670756,0.052170553,everolimus
SYNTHESIS_OF_DNA,1.770951555,0.049808923,everolimus
G2_M_CHECKPOINTS,1.754424955,0.055648589,everolimus
RHO_GTPASE_EFFECTORS,2.246580511,0.047852199,chlordiazepoxide
COPI_MEDIATED_ANTEROGRADE_TRANSPORT,2.131187912,0.079221974,chlordiazepoxide
AUTOPHAGY,2.063384323,0.104920377,chlordiazepoxide
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,2.042617344,0.097033626,chlordiazepoxide
NEUTROPHIL_DEGRANULATION,1.961989074,0.153339714,chlordiazepoxide
NONSENSE_MEDIATED_DECAY_NMD,-1.708868473,0.497789908,chlordiazepoxide
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,1.941852097,0.149936891,chlordiazepoxide
INNATE_IMMUNE_SYSTEM,1.918742799,0.154798066,chlordiazepoxide
HIV_LIFE_CYCLE,1.916112188,0.137043381,chlordiazepoxide
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,1.888676686,0.148164587,chlordiazepoxide
MITOTIC_PROMETAPHASE,2.142195238,0.119760479,flecainide
CELL_CYCLE,2.121441338,0.063872255,flecainide
TOLL_LIKE_RECEPTOR_CASCADES,2.072765904,0.050565536,flecainide
CELL_CYCLE_MITOTIC,2.029083272,0.0499002,flecainide
UB_SPECIFIC_PROCESSING_PROTEASES,1.988211783,0.046307385,flecainide
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,1.961237585,0.049234864,flecainide
CELL_CYCLE_CHECKPOINTS,1.959813135,0.042201312,flecainide
M_PHASE,1.957803271,0.036926148,flecainide
HIV_INFECTION,1.944987439,0.032823242,flecainide
HIV_LIFE_CYCLE,1.936485573,0.031936128,flecainide
RRNA_PROCESSING,3.359853435,0,alosetron
EUKARYOTIC_TRANSLATION_INITIATION,3.280421613,0,alosetron
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.023479009,0,alosetron
EUKARYOTIC_TRANSLATION_ELONGATION,2.92629456,0,alosetron
METABOLISM_OF_RNA,2.909737322,0,alosetron
SIGNALING_BY_ROBO_RECEPTORS,2.872717749,0.000422251,alosetron
INFLUENZA_INFECTION,2.708399921,0.00072386,alosetron
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.647477366,0.000633377,alosetron
NONSENSE_MEDIATED_DECAY_NMD,2.529746297,0.001407505,alosetron
FORMATION_OF_PARAXIAL_MESODERM,2.512951661,0.001266754,alosetron
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.520403141,0.000848315,domperidone
HEMOSTASIS,-2.40809606,0.000424157,domperidone
PEROXISOMAL_PROTEIN_IMPORT,-2.377005286,0.001131086,domperidone
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.32418346,0.023591042,domperidone
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.30853103,0.003393258,domperidone
MUSCLE_CONTRACTION,2.214461776,0.028448022,domperidone
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.219234569,0.00933146,domperidone
GPCR_LIGAND_BINDING,2.180768965,0.023128473,domperidone
NEUTROPHIL_DEGRANULATION,-2.211686768,0.008200374,domperidone
VESICLE_MEDIATED_TRANSPORT,-2.163298582,0.011028089,domperidone
MUSCLE_CONTRACTION,3.789357007,0,BRD-K97440753
STRIATED_MUSCLE_CONTRACTION,3.032874508,0,BRD-K97440753
NEURONAL_SYSTEM,2.986297456,0,BRD-K97440753
CARDIAC_CONDUCTION,2.763106171,0,BRD-K97440753
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,2.477448934,0.000563405,BRD-K97440753
PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES,2.293070418,0.002910924,BRD-K97440753
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,2.126729771,0.00845107,BRD-K97440753
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.118268704,0.007958091,BRD-K97440753
RRNA_PROCESSING,-2.119270007,0.144251359,BRD-K97440753
GPCR_LIGAND_BINDING,2.024797706,0.013396512,BRD-K97440753
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.215565389,0.044401223,piribedil
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.192351837,0.02350653,piribedil
RRNA_PROCESSING,2.177513903,0.016976938,piribedil
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,2.097899651,0.024485968,piribedil
INTERFERON_ALPHA_BETA_SIGNALING,1.760678861,0.138949708,piribedil
HEME_SIGNALING,1.636491245,0.214605909,piribedil
BIOLOGICAL_OXIDATIONS,1.628273675,0.19327591,piribedil
TRANSPORT_OF_SMALL_MOLECULES,1.568267553,0.236860934,piribedil
SIGNALING_BY_FGFR,-2.091594387,1,piribedil
GPCR_LIGAND_BINDING,1.55051513,0.232743663,piribedil
GASTRULATION,-2.158871181,0.078096994,mepyramine
BIOLOGICAL_OXIDATIONS,1.693442814,1,mepyramine
PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS,1.679492901,0.771653221,mepyramine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.791340491,0.954865912,mepyramine
FATTY_ACID_METABOLISM,1.610575387,0.752583371,mepyramine
RRNA_PROCESSING,-1.728753623,0.996170544,mepyramine
COLLAGEN_DEGRADATION,-1.691742394,0.947837183,mepyramine
SIGNALING_BY_ALK_IN_CANCER,1.535826485,0.823457144,mepyramine
HEMOSTASIS,1.517246114,0.728318113,mepyramine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.482504712,0.717146484,mepyramine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,3.432506406,0,DR-2313
GPCR_LIGAND_BINDING,3.368997587,0,DR-2313
SIGNALING_BY_GPCR,3.325117732,0,DR-2313
MEMBRANE_TRAFFICKING,-2.873393134,0,DR-2313
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.749704053,0,DR-2313
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,-2.683623558,0.000457838,DR-2313
VESICLE_MEDIATED_TRANSPORT,-2.667262974,0.000343378,DR-2313
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,-2.608917437,0.000824108,DR-2313
G_ALPHA_Q_SIGNALLING_EVENTS,2.480765307,0.000728595,DR-2313
TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,-2.484698601,0.001602432,DR-2313
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.550800284,0.007133378,amfepramone
MRNA_SPLICING,2.03063598,0.04458361,amfepramone
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.396239064,0.43715847,amfepramone
RAB_GEFS_EXCHANGE_GTP_FOR_GDP_ON_RABS,1.512306396,0.658648529,amfepramone
GPCR_LIGAND_BINDING,-2.326480859,0.450540872,amfepramone
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.307677986,0.341697335,amfepramone
SELENOAMINO_ACID_METABOLISM,-2.122619339,0.551131928,amfepramone
EUKARYOTIC_TRANSLATION_ELONGATION,-2.118779275,0.444474183,amfepramone
G_ALPHA_I_SIGNALLING_EVENTS,-2.10310605,0.383034088,amfepramone
NONSENSE_MEDIATED_DECAY_NMD,-2.082568962,0.340805175,amfepramone
CELL_CYCLE_MITOTIC,-3.701654311,0,pralatrexate
REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS,-2.554996209,0,pralatrexate
DNA_REPLICATION,-2.614222299,0,pralatrexate
APC_C_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS,-2.649727983,0,pralatrexate
KINESINS,-2.773731385,0,pralatrexate
MRNA_SPLICING,-2.913588363,0,pralatrexate
MITOTIC_SPINDLE_CHECKPOINT,-2.958857301,0,pralatrexate
CELL_CYCLE_CHECKPOINTS,-2.986956786,0,pralatrexate
METABOLISM_OF_RNA,-2.987595973,0,pralatrexate
MITOTIC_G2_G2_M_PHASES,-2.703527945,0,pralatrexate
GPCR_LIGAND_BINDING,-2.420366716,0,phenylephrine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.290470332,0.000364183,phenylephrine
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.240009877,0.001213943,phenylephrine
FATTY_ACID_METABOLISM,2.40944286,0.024657534,phenylephrine
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,2.353610175,0.017808219,phenylephrine
SIGNALING_BY_GPCR,-2.102766409,0.005826926,phenylephrine
ESTROGEN_DEPENDENT_GENE_EXPRESSION,2.125398324,0.03652968,phenylephrine
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,2.108622975,0.030821918,phenylephrine
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,2.049691656,0.033972603,phenylephrine
RESPIRATORY_ELECTRON_TRANSPORT,2.047695782,0.029223744,phenylephrine
GPCR_LIGAND_BINDING,-2.051963196,0.253991038,dexniguldipine
G_ALPHA_Q_SIGNALLING_EVENTS,-1.946403624,0.311759676,dexniguldipine
METABOLISM_OF_STEROIDS,1.755043984,0.688231956,dexniguldipine
METABOLISM_OF_LIPIDS,1.676350976,0.525666821,dexniguldipine
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-1.849644412,0.45037258,dexniguldipine
TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT,-1.809086184,0.455703846,dexniguldipine
INTEGRIN_CELL_SURFACE_INTERACTIONS,-1.796496716,0.402375276,dexniguldipine
SIGNALING_BY_GPCR,-1.794940088,0.34024614,dexniguldipine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.783035046,0.314692441,dexniguldipine
ECM_PROTEOGLYCANS,-1.765508302,0.308656403,dexniguldipine
RRNA_PROCESSING,-2.96591317,0,acenocoumarol
METABOLISM_OF_RNA,-2.931125896,0,acenocoumarol
TRANSLATION,-2.640114815,0,acenocoumarol
CELL_CYCLE_CHECKPOINTS,-2.499965638,0.002592922,acenocoumarol
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.413955684,0.004741343,acenocoumarol
INFLUENZA_INFECTION,-2.412740531,0.003951119,acenocoumarol
MITOTIC_METAPHASE_AND_ANAPHASE,-2.405259024,0.003598341,acenocoumarol
SEPARATION_OF_SISTER_CHROMATIDS,-2.333165008,0.00574147,acenocoumarol
EUKARYOTIC_TRANSLATION_INITIATION,-2.322025488,0.005762049,acenocoumarol
HIV_INFECTION,-2.280495527,0.00681568,acenocoumarol
PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS,2.105160972,0.129898082,EMD-1214063
GASTRULATION,-2.082092454,0.162525589,EMD-1214063
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,1.775193195,0.480850794,EMD-1214063
FATTY_ACID_METABOLISM,1.711854054,0.461100209,EMD-1214063
SIGNALING_BY_ALK_IN_CANCER,1.658395957,0.468316769,EMD-1214063
COLLAGEN_DEGRADATION,-1.797553436,0.858249162,EMD-1214063
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.791369486,0.597828043,EMD-1214063
SIGNALING_BY_NTRKS,1.629850348,0.436184086,EMD-1214063
GPCR_LIGAND_BINDING,-1.762224456,0.546266562,EMD-1214063
DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR,-1.757506501,0.447848289,EMD-1214063
C_TYPE_LECTIN_RECEPTORS_CLRS,-2.218396004,0.023425603,macitentan
HDR_THROUGH_HOMOLOGOUS_RECOMBINATION_HRR,-2.208464565,0.011712801,macitentan
CELL_CYCLE,-2.037688635,0.042017351,macitentan
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-1.995714626,0.051592101,macitentan
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.994153709,0.041496782,macitentan
CELL_CYCLE_CHECKPOINTS,-1.976211104,0.042389186,macitentan
HOMOLOGY_DIRECTED_REPAIR,-1.972394056,0.037130377,macitentan
SEPARATION_OF_SISTER_CHROMATIDS,-1.970204702,0.032767956,macitentan
CELL_CYCLE_MITOTIC,-1.926456376,0.044248361,macitentan
MITOTIC_SPINDLE_CHECKPOINT,-1.903778939,0.050755473,macitentan
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.679353506,0,ORE-1001
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.648806325,0.000984631,ORE-1001
CELLULAR_RESPONSE_TO_STARVATION,2.565156016,0.001969262,ORE-1001
SELENOAMINO_ACID_METABOLISM,2.530642674,0.001969262,ORE-1001
EUKARYOTIC_TRANSLATION_ELONGATION,2.48847067,0.00157541,ORE-1001
GPCR_LIGAND_BINDING,-2.411878305,0.000993159,ORE-1001
NONSENSE_MEDIATED_DECAY_NMD,2.442745622,0.001641052,ORE-1001
INFLUENZA_INFECTION,2.290701197,0.007595726,ORE-1001
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.246427388,0.009107839,ORE-1001
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.144076195,0.020608051,ORE-1001
RAB_REGULATION_OF_TRAFFICKING,1.749179073,0.800989314,theobromine
MRNA_SPLICING,1.739835481,0.423669755,theobromine
RAB_GEFS_EXCHANGE_GTP_FOR_GDP_ON_RABS,1.728998171,0.302724714,theobromine
NEUTROPHIL_DEGRANULATION,-2.853940551,1,theobromine
RHOG_GTPASE_CYCLE,1.60038627,0.457346069,theobromine
VESICLE_MEDIATED_TRANSPORT,-2.663337223,1,theobromine
RAC2_GTPASE_CYCLE,1.577011016,0.410199229,theobromine
INNATE_IMMUNE_SYSTEM,-2.400029402,0.937431387,theobromine
MITF_M_DEPENDENT_GENE_EXPRESSION,1.558813012,0.37900941,theobromine
TOLL_LIKE_RECEPTOR_CASCADES,-2.106768633,0.78425779,theobromine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.888377887,0.08699855,enprofylline
MRNA_SPLICING,1.684274462,0.128322861,enprofylline
SENSORY_PERCEPTION,-1.832766305,0.062816861,enprofylline
DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA,-1.817040659,0.037412983,enprofylline
RAB_REGULATION_OF_TRAFFICKING,1.647827564,0.10439826,enprofylline
VISUAL_PHOTOTRANSDUCTION,-1.810412714,0.02709747,enprofylline
GPCR_LIGAND_BINDING,-1.799989078,0.024018212,enprofylline
POTASSIUM_CHANNELS,-1.791975899,0.021985901,enprofylline
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.748442323,0.032486171,enprofylline
MITF_M_DEPENDENT_GENE_EXPRESSION,1.429722114,0.264258096,enprofylline
ECM_PROTEOGLYCANS,-2.536867675,0.001001817,tiagabine
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.191491918,0.045081786,tiagabine
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.046207875,0.092501145,tiagabine
BACTERIAL_INFECTION_PATHWAYS,1.890553544,0.674797101,tiagabine
COLLAGEN_FORMATION,-1.858912699,0.267485261,tiagabine
CELLULAR_RESPONSE_TO_STARVATION,1.807859618,0.58395903,tiagabine
HIV_LIFE_CYCLE,1.788773479,0.44221171,tiagabine
PROTEIN_LOCALIZATION,1.770682371,0.37283538,tiagabine
INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,-1.758761165,0.404133162,tiagabine
HIV_INFECTION,1.731722477,0.388507443,tiagabine
EUKARYOTIC_TRANSLATION_ELONGATION,5.579927717,0,sulfapyridine
AUF1_HNRNP_D0_BINDS_AND_DESTABILIZES_MRNA,2.896888031,0,sulfapyridine
ORC1_REMOVAL_FROM_CHROMATIN,2.884791721,0,sulfapyridine
DEGRADATION_OF_AXIN,2.856377301,0,sulfapyridine
REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS,2.85322897,0,sulfapyridine
UCH_PROTEINASES,2.848478692,0,sulfapyridine
VIF_MEDIATED_DEGRADATION_OF_APOBEC3G,2.842840597,0,sulfapyridine
ASYMMETRIC_LOCALIZATION_OF_PCP_PROTEINS,2.834450017,0,sulfapyridine
CIRCADIAN_CLOCK,2.832961382,0,sulfapyridine
DECTIN_1_MEDIATED_NONCANONICAL_NF_KB_SIGNALING,2.823133696,0,sulfapyridine
GPCR_LIGAND_BINDING,-2.336583583,0.000693364,diflunisal
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.32972147,0.000346682,diflunisal
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.233433066,0.000462242,diflunisal
SIGNALING_BY_GPCR,-2.222382892,0.000693364,diflunisal
GOLGI_TO_ER_RETROGRADE_TRANSPORT,2.149552414,0.059067688,diflunisal
MITOCHONDRIAL_PROTEIN_DEGRADATION,2.10850914,0.035440613,diflunisal
SENSORY_PERCEPTION,-2.148479464,0.001941418,diflunisal
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,2.064761402,0.035440613,diflunisal
MHC_CLASS_II_ANTIGEN_PRESENTATION,2.045513016,0.031010536,diflunisal
G_ALPHA_Q_SIGNALLING_EVENTS,-2.068649136,0.003929061,diflunisal
GPCR_LIGAND_BINDING,-2.444986757,0,mephentermine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.345608295,0.000421599,mephentermine
KERATINIZATION,-2.148834925,0.006464525,mephentermine
MHC_CLASS_II_ANTIGEN_PRESENTATION,2.148003081,0.092302257,mephentermine
G_ALPHA_Q_SIGNALLING_EVENTS,-2.114651204,0.00779959,mephentermine
SIGNALING_BY_GPCR,-2.096533921,0.00809471,mephentermine
NEUTROPHIL_DEGRANULATION,1.869414976,0.207680078,mephentermine
G_ALPHA_I_SIGNALLING_EVENTS,-1.910380932,0.055932195,mephentermine
SENSORY_PERCEPTION,-1.905140289,0.050351021,mephentermine
NUCLEAR_ENVELOPE_NE_REASSEMBLY,1.662536976,0.414550487,mephentermine
EUKARYOTIC_TRANSLATION_ELONGATION,-3.107299359,0,doxazosin
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.506925344,0,doxazosin
NERVOUS_SYSTEM_DEVELOPMENT,-2.589114553,0,doxazosin
SARS_COV_1_INFECTION,-2.626735583,0,doxazosin
RRNA_PROCESSING,-2.627265164,0,doxazosin
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.698236465,0,doxazosin
SARS_COV_1_HOST_INTERACTIONS,-2.725978087,0,doxazosin
SIGNALING_BY_ROBO_RECEPTORS,-2.769669268,0,doxazosin
TRANSLATION,-2.784015304,0,doxazosin
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.656119689,0,doxazosin
SIGNALING_BY_GPCR,2.255961805,0.013243543,BRD-K59946561
GPCR_LIGAND_BINDING,2.074800314,0.033498373,BRD-K59946561
NEURONAL_SYSTEM,1.993777125,0.043625788,BRD-K59946561
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.964994158,0.04050966,BRD-K59946561
TRANSCRIPTIONAL_REGULATION_BY_RUNX1,1.94279713,0.03708192,BRD-K59946561
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.817942984,0.454298185,BRD-K59946561
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,1.770883892,0.094003185,BRD-K59946561
REGULATION_OF_INSULIN_SECRETION,1.717498523,0.112848339,BRD-K59946561
NEUTROPHIL_DEGRANULATION,-2.714859374,0.828072617,BRD-K59946561
G_ALPHA_Q_SIGNALLING_EVENTS,1.628303551,0.172458192,BRD-K59946561
CELL_CYCLE_CHECKPOINTS,2.790375968,0.003104907,alprazolam
CELL_CYCLE_MITOTIC,2.698270207,0.003104907,alprazolam
M_PHASE,2.657744815,0.002069938,alprazolam
METABOLISM_OF_RNA,2.597768391,0.002328681,alprazolam
MITOTIC_METAPHASE_AND_ANAPHASE,2.543541624,0.003725889,alprazolam
SEPARATION_OF_SISTER_CHROMATIDS,2.538739439,0.003104907,alprazolam
THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT,2.461593725,0.004435582,alprazolam
RRNA_PROCESSING,2.449610368,0.004269248,alprazolam
PCP_CE_PATHWAY,2.447479255,0.003794887,alprazolam
DNA_REPLICATION_PRE_INITIATION,2.434043297,0.003415398,alprazolam
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.406587354,0.001512667,FR-180204
GPCR_LIGAND_BINDING,2.31978786,0.0011345,FR-180204
METABOLISM_OF_RNA,-2.259435378,0.06408315,FR-180204
ADAPTIVE_IMMUNE_SYSTEM,-2.227545563,0.035414372,FR-180204
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.193625283,0.00655489,FR-180204
G_ALPHA_Q_SIGNALLING_EVENTS,2.16677538,0.007185167,FR-180204
RRNA_PROCESSING,-2.063941317,0.048343429,FR-180204
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-1.961079006,0.073358343,FR-180204
CELL_CYCLE,-1.867990214,0.08904185,FR-180204
CELL_CYCLE_MITOTIC,-1.837284007,0.087130598,FR-180204
EUKARYOTIC_TRANSLATION_ELONGATION,2.422987208,0.005535636,butalbital
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.326854614,0.004428509,butalbital
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.312698918,0.004797551,butalbital
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,2.302721129,0.003874945,butalbital
SIGNALING_BY_ROBO_RECEPTORS,2.280726776,0.003985658,butalbital
NONSENSE_MEDIATED_DECAY_NMD,2.241904284,0.005166594,butalbital
CELLULAR_RESPONSE_TO_STARVATION,2.18087836,0.00774989,butalbital
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.170419883,0.008303454,butalbital
EUKARYOTIC_TRANSLATION_INITIATION,2.099958128,0.015376767,butalbital
SELENOAMINO_ACID_METABOLISM,2.051375811,0.021035417,butalbital
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.988156224,0,pregnenolone
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.966161864,0,pregnenolone
DRUG_ADME,-2.813389838,0.002922746,pregnenolone
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.367176688,0.01673442,pregnenolone
SIGNALING_BY_GPCR,2.309765106,0.011504914,pregnenolone
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.79212986,0.005845493,pregnenolone
GPCR_LIGAND_BINDING,2.207319068,0.013596716,pregnenolone
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,1.985152402,0.051772112,pregnenolone
HEMOSTASIS,-2.644801043,0.043061798,pregnenolone
NEUTROPHIL_DEGRANULATION,-2.613549433,0.048874816,pregnenolone
MUSCLE_CONTRACTION,3.48439536,0,carteolol
CARDIAC_CONDUCTION,2.199394638,0.01950573,carteolol
SENSORY_PERCEPTION,2.038680724,0.037753026,carteolol
PEPTIDE_HORMONE_METABOLISM,1.715152804,0.198517993,carteolol
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.009187262,1,carteolol
COPII_MEDIATED_VESICLE_TRANSPORT,-2.004616228,1,carteolol
EUKARYOTIC_TRANSLATION_ELONGATION,-1.979676578,1,carteolol
POST_TRANSLATIONAL_PROTEIN_MODIFICATION,-1.955819458,0.969822244,carteolol
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-1.95022443,0.778878901,carteolol
DEVELOPMENTAL_CELL_LINEAGES,1.50363582,0.489782585,carteolol
GPCR_LIGAND_BINDING,2.473132889,0.004251953,amperozide
NEUTROPHIL_DEGRANULATION,-2.300614147,0.019099664,amperozide
MUSCLE_CONTRACTION,2.260245561,0.027637694,amperozide
G_ALPHA_I_SIGNALLING_EVENTS,2.235827247,0.020314886,amperozide
PEROXISOMAL_PROTEIN_IMPORT,-2.254402773,0.017854034,amperozide
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.19589808,0.020905435,amperozide
BACTERIAL_INFECTION_PATHWAYS,-2.203339564,0.018822857,amperozide
SIGNALING_BY_GPCR,2.160143748,0.023244009,amperozide
INNATE_IMMUNE_SYSTEM,-2.105347846,0.034254832,amperozide
ORC1_REMOVAL_FROM_CHROMATIN,1.994529975,0.055984047,amperozide
METABOLISM_OF_RNA,-2.105940548,0.167438272,BRD-K60174629
CELLULAR_RESPONSE_TO_STARVATION,-2.068680771,0.105464366,BRD-K60174629
SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES,2.039258678,0.213436881,BRD-K60174629
NEUTROPHIL_DEGRANULATION,2.028979938,0.114145731,BRD-K60174629
SARS_COV_1_INFECTION,-1.895539396,0.195707071,BRD-K60174629
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-1.867382498,0.170156425,BRD-K60174629
EUKARYOTIC_TRANSLATION_INITIATION,-1.696179502,0.309217172,BRD-K60174629
MRNA_SPLICING,-1.683916513,0.270728114,BRD-K60174629
HEMOSTASIS,1.902600669,0.220212655,BRD-K60174629
SELENOAMINO_ACID_METABOLISM,-1.662284944,0.256283069,BRD-K60174629
METABOLISM_OF_RNA,-2.787665762,0,melatonin
DISEASES_OF_METABOLISM,-2.697144079,0,melatonin
REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS,-2.638832423,0.000610874,melatonin
CELL_CYCLE_MITOTIC,-2.561027756,0.001374465,melatonin
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,-2.524376846,0.001466097,melatonin
GPCR_LIGAND_BINDING,2.504476619,0.002026058,melatonin
CELL_CYCLE_CHECKPOINTS,-2.448886764,0.002443494,melatonin
SYNTHESIS_OF_DNA,-2.447148462,0.002094424,melatonin
CELL_CYCLE,-2.432459139,0.002061698,melatonin
G2_M_CHECKPOINTS,-2.425157523,0.002443494,melatonin
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-3.226580801,0,otamixaban
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,2.773882033,0,otamixaban
EUKARYOTIC_TRANSLATION_INITIATION,-2.92859483,0,otamixaban
SIGNALING_BY_ROBO_RECEPTORS,-2.936647604,0,otamixaban
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.959890714,0,otamixaban
CELLULAR_RESPONSE_TO_STARVATION,-2.917928095,0,otamixaban
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-3.048663307,0,otamixaban
SELENOAMINO_ACID_METABOLISM,-3.085721194,0,otamixaban
NONSENSE_MEDIATED_DECAY_NMD,-3.106682807,0,otamixaban
EUKARYOTIC_TRANSLATION_ELONGATION,-3.196026815,0,otamixaban
CELL_CYCLE_MITOTIC,-3.769957232,0,amsacrine
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,-2.448942894,0,amsacrine
HOMOLOGY_DIRECTED_REPAIR,-2.453702484,0,amsacrine
RHO_GTPASE_EFFECTORS,-2.500607441,0,amsacrine
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,-2.550657661,0,amsacrine
DNA_DOUBLE_STRAND_BREAK_REPAIR,-2.557977106,0,amsacrine
MITOTIC_G2_G2_M_PHASES,-2.559939667,0,amsacrine
DNA_STRAND_ELONGATION,-2.594083899,0,amsacrine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.606113947,0,amsacrine
DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE,-2.615933495,0,amsacrine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.516438028,0.001724512,BRD-K41170226
MUSCLE_CONTRACTION,2.185276658,0.016957705,BRD-K41170226
C_TYPE_LECTIN_RECEPTORS_CLRS,-1.84478118,1,BRD-K41170226
RAB_REGULATION_OF_TRAFFICKING,1.732019261,0.282628412,BRD-K41170226
VESICLE_MEDIATED_TRANSPORT,1.716577513,0.228641595,BRD-K41170226
G_ALPHA_I_SIGNALLING_EVENTS,-1.745167062,1,BRD-K41170226
GASTRULATION,-1.710435108,0.933436355,BRD-K41170226
CARDIAC_CONDUCTION,1.610570904,0.321794004,BRD-K41170226
TRANSCRIPTIONAL_ACTIVATION_OF_MITOCHONDRIAL_BIOGENESIS,-1.668323501,0.927163261,BRD-K41170226
CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS,1.583651396,0.309358354,BRD-K41170226
GPCR_LIGAND_BINDING,2.740183094,0,stiripentol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.584922477,0,stiripentol
SIGNALING_BY_GPCR,2.445758988,0.001319951,stiripentol
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.403120686,0.001979927,stiripentol
NEUTROPHIL_DEGRANULATION,-3.531163928,0.026958595,stiripentol
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,1.899793831,0.179513389,stiripentol
GASTRULATION,1.882964035,0.170273729,stiripentol
KEAP1_NFE2L2_PATHWAY,1.78613176,0.282281032,stiripentol
ORC1_REMOVAL_FROM_CHROMATIN,1.782427035,0.254090642,stiripentol
G_ALPHA_I_SIGNALLING_EVENTS,1.777655866,0.23187146,stiripentol
TRNA_PROCESSING_IN_THE_NUCLEUS,2.240232296,0.023746575,ketotifen
SENSORY_PERCEPTION,2.097302309,0.036989857,ketotifen
TRNA_PROCESSING,1.978595308,0.056626448,ketotifen
GLYCOSAMINOGLYCAN_METABOLISM,1.714857019,0.184492621,ketotifen
SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,1.709877472,0.152160746,ketotifen
TRANSCRIPTIONAL_REGULATION_BY_RUNX1,1.615885182,0.201693666,ketotifen
TRANSPORT_OF_SMALL_MOLECULES,1.585610748,0.201454461,ketotifen
RAB_GERANYLGERANYLATION,-1.75186384,1,ketotifen
MUSCLE_CONTRACTION,1.489501639,0.283360573,ketotifen
HOST_INTERACTIONS_OF_HIV_FACTORS,1.423140348,0.340672018,ketotifen
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,2.132860351,0.109758253,fexofenadine
NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK,1.900867851,0.373313564,fexofenadine
TOLL_LIKE_RECEPTOR_CASCADES,1.849694924,0.355020522,fexofenadine
MUSCLE_CONTRACTION,1.807699458,0.359763163,fexofenadine
CELL_CELL_COMMUNICATION,1.690999056,0.616001257,fexofenadine
PI3K_AKT_SIGNALING_IN_CANCER,1.672953569,0.569794387,fexofenadine
MYD88_INDEPENDENT_TLR4_CASCADE,1.668781565,0.499622665,fexofenadine
PLASMA_LIPOPROTEIN_ASSEMBLY_REMODELING_AND_CLEARANCE,-1.701216176,1,fexofenadine
PHOSPHOLIPID_METABOLISM,-1.68773332,1,fexofenadine
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,1.637336937,0.528296282,fexofenadine
STRIATED_MUSCLE_CONTRACTION,2.801828604,0,lamotrigine
MUSCLE_CONTRACTION,2.785735301,0,lamotrigine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.903033926,0.120441188,lamotrigine
GPCR_LIGAND_BINDING,1.882820186,0.103045533,lamotrigine
NEURONAL_SYSTEM,1.818153821,0.127070514,lamotrigine
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,1.803243124,0.116645773,lamotrigine
APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1,-1.838893738,1,lamotrigine
NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK,1.801766578,0.101066495,lamotrigine
G_ALPHA_I_SIGNALLING_EVENTS,1.785639846,0.097826837,lamotrigine
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,1.773671467,0.093282881,lamotrigine
MUSCLE_CONTRACTION,2.133689504,0.092937939,xylazine
GPCR_LIGAND_BINDING,2.107922228,0.054417609,xylazine
SIGNALING_BY_GPCR,2.022345339,0.059512891,xylazine
SENSORY_PERCEPTION,2.021410302,0.044940385,xylazine
MITOCHONDRIAL_TRANSLATION,1.842209689,0.095628248,xylazine
G_ALPHA_Q_SIGNALLING_EVENTS,1.810283046,0.09619892,xylazine
SIGNALING_BY_WNT,-3.005196862,0.597372624,xylazine
TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT,-2.996780734,0.345697353,xylazine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.77197985,0.101847404,xylazine
S_PHASE,1.649822809,0.174411495,xylazine
MRNA_SPLICING,3.794373712,0,itraconazole
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,3.539936784,0,itraconazole
RAB_GEFS_EXCHANGE_GTP_FOR_GDP_ON_RABS,2.138049575,0.03069644,itraconazole
RAB_REGULATION_OF_TRAFFICKING,1.880777906,0.126622815,itraconazole
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.4423773,0.114702248,itraconazole
NUCLEOTIDE_EXCISION_REPAIR,1.67120435,0.297316947,itraconazole
REGULATION_OF_RAS_BY_GAPS,1.580263978,0.410016733,itraconazole
INTERLEUKIN_1_SIGNALING,1.561388244,0.393728826,itraconazole
SYNTHESIS_OF_DNA,1.554930848,0.358490566,itraconazole
TNFR2_NON_CANONICAL_NF_KB_PATHWAY,1.535262911,0.355932529,itraconazole
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.937959867,0,cariporide
MRNA_SPLICING,2.680238013,0,cariporide
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,1.835240805,0.245177231,cariporide
RAB_GEFS_EXCHANGE_GTP_FOR_GDP_ON_RABS,1.786290875,0.241613608,cariporide
GLUCOSE_METABOLISM,1.673039656,0.383160696,cariporide
RAB_REGULATION_OF_TRAFFICKING,1.666042105,0.329278723,cariporide
DNA_REPLICATION,1.634507363,0.33355507,cariporide
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.400162091,0.322554882,cariporide
NUCLEOTIDE_EXCISION_REPAIR,1.520661817,0.509954386,cariporide
DNA_REPLICATION_PRE_INITIATION,1.514440019,0.461845481,cariporide
RAB_GEFS_EXCHANGE_GTP_FOR_GDP_ON_RABS,2.418011162,0.002321263,BRD-K44408410
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.216325738,0.006963788,BRD-K44408410
RAB_REGULATION_OF_TRAFFICKING,2.189346858,0.00406221,BRD-K44408410
MRNA_SPLICING,2.195559235,0.00541628,BRD-K44408410
NUCLEAR_ENVELOPE_NE_REASSEMBLY,1.552963186,0.218662953,BRD-K44408410
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.374352946,0.754170077,BRD-K44408410
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.359286364,0.43553322,BRD-K44408410
GPCR_LIGAND_BINDING,-2.252493211,0.539231605,BRD-K44408410
SELENOAMINO_ACID_METABOLISM,-2.093871564,0.656599324,BRD-K44408410
EUKARYOTIC_TRANSLATION_ELONGATION,-2.090955103,0.529050309,BRD-K44408410
GPCR_LIGAND_BINDING,-2.606521944,0,setiptiline
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.452699479,0.00085288,setiptiline
NEUTROPHIL_DEGRANULATION,2.441601219,0.004786734,setiptiline
SIGNALING_BY_GPCR,-2.309916905,0.00085288,setiptiline
SIGNALING_BY_NTRKS,2.185475799,0.025130353,setiptiline
SENSORY_PERCEPTION,-2.142492666,0.005543723,setiptiline
G_ALPHA_Q_SIGNALLING_EVENTS,-2.118952416,0.006311315,setiptiline
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.10993511,0.005543723,setiptiline
SUMOYLATION,2.020401031,0.043080605,setiptiline
TOLL_LIKE_RECEPTOR_CASCADES,2.002786675,0.034703821,setiptiline
G_ALPHA_I_SIGNALLING_EVENTS,-2.150305278,0.085456531,istaroxime
TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM,2.10295455,0.181506632,istaroxime
SIGNALING_BY_GPCR,-2.028544005,0.126724002,istaroxime
GPCR_LIGAND_BINDING,-2.012296895,0.097142895,istaroxime
ECM_PROTEOGLYCANS,-1.976740362,0.097508094,istaroxime
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.910069254,0.131325507,istaroxime
PROTEIN_LOCALIZATION,1.75292334,0.805229422,istaroxime
INTERLEUKIN_3_INTERLEUKIN_5_AND_GM_CSF_SIGNALING,1.720642641,0.643523513,istaroxime
ADAPTIVE_IMMUNE_SYSTEM,1.711266335,0.507393539,istaroxime
PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS,1.681466221,0.48577775,istaroxime
CELL_CYCLE,-3.962456021,0,crizotinib
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,-2.593921998,0,crizotinib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.594006137,0,crizotinib
DNA_STRAND_ELONGATION,-2.605071724,0,crizotinib
HOMOLOGOUS_DNA_PAIRING_AND_STRAND_EXCHANGE,-2.693606984,0,crizotinib
AURKA_ACTIVATION_BY_TPX2,-2.717543508,0,crizotinib
ANCHORING_OF_THE_BASAL_BODY_TO_THE_PLASMA_MEMBRANE,-2.730489399,0,crizotinib
DISEASES_OF_DNA_REPAIR,-2.756994612,0,crizotinib
RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES,-2.788681757,0,crizotinib
S_PHASE,-2.809819077,0,crizotinib
ECM_PROTEOGLYCANS,-2.473741786,0.001183018,fomepizole
CELL_CELL_JUNCTION_ORGANIZATION,2.132473972,0.060544566,fomepizole
C_TYPE_LECTIN_RECEPTORS_CLRS,-2.153012207,0.089909334,fomepizole
INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,-2.114985568,0.08202255,fomepizole
CELLULAR_RESPONSE_TO_STARVATION,2.025387737,0.08335245,fomepizole
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.024105447,0.055844759,fomepizole
RAB_GEFS_EXCHANGE_GTP_FOR_GDP_ON_RABS,1.969807986,0.069253031,fomepizole
CELL_JUNCTION_ORGANIZATION,1.966513584,0.056397678,fomepizole
BACTERIAL_INFECTION_PATHWAYS,1.959900944,0.049624427,fomepizole
RAB_REGULATION_OF_TRAFFICKING,1.946751808,0.047393007,fomepizole
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.295268248,0.227774905,amrinone
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.979893116,0.689465704,amrinone
INNATE_IMMUNE_SYSTEM,-1.973070683,0.468948333,amrinone
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.956993583,0.379624841,amrinone
NEUTROPHIL_DEGRANULATION,-1.927561254,0.352381176,amrinone
GPCR_LIGAND_BINDING,-1.918637927,0.308352138,amrinone
TOLL_LIKE_RECEPTOR_CASCADES,-1.892425416,0.299871723,amrinone
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-1.864494078,0.300629378,amrinone
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.863950766,0.268094537,amrinone
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,-1.853521739,0.253120446,amrinone
GPCR_LIGAND_BINDING,1.978339735,0.513287404,BRD-K30697463
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.861902583,0.68005588,BRD-K30697463
ADIPOGENESIS,-1.571543706,1,BRD-K30697463
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-1.423574359,1,BRD-K30697463
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.763960879,0.911734241,BRD-K30697463
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,1.752123847,0.745465072,BRD-K30697463
CELLULAR_RESPONSE_TO_STARVATION,-1.38380381,0.979818365,BRD-K30697463
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.73670047,0.66028333,BRD-K30697463
G_ALPHA_12_13_SIGNALLING_EVENTS,-1.287315969,1,BRD-K30697463
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,1.681658966,0.780915856,BRD-K30697463
GPCR_LIGAND_BINDING,3.206179952,0,terbutaline
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,3.131292426,0,terbutaline
EUKARYOTIC_TRANSLATION_ELONGATION,-3.405139848,0.001102192,terbutaline
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-3.34874074,0.001102192,terbutaline
SELENOAMINO_ACID_METABOLISM,-3.345111519,0.000734795,terbutaline
EUKARYOTIC_TRANSLATION_INITIATION,-3.298096627,0.001102192,terbutaline
NONSENSE_MEDIATED_DECAY_NMD,-3.278079945,0.001763507,terbutaline
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-3.260270639,0.00275548,terbutaline
SIGNALING_BY_GPCR,2.314356338,0.003128422,terbutaline
RRNA_PROCESSING,-3.228339227,0.007085521,terbutaline
EUKARYOTIC_TRANSLATION_ELONGATION,-3.071730964,0,phenoxybenzamine
RRNA_PROCESSING,-2.583009191,0,phenoxybenzamine
SIGNALING_BY_ROBO_RECEPTORS,-2.630682425,0,phenoxybenzamine
TRANSLATION,-2.632770892,0,phenoxybenzamine
SIGNALING_BY_GPCR,2.663559136,0,phenoxybenzamine
SARS_COV_1_INFECTION,-2.707687959,0,phenoxybenzamine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.716366725,0,phenoxybenzamine
CELLULAR_RESPONSE_TO_STARVATION,-2.763312574,0,phenoxybenzamine
INFLUENZA_INFECTION,-2.83364178,0,phenoxybenzamine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.716196156,0,phenoxybenzamine
REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF,2.423189861,0.000894709,fingolimod
METABOLISM_OF_STEROIDS,2.153731556,0.0049209,fingolimod
GPCR_LIGAND_BINDING,-2.119966489,0.023165933,fingolimod
FORMATION_OF_THE_CORNIFIED_ENVELOPE,-1.988758504,0.076868777,fingolimod
KERATINIZATION,-1.940944754,0.088100745,fingolimod
METABOLISM_OF_LIPIDS,1.689814522,0.063076986,fingolimod
SIGNALING_BY_GPCR,-1.87168299,0.140311843,fingolimod
GLOBAL_GENOME_NUCLEOTIDE_EXCISION_REPAIR_GG_NER,1.59403972,0.077616007,fingolimod
PARASITE_INFECTION,1.578182576,0.067371589,fingolimod
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.815162746,0.196068031,fingolimod
MITOTIC_METAPHASE_AND_ANAPHASE,-2.739099077,0,gemcitabine
RESOLUTION_OF_SISTER_CHROMATID_COHESION,-2.725405031,0,gemcitabine
M_PHASE,-2.678645437,0.000506566,gemcitabine
SEPARATION_OF_SISTER_CHROMATIDS,-2.672632708,0.000379925,gemcitabine
MITOTIC_PROMETAPHASE,-2.642091302,0.00030394,gemcitabine
CELL_CYCLE,-2.620035632,0.000253283,gemcitabine
MITOTIC_SPINDLE_CHECKPOINT,-2.521091561,0.000868399,gemcitabine
CELL_CYCLE_MITOTIC,-2.515613052,0.000949811,gemcitabine
SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3,-2.361267356,0.00219512,gemcitabine
RHO_GTPASE_EFFECTORS,-2.278562937,0.004255155,gemcitabine
NEUTROPHIL_DEGRANULATION,3.028370307,0.001728964,rotundine
GPCR_LIGAND_BINDING,-2.363373927,0.000916356,rotundine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.334841396,0.000458178,rotundine
SIGNALING_BY_GPCR,-2.205041924,0.001527261,rotundine
INNATE_IMMUNE_SYSTEM,2.301975181,0.007780339,rotundine
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.289073508,0.005763214,rotundine
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.08707637,0.011912634,rotundine
G_ALPHA_Q_SIGNALLING_EVENTS,-2.075214528,0.011912634,rotundine
TOLL_LIKE_RECEPTOR_CASCADES,1.802619373,0.094228553,rotundine
SENSORY_PERCEPTION,-1.948618046,0.045970551,rotundine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.247703699,0.060519526,tamsulosin
GPCR_LIGAND_BINDING,-2.103849714,0.074114491,tamsulosin
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.085331809,0.056426418,tamsulosin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.957129473,0.105251349,tamsulosin
TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,1.93895068,0.466319485,tamsulosin
GASTRULATION,-1.902675813,0.118407767,tamsulosin
MYD88_INDEPENDENT_TLR4_CASCADE,1.883624135,0.350016525,tamsulosin
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.848462691,0.140335132,tamsulosin
REGULATION_OF_T_CELL_ACTIVATION_BY_CD28_FAMILY,1.824643811,0.357770056,tamsulosin
TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,1.820121995,0.276634896,tamsulosin
RESPIRATORY_ELECTRON_TRANSPORT,2.972657924,0,epinephrine
GPCR_LIGAND_BINDING,-2.600212157,0,epinephrine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.469592733,0,epinephrine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.412926946,0.002946323,epinephrine
SIGNALING_BY_GPCR,-2.268911665,0.00224315,epinephrine
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.267845095,0.001682363,epinephrine
PROTEIN_LOCALIZATION,2.069966708,0.040593788,epinephrine
G_ALPHA_I_SIGNALLING_EVENTS,-2.052245322,0.014636557,epinephrine
G_ALPHA_S_SIGNALLING_EVENTS,-2.024747059,0.018786385,epinephrine
FATTY_ACID_METABOLISM,1.80939219,0.130620335,epinephrine
METABOLISM_OF_RNA,3.811073112,0,tegafur
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,3.088029849,0,tegafur
CELL_CYCLE,2.769047055,0.004018626,tegafur
MRNA_SPLICING,2.725416249,0.00301397,tegafur
CELL_CYCLE_CHECKPOINTS,2.722501295,0.002411176,tegafur
CELL_CYCLE_MITOTIC,2.553678081,0.002679084,tegafur
MITOTIC_METAPHASE_AND_ANAPHASE,2.518900826,0.002870447,tegafur
VIRAL_INFECTION_PATHWAYS,2.490819513,0.00301397,tegafur
KEAP1_NFE2L2_PATHWAY,2.386002328,0.004911654,tegafur
M_PHASE,2.347162237,0.004822351,tegafur
RRNA_PROCESSING,3.684223781,0,fenofibrate
RRNA_MODIFICATION_IN_THE_NUCLEUS_AND_CYTOSOL,3.286846627,0,fenofibrate
SEPARATION_OF_SISTER_CHROMATIDS,3.062089079,0,fenofibrate
MITOTIC_SPINDLE_CHECKPOINT,3.013410691,0,fenofibrate
CELL_CYCLE_CHECKPOINTS,2.872484616,0,fenofibrate
RHO_GTPASES_ACTIVATE_FORMINS,2.852714256,0,fenofibrate
RESOLUTION_OF_SISTER_CHROMATID_COHESION,2.847165143,0,fenofibrate
METABOLISM_OF_RNA,2.789142917,0.000516917,fenofibrate
MITOTIC_METAPHASE_AND_ANAPHASE,2.452511684,0.00229741,fenofibrate
MITOTIC_PROMETAPHASE,2.303461633,0.004548872,fenofibrate
TRANSLATION,4.495407754,0,metyrapone
SCF_SKP2_MEDIATED_DEGRADATION_OF_P27_P21,2.838998472,0,metyrapone
SYNTHESIS_OF_DNA,2.82919013,0,metyrapone
THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT,2.773230357,0,metyrapone
APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1,2.726297337,0,metyrapone
REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS,2.708322273,0,metyrapone
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,2.700912433,0,metyrapone
DNA_REPLICATION_PRE_INITIATION,2.840349955,0,metyrapone
UCH_PROTEINASES,2.658422433,0,metyrapone
CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6,2.603454799,0,metyrapone
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.200823795,0.015182186,camostat-mesilate
RAB_GEFS_EXCHANGE_GTP_FOR_GDP_ON_RABS,2.044627444,0.03340081,camostat-mesilate
RAB_REGULATION_OF_TRAFFICKING,1.828343374,0.096153846,camostat-mesilate
MRNA_SPLICING,1.783361126,0.090334008,camostat-mesilate
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.391225651,0.37160897,camostat-mesilate
GPCR_LIGAND_BINDING,-2.294102059,0.480417552,camostat-mesilate
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.233505028,0.434312221,camostat-mesilate
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,1.391550891,0.558097166,camostat-mesilate
FATTY_ACID_METABOLISM,1.384297686,0.479757085,camostat-mesilate
SELENOAMINO_ACID_METABOLISM,-2.127242384,0.463589106,camostat-mesilate
GPCR_LIGAND_BINDING,-1.97086447,0.525648383,nafamostat
SIGNALING_BY_GPCR,-1.955937312,0.288622885,nafamostat
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.923197455,0.244729275,nafamostat
G_ALPHA_Q_SIGNALLING_EVENTS,-1.917587471,0.191609048,nafamostat
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.807728481,0.305284542,nafamostat
CELL_CYCLE_CHECKPOINTS,-1.805638049,0.258166094,nafamostat
SEPARATION_OF_SISTER_CHROMATIDS,-1.708622049,0.382527059,nafamostat
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.678924882,0.392892606,nafamostat
DNA_REPLICATION,-1.670874088,0.366198124,nafamostat
HOMOLOGY_DIRECTED_REPAIR,-1.662628458,0.344842539,nafamostat
EUKARYOTIC_TRANSLATION_ELONGATION,2.267230786,0.020583779,E-7438
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.246700344,0.014580177,E-7438
CELLULAR_RESPONSE_TO_STARVATION,2.222436759,0.011721319,E-7438
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.160686859,0.015866663,E-7438
SELENOAMINO_ACID_METABOLISM,2.080224433,0.02761657,E-7438
NONSENSE_MEDIATED_DECAY_NMD,2.064907031,0.025872666,E-7438
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.052657174,0.025484679,E-7438
SIGNALING_BY_ROBO_RECEPTORS,1.932376979,0.061429715,E-7438
EUKARYOTIC_TRANSLATION_INITIATION,1.885514371,0.079762143,E-7438
DEVELOPMENTAL_CELL_LINEAGES,-3.485895076,1,E-7438
GPCR_LIGAND_BINDING,2.744359888,0,clemastine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.595974359,0,clemastine
SIGNALING_BY_GPCR,2.52658828,0,clemastine
G_ALPHA_Q_SIGNALLING_EVENTS,2.364970909,0.002577046,clemastine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.300315614,0.035581355,clemastine
NEUTROPHIL_DEGRANULATION,-2.114125049,0.085915955,clemastine
MEMBRANE_TRAFFICKING,-2.014818249,0.123522265,clemastine
SYNTHESIS_OF_DNA,1.877788922,0.126905211,clemastine
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-1.98562861,0.115205485,clemastine
DNA_REPLICATION,1.854918589,0.122934651,clemastine
EUKARYOTIC_TRANSLATION_ELONGATION,-3.442641947,0,anastrozole
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.617144688,0,anastrozole
SARS_COV_1_HOST_INTERACTIONS,-2.73108324,0,anastrozole
SIGNALING_BY_ROBO_RECEPTORS,-2.87517054,0,anastrozole
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.905710434,0,anastrozole
TRANSLATION,-2.924361823,0,anastrozole
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.993095445,0,anastrozole
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.993786201,0,anastrozole
SARS_COV_1_INFECTION,-2.490073361,0,anastrozole
RRNA_PROCESSING,-3.006877064,0,anastrozole
METABOLISM_OF_RNA,-4.051217848,0,NVP-TAE226
MITOTIC_METAPHASE_AND_ANAPHASE,-2.940498082,0,NVP-TAE226
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.911067423,0,NVP-TAE226
CELL_CYCLE_CHECKPOINTS,-2.884293986,0,NVP-TAE226
CELL_CYCLE,-2.830642803,0,NVP-TAE226
GPCR_LIGAND_BINDING,2.791263387,0,NVP-TAE226
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.742844234,0,NVP-TAE226
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.58641741,0.000790473,NVP-TAE226
CELL_CYCLE_MITOTIC,-2.573375114,0.000658727,NVP-TAE226
MRNA_SPLICING,-2.505633299,0.001129247,NVP-TAE226
GPCR_LIGAND_BINDING,-2.469035608,0,folic-acid
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.431092399,0,folic-acid
SIGNALING_BY_GPCR,-2.298891653,0.001042916,folic-acid
SIGNALING_BY_NTRKS,2.372487949,0.017003952,folic-acid
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.158355116,0.009581791,folic-acid
G_ALPHA_Q_SIGNALLING_EVENTS,-2.145753307,0.010168431,folic-acid
SENSORY_PERCEPTION,-2.092025332,0.015904469,folic-acid
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,1.914060872,0.167205524,folic-acid
G_ALPHA_S_SIGNALLING_EVENTS,-2.033990486,0.023689092,folic-acid
POTENTIAL_THERAPEUTICS_FOR_SARS,1.819072936,0.193656116,folic-acid
GPCR_LIGAND_BINDING,-2.504371158,0,cefdinir
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.446082896,0,cefdinir
RESOLUTION_OF_SISTER_CHROMATID_COHESION,2.362302056,0.016053858,cefdinir
SIGNALING_BY_GPCR,-2.191427191,0.007842922,cefdinir
G_ALPHA_Q_SIGNALLING_EVENTS,-2.187885666,0.005882192,cefdinir
KERATINIZATION,-2.15367659,0.006722505,cefdinir
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.107274832,0.008543183,cefdinir
SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3,1.848114493,0.22934083,cefdinir
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,1.845233264,0.158245173,cefdinir
RHO_GTPASE_CYCLE,1.822450464,0.130150921,cefdinir
INFLUENZA_INFECTION,3.285381372,0,pilaralisib
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.571014067,0,pilaralisib
CELLULAR_RESPONSES_TO_STIMULI,2.619228105,0,pilaralisib
SARS_COV_2_HOST_INTERACTIONS,2.647496592,0,pilaralisib
SARS_COV_1_HOST_INTERACTIONS,2.676528668,0,pilaralisib
SARS_COV_1_INFECTION,2.677705356,0,pilaralisib
NERVOUS_SYSTEM_DEVELOPMENT,2.739388957,0,pilaralisib
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,2.773405364,0,pilaralisib
TRANSLATION,2.844654936,0,pilaralisib
RRNA_PROCESSING,2.869532725,0,pilaralisib
CELLULAR_RESPONSE_TO_STARVATION,2.195593917,0.053472187,lonafarnib
GPCR_LIGAND_BINDING,-2.145902209,0.071011374,lonafarnib
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.141981078,0.036427913,lonafarnib
ECM_PROTEOGLYCANS,-2.107212439,0.033200123,lonafarnib
MITF_M_DEPENDENT_GENE_EXPRESSION,2.057014168,0.06851124,lonafarnib
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.038299854,0.05607153,lonafarnib
NEURONAL_SYSTEM,-1.995483177,0.068936366,lonafarnib
SIGNALING_BY_GPCR,-1.967475104,0.069535813,lonafarnib
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,1.879881844,0.146770015,lonafarnib
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,-1.824120469,0.15862281,lonafarnib
GPCR_LIGAND_BINDING,-2.436731823,0.000991467,rimexolone
EUKARYOTIC_TRANSLATION_ELONGATION,-2.36089598,0.001982933,rimexolone
SIGNALING_BY_GPCR,-2.358538812,0.001321956,rimexolone
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.319737771,0.002478667,rimexolone
CELLULAR_RESPONSE_TO_STARVATION,-2.312772225,0.001982933,rimexolone
SELENOAMINO_ACID_METABOLISM,-2.309806812,0.001817689,rimexolone
RRNA_PROCESSING,-2.302586838,0.001699657,rimexolone
NONSENSE_MEDIATED_DECAY_NMD,-2.246351879,0.00187277,rimexolone
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.259451103,0.002106867,rimexolone
INFLUENZA_INFECTION,-2.204872878,0.003172693,rimexolone
GPCR_LIGAND_BINDING,2.902951176,0,A-443654
EXTRACELLULAR_MATRIX_ORGANIZATION,2.895831956,0,A-443654
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.755132767,0,A-443654
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.663612994,0,A-443654
CELL_CYCLE_CHECKPOINTS,-2.626771104,0,A-443654
SIGNALING_BY_GPCR,2.577297559,0,A-443654
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,2.572822081,0,A-443654
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.556824677,0.000115821,A-443654
MITOTIC_METAPHASE_AND_ANAPHASE,-2.492335754,0.000560621,A-443654
RESOLUTION_OF_SISTER_CHROMATID_COHESION,-2.446184109,0.000373748,A-443654
MYD88_INDEPENDENT_TLR4_CASCADE,2.405851738,0.005640892,pelitinib
GPCR_LIGAND_BINDING,-2.165615818,0.000696975,pelitinib
TOLL_LIKE_RECEPTOR_CASCADES,2.275577144,0.008461338,pelitinib
GLOBAL_GENOME_NUCLEOTIDE_EXCISION_REPAIR_GG_NER,2.215452924,0.015042379,pelitinib
REGULATION_OF_PLK1_ACTIVITY_AT_G2_M_TRANSITION,2.187434044,0.012692007,pelitinib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.115451409,0.003833361,pelitinib
MITOTIC_PROMETAPHASE,2.087898533,0.013538141,pelitinib
KERATINIZATION,-2.038278157,0.009525321,pelitinib
SIGNALING_BY_GPCR,-2.033568373,0.00714399,pelitinib
UB_SPECIFIC_PROCESSING_PROTEASES,1.902445108,0.044186988,pelitinib
M_PHASE,-2.226266016,0.028587519,clofarabine
G_ALPHA_I_SIGNALLING_EVENTS,-2.217255492,0.017042559,clofarabine
MITOTIC_METAPHASE_AND_ANAPHASE,-2.203334026,0.012461226,clofarabine
SEPARATION_OF_SISTER_CHROMATIDS,-2.203260583,0.00934592,clofarabine
MITOTIC_PROMETAPHASE,-2.17782609,0.009235968,clofarabine
GPCR_LIGAND_BINDING,-2.175526168,0.008063146,clofarabine
SIGNALING_BY_WNT,-2.143393693,0.009424457,clofarabine
OPIOID_SIGNALLING,-2.072690965,0.020341119,clofarabine
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,2.028090249,0.130253995,clofarabine
CELL_CYCLE_MITOTIC,-2.065206656,0.019547022,clofarabine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,3.604875126,0,vernakalant
MRNA_SPLICING,3.073886675,0,vernakalant
RAB_GEFS_EXCHANGE_GTP_FOR_GDP_ON_RABS,2.083453103,0.043447148,vernakalant
RAB_REGULATION_OF_TRAFFICKING,2.046078576,0.047791863,vernakalant
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.47394585,0.077211859,vernakalant
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,1.719021996,0.239828256,vernakalant
SYNTHESIS_OF_DNA,1.611203761,0.380886663,vernakalant
GPCR_LIGAND_BINDING,-2.381768053,0.156997446,vernakalant
G1_S_DNA_DAMAGE_CHECKPOINTS,1.581335284,0.374886818,vernakalant
CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6,1.579005767,0.330198323,vernakalant
EUKARYOTIC_TRANSLATION_INITIATION,-2.690057111,0,blonanserin
EUKARYOTIC_TRANSLATION_ELONGATION,-2.656902065,0,blonanserin
CELLULAR_RESPONSE_TO_STARVATION,-2.483899693,7.41E-05,blonanserin
RRNA_PROCESSING,-2.4992003,8.15E-05,blonanserin
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.517108672,9.05E-05,blonanserin
NONSENSE_MEDIATED_DECAY_NMD,-2.539515941,0.000101843,blonanserin
SENSORY_PERCEPTION,-2.466498697,6.79E-05,blonanserin
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.566848217,0.00013579,blonanserin
TRANSLATION,-2.576640062,0.000162948,blonanserin
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.588211083,0.000203685,blonanserin
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.172977701,0.038260488,nepafenac
RHO_GTPASES_ACTIVATE_FORMINS,-2.044899725,0.177782925,nepafenac
MITOTIC_PROMETAPHASE,-2.014162474,0.120471324,nepafenac
RESOLUTION_OF_SISTER_CHROMATID_COHESION,-2.013413871,0.080704091,nepafenac
MITOTIC_SPINDLE_CHECKPOINT,-1.983244254,0.078364842,nepafenac
GPCR_LIGAND_BINDING,-1.978698495,0.065732897,nepafenac
SEPARATION_OF_SISTER_CHROMATIDS,-1.960514026,0.063354661,nepafenac
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,1.871331583,0.138480123,nepafenac
CELL_CYCLE_MITOTIC,-1.90822717,0.089559819,nepafenac
MITOTIC_METAPHASE_AND_ANAPHASE,-1.852958237,0.129974523,nepafenac
GASTRULATION,-2.247381591,0.034242544,PH-797804
PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS,1.949394178,0.318503182,PH-797804
INTRA_GOLGI_TRAFFIC,1.923875044,0.185944329,PH-797804
FATTY_ACID_METABOLISM,1.721681618,0.408987041,PH-797804
TP53_REGULATES_METABOLIC_GENES,1.674137244,0.39699793,PH-797804
BIOLOGICAL_OXIDATIONS,1.640758659,0.375508013,PH-797804
RRNA_PROCESSING,-1.750674053,1,PH-797804
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.600133643,0.384858012,PH-797804
CLEC7A_DECTIN_1_SIGNALING,-1.738602851,1,PH-797804
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,-1.706545273,0.938038169,PH-797804
INTERFERON_GAMMA_SIGNALING,2.294438401,0.02509437,brequinar
BIOLOGICAL_OXIDATIONS,2.233047854,0.020767755,brequinar
PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS,2.135020726,0.027113458,brequinar
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,-2.158617242,0.146221312,brequinar
CHROMATIN_ORGANIZATION,-2.123542929,0.099600024,brequinar
TP53_REGULATES_METABOLIC_GENES,2.001724716,0.058841972,brequinar
MUSCLE_CONTRACTION,1.968193755,0.057976649,brequinar
SIGNALING_BY_ALK_IN_CANCER,1.957047201,0.052928931,brequinar
CELL_CYCLE,-2.038499395,0.141983014,brequinar
METABOLISM_OF_RNA,-2.037947906,0.106752154,brequinar
GPCR_LIGAND_BINDING,2.438459788,0.004591225,acitretin
SIGNALING_BY_GPCR,2.426153726,0.003213858,acitretin
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.407918289,0.016113757,acitretin
NEUTROPHIL_DEGRANULATION,-2.220568781,0.038135893,acitretin
INNATE_IMMUNE_SYSTEM,-2.167853396,0.036524517,acitretin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.025990917,0.047442662,acitretin
PROTEIN_LOCALIZATION,-2.085861077,0.052101149,acitretin
METABOLISM_OF_LIPIDS,-2.009314582,0.06509958,acitretin
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,-1.968955118,0.070900533,acitretin
NEURONAL_SYSTEM,1.898874261,0.088610649,acitretin
GPCR_LIGAND_BINDING,4.043803363,0,sulindac
NERVOUS_SYSTEM_DEVELOPMENT,-2.493017662,0,sulindac
G_ALPHA_Q_SIGNALLING_EVENTS,2.759650497,0,sulindac
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,2.848018338,0,sulindac
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.891407392,0,sulindac
INFLUENZA_INFECTION,-3.002940476,0,sulindac
SARS_COV_1_INFECTION,-3.014966654,0,sulindac
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-3.051114258,0,sulindac
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-3.128191354,0,sulindac
TRANSLATION,-3.151177244,0,sulindac
NEUTROPHIL_DEGRANULATION,-2.465983613,0.103574384,somatostatin
INNATE_IMMUNE_SYSTEM,-2.463695532,0.052854969,somatostatin
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.331129261,0.112472527,somatostatin
SIGNALING_BY_GPCR,1.815459365,0.639050065,somatostatin
GPCR_LIGAND_BINDING,1.779617408,0.416991661,somatostatin
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.007756034,0.42390753,somatostatin
HEMOSTASIS,-2.0026833,0.344251355,somatostatin
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-1.964408415,0.319265369,somatostatin
RHO_GTPASE_CYCLE,-1.873794576,0.337570121,somatostatin
METABOLISM_OF_LIPIDS,-1.868506451,0.297909826,somatostatin
TRANSLATION,5.622573807,0,nalbuphine
GPCR_LIGAND_BINDING,-2.394830538,0,nalbuphine
S_PHASE,2.773062196,0,nalbuphine
SYNTHESIS_OF_DNA,2.799967632,0,nalbuphine
CELL_CYCLE_CHECKPOINTS,2.823273282,0,nalbuphine
DNA_REPLICATION_PRE_INITIATION,2.888330635,0,nalbuphine
SARS_COV_1_INFECTION,2.914652664,0,nalbuphine
SARS_COV_1_HOST_INTERACTIONS,2.935759298,0,nalbuphine
G2_M_CHECKPOINTS,3.214701521,0,nalbuphine
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,3.232967016,0,nalbuphine
METABOLISM_OF_RNA,2.851295067,0,pefloxacin
SEPARATION_OF_SISTER_CHROMATIDS,2.473222137,0.003580297,pefloxacin
SIGNALING_BY_HEDGEHOG,2.418080229,0.003580297,pefloxacin
MITOTIC_METAPHASE_AND_ANAPHASE,2.373134925,0.004475371,pefloxacin
CELL_CYCLE_MITOTIC,2.323811116,0.005012416,pefloxacin
MITOTIC_G2_G2_M_PHASES,2.275654209,0.004773729,pefloxacin
SIGNALING_BY_GPCR,-2.103415417,0.005529213,pefloxacin
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.131832481,0.017390013,pefloxacin
TRANSCRIPTIONAL_REGULATION_BY_RUNX2,2.120514116,0.016558873,pefloxacin
RRNA_PROCESSING,2.109283222,0.01551462,pefloxacin
PEROXISOMAL_PROTEIN_IMPORT,-1.991528574,0.162385216,timolol
HOST_INTERACTIONS_OF_HIV_FACTORS,1.723620967,0.7023388,timolol
S_PHASE,1.717163911,0.359555535,timolol
HIV_INFECTION,1.674069442,0.303997391,timolol
NONSENSE_MEDIATED_DECAY_NMD,-1.882238124,0.24972213,timolol
EUKARYOTIC_TRANSLATION_ELONGATION,-1.877636333,0.173210897,timolol
SELENOAMINO_ACID_METABOLISM,-1.872006962,0.136491357,timolol
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-1.864355157,0.120077284,timolol
CILIUM_ASSEMBLY,-1.830099705,0.137076529,timolol
EUKARYOTIC_TRANSLATION_INITIATION,-1.795950712,0.160253518,timolol
GPCR_LIGAND_BINDING,-2.174015931,0,clofibrate
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.093683626,0.002241225,clofibrate
METABOLISM_OF_RNA,2.124526163,0.034147807,clofibrate
PI3K_AKT_SIGNALING_IN_CANCER,-2.025748375,0.00418362,clofibrate
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.073164497,0.024834769,clofibrate
SIGNALING_BY_GPCR,-1.975165562,0.007620164,clofibrate
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,1.810562087,0.091060818,clofibrate
G_ALPHA_S_SIGNALLING_EVENTS,-1.882435699,0.021695056,clofibrate
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,-1.862681036,0.025101717,clofibrate
METABOLISM_OF_VITAMINS_AND_COFACTORS,1.620880164,0.184708592,clofibrate
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.861374197,0,doxapram
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.066910441,0.002497002,doxapram
GPCR_LIGAND_BINDING,-2.036885324,0.00291317,doxapram
MRNA_SPLICING,2.032123009,0.028253148,doxapram
G_ALPHA_Q_SIGNALLING_EVENTS,-2.017730582,0.003884226,doxapram
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.963833407,0.006034423,doxapram
SEMAPHORIN_INTERACTIONS,1.83685271,0.065924012,doxapram
SIGNALING_BY_GPCR,-1.907916552,0.008989209,doxapram
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,1.583825371,0.275468195,doxapram
COPI_MEDIATED_ANTEROGRADE_TRANSPORT,1.581798336,0.221504682,doxapram
FATTY_ACID_METABOLISM,-2.260408945,0.075240414,vinblastine
METABOLISM_OF_LIPIDS,-2.24057798,0.04410645,vinblastine
RRNA_PROCESSING,2.101385092,0.096058237,vinblastine
MHC_CLASS_II_ANTIGEN_PRESENTATION,-2.114743992,0.078267327,vinblastine
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,-1.989322461,0.153723949,vinblastine
BIOLOGICAL_OXIDATIONS,-1.951454948,0.161118266,vinblastine
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,-1.846033066,0.258152455,vinblastine
KERATINIZATION,-1.840510814,0.200587052,vinblastine
FORMATION_OF_THE_CORNIFIED_ENVELOPE,-1.840510814,0.200587052,vinblastine
GOLGI_TO_ER_RETROGRADE_TRANSPORT,-1.840369413,0.17844374,vinblastine
INFLUENZA_INFECTION,3.57267776,0,tafamidis-meglumine
GPCR_LIGAND_BINDING,-2.52196184,0,tafamidis-meglumine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.533158948,0,tafamidis-meglumine
CELLULAR_RESPONSE_TO_STARVATION,2.64505556,0,tafamidis-meglumine
TRANSLATION,2.680980013,0,tafamidis-meglumine
SELENOAMINO_ACID_METABOLISM,2.685995124,0,tafamidis-meglumine
EUKARYOTIC_TRANSLATION_INITIATION,2.688841746,0,tafamidis-meglumine
SIGNALING_BY_GPCR,-2.361258673,0,tafamidis-meglumine
METABOLISM_OF_RNA,2.717802666,0,tafamidis-meglumine
SARS_COV_1_INFECTION,2.756661822,0,tafamidis-meglumine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.287495365,0.013524403,BMS-927711
C_TYPE_LECTIN_RECEPTORS_CLRS,-2.052818043,0.181663589,BMS-927711
G_ALPHA_Q_SIGNALLING_EVENTS,-1.991469339,0.16052663,BMS-927711
DISEASES_OF_GLYCOSYLATION,-1.805125025,0.50462108,BMS-927711
SIGNALING_BY_GPCR,-1.793151356,0.412456324,BMS-927711
ESTROGEN_DEPENDENT_GENE_EXPRESSION,1.663024876,0.661983937,BMS-927711
NEUTROPHIL_DEGRANULATION,1.624612071,0.546907876,BMS-927711
CLEC7A_DECTIN_1_SIGNALING,-1.70618959,0.600061113,BMS-927711
BACTERIAL_INFECTION_PATHWAYS,1.556144773,0.583684762,BMS-927711
PHOSPHOLIPID_METABOLISM,-1.664689153,0.663814749,BMS-927711
METABOLISM_OF_RNA,-3.474784619,0,trimetazidine
CELL_CYCLE_CHECKPOINTS,-2.597246499,0,trimetazidine
NONSENSE_MEDIATED_DECAY_NMD,-2.642096845,0,trimetazidine
EUKARYOTIC_TRANSLATION_ELONGATION,-2.788283501,0,trimetazidine
EUKARYOTIC_TRANSLATION_INITIATION,-2.804603129,0,trimetazidine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.831675133,0,trimetazidine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.757549566,0,trimetazidine
SIGNALING_BY_ROBO_RECEPTORS,-2.882331035,0,trimetazidine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-3.074981541,0,trimetazidine
RRNA_PROCESSING,-3.162618442,0,trimetazidine
METABOLISM_OF_RNA,3.112917623,0,alitretinoin
MRNA_SPLICING,2.603952816,0,alitretinoin
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.462931229,0.00174796,alitretinoin
RRNA_PROCESSING,2.453146268,0.00131097,alitretinoin
DNA_REPLICATION,2.414584425,0.00174796,alitretinoin
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.412702945,0.001456633,alitretinoin
INFLUENZA_INFECTION,2.39574726,0.00174796,alitretinoin
HOST_INTERACTIONS_OF_HIV_FACTORS,2.347363974,0.00218495,alitretinoin
SYNTHESIS_OF_DNA,2.295425682,0.003301702,alitretinoin
TRANSLATION,2.269468622,0.0043699,alitretinoin
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.409510668,0.01530335,doxofylline
MUSCLE_CONTRACTION,2.063767137,0.13597566,doxofylline
EXTRA_NUCLEAR_ESTROGEN_SIGNALING,-1.840686404,0.584470269,doxofylline
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,1.803378217,0.510122523,doxofylline
METABOLISM_OF_RNA,-1.795852454,0.525807425,doxofylline
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,-1.773264584,0.446151524,doxofylline
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.733595244,0.441207365,doxofylline
TRANSCRIPTIONAL_REGULATION_BY_RUNX2,-1.720156789,0.397887111,doxofylline
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,1.679478861,0.776230025,doxofylline
TRANSPORT_OF_SMALL_MOLECULES,-1.663530524,0.472554008,doxofylline
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.567071806,0.002373162,dexfenfluramine
NEUTROPHIL_DEGRANULATION,2.373855057,0.007712776,dexfenfluramine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.048282678,0.145519037,dexfenfluramine
GPCR_LIGAND_BINDING,-2.046969129,0.074141028,dexfenfluramine
SIGNALING_BY_GPCR,-1.996274773,0.080127571,dexfenfluramine
MUSCLE_CONTRACTION,1.903742892,0.159792888,dexfenfluramine
C_TYPE_LECTIN_RECEPTORS_CLRS,-1.945120998,0.096245186,dexfenfluramine
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,1.728446136,0.329869476,dexfenfluramine
G_ALPHA_Q_SIGNALLING_EVENTS,-1.784371862,0.274275754,dexfenfluramine
BACTERIAL_INFECTION_PATHWAYS,1.644753216,0.41079429,dexfenfluramine
TRANSLATION,3.359710223,0,CP-945598
SARS_COV_INFECTIONS,2.568808444,0,CP-945598
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.591976319,0,CP-945598
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.633125639,0,CP-945598
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,2.638221628,0,CP-945598
INFLUENZA_INFECTION,2.852741558,0,CP-945598
EUKARYOTIC_TRANSLATION_ELONGATION,2.917782557,0,CP-945598
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,2.556532386,0,CP-945598
SELENOAMINO_ACID_METABOLISM,2.962695899,0,CP-945598
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.998954033,0,CP-945598
HIV_LIFE_CYCLE,2.007572897,0.115526666,andarine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.994177295,0.057763333,andarine
PLATELET_AGGREGATION_PLUG_FORMATION,-1.931882545,0.035510211,andarine
RAB_REGULATION_OF_TRAFFICKING,1.814931457,0.090412173,andarine
MRNA_SPLICING,1.803878243,0.070320579,andarine
SIGNALING_BY_VEGF,1.782797526,0.065297681,andarine
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-1.87156903,0.038046655,andarine
HIV_INFECTION,1.710423167,0.085389275,andarine
GPCR_LIGAND_BINDING,-1.860936919,0.031000978,andarine
MITF_M_DEPENDENT_GENE_EXPRESSION,1.701853959,0.077496148,andarine
DISEASES_OF_METABOLISM,-3.708992814,0.006176112,filanesib
RNA_POLYMERASE_II_PRE_TRANSCRIPTION_EVENTS,1.844926295,1,filanesib
INTERLEUKIN_1_FAMILY_SIGNALING,1.822209683,0.724831349,filanesib
NONSENSE_MEDIATED_DECAY_NMD,1.80146756,0.562777949,filanesib
INTERFERON_ALPHA_BETA_SIGNALING,-2.53889246,1,filanesib
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.478300454,1,filanesib
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.225464093,0.858286594,filanesib
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.121758335,0.722759532,filanesib
TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,-2.076118758,0.617868559,filanesib
TOLL_LIKE_RECEPTOR_CASCADES,-1.931262365,0.582208864,filanesib
NEUTROPHIL_DEGRANULATION,2.303156511,0.014625229,tamibarotene
SIGNALING_BY_NTRKS,2.203164189,0.013711152,tamibarotene
GPCR_LIGAND_BINDING,-2.212174545,0.020701522,tamibarotene
SUMOYLATION,2.132590502,0.023156612,tamibarotene
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.133195686,0.028802118,tamibarotene
SENSORY_PERCEPTION,-2.117849779,0.022201632,tamibarotene
RRNA_PROCESSING,-2.108269462,0.018451357,tamibarotene
EUKARYOTIC_TRANSLATION_ELONGATION,-2.10287166,0.015841165,tamibarotene
TOLL_LIKE_RECEPTOR_CASCADES,2.020592735,0.036563071,tamibarotene
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.089386608,0.015151114,tamibarotene
GLYCOSAMINOGLYCAN_METABOLISM,2.400903599,0.007536681,tibolone
CHEMOKINE_RECEPTORS_BIND_CHEMOKINES,1.931330069,0.397559947,tibolone
NEUTROPHIL_DEGRANULATION,1.888300571,0.357050284,tibolone
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,1.886553451,0.270378448,tibolone
DISEASES_OF_GLYCOSYLATION,1.858373298,0.264914354,tibolone
METABOLISM_OF_VITAMINS_AND_COFACTORS,1.836407683,0.258288354,tibolone
PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS,-1.521824962,1,tibolone
HEMOSTASIS,1.820588039,0.24467298,tibolone
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,1.786106856,0.270613969,tibolone
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,1.783855541,0.244523443,tibolone
EUKARYOTIC_TRANSLATION_INITIATION,5.12501046,0,guaifenesin
ACTIVATION_OF_APC_C_AND_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS,2.778767173,0,guaifenesin
APC_C_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS,2.791639875,0,guaifenesin
CELL_CYCLE_CHECKPOINTS,2.911093048,0,guaifenesin
THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT,2.955579151,0,guaifenesin
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,2.983161114,0,guaifenesin
APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1,2.993673047,0,guaifenesin
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.057987846,0,guaifenesin
DNA_REPLICATION,3.062923467,0,guaifenesin
SYNTHESIS_OF_DNA,3.063363314,0,guaifenesin
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,4.770453939,0,liothyronine
CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6,3.126386336,0,liothyronine
CELLULAR_RESPONSE_TO_STARVATION,3.108059158,0,liothyronine
CELLULAR_RESPONSE_TO_HYPOXIA,3.100890565,0,liothyronine
INFLUENZA_INFECTION,3.072824075,0,liothyronine
CELL_CYCLE_CHECKPOINTS,3.052386656,0,liothyronine
UCH_PROTEINASES,3.02521019,0,liothyronine
REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS,2.985808697,0,liothyronine
NONSENSE_MEDIATED_DECAY_NMD,2.968396778,0,liothyronine
REGULATION_OF_RAS_BY_GAPS,2.95592107,0,liothyronine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-3.111374598,0.062956105,methantheline
ECM_PROTEOGLYCANS,2.017849381,0.142261595,methantheline
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-3.043473551,0.077306394,methantheline
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-3.01461258,0.083324257,methantheline
MUSCLE_CONTRACTION,-2.941626479,0.247195295,methantheline
GPCR_LIGAND_BINDING,1.640759881,0.678113601,methantheline
SENSORY_PERCEPTION,1.626085241,0.490463783,methantheline
CARDIAC_CONDUCTION,-2.882930181,0.416436118,methantheline
SIGNALING_BY_GPCR,1.567006301,0.502996352,methantheline
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,-2.870669314,0.385451839,methantheline
NEURONAL_SYSTEM,-1.9782856,0.120937833,roflumilast
GPCR_LIGAND_BINDING,-1.918179441,0.110295303,roflumilast
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.831930402,0.188663019,roflumilast
POTASSIUM_CHANNELS,-1.801560617,0.190114273,roflumilast
G_ALPHA_Q_SIGNALLING_EVENTS,-1.750323668,0.250389689,roflumilast
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.719153995,0.278640766,roflumilast
RAC2_GTPASE_CYCLE,1.364013077,1,roflumilast
SENSORY_PERCEPTION,-1.697853258,0.284031138,roflumilast
PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS,1.354553618,1,roflumilast
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,-1.682429081,0.283357342,roflumilast
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.872358533,0,mercaptopurine
CELL_CYCLE,-2.722802272,0,mercaptopurine
CELL_CYCLE_MITOTIC,-2.528180938,0.000560542,mercaptopurine
MITOTIC_METAPHASE_AND_ANAPHASE,-2.399534279,0.001494778,mercaptopurine
INTERLEUKIN_2_FAMILY_SIGNALING,2.462767452,0.003065475,mercaptopurine
REGULATION_OF_T_CELL_ACTIVATION_BY_CD28_FAMILY,2.446880271,0.00204365,mercaptopurine
CELL_CYCLE_CHECKPOINTS,-2.333044139,0.003923792,mercaptopurine
DNA_REPAIR,-2.315359018,0.003811684,mercaptopurine
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,2.285457195,0.00613095,mercaptopurine
RESOLUTION_OF_SISTER_CHROMATID_COHESION,-2.263986599,0.006352806,mercaptopurine
SARS_COV_2_HOST_INTERACTIONS,2.346341253,0.006289873,naphazoline
SARS_COV_INFECTIONS,2.143078558,0.044029113,naphazoline
SARS_COV_2_INFECTION,2.008126791,0.054512235,naphazoline
SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES,1.994149477,0.044029113,naphazoline
SIGNALING_BY_NUCLEAR_RECEPTORS,1.804471636,0.119507593,naphazoline
SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS,1.765660097,0.123700842,naphazoline
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,1.723699818,0.132985893,naphazoline
TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,1.67593681,0.153315662,naphazoline
G2_M_CHECKPOINTS,1.663751294,0.143968211,naphazoline
ESR_MEDIATED_SIGNALING,1.640588929,0.149698985,naphazoline
NEUTROPHIL_DEGRANULATION,-2.860843814,0,epothilone
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.787372631,0.000523462,epothilone
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.786264158,0.000348974,epothilone
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.369751681,0.042400395,epothilone
INNATE_IMMUNE_SYSTEM,-2.230231642,0.089407253,epothilone
MEMBRANE_TRAFFICKING,-2.186828906,0.09928323,epothilone
VESICLE_MEDIATED_TRANSPORT,-2.162334183,0.098261233,epothilone
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,-2.143233993,0.095924351,epothilone
TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,-2.140275406,0.086196688,epothilone
CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS,-2.1369797,0.079461481,epothilone
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.726624571,0,OSI-930
GPCR_LIGAND_BINDING,2.694475316,0,OSI-930
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.455552396,0,OSI-930
SIGNALING_BY_GPCR,2.311713812,0.000681696,OSI-930
INTERFERON_SIGNALING,-2.353029566,0.036540804,OSI-930
INTERFERON_ALPHA_BETA_SIGNALING,-2.251029256,0.027405603,OSI-930
METABOLISM_OF_VITAMINS_AND_COFACTORS,-2.241265662,0.019488429,OSI-930
CELL_CYCLE,-2.1821878,0.018270402,OSI-930
ADAPTIVE_IMMUNE_SYSTEM,-2.144186905,0.02046285,OSI-930
METABOLISM_OF_RNA,-2.060399667,0.029841657,OSI-930
REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF,3.073593254,0,levocetirizine
INFLUENZA_INFECTION,2.939400277,0,levocetirizine
SARS_COV_1_INFECTION,2.76880679,0,levocetirizine
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.511632806,0,levocetirizine
NONSENSE_MEDIATED_DECAY_NMD,2.487341594,0,levocetirizine
GPCR_LIGAND_BINDING,-2.460487087,0,levocetirizine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.428253465,0,levocetirizine
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.214023628,0,levocetirizine
AMINE_LIGAND_BINDING_RECEPTORS,-2.270965007,0,levocetirizine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.459608424,0.001315347,levocetirizine
COLLAGEN_DEGRADATION,-2.46834549,0.550273113,BVD-523
TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM,1.517379619,0.533124265,BVD-523
FATTY_ACID_METABOLISM,1.437590583,0.395139161,BVD-523
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.263300171,1,BVD-523
RNA_POLYMERASE_II_TRANSCRIPTION_TERMINATION,1.381904627,0.345746766,BVD-523
EUKARYOTIC_TRANSLATION_ELONGATION,-2.004167747,1,BVD-523
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.00125336,0.883066963,BVD-523
NONSENSE_MEDIATED_DECAY_NMD,-1.977575331,0.727493425,BVD-523
SELENOAMINO_ACID_METABOLISM,-1.956622446,0.626812327,BVD-523
GPCR_LIGAND_BINDING,-1.927783141,0.561977978,BVD-523
EUKARYOTIC_TRANSLATION_ELONGATION,2.317867976,0.017278618,metharbital
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.261389805,0.017278618,metharbital
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.233585955,0.013678906,metharbital
SELENOAMINO_ACID_METABOLISM,2.191044628,0.015658747,metharbital
CELLULAR_RESPONSE_TO_STARVATION,2.168498355,0.015982721,metharbital
EUKARYOTIC_TRANSLATION_INITIATION,2.159901792,0.014758819,metharbital
NONSENSE_MEDIATED_DECAY_NMD,2.076492014,0.031317495,metharbital
INFLUENZA_INFECTION,1.980278735,0.06088013,metharbital
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,1.927883555,0.083993281,metharbital
SIGNALING_BY_ROBO_RECEPTORS,1.902854,0.09600432,metharbital
NEUTROPHIL_DEGRANULATION,-2.824261659,0.003250657,vardenafil
INNATE_IMMUNE_SYSTEM,-2.247706203,0.174722804,vardenafil
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.035835023,0.367595108,vardenafil
GPCR_LIGAND_BINDING,1.796454201,1,vardenafil
CIRCADIAN_CLOCK,1.746119151,1,vardenafil
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-1.80716365,0.694015229,vardenafil
TRANSCRIPTIONAL_REGULATION_BY_RUNX2,1.70032915,0.989164606,vardenafil
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.692235548,0.778089582,vardenafil
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,1.691564855,0.625368956,vardenafil
VESICLE_MEDIATED_TRANSPORT,-1.753443059,0.669635303,vardenafil
ORC1_REMOVAL_FROM_CHROMATIN,2.50401499,0.006860766,tripelennamine
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.433651754,0.004287978,tripelennamine
DNA_REPLICATION,2.238709448,0.016580183,tripelennamine
TRANSCRIPTIONAL_REGULATION_BY_RUNX3,2.234335264,0.012863935,tripelennamine
S_PHASE,2.221752139,0.010634187,tripelennamine
SYNTHESIS_OF_DNA,2.21511161,0.009433553,tripelennamine
CELL_CYCLE_MITOTIC,2.106234106,0.018622078,tripelennamine
GASTRULATION,2.101642172,0.017795111,tripelennamine
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,2.046751407,0.02515614,tripelennamine
G2_M_CHECKPOINTS,1.961427515,0.038248768,tripelennamine
INTERLEUKIN_1_FAMILY_SIGNALING,2.296104043,0.028845681,BRD-A04553218
SIGNALING_BY_ROBO_RECEPTORS,2.153128011,0.044377971,BRD-A04553218
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.151836411,0.029955131,BRD-A04553218
EUKARYOTIC_TRANSLATION_ELONGATION,2.094607922,0.033283478,BRD-A04553218
INTERLEUKIN_1_SIGNALING,2.075657167,0.031952139,BRD-A04553218
GPCR_LIGAND_BINDING,2.070866496,0.027366416,BRD-A04553218
TRANSCRIPTIONAL_REGULATION_BY_RUNX1,2.062710138,0.02472487,BRD-A04553218
SELENOAMINO_ACID_METABOLISM,2.055795744,0.02274371,BRD-A04553218
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.010231471,0.02761296,BRD-A04553218
METABOLISM_OF_STEROIDS,-2.477430756,0.288664368,BRD-A04553218
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,4.073591929,0,flurbiprofen
GPCR_LIGAND_BINDING,3.915304335,0,flurbiprofen
PEPTIDE_LIGAND_BINDING_RECEPTORS,3.37212252,0,flurbiprofen
SIGNALING_BY_GPCR,3.311024699,0,flurbiprofen
G_ALPHA_Q_SIGNALLING_EVENTS,3.044800847,0,flurbiprofen
EXTRACELLULAR_MATRIX_ORGANIZATION,2.822873021,0,flurbiprofen
INTEGRIN_CELL_SURFACE_INTERACTIONS,2.720206201,0,flurbiprofen
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,2.457234031,0.000895024,flurbiprofen
DEVELOPMENTAL_CELL_LINEAGES,2.440100932,0.000984526,flurbiprofen
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,2.446824933,0.001093918,flurbiprofen
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.056191532,0.198391506,phenolphthalein
KERATINIZATION,1.966849277,0.179367663,phenolphthalein
FORMATION_OF_THE_CORNIFIED_ENVELOPE,1.90083195,0.182991252,phenolphthalein
TRANSLATION,1.899346927,0.139281708,phenolphthalein
MITOCHONDRIAL_TRANSLATION,1.883271474,0.121209057,phenolphthalein
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.642928449,1,phenolphthalein
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.622377029,1,phenolphthalein
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.316511003,1,phenolphthalein
NEUTROPHIL_DEGRANULATION,-2.298841152,0.757932261,phenolphthalein
VESICLE_MEDIATED_TRANSPORT,-2.176945225,0.629673303,phenolphthalein
RESOLUTION_OF_SISTER_CHROMATID_COHESION,2.971506795,0.003529469,betamethasone
RHO_GTPASES_ACTIVATE_FORMINS,2.829911708,0.001764734,betamethasone
SEPARATION_OF_SISTER_CHROMATIDS,2.771722752,0.00117649,betamethasone
MITOTIC_METAPHASE_AND_ANAPHASE,2.356441502,0.007941304,betamethasone
MITOTIC_PROMETAPHASE,2.219258999,0.016235556,betamethasone
RRNA_PROCESSING,2.192070797,0.014706119,betamethasone
THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT,2.185963128,0.014117875,betamethasone
RESPIRATORY_ELECTRON_TRANSPORT,2.154296796,0.012794324,betamethasone
MITOTIC_G2_G2_M_PHASES,2.121015048,0.014510038,betamethasone
RHO_GTPASE_EFFECTORS,2.085109366,0.015529662,betamethasone
GPCR_LIGAND_BINDING,4.036599252,0,spironolactone
ASPARAGINE_N_LINKED_GLYCOSYLATION,-2.493682408,0,spironolactone
TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,-2.537126397,0,spironolactone
COPII_MEDIATED_VESICLE_TRANSPORT,-2.550799552,0,spironolactone
SARS_COV_1_INFECTION,-2.580770207,0,spironolactone
CELLULAR_RESPONSES_TO_STIMULI,-2.614019546,0,spironolactone
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.654961558,0,spironolactone
METABOLISM_OF_RNA,-2.682695892,0,spironolactone
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,-2.68763891,0,spironolactone
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.707841713,0,spironolactone
TRANSLATION,2.872479736,0.009249118,propranolol
TOLL_LIKE_RECEPTOR_CASCADES,2.844771666,0.004624559,propranolol
INFLUENZA_INFECTION,2.829480143,0.003083039,propranolol
SARS_COV_2_HOST_INTERACTIONS,2.712032645,0.002312279,propranolol
EUKARYOTIC_TRANSLATION_INITIATION,2.666888637,0.003699647,propranolol
CELLULAR_RESPONSE_TO_STARVATION,2.618962276,0.003083039,propranolol
SELENOAMINO_ACID_METABOLISM,2.6023438,0.002642605,propranolol
NONSENSE_MEDIATED_DECAY_NMD,2.526800172,0.002312279,propranolol
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.501268211,0.002055359,propranolol
MYD88_INDEPENDENT_TLR4_CASCADE,2.475211499,0.001849824,propranolol
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,3.14449556,0,dequalinium
SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES,2.990133266,0,dequalinium
INFLUENZA_INFECTION,2.924791652,0,dequalinium
EUKARYOTIC_TRANSLATION_INITIATION,2.69941923,0,dequalinium
SARS_COV_2_HOST_INTERACTIONS,2.635239132,0,dequalinium
NONSENSE_MEDIATED_DECAY_NMD,2.585978678,0,dequalinium
SIGNALING_BY_ALK_IN_CANCER,2.472790133,0,dequalinium
REGULATION_OF_TP53_ACTIVITY,2.462558024,0,dequalinium
SARS_COV_INFECTIONS,2.443213848,0,dequalinium
PEROXISOMAL_PROTEIN_IMPORT,2.387824989,0,dequalinium
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-3.075164804,0,dicoumarol
EUKARYOTIC_TRANSLATION_ELONGATION,-3.03766285,0,dicoumarol
SELENOAMINO_ACID_METABOLISM,-2.99768368,0.000377062,dicoumarol
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.962853429,0.000848389,dicoumarol
NONSENSE_MEDIATED_DECAY_NMD,-2.943130311,0.003167321,dicoumarol
CELLULAR_RESPONSE_TO_STARVATION,-2.908746919,0.006032992,dicoumarol
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.89594241,0.006625518,dicoumarol
GPCR_LIGAND_BINDING,2.221311567,0.00959826,dicoumarol
EUKARYOTIC_TRANSLATION_INITIATION,-2.829340996,0.014705417,dicoumarol
CELL_CELL_COMMUNICATION,-2.826298309,0.013322857,dicoumarol
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.311811536,0.017108602,etomidate
INTERFERON_SIGNALING,2.084933282,0.101645226,etomidate
ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES,1.993309226,0.151964645,etomidate
CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM,1.962650919,0.145674718,etomidate
PROGRAMMED_CELL_DEATH,-1.500565746,1,etomidate
NEUTROPHIL_DEGRANULATION,1.809080248,0.369143257,etomidate
INTERFERON_GAMMA_SIGNALING,1.793956119,0.34468802,etomidate
ESTROGEN_DEPENDENT_GENE_EXPRESSION,1.774814256,0.33498356,etomidate
RRNA_PROCESSING,-1.359323684,1,etomidate
APOPTOSIS,-1.33987489,1,etomidate
CELL_CYCLE,-3.434610509,0,MK-1775
CELL_CYCLE_MITOTIC,-3.254893296,0,MK-1775
CELL_CYCLE_CHECKPOINTS,-2.960980188,0,MK-1775
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.552138556,0,MK-1775
DNA_REPLICATION_PRE_INITIATION,-2.44121042,0.000171735,MK-1775
G2_M_CHECKPOINTS,-2.48386345,9.16E-05,MK-1775
DNA_DOUBLE_STRAND_BREAK_REPAIR,-2.491685759,9.81E-05,MK-1775
G2_M_DNA_DAMAGE_CHECKPOINT,-2.548341393,0.000105683,MK-1775
MITOTIC_PROMETAPHASE,-2.597651187,0.000124898,MK-1775
S_PHASE,-2.593364048,0.00011449,MK-1775
INFLUENZA_INFECTION,2.074279688,0.156663957,safinamide
SIGNALING_BY_ALK_IN_CANCER,1.766661356,0.471498255,safinamide
GASTRULATION,-1.93629242,0.631348795,safinamide
SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES,1.620020645,0.632681364,safinamide
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,1.597696296,0.526104682,safinamide
TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION,1.548419943,0.53868299,safinamide
AUTOPHAGY,-1.783774304,1,safinamide
ESTROGEN_DEPENDENT_GENE_EXPRESSION,1.527216763,0.499366362,safinamide
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.507419706,0.477738989,safinamide
SIGNALING_BY_NTRKS,1.501315285,0.430449285,safinamide
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.710529385,0,vortioxetine
MUSCLE_CONTRACTION,2.241943499,0.010244269,vortioxetine
GPCR_LIGAND_BINDING,-2.229875489,0.017379155,vortioxetine
NEUTROPHIL_DEGRANULATION,2.189642646,0.011382521,vortioxetine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.139417361,0.030413522,vortioxetine
G_ALPHA_Q_SIGNALLING_EVENTS,-2.127146813,0.023172207,vortioxetine
SIGNALING_BY_GPCR,-2.082422917,0.027758373,vortioxetine
PROTEIN_LOCALIZATION,1.843750786,0.108418513,vortioxetine
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.855052444,0.205267134,vortioxetine
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,1.665524909,0.239260591,vortioxetine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.709739582,0,carbachol
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.950847096,0.182784315,carbachol
COLLAGEN_FORMATION,-1.909643628,0.161193287,carbachol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.664187283,0.578964881,carbachol
NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,-1.605258854,0.646843522,carbachol
RRNA_PROCESSING,-1.537807346,0.761749196,carbachol
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.528961682,0.68601159,carbachol
CILIUM_ASSEMBLY,1.552212064,1,carbachol
TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT,-1.51874963,0.630872077,carbachol
REGULATION_OF_T_CELL_ACTIVATION_BY_CD28_FAMILY,1.546306616,1,carbachol
METABOLISM_OF_RNA,4.269429802,0,chlorpropamide
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,2.665073301,0,chlorpropamide
CELL_CYCLE_CHECKPOINTS,2.69301078,0,chlorpropamide
REGULATION_OF_TP53_ACTIVITY,2.695970539,0,chlorpropamide
RRNA_PROCESSING,2.719746164,0,chlorpropamide
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,2.733807868,0,chlorpropamide
TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM,2.742965102,0,chlorpropamide
CELLULAR_RESPONSE_TO_STARVATION,3.028740797,0,chlorpropamide
RESPIRATORY_ELECTRON_TRANSPORT,2.983500651,0,chlorpropamide
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.084469741,0,chlorpropamide
METABOLISM_OF_RNA,-2.543685266,0.011598817,desvenlafaxine
PLATELET_HOMEOSTASIS,2.176383204,0.056614468,desvenlafaxine
RRNA_PROCESSING,-2.317170496,0.054514442,desvenlafaxine
REGULATION_OF_T_CELL_ACTIVATION_BY_CD28_FAMILY,2.09412043,0.054222308,desvenlafaxine
TRANSLATION,-2.22251403,0.079258585,desvenlafaxine
CELL_CELL_JUNCTION_ORGANIZATION,2.027245859,0.059272425,desvenlafaxine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.010807219,0.050634067,desvenlafaxine
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.006208908,0.04130464,desvenlafaxine
CELL_JUNCTION_ORGANIZATION,1.966154568,0.047045826,desvenlafaxine
GASTRULATION,-2.092013121,0.154264271,desvenlafaxine
EUKARYOTIC_TRANSLATION_INITIATION,4.345338363,0,estropipate
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,3.090764734,0,estropipate
INFLUENZA_INFECTION,3.090311199,0,estropipate
DECTIN_1_MEDIATED_NONCANONICAL_NF_KB_SIGNALING,3.063097984,0,estropipate
SCF_BETA_TRCP_MEDIATED_DEGRADATION_OF_EMI1,3.063097984,0,estropipate
DEGRADATION_OF_GLI1_BY_THE_PROTEASOME,3.063097984,0,estropipate
REGULATION_OF_RUNX2_EXPRESSION_AND_ACTIVITY,3.043563495,0,estropipate
ASYMMETRIC_LOCALIZATION_OF_PCP_PROTEINS,3.017831808,0,estropipate
AUF1_HNRNP_D0_BINDS_AND_DESTABILIZES_MRNA,3.002994048,0,estropipate
MITOTIC_METAPHASE_AND_ANAPHASE,3.000438987,0,estropipate
GPCR_LIGAND_BINDING,-2.48030375,0,esmolol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.363773139,0.002013859,esmolol
SIGNALING_BY_GPCR,-2.289037713,0.003020789,esmolol
INTERFERON_ALPHA_BETA_SIGNALING,2.331935207,0.015754123,esmolol
COMPLEMENT_CASCADE,-2.205025095,0.004531183,esmolol
G_ALPHA_I_SIGNALLING_EVENTS,-2.051696877,0.022353837,esmolol
PROGRAMMED_CELL_DEATH,-1.887433628,0.08726723,esmolol
GASTRULATION,-1.88495475,0.076095107,esmolol
APOPTOSIS,-1.850719341,0.088987401,esmolol
RHO_GTPASES_ACTIVATE_FORMINS,-1.821604155,0.102818698,esmolol
INTEGRIN_CELL_SURFACE_INTERACTIONS,2.27696414,0.021893491,PP-1
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,2.018162193,0.067732988,PP-1
COLLAGEN_FORMATION,1.923595298,0.080276134,PP-1
EXTRACELLULAR_MATRIX_ORGANIZATION,1.820854363,0.105704512,PP-1
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,1.76046116,0.116035503,PP-1
COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC,-1.865852611,0.387557705,PP-1
ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS,-1.806835371,0.342657727,PP-1
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,1.64399335,0.177428501,PP-1
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,-1.8029161,0.241041987,PP-1
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,1.623381978,0.169283601,PP-1
RHOA_GTPASE_CYCLE,1.480702392,0.922937902,colchicine
METABOLISM_OF_NUCLEOTIDES,1.46318357,0.505096508,colchicine
TOLL_LIKE_RECEPTOR_CASCADES,-2.393760664,1,colchicine
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.388553907,0.746787926,colchicine
CELL_CELL_COMMUNICATION,-2.386676319,0.507090433,colchicine
TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,-2.37127524,0.450298282,colchicine
COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC,1.244792096,0.948336104,colchicine
DISEASES_OF_METABOLISM,-2.204602662,0.870230486,colchicine
GPCR_LIGAND_BINDING,-2.168613892,0.784869164,colchicine
ESTROGEN_DEPENDENT_GENE_EXPRESSION,1.194508015,0.884226126,colchicine
CELL_CYCLE_MITOTIC,3.11230207,0,parachlorophenol
MITOTIC_METAPHASE_AND_ANAPHASE,2.781439237,0,parachlorophenol
RESOLUTION_OF_SISTER_CHROMATID_COHESION,2.671251301,0,parachlorophenol
SEPARATION_OF_SISTER_CHROMATIDS,2.616294453,0.001105037,parachlorophenol
RHO_GTPASES_ACTIVATE_FORMINS,2.53862115,0.000884029,parachlorophenol
NUCLEAR_ENVELOPE_NE_REASSEMBLY,2.46070454,0.002210073,parachlorophenol
METABOLISM_OF_RNA,2.211837199,0.009471743,parachlorophenol
M_PHASE,2.137241658,0.016023031,parachlorophenol
CELL_CYCLE,2.080435233,0.016354542,parachlorophenol
RRNA_PROCESSING,2.081726089,0.018171714,parachlorophenol
METABOLISM_OF_RNA,3.589140491,0,gabexate
APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1,2.716753938,0,gabexate
CELL_CYCLE_CHECKPOINTS,2.726504627,0,gabexate
SIGNALING_BY_NOTCH4,2.74030725,0,gabexate
S_PHASE,2.779165555,0,gabexate
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,2.791056901,0,gabexate
SYNTHESIS_OF_DNA,2.969897188,0,gabexate
ORC1_REMOVAL_FROM_CHROMATIN,2.997207854,0,gabexate
DNA_REPLICATION,2.930590485,0,gabexate
MITOTIC_METAPHASE_AND_ANAPHASE,3.103700339,0,gabexate
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.021503704,0.151889121,iloprost
MUSCLE_CONTRACTION,-3.158398542,0.299055501,iloprost
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,1.842775118,0.236648675,iloprost
RRNA_PROCESSING,1.730913302,0.294737223,iloprost
TRANSLATION,1.7233586,0.228850796,iloprost
PI3K_AKT_SIGNALING_IN_CANCER,1.72247824,0.184165559,iloprost
DNA_DOUBLE_STRAND_BREAK_REPAIR,1.697866768,0.176977949,iloprost
HOMOLOGY_DIRECTED_REPAIR,1.690095047,0.158088677,iloprost
BIOLOGICAL_OXIDATIONS,-3.041451873,0.66153299,iloprost
CARDIAC_CONDUCTION,-3.026597247,0.491327511,iloprost
GPCR_LIGAND_BINDING,3.873695874,0,azacitidine
RESPIRATORY_ELECTRON_TRANSPORT,-2.782269269,0,azacitidine
VIRAL_INFECTION_PATHWAYS,-2.851320827,0,azacitidine
INFECTIOUS_DISEASE,-2.855263783,0,azacitidine
INFLUENZA_INFECTION,-2.88669763,0,azacitidine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.952978653,0,azacitidine
G_ALPHA_Q_SIGNALLING_EVENTS,2.959777087,0,azacitidine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,-2.778202782,0,azacitidine
MITOTIC_METAPHASE_AND_ANAPHASE,-2.978567815,0,azacitidine
PEPTIDE_LIGAND_BINDING_RECEPTORS,3.218991646,0,azacitidine
GPCR_LIGAND_BINDING,3.142742281,0,T-0901317
SIGNALING_BY_GPCR,3.056955102,0,T-0901317
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.910017698,0,T-0901317
G_ALPHA_I_SIGNALLING_EVENTS,2.579345452,0,T-0901317
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.302444232,0.001892082,T-0901317
G_ALPHA_Q_SIGNALLING_EVENTS,2.279703618,0.002365102,T-0901317
NEUTROPHIL_DEGRANULATION,-2.31470237,0.039479215,T-0901317
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.183223828,0.056551308,T-0901317
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,-2.130897898,0.05335029,T-0901317
NEURONAL_SYSTEM,1.878048161,0.092712013,T-0901317
SELENOAMINO_ACID_METABOLISM,2.630746632,0,enzastaurin
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.558759396,0.002594505,enzastaurin
EUKARYOTIC_TRANSLATION_ELONGATION,2.529179799,0.00172967,enzastaurin
NONSENSE_MEDIATED_DECAY_NMD,2.474360221,0.002270192,enzastaurin
GPCR_LIGAND_BINDING,-2.437396373,0.004918372,enzastaurin
CELLULAR_RESPONSE_TO_STARVATION,2.460519762,0.002594505,enzastaurin
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.424502044,0.002594505,enzastaurin
EUKARYOTIC_TRANSLATION_INITIATION,2.320696961,0.004818367,enzastaurin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.24195313,0.015809051,enzastaurin
SIGNALING_BY_ROBO_RECEPTORS,2.254828714,0.008269986,enzastaurin
SIGNALING_BY_NTRKS,2.331130899,0.013171512,ciclesonide
NEUTROPHIL_DEGRANULATION,2.238590673,0.011525073,ciclesonide
GPCR_LIGAND_BINDING,-2.057389727,0.207281981,ciclesonide
INNATE_IMMUNE_SYSTEM,1.922696084,0.065583153,ciclesonide
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,1.896678723,0.056802145,ciclesonide
REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE,1.850126173,0.058613228,ciclesonide
EUKARYOTIC_TRANSLATION_INITIATION,-1.964912693,0.244407112,ciclesonide
EUKARYOTIC_TRANSLATION_ELONGATION,-1.962757463,0.166719338,ciclesonide
NONSENSE_MEDIATED_DECAY_NMD,-1.957674154,0.129422332,ciclesonide
SIGNALING_BY_GPCR,-1.951546062,0.108075381,ciclesonide
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.146999738,0.183657684,indoramin
REGULATION_OF_T_CELL_ACTIVATION_BY_CD28_FAMILY,2.052456192,0.166990571,indoramin
RRNA_PROCESSING,-2.082556973,0.157967472,indoramin
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.071137102,0.113692852,indoramin
GASTRULATION,-2.059210101,0.091828842,indoramin
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.905054653,0.270431952,indoramin
CELL_CELL_COMMUNICATION,1.881477397,0.214613808,indoramin
RRNA_MODIFICATION_IN_THE_NUCLEUS_AND_CYTOSOL,-1.910079792,0.193059208,indoramin
METABOLISM_OF_RNA,-1.783358469,0.338345554,indoramin
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,1.72113432,0.489375145,indoramin
RESPIRATORY_ELECTRON_TRANSPORT,2.958438667,0,valsartan
RRNA_PROCESSING,2.701654264,0,valsartan
METABOLISM_OF_RNA,2.529151373,0,valsartan
GPCR_LIGAND_BINDING,-2.299007467,0.000820182,valsartan
TRNA_PROCESSING,2.432608222,0.001216371,valsartan
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.220837342,0.003690821,valsartan
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.052291588,0.008201825,valsartan
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.896968673,0.052547224,valsartan
SIGNALING_BY_GPCR,-1.940898661,0.028706387,valsartan
HIV_INFECTION,1.817526168,0.073793169,valsartan
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.525889827,0.002849558,tiapride
C_TYPE_LECTIN_RECEPTORS_CLRS,-2.105904057,0.130634826,tiapride
O_LINKED_GLYCOSYLATION,-2.07705753,0.081775344,tiapride
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.062169625,0.079312696,tiapride
NEUTROPHIL_DEGRANULATION,1.958273503,0.101317616,tiapride
RAB_REGULATION_OF_TRAFFICKING,1.818518127,0.203743394,tiapride
GLYCEROPHOSPHOLIPID_BIOSYNTHESIS,-1.846918977,0.350416777,tiapride
RAB_GEFS_EXCHANGE_GTP_FOR_GDP_ON_RABS,1.747093177,0.25095107,tiapride
G_ALPHA_Q_SIGNALLING_EVENTS,-1.725235003,0.60200025,tiapride
OPIOID_SIGNALLING,-1.712806423,0.521922131,tiapride
EUKARYOTIC_TRANSLATION_ELONGATION,5.138034456,0,hypoxanthine
DNA_REPLICATION_PRE_INITIATION,2.761295187,0,hypoxanthine
DNA_REPLICATION,2.787023916,0,hypoxanthine
KEAP1_NFE2L2_PATHWAY,2.802922579,0,hypoxanthine
HOST_INTERACTIONS_OF_HIV_FACTORS,2.812247623,0,hypoxanthine
REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS,2.815381575,0,hypoxanthine
MITOCHONDRIAL_BIOGENESIS,2.836710602,0,hypoxanthine
SARS_COV_2_INFECTION,3.090016553,0,hypoxanthine
SARS_COV_1_INFECTION,3.315672642,0,hypoxanthine
NERVOUS_SYSTEM_DEVELOPMENT,3.377107863,0,hypoxanthine
EUKARYOTIC_TRANSLATION_ELONGATION,4.392150827,0,sapropterin
INFECTIOUS_DISEASE,2.798911238,0,sapropterin
SARS_COV_2_INFECTION,2.768032325,0,sapropterin
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.754415989,0,sapropterin
SARS_COV_INFECTIONS,2.666451996,0,sapropterin
SARS_COV_2_HOST_INTERACTIONS,3.040896969,0,sapropterin
NERVOUS_SYSTEM_DEVELOPMENT,3.06276816,0,sapropterin
SARS_COV_1_INFECTION,3.321394822,0,sapropterin
SARS_COV_1_HOST_INTERACTIONS,3.538347818,0,sapropterin
VIRAL_INFECTION_PATHWAYS,2.811347903,0,sapropterin
HEMOSTASIS,2.188125453,0.087075831,NPI-2358
COMPLEMENT_CASCADE,2.145915753,0.061642791,NPI-2358
RHO_GTPASE_EFFECTORS,2.141448683,0.043968984,NPI-2358
RNA_POLYMERASE_II_PRE_TRANSCRIPTION_EVENTS,-1.960361788,0.371280533,NPI-2358
VESICLE_MEDIATED_TRANSPORT,2.094537453,0.052159285,NPI-2358
PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS,2.068204586,0.052590354,NPI-2358
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,2.057608107,0.048854427,NPI-2358
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,-1.884321313,0.285122132,NPI-2358
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,2.050990629,0.045200608,NPI-2358
TRANSCRIPTION_OF_THE_HIV_GENOME,-1.845457855,0.240414508,NPI-2358
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,2.159861101,0.095447919,talniflumate
HEMOSTASIS,2.00255372,0.19948615,talniflumate
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,1.981214186,0.157170906,talniflumate
CELLULAR_RESPONSE_TO_STARVATION,-1.737565626,0.725291579,talniflumate
INTEGRIN_CELL_SURFACE_INTERACTIONS,1.956925701,0.143410498,talniflumate
INTERLEUKIN_1_FAMILY_SIGNALING,1.927393155,0.142026503,talniflumate
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-1.499413999,1,talniflumate
VISUAL_PHOTOTRANSDUCTION,1.784701806,0.326750042,talniflumate
EUKARYOTIC_TRANSLATION_INITIATION,-1.479263069,0.820166209,talniflumate
NONSENSE_MEDIATED_DECAY_NMD,-1.475661599,0.624487285,talniflumate
EUKARYOTIC_TRANSLATION_ELONGATION,-3.297917758,0,memantine
CELLULAR_RESPONSES_TO_STIMULI,-2.556083254,0,memantine
SARS_COV_1_INFECTION,-2.579968088,0,memantine
TRANSLATION,-2.694033925,0,memantine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.707951719,0,memantine
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.79052437,0,memantine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,2.959416354,0,memantine
SARS_COV_1_HOST_INTERACTIONS,-2.9757554,0,memantine
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.985643448,0,memantine
CELLULAR_RESPONSE_TO_STARVATION,-3.001532104,0,memantine
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,2.896696837,0,biotin
NEUTROPHIL_DEGRANULATION,2.279069654,0.01885046,biotin
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,2.267025971,0.014178124,biotin
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.198396106,0.01981715,biotin
SIGNALING_BY_TGFB_FAMILY_MEMBERS,2.120263215,0.026873989,biotin
HEMOSTASIS,1.919167396,0.125186388,biotin
SIGNALING_BY_GPCR,1.891812815,0.132850861,biotin
SIGNALING_BY_NUCLEAR_RECEPTORS,1.883510382,0.122890499,biotin
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,1.872584968,0.116539881,biotin
INNATE_IMMUNE_SYSTEM,1.847007121,0.128473135,biotin
MITOTIC_METAPHASE_AND_ANAPHASE,3.346363403,0,cirazoline
SEPARATION_OF_SISTER_CHROMATIDS,3.197397736,0,cirazoline
RRNA_PROCESSING,3.133252117,0,cirazoline
METABOLISM_OF_RNA,3.126556078,0,cirazoline
M_PHASE,2.986846458,0,cirazoline
CELL_CYCLE_MITOTIC,2.965427152,0,cirazoline
RESOLUTION_OF_SISTER_CHROMATID_COHESION,2.935157467,0,cirazoline
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.800629254,0,cirazoline
MITOTIC_G2_G2_M_PHASES,2.720673244,0,cirazoline
MITOTIC_PROMETAPHASE,2.620364083,0,cirazoline
NEUTROPHIL_DEGRANULATION,2.391565862,0.006477251,vilazodone
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.219156898,0.023210151,vilazodone
SIGNALING_BY_GPCR,-1.907294858,0.519371224,vilazodone
SIGNALING_BY_ROBO_RECEPTORS,1.818387445,0.271324864,vilazodone
CELLULAR_RESPONSE_TO_STARVATION,1.801438218,0.224274829,vilazodone
NEURONAL_SYSTEM,1.79696773,0.184169848,vilazodone
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,1.786454603,0.166069529,vilazodone
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,1.74437264,0.175348448,vilazodone
G_ALPHA_Q_SIGNALLING_EVENTS,-1.799723798,0.598238706,vilazodone
C_TYPE_LECTIN_RECEPTORS_CLRS,-1.776382025,0.472243095,vilazodone
GPCR_LIGAND_BINDING,-2.051282284,0.003301149,piclamilast
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.223976967,0.030683811,piclamilast
NEUTROPHIL_DEGRANULATION,2.135628872,0.028126826,piclamilast
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.007723568,0.00453908,piclamilast
CIRCADIAN_CLOCK,2.108395167,0.023865186,piclamilast
GLYCOSAMINOGLYCAN_METABOLISM,1.75814173,0.102279369,piclamilast
MITF_M_DEPENDENT_GENE_EXPRESSION,1.7542884,0.083869082,piclamilast
ASPARAGINE_N_LINKED_GLYCOSYLATION,1.712502952,0.084380479,piclamilast
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,1.684132376,0.081092928,piclamilast
SIGNALING_BY_GPCR,-1.828759906,0.047591568,piclamilast
REGULATION_OF_T_CELL_ACTIVATION_BY_CD28_FAMILY,2.051033037,0.213087463,lisinopril
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.03779077,0.23102268,lisinopril
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.97225454,0.183675276,lisinopril
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,1.928562301,0.273969596,lisinopril
AMYLOID_FIBER_FORMATION,-1.862716779,0.257961721,lisinopril
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,1.778779942,0.529986767,lisinopril
EXTRA_NUCLEAR_ESTROGEN_SIGNALING,-1.684694074,0.537760391,lisinopril
TCR_SIGNALING,1.676762805,0.754587198,lisinopril
BIOLOGICAL_OXIDATIONS,1.617345711,0.851413205,lisinopril
G_ALPHA_I_SIGNALLING_EVENTS,1.610218337,0.743074231,lisinopril
AUTOPHAGY,-2.413952289,0.105213715,chlormezanone
CLEC7A_DECTIN_1_SIGNALING,-2.133900377,0.300053929,chlormezanone
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,-2.07100502,0.287714049,chlormezanone
PROGRAMMED_CELL_DEATH,-1.941015572,0.428161369,chlormezanone
TRANSCRIPTIONAL_REGULATION_BY_RUNX2,-1.890371968,0.432155594,chlormezanone
C_TYPE_LECTIN_RECEPTORS_CLRS,-1.877700981,0.381886819,chlormezanone
TNFR2_NON_CANONICAL_NF_KB_PATHWAY,-1.837977525,0.388845398,chlormezanone
TRANSLATION,-1.831754869,0.34681558,chlormezanone
APOPTOSIS,-1.822971087,0.319104972,chlormezanone
INTERFERON_ALPHA_BETA_SIGNALING,-1.803001228,0.306678496,chlormezanone
INTERFERON_ALPHA_BETA_SIGNALING,2.157936654,0.055474453,loxoprofen
RRNA_PROCESSING,1.776566139,0.200464499,loxoprofen
ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES,1.721805667,0.181552754,loxoprofen
CELL_CYCLE_CHECKPOINTS,1.709176533,0.148772395,loxoprofen
MITOTIC_METAPHASE_AND_ANAPHASE,1.675714461,0.153311214,loxoprofen
DRUG_ADME,1.616887715,0.17146649,loxoprofen
POTASSIUM_CHANNELS,-1.984013135,0.388498081,loxoprofen
MITOTIC_G2_G2_M_PHASES,1.521548028,0.242790786,loxoprofen
GLYCOSAMINOGLYCAN_METABOLISM,1.444839021,0.306055076,loxoprofen
UB_SPECIFIC_PROCESSING_PROTEASES,1.440279056,0.279613655,loxoprofen
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.846554062,0,piretanide
MRNA_SPLICING,2.453294701,0.001903114,piretanide
TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM,2.435342765,0.002537486,piretanide
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.130686956,0.000919258,piretanide
SARS_COV_1_HOST_INTERACTIONS,-2.056307995,0.005975177,piretanide
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.047351941,0.005821967,piretanide
SELENOAMINO_ACID_METABOLISM,-2.041827528,0.00459629,piretanide
EUKARYOTIC_TRANSLATION_ELONGATION,-2.041033712,0.003677032,piretanide
NONSENSE_MEDIATED_DECAY_NMD,-1.999177266,0.005821967,piretanide
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-1.994317411,0.005252903,piretanide
MRNA_SPLICING,3.16371816,0,sufentanil
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,3.089676122,0,sufentanil
NUCLEOTIDE_EXCISION_REPAIR,1.866827651,0.308538719,sufentanil
SYNTHESIS_OF_DNA,1.680385466,0.586373343,sufentanil
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.349192094,0.282577866,sufentanil
REGULATION_OF_RAS_BY_GAPS,1.54958465,0.821372008,sufentanil
DNA_REPLICATION,1.506750113,0.805795296,sufentanil
HOST_INTERACTIONS_OF_HIV_FACTORS,1.501240926,0.713789991,sufentanil
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,1.495451406,0.641416051,sufentanil
CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6,1.486480028,0.594111773,sufentanil
GPCR_LIGAND_BINDING,-2.06082624,0.192373462,levomequitazine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.936779246,0.241522168,levomequitazine
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,1.826151543,1,levomequitazine
SUMOYLATION_OF_TRANSCRIPTION_COFACTORS,1.801355374,0.722091022,levomequitazine
CELLULAR_RESPONSE_TO_STARVATION,1.765901315,0.5929899,levomequitazine
ESTROGEN_DEPENDENT_GENE_EXPRESSION,1.716416763,0.58464756,levomequitazine
TCR_SIGNALING,1.69973896,0.516951527,levomequitazine
G_ALPHA_Q_SIGNALLING_EVENTS,-1.812498062,0.342533312,levomequitazine
SIGNALING_BY_GPCR,-1.808327958,0.263232026,levomequitazine
REGULATION_OF_TP53_ACTIVITY,1.658991853,0.547038653,levomequitazine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.544492945,0.014739912,miconazole
TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM,-2.0840864,0.190881859,miconazole
GENE_SILENCING_BY_RNA,-1.964349579,0.250578502,miconazole
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.891715416,0.292218753,miconazole
CILIUM_ASSEMBLY,1.824075611,0.850779953,miconazole
FATTY_ACID_METABOLISM,1.788029818,0.561672321,miconazole
RAB_REGULATION_OF_TRAFFICKING,1.764249662,0.443771025,miconazole
ORGANELLE_BIOGENESIS_AND_MAINTENANCE,1.727746085,0.424208337,miconazole
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,1.71793782,0.362999446,miconazole
TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,1.703332092,0.331909216,miconazole
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.351135337,0,torcitabine
GPCR_LIGAND_BINDING,-2.303269347,0.000887563,torcitabine
HIV_LIFE_CYCLE,2.368711149,0.030114076,torcitabine
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,2.350121446,0.017208043,torcitabine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.12865785,0.006311562,torcitabine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.107721928,0.057360144,torcitabine
MYD88_INDEPENDENT_TLR4_CASCADE,2.044247887,0.06345466,torcitabine
REGULATION_OF_TP53_ACTIVITY,2.040998451,0.052484532,torcitabine
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,2.010775459,0.052341132,torcitabine
MITOTIC_PROPHASE,1.977574039,0.056540714,torcitabine
RHO_GTPASE_EFFECTORS,2.383798757,0.005373248,parecoxib
SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3,2.14516258,0.053732479,parecoxib
CHROMOSOME_MAINTENANCE,1.973981863,0.180899346,parecoxib
TCR_SIGNALING,-1.757707728,0.267550319,parecoxib
CELLULAR_SENESCENCE,1.945329443,0.171943933,parecoxib
REPRODUCTION,1.911954282,0.18075606,parecoxib
DOWNSTREAM_TCR_SIGNALING,-1.641058792,0.227049583,parecoxib
SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX,-1.59332608,0.191621666,parecoxib
DNA_REPAIR,1.84254837,0.261318957,parecoxib
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,1.76818647,0.380118909,parecoxib
KERATINIZATION,-2.201077484,0.10257761,paclitaxel
UB_SPECIFIC_PROCESSING_PROTEASES,-2.053144053,0.156129156,paclitaxel
SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3,-1.992954124,0.147329606,paclitaxel
CELL_CYCLE,-1.970977378,0.126336394,paclitaxel
NEUTROPHIL_DEGRANULATION,-1.961225939,0.105594598,paclitaxel
CELL_CYCLE_MITOTIC,-1.945615984,0.094783723,paclitaxel
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,-1.941900026,0.083829181,paclitaxel
M_PHASE,-1.91293048,0.090698217,paclitaxel
MITOTIC_G2_G2_M_PHASES,-1.906583738,0.083637626,paclitaxel
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,-1.864666798,0.098957223,paclitaxel
MRNA_SPLICING,2.587187121,0,cyclobenzaprine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.48394113,0,cyclobenzaprine
INFLUENZA_INFECTION,2.317360616,0.00225093,cyclobenzaprine
HOST_INTERACTIONS_OF_HIV_FACTORS,2.08120332,0.027011157,cyclobenzaprine
INTERLEUKIN_1_SIGNALING,1.960549371,0.040516735,cyclobenzaprine
ORC1_REMOVAL_FROM_CHROMATIN,1.820779957,0.076531611,cyclobenzaprine
FCERI_MEDIATED_NF_KB_ACTIVATION,1.724916183,0.128302995,cyclobenzaprine
DEGRADATION_OF_BETA_CATENIN_BY_THE_DESTRUCTION_COMPLEX,1.724238819,0.113953318,cyclobenzaprine
STABILIZATION_OF_P53,1.687127431,0.123801135,cyclobenzaprine
NUCLEAR_ENVELOPE_NE_REASSEMBLY,1.682381561,0.117498532,cyclobenzaprine
SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR,-2.014689703,0.296996663,trimebutine
GASTRULATION,-2.00261717,0.168520578,trimebutine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.92281681,0.231738969,trimebutine
CILIUM_ASSEMBLY,1.808218154,0.521227597,trimebutine
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.737922569,0.675194661,trimebutine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.579572325,0.873927307,trimebutine
DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS,-1.71075749,0.647608454,trimebutine
SIGNALING_BY_NTRKS,1.503593552,0.848802194,trimebutine
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,1.391524002,1,trimebutine
CLEC7A_DECTIN_1_SIGNALING,-1.595726294,1,trimebutine
INFLUENZA_INFECTION,4.30585124,0,mibefradil
GPCR_LIGAND_BINDING,-2.365612319,0,mibefradil
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.437516076,0,mibefradil
GLOBAL_GENOME_NUCLEOTIDE_EXCISION_REPAIR_GG_NER,2.569612327,0,mibefradil
TOLL_LIKE_RECEPTOR_CASCADES,2.578092507,0,mibefradil
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.65575605,0,mibefradil
RRNA_PROCESSING,2.662690546,0,mibefradil
EUKARYOTIC_TRANSLATION_INITIATION,3.079545426,0,mibefradil
NONSENSE_MEDIATED_DECAY_NMD,3.027604855,0,mibefradil
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.143859725,0,mibefradil
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.367701452,0.006758607,nitazoxanide
SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES,-2.235297176,0.038462828,nitazoxanide
CELLULAR_RESPONSES_TO_MECHANICAL_STIMULI,-2.072562053,0.05521277,nitazoxanide
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-1.806123229,0.174116674,nitazoxanide
METABOLISM_OF_FAT_SOLUBLE_VITAMINS,2.006564834,0.242827086,nitazoxanide
MRNA_SPLICING,-1.524850134,0.509942658,nitazoxanide
NEUTROPHIL_DEGRANULATION,1.828190476,0.636596391,nitazoxanide
AUTOPHAGY,1.825369239,0.488792097,nitazoxanide
TRNA_PROCESSING,-1.410087097,0.702256799,nitazoxanide
INFLUENZA_INFECTION,-1.362287783,0.707219744,nitazoxanide
METABOLISM_OF_RNA,2.454405132,0,loteprednol
CELL_CYCLE,2.443684545,0,loteprednol
CELL_CYCLE_CHECKPOINTS,2.419661545,0.001788618,loteprednol
SEPARATION_OF_SISTER_CHROMATIDS,2.318768667,0.002012195,loteprednol
DNA_REPLICATION,2.276047495,0.003130081,loteprednol
MITOTIC_G2_G2_M_PHASES,2.277723902,0.003756098,loteprednol
CELL_CYCLE_MITOTIC,2.270164914,0.003066202,loteprednol
M_PHASE,2.142432402,0.009390244,loteprednol
SYNTHESIS_OF_DNA,2.036924513,0.019078591,loteprednol
SIGNALING_BY_RECEPTOR_TYROSINE_KINASES,-2.771556053,0.052281369,loteprednol
RRNA_PROCESSING,3.322747866,0,acamprosate
METABOLISM_OF_RNA,3.318004562,0,acamprosate
MITOTIC_G2_G2_M_PHASES,2.943793879,0,acamprosate
SEPARATION_OF_SISTER_CHROMATIDS,2.842083977,0,acamprosate
MITOTIC_PROMETAPHASE,2.685781579,0,acamprosate
RESOLUTION_OF_SISTER_CHROMATID_COHESION,2.617510917,0,acamprosate
M_PHASE,2.611733526,0,acamprosate
RHO_GTPASES_ACTIVATE_FORMINS,2.474827667,0.000329852,acamprosate
CELL_CYCLE_MITOTIC,2.51267712,0.000357339,acamprosate
MRNA_SPLICING,2.513177792,0.000389825,acamprosate
GPCR_LIGAND_BINDING,3.166859697,0,cinacalcet
SIGNALING_BY_GPCR,2.778900603,0,cinacalcet
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.819956929,0,cinacalcet
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.450881906,0.000136191,cinacalcet
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,2.163029104,0.004467062,cinacalcet
G_ALPHA_Q_SIGNALLING_EVENTS,2.13107114,0.005084461,cinacalcet
POTASSIUM_CHANNELS,2.079143019,0.007081927,cinacalcet
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-3.106419246,0.155094783,cinacalcet
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-3.064409254,0.179701167,cinacalcet
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,-3.016067057,0.248549332,cinacalcet
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.362439682,0.015894698,sertindole
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.021553785,0.232949718,sertindole
MYD88_INDEPENDENT_TLR4_CASCADE,1.911430788,0.269599135,sertindole
METABOLISM_OF_RNA,-1.878327483,0.303986092,sertindole
TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,1.80632375,0.415360058,sertindole
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,1.787298538,0.356704256,sertindole
TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,1.77786632,0.303637908,sertindole
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,-1.705209859,0.588434952,sertindole
REGULATION_OF_T_CELL_ACTIVATION_BY_CD28_FAMILY,1.73381579,0.342228573,sertindole
APOPTOSIS,-1.66479131,0.538432882,sertindole
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.264060516,0.016200891,betahistine
CELL_CYCLE_CHECKPOINTS,-2.242106156,0.042588425,betahistine
INTERLEUKIN_1_SIGNALING,-2.089030093,0.100995407,betahistine
MITOTIC_METAPHASE_AND_ANAPHASE,-2.002294302,0.134660543,betahistine
CELL_CELL_COMMUNICATION,1.916939993,0.177824066,betahistine
DNA_REPAIR,-1.885554021,0.251880112,betahistine
CELL_CYCLE,-1.880954754,0.207101425,betahistine
PROGRAMMED_CELL_DEATH,-1.843144006,0.216998164,betahistine
S_PHASE,-1.808307134,0.230325154,betahistine
GLOBAL_GENOME_NUCLEOTIDE_EXCISION_REPAIR_GG_NER,-1.784591913,0.233171625,betahistine
METABOLISM_OF_RNA,6.15739246,0,alogliptin
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,4.082159701,0,alogliptin
SARS_COV_1_HOST_INTERACTIONS,3.965223074,0,alogliptin
SARS_COV_1_INFECTION,3.853553117,0,alogliptin
HOST_INTERACTIONS_OF_HIV_FACTORS,3.425246401,0,alogliptin
SARS_COV_2_HOST_INTERACTIONS,3.329028366,0,alogliptin
HIV_INFECTION,3.328439405,0,alogliptin
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,4.082935372,0,alogliptin
SARS_COV_INFECTIONS,3.136920553,0,alogliptin
CELL_CYCLE_CHECKPOINTS,3.058711969,0,alogliptin
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,2.018049613,0.421397957,diphenhydramine
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,1.949385714,0.368982694,diphenhydramine
REGULATION_OF_TP53_ACTIVITY,-1.676920098,0.49742771,diphenhydramine
DEVELOPMENTAL_CELL_LINEAGES,1.909872639,0.331790345,diphenhydramine
DISEASES_OF_METABOLISM,1.744179941,0.849801914,diphenhydramine
HEMOSTASIS,1.714630835,0.827849779,diphenhydramine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,1.712725529,0.6999081,diphenhydramine
SIGNALING_BY_NOTCH,1.703165288,0.643365846,diphenhydramine
ACTIVATION_OF_APC_C_AND_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS,1.688968717,0.619382341,diphenhydramine
INTEGRATION_OF_ENERGY_METABOLISM,-1.24986288,1,diphenhydramine
DEVELOPMENTAL_CELL_LINEAGES,2.119206495,0.024044205,floxuridine
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-1.957226694,0.450400222,floxuridine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-1.938400969,0.261490636,floxuridine
G_ALPHA_Q_SIGNALLING_EVENTS,1.563751554,0.367458184,floxuridine
GOLGI_TO_ER_RETROGRADE_TRANSPORT,-1.861274559,0.322803396,floxuridine
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,-1.849458453,0.26497055,floxuridine
COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC,-1.813744395,0.277001108,floxuridine
MEMBRANE_TRAFFICKING,-1.813142903,0.232657068,floxuridine
EXTRACELLULAR_MATRIX_ORGANIZATION,1.427011441,0.504579849,floxuridine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-1.765881965,0.284642713,floxuridine
GPCR_LIGAND_BINDING,-2.335699581,0,cobimetinib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.219663402,0.001471788,cobimetinib
G_ALPHA_Q_SIGNALLING_EVENTS,-2.050928335,0.018642653,cobimetinib
SIGNALING_BY_GPCR,-1.96305086,0.040964777,cobimetinib
EUKARYOTIC_TRANSLATION_ELONGATION,-1.929142934,0.047685944,cobimetinib
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.905147222,0.048569017,cobimetinib
NONSENSE_MEDIATED_DECAY_NMD,-1.894104032,0.046816888,cobimetinib
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-1.893602488,0.041210075,cobimetinib
RAB_REGULATION_OF_TRAFFICKING,1.668094235,0.416238567,cobimetinib
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,-1.840216234,0.064431625,cobimetinib
GPCR_LIGAND_BINDING,-2.120485991,0.248223714,oxandrolone
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.02465701,0.286096082,oxandrolone
INFLUENZA_INFECTION,1.640901857,1,oxandrolone
PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS,1.584134748,1,oxandrolone
TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION,1.539796038,0.989005201,oxandrolone
LEISHMANIA_INFECTION,1.50671574,0.874827178,oxandrolone
SIGNALING_BY_GPCR,-1.790199707,1,oxandrolone
ORGANELLE_BIOGENESIS_AND_MAINTENANCE,1.484310255,0.650273224,oxandrolone
SIGNALING_BY_ALK_IN_CANCER,1.484355875,0.780327869,oxandrolone
GASTRULATION,-1.724510789,1,oxandrolone
CELL_CYCLE,3.51004519,0,ezetimibe
METABOLISM_OF_RNA,3.401370084,0,ezetimibe
CELL_CYCLE_MITOTIC,3.366493231,0,ezetimibe
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.798173028,0,ezetimibe
RRNA_PROCESSING,2.769491847,0,ezetimibe
MITOTIC_METAPHASE_AND_ANAPHASE,2.702286825,0,ezetimibe
M_PHASE,2.698856292,0,ezetimibe
HIV_INFECTION,2.601751656,0.00029453,ezetimibe
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,2.612361528,0.000323983,ezetimibe
CELL_CYCLE_CHECKPOINTS,2.61519079,0.000359981,ezetimibe
EXTRACELLULAR_MATRIX_ORGANIZATION,2.499571497,0.006743326,idarubicin
L1CAM_INTERACTIONS,2.43366514,0.004214579,idarubicin
RESPIRATORY_ELECTRON_TRANSPORT,2.273711066,0.00730527,idarubicin
HOST_INTERACTIONS_OF_HIV_FACTORS,2.232570118,0.008429157,idarubicin
NERVOUS_SYSTEM_DEVELOPMENT,2.177124372,0.010114989,idarubicin
SENSORY_PERCEPTION,2.127220508,0.012643736,idarubicin
HEMOSTASIS,1.990911945,0.029140801,idarubicin
GPCR_LIGAND_BINDING,1.963210645,0.032873714,idarubicin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.948982008,0.032218112,idarubicin
SIGNALING_BY_ROBO_RECEPTORS,1.928389954,0.031187882,idarubicin
NEUTROPHIL_DEGRANULATION,-2.616465612,0,terfenadine
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.486658061,0,terfenadine
MUSCLE_CONTRACTION,2.688635554,0.001324006,terfenadine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.264793066,0.005909674,terfenadine
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.228661334,0.006205158,terfenadine
CARDIAC_CONDUCTION,2.261481291,0.017874081,terfenadine
INNATE_IMMUNE_SYSTEM,-2.08653962,0.021983988,terfenadine
MEMBRANE_TRAFFICKING,-1.970846453,0.052152876,terfenadine
VESICLE_MEDIATED_TRANSPORT,-1.951252184,0.053187069,terfenadine
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,-1.925409059,0.058616582,terfenadine
MITOTIC_METAPHASE_AND_ANAPHASE,2.621454554,0,BRD-K14643723
SEPARATION_OF_SISTER_CHROMATIDS,2.608619968,0,BRD-K14643723
DNA_REPLICATION,2.507419341,0,BRD-K14643723
MITOTIC_SPINDLE_CHECKPOINT,2.472549194,0.001198735,BRD-K14643723
SYNTHESIS_OF_DNA,2.201289475,0.00958988,BRD-K14643723
RESOLUTION_OF_SISTER_CHROMATID_COHESION,2.145391354,0.011188193,BRD-K14643723
S_PHASE,2.051689674,0.018494768,BRD-K14643723
CELL_CYCLE_CHECKPOINTS,1.998190279,0.025173434,BRD-K14643723
MITOCHONDRIAL_TRANSLATION,1.929152798,0.032499036,BRD-K14643723
DEATH_RECEPTOR_SIGNALING,1.73750482,0.080075495,BRD-K14643723
CELLULAR_RESPONSE_TO_STARVATION,2.742731091,0,aspirin
EUKARYOTIC_TRANSLATION_ELONGATION,2.535535474,0.010677308,aspirin
EUKARYOTIC_TRANSLATION_INITIATION,2.533606871,0.007118205,aspirin
SELENOAMINO_ACID_METABOLISM,2.532745868,0.005338654,aspirin
NONSENSE_MEDIATED_DECAY_NMD,2.488005605,0.008541846,aspirin
INFLUENZA_INFECTION,2.393056964,0.008897757,aspirin
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.357555216,0.007626649,aspirin
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.346900777,0.008007981,aspirin
RRNA_PROCESSING,2.321106052,0.00949094,aspirin
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.305015352,0.008541846,aspirin
METABOLISM_OF_RNA,-3.181675364,0,telcagepant
RRNA_PROCESSING,-2.9422618,0,telcagepant
TRANSLATION,-2.664496036,0,telcagepant
SIGNALING_BY_ROBO_RECEPTORS,-2.562378426,0.000385045,telcagepant
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.531904847,0.000308036,telcagepant
EUKARYOTIC_TRANSLATION_INITIATION,-2.376661772,0.001540181,telcagepant
MITOTIC_METAPHASE_AND_ANAPHASE,-2.320870817,0.002640311,telcagepant
CLEC7A_DECTIN_1_SIGNALING,-2.287999777,0.003272885,telcagepant
CELL_CELL_JUNCTION_ORGANIZATION,2.300196058,0.011300315,telcagepant
APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1,-2.220658659,0.005818463,telcagepant
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.821733324,0,flavoxate
METABOLISM_OF_RNA,2.643319709,0,flavoxate
MRNA_SPLICING,2.575981824,0,flavoxate
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.968717338,0.02786145,flavoxate
GPCR_LIGAND_BINDING,-1.959870661,0.014775011,flavoxate
SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR,1.860419231,0.045025729,flavoxate
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.881519253,0.028142879,flavoxate
SIGNALING_BY_GPCR,-1.837980272,0.035671099,flavoxate
G_ALPHA_I_SIGNALLING_EVENTS,-1.828095631,0.031745167,flavoxate
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,1.517722617,0.295805395,flavoxate
DEUBIQUITINATION,1.867335856,0.56589289,acrivastine
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-1.902428732,1,acrivastine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.841692629,0.838873061,acrivastine
UB_SPECIFIC_PROCESSING_PROTEASES,1.653756286,1,acrivastine
MYD88_INDEPENDENT_TLR4_CASCADE,1.64904042,0.747943703,acrivastine
TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,1.627159067,0.637177847,acrivastine
ADIPOGENESIS,1.611804019,0.55141656,acrivastine
TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,1.604566125,0.478705904,acrivastine
REGULATION_OF_T_CELL_ACTIVATION_BY_CD28_FAMILY,1.592879655,0.439146669,acrivastine
HEMOSTASIS,-1.700629975,1,acrivastine
METABOLISM_OF_RNA,2.934976393,0,vincristine
MAPK_FAMILY_SIGNALING_CASCADES,2.676555823,0.004295877,vincristine
RRNA_PROCESSING,2.642247058,0.002863918,vincristine
MAPK1_MAPK3_SIGNALING,2.578285721,0.002147938,vincristine
CELL_CYCLE_MITOTIC,2.482731354,0.002863918,vincristine
PTEN_REGULATION,2.444789697,0.002386598,vincristine
CELL_CYCLE,2.398507387,0.002863918,vincristine
APOPTOSIS,2.35534692,0.002505928,vincristine
ACTIVATION_OF_APC_C_AND_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS,2.328174512,0.002545705,vincristine
S_PHASE,2.314018594,0.002577526,vincristine
GPCR_LIGAND_BINDING,2.308905872,0.006148754,androstenedione
SIGNALING_BY_GPCR,2.17256032,0.013663898,androstenedione
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.085670066,0.019357189,androstenedione
SARS_COV_2_INFECTION,-3.123230097,0.208422087,androstenedione
DISEASES_OF_METABOLISM,-3.057180749,0.313288547,androstenedione
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-3.033341899,0.284013327,androstenedione
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,-3.02038763,0.249713256,androstenedione
METABOLISM_OF_VITAMINS_AND_COFACTORS,-3.006176053,0.237260364,androstenedione
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.78847873,0.150132084,androstenedione
TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,-2.985194596,0.245562292,androstenedione
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,2.29231646,0.025522332,latanoprost
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.234102302,0.004256555,latanoprost
VIRAL_INFECTION_PATHWAYS,2.220771872,0.028712624,latanoprost
GPCR_LIGAND_BINDING,-2.173478175,0.004965981,latanoprost
TOLL_LIKE_RECEPTOR_CASCADES,1.957183619,0.076566996,latanoprost
SARS_COV_2_HOST_INTERACTIONS,1.868536614,0.089328162,latanoprost
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.018044468,0.014188518,latanoprost
HIV_LIFE_CYCLE,1.814360052,0.100813212,latanoprost
SIGNALING_BY_GPCR,-1.983682604,0.015252657,latanoprost
SENSORY_PERCEPTION,-1.920453653,0.026106873,latanoprost
EUKARYOTIC_TRANSLATION_ELONGATION,4.978282922,0,temocapril
HOST_INTERACTIONS_OF_HIV_FACTORS,2.698125835,0,temocapril
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.81674226,0,temocapril
MRNA_SPLICING,3.018682555,0,temocapril
INFECTIOUS_DISEASE,3.157875713,0,temocapril
SARS_COV_2_INFECTION,3.188112766,0,temocapril
SARS_COV_2_HOST_INTERACTIONS,3.233089528,0,temocapril
VIRAL_INFECTION_PATHWAYS,3.327289651,0,temocapril
NERVOUS_SYSTEM_DEVELOPMENT,3.353342152,0,temocapril
SARS_COV_1_INFECTION,3.624715852,0,temocapril
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.659177365,0,benazepril
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,1.711965312,0.149795601,benazepril
SIGNALING_BY_GPCR,-1.864362018,0.088715202,benazepril
FATTY_ACID_METABOLISM,1.591938794,0.208487444,benazepril
GPCR_LIGAND_BINDING,-1.842657833,0.062622496,benazepril
G_ALPHA_Q_SIGNALLING_EVENTS,-1.811040552,0.060593063,benazepril
MHC_CLASS_II_ANTIGEN_PRESENTATION,1.507605835,0.268055285,benazepril
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.804125685,0.050445899,benazepril
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.803515097,0.040530671,benazepril
ASPARAGINE_N_LINKED_GLYCOSYLATION,1.464147592,0.27751606,benazepril
METABOLISM_OF_RNA,3.432589196,0,tropisetron
RRNA_PROCESSING,2.602379158,0,tropisetron
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.415975179,0.005524563,tropisetron
MRNA_SPLICING,2.26371916,0.010358555,tropisetron
SARS_COV_2_INFECTION,2.061512222,0.020993338,tropisetron
NEURONAL_SYSTEM,-2.061366938,0.026346853,tropisetron
SEPARATION_OF_SISTER_CHROMATIDS,1.903970126,0.051562585,tropisetron
VIRAL_INFECTION_PATHWAYS,1.83700647,0.069057033,tropisetron
CELL_CYCLE_CHECKPOINTS,1.819624356,0.065258896,tropisetron
CELL_CYCLE,1.775501225,0.073967755,tropisetron
EUKARYOTIC_TRANSLATION_ELONGATION,-3.283563848,0,digoxin
SIGNALING_BY_GPCR,2.61797287,0,digoxin
SARS_COV_1_INFECTION,-2.641190332,0,digoxin
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.671646301,0,digoxin
RRNA_PROCESSING,-2.907889311,0,digoxin
INFLUENZA_INFECTION,-2.936376094,0,digoxin
SIGNALING_BY_ROBO_RECEPTORS,-2.947542934,0,digoxin
GPCR_LIGAND_BINDING,2.975050803,0,digoxin
EUKARYOTIC_TRANSLATION_INITIATION,-3.030663764,0,digoxin
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.637490376,0,digoxin
SEPARATION_OF_SISTER_CHROMATIDS,3.247139845,0,brinzolamide
MITOTIC_METAPHASE_AND_ANAPHASE,3.162755092,0,brinzolamide
METABOLISM_OF_RNA,3.067840796,0,brinzolamide
RESOLUTION_OF_SISTER_CHROMATID_COHESION,2.800816304,0.001242983,brinzolamide
RHO_GTPASES_ACTIVATE_FORMINS,2.722790416,0.000994387,brinzolamide
MITOTIC_SPINDLE_CHECKPOINT,2.626416804,0.000828655,brinzolamide
M_PHASE,2.441490871,0.002130828,brinzolamide
MITOTIC_PROMETAPHASE,2.366570902,0.003314622,brinzolamide
CELL_CYCLE_MITOTIC,2.405265003,0.003107458,brinzolamide
MITOTIC_G2_G2_M_PHASES,2.321457315,0.004971933,brinzolamide
EUKARYOTIC_TRANSLATION_ELONGATION,-2.907927811,0.210904856,sasapyrine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.898975411,0.116914649,sasapyrine
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.885337945,0.087877023,sasapyrine
NONSENSE_MEDIATED_DECAY_NMD,-2.85558345,0.079948988,sasapyrine
SELENOAMINO_ACID_METABOLISM,-2.850296637,0.065105412,sasapyrine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.838549453,0.057311102,sasapyrine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.820912069,0.054199928,sasapyrine
EUKARYOTIC_TRANSLATION_INITIATION,-2.792620853,0.053156047,sasapyrine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.906397501,0.061648624,sasapyrine
GPCR_LIGAND_BINDING,-2.749205618,0.054127152,sasapyrine
MUSCLE_CONTRACTION,1.898475207,0.416192849,diminazene-aceturate
NEURONAL_SYSTEM,1.811871183,0.319597947,diminazene-aceturate
AUTOPHAGY,-1.977468048,0.646890749,diminazene-aceturate
CARDIAC_CONDUCTION,1.805659205,0.219425456,diminazene-aceturate
REGULATION_OF_T_CELL_ACTIVATION_BY_CD28_FAMILY,1.757630465,0.210481484,diminazene-aceturate
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,1.757603456,0.168385187,diminazene-aceturate
GASTRULATION,-1.918995817,0.497571571,diminazene-aceturate
NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK,1.667440757,0.229164448,diminazene-aceturate
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,-1.842409553,0.559112063,diminazene-aceturate
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,1.599177809,0.280074107,diminazene-aceturate
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.895630927,1,pomalidomide
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.893482986,1,pomalidomide
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,1.714320363,1,pomalidomide
MITOCHONDRIAL_TRANSLATION,-1.68714484,1,pomalidomide
DISEASES_OF_METABOLISM,-1.683507666,1,pomalidomide
NEUTROPHIL_DEGRANULATION,-1.524295766,1,pomalidomide
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,1.550802956,1,pomalidomide
RHOC_GTPASE_CYCLE,-1.448088104,1,pomalidomide
CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE,-1.397619026,1,pomalidomide
LEISHMANIA_INFECTION,1.499582288,1,pomalidomide
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,3.382420556,0,moxonidine
MRNA_SPLICING,2.897983382,0,moxonidine
TRANSCRIPTIONAL_REGULATION_BY_RUNX3,1.973306542,0.037855834,moxonidine
MITOTIC_METAPHASE_AND_ANAPHASE,1.8941003,0.067108069,moxonidine
HEDGEHOG_LIGAND_BIOGENESIS,1.777705888,0.111846781,moxonidine
HH_MUTANTS_ABROGATE_LIGAND_SECRETION,1.777705888,0.111846781,moxonidine
ACTIVATION_OF_APC_C_AND_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS,1.756653039,0.112092598,moxonidine
SOMITOGENESIS,1.707058287,0.134216137,moxonidine
CELL_CYCLE_CHECKPOINTS,1.693858446,0.115632364,moxonidine
HEDGEHOG_ON_STATE,1.694686633,0.127333259,moxonidine
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,2.779435159,0,ciprofibrate
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,2.368381806,0.004207379,ciprofibrate
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,2.302469136,0.005048854,ciprofibrate
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.29164219,0.005259223,ciprofibrate
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,2.234837996,0.00622692,ciprofibrate
TRANSLATION,-2.061572012,0.190515323,ciprofibrate
VIRAL_INFECTION_PATHWAYS,-2.000855316,0.136209553,ciprofibrate
NEURONAL_SYSTEM,2.092166824,0.024122304,ciprofibrate
HEMOSTASIS,2.089604655,0.020796471,ciprofibrate
NONSENSE_MEDIATED_DECAY_NMD,-1.827277025,0.221971124,ciprofibrate
METABOLISM_OF_RNA,-4.532474504,0,MEK-162
ORC1_REMOVAL_FROM_CHROMATIN,-2.880385109,0,MEK-162
HOMOLOGY_DIRECTED_REPAIR,-2.804072465,0,MEK-162
DNA_DOUBLE_STRAND_BREAK_REPAIR,-2.78163122,0,MEK-162
ACTIVATION_OF_THE_PRE_REPLICATIVE_COMPLEX,-2.75544312,0,MEK-162
RESOLUTION_OF_SISTER_CHROMATID_COHESION,-2.739209369,0,MEK-162
REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS,-2.726505926,0,MEK-162
SNRNP_ASSEMBLY,-2.699996636,0,MEK-162
TRNA_PROCESSING,-2.662980337,0,MEK-162
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,-2.656230779,0,MEK-162
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.503645915,0,darifenacin
CELLULAR_RESPONSE_TO_STARVATION,2.227598043,0.012304929,darifenacin
PROTEIN_LOCALIZATION,2.134060445,0.01893066,darifenacin
GPCR_LIGAND_BINDING,-2.121155722,0.05370277,darifenacin
SIGNALING_BY_ALK_IN_CANCER,2.009093403,0.044960318,darifenacin
SIGNALING_BY_GPCR,-2.00802957,0.07831654,darifenacin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.990762072,0.064393599,darifenacin
ECM_PROTEOGLYCANS,-1.899215135,0.118407149,darifenacin
TRANSLATION,1.747327009,0.23019683,darifenacin
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.733058594,0.205713176,darifenacin
EUKARYOTIC_TRANSLATION_ELONGATION,2.352139724,0.005902645,istradefylline
CELLULAR_RESPONSE_TO_STARVATION,2.322566126,0.003935097,istradefylline
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.312480763,0.002623398,istradefylline
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.288962504,0.003197266,istradefylline
NONSENSE_MEDIATED_DECAY_NMD,2.270048215,0.002951323,istradefylline
INTERFERON_ALPHA_BETA_SIGNALING,-2.650690968,0.019532254,istradefylline
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.641595895,0.01079414,istradefylline
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.547420831,0.0154202,istradefylline
EUKARYOTIC_TRANSLATION_INITIATION,2.168577338,0.009509817,istradefylline
SELENOAMINO_ACID_METABOLISM,2.150631876,0.009135046,istradefylline
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.869066461,0.382519354,nateglinide
CHEMOKINE_RECEPTORS_BIND_CHEMOKINES,-1.806668946,0.353360902,nateglinide
RHOG_GTPASE_CYCLE,1.495957364,0.850401133,nateglinide
GPCR_LIGAND_BINDING,-1.729569775,0.496846844,nateglinide
C_TYPE_LECTIN_RECEPTORS_CLRS,-1.693162639,0.504095273,nateglinide
TNFR2_NON_CANONICAL_NF_KB_PATHWAY,-1.689797138,0.413753493,nateglinide
UNFOLDED_PROTEIN_RESPONSE_UPR,1.246807689,1,nateglinide
G_ALPHA_I_SIGNALLING_EVENTS,-1.644822593,0.498988426,nateglinide
SIGNALING_BY_GPCR,-1.640528736,0.441401071,nateglinide
INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,-1.634683021,0.402534902,nateglinide
INTERLEUKIN_17_SIGNALING,2.369758182,0.015332835,lomitapide
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,2.179367043,0.045998504,lomitapide
TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,2.045470956,0.068486662,lomitapide
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,2.026594068,0.055964847,lomitapide
MEMBRANE_TRAFFICKING,2.021349082,0.048451758,lomitapide
INNATE_IMMUNE_SYSTEM,2.015909149,0.041398654,lomitapide
TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,2.001004891,0.037674965,lomitapide
SIGNALING_BY_ALK_IN_CANCER,2.000332467,0.033348915,lomitapide
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,1.99912203,0.02964348,lomitapide
GPCR_LIGAND_BINDING,-2.027888938,0.062947674,lomitapide
GOLGI_TO_ER_RETROGRADE_TRANSPORT,2.095813367,0.00752046,elacridar
METABOLISM_OF_RNA,1.751528443,0.071444371,elacridar
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,1.609165509,0.126594411,elacridar
G_ALPHA_Q_SIGNALLING_EVENTS,-1.851184422,0.151841461,elacridar
ANTIGEN_PROCESSING_CROSS_PRESENTATION,-1.826658385,0.098006761,elacridar
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,1.502693058,0.178610927,elacridar
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-1.80878494,0.079755111,elacridar
TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,-1.803123659,0.062577087,elacridar
FATTY_ACID_METABOLISM,1.438739202,0.21282902,elacridar
GPCR_LIGAND_BINDING,-1.792006295,0.058896082,elacridar
METABOLISM_OF_RNA,1.836615297,0.380664909,desloratadine
ESR_MEDIATED_SIGNALING,-2.776154056,0.336198571,desloratadine
TRANSCRIPTIONAL_REGULATION_BY_RUNX1,-2.76049907,0.207987251,desloratadine
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,-2.751785005,0.159009171,desloratadine
HIV_INFECTION,1.709910824,0.378305416,desloratadine
G2_M_CHECKPOINTS,1.69041161,0.282614857,desloratadine
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,1.66390573,0.245780546,desloratadine
RESPIRATORY_ELECTRON_TRANSPORT,1.6277262,0.239409914,desloratadine
VIRAL_INFECTION_PATHWAYS,1.584251618,0.252203611,desloratadine
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,-2.666322309,0.361637324,desloratadine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.079835349,0,hesperetin
NONSENSE_MEDIATED_DECAY_NMD,2.787266541,0,hesperetin
EUKARYOTIC_TRANSLATION_INITIATION,2.789879282,0,hesperetin
CELLULAR_RESPONSE_TO_STARVATION,2.863725867,0,hesperetin
SIGNALING_BY_ROBO_RECEPTORS,2.663921136,0,hesperetin
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.059857786,0,hesperetin
EUKARYOTIC_TRANSLATION_ELONGATION,3.063474479,0,hesperetin
EXTRACELLULAR_MATRIX_ORGANIZATION,-3.077066775,0,hesperetin
SELENOAMINO_ACID_METABOLISM,2.967687084,0,hesperetin
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,2.603416258,0.000135983,hesperetin
INFLUENZA_INFECTION,2.693040641,0.004444444,ibutilide
GPCR_LIGAND_BINDING,-2.223464365,0.00616182,ibutilide
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.037017644,0.031425281,ibutilide
MITOTIC_PROPHASE,1.944845248,0.246666667,ibutilide
TRANS_GOLGI_NETWORK_VESICLE_BUDDING,1.913626723,0.183703704,ibutilide
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,1.912825992,0.138888889,ibutilide
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.013275144,0.026701219,ibutilide
REGULATION_OF_TP53_ACTIVITY,1.892368127,0.122666667,ibutilide
MYD88_INDEPENDENT_TLR4_CASCADE,1.877798455,0.112592593,ibutilide
SIGNALING_BY_ALK_IN_CANCER,1.874503895,0.097777778,ibutilide
G_ALPHA_Q_SIGNALLING_EVENTS,-2.072946025,0.073754973,rimonabant
SIGNALING_BY_GPCR,-2.050539849,0.044560296,rimonabant
GPCR_LIGAND_BINDING,-2.012551992,0.041316443,rimonabant
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.92131671,0.080669502,rimonabant
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.768746644,0.226796543,rimonabant
TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,1.66482266,1,rimonabant
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,1.587514504,0.788728169,rimonabant
ASPARAGINE_N_LINKED_GLYCOSYLATION,1.549029386,0.646508804,rimonabant
SENSORY_PERCEPTION,-1.632839499,0.505016692,rimonabant
GASTRULATION,-1.625529486,0.455407692,rimonabant
TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,1.815260195,0.497623327,ARRY-334543
TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,1.815260195,0.497623327,ARRY-334543
GPCR_LIGAND_BINDING,-1.758273247,1,ARRY-334543
TOLL_LIKE_RECEPTOR_CASCADES,1.718258152,0.60583487,ARRY-334543
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.686940004,1,ARRY-334543
MYD88_INDEPENDENT_TLR4_CASCADE,1.648233186,0.672858629,ARRY-334543
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.66300691,0.874028501,ARRY-334543
ADAPTIVE_IMMUNE_SYSTEM,1.600397889,0.688135553,ARRY-334543
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.627741563,0.802076415,ARRY-334543
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.570228832,0.681470621,ARRY-334543
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.990061565,0,lypressin
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.92298072,0,lypressin
EXTRACELLULAR_MATRIX_ORGANIZATION,2.407063924,0.006978111,lypressin
SIGNALING_BY_GPCR,2.369743364,0.006978111,lypressin
GPCR_LIGAND_BINDING,2.339130947,0.005648947,lypressin
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,2.230335064,0.009470293,lypressin
NEUTROPHIL_DEGRANULATION,-2.542828615,0.021728334,lypressin
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.523449558,0.019806212,lypressin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.172052345,0.013756847,lypressin
CLATHRIN_MEDIATED_ENDOCYTOSIS,-2.496177178,0.019254647,lypressin
NUCLEAR_EVENTS_MEDIATED_BY_NFE2L2,2.757611028,0,tegaserod
KEAP1_NFE2L2_PATHWAY,2.525985493,0.00368899,tegaserod
BACTERIAL_INFECTION_PATHWAYS,-2.746349976,0.105496683,tegaserod
SIGNALING_BY_NOTCH4,1.913230483,0.205763652,tegaserod
CIRCADIAN_CLOCK,1.897142614,0.172152857,tegaserod
SIGNALING_BY_NTRKS,1.852801444,0.18641695,tegaserod
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,1.787121391,0.223798714,tegaserod
INTERLEUKIN_1_SIGNALING,1.749989696,0.23960867,tegaserod
SIGNALING_BY_INTERLEUKINS,1.693083902,0.285589292,tegaserod
INTERLEUKIN_1_FAMILY_SIGNALING,1.669431498,0.286101652,tegaserod
GPCR_LIGAND_BINDING,-2.175944087,0.009401174,gimeracil
INNATE_IMMUNE_SYSTEM,2.308210477,0.023647112,gimeracil
NEUTROPHIL_DEGRANULATION,2.28890815,0.011823556,gimeracil
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.185199435,0.017242686,gimeracil
SIGNALING_BY_NTRKS,2.047853014,0.027341974,gimeracil
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.046855863,0.043715458,gimeracil
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,1.987678975,0.032810368,gimeracil
SIGNALING_BY_GPCR,-2.012216073,0.047632614,gimeracil
G_ALPHA_Q_SIGNALLING_EVENTS,-1.942245889,0.077324654,gimeracil
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,1.701386899,0.121191451,gimeracil
EUKARYOTIC_TRANSLATION_ELONGATION,3.007809889,0,BRD-K65856711
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.938216644,0,BRD-K65856711
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.904234518,0,BRD-K65856711
EUKARYOTIC_TRANSLATION_INITIATION,2.881936487,0,BRD-K65856711
CELLULAR_RESPONSE_TO_STARVATION,2.859606818,0,BRD-K65856711
NONSENSE_MEDIATED_DECAY_NMD,2.810688038,0,BRD-K65856711
INFLUENZA_INFECTION,2.604864319,0.000114758,BRD-K65856711
SIGNALING_BY_ROBO_RECEPTORS,2.655600277,0.000163939,BRD-K65856711
SELENOAMINO_ACID_METABOLISM,2.630583929,0.000143447,BRD-K65856711
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.626628254,0.000127508,BRD-K65856711
CELL_CYCLE_MITOTIC,3.22724753,0,dexbrompheniramine
METABOLISM_OF_RNA,3.026307048,0,dexbrompheniramine
CELL_CYCLE,2.983685703,0,dexbrompheniramine
M_PHASE,2.778120962,0,dexbrompheniramine
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.67684635,0,dexbrompheniramine
TRANSCRIPTIONAL_REGULATION_BY_TP53,2.644486078,0,dexbrompheniramine
MITOTIC_METAPHASE_AND_ANAPHASE,2.57868982,0,dexbrompheniramine
RRNA_PROCESSING,2.568974479,0,dexbrompheniramine
MITOTIC_G2_G2_M_PHASES,2.465701645,0.000307191,dexbrompheniramine
S_PHASE,2.458620368,0.000276472,dexbrompheniramine
UNFOLDED_PROTEIN_RESPONSE_UPR,-1.92129784,0.234188818,miglitol
INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,2.062288987,0.233995299,miglitol
CHEMOKINE_RECEPTORS_BIND_CHEMOKINES,2.046421055,0.138646821,miglitol
MITOCHONDRIAL_PROTEIN_DEGRADATION,1.92327508,0.258561735,miglitol
INTEGRIN_CELL_SURFACE_INTERACTIONS,1.912732818,0.211194576,miglitol
ESR_MEDIATED_SIGNALING,1.843831485,0.276003904,miglitol
NONSENSE_MEDIATED_DECAY_NMD,-1.537479608,1,miglitol
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-1.524467981,0.77421326,miglitol
EUKARYOTIC_TRANSLATION_ELONGATION,-1.516272983,0.602715399,miglitol
C_TYPE_LECTIN_RECEPTORS_CLRS,-1.509899256,0.496608616,miglitol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.569898828,0,AS-604850
GPCR_LIGAND_BINDING,2.708108238,0,AS-604850
SIGNALING_BY_GPCR,2.709557351,0,AS-604850
G_ALPHA_Q_SIGNALLING_EVENTS,2.354874698,0.000135645,AS-604850
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.31728657,0.000325548,AS-604850
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-3.153851153,0.004333868,AS-604850
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.967379704,0.050561798,AS-604850
MUSCLE_CONTRACTION,-2.818860091,0.162279294,AS-604850
BIOLOGICAL_OXIDATIONS,-2.812412944,0.13687801,AS-604850
TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,-2.786608721,0.158330658,AS-604850
PEROXISOMAL_PROTEIN_IMPORT,-2.166068545,0.009255564,carbenoxolone
EXTRACELLULAR_MATRIX_ORGANIZATION,2.228770659,0.056874322,carbenoxolone
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,2.011293911,0.090643451,carbenoxolone
SEPARATION_OF_SISTER_CHROMATIDS,1.768381684,0.234606579,carbenoxolone
RHO_GTPASES_ACTIVATE_FORMINS,1.57792538,0.494095674,carbenoxolone
RESOLUTION_OF_SISTER_CHROMATID_COHESION,1.553325425,0.450729003,carbenoxolone
INFLUENZA_INFECTION,1.54308107,0.401674901,carbenoxolone
MITOTIC_G2_G2_M_PHASES,1.532358135,0.361050385,carbenoxolone
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,1.497593695,0.375015062,carbenoxolone
S_PHASE,1.484492737,0.355069553,carbenoxolone
INTERFERON_ALPHA_BETA_SIGNALING,-3.131270651,0,NVP-BGJ398
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.655967185,0,NVP-BGJ398
GPCR_LIGAND_BINDING,2.543271276,0,NVP-BGJ398
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.424800568,0.0002079,NVP-BGJ398
METABOLISM_OF_RNA,-2.604584018,0.004241362,NVP-BGJ398
INTERFERON_SIGNALING,-2.547236144,0.002827575,NVP-BGJ398
SENSORY_PERCEPTION,2.410882106,0.00031185,NVP-BGJ398
AMINE_LIGAND_BINDING_RECEPTORS,2.261490926,0.002494797,NVP-BGJ398
G_ALPHA_Q_SIGNALLING_EVENTS,2.254447565,0.002182947,NVP-BGJ398
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.209288302,0.019086128,NVP-BGJ398
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,1.972210812,0.361073733,fulvestrant
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,1.893313156,0.322611531,fulvestrant
METABOLISM_OF_STEROIDS,1.891459204,0.21664424,fulvestrant
GLYCOSAMINOGLYCAN_METABOLISM,-1.925713391,0.506157902,fulvestrant
CYTOPROTECTION_BY_HMOX1,1.813237945,0.262563399,fulvestrant
FORMATION_OF_THE_CORNIFIED_ENVELOPE,-1.876716147,0.368760905,fulvestrant
TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,1.716775183,0.353538281,fulvestrant
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,1.715056992,0.297231711,fulvestrant
METABOLISM_OF_VITAMINS_AND_COFACTORS,1.711060674,0.26127385,fulvestrant
KERATINIZATION,-1.835030063,0.335596113,fulvestrant
GPCR_LIGAND_BINDING,-2.250618061,0,sacubitril
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.220191027,0,sacubitril
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.203422053,0,sacubitril
SIGNALING_BY_GPCR,-2.153729913,0.000989386,sacubitril
MYD88_INDEPENDENT_TLR4_CASCADE,2.140619045,0.133916162,sacubitril
INFLUENZA_INFECTION,1.990716009,0.170858552,sacubitril
INNATE_IMMUNE_SYSTEM,1.972465031,0.127759097,sacubitril
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,1.959864464,0.101591571,sacubitril
SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX,1.95352444,0.086814616,sacubitril
SARS_COV_2_HOST_INTERACTIONS,1.95294395,0.072345513,sacubitril
GPCR_LIGAND_BINDING,-2.286440948,0,lofexidine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.221636767,0,lofexidine
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,2.00367183,0.162611488,lofexidine
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.013348916,0.014615897,lofexidine
MRNA_SPLICING,1.907611975,0.168283981,lofexidine
NUCLEOTIDE_EXCISION_REPAIR,1.796572885,0.199167559,lofexidine
SIGNALING_BY_GPCR,-1.952892494,0.027512276,lofexidine
SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES,-1.889834379,0.051585517,lofexidine
GLUCOSE_METABOLISM,1.662209181,0.30915091,lofexidine
DNA_REPLICATION,1.62680155,0.29345701,lofexidine
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,2.689859508,0,dydrogesterone
NEUTROPHIL_DEGRANULATION,2.537929529,0.000874952,dydrogesterone
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,2.24749464,0.013415936,dydrogesterone
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.219949491,0.012249333,dydrogesterone
HEMOSTASIS,2.118900509,0.024498666,dydrogesterone
INNATE_IMMUNE_SYSTEM,1.951827856,0.085599507,dydrogesterone
G_ALPHA_I_SIGNALLING_EVENTS,1.932134274,0.081995537,dydrogesterone
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.926365529,0.07458969,dydrogesterone
SIGNALING_BY_VEGF,-1.637215399,1,dydrogesterone
ASPARAGINE_N_LINKED_GLYCOSYLATION,-1.554515114,1,dydrogesterone
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.710208098,0,scopolamine
GPCR_LIGAND_BINDING,3.024481911,0,scopolamine
SIGNALING_BY_GPCR,3.075211042,0,scopolamine
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-3.675739936,0.006290882,scopolamine
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,2.408229214,0.000582259,scopolamine
G_ALPHA_I_SIGNALLING_EVENTS,2.339985663,0.000931615,scopolamine
G_ALPHA_Q_SIGNALLING_EVENTS,2.254064921,0.001940864,scopolamine
SENSORY_PERCEPTION,2.218388965,0.002911297,scopolamine
MUSCLE_CONTRACTION,2.067144198,0.011717969,scopolamine
G_ALPHA_S_SIGNALLING_EVENTS,2.015148257,0.015009352,scopolamine
EXTRACELLULAR_MATRIX_ORGANIZATION,2.321639432,0.010252291,clobetasol
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,2.189132524,0.006590759,clobetasol
G_ALPHA_I_SIGNALLING_EVENTS,2.203609315,0.009886138,clobetasol
SENSORY_PERCEPTION,1.918561524,0.036798403,clobetasol
G_ALPHA_Q_SIGNALLING_EVENTS,1.719104166,0.093149391,clobetasol
SIGNALING_BY_GPCR,1.648290075,0.117657249,clobetasol
NEURONAL_SYSTEM,1.637508258,0.107021369,clobetasol
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.992595425,1,clobetasol
MUSCLE_CONTRACTION,-2.979739409,0.948471019,clobetasol
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.969680451,0.676054606,clobetasol
SEPARATION_OF_SISTER_CHROMATIDS,3.212878565,0,BRD-K14965640
METABOLISM_OF_RNA,2.894905006,0,BRD-K14965640
MITOTIC_SPINDLE_CHECKPOINT,2.790514332,0,BRD-K14965640
RESOLUTION_OF_SISTER_CHROMATID_COHESION,2.496216527,0.0010063,BRD-K14965640
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.503906576,0.001150058,BRD-K14965640
MRNA_SPLICING,2.583946817,0.001341734,BRD-K14965640
MITOTIC_METAPHASE_AND_ANAPHASE,2.650875659,0.002012601,BRD-K14965640
CELL_CYCLE_CHECKPOINTS,2.591169571,0.001610081,BRD-K14965640
M_PHASE,2.407768887,0.001788978,BRD-K14965640
RRNA_PROCESSING,2.336992371,0.001829637,BRD-K14965640
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.227192465,0.039041361,VX-809
GPCR_LIGAND_BINDING,-2.243678989,0.034682277,VX-809
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,1.984708449,0.150675251,VX-809
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,-1.961036377,0.193713203,VX-809
SIGNALING_BY_GPCR,-1.944999608,0.148598047,VX-809
PEROXISOMAL_PROTEIN_IMPORT,1.862887639,0.253362163,VX-809
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,1.846789666,0.21289742,VX-809
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.866176214,0.198154226,VX-809
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.794002834,0.261047574,VX-809
REGULATION_OF_TP53_ACTIVITY,1.658544954,0.525594318,VX-809
NONSENSE_MEDIATED_DECAY_NMD,4.09889347,0,enzalutamide
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.773561599,0,enzalutamide
G2_M_CHECKPOINTS,2.827681284,0,enzalutamide
ANTIGEN_PROCESSING_CROSS_PRESENTATION,2.955950165,0,enzalutamide
METABOLISM_OF_RNA,2.99448081,0,enzalutamide
SIGNALING_BY_ROBO_RECEPTORS,3.007025261,0,enzalutamide
CELLULAR_RESPONSE_TO_STARVATION,3.345211445,0,enzalutamide
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.527770749,0,enzalutamide
RRNA_PROCESSING,3.22466308,0,enzalutamide
INFLUENZA_INFECTION,3.807819905,0,enzalutamide
METABOLISM_OF_RNA,6.626501208,0,vildagliptin
SARS_COV_2_INFECTION,3.513764936,0,vildagliptin
SARS_COV_INFECTIONS,3.437699675,0,vildagliptin
SEPARATION_OF_SISTER_CHROMATIDS,3.298293585,0,vildagliptin
HIV_INFECTION,3.118132468,0,vildagliptin
MITOTIC_METAPHASE_AND_ANAPHASE,3.103656291,0,vildagliptin
RNA_POLYMERASE_II_TRANSCRIPTION_TERMINATION,3.097670772,0,vildagliptin
CELL_CYCLE_MITOTIC,3.079510411,0,vildagliptin
DNA_REPLICATION,3.04865968,0,vildagliptin
NERVOUS_SYSTEM_DEVELOPMENT,3.02447896,0,vildagliptin
ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS,-1.946593327,0.110152357,H-89
NEURONAL_SYSTEM,-1.922061695,0.076038008,H-89
MITOTIC_SPINDLE_CHECKPOINT,1.858611819,0.453594884,H-89
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,-1.90193084,0.066310623,H-89
G_ALPHA_S_SIGNALLING_EVENTS,-1.892652453,0.054254146,H-89
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,1.784509736,0.378413412,H-89
TRNA_PROCESSING,1.776696566,0.269817951,H-89
GPCR_LIGAND_BINDING,-1.858484142,0.061159219,H-89
EXTRACELLULAR_MATRIX_ORGANIZATION,1.7170966,0.283810059,H-89
PI3K_AKT_SIGNALING_IN_CANCER,1.61547678,0.371897684,H-89
TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,-2.51002776,0.355885776,histamine
DNA_REPLICATION_PRE_INITIATION,1.508662616,1,histamine
MRNA_SPLICING,1.471301711,0.667381645,histamine
NUCLEOTIDE_EXCISION_REPAIR,1.453554621,0.489658342,histamine
DISEASES_OF_METABOLISM,-2.425598888,0.626166596,histamine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.421609839,0.430672591,histamine
CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6,1.392826582,0.401899801,histamine
RAB_REGULATION_OF_TRAFFICKING,1.384639155,0.350850314,histamine
RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_HSCS,1.368253704,0.325680142,histamine
RAB_GEFS_EXCHANGE_GTP_FOR_GDP_ON_RABS,1.349042907,0.310479546,histamine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.342265538,0.020727599,cariprazine
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,1.759131481,0.540512014,cariprazine
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,1.744161445,0.393824388,cariprazine
MEMBRANE_TRAFFICKING,1.68512793,0.418139457,cariprazine
TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM,1.678201084,0.346948125,cariprazine
INFLUENZA_INFECTION,1.660121407,0.31436859,cariprazine
NEUTROPHIL_DEGRANULATION,1.656272755,0.275608739,cariprazine
SIGNALING_BY_ROBO_RECEPTORS,1.604741617,0.316494498,cariprazine
VESICLE_MEDIATED_TRANSPORT,1.592517509,0.299930134,cariprazine
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,1.55996593,0.31713227,cariprazine
MRNA_SPLICING,1.767426041,0.208790354,levosimendan
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.636308651,0.227615714,levosimendan
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.375284504,1,levosimendan
RAB_REGULATION_OF_TRAFFICKING,1.47340842,0.386775574,levosimendan
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.322102249,0.705133181,levosimendan
GPCR_LIGAND_BINDING,-2.312506066,0.496563568,levosimendan
G_ALPHA_I_SIGNALLING_EVENTS,-2.104712473,0.703438149,levosimendan
SIGNALING_BY_GPCR,-2.071519256,0.590645898,levosimendan
TRNA_PROCESSING,1.329855129,0.625087515,levosimendan
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-1.951901746,0.583252331,levosimendan
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.305436886,0.010917362,rasagiline
NEUTROPHIL_DEGRANULATION,2.161495482,0.020924943,rasagiline
CELLULAR_RESPONSE_TO_STARVATION,2.083776734,0.023351024,rasagiline
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.922095261,0.057316149,rasagiline
GPCR_LIGAND_BINDING,-1.910252428,0.459861903,rasagiline
SIGNALING_BY_GPCR,-1.889355597,0.272395677,rasagiline
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.88611006,0.188501951,rasagiline
RAB_GEFS_EXCHANGE_GTP_FOR_GDP_ON_RABS,1.789613264,0.109173616,rasagiline
C_TYPE_LECTIN_RECEPTORS_CLRS,-1.850874233,0.191868058,rasagiline
MUSCLE_CONTRACTION,1.740973944,0.123578469,rasagiline
CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM,2.14441581,0.055921403,vecuronium
INTERLEUKIN_1_FAMILY_SIGNALING,2.028085974,0.080472263,vecuronium
G_ALPHA_Q_SIGNALLING_EVENTS,1.911405497,0.117753199,vecuronium
INTERLEUKIN_1_SIGNALING,1.875323102,0.115934616,vecuronium
CELL_CYCLE_MITOTIC,1.840972799,0.114025105,vecuronium
SIGNALING_BY_INTERLEUKINS,1.833783494,0.098430762,vecuronium
SIGNALING_BY_GPCR,1.80374864,0.102100402,vecuronium
BETA_CATENIN_INDEPENDENT_WNT_SIGNALING,1.723682346,0.146111715,vecuronium
HEMOSTASIS,-2.759596266,0.719106916,vecuronium
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,1.709706625,0.142455607,vecuronium
METABOLISM_OF_RNA,4.745755734,0,BRD-K20152659
NONSENSE_MEDIATED_DECAY_NMD,3.283731183,0,BRD-K20152659
CELL_CYCLE,3.282664651,0,BRD-K20152659
APC_C_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS,3.25799348,0,BRD-K20152659
ACTIVATION_OF_APC_C_AND_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS,3.25799348,0,BRD-K20152659
SIGNALING_BY_ROBO_RECEPTORS,3.228894701,0,BRD-K20152659
M_PHASE,3.2171997,0,BRD-K20152659
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,3.203523028,0,BRD-K20152659
MRNA_SPLICING,3.178211405,0,BRD-K20152659
ORC1_REMOVAL_FROM_CHROMATIN,3.169843969,0,BRD-K20152659
EUKARYOTIC_TRANSLATION_INITIATION,3.709936917,0,alpelisib
SARS_COV_1_HOST_INTERACTIONS,2.844655388,0,alpelisib
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,2.845173795,0,alpelisib
SIGNALING_BY_ROBO_RECEPTORS,2.946775799,0,alpelisib
TRANSLATION,2.963375205,0,alpelisib
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.97673431,0,alpelisib
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,3.196136943,0,alpelisib
RRNA_PROCESSING,3.125894135,0,alpelisib
SELENOAMINO_ACID_METABOLISM,3.501965388,0,alpelisib
NONSENSE_MEDIATED_DECAY_NMD,3.55249953,0,alpelisib
MYD88_INDEPENDENT_TLR4_CASCADE,2.531989763,0.020933522,resiquimod
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.312839469,0.003766727,resiquimod
GPCR_LIGAND_BINDING,-2.266159333,0.003452833,resiquimod
INNATE_IMMUNE_SYSTEM,2.11629634,0.062800566,resiquimod
TOLL_LIKE_RECEPTOR_CASCADES,1.995013106,0.078151815,resiquimod
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.104326265,0.015066909,resiquimod
ORGANELLE_BIOGENESIS_AND_MAINTENANCE,1.980340731,0.069080622,resiquimod
SIGNALING_BY_GPCR,-2.085451136,0.01396828,resiquimod
CILIUM_ASSEMBLY,1.891692956,0.098806223,resiquimod
RESPIRATORY_ELECTRON_TRANSPORT,1.882523935,0.084431872,resiquimod
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.111543524,0.134807585,diacerein
EXTRA_NUCLEAR_ESTROGEN_SIGNALING,-1.996472019,0.158181481,diacerein
RRNA_PROCESSING,-1.972406945,0.125747936,diacerein
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.90258804,0.14296127,diacerein
NEURONAL_SYSTEM,1.829757455,0.897938445,diacerein
GLOBAL_GENOME_NUCLEOTIDE_EXCISION_REPAIR_GG_NER,-1.770645112,0.255916981,diacerein
MUSCLE_CONTRACTION,1.763490806,0.719574362,diacerein
TRANSPORT_OF_SMALL_MOLECULES,-1.665126319,0.39373237,diacerein
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.664566298,0.338882663,diacerein
METABOLISM_OF_RNA,-1.643283181,0.332398542,diacerein
EUKARYOTIC_TRANSLATION_INITIATION,-2.647030648,0,FK-866
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.567417856,0,FK-866
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.535114998,0,FK-866
EUKARYOTIC_TRANSLATION_ELONGATION,-2.524159143,0,FK-866
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.512995171,0,FK-866
SARS_COV_1_HOST_INTERACTIONS,-2.462786803,0,FK-866
NONSENSE_MEDIATED_DECAY_NMD,-2.445335641,0,FK-866
SELENOAMINO_ACID_METABOLISM,-2.434903812,0,FK-866
CELLULAR_RESPONSE_TO_STARVATION,-2.425607628,0,FK-866
SARS_COV_1_INFECTION,-2.32833593,0.000103079,FK-866
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,2.069974705,0.125608785,diosmin
MEMBRANE_TRAFFICKING,2.033075861,0.075535012,diosmin
VESICLE_MEDIATED_TRANSPORT,1.970412487,0.082324677,diosmin
DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR,-1.971683402,0.681123001,diosmin
GASTRULATION,-1.852764269,0.781193205,diosmin
SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR,-1.851139098,0.526534263,diosmin
INTERLEUKIN_1_SIGNALING,-1.834384344,0.439017669,diosmin
SIGNALING_BY_GPCR,-1.758313243,0.56663408,diosmin
FATTY_ACID_METABOLISM,1.599009989,0.587093763,diosmin
GPCR_LIGAND_BINDING,-1.682161269,0.732592802,diosmin
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.418453413,0.004496954,gavestinel
CHEMOKINE_RECEPTORS_BIND_CHEMOKINES,2.313142928,0.012141777,gavestinel
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,2.28799463,0.011392284,gavestinel
SIGNALING_BY_GPCR,2.245205233,0.013266015,gavestinel
GPCR_LIGAND_BINDING,2.171224604,0.019786599,gavestinel
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.064433958,0.040772386,gavestinel
DEVELOPMENTAL_CELL_LINEAGES,-1.8731751,0.394335363,gavestinel
HEMOSTASIS,2.004133016,0.053963452,gavestinel
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-1.749778034,0.391325169,gavestinel
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,1.941866574,0.077010343,gavestinel
ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES,3.000910153,0,salbutamol
METABOLISM_OF_RNA,2.906799676,0,salbutamol
ORC1_REMOVAL_FROM_CHROMATIN,2.665248288,0.000284192,salbutamol
DNA_REPLICATION,2.673955278,0.000310028,salbutamol
KEAP1_NFE2L2_PATHWAY,2.684624656,0.000378923,salbutamol
SEPARATION_OF_SISTER_CHROMATIDS,2.695880761,0.000426288,salbutamol
CELL_CYCLE_MITOTIC,2.707097496,0.000487187,salbutamol
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,2.722929362,0.000568384,salbutamol
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,2.752270532,0.000682061,salbutamol
THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT,2.684303742,0.000341031,salbutamol
DNA_REPLICATION_PRE_INITIATION,3.091197145,0,cerivastatin
DEFECTIVE_CFTR_CAUSES_CYSTIC_FIBROSIS,2.606660575,0,cerivastatin
METABOLISM_OF_RNA,2.671215046,0,cerivastatin
MITOTIC_METAPHASE_AND_ANAPHASE,2.671500421,0,cerivastatin
SIGNALING_BY_NOTCH4,2.686093796,0,cerivastatin
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.693725232,0,cerivastatin
REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS,2.725515441,0,cerivastatin
SYNTHESIS_OF_DNA,2.791021246,0,cerivastatin
NEGATIVE_REGULATION_OF_NOTCH4_SIGNALING,2.838423097,0,cerivastatin
CELL_CYCLE_CHECKPOINTS,2.838823257,0,cerivastatin
PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS,2.004054504,0.270566834,VX-661
GPCR_LIGAND_BINDING,-2.135439227,0.364515836,VX-661
MEMBRANE_TRAFFICKING,1.910971611,0.26996289,VX-661
CILIUM_ASSEMBLY,1.833430052,0.300361396,VX-661
BIOLOGICAL_OXIDATIONS,1.831331995,0.225874991,VX-661
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,-1.959632709,0.641785401,VX-661
GASTRULATION,-1.951896624,0.449478174,VX-661
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.937629526,0.368398524,VX-661
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.888314715,0.392288471,VX-661
NEUTROPHIL_DEGRANULATION,-1.847188664,0.40532212,VX-661
STRIATED_MUSCLE_CONTRACTION,3.537479555,0,alverine
MUSCLE_CONTRACTION,3.499695216,0,alverine
SELENOAMINO_ACID_METABOLISM,-2.341678856,0.003559916,alverine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.328909613,0.002224947,alverine
EUKARYOTIC_TRANSLATION_ELONGATION,-2.31154758,0.001779958,alverine
EUKARYOTIC_TRANSLATION_INITIATION,-2.308371245,0.001557463,alverine
CELLULAR_RESPONSE_TO_STARVATION,-2.202785199,0.005161878,alverine
GPCR_LIGAND_BINDING,2.177316028,0.024858646,alverine
NONSENSE_MEDIATED_DECAY_NMD,-2.118563921,0.012756365,alverine
SIGNALING_BY_GPCR,2.059663013,0.042614822,alverine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,3.042900573,0,pheniramine
CELL_CYCLE_CHECKPOINTS,3.034388103,0,pheniramine
METABOLISM_OF_RNA,2.922551504,0,pheniramine
MITOTIC_METAPHASE_AND_ANAPHASE,2.889481382,0,pheniramine
CELL_CYCLE,2.873866738,0,pheniramine
MRNA_SPLICING,2.853826487,0,pheniramine
SEPARATION_OF_SISTER_CHROMATIDS,2.802967822,0,pheniramine
M_PHASE,2.648353803,0,pheniramine
RRNA_PROCESSING,2.769896841,0,pheniramine
RHO_GTPASES_ACTIVATE_FORMINS,2.606902757,0.000497814,pheniramine
INTERFERON_ALPHA_BETA_SIGNALING,2.150919583,0.044300392,plerixafor
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,-2.153065264,0.278385075,plerixafor
M_PHASE,-2.037122744,0.327735157,plerixafor
MITOTIC_PROMETAPHASE,-1.93276585,0.458069987,plerixafor
STIMULI_SENSING_CHANNELS,1.769960747,0.275538702,plerixafor
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.873979652,0.506471029,plerixafor
CELL_CYCLE_MITOTIC,-1.865282584,0.431749944,plerixafor
ION_CHANNEL_TRANSPORT,1.636034517,0.378744011,plerixafor
GPCR_LIGAND_BINDING,1.586603392,0.368520843,plerixafor
DISEASES_OF_METABOLISM,-1.744837597,0.731393515,plerixafor
GPCR_LIGAND_BINDING,-2.116938028,0.145022158,eflornithine
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,1.852275196,0.457200763,eflornithine
NEURONAL_SYSTEM,1.782266345,0.358023367,eflornithine
GASTRULATION,-1.940057066,0.367571885,eflornithine
VISUAL_PHOTOTRANSDUCTION,-1.922102863,0.287004019,eflornithine
REGULATION_OF_T_CELL_ACTIVATION_BY_CD28_FAMILY,1.663829913,0.46657924,eflornithine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.875698591,0.308058075,eflornithine
ORGANELLE_BIOGENESIS_AND_MAINTENANCE,1.640678363,0.386510491,eflornithine
SENSORY_PERCEPTION,-1.8204943,0.362829022,eflornithine
TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION,1.54567492,0.507281831,eflornithine
CELLULAR_RESPONSE_TO_STARVATION,2.330248845,0.016294831,azilsartan-medoxomil
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.32167502,0.009233738,azilsartan-medoxomil
EUKARYOTIC_TRANSLATION_ELONGATION,2.30441924,0.007604254,azilsartan-medoxomil
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.204088606,0.016023251,azilsartan-medoxomil
NONSENSE_MEDIATED_DECAY_NMD,2.198603811,0.014339451,azilsartan-medoxomil
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.194188254,0.012492704,azilsartan-medoxomil
SIGNALING_BY_ROBO_RECEPTORS,2.145096328,0.015674076,azilsartan-medoxomil
EUKARYOTIC_TRANSLATION_INITIATION,2.117357152,0.017788524,azilsartan-medoxomil
SELENOAMINO_ACID_METABOLISM,2.077262096,0.022933466,azilsartan-medoxomil
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,2.07550246,0.020966016,azilsartan-medoxomil
METABOLISM_OF_RNA,3.076072787,0,BRD-K48195008
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.66130332,0,BRD-K48195008
MRNA_SPLICING,2.567620631,0,BRD-K48195008
RRNA_PROCESSING,2.328749572,0.001111875,BRD-K48195008
HOST_INTERACTIONS_OF_HIV_FACTORS,2.092257105,0.016010997,BRD-K48195008
MAPK_FAMILY_SIGNALING_CASCADES,-2.81083954,0.077472031,BRD-K48195008
SARS_COV_INFECTIONS,1.908098929,0.049663742,BRD-K48195008
MAPK1_MAPK3_SIGNALING,-2.758991272,0.064102964,BRD-K48195008
CELL_CYCLE_CHECKPOINTS,1.798523401,0.089585343,BRD-K48195008
SIGNALING_BY_NOTCH,1.759822468,0.095621235,BRD-K48195008
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.343179141,0.015482609,furosemide
GASTRULATION,-2.160067578,0.050318478,furosemide
RRNA_PROCESSING,-2.07340595,0.063404969,furosemide
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.037613979,0.064971661,furosemide
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,1.910982797,0.499220683,furosemide
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.870307507,0.172078136,furosemide
SIGNALING_BY_GPCR,-1.845648047,0.164779192,furosemide
GPCR_LIGAND_BINDING,-1.782951929,0.209963132,furosemide
REGULATION_OF_TP53_ACTIVITY,1.768807345,0.699001233,furosemide
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.754482486,0.21565062,furosemide
NEUTROPHIL_DEGRANULATION,-3.189911545,0.058877922,PF-02545920
RHOA_GTPASE_CYCLE,2.056336056,0.140190293,PF-02545920
RAB_REGULATION_OF_TRAFFICKING,1.74557457,0.467541852,PF-02545920
VESICLE_MEDIATED_TRANSPORT,-2.702527409,1,PF-02545920
INNATE_IMMUNE_SYSTEM,-2.508254289,0.842452263,PF-02545920
GPCR_LIGAND_BINDING,-2.19588827,0.700603338,PF-02545920
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.084138445,0.57840968,PF-02545920
G_ALPHA_Q_SIGNALLING_EVENTS,-1.902528785,0.538689051,PF-02545920
SIGNALING_BY_GPCR,-1.882074324,0.471776615,PF-02545920
INTERFERON_ALPHA_BETA_SIGNALING,-1.871883006,0.417527954,PF-02545920
GPCR_LIGAND_BINDING,3.4299982,0,BRD-K33396764
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,3.319958255,0,BRD-K33396764
NEUTROPHIL_DEGRANULATION,-3.206316667,0,BRD-K33396764
SIGNALING_BY_GPCR,3.174995579,0,BRD-K33396764
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.737424433,0,BRD-K33396764
G_ALPHA_I_SIGNALLING_EVENTS,2.583593927,9.29E-05,BRD-K33396764
VESICLE_MEDIATED_TRANSPORT,-2.668540198,0.001866919,BRD-K33396764
MEMBRANE_TRAFFICKING,-2.643551989,0.001866919,BRD-K33396764
G_ALPHA_Q_SIGNALLING_EVENTS,2.398439806,0.000542057,BRD-K33396764
INNATE_IMMUNE_SYSTEM,-2.510160084,0.005134028,BRD-K33396764
GPCR_LIGAND_BINDING,-2.160551478,0.047697561,aclidinium
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.143878984,0.096019548,aclidinium
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.969698901,0.152035976,aclidinium
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,1.89152163,0.28932206,aclidinium
TRANSPORT_OF_SMALL_MOLECULES,-1.892312346,0.176310628,aclidinium
SIGNALING_BY_GPCR,-1.796906027,0.270002266,aclidinium
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,1.704542445,0.643499428,aclidinium
ADIPOGENESIS,1.698016069,0.501891652,aclidinium
REGULATION_OF_TP53_ACTIVITY,1.676835567,0.452302609,aclidinium
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,1.66890262,0.393553806,aclidinium
NEUTROPHIL_DEGRANULATION,2.076132162,0.210305313,diclofenamide
EUKARYOTIC_TRANSLATION_ELONGATION,-1.937659232,0.257883158,diclofenamide
NONSENSE_MEDIATED_DECAY_NMD,-1.91805989,0.144830115,diclofenamide
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-1.897644252,0.109590157,diclofenamide
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,2.033411252,0.146547594,diclofenamide
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,2.025668419,0.101822029,diclofenamide
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-1.69100827,0.260938646,diclofenamide
CELLULAR_RESPONSE_TO_STARVATION,-1.688824559,0.211439746,diclofenamide
SELENOAMINO_ACID_METABOLISM,-1.633775473,0.227939379,diclofenamide
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,1.866896667,0.271446111,diclofenamide
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,1.865736578,1,argatroban
SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES,-1.453206858,1,argatroban
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,-1.395481188,1,argatroban
INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,1.746921211,1,argatroban
DEVELOPMENTAL_CELL_LINEAGES,1.719971131,1,argatroban
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.682080439,1,argatroban
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,1.681930939,1,argatroban
UB_SPECIFIC_PROCESSING_PROTEASES,-1.309649505,0.964766839,argatroban
SIGNALING_BY_PTK6,1.648934886,1,argatroban
G2_M_CHECKPOINTS,-1.244692112,0.940587219,argatroban
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.803349752,0,carglumic-acid
NEUTROPHIL_DEGRANULATION,2.162048965,0.027841336,carglumic-acid
GPCR_LIGAND_BINDING,-2.048047534,0.161294461,carglumic-acid
SIGNALING_BY_GPCR,-1.97833653,0.16284537,carglumic-acid
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.960255724,0.129587003,carglumic-acid
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.942223105,0.114767213,carglumic-acid
G_ALPHA_I_SIGNALLING_EVENTS,-1.90896289,0.12055727,carglumic-acid
C_TYPE_LECTIN_RECEPTORS_CLRS,-1.78190871,0.260724914,carglumic-acid
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.681034552,0.471137281,carglumic-acid
RAB_REGULATION_OF_TRAFFICKING,1.647424622,0.427364513,carglumic-acid
GPCR_LIGAND_BINDING,-2.556692607,0,atrasentan
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.514716781,0,atrasentan
MHC_CLASS_II_ANTIGEN_PRESENTATION,2.3534652,0,atrasentan
G_ALPHA_Q_SIGNALLING_EVENTS,-2.438646294,0.000490717,atrasentan
NEUTROPHIL_DEGRANULATION,2.276381117,0.005055961,atrasentan
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.394211758,0.001104114,atrasentan
SIGNALING_BY_GPCR,-2.321320448,0.002061013,atrasentan
SIGNALING_BY_NTRKS,2.202586556,0.016853204,atrasentan
GOLGI_TO_ER_RETROGRADE_TRANSPORT,2.172717844,0.015167884,atrasentan
SARS_COV_INFECTIONS,2.022677142,0.035728793,atrasentan
METABOLISM_OF_RNA,-4.098088494,0,PD-168393
GPCR_LIGAND_BINDING,2.883252342,0,PD-168393
SYNTHESIS_OF_DNA,-2.991968954,0,PD-168393
MITOTIC_METAPHASE_AND_ANAPHASE,-2.997599813,0,PD-168393
CELL_CYCLE_CHECKPOINTS,-2.9985688,0,PD-168393
S_PHASE,-3.043212056,0,PD-168393
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.764035619,0,PD-168393
M_PHASE,-3.292677692,0,PD-168393
MRNA_SPLICING,-3.358785033,0,PD-168393
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-3.443735058,0,PD-168393
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.106794688,0,PD-407824
SELENOAMINO_ACID_METABOLISM,2.716200604,0,PD-407824
SIGNALING_BY_ALK_IN_CANCER,2.693796766,0,PD-407824
EUKARYOTIC_TRANSLATION_INITIATION,2.537205093,0,PD-407824
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.502079161,0.000805145,PD-407824
GPCR_LIGAND_BINDING,-2.212446036,0.00284757,PD-407824
CARDIAC_CONDUCTION,-2.108542804,0.003203517,PD-407824
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.985052308,0.011390281,PD-407824
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.94316944,0.01637353,PD-407824
INFLUENZA_INFECTION,1.872611597,0.081856364,PD-407824
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,3.416668654,0,anisomycin
GPCR_LIGAND_BINDING,3.14987677,0,anisomycin
SIGNALING_BY_GPCR,2.584120864,0,anisomycin
INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,2.494380074,0.000497195,anisomycin
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.390578234,0.001193268,anisomycin
METABOLISM_OF_STEROIDS,-3.1146231,0.051865789,anisomycin
METABOLISM_OF_VITAMINS_AND_COFACTORS,-3.071913904,0.048361344,anisomycin
SENSORY_PERCEPTION,-2.943719076,0.114011284,anisomycin
G_ALPHA_Q_SIGNALLING_EVENTS,1.85599243,0.073999199,anisomycin
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.799147462,0.393549197,anisomycin
MRNA_SPLICING,-1.642094647,1,mafenide
EPIGENETIC_REGULATION_BY_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES,-1.55179845,0.884562203,mafenide
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.806059718,1,mafenide
INNATE_IMMUNE_SYSTEM,1.752322123,1,mafenide
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.738446539,0.778984789,mafenide
DNA_REPAIR,-1.419889187,1,mafenide
NEUTROPHIL_DEGRANULATION,1.728432762,0.619894158,mafenide
METABOLISM_OF_RNA,-1.409304377,0.835457229,mafenide
TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT,-1.312481949,0.99366942,mafenide
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,-1.297328705,0.876490153,mafenide
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.002414854,0.250826771,cabergoline
TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,1.975259277,0.336871398,cabergoline
TOLL_LIKE_RECEPTOR_CASCADES,1.968367612,0.176237898,cabergoline
PKR_MEDIATED_SIGNALING,-1.86704951,0.293636148,cabergoline
MYD88_INDEPENDENT_TLR4_CASCADE,1.907238271,0.187864704,cabergoline
PROTEIN_FOLDING,-1.798791659,0.284189947,cabergoline
TRANSLATION,-1.796583222,0.216760154,cabergoline
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,1.874025079,0.186564337,cabergoline
NEUTROPHIL_DEGRANULATION,-1.741751794,0.231532404,cabergoline
INFLUENZA_INFECTION,-1.732948411,0.202992819,cabergoline
TRANSLATION,3.157580305,0,norfloxacin
SELENOAMINO_ACID_METABOLISM,2.777473401,0,norfloxacin
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.816821092,0,norfloxacin
INFLUENZA_INFECTION,2.854269185,0,norfloxacin
EUKARYOTIC_TRANSLATION_INITIATION,2.95262455,0,norfloxacin
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.713450514,0,norfloxacin
NONSENSE_MEDIATED_DECAY_NMD,3.051346249,0,norfloxacin
EUKARYOTIC_TRANSLATION_ELONGATION,3.143237762,0,norfloxacin
SARS_COV_2_INFECTION,3.150493815,0,norfloxacin
CELLULAR_RESPONSE_TO_STARVATION,3.022596461,0,norfloxacin
METABOLISM_OF_RNA,-3.033565446,0,carisoprodol
RRNA_PROCESSING,-2.500129645,0.002085984,carisoprodol
DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR,-2.327198692,0.006953281,carisoprodol
INTERLEUKIN_1_SIGNALING,-2.322797954,0.005214961,carisoprodol
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.317541357,0.012714019,carisoprodol
TRANSLATION,-2.261896765,0.0089002,carisoprodol
CELL_CYCLE_CHECKPOINTS,-2.216286595,0.010198146,carisoprodol
CLEC7A_DECTIN_1_SIGNALING,-2.216275084,0.008741268,carisoprodol
TRANSCRIPTIONAL_REGULATION_BY_RUNX3,-2.214997648,0.007822441,carisoprodol
REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS,-2.188517967,0.008498455,carisoprodol
GPCR_LIGAND_BINDING,3.281216705,0,benzydamine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,3.264936552,0,benzydamine
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.842661338,0,benzydamine
SIGNALING_BY_GPCR,3.074729171,0,benzydamine
G_ALPHA_I_SIGNALLING_EVENTS,2.468481458,0.000102197,benzydamine
MUSCLE_CONTRACTION,2.389061491,0.000510986,benzydamine
G_ALPHA_Q_SIGNALLING_EVENTS,2.364546322,0.000510986,benzydamine
FATTY_ACID_METABOLISM,-3.322542061,0.028293798,benzydamine
PROTEIN_LOCALIZATION,-3.263879679,0.026721921,benzydamine
METABOLISM_OF_STEROIDS,-3.12917995,0.130465847,benzydamine
GPCR_LIGAND_BINDING,2.481129476,0.001159671,calcifediol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.41619448,0.001159671,calcifediol
KERATINIZATION,2.383988743,0.001159671,calcifediol
VIRAL_INFECTION_PATHWAYS,-2.361491866,0.010841567,calcifediol
FORMATION_OF_THE_CORNIFIED_ENVELOPE,2.305820011,0.002029424,calcifediol
SIGNALING_BY_GPCR,2.294938199,0.001855473,calcifediol
G_ALPHA_Q_SIGNALLING_EVENTS,2.274002949,0.002319341,calcifediol
MITOTIC_METAPHASE_AND_ANAPHASE,-2.227537523,0.022360732,calcifediol
INFECTIOUS_DISEASE,-2.218912562,0.015358887,calcifediol
SARS_COV_1_INFECTION,-2.188556646,0.015245954,calcifediol
SIGNALING_BY_GPCR,3.367165903,0,DPPE
GPCR_LIGAND_BINDING,3.34656041,0,DPPE
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,3.056729547,0,DPPE
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.581107693,0,DPPE
G_ALPHA_I_SIGNALLING_EVENTS,2.564357729,0,DPPE
G_ALPHA_Q_SIGNALLING_EVENTS,2.53005918,0.000119436,DPPE
NEUTROPHIL_DEGRANULATION,-2.659060443,0.004215088,DPPE
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,-2.567230691,0.006322631,DPPE
TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,-2.526474167,0.00608846,DPPE
MEMBRANE_TRAFFICKING,-2.487597805,0.007727661,DPPE
EPIGENETIC_REGULATION_BY_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES,-1.88053441,0.768895126,lacosamide
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.883625755,0.58700698,lacosamide
EXTRA_NUCLEAR_ESTROGEN_SIGNALING,-1.871411993,0.40744366,lacosamide
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.865460905,0.280670307,lacosamide
PROTEIN_FOLDING,-1.818488532,0.275068693,lacosamide
METABOLISM_OF_STEROIDS,-1.792502269,0.255197707,lacosamide
METABOLISM_OF_VITAMINS_AND_COFACTORS,-1.789418579,0.216988809,lacosamide
INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS,1.787095624,0.597926009,lacosamide
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,-1.744513449,0.249334966,lacosamide
NEURONAL_SYSTEM,1.673394376,0.817034517,lacosamide
TRANSLATION,-2.879801447,0,felbinac
METABOLISM_OF_RNA,-2.867010101,0,felbinac
RRNA_PROCESSING,-2.812595034,0,felbinac
KERATINIZATION,2.378762568,0.001109362,felbinac
FORMATION_OF_THE_CORNIFIED_ENVELOPE,2.378762568,0.001109362,felbinac
EUKARYOTIC_TRANSLATION_INITIATION,-2.409519698,0.004687741,felbinac
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.323455768,0.00865429,felbinac
MITOTIC_METAPHASE_AND_ANAPHASE,-2.316542709,0.008173496,felbinac
CELL_CYCLE_CHECKPOINTS,-2.236510326,0.012981435,felbinac
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.228496628,0.012260245,felbinac
RESPIRATORY_ELECTRON_TRANSPORT,2.297499449,0.021781566,BRD-K49668410
INFLUENZA_INFECTION,2.171169475,0.039602846,BRD-K49668410
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,1.975095608,0.157421315,BRD-K49668410
G_ALPHA_S_SIGNALLING_EVENTS,-1.769939674,0.5524723,BRD-K49668410
HIV_LIFE_CYCLE,1.946761283,0.151728405,BRD-K49668410
MITOTIC_SPINDLE_CHECKPOINT,1.932569802,0.140788119,BRD-K49668410
G_ALPHA_Q_SIGNALLING_EVENTS,-1.725019087,0.351910038,BRD-K49668410
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.906527656,0.140920129,BRD-K49668410
RNA_POLYMERASE_II_TRANSCRIBES_SNRNA_GENES,1.896142894,0.130972271,BRD-K49668410
HIV_INFECTION,1.841694558,0.179697916,BRD-K49668410
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.392111993,0.006912357,metergoline
MUSCLE_CONTRACTION,2.305056602,0.011849754,metergoline
TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT,-2.261184227,0.034017009,metergoline
NEDDYLATION,-2.195062768,0.030827914,metergoline
G_ALPHA_Q_SIGNALLING_EVENTS,2.154556427,0.03949918,metergoline
STRIATED_MUSCLE_CONTRACTION,2.097309564,0.046905276,metergoline
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,-1.696297021,0.283475071,metergoline
SIGNALING_BY_HEDGEHOG,-1.571135409,0.398371061,metergoline
INTERLEUKIN_1_FAMILY_SIGNALING,-1.546441808,0.353989495,metergoline
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,1.80101029,0.377809659,metergoline
NEUTROPHIL_DEGRANULATION,2.808873995,0,suprofen
REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF,2.668727024,0,suprofen
GPCR_LIGAND_BINDING,-2.311630796,0.001618268,suprofen
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.283889017,0.000809134,suprofen
INNATE_IMMUNE_SYSTEM,2.120599054,0.031626323,suprofen
SIGNALING_BY_GPCR,-2.080988605,0.014294705,suprofen
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.07209668,0.011530163,suprofen
RHO_GTPASE_CYCLE,1.979620267,0.058640474,suprofen
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,-1.960736221,0.037867482,suprofen
SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3,1.831778081,0.114908973,suprofen
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,-2.239283227,0.004043394,camptothecin
CYCLIN_D_ASSOCIATED_EVENTS_IN_G1,-2.138829022,0.014657303,camptothecin
G1_S_DNA_DAMAGE_CHECKPOINTS,-2.10952195,0.014151879,camptothecin
MITOTIC_G2_G2_M_PHASES,-2.086588103,0.015920864,camptothecin
SIGNALING_BY_GPCR,-2.083477096,0.012938861,camptothecin
FBXL7_DOWN_REGULATES_AURKA_DURING_MITOTIC_ENTRY_AND_IN_EARLY_MITOSIS,-2.01479851,0.026113587,camptothecin
STABILIZATION_OF_P53,-2.005995291,0.025126806,camptothecin
ASYMMETRIC_LOCALIZATION_OF_PCP_PROTEINS,-2.00467323,0.022365023,camptothecin
RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_HSCS,-2.004605222,0.019880021,camptothecin
UBIQUITIN_DEPENDENT_DEGRADATION_OF_CYCLIN_D,-1.992379809,0.020318055,camptothecin
EUKARYOTIC_TRANSLATION_ELONGATION,2.930892404,0,PIK-93
INFLUENZA_INFECTION,2.687487934,0,PIK-93
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.697869938,0,PIK-93
SELENOAMINO_ACID_METABOLISM,2.722612552,0,PIK-93
CELLULAR_RESPONSE_TO_STARVATION,2.65700659,0,PIK-93
EUKARYOTIC_TRANSLATION_INITIATION,2.824972267,0,PIK-93
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.887876977,0,PIK-93
NONSENSE_MEDIATED_DECAY_NMD,2.517532661,0.000108291,PIK-93
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.441961167,0.000288777,PIK-93
G2_M_CHECKPOINTS,-2.909550661,0.013278579,PIK-93
MUSCLE_CONTRACTION,2.234358079,0.04052706,talazoparib
CELL_CYCLE_MITOTIC,-2.130145809,0.162843545,talazoparib
MITOTIC_SPINDLE_CHECKPOINT,-2.123188065,0.08654622,talazoparib
CELL_CYCLE,-2.116290459,0.06339131,talazoparib
RESOLUTION_OF_SISTER_CHROMATID_COHESION,-2.097048088,0.054945462,talazoparib
FATTY_ACID_METABOLISM,1.918939678,0.13249231,talazoparib
RHO_GTPASES_ACTIVATE_FORMINS,-1.979448166,0.130047083,talazoparib
M_PHASE,-1.965964136,0.122227556,talazoparib
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-1.95121578,0.118919712,talazoparib
SEPARATION_OF_SISTER_CHROMATIDS,-1.950743257,0.104197093,talazoparib
GPCR_LIGAND_BINDING,-2.293117137,0.006803378,itopride
SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES,1.764063191,0.779819029,itopride
SIGNALING_BY_NOTCH,-1.855859177,0.40966057,itopride
CELL_JUNCTION_ORGANIZATION,1.712419949,0.522621333,itopride
SIGNALING_BY_GPCR,-1.801721153,0.42180946,itopride
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.790723629,0.345271453,itopride
CELL_CELL_COMMUNICATION,1.627521499,0.531944064,itopride
NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK,1.539817322,0.643542638,itopride
ESTROGEN_DEPENDENT_GENE_EXPRESSION,1.494259424,0.650836304,itopride
ADAPTIVE_IMMUNE_SYSTEM,1.407507523,0.81345398,itopride
GPCR_LIGAND_BINDING,3.42082904,0,alprostadil
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,3.291613577,0,alprostadil
SIGNALING_BY_GPCR,2.930679039,0,alprostadil
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.63089725,0,alprostadil
G_ALPHA_I_SIGNALLING_EVENTS,2.446287299,0.000106377,alprostadil
AMINE_LIGAND_BINDING_RECEPTORS,2.293283243,0.000886476,alprostadil
G_ALPHA_S_SIGNALLING_EVENTS,2.270266302,0.00083582,alprostadil
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-3.189839134,0.039546749,alprostadil
POTASSIUM_CHANNELS,2.135067923,0.004786971,alprostadil
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.918383659,0.417819996,alprostadil
BIOLOGICAL_OXIDATIONS,2.007122279,0.221237155,tanaproget
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.033027809,0.345859665,tanaproget
PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS,1.890588762,0.228260557,tanaproget
VESICLE_MEDIATED_TRANSPORT,1.676159241,0.508611343,tanaproget
MEMBRANE_TRAFFICKING,1.66932306,0.395724792,tanaproget
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.612551757,0.434397398,tanaproget
MUSCLE_CONTRACTION,1.604656004,0.376629919,tanaproget
GPCR_LIGAND_BINDING,-1.781523403,1,tanaproget
CELL_CELL_JUNCTION_ORGANIZATION,1.561811512,0.398327213,tanaproget
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,1.477432264,0.517646657,tanaproget
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,2.293283174,0.034640715,BRD-K18135438
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.269380572,0.021650447,BRD-K18135438
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,2.040275914,0.137480336,BRD-K18135438
NEUTROPHIL_DEGRANULATION,1.976693241,0.168332222,BRD-K18135438
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,-1.609134712,0.565545529,BRD-K18135438
INNATE_IMMUNE_SYSTEM,1.864274455,0.311766431,BRD-K18135438
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,1.804336239,0.388625517,BRD-K18135438
HEMOSTASIS,1.779788651,0.391873084,BRD-K18135438
TRANSCRIPTION_OF_THE_HIV_GENOME,-1.38865078,0.76685808,BRD-K18135438
SIGNALING_BY_INTERLEUKINS,1.716381621,0.530706572,BRD-K18135438
G2_M_DNA_DAMAGE_CHECKPOINT,-2.150933333,0.058629392,carfilzomib
CELL_CYCLE,-2.083672986,0.057618541,carfilzomib
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,-2.065334013,0.045151371,carfilzomib
RESOLUTION_OF_SISTER_CHROMATID_COHESION,-2.053266044,0.037401509,carfilzomib
MITOTIC_SPINDLE_CHECKPOINT,-2.047266606,0.031134229,carfilzomib
RHO_GTPASES_ACTIVATE_FORMINS,-2.035820271,0.02847232,carfilzomib
CELL_CYCLE_CHECKPOINTS,-1.975704777,0.044333063,carfilzomib
REGULATION_OF_TP53_ACTIVITY,-1.944175125,0.051553431,carfilzomib
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,1.921245628,0.428778673,carfilzomib
CHROMOSOME_MAINTENANCE,-1.911012972,0.062785116,carfilzomib
GPCR_LIGAND_BINDING,-2.688332616,0,apixaban
SIGNALING_BY_GPCR,-2.556089673,0,apixaban
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.470865252,0,apixaban
RESPIRATORY_ELECTRON_TRANSPORT,2.59673685,0.003794586,apixaban
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.189330133,0.004594969,apixaban
G_ALPHA_Q_SIGNALLING_EVENTS,-2.171060668,0.004594969,apixaban
G_ALPHA_I_SIGNALLING_EVENTS,-2.163185875,0.004212055,apixaban
GLOBAL_GENOME_NUCLEOTIDE_EXCISION_REPAIR_GG_NER,1.991730577,0.134707817,apixaban
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,1.987943141,0.092334935,apixaban
G_ALPHA_S_SIGNALLING_EVENTS,-2.001881914,0.019583322,apixaban
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,2.678824769,0.000913212,levomepromazine
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,2.354659723,0.009588724,levomepromazine
HEMOSTASIS,2.352389188,0.006392483,levomepromazine
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,-2.015836764,0.20372349,levomepromazine
P75_NTR_RECEPTOR_MEDIATED_SIGNALLING,-1.683839005,0.596924073,levomepromazine
STRIATED_MUSCLE_CONTRACTION,1.813618376,0.411858518,levomepromazine
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,1.803894004,0.352499752,levomepromazine
DEATH_RECEPTOR_SIGNALING,-1.530943068,0.821542281,levomepromazine
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,1.797110899,0.30744797,levomepromazine
NEUTROPHIL_DEGRANULATION,1.78449509,0.284922079,levomepromazine
ECM_PROTEOGLYCANS,-2.312253776,0.009307995,bazedoxifene
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.223799139,0.017840324,bazedoxifene
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.15167261,0.094654729,bazedoxifene
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.058618554,0.058433524,bazedoxifene
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.913525684,0.278227536,bazedoxifene
NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION,1.858372174,0.26388591,bazedoxifene
INTEGRIN_CELL_SURFACE_INTERACTIONS,-1.912915818,0.125076182,bazedoxifene
CILIUM_ASSEMBLY,1.841283184,0.222653737,bazedoxifene
NEUTROPHIL_DEGRANULATION,1.776951324,0.269048896,bazedoxifene
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,1.662895839,0.451522178,bazedoxifene
REGULATION_OF_T_CELL_ACTIVATION_BY_CD28_FAMILY,2.584105764,0.003733389,goserelin-acetate
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.226708512,0.023644795,goserelin-acetate
CELL_CELL_COMMUNICATION,2.179585719,0.027378183,goserelin-acetate
GPCR_LIGAND_BINDING,-2.07867688,0.294748929,goserelin-acetate
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.061798953,0.166188226,goserelin-acetate
SIGNALING_BY_ALK_IN_CANCER,1.860812311,0.167069142,goserelin-acetate
GASTRULATION,-1.974371465,0.211430843,goserelin-acetate
SIGNALING_BY_GPCR,-1.943629981,0.201352042,goserelin-acetate
VESICLE_MEDIATED_TRANSPORT,1.777903279,0.223754426,goserelin-acetate
CELL_JUNCTION_ORGANIZATION,1.731640423,0.245988829,goserelin-acetate
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-3.258728706,0,iloperidone
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-3.189811089,0,iloperidone
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-3.14853329,0.000383233,iloperidone
NEUTROPHIL_DEGRANULATION,-3.037439072,0.006035923,iloperidone
HEMOSTASIS,-2.957115912,0.012646695,iloperidone
NEURONAL_SYSTEM,2.075896758,0.050449863,iloperidone
SIGNALING_BY_GPCR,2.018378609,0.038457683,iloperidone
GPCR_LIGAND_BINDING,1.765013708,0.152452319,iloperidone
TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,-2.769352252,0.123784319,iloperidone
G_ALPHA_S_SIGNALLING_EVENTS,1.705343301,0.162721486,iloperidone
METABOLISM_OF_RNA,-2.977973333,0,epinastine
RRNA_PROCESSING,-2.845509071,0,epinastine
TRANSLATION,-2.770874353,0,epinastine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.550271344,0.000977763,epinastine
SIGNALING_BY_ROBO_RECEPTORS,-2.517428875,0.00078221,epinastine
EUKARYOTIC_TRANSLATION_INITIATION,-2.492276334,0.001086403,epinastine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.347823877,0.004283534,epinastine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.288844592,0.005377697,epinastine
EUKARYOTIC_TRANSLATION_ELONGATION,-2.283412553,0.005214737,epinastine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,-2.236481932,0.007039894,epinastine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-3.546369433,0,pimavanserin
TRANSLATION,-3.097298677,0,pimavanserin
EUKARYOTIC_TRANSLATION_INITIATION,-3.123623774,0,pimavanserin
SIGNALING_BY_ROBO_RECEPTORS,-3.124394038,0,pimavanserin
INFLUENZA_INFECTION,-3.125694259,0,pimavanserin
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-3.159612811,0,pimavanserin
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-3.110927714,0,pimavanserin
CELLULAR_RESPONSE_TO_STARVATION,-3.231782994,0,pimavanserin
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-3.311421784,0,pimavanserin
SELENOAMINO_ACID_METABOLISM,-3.345988974,0,pimavanserin
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,2.658078454,0,enalaprilat
DEVELOPMENTAL_CELL_LINEAGES,2.307652245,0.01056904,enalaprilat
INTEGRIN_CELL_SURFACE_INTERACTIONS,1.934518901,0.220540626,enalaprilat
DISEASES_OF_METABOLISM,1.863204691,0.287742103,enalaprilat
PARASITE_INFECTION,-1.461466022,1,enalaprilat
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,1.756781171,0.496744861,enalaprilat
RHOA_GTPASE_CYCLE,1.719321138,0.535321855,enalaprilat
EXTRACELLULAR_MATRIX_ORGANIZATION,1.691052181,0.548382169,enalaprilat
NEUTROPHIL_DEGRANULATION,1.642304082,0.653695099,enalaprilat
RHO_GTPASE_EFFECTORS,1.631410048,0.622516432,enalaprilat
MRNA_SPLICING,2.510719721,0.002164636,ampalex
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.201554723,0.011905498,ampalex
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,-2.663073255,0.054244561,ampalex
RAB_REGULATION_OF_TRAFFICKING,1.76704018,0.157296885,ampalex
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION_BY_MLL3_AND_MLL4_COMPLEXES,1.681578251,0.188323335,ampalex
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.550510151,0.209963862,ampalex
RAB_GEFS_EXCHANGE_GTP_FOR_GDP_ON_RABS,1.645605562,0.18442699,ampalex
METABOLISM_OF_POLYAMINES,1.60102857,0.183994063,ampalex
DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS,1.588949131,0.169460078,ampalex
REGULATION_OF_ORNITHINE_DECARBOXYLASE_ODC,1.532652204,0.188052755,ampalex
MRNA_SPLICING,2.917200212,0,LY-215490
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.428104099,0.002486963,LY-215490
RAB_REGULATION_OF_TRAFFICKING,2.09561679,0.014921781,LY-215490
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,1.650662797,0.162274368,LY-215490
COLLAGEN_DEGRADATION,-2.450658803,0.707326213,LY-215490
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,1.4503459,0.384981949,LY-215490
TRNA_PROCESSING,1.422626626,0.380505415,LY-215490
NUCLEOTIDE_EXCISION_REPAIR,1.421263767,0.329345023,LY-215490
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.393074753,0.790706389,LY-215490
FATTY_ACID_METABOLISM,1.305672581,0.452351027,LY-215490
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.727034386,0,ciprofloxacin
GPCR_LIGAND_BINDING,-2.000634315,0.303863629,ciprofloxacin
G_ALPHA_I_SIGNALLING_EVENTS,-1.959598935,0.233084149,ciprofloxacin
RHO_GTPASES_ACTIVATE_FORMINS,-1.932601788,0.197287631,ciprofloxacin
SIGNALING_BY_GPCR,-1.883308198,0.224541798,ciprofloxacin
PKR_MEDIATED_SIGNALING,-1.865406026,0.204040156,ciprofloxacin
RESOLUTION_OF_SISTER_CHROMATID_COHESION,-1.837954424,0.213762165,ciprofloxacin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.820541955,0.204667757,ciprofloxacin
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,-1.798003598,0.206389302,ciprofloxacin
EPIGENETIC_REGULATION_BY_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES,-1.7560673,0.245558694,ciprofloxacin
NEURONAL_SYSTEM,2.302428824,0.015567313,dexloxiglumide
CARDIAC_CONDUCTION,2.300689021,0.007783657,dexloxiglumide
CELL_CYCLE_MITOTIC,-2.448861881,0.025682221,dexloxiglumide
MUSCLE_CONTRACTION,2.27925975,0.005765671,dexloxiglumide
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,2.186095959,0.011891697,dexloxiglumide
MITOTIC_PROMETAPHASE,-2.310628087,0.043415184,dexloxiglumide
TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,2.159411408,0.012972761,dexloxiglumide
MITOTIC_SPINDLE_CHECKPOINT,-2.288459519,0.035873579,dexloxiglumide
MITOTIC_METAPHASE_AND_ANAPHASE,-2.198844639,0.046778332,dexloxiglumide
SEPARATION_OF_SISTER_CHROMATIDS,-2.198545601,0.037911851,dexloxiglumide
MRNA_SPLICING,2.321488326,0.004394757,KX-2391
RAB_REGULATION_OF_TRAFFICKING,2.221737443,0.005859676,KX-2391
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.208851464,0.004394757,KX-2391
TRNA_PROCESSING,1.822293635,0.047609869,KX-2391
GLUCOSE_METABOLISM,1.760571345,0.053323053,KX-2391
ONCOGENIC_MAPK_SIGNALING,-2.48446487,0.275237221,KX-2391
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,1.323913327,0.378681573,KX-2391
COLLAGEN_DEGRADATION,-2.292190956,1,KX-2391
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.225233645,1,KX-2391
G_ALPHA_Q_SIGNALLING_EVENTS,-2.107310736,1,KX-2391
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.528231491,0.002641888,adapalene
MRNA_SPLICING,1.944761783,0.046233033,adapalene
RAB_REGULATION_OF_TRAFFICKING,1.815731958,0.067808448,adapalene
MEMBRANE_TRAFFICKING,1.595582604,0.197481097,adapalene
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.448268189,0.393903358,adapalene
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.443860677,0.211921878,adapalene
VESICLE_MEDIATED_TRANSPORT,1.463947343,0.318611643,adapalene
TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,1.397475295,0.383514014,adapalene
ASPARAGINE_N_LINKED_GLYCOSYLATION,1.343317537,0.444969352,adapalene
MITOCHONDRIAL_BIOGENESIS,1.33250518,0.411804227,adapalene
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.860253287,0,lesinurad
SIGNALING_BY_ROBO_RECEPTORS,2.610540495,0,lesinurad
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.481089129,0.002421533,lesinurad
INFLUENZA_INFECTION,2.456941992,0.0036323,lesinurad
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.375693522,0.00290584,lesinurad
CELLULAR_RESPONSE_TO_STARVATION,2.332554562,0.002421533,lesinurad
METABOLISM_OF_RNA,2.302933164,0.0020756,lesinurad
NONSENSE_MEDIATED_DECAY_NMD,2.300756331,0.00181615,lesinurad
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.185325527,0.002421533,lesinurad
EUKARYOTIC_TRANSLATION_INITIATION,2.205684282,0.002641672,lesinurad
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,2.657115939,0,ixabepilone
NEURONAL_SYSTEM,2.435068616,0.0006399,ixabepilone
EPIGENETIC_REGULATION_BY_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES,-2.564259981,0.005222887,ixabepilone
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,2.387103836,0.0012798,ixabepilone
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION_BY_MLL3_AND_MLL4_COMPLEXES,-2.419165076,0.004352406,ixabepilone
MITOTIC_METAPHASE_AND_ANAPHASE,-2.360254305,0.004642566,ixabepilone
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,-2.315417647,0.007834331,ixabepilone
MITOTIC_SPINDLE_CHECKPOINT,-2.307740065,0.006963849,ixabepilone
RESOLUTION_OF_SISTER_CHROMATID_COHESION,-2.283298253,0.006383529,ixabepilone
CELL_CYCLE,-2.243593674,0.006963849,ixabepilone
MRNA_SPLICING,3.053269137,0,darapladib
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.835708051,0,darapladib
RAB_GEFS_EXCHANGE_GTP_FOR_GDP_ON_RABS,2.315181951,0.001066423,darapladib
RAB_REGULATION_OF_TRAFFICKING,2.069330677,0.010397623,darapladib
MRNA_SPLICING_MINOR_PATHWAY,1.806361961,0.040310786,darapladib
COLLAGEN_DEGRADATION,-2.416844097,0.353283572,darapladib
GLUCOSE_METABOLISM,1.548295796,0.201020719,darapladib
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,1.459407625,0.284277879,darapladib
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.317634188,0.663439019,darapladib
MYD88_INDEPENDENT_TLR4_CASCADE,1.331146729,0.493087294,darapladib
TRNA_PROCESSING,2.458146915,0.004060685,dipraglurant
PROTEIN_LOCALIZATION,2.134452224,0.022333766,dipraglurant
FATTY_ACID_METABOLISM,2.069716219,0.024364108,dipraglurant
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.005355941,0.080757747,dipraglurant
GPCR_LIGAND_BINDING,-1.990081547,0.048545387,dipraglurant
EPIGENETIC_REGULATION_BY_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES,1.701228338,0.140093621,dipraglurant
SIGNALING_BY_GPCR,-1.832553339,0.169379544,dipraglurant
G_ALPHA_Q_SIGNALLING_EVENTS,-1.830451635,0.129076287,dipraglurant
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,1.574521546,0.224555863,dipraglurant
NUCLEOTIDE_EXCISION_REPAIR,1.501329556,0.275788168,dipraglurant
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.865323298,0,urea
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.968238877,0,urea
NONSENSE_MEDIATED_DECAY_NMD,2.85756236,0,urea
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.707038163,0,urea
EUKARYOTIC_TRANSLATION_ELONGATION,2.556514155,0,urea
EUKARYOTIC_TRANSLATION_INITIATION,2.426630265,0.001920298,urea
SELENOAMINO_ACID_METABOLISM,2.311838773,0.00164597,urea
REGULATION_OF_RAS_BY_GAPS,2.297619313,0.002880447,urea
CELLULAR_RESPONSE_TO_STARVATION,2.25859137,0.003840596,urea
SYNTHESIS_OF_DNA,2.160048536,0.004608715,urea
MRNA_SPLICING,2.512704376,0,seocalcitol
RAB_GEFS_EXCHANGE_GTP_FOR_GDP_ON_RABS,2.478446801,0,seocalcitol
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.36434272,0,seocalcitol
RAB_REGULATION_OF_TRAFFICKING,2.182395599,0.003637598,seocalcitol
ONCOGENIC_MAPK_SIGNALING,-2.438248965,0.250196137,seocalcitol
COLLAGEN_DEGRADATION,-2.414113033,0.176718461,seocalcitol
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.378724327,0.197180599,seocalcitol
PEPTIDE_HORMONE_METABOLISM,1.324552039,0.694344747,seocalcitol
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,1.261409649,0.790086332,seocalcitol
EPIGENETIC_REGULATION_BY_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES,1.24556224,0.722115211,seocalcitol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.599931535,0,triptorelin
GPCR_LIGAND_BINDING,-2.558407673,0,triptorelin
SIGNALING_BY_GPCR,-2.326600833,0,triptorelin
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.311006769,0,triptorelin
PROTEIN_LOCALIZATION,2.090541169,0.099756395,triptorelin
G_ALPHA_Q_SIGNALLING_EVENTS,-2.027378094,0.009530707,triptorelin
G2_M_DNA_DAMAGE_CHECKPOINT,2.014632803,0.099756395,triptorelin
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-1.983224152,0.014191899,triptorelin
CONSTITUTIVE_SIGNALING_BY_ABERRANT_PI3K_IN_CANCER,-1.964207838,0.015512508,triptorelin
ADIPOGENESIS,1.881883035,0.161997564,triptorelin
G_ALPHA_Q_SIGNALLING_EVENTS,-2.342011092,0,berberine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.288359902,0.001540363,berberine
SIGNALING_BY_GPCR,-2.270883026,0.001711514,berberine
GPCR_LIGAND_BINDING,-2.263949252,0.001283636,berberine
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.150222279,0.004929161,berberine
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.103731569,0.006846057,berberine
G_ALPHA_I_SIGNALLING_EVENTS,-2.071196258,0.007921865,berberine
HEMOSTASIS,-2.029862803,0.011809448,berberine
ANTIGEN_PROCESSING_CROSS_PRESENTATION,-1.854038829,0.058761985,berberine
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.829722793,0.064387162,berberine
CHOLESTEROL_BIOSYNTHESIS,3.16809001,0,romidepsin
MITOTIC_PROMETAPHASE,-2.575445212,0,romidepsin
RESOLUTION_OF_SISTER_CHROMATID_COHESION,-2.620327091,0,romidepsin
SEPARATION_OF_SISTER_CHROMATIDS,-2.679948344,0,romidepsin
CELL_CYCLE_CHECKPOINTS,-2.717965347,0,romidepsin
METABOLISM_OF_STEROIDS,2.792475843,0,romidepsin
RHO_GTPASES_ACTIVATE_FORMINS,-2.706380611,0,romidepsin
MITOTIC_METAPHASE_AND_ANAPHASE,-2.893580362,0,romidepsin
MITOTIC_SPINDLE_CHECKPOINT,-2.934090146,0,romidepsin
CELL_CYCLE_MITOTIC,-3.020477141,0,romidepsin
REGULATION_OF_TP53_ACTIVITY,1.827235369,1,rilpivirine
DEUBIQUITINATION,1.79672501,0.670937016,rilpivirine
MYD88_INDEPENDENT_TLR4_CASCADE,1.750241583,0.629421951,rilpivirine
INTERLEUKIN_17_SIGNALING,1.744420329,0.490898902,rilpivirine
DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA,1.739490503,0.403365727,rilpivirine
TRANSCRIPTIONAL_REGULATION_BY_TP53,1.720047241,0.388701535,rilpivirine
GASTRULATION,-1.579782075,1,rilpivirine
INTEGRATION_OF_ENERGY_METABOLISM,-1.579880524,1,rilpivirine
SIGNALING_BY_GPCR,1.673970961,0.456857027,rilpivirine
TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,1.666676945,0.420088932,rilpivirine
METABOLISM_OF_RNA,-3.234372196,0,clinofibrate
RRNA_PROCESSING,-2.870250807,0,clinofibrate
TRANSLATION,-2.580025779,0.000470418,clinofibrate
CLEC7A_DECTIN_1_SIGNALING,-2.508238615,0.000705627,clinofibrate
CELL_CYCLE_CHECKPOINTS,-2.507598775,0.000846752,clinofibrate
INTERLEUKIN_1_SIGNALING,-2.427878714,0.001881672,clinofibrate
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.418359557,0.001612862,clinofibrate
DNA_REPLICATION,-2.412217798,0.001411254,clinofibrate
DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR,-2.370491535,0.001724866,clinofibrate
SIGNALING_BY_ROBO_RECEPTORS,-2.350716703,0.001975756,clinofibrate
GPCR_LIGAND_BINDING,-2.492039917,0,oxybuprocaine
GASTRULATION,-2.375900824,0.001671775,oxybuprocaine
RHO_GTPASES_ACTIVATE_FORMINS,-2.236127613,0.005572583,oxybuprocaine
SIGNALING_BY_GPCR,-2.172853312,0.008358874,oxybuprocaine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.147107996,0.061342284,oxybuprocaine
MITOTIC_METAPHASE_AND_ANAPHASE,-2.08486164,0.020061298,oxybuprocaine
MITOTIC_SPINDLE_CHECKPOINT,-2.060943174,0.020432804,oxybuprocaine
CELL_CYCLE_MITOTIC,-2.035564528,0.023564065,oxybuprocaine
RESOLUTION_OF_SISTER_CHROMATID_COHESION,-2.018680041,0.023683477,oxybuprocaine
SEPARATION_OF_SISTER_CHROMATIDS,-1.999690692,0.02489087,oxybuprocaine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.099324248,0.074771061,thiomersal
SIGNALING_BY_NTRKS,1.988642606,0.101771722,thiomersal
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,1.909039995,0.119772162,thiomersal
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,1.858140897,0.125656922,thiomersal
CELL_JUNCTION_ORGANIZATION,1.73747137,0.216212984,thiomersal
NUCLEAR_EVENTS_MEDIATED_BY_NFE2L2,1.73725605,0.180350568,thiomersal
SIGNALING_BY_ALK_IN_CANCER,1.706203655,0.18292206,thiomersal
NEURONAL_SYSTEM,1.662138614,0.207307959,thiomersal
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,-1.767299766,1,thiomersal
RESPIRATORY_ELECTRON_TRANSPORT,-1.764397026,0.979797033,thiomersal
MRNA_SPLICING,3.327257658,0,tirofiban
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,3.053495893,0,tirofiban
HOST_INTERACTIONS_OF_HIV_FACTORS,2.226069746,0.02568948,tirofiban
DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS,2.142370907,0.030276888,tirofiban
HEDGEHOG_ON_STATE,2.035918082,0.038534221,tirofiban
ABC_TRANSPORTER_DISORDERS,1.938432042,0.060553775,tirofiban
UCH_PROTEINASES,1.910244552,0.059767363,tirofiban
DEFECTIVE_CFTR_CAUSES_CYSTIC_FIBROSIS,1.853245936,0.070875442,tirofiban
NUCLEOTIDE_EXCISION_REPAIR,1.821925024,0.077068441,tirofiban
VIF_MEDIATED_DEGRADATION_OF_APOBEC3G,1.775421007,0.086426752,tirofiban
PROTEIN_LOCALIZATION,2.779599573,0,ifosfamide
GPCR_LIGAND_BINDING,-2.057990944,0.037948575,ifosfamide
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.985285725,0.043786817,ifosfamide
SIGNALING_BY_ALK_IN_CANCER,1.742259856,0.128542586,ifosfamide
SIGNALING_BY_GPCR,-1.882025763,0.099898812,ifosfamide
FATTY_ACID_METABOLISM,1.501079461,0.304643685,ifosfamide
GLOBAL_GENOME_NUCLEOTIDE_EXCISION_REPAIR_GG_NER,1.478367184,0.253047185,ifosfamide
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,1.458624272,0.224242877,ifosfamide
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.718248518,0.350294534,ifosfamide
G_ALPHA_I_SIGNALLING_EVENTS,-1.677495964,0.390967622,ifosfamide
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,-2.099713785,0.07166533,tipiracil
GPCR_LIGAND_BINDING,-2.029162629,0.078617936,tipiracil
PLATELET_HOMEOSTASIS,1.959180265,0.224211257,tipiracil
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,1.914080228,0.144135808,tipiracil
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.842266851,0.152143353,tipiracil
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,-1.845804905,0.290939846,tipiracil
SIGNALING_BY_GPCR,-1.772899662,0.404855631,tipiracil
SIGNALING_BY_WNT,-1.748048606,0.396619466,tipiracil
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.722260354,0.398794384,tipiracil
HEMOSTASIS,1.582813887,0.477650052,tipiracil
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.114360231,0.080215253,bopindolol
GPCR_LIGAND_BINDING,-1.94415671,0.57275922,bopindolol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.751367295,1,bopindolol
GASTRULATION,-1.713290213,0.878637016,bopindolol
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,-1.702902863,0.698278794,bopindolol
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,-1.673410988,0.657088875,bopindolol
BETA_CATENIN_INDEPENDENT_WNT_SIGNALING,-1.663166369,0.581898995,bopindolol
DNA_REPLICATION,-1.628376007,0.606706955,bopindolol
NEURONAL_SYSTEM,-1.626636343,0.534372166,bopindolol
SIGNALING_BY_WNT,-1.624724885,0.479736623,bopindolol
RAB_GEFS_EXCHANGE_GTP_FOR_GDP_ON_RABS,1.880657714,0.097020512,perampanel
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.456425424,0.287383957,perampanel
NUCLEAR_ENVELOPE_NE_REASSEMBLY,1.540884399,0.315316664,perampanel
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.342430969,0.500461446,perampanel
GPCR_LIGAND_BINDING,-2.227442469,0.54557023,perampanel
RAB_REGULATION_OF_TRAFFICKING,1.375199311,0.52238359,perampanel
G_ALPHA_I_SIGNALLING_EVENTS,-2.022316346,0.614873724,perampanel
EUKARYOTIC_TRANSLATION_ELONGATION,-1.993591577,0.513748033,perampanel
SELENOAMINO_ACID_METABOLISM,-1.97280737,0.442886236,perampanel
INTRINSIC_PATHWAY_FOR_APOPTOSIS,-1.958927391,0.390864678,perampanel
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.100697461,0.05702067,mitiglinide
MRNA_SPLICING,1.934831441,0.05702067,mitiglinide
RAB_GEFS_EXCHANGE_GTP_FOR_GDP_ON_RABS,1.661230646,0.210976479,mitiglinide
RAB_REGULATION_OF_TRAFFICKING,1.471788519,0.496079829,mitiglinide
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.259195512,1,mitiglinide
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.23094395,1,mitiglinide
GPCR_LIGAND_BINDING,-2.179733023,0.898461719,mitiglinide
COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC,1.327982316,0.790876693,mitiglinide
G_ALPHA_I_SIGNALLING_EVENTS,-2.005395284,0.90981911,mitiglinide
SELENOAMINO_ACID_METABOLISM,-1.978671227,0.752350418,mitiglinide
MRNA_SPLICING,3.920379656,0,acetazolamide
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,3.752808292,0,acetazolamide
HOST_INTERACTIONS_OF_HIV_FACTORS,2.440875141,0.001912458,acetazolamide
TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM,2.048500032,0.031555556,acetazolamide
HEDGEHOG_ON_STATE,1.933570944,0.049341414,acetazolamide
REGULATION_OF_RAS_BY_GAPS,1.907872091,0.049723906,acetazolamide
ABC_TRANSPORTER_DISORDERS,1.836580404,0.064750361,acetazolamide
VIF_MEDIATED_DEGRADATION_OF_APOBEC3G,1.83500426,0.057373737,acetazolamide
GPCR_LIGAND_BINDING,-1.991128058,0.071140065,acetazolamide
STABILIZATION_OF_P53,1.828969733,0.054186308,acetazolamide
MRNA_SPLICING,3.0992449,0,efaproxiral
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.905053212,0,efaproxiral
DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS,2.335487724,0.007546031,efaproxiral
HEDGEHOG_ON_STATE,2.15642241,0.01839345,efaproxiral
DEGRADATION_OF_DVL,1.97968515,0.049803803,efaproxiral
VIF_MEDIATED_DEGRADATION_OF_APOBEC3G,1.948382573,0.044332931,efaproxiral
DNA_REPLICATION_PRE_INITIATION,1.886960852,0.054978224,efaproxiral
REGULATION_OF_RAS_BY_GAPS,1.78644743,0.089137489,efaproxiral
ABC_TRANSPORTER_DISORDERS,1.710444574,0.126396016,efaproxiral
STABILIZATION_OF_P53,1.681794712,0.135262602,efaproxiral
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.382570371,0,miglustat
SYNTHESIS_OF_DNA,2.218329423,0.028753994,miglustat
INTERLEUKIN_1_SIGNALING,2.174353306,0.03514377,miglustat
DOWNSTREAM_TCR_SIGNALING,2.149246963,0.03115016,miglustat
HOST_INTERACTIONS_OF_HIV_FACTORS,2.122648903,0.024920128,miglustat
DEGRADATION_OF_BETA_CATENIN_BY_THE_DESTRUCTION_COMPLEX,2.103557818,0.023961661,miglustat
SCF_SKP2_MEDIATED_DEGRADATION_OF_P27_P21,2.078347226,0.031492469,miglustat
FCERI_MEDIATED_NF_KB_ACTIVATION,2.074935787,0.028753994,miglustat
UCH_PROTEINASES,2.064563678,0.026624068,miglustat
CLEC7A_DECTIN_1_SIGNALING,2.034221808,0.030670927,miglustat
MRNA_SPLICING,3.729725181,0,butorphanol-(+)-tartrate
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,3.005116521,0,butorphanol-(+)-tartrate
HOST_INTERACTIONS_OF_HIV_FACTORS,2.178311809,0.005638134,butorphanol-(+)-tartrate
INFLUENZA_INFECTION,2.086944234,0.011628652,butorphanol-(+)-tartrate
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.015500956,0.012685802,butorphanol-(+)-tartrate
DNA_REPLICATION_PRE_INITIATION,1.756473599,0.069771912,butorphanol-(+)-tartrate
SYNTHESIS_OF_DNA,1.622522535,0.125045764,butorphanol-(+)-tartrate
INTERLEUKIN_1_SIGNALING,1.612857927,0.11522937,butorphanol-(+)-tartrate
DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS,1.60648407,0.109473774,butorphanol-(+)-tartrate
EPIGENETIC_REGULATION_BY_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES,1.533746919,0.144618145,butorphanol-(+)-tartrate
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,3.044860945,0,asymmetrical-dimethylarginine
EUKARYOTIC_TRANSLATION_INITIATION,2.882188171,0,asymmetrical-dimethylarginine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.752323478,0,asymmetrical-dimethylarginine
NONSENSE_MEDIATED_DECAY_NMD,2.651881936,0,asymmetrical-dimethylarginine
CELLULAR_RESPONSE_TO_STARVATION,2.596415401,0,asymmetrical-dimethylarginine
SELENOAMINO_ACID_METABOLISM,2.546160356,0,asymmetrical-dimethylarginine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.285753774,0.003532327,asymmetrical-dimethylarginine
HOST_INTERACTIONS_OF_HIV_FACTORS,2.107323848,0.01030262,asymmetrical-dimethylarginine
SYNTHESIS_OF_DNA,1.946968706,0.029305231,asymmetrical-dimethylarginine
FATTY_ACID_METABOLISM,1.917599528,0.030495756,asymmetrical-dimethylarginine
NONSENSE_MEDIATED_DECAY_NMD,3.288877936,0,isoniazid
EUKARYOTIC_TRANSLATION_INITIATION,3.283116676,0,isoniazid
SELENOAMINO_ACID_METABOLISM,3.026391901,0,isoniazid
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.947093848,0,isoniazid
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.927329769,0,isoniazid
EUKARYOTIC_TRANSLATION_ELONGATION,2.689282964,0,isoniazid
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.4326119,0,isoniazid
INTERLEUKIN_1_SIGNALING,2.383843236,0,isoniazid
SYNTHESIS_OF_DNA,2.31475249,0.001301805,isoniazid
TNFR2_NON_CANONICAL_NF_KB_PATHWAY,2.264109081,0.001171625,isoniazid
COMPLEMENT_CASCADE,-2.466772153,0.006738946,emedastine
SIGNALING_BY_NTRKS,1.841163394,0.645157536,emedastine
RRNA_PROCESSING,-1.856194204,0.513122608,emedastine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.836535034,0.382836317,emedastine
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.819129069,0.318415202,emedastine
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-1.809410186,0.268017512,emedastine
DEUBIQUITINATION,1.689164123,0.860384604,emedastine
GPCR_LIGAND_BINDING,-1.753190074,0.310312421,emedastine
NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK,1.672754543,0.632589532,emedastine
BIOLOGICAL_OXIDATIONS,-1.66241903,0.429917253,emedastine
GPCR_LIGAND_BINDING,-2.086221973,0.146391324,temazepam
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.873621233,0.488947022,temazepam
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.872927581,0.327916566,temazepam
NEUTROPHIL_DEGRANULATION,-1.772298858,0.546283624,temazepam
SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX,1.537818476,1,temazepam
VISUAL_PHOTOTRANSDUCTION,-1.686778226,0.772165437,temazepam
CILIUM_ASSEMBLY,1.42891827,1,temazepam
NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK,1.404409666,1,temazepam
CELL_CELL_COMMUNICATION,1.407034059,1,temazepam
INTERFERON_GAMMA_SIGNALING,1.386443482,0.984253878,temazepam
GPCR_LIGAND_BINDING,-2.177227856,0.042755931,pentamidine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.146403439,0.030879284,pentamidine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,1.971924971,0.181327801,pentamidine
CELLULAR_RESPONSE_TO_STARVATION,1.86459281,0.158333333,pentamidine
SIGNALING_BY_GPCR,-1.90170007,0.201111233,pentamidine
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.866682152,0.202853141,pentamidine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.657412015,0.328054403,pentamidine
NEUTROPHIL_DEGRANULATION,-1.805835392,0.265466828,pentamidine
FATTY_ACID_METABOLISM,1.536189212,0.445107192,pentamidine
G_ALPHA_Q_SIGNALLING_EVENTS,-1.74424714,0.354557521,pentamidine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.43784127,0.002567088,dronedarone
RHO_GTPASES_ACTIVATE_FORMINS,-2.073891319,0.188239526,dronedarone
MITOTIC_SPINDLE_CHECKPOINT,-2.007505177,0.162832964,dronedarone
RESOLUTION_OF_SISTER_CHROMATID_COHESION,-1.989385014,0.126647861,dronedarone
GPCR_LIGAND_BINDING,-1.91791427,0.160523277,dronedarone
CELL_CYCLE_MITOTIC,-1.880547266,0.166528464,dronedarone
MITOTIC_METAPHASE_AND_ANAPHASE,-1.792111805,0.246944082,dronedarone
RHO_GTPASE_EFFECTORS,-1.769529705,0.243507047,dronedarone
SIGNALING_BY_GPCR,-1.741844526,0.252766419,dronedarone
DEADENYLATION_DEPENDENT_MRNA_DECAY,-1.72242536,0.249317927,dronedarone
MRNA_SPLICING,3.335732866,0,armodafinil
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,3.029348216,0,armodafinil
FATTY_ACID_METABOLISM,2.107494862,0.033781219,armodafinil
DOWNSTREAM_TCR_SIGNALING,2.106890943,0.025335914,armodafinil
INTERLEUKIN_1_SIGNALING,2.032924868,0.030403097,armodafinil
DEGRADATION_OF_BETA_CATENIN_BY_THE_DESTRUCTION_COMPLEX,1.987952977,0.03547028,armodafinil
REGULATION_OF_RAS_BY_GAPS,1.970943645,0.03329863,armodafinil
HOST_INTERACTIONS_OF_HIV_FACTORS,1.960953054,0.030403097,armodafinil
G1_S_DNA_DAMAGE_CHECKPOINTS,1.938307541,0.037159341,armodafinil
FCERI_MEDIATED_NF_KB_ACTIVATION,1.899646653,0.043577773,armodafinil
EUKARYOTIC_TRANSLATION_ELONGATION,-2.194279341,0.020136286,lacidipine
SELENOAMINO_ACID_METABOLISM,-2.169701073,0.015102214,lacidipine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.137945641,0.01476661,lacidipine
RAB_GEFS_EXCHANGE_GTP_FOR_GDP_ON_RABS,1.873825186,0.056749785,lacidipine
INFLUENZA_INFECTION,-2.090156375,0.022149914,lacidipine
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-2.088790931,0.017719931,lacidipine
NONSENSE_MEDIATED_DECAY_NMD,-2.071601599,0.01829046,lacidipine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.047543436,0.020999269,lacidipine
EUKARYOTIC_TRANSLATION_INITIATION,-2.038810093,0.020387989,lacidipine
RRNA_PROCESSING,-2.030610091,0.020583759,lacidipine
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,2.244781792,0.020659971,tioconazole
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.196744832,0.013945481,tioconazole
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.825463381,0.049895673,tioconazole
MRNA_SPLICING,2.126946026,0.012395983,tioconazole
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.64179144,0.07933412,tioconazole
COLLAGEN_DEGRADATION,-2.542472773,0.24848045,tioconazole
DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS,1.521273977,0.219512195,tioconazole
GPCR_LIGAND_BINDING,-2.461749592,0.510183253,tioconazole
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.440293516,0.505542956,tioconazole
GLUCOSE_METABOLISM,1.277441773,0.535299857,tioconazole
GASTRULATION,-2.072083184,0.130251399,milnacipran
GPCR_LIGAND_BINDING,-1.802363449,0.543658011,milnacipran
SIGNALING_BY_NTRKS,1.732243303,1,milnacipran
NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK,1.703144907,0.823016884,milnacipran
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,-1.752834163,0.509994003,milnacipran
EPIGENETIC_REGULATION_BY_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES,-1.730653247,0.436766918,milnacipran
RHO_GTPASES_ACTIVATE_FORMINS,-1.69964055,0.428130684,milnacipran
CELL_CYCLE_MITOTIC,-1.680691068,0.40349618,milnacipran
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,1.571778317,1,milnacipran
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.614865449,0.505094968,milnacipran
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.895154523,0,AMD-11070
MRNA_SPLICING,2.513653769,0.002806466,AMD-11070
INFLUENZA_INFECTION,2.339119375,0.005612932,AMD-11070
HEDGEHOG_ON_STATE,2.098285676,0.022451729,AMD-11070
HOST_INTERACTIONS_OF_HIV_FACTORS,1.802654842,0.093174674,AMD-11070
ABC_TRANSPORTER_DISORDERS,1.751708657,0.104774734,AMD-11070
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,1.664461448,0.136314068,AMD-11070
ACTIVATION_OF_NF_KAPPAB_IN_B_CELLS,1.631809954,0.142428154,AMD-11070
DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS,1.626977842,0.1297211,AMD-11070
SYNTHESIS_OF_DNA,1.624097731,0.117871576,AMD-11070
MRNA_SPLICING,1.631755656,0.799158042,bupivacaine
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.4340862,0.347255394,bupivacaine
DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS,1.522269051,0.757410981,bupivacaine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.451973987,0.717651874,bupivacaine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.249500618,0.803951651,bupivacaine
GPCR_LIGAND_BINDING,-2.204654239,0.62524442,bupivacaine
NUCLEAR_ENVELOPE_NE_REASSEMBLY,1.360381853,0.874451851,bupivacaine
G_ALPHA_I_SIGNALLING_EVENTS,-2.008705976,0.697050555,bupivacaine
EUKARYOTIC_TRANSLATION_INITIATION,-1.968738486,0.593104825,bupivacaine
SELENOAMINO_ACID_METABOLISM,-1.934919156,0.51734281,bupivacaine
MRNA_SPLICING,3.695315273,0,clonazepam
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,3.221515437,0,clonazepam
DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS,1.855086785,0.141474551,clonazepam
HEDGEHOG_ON_STATE,1.839396818,0.116716504,clonazepam
UCH_PROTEINASES,1.752412586,0.150670396,clonazepam
HOST_INTERACTIONS_OF_HIV_FACTORS,1.725986012,0.15031671,clonazepam
COLLAGEN_DEGRADATION,-2.358802147,0.30678162,clonazepam
INTERLEUKIN_1_SIGNALING,1.561662863,0.281938569,clonazepam
INFLUENZA_INFECTION,1.487920802,0.370044372,clonazepam
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,1.48209784,0.33777049,clonazepam
POTASSIUM_CHANNELS,2.299908812,0.005338672,methyldopa
GPCR_LIGAND_BINDING,1.970426031,0.031031031,methyldopa
G_ALPHA_S_SIGNALLING_EVENTS,1.793404437,0.054165276,methyldopa
SIGNALING_BY_GPCR,1.731254647,0.061394728,methyldopa
DEVELOPMENTAL_CELL_LINEAGES,1.588994802,0.107440774,methyldopa
CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS,-2.404923782,1,methyldopa
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,1.526014173,0.122900678,methyldopa
CLATHRIN_MEDIATED_ENDOCYTOSIS,-2.387491513,1,methyldopa
ACTIVATION_OF_ANTERIOR_HOX_GENES_IN_HINDBRAIN_DEVELOPMENT_DURING_EARLY_EMBRYOGENESIS,-2.326678815,1,methyldopa
ANTI_INFLAMMATORY_RESPONSE_FAVOURING_LEISHMANIA_PARASITE_INFECTION,1.394157091,0.19643453,methyldopa
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.271248375,0.010606808,trovafloxacin
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,1.792298947,0.162637724,trovafloxacin
MRNA_SPLICING,1.77598254,0.117853423,trovafloxacin
NUCLEOTIDE_EXCISION_REPAIR,1.723418018,0.146727512,trovafloxacin
DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS,1.717352709,0.123038974,trovafloxacin
UCH_PROTEINASES,1.516144063,0.31879351,trovafloxacin
REGULATION_OF_RAS_BY_GAPS,1.413590384,0.452052059,trovafloxacin
SYNTHESIS_OF_DNA,1.413211709,0.396429452,trovafloxacin
MYD88_INDEPENDENT_TLR4_CASCADE,1.381505846,0.426629392,trovafloxacin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.212657467,1,trovafloxacin
METABOLISM_OF_RNA,3.451084152,0,BRD-K76674262
RRNA_PROCESSING,3.189007052,0,BRD-K76674262
SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES,2.625412104,0.002200121,BRD-K76674262
SENSORY_PERCEPTION,-2.317222942,0.004152922,BRD-K76674262
RRNA_MODIFICATION_IN_THE_NUCLEUS_AND_CYTOSOL,2.504188649,0.003712703,BRD-K76674262
NONSENSE_MEDIATED_DECAY_NMD,2.462339066,0.003300181,BRD-K76674262
DEUBIQUITINATION,2.413142369,0.003300181,BRD-K76674262
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.304159045,0.004950271,BRD-K76674262
HIV_LIFE_CYCLE,2.301152819,0.004331487,BRD-K76674262
SARS_COV_2_HOST_INTERACTIONS,2.293276685,0.004216898,BRD-K76674262
METABOLISM_OF_RNA,-3.599482838,0,ponatinib
MRNA_SPLICING,-2.912663973,0,ponatinib
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.774052595,0,ponatinib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.646708081,0,ponatinib
GPCR_LIGAND_BINDING,2.466362475,0,ponatinib
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.439446888,0,ponatinib
RRNA_PROCESSING,-2.541851848,0.001838146,ponatinib
MITOTIC_METAPHASE_AND_ANAPHASE,-2.510783697,0.002205776,ponatinib
CHROMATIN_ORGANIZATION,-2.132967484,0.02021961,ponatinib
CELL_CYCLE_CHECKPOINTS,-2.042068275,0.027834788,ponatinib
TRANSLATION,3.264993581,0,ceritinib
RESPIRATORY_ELECTRON_TRANSPORT,3.086535119,0,ceritinib
METABOLISM_OF_STEROIDS,2.868217362,0,ceritinib
SELENOAMINO_ACID_METABOLISM,2.859686387,0,ceritinib
EUKARYOTIC_TRANSLATION_INITIATION,2.844186143,0,ceritinib
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.616700089,0.000418746,ceritinib
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.542033723,0.00071785,ceritinib
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.540941638,0.000628119,ceritinib
CELLULAR_RESPONSE_TO_STARVATION,2.513469904,0.000837492,ceritinib
INFLUENZA_INFECTION,2.254077855,0.00602994,ceritinib
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.48573581,0.021512737,ambrisentan
PEPTIDE_HORMONE_METABOLISM,-2.454969531,0.015058916,ambrisentan
SIGNALING_BY_ROBO_RECEPTORS,-2.44423098,0.010039277,ambrisentan
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.429313465,0.008067276,ambrisentan
SELENOAMINO_ACID_METABOLISM,-2.278517119,0.015417461,ambrisentan
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.278517119,0.015417461,ambrisentan
NONSENSE_MEDIATED_DECAY_NMD,-2.266577361,0.013829616,ambrisentan
CELLULAR_RESPONSE_TO_STARVATION,-2.241777639,0.014252188,ambrisentan
DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS,-2.209991439,0.016015037,ambrisentan
INFLUENZA_INFECTION,-2.187558498,0.015919425,ambrisentan
MRNA_SPLICING,3.31718588,0,lenvatinib
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.715474231,0,lenvatinib
INFLUENZA_INFECTION,2.067253766,0.042929293,lenvatinib
EPIGENETIC_REGULATION_BY_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES,1.948213584,0.052469136,lenvatinib
COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC,1.58774017,0.339618406,lenvatinib
HOST_INTERACTIONS_OF_HIV_FACTORS,1.473494651,0.487326973,lenvatinib
GLOBAL_GENOME_NUCLEOTIDE_EXCISION_REPAIR_GG_NER,1.410776474,0.492494388,lenvatinib
NUCLEOTIDE_EXCISION_REPAIR,1.410776474,0.492494388,lenvatinib
MITOTIC_METAPHASE_AND_ANAPHASE,1.253219143,0.909995012,lenvatinib
REGULATION_OF_RAS_BY_GAPS,1.240202212,0.867648709,lenvatinib
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.310946797,0,LY-2835219
EUKARYOTIC_TRANSLATION_INITIATION,3.113676087,0,LY-2835219
SELENOAMINO_ACID_METABOLISM,3.062469934,0,LY-2835219
EUKARYOTIC_TRANSLATION_ELONGATION,2.920009728,0,LY-2835219
CELLULAR_RESPONSE_TO_STARVATION,2.582930586,0.001001515,LY-2835219
TRANSLATION,2.523678279,0.000834596,LY-2835219
INFLUENZA_INFECTION,2.426370822,0.001430736,LY-2835219
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.426011772,0.001251894,LY-2835219
NONSENSE_MEDIATED_DECAY_NMD,2.252101976,0.00222559,LY-2835219
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,2.179612597,0.003505304,LY-2835219
CELL_CYCLE_MITOTIC,2.132847085,0.192362638,levothyroxine
TOLL_LIKE_RECEPTOR_CASCADES,2.094103836,0.130806594,levothyroxine
CELL_CYCLE,2.070735587,0.108089482,levothyroxine
TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,2.065508806,0.086288383,levothyroxine
CELLULAR_RESPONSE_TO_HEAT_STRESS,2.055938811,0.075625997,levothyroxine
DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS,2.024027768,0.084456358,levothyroxine
SIGNALING_BY_ALK_IN_CANCER,2.004042582,0.086837991,levothyroxine
TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,1.994529881,0.082028925,levothyroxine
MITOTIC_PROMETAPHASE,1.980018633,0.08219686,levothyroxine
CELLULAR_SENESCENCE,1.958755898,0.088047127,levothyroxine
